
<html lang="en"     class="pb-page"  data-request-id="5803c5e4-b771-4e41-8d01-28357027706e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;article:article:10.1021/jm4011669;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;issue:issue:10.1021/jmcmar.2014.57.issue-9"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Adenosine A2A Receptor as a Drug Discovery Target" /></meta><meta name="dc.Creator" content="Manuel  de Lera Ruiz" /></meta><meta name="dc.Creator" content="Yeon-Hee  Lim" /></meta><meta name="dc.Creator" content="Junying  Zheng" /></meta><meta name="dc.Description" content="The adenosine A2A receptor is a G-protein-coupled receptor (GPCR) that has been extensively studied during the past few decades because it offers numerous possibilities for therapeutic applications..." /></meta><meta name="Description" content="The adenosine A2A receptor is a G-protein-coupled receptor (GPCR) that has been extensively studied during the past few decades because it offers numerous possibilities for therapeutic applications..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 15, 2013" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4011669" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4011669" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4011669" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4011669" /></link>
        
    
    

<title>Adenosine A2A Receptor as a Drug Discovery Target | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4011669" /></meta><meta property="og:title" content="Adenosine A2A Receptor as a Drug Discovery Target" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0017.jpeg" /></meta><meta property="og:description" content="The adenosine A2A receptor is a G-protein-coupled receptor (GPCR) that has been extensively studied during the past few decades because it offers numerous possibilities for therapeutic applications. Herein we describe adenosine A2A receptor distribution, signaling pathways, pharmacology, and molecular structure, followed by a summary and SAR discussion of the most relevant series of adenosine A2A agonists and antagonists. This review also provides an update of the A2A ligands that are undergoing or have undergone clinical studies, including the two currently marketed agonists adenosine and regadenoson." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4011669"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4011669">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4011669&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4011669&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4011669&amp;href=/doi/10.1021/jm4011669" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 9</span><span class="cit-fg-pageRange">, 3623-3650</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/9" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm401006s" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/jm401425e" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Adenosine A<sub>2A</sub> Receptor as a Drug Discovery Target</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Manuel++de+Lera+Ruiz">Manuel de Lera Ruiz</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yeon-Hee++Lim">Yeon-Hee Lim</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Junying++Zheng">Junying Zheng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">â </span> <span class="aff-text">Department of Chemical Research, Merck Research Laboratories, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">â¡</span> <span class="aff-text">Department of Chemical Research, Merck Research Laboratories, 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 215-9938959. E-mail: <a href="/cdn-cgi/l/email-protection#8ee3efe0fbebe2a0fcfbe7f4cee3ebfcede5a0ede1e3"><span class="__cf_email__" data-cfemail="234e424d56464f0d51564a59634e465140480d404c4e">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4011669&amp;href=/doi/10.1021%2Fjm4011669" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 9</span><span class="cit-pageRange">, 3623â3650</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 28, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 July 2013</li><li><span class="item_label"><b>Published</b> online</span>15 November 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 May 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4011669" title="DOI URL">https://doi.org/10.1021/jm4011669</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3623%26pageCount%3D28%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DManuel%2Bde%2BLera%2BRuiz%252C%2BYeon-Hee%2BLim%252C%2BJunying%2BZheng%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D9%26contentID%3Djm4011669%26title%3DAdenosine%2BA2A%2BReceptor%2Bas%2Ba%2BDrug%2BDiscovery%2BTarget%26numPages%3D28%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3650%26publicationDate%3DMay%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4011669"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">7703</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">161</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4011669" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Adenosine A2A Receptor as a Drug Discovery Target&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Manuel&quot;,&quot;last_name&quot;:&quot;de Lera Ruiz&quot;},{&quot;first_name&quot;:&quot;Yeon-Hee&quot;,&quot;last_name&quot;:&quot;Lim&quot;},{&quot;first_name&quot;:&quot;Junying&quot;,&quot;last_name&quot;:&quot;Zheng&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;15&quot;,&quot;issue&quot;:&quot;9&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;3623-3650&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4011669&quot;},&quot;abstract&quot;:&quot;The adenosine A2A receptor is a G-protein-coupled receptor (GPCR) that has been extensively studied during the past few decades because it offers numerous possibilities for therapeutic applications. Herein we describe adenosine A2A receptor distribution, signaling pathways, pharmacology, and molecular structure, followed by a summary and SAR discussion of the most relevant series of adenosine A2A agonists and antagonists. This review also provides an update of the A2A ligands that are undergoing or have undergone clinical studies, including the two currently marketed agonists adenosine and regadenoson.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4011669&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4011669" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4011669&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4011669" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4011669&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4011669" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4011669&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4011669&amp;href=/doi/10.1021/jm4011669" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4011669" /></input><a href="/doi/pdf/10.1021/jm4011669" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4011669&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4011669%26sid%3Dliteratum%253Aachs%26pmid%3D24164628%26genre%3Darticle%26aulast%3Dde%2BLera%2BRuiz%26date%3D2014%26atitle%3DAdenosine%2BA2A%2BReceptor%2Bas%2Ba%2BDrug%2BDiscovery%2BTarget%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D9%26spage%3D3623%26epage%3D3650%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=291308" title="Nucleic acids">Nucleic acids</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292186" title="Receptors">Receptors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/9" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jmcmar.2014.57.issue-9/production/jmcmar.2014.57.issue-9.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_null" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0017.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The adenosine A<sub>2A</sub> receptor is a G-protein-coupled receptor (GPCR) that has been extensively studied during the past few decades because it offers numerous possibilities for therapeutic applications. Herein we describe adenosine A<sub>2A</sub> receptor distribution, signaling pathways, pharmacology, and molecular structure, followed by a summary and SAR discussion of the most relevant series of adenosine A<sub>2A</sub> agonists and antagonists. This review also provides an update of the A<sub>2A</sub> ligands that are undergoing or have undergone clinical studies, including the two currently marketed agonists adenosine and regadenoson.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54860" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54860" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In 1929, Drury and Szent-GyÃ¶rgyi discovered that adenosine (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), a naturally occurring nucleoside, can influence a wide range of physiological functions.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The pronounced effects of adenosine in the heart were of particular interest and inspired much research in this area. Several adenosine analogues were synthesized, and examination of the doseâresponse relationships suggested the presence of specific adenosine receptors (ARs).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In 1965, De Gubareff and Sleator documented the effect of caffeine (<b>7</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) on mammalian atrial muscle,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and 5 years later Sattin and Rall described the effects of adenosine and adenine nucleotides on the cAMP content in the guinea pig brain.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> In 1980, Fredholm et al. observed that in mice the naturally occurring methylxanthines caffeine and theophylline (<b>8</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) have a stimulant effect and enhance locomotor activity by blocking adenosine receptors.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> The existence of distinct types of adenosine receptors was first suggested by Van Calker et al.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Working with cultured glial cells from perinatal mouse brain, it was found that some adenosine derivatives were able to increase intracellular cAMP levels whereas others inhibited its accumulation. These experimental results were obtained using adenosine-based agonists with different potencies at the distinct receptor subtypes. The receptors that inhibited adenylyl cyclase were classified as A<sub>1</sub> receptors, and those that stimulated adenylyl cyclase were classified as A<sub>2</sub>. That there may yet be more adenosine receptors of the A<sub>2</sub> subtype was suggested in 1983 by the results of Daly and co-workers, who were studying which adenosine receptors were crucial to the various central activities of caffeine.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Adenosine A<sub>2A</sub> receptor historical agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Adenosine A<sub>2A</sub> receptor historical antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">After several decades of intense research, it is well established that adenosine is one of the human bodyâs most important neuromodulators in both the central and the peripheral nervous systems.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The effects of this purine nucleoside are modulated via four receptor subtypes: A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub>, and A<sub>3</sub>, all of which belong to the family of G-protein-coupled receptors (GPCRs).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In 1989, Libert and co-workers cloned several orphan G-protein-coupled receptors from the dog thyroid, one of which was subsequently identified as an A<sub>2A</sub> receptor.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> A<sub>2A</sub> receptors have thereafter been cloned from several species including rat,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> human,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> mouse,<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> and guinea pig.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a></div><div class="NLM_p">Adenosine receptors have distinct distributions and control different functions in the mammalian organism. Only receptors related to the A<sub>2A</sub> receptor subtype will be included in this review. Adenosine A<sub>2A</sub> receptors are highly expressed in the spleen, thymus, leukocytes, blood platelets, striatopallidal GABAergic neurons, and the olfactory bulb and expressed to a lesser extent in the heart, lung, blood vessels, and other brain regions.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The actions of the A<sub>2A</sub> receptor are complicated by the fact that this subtype colocalizes and physically associates to other unrelated G-protein-coupled receptors, forming heterodimers such as dopamine D<sub>2</sub>/A<sub>2A</sub><a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and D<sub>3</sub>/A<sub>2A</sub>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> cannabinoid CB<sub>1</sub>/A<sub>2A</sub>,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> and glutamate mGluR5/A<sub>2A</sub>,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> as well as CB<sub>1</sub>/A<sub>2A</sub>/D<sub>2</sub> heterotrimers.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> The A<sub>2A</sub> receptor is important in mediating vasodilation, supporting the synthesis of new blood vessels and protecting tissues from collateral inflammatory damage. In the brain, A<sub>2A</sub> receptors influence the activity of the indirect pathway of the basal ganglia.</div><div class="NLM_p last">The therapeutic potential of interaction between the A<sub>2A</sub> receptor and small molecules has been validated by the U.S. Food and Drug Administrationâs approval of regadenoson (<b>19</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>), a selective A<sub>2A</sub> adenosine receptor agonist that increases blood flow during cardiac nuclear stress tests.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> A number of agonists and antagonists discussed in this review are currently undergoing clinical trials. Adenosine A<sub>2A</sub> receptor antagonists have emerged as an attractive approach to treat Parkinson disease (PD). In addition, investigations are being conducted on a number of compounds to treat inflammation, cancer, ischemia reperfusion injury, sickle cell disease, diabetic nephropathy, infectious diseases, and cognition and other CNS disorders. The numerous A<sub>2A</sub> antagonists in the early discovery phase and the abundance of publications and patents are proof of the intense interest in this area.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Receptor Distribution and Signaling Pathways</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_35817" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_35817" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The discovery of A<sub>2A</sub> selective radioligands and the development of antibody, immunohistochemical, and electron microscopy techniques have made it possible to map the distribution of A<sub>2A</sub> receptors. This is critical not only to determine where agonists and antagonists could interact but also to estimate receptor density in a particular area. Adenosine A<sub>2A</sub> receptors are found to be concentrated in the dopamine-rich regions of the brain, in GABAergic medium-sized spiny neurons in the dorsal striatum, in neurons in the core and shell regions of the nucleus accumbens, and in the tuberculum olfactorium. They are found associated with the plasma membrane or with cytoplasmic structures in dendrites and dendritic spines, where they are primarily located at asymmetric synapses, although some receptors are present in the vicinity of symmetric, inhibitory synapses and in axon terminals. The distribution of A<sub>2A</sub> receptors is not restricted to the medium-sized spiny neurons in the basal ganglia, as the A<sub>2A</sub> translated protein is also expressed in numerous other tissues, such as blood vessels, endothelial and lymphoid cells, smooth muscle cells, and a number of neurons of both sympathetic and parasympathetic nervous systems.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><div class="NLM_p last">The adenosine A<sub>2A</sub> receptor is a G-protein Î±-s coupled receptor that induces classical second messenger pathways, such as modulation of cAMP production. Activation of the A<sub>2A</sub> receptor increases the level of adenylyl cyclase, which results in an enhancement of the levels of cAMP. The signaling pathways used by the A<sub>2A</sub> receptor vary, depending on the type of cell and tissue where the receptor is localized, the specific G-protein to which it is coupled, and the signaling machinery that the cell possesses. In the peripheral system, the major G-protein associated with A<sub>2A</sub> receptors appears to be G<sub>s</sub>. In the striatum, where A<sub>2A</sub> receptor density is the greatest, the situation is different, and in rats it has been shown that striatal A<sub>2A</sub> receptors mediate their effects predominantly through activation of G<sub>olf</sub>, which is similar to G<sub>s</sub> and like G<sub>s</sub> couples to adenylyl cyclase.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Adenosine A<sub>2A</sub> receptor interaction with the G protein causes the exchange of GDP for the GTP bound to the G protein Î± subunit and the dissociation of the Î²/Î³ heterodimer. The activated G<sub>Î±-s</sub> stimulates adenylate cyclase type VI, which increases the cAMP levels in cells, and activates protein kinase A (PKA); the latter phosphorylates and stimulates cAMP responsive element binding protein 1 (CREB1). The activation of G<sub>s</sub> and G<sub>olf</sub> proteins that results in increasing the concentration of cAMP is the major general pathway of A<sub>2A</sub> receptor activation; however, in monkey COS-7 cells, activation of G<sub>Î±15</sub> and G<sub>Î±16</sub> proteins stimulate the formation of phospholipid C (PLC), which induces the formation of inositol phosphates, raises intracellular calcium, and activates protein kinase C (PKC). There is good evidence that after activation of the A<sub>2A</sub> receptors several other kinases of the mitogen-activated protein kinases (MAPK) and of the extracellular signal-regulated kinases (ERK) are also activated.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Phosphorylation of some of the kinases mentioned in this paragraph (plus others omitted for brevity) lead to specific cellular responses.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Historic Ligands</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27647" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27647" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Adenosine (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) is the natural ligand for the ARs. It is an endogenous purine nucleoside that acts as an agonist with a high affinity for the A<sub>2A</sub>, A<sub>1</sub>, and A<sub>3</sub> receptors (hA<sub>2A</sub><i>K</i><sub>i</sub> = 700 nM, hA<sub>1</sub><i>K</i><sub>i</sub> = 310 nM, hA<sub>3</sub><i>K</i><sub>i</sub> = 290 nM) and with considerably lower affinity for the A<sub>2B</sub> receptor (hA<sub>2B</sub><i>K</i><sub>i</sub> â¥ 10 Î¼M).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The unmodified molecule has been of restricted interest in studying adenosine receptors because it is readily metabolized by a number of enzymes. The main approach to discovering AR agonists has been modification of adenosine itself. Many attempts to modify the adenosine structure or its stereochemistry led to the conclusion that the adenosine scaffold must be conserved as the structural basis for agonist design. Therefore, most of the useful agonists are modified at the N6 or the 2-position of the purine and at the 5â²-position of the ribose, changes that give better metabolic stability compared with adenosine. An increase in A<sub>2A</sub> potency was shown by 2-chloroadenosine (2-Cl-Ado) (<b>2</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 180 nM), which contains a chlorine atom at the 2-position of adenine, and a 20-fold potency increase was shown by <i>N</i>-ethylcarboxamidoadenosine (NECA) (<b>3</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 20 nM) where a small alkylamide group is substituted at the 5â²-position; however, both 2-Cl-Ado and NECA are nonselective agonists (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). 2-Hexynyl-NECA (HENECA) (<b>4</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) exhibits high affinity at A<sub>2</sub> adenosine receptors (hA<sub>2A</sub><i>K</i><sub>i</sub> = 6.4 nM) and 10-fold selectivity over A<sub>1</sub> in recombinant human receptors.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> NECA and HENECA exhibit effective in vivo inhibitory activity on platelet function in the rabbit. Although agonist <b>5</b> (CV1808, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), which has an intact ribose structure, was the first adenosine derivative found to have some A<sub>2A</sub> AR selectivity over the A<sub>1</sub> receptor (rA<sub>2A</sub><i>K</i><sub>i</sub> = 100 nM, rA<sub>1</sub><i>K</i><sub>i</sub> = 400 nM),<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> the therapeutic potential of HENECA for treatment of cardiovascular disease prompted Cristalli et al. to synthesize a number of N6- and 2-adenine substituted analogues that culminated in the discovery of CGS21680 <b>6</b>, a moderately A<sub>2A</sub> AR-selective agonist that displays binding affinities of 27 and 19 nM at the human and rat A<sub>2A</sub> receptor, respectively.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The A<sub>2A</sub> binding of CGS21680 (<b>6</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) is 10-fold selective against A<sub>1</sub> and has a similar potency on A<sub>3</sub> (hA<sub>3</sub><i>K</i><sub>i</sub> = 67 nM), whereas it is highly selective against A<sub>2B</sub> (hA<sub>2B</sub><i>K</i><sub>i</sub> > 10â000 nM).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a></div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Affinities of A<sub>2A</sub> Adenosine Receptor Agonists (Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a> and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) in Binding and Functional Assays at A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub>, and A<sub>3</sub> Adenosine Receptors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">agonist</th><th class="colsep0 rowsep0" align="center">A<sub>2A</sub><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">A<sub>2B</sub> EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">A<sub>1</sub><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">A<sub>3</sub><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b>,Â adenosine</td><td class="colsep0 rowsep0" align="left">700<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">24000<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">310<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">290<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b>,Â 2-Cl-Ado</td><td class="colsep0 rowsep0" align="left">180</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">1.39</td><td class="colsep0 rowsep0" align="left">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b>,Â NECA</td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">330<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">14</td><td class="colsep0 rowsep0" align="left">6.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b>,Â HENECA</td><td class="colsep0 rowsep0" align="left">6.4</td><td class="colsep0 rowsep0" align="left">6100<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">60</td><td class="colsep0 rowsep0" align="left">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b>,Â CV1808</td><td class="colsep0 rowsep0" align="left">100Â (r)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">400Â (r)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b>,Â CGS21680</td><td class="colsep0 rowsep0" align="left">27</td><td class="colsep0 rowsep0" align="left">361000<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="left">67</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b>, binodenoson (WRC0470)</td><td class="colsep0 rowsep0" align="left">270</td><td class="colsep0 rowsep0" align="left">>100000<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">48000</td><td class="colsep0 rowsep0" align="left">903</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b>, apadenoson (ATL146e)</td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left">45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b>, regadenoson (CVT3146)</td><td class="colsep0 rowsep0" align="left">290</td><td class="colsep0 rowsep0" align="left">10000<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">3770</td><td class="colsep0 rowsep0" align="left">10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b>, GW328267</td><td class="colsep0 rowsep0" align="left">46</td><td class="colsep0 rowsep0" align="left">1300<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">369</td><td class="colsep0 rowsep0" align="left">92</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b>, UK432097</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b>, sonedenoson (MRE0094)</td><td class="colsep0 rowsep0" align="left">490</td><td class="colsep0 rowsep0" align="left">10000<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">10000</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">167</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">107Â (r)</td><td class="colsep0 rowsep0" align="left">92</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">Binding data (<i>K</i><sub>i</sub>) from recombinant human A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub>, and A<sub>3</sub> adenosine receptors, unless rat (r) is indicated.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Functional assay data (cAMP) from human A<sub>2A</sub>, A<sub>2B</sub>, A<sub>1</sub> and A<sub>3</sub> adenosine receptors expressed as EC<sub>50</sub> (nM).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">ND: not determined or not disclosed.</p></div></div></div><div class="NLM_p">Unlike A<sub>2A</sub> agonists, antagonists of the A<sub>2A</sub> AR lack the sugar moiety and in general possess a mono-, bi-, or tricyclic structure that mimics the adenine part of adenosine. They are classified as xanthines and non-xanthines. It is well-known that caffeine is the most widely consumed behaviorally active substance in the world. Caffeine and theophylline (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), another naturally occurring xanthine mainly found in tea, are nonselective AR antagonists. Their stimulating properties are associated with micromolar range affinities for the A<sub>2A</sub> AR. Although caffeine and theophylline have similar in vitro affinities for the A<sub>2A</sub> receptor (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), caffeine has a higher stimulating effect due to a higher brain unbound fraction.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Affinities of A<sub>2A</sub> Adenosine Receptor Antagonists (Figures <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> and <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>â<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>) in Binding and Functional Assays at A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub>, and A<sub>3</sub> Adenosine Receptors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">antagonists</th><th class="colsep0 rowsep0" align="center">A<sub>2A</sub><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">A<sub>2B</sub><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">A<sub>1</sub><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">A<sub>3</sub><i>K</i><sub>i</sub> (nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b>,Â caffeine</td><td class="colsep0 rowsep0" align="left">23400</td><td class="colsep0 rowsep0" align="left">20500</td><td class="colsep0 rowsep0" align="left">44900</td><td class="colsep0 rowsep0" align="left">>100000Â (r)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b>,Â theofylline</td><td class="colsep0 rowsep0" align="left">25000Â (r)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">8500Â (r)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b>,Â CSC</td><td class="colsep0 rowsep0" align="left">54Â (r)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">28000Â (r)</td><td class="colsep0 rowsep0" align="left">>10000Â (r)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b>,Â MSX-2</td><td class="colsep0 rowsep0" align="left">5,Â 8Â (r)</td><td class="colsep0 rowsep0" align="left">2900</td><td class="colsep0 rowsep0" align="left">2500,Â 900Â (r)</td><td class="colsep0 rowsep0" align="left">>10000Â (r)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b>,Â istradefylline</td><td class="colsep0 rowsep0" align="left">36,Â 12</td><td class="colsep0 rowsep0" align="left">1800</td><td class="colsep0 rowsep0" align="left">2830,Â 9600</td><td class="colsep0 rowsep0" align="left">>3000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b>,Â CGS15943</td><td class="colsep0 rowsep0" align="left">0.4,Â 1.2Â (r)</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">3.5,Â 6Â (r)</td><td class="colsep0 rowsep0" align="left">95</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b>,Â SCH58261</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">1110</td><td class="colsep0 rowsep0" align="left">549</td><td class="colsep0 rowsep0" align="left">1200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b>,Â ZM241385</td><td class="colsep0 rowsep0" align="left">0.8</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">255</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">2.4</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">406</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b>,Â SCH412348</td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">>996</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b>,Â preladenant</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">>1700</td><td class="colsep0 rowsep0" align="left">1474</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">0.9</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">602</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">12.6</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1361</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">358</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1116</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">5.2</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1398</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">14.2</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1405</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">25</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">8775</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">2100</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b>,Â tozadenant</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">700</td><td class="colsep0 rowsep0" align="left">1350</td><td class="colsep0 rowsep0" align="left">1570</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">61</td><td class="colsep0 rowsep0" align="left">7072</td><td class="colsep0 rowsep0" align="left">244</td><td class="colsep0 rowsep0" align="left">6941</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b>,Â VER-6623</td><td class="colsep0 rowsep0" align="left">1.4</td><td class="colsep0 rowsep0" align="left">865</td><td class="colsep0 rowsep0" align="left">207</td><td class="colsep0 rowsep0" align="left">476</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b>,Â VER-6947</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">112</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">1472</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b>,Â VER-7835</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">141</td><td class="colsep0 rowsep0" align="left">170</td><td class="colsep0 rowsep0" align="left">1931</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b>,Â vipadenant</td><td class="colsep0 rowsep0" align="left">1.3</td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">68</td><td class="colsep0 rowsep0" align="left">1005</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">460</td><td class="colsep0 rowsep0" align="left">42</td><td class="colsep0 rowsep0" align="left">1740</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">2.5</td><td class="colsep0 rowsep0" align="left">3185</td><td class="colsep0 rowsep0" align="left">133</td><td class="colsep0 rowsep0" align="left">366</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">115</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">270</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">10000</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">10000</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">4.0</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">39%Â atÂ 10Â nM<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">81%Â atÂ 1Â Î¼M<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">37%Â atÂ 1Â Î¼M<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">81%Â atÂ 100Â nM<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">98%Â atÂ 10Â Î¼M<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">82%Â atÂ 10Â Î¼M<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">30%Â atÂ 10Â nM<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">21%Â atÂ 1Â Î¼M<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">4%Â atÂ 1Â Î¼M<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">73%Â atÂ 100Â nM<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">28%Â atÂ 10Â nM<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">85%Â atÂ 100Â nM<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">4.0Â (r)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">820Â (r)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>56</b></td><td class="colsep0 rowsep0" align="left">(r)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">>250Â (r)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>57</b></td><td class="colsep0 rowsep0" align="left">63Â (r)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1071Â (r)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">12Â (r)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">40.8Â (r)</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b>,Â ST-1535</td><td class="colsep0 rowsep0" align="left">6.6</td><td class="colsep0 rowsep0" align="left">352</td><td class="colsep0 rowsep0" align="left">79.2</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b>,Â ST-3932</td><td class="colsep0 rowsep0" align="left">8.0</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b>,Â ST-4206</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">192</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b>,Â ASP-5854</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">>557</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">0.1<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">0.4<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">4.1<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">17<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">6.5<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">48.2<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left">4.4<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">32.7<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="left">29<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1680<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">6.6<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">290<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">5.3<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">100<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">10.2</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="left">9.0</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">1998</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>72</b></td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>73</b></td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="left">77.2</td><td class="colsep0 rowsep0" align="left">ND<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Binding data (<i>K</i><sub>i</sub>) from recombinant human A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub>, and A<sub>3</sub> adenosine receptors, unless rat (r) is indicated.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Percentage (%) inhibition from human A<sub>1</sub>, A<sub>2A</sub>, and A<sub>2B</sub> adenosine receptors.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Functional assay data (cAMP) from human A<sub>1</sub>, and A<sub>2A</sub> adenosine receptors expressed as <i>K</i><sub>i</sub> (nM).</p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">ND: not disclosed.</p></div></div></div><div class="NLM_p">The xanthine scaffold has been used as an important starting point for the development of selective A<sub>2A</sub> antagonists. Medicinal chemistry efforts were directed not only at identifying A<sub>2A</sub> selective antagonists but also at improving the poor aqueous solubility typical of xanthines. A screening of various 1,3,8-substituted xanthines led to the discovery of 3-chlorostyrylcaffeine (<b>9</b>, also named CSC), <b>10</b> (MSX-2),<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and istradefylline<a onclick="showRef(event, 'cit32a'); return false;" href="javascript:void(0);" class="ref cit32a">(32a)</a> (<b>13</b>, also named KW6002, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), all being potent and selective A<sub>2A</sub> AR antagonists (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). It is well established that the trans-styryl substituent at the 8-position of these analogues is critical to the A<sub>2A</sub> selectivity. Among these compounds, <b>10</b> has been extensively studied because of a very high affinity at the A<sub>2A</sub> receptor (rA<sub>2A</sub><i>K</i><sub>i</sub> = 8 nM, hA<sub>2A</sub><i>K</i><sub>i</sub> = 5 nM) and a good selectivity profile. Different approaches have been explored to improve the aqueous solubility of styrylxanthines, such as the introduction of polar groups on the phenyl ring and the preparation of phosphate or amino acid prodrugs. Antagonists <b>11</b> (MSX-3) and <b>12</b> (MSX-4), the phosphate and the <span class="smallcaps smallerCapital">l</span>-valine prodrugs, respectively, of <b>10</b>, are stable and soluble in aqueous solutions but readily cleaved (by phosphatases in the case of <b>11</b> and esterases in the case of <b>12</b>) to liberate <b>10</b>.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Istradefylline is the most extensively studied xanthine derivative. It has hA<sub>2A</sub><i>K</i><sub>i</sub> = 36 nM, hA<sub>1</sub> = 2830 nM, hA<sub>2B</sub> = 1800 nM, and hA<sub>3</sub><i>K</i><sub>i</sub> > 3000 nM.<a onclick="showRef(event, 'cit32b'); return false;" href="javascript:void(0);" class="ref cit32b">(32b)</a> This compound showed anticataleptic activity at a low dose (0.03 mg/kg, po) in a mouse haloperidol model and exhibited antiparkinsonian activity without provoking dyskinesia in MPTP-treated primates.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> However, istradefylline possesses poor photostability and undergoes dimerization via [2 + 2] cycloaddition of the styryl double bond. Furthermore, the styryl double bond in this series of compounds isomerizes in dilute solutions from the <i>E</i> to the <i>Z</i> isomer.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p">Since xanthine derivatives present several problems such as poor water solubility and instability, a search was initiated for a different structural class based on mono-, bi-, and triheterocycles. In 1987 Williams et al. discovered CGS15943 (<b>14</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>),<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> a very potent A<sub>2A</sub> antagonist (hA<sub>2A</sub><i>K</i><sub>i</sub> = 0.4 nM) that also has high affinity for the other ARs (hA<sub>1</sub><i>K</i><sub>i</sub> = 3.5 nM, hA<sub>2B</sub><i>K</i><sub>i</sub> = 44 nM, hA<sub>3</sub><i>K</i><sub>i</sub> = 95 nM). Blockade of the A<sub>1</sub> receptor is correlated with undesirable cardiovascular effects and has been suggested to disrupt the activity of antiparkinsonian agents.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> In 1993, Gatta et al. synthesized a series of compounds based on the replacement of the phenyl ring of CGS15943 with a heterocycle, either pyrazole or imidazole, but their A<sub>2A</sub> vs A<sub>1</sub> selectivity was not satisfactory.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Subsequent synthetic efforts by Baraldi et al. led to the major discovery that Nâ²-substituted pyrazolotriazolopyrimidines retain A<sub>2A</sub>-receptor affinity while losing affinity at the other adenosine receptors. One of the compounds synthesized was SCH58261 (<b>15</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>)<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> (hA<sub>2A</sub><i>K</i><sub>i</sub> = 1.1 nM, hA<sub>1</sub><i>K</i><sub>i</sub> = 549 nM), which was rapidly and widely accepted as a reference A<sub>2A</sub> receptor antagonist, largely due to its ability to cross the bloodâbrain barrier (BBB). SCH58261 has been useful as a tool to characterize the A<sub>2A</sub> receptor, as well as to learn about its intracellular signaling. It shares with caffeine some stimulatory effects such as increase in locomotor activity and waking behavior in the rat. In the cardiovascular system it increases blood pressure and heart rate in rats.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> SCH58261 showed a positive effect in the 6-hydroxydopamine (6-OHDA) lesioned rat model (5 mg/kg, po), providing support for the notion that A<sub>2A</sub> receptor antagonists represent an interesting approach to the treatment of Parkinson disease. The development, SAR, and clinical status of this series will be discussed in the antagonist therapeutic applications section of this review. In general, these non-xanthines have poor water solubility, and their structures are complex and difficult to synthesize. In order to circumvent these two liabilities, the Zeneca group developed ZM241385 (<b>16</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), a very potent bicyclic non-xanthine antagonist (hA<sub>2A</sub><i>K</i><sub>i</sub> = 0.8 nM) that is selective over the A<sub>1</sub> and A<sub>3</sub> receptors (hA<sub>1</sub><i>K</i><sub>i</sub> = 255 nM, hA<sub>3</sub><i>K</i><sub>i</sub> > 10â000 nM) although also potent at the A<sub>2B</sub> AR (hA<sub>2B</sub><i>K</i><sub>i</sub> = 50 nM).<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> Compared with the tricycles discussed earlier, this compound showed a favorable aqueous solubility profile due to its bicyclic nature and the presence of two additional hydrogen donors.</div><div class="NLM_p last">The historical adenosine A<sub>2A</sub> ligands described in this section have been excellent tools for examining the pharmacology and signaling pathways of these receptors. As we will see in the agonist and antagonist radioligand sections of this review, some of these compounds have been radiolabeled and successfully used to investigate receptor distribution and to calculate A<sub>2A</sub> binding affinities. Efforts to optimize these ligands and use them as a basis for the design of novel therapeutic agents will be described later in this review after the A<sub>2A</sub> receptor pharmacology and structure sections.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Receptor Pharmacology</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26543" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26543" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In recent years, studies using genetically modified mice have provided insights into the pharmacology of adenosine A<sub>2A</sub> receptors. In 1997, Ledent et al. generated the first knockout (KO) mice, in which the first coding exon of the A<sub>2A</sub> receptor was targeted. These mice showed aggressiveness, decreased sensitivity to pain, and slightly higher blood pressure.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Two years later, Chen and co-workers targeted the second exon and observed that the corresponding A<sub>2A</sub> receptor deficiency attenuates brain injury induced by transient local ischemia in mice.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> A<sub>2A</sub> KO mice are viable, fertile, and normal in size and do not display any gross physical or behavioral abnormalities. These mice show a reduction in the volume of experimentally induced cerebral infarction and resulting impairment of neurological function compared with the wild type. Treatment with receptor agonist CGS21680 does not elicit decreased locomotor activity in the A<sub>2A</sub> receptor KO mice, compared with the wild type. A reduction of spontaneous activity and increased resistance to the addictive substances amphetamine and cocaine were also observed.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a></div><div class="NLM_p">Adenosine is a potent biological mediator that affects numerous cell types, including neuronal cells, platelets, neutrophils, and smooth muscle cells. Although a number of nonselective A<sub>2A</sub> ligands have been used as tools to understand the pharmacology of A<sub>2A</sub> receptors, we are going to focus on the effects of the more A<sub>2A</sub>-selective agonists CGS21680 and HENECA and the A<sub>2A</sub>-selective antagonists istradefylline and SCH58261 in order to simplify the complex nature of this subject.</div><div class="NLM_p">The A<sub>2A</sub> receptor is responsible for regulating myocardial blood flow by vasodilating the coronary arteries, which increases blood flow in the myocardium but may lead to hypotension. As we mentioned earlier, A<sub>2A</sub> KO mice are slightly hypertensive. Direct activation of the A<sub>2A</sub> receptors by adenosine or other A<sub>2A</sub> agonists results in vasodilation of different types of vessels such as coronary arteries, afferent arterioles of the kidney, mesenteric arteries, and CNS vessels. Monopoli et al. have shown that non-xanthine A<sub>2A</sub> adenosine receptor antagonist SCH58261 blocks blood pressure (BP) and heart rate (HR) changes induced by the A<sub>2A</sub>-selective receptor agonist HENECA but does not affect the responses evoked by the A<sub>1</sub> receptor agonist 2-chloro-<i>N</i>6-cyclopentyladenosine (CCPA). Moreover, SCH58261 alone has been found to increase both BP and HR at a dose consistent with A<sub>2A</sub> receptor antagonist activity. In conscious, spontaneously hypertensive rats, HENECA given intraperitoneally causes a dose-dependent decrease in BP. This hypotensive response is short-lasting and, as expected, is accompanied by reflex tachycardia. SCH58261 was effective in antagonizing the A<sub>2A</sub> agonist-induced fall in BP and the reflex increase in heart rate.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> All of these findings show the importance of the A<sub>2A</sub> receptors in regulating blood flow. Related therapeutic applications will be discussed in the agonist therapeutic applications section of this review.</div><div class="NLM_p">The A<sub>2A</sub> receptor is also expressed in the brain, where it has important roles in the regulation of glutamate and dopamine release. In 1996, Bertorelli et al. found that SCH58261 at a 10 mg/kg dose produced stimulatory effects comparable with those induced by caffeine in rats.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In the striatopallidal neurons, dopamine D<sub>2</sub> receptors are colocalized with adenosine A<sub>2A</sub> receptors.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The stimulation of A<sub>2A</sub> receptors decreases the affinity of D<sub>2</sub> receptors for dopamine in rat striatal membranes<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> and in a mouse fibroblast cell line stably cotransfected with A<sub>2A</sub> and D<sub>2</sub> receptors.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Adenosine A<sub>2A</sub> receptor agonists inhibit, while A<sub>2A</sub> receptor antagonists potentiate, the effects of the D<sub>2</sub> receptor agonist on motor activity, neurotransmitter release, and striatal expression of c-Fos, a transcription factor that is used as an indirect marker of neuronal activity; this expression is also increased after consumption of cocaine, methamphetamine, heroin, and other psychoactive drugs.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Because of the key role played by adenosine A<sub>2A</sub> receptors in the regulation of striatal dopaminergic neurotransmission, drugs acting on these receptors are likely to be useful in the treatment of neurological disorders related to dopaminergic dysfunction, in particular Parkinson disease which will be described later in this review. Popoli et al. have observed the ability of the A<sub>2A</sub>-selective SCH58261 to selectively potentiate D<sub>2</sub>-dependent rotations in rats unilaterally lesioned with 6-OHDA, a rodent model of PD.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> This finding is in line with a previous study showing that CGS21680, an adenosine A<sub>2A</sub> receptor agonist, antagonized quinpirole-induced turning in 6-OHDA-lesioned rats.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Popoli and co-workers also observed that chronic adenosine receptor blockade does not induce tolerance to the potentiating effects of SCH58261 presumably because A<sub>2A</sub> receptors are not up-regulated after chronic caffeine intake, a finding in agreement with a report by Kanda et al. showing that chronic administration of istradefylline over 21 days reversed motor defects in parkinsonian monkeys.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_p">Adenosine A<sub>2A</sub> receptor knockout mice displayed reduction of immobility in functional in vivo assays, including the tail suspension and forced swim tests, that are predictive of clinical antidepressant activity. Reduction of immobility by antidepressants cannot be explained by a nonspecific behavioral stimulation, as many antidepressants tend to decrease motor activity. SCH58261 reduced immobility in the tail suspension test performed with mice that were selectively bred for their spontaneous âhelplessnessâ in this test. Istradefylline and SCH58261 were also examined in the forced swim test, where both drugs reduced the duration of immobility in mice.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p">In addition, blockade of striatal adenosine A<sub>2A</sub> receptor by SCH58261 exerts neuroprotective effects in quinolinic acid (QA) lesioned rats. These effects are paralleled by an inhibition of QA-induced glutamate outflow. The beneficial effect of SCH58261 in this model suggests that striatal A<sub>2A</sub> receptors could represent a target for Huntington disease (HD).<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div><div class="NLM_p">Paterniti et al. observed that 24 h after spinal cord injury (SCI), A<sub>2A</sub> receptors were expressed in neurons in the central part of the gray matter in the ventral horn of the spinal cord. Systemic and continuous administration of SCH58261 after SCI for 10 days shows protection from motor deficits up to 10 days after trauma. This A<sub>2A</sub> antagonist affords protection from tissue damage, demyelination, and expression of death signals such as TNF-Î±, Fas-L, PAR, and Bax and from activation of Jun N-terminal kinase (JNK) MAPK. Also, when centrally applied, SCH58261 protects from tissue damage based on evaluation 24 h after SCI. In contrast, A<sub>2A</sub>-selective agonist CGS21680 centrally applied is not protective.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Recently Mohamed and co-workers have observed that central blockade of adenosine A<sub>2A</sub> using SCH58261 significantly ameliorates hippocampal damage following ischemia reperfusion injury (IR) by halting inflammatory cascades and modulating excitotoxicity in rats. After IR, rats showed increased infarct size and lactate dehydrogenase, habituation deficit, increased anxiety and locomotor activity, increased hippocampal glutamate, GABA, glycine, and aspartate compared with their control counterparts. IR also raised myeloperoxidase, TNF-Î±, nitric oxide, prostaglandin E<sub>2</sub> but decreased interleukin-10. SCH58261, when administered intraperitoneally after carotid occlusion and before exposure to a 24 h reperfusion period, significantly reversed these effects.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a></div><div class="NLM_p">A summary of the adenosine A<sub>2A</sub> receptor distribution, the functions of the cells or tissue, and the possible therapeutic applications is shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Adenosine A<sub>2A</sub> receptor location (black), cell or tissue function (red), and possible therapeutic applications (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Receptor Structure</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27501" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27501" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A shows the structure of the adenosine A<sub>2A</sub> receptor. Adenosine receptors display the topology typical of GPCRs. They have in common a central core consisting of seven transmembrane helices (TM1â7), each TM being mainly Î±-helical and composed of 20â27 amino acids. Each TM domain is linked by three intracellular (IL1, IL2, and IL3) and three extracellular (EL1, EL2, and EL3) loops. There is also a short helix TM8 that runs parallel to the cytoplasmic surface of the membrane. Two cysteine residues (one in TM3 and one in EL2) form a disulfide link. ARs differ in the length and function of their N-terminal extracellular domain, their C-terminal intracellular domain, and their intracellular/extracellular loops. Each of these areas provides very specific properties that are critical for achieving ligand selectivity among the different receptor subtypes. Considering overall sequence identity at the amino acid level, the human A<sub>2A</sub> AR shares 49% amino acid sequence identity with human A<sub>1</sub> AR, 58% with human A<sub>2B</sub> AR, and only 41% with the human A<sub>3</sub> AR. Within the seven TM domains the residues critical for interaction with the ligand are located toward the extracellular part of the receptor and are highly conserved, with an average identity of 71%.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> The primary sequence of the cloned A<sub>2A</sub> ARs from various species ranges from 409 to 412 residues with the human ortholog length being 412 amino acids.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Crystal structure of the A<sub>2A</sub> receptor. (B) Overlap between the crystal structure of the agonist adenosine <b>1</b> (yellow) and the antagonist ZM241385 <b>16</b> (cyan).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Mutation studies and homology models based on other GPCRs such as bovine and squid rhodopsin and human Î²<sub>2</sub> adrenergic receptor have provided us with detailed structural information about the A<sub>2A</sub> receptor. In 2008, the resolution of the crystal structure of the A<sub>2A</sub> receptor bound to ZM241385 was reported,<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> and three years later crystal structures were resolved for the A<sub>2A</sub> receptor bound to the agonists adenosine and NECA.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B shows a picture of the overlap between the crystal structures of the agonist adenosine and ZM241385 at the orthosteric site of the A<sub>2A</sub> receptor. These structures are of the utmost importance in this field, and although they reveal numerous insightful details with respect to the changes in the conformation of these receptors, we are going to focus only on analysis of the ligand-binding cavity.</div><div class="NLM_p">X-ray analysis of the A<sub>2A</sub> receptor bound to ZM241385 showed that the bicyclic triazolotriazine core of ZM241385 is anchored by an aromatic stacking interaction with Phe168 (5.29) and an aliphatic hydrophobic interaction with Ile274 (7.39). Analysis of the shape of the binding site of the A<sub>2A</sub> receptor shows that it consists of a deep, planar, and narrow cavity that comfortably accommodates fused polyheteroaromatic cores.<a onclick="showRef(event, 'cit57a'); return false;" href="javascript:void(0);" class="ref cit57a">(57a)</a> Nitrogen N17 forms a hydrogen-bond interaction with Asn253 (6.55). Adjacent to Phe168 (5.29), a polar residue (Glu169 (5.30)) interacts with the exocyclic amino group (N15 atom) linked to the bicyclic core of ZM241385. The phenolic hydroxyl group extending from the ethylamine chain forms a hydrogen bond with an ordered water molecule, while the phenyl ring forms hydrophobic interactions with Leu267 (7.32) and Met270 (7.35). A ZM241385 derivative with a cycloalkyl substituent (LUF5477)<a onclick="showRef(event, 'cit57b'); return false;" href="javascript:void(0);" class="ref cit57b">(57b)</a> instead of the phenylmethylene also has high affinity for the A<sub>2A</sub> adenosine receptor, suggesting that the nature of this interaction is hydrophobic and not Ï-stacking and demonstrating furthermore the tremendous substituent flexibility that exists in this area of the pharmacophore. The phenylethylamine chain in ZM241385 is directed toward the more solvent-exposed extracellular region (EL2 and EL3). These interactions appear to be important in designing synthetic A<sub>2A</sub> selective antagonists, since different ARs have different residues located in this area. The furan ring of ZM241385 is situated deep in the ligand-binding cavity. Its oxygen atom forms a hydrogen bond to Asn253 (6.55), and the furan ring has hydrophobic interactions with His250 (6.52) and Leu249 (6.51). The furan ring is approximately 3 Ã away from the highly conserved Trp246 (6.48), limiting the motion of this tryptophan residue, which is believed to act as the âtoggle switchâ of this receptor, so that hydrophobic interactions between the furan ring and Trp246 hinder the structural rearrangements necessary for activation and constrain the receptor in the inactive state.</div><div class="NLM_p">The crystal structures of A<sub>2A</sub>-bound agonists adenosine and NECA show that both of these ligands bind to the stabilized receptor A<sub>2A</sub>R-GL31 (vide infra) in a virtually identical fashion. Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a> shows the binding interactions of the antagonist ZM241385 (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>A) and the agonist NECA (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>B) at the orthosteric site of the A<sub>2A</sub> receptor. The interaction of the adenine ring of adenosine and NECA with the A<sub>2A</sub> receptor is similar to that of the chemically related triazolotriazine ring of the antagonist ZM241385. Thus, a similar hydrogen bond network joins the adenine scaffold to both Glu169 (5.30) and Asn253 (6.55), and the Ï-stacking and hydrophobic interactions with Phe168 (5.29) and Ile274 (7.39) are maintained. The main difference between agonists and antagonists is that agonists have a ribose moiety that forms hydrogen bonds with Ser277 (7.42) and His278 (7.43). These strong, attractive noncovalent interactions pull the extracellular ends of TM3, TM5, and TM7 together, which is believed to be the necessary prerequisite for receptor activation. In addition, because of the presence of the hydrogen donors at the ribose moiety, amino acids Val84 (3.32) and Trp246 (6.48) have to significantly shift their positions, a change that seems to be critical to achieving the conformation required to activate this receptor.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding interactions at the adenosine A<sub>2A</sub> receptor: (A) antagonist ZM241385; (B) agonist NECA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The structural information just summarized suggests alternative receptor-based approaches to finding new A<sub>2A</sub> ligand chemotypes. For example, since the A<sub>2A</sub> receptor has a deep and well-defined pocket, Katritch et al. developed a homology model and virtually screened more than 4 million commercially available âdruglikeâ and âleadlikeâ compounds, looking for antagonists of novel structural types. This screen resulted in the identification of 23 high ligand efficiency (0.3â0.5 kcal/mol per heavy atom) hits with affinities under 10 Î¼M in A<sub>2A</sub> AR binding assays, 11 of those had submicromolar affinities, and two compounds had affinities under 60 nM.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div><div class="NLM_p last">Despite being membrane-bound, these receptors are very dynamic structures that can adopt numerous thermodynamically stable conformations. To obtain diffraction-quality crystals, it is necessary to considerably stabilize the receptor. For example, the structure of the A<sub>2A</sub> receptor bound to ZM241385 (A<sub>2A</sub>-T4L) was modified by T4 lysozyme fusion in cytoplasmic loop 3 and the deletion of the carboxy-terminal tail (Ala317-Ser412). The A<sub>2A</sub> structure bound to NECA is a thermostabilized construct (A<sub>2A</sub>R-GL31) that contains four point mutations. Although none of the thermostabilizing mutations occurred in the binding pocket, these variations have an impact on the affinity values with respect to the wild type. As we have seen before, NECA is an agonist that activates the receptor; however, analysis of its crystal structure with the A<sub>2A</sub> receptor shows a conformation between the inactive state (R) and the active state (R*). Although the X-ray crystal structures mentioned here represent the best tools to inspire rational ligand design and a platform to build homology models for virtual screening, unexpected results are sometimes obtained, due mainly to the conformational differences between the stabilized nature of the crystallized receptor and the dynamic nature of the wild type.</div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Therapeutic Applications of A<sub>2A</sub> Receptor Agonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51223" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51223" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The therapeutic value of adenosine was first considered and investigated in the late 1980s,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> and the development of potent and selective A<sub>2A</sub> agonists has been a subject of medicinal chemistry research for the ensuing 3 decades. The SAR of adenosine-based ligands has been recently reviewed,<a onclick="showRef(event, 'ref60 ref61 ref62'); return false;" href="javascript:void(0);" class="ref ref60 ref61 ref62">(60-62)</a> and it has been widely accepted that the basic adenosine scaffold must be maintained.<a onclick="showRef(event, 'ref63 ref64'); return false;" href="javascript:void(0);" class="ref ref63 ref64">(63, 64)</a> As we discussed in the receptor structure section of this review, these adenosine-based ligands have little or no oral bioavailability and short half-lives due to the presence of three hydrogen bond donors in the sugar moiety which are critical for A<sub>2A</sub> receptor activation but are subject to extensive metabolism. Research in medicinal chemistry has focused on improving the pharmacokinetic and A<sub>2A</sub> selectivity profiles of these agonists by performing chemical modifications at the ribose and/or the purine moiety. Adenosine (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) shows the standard numbering of positions of these agonists to facilitate the understanding of the SAR discussed below.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Ribose-Modified Adenosine Derivatives</h3><div class="NLM_p last">Structural modifications of the ribose ring have been extensively explored. Most of these analogues are devoid of adenosine agonist activity because they lack the 2â²- and 3â²-hydroxyl groups essential for activity.<a onclick="showRef(event, 'ref63 ref65'); return false;" href="javascript:void(0);" class="ref ref63 ref65">(63, 65)</a> Replacement of the ribose furan ring with cyclopentane results in carbocyclic analogues with very weak A<sub>2A</sub> activity.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> The most promising position for structural changes in the ribose unit is the primary 5â²-hydroxyl group. In 1980, Prasad and co-workers discovered that <i>N</i>-alkylcarboxamide analogues showed increased agonist activity for all adenosine receptors.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> As previously seen, the <i>N</i>-ethylcarboxamide derivative NECA shows good binding affinity at A<sub>2A</sub> receptors (hA<sub>2A</sub><i>K</i><sub>i</sub> = 20 nM). Apparently the carbonyl group of NECA is involved in an important hydrogen bonding interaction with Ser277 on the seventh transmembrane domain of the activated conformation of A<sub>2A</sub> receptors.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a><i>N</i>-Alkylthiocarboxamides are also agonists, although these analogues are less active.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Among the most active A<sub>2A</sub> agonists are 2-alkynyl NECA derivatives. Many compounds from this class have A<sub>2A</sub> affinities in the nanomolar range. The alkylalkynyl derivatives generally exhibit higher potencies in binding and functional assays than those with aryl or heteroarylalkynyl groups.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> In addition, good levels of potency and selectivity are shown by a number of different derivatives with a heteroaryl group as a bioisostere replacement of the amide moiety at the 5â²-position.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Purine-Modified Adenosine Derivatives</h3><div class="NLM_p">Substitution at C8 of the adenine ring of adenosine led to a decreased affinity for all adenosine receptors, presumably due to a conformational change of the nucleoside from an <i>anti</i>-conformation to a less favorable <i>syn</i>-conformation. The presence of nitrogen at the 3 and 7 positions is important for activity with all receptor subtypes.<a onclick="showRef(event, 'ref63 ref71'); return false;" href="javascript:void(0);" class="ref ref63 ref71">(63, 71)</a> A number of SAR studies have revealed that modifications at C2 and N6 of the adenine can be tolerated. Agonist <b>5</b>, a C2 aniline derivative briefly discussed in the historical agonists section of this review, displays 10-fold selectivity for A<sub>2</sub> versus A<sub>1</sub> and as such was the first reported A<sub>2</sub> selective agonist.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Since then, a variety of other A<sub>2A</sub>-selective C2-substituted analogues have been discovered, including ethers,<a onclick="showRef(event, 'ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref72 ref73">(72, 73)</a> thioethers,<a onclick="showRef(event, 'ref73 ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref73 ref74 ref75">(73-75)</a> amines such as CGS21680,<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> alkynes such as HENECA,<a onclick="showRef(event, 'ref69 ref77 ref78'); return false;" href="javascript:void(0);" class="ref ref69 ref77 ref78">(69, 77, 78)</a> and hydrazines.<a onclick="showRef(event, 'ref79 ref80 ref81'); return false;" href="javascript:void(0);" class="ref ref79 ref80 ref81">(79-81)</a> 2-(<i>N</i>â²-Alkylidenehydrazino)adenosines and 2-(<i>N</i>â²-arylalkylidenehydrazino)adenosines have been reported to be potent and selective agonists that have been used as coronary vasodilators.<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79, 80)</a> The cyclohexylmethylene, cyclohexylethylidene, and benzylidene analogues all have EC<sub>50</sub> values of less than 1 nM. Of particular interest are 2-(<i>N</i>â²-cyclohexymethylidenehydrazino)adenosines where the hydrazone moiety has an <i>E</i>-conformation. Potency at A<sub>2</sub> receptors increases when bigger alkyl groups at the hydrazone are introduced and is higher for cycloalkyl than for linear alkyl groups. The size of the alkyl group is irrelevant for binding to A<sub>1</sub> receptors. Substitutions that limit the flexibility of this part of the molecule by conjugation with the âCHâNâ bond (e.g., 1-cyclohexene) result in a reduction of potency. The most relevant compound of this series is binodenoson (<b>17</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) which will be discussed in the agonist therapeutic applications part of this review.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of therapeutically relevant A<sub>2A</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Although N6 substitution is tolerated, it generally decreases A<sub>2A</sub> potency. In many cases, N6 substituents can actually enhance A<sub>1</sub> and A<sub>3</sub> affinity and selectivities.<a onclick="showRef(event, 'ref78 ref82'); return false;" href="javascript:void(0);" class="ref ref78 ref82">(78, 82)</a> This is exemplified by <i>N</i>6-(tetrahydrofuryl)adenosine (tecadenoson), which is a potent A<sub>1</sub>-selective agonist.<a onclick="showRef(event, 'ref83 ref84'); return false;" href="javascript:void(0);" class="ref ref83 ref84">(83, 84)</a></div></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Ribose and Purine-Modified Adenosine Derivatives</h3><div class="NLM_p last">As we have seen already, the 2-position of the adenine moiety and the 5â²-position of the ribose offer us two opportunities for structural modification. These can both be modified simultaneously to prepare active and selective analogues. One example is CGS21680, a 5â²-NECA derivative bearing a 2-(2-phenylethyl)amino group at the adenine 2-position, a compound already discussed in the historical ligand section of this review.<a onclick="showRef(event, 'cit28b'); return false;" href="javascript:void(0);" class="ref cit28b">(28b)</a> Bulky groups can be incorporated at the terminal carboxylate group of such analogues without compromising A<sub>2A</sub> potency.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> In the following section we will discuss other A<sub>2A</sub> active and selective agonists in which adenosine has been successfully modified at C2 and 5â², such as apadenoson (<b>18</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) and antagonist <b>20</b> (GW328267, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).</div></div><div id="sec6_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> A<sub>2A</sub> Agonist Therapeutic Applications</h3><div id="sec6_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Myocardial Perfusion Imaging (MPI)</h4><div class="NLM_p">In cardiac stress tests, either physical exercise or a pharmacologic vasodilating agent is used to stimulate the heart and achieve maximum myocardial hyperemia. Pharmacologic agents are generally used when a patient is unable to achieve an adequate work level with treadmill exercise or has poorly controlled hypertension.<a onclick="showRef(event, 'ref86 ref87'); return false;" href="javascript:void(0);" class="ref ref86 ref87">(86, 87)</a> Almost 50% of myocardial perfusion imaging (MPI) is performed with a pharmacologic stress agent.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> The endogenous agonist adenosine has a vasodilating effect that is mediated primarily through stimulating A<sub>2A</sub> receptors on arteriolar vascular smooth muscle cells. Adenosine, marketed by Astellas Pharma under the trade name Adenoscan, is widely used in clinical practice to induce coronary arterial vasodilation after being intravenously administered.<a onclick="showRef(event, 'ref88 ref89'); return false;" href="javascript:void(0);" class="ref ref88 ref89">(88, 89)</a> Because of its nonselective nature adenosine activates the A<sub>1</sub>, A<sub>2B</sub>, and A<sub>3</sub> receptors as well as the A<sub>2A</sub>, and so has limited therapeutic applications. To be useful in stress tests, the activity of an agonist needs to be sufficiently short to minimize side effects, while long enough (ideally 2â4 min) to allow maximal extraction of the radiotracer during the vasodilation. Although adenosineâs extremely short half-life minimizes many of its side effects such as bronchospasms, dyspnea, and high-grade atrioventricular (AV) block, an A<sub>2A</sub> selective agonist would be preferable.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><div class="NLM_p">Binodenoson (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, also known as WRC-0470 or MRE-0470) was a clinical candidate for myocardial perfusion imaging. Binodenoson has moderate binding affinity at the human A<sub>2A</sub> receptor (h<i>K</i><sub>i</sub> A<sub>2A</sub> = 270 nM), with a 370-fold selectivity for A<sub>2A</sub> versus A<sub>2B</sub> and more than 170-fold selectivity versus A<sub>1</sub> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref79 ref80'); return false;" href="javascript:void(0);" class="ref ref79 ref80">(79, 80)</a> The hydrazone double bond has a <i>E</i>-configuration.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> Binodenoson was developed by King Pharmaceuticals as a potential coronary vasodilator and an adjunct to a SPECT imaging agent for myocardial perfusion imaging in the diagnosis of coronary artery disease (CAD).<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> In a rat study, binodenoson produced systemic vasodilation (ED<sub>50</sub> = 0.31 mg) and a decrease in heart rate (A<sub>1</sub> mediated ED<sub>50</sub> = 620 mg). Intravenous infusion of binodenoson (0.6 mg kg<sup>â1</sup> min<sup>â1</sup>) was equipotent to adenosine (300 mg kg<sup>â1</sup> min<sup>â1</sup>) in increasing coronary flow. Blood pressure was markedly reduced by adenosine but remained unchanged with binodenoson.<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> King Pharmaceuticals filed an NDA in 2008, but the application was rejected by FDA. Binodenoson development appears to have been halted after Pfizer acquired King Pharmaceuticals, since binodenoson is not listed in Pfizerâs pipeline.</div><div class="NLM_p">Apadenoson (also named ATL164e or stedivaze, <b>18</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) is a derivative with a propynylcyclohexanemethylester group at the 2-position of adenine. Apadenoson displays a remarkable binding potency with recombinant human A<sub>2A</sub> receptors (hA<sub>2A</sub><i>K</i><sub>i</sub> = 0.5 nM), with 150-fold and 90-fold selectivity versus A<sub>1</sub> and A<sub>3</sub>, respectively (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> In 2000, Adenosine Therapeutics (since acquired by Forest Laboratories) licensed apadenoson from the University of Virginia. In 2009, the first phase III trial in myocardial perfusion imaging (MPI) was initiated, followed by a second phase III trial in June 2011. However, by May 2012, further development was discontinued, and no clinical data were reported.</div><div class="NLM_p last">Regadenoson (also known as CVT3146, <b>19</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>)<a onclick="showRef(event, 'ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref93 ref94">(93, 94)</a> is an adenosine derivative bearing a <i>N</i>-pyrazole at its 2-position. The <i>N</i>-pyrazole is designed as a constrained mimetic of the <i>E</i>-hydrazone moiety in binodenoson. A large variation of hydrophilic and lipophilic substitutuents can be placed on the pyrazole ring while retaining activity at the A<sub>2A</sub> receptor. Regadenoson was approved by FDA in 2008 for MPI and is marketed by Astellas Pharma under the trade name Lexiscan. Regadenoson has a relatively low binding affinity (hA<sub>2A</sub><i>K</i><sub>i</sub> = 290 nM) for human A<sub>2A</sub> receptors and greater than 30-fold selectivity versus the A<sub>2B</sub> and A<sub>3</sub> AR subtypes and 13-fold over the A<sub>1</sub> AR.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Regadenoson can produce a response of equivalent magnitude and a more rapid termination of action than other higher affinity agonists (e.g., CGS21680). This drug is administered as an iv bolus 30 s before the radionuclide.<a onclick="showRef(event, 'ref86 ref95'); return false;" href="javascript:void(0);" class="ref ref86 ref95">(86, 95)</a></div></div><div id="sec6_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Inflammation</h4><div class="NLM_p">Because of its potentially severe side effects, including hypotension and bradycardia, as a result of nonselective activation of all four widely expressed subtypes of adenosine receptors, systemic administration of adenosine has limited clinical potential for treating inflammation. The activation of the A<sub>2A</sub> receptors regulates the activity of the inflammatory cells involved in innate and adaptive immune responses and plays a role in terminating inflammation.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> A<sub>2A</sub> agonists modulate the activity of neutrophils, macrophages, and T lymphocytes, as well as various other inflammatory cells including fibroblasts, monocytes, platelets, and mast cells.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> In vivo studies showed that <b>18</b> reduces joint destruction due to septic arthrosis, and CGS21680 regulates HIV-1 transactivating regulatory protein (Tat) induced inflammatory responses.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Although A<sub>2A</sub> agonists are vasodilators, they inhibit inflammation at lower doses which produce few or no cardiovascular side effects. The wide distribution of the A<sub>2A</sub> receptor, however, suggests that the therapeutic potential of A<sub>2A</sub> agonists is likely to reside in topical treatments to avoid systemic side effects associated with oral administration.</div><div class="NLM_p">Agonist <b>20</b> has good A<sub>2A</sub> binding affinity (A<sub>2A</sub><i>K</i><sub>i</sub> = 46 nM) with a selectivity of 28-fold, 8-fold, and 2-fold versus A<sub>2B</sub>, A<sub>1</sub>, and A<sub>3</sub> receptors, respectively.<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99, 100)</a> In functional assays, it shows high potency and efficacy in cAMP formation (EC<sub>50</sub> = 9 nM, <i>E</i><sub>max(NECA)</sub> = 78%) and in the isolated rat aorta assay (EC<sub>50</sub> = 10 nM, <i>E</i><sub>max(NECA)</sub> = 90%).<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> Studies showed that <b>20</b> improved lung function after acute lung injury in rats, and it was developed by GlaxoSmithKline for the treatment of allergic rhinitis and asthma.<a onclick="showRef(event, 'ref101 ref102'); return false;" href="javascript:void(0);" class="ref ref101 ref102">(101, 102)</a></div><div class="NLM_p last">The C2- and N6-modified adenosine analogue UK432097 (<b>21</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>) was developed by Pfizer for the treatment of chronic obstructive pulmonary disease. It has a very potent A<sub>2A</sub> binding affinity (hA<sub>2A</sub><i>K</i><sub>i</sub> = 4 nM),<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> but its development was discontinued because of poor efficacy results. The use of A<sub>2A</sub> receptor agonists as potential agents to treat rheumatoid arthritis has also been proposed, but there are no clinical reports yet available.<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a></div></div><div id="sec6_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> Neuropathic Pain</h4><div class="NLM_p last">Studies show that glial proinflammatory cytokines have been identified as important contributors to neuropathic pain and that interleukin 10 (IL-10) can suppress such pain.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Activation of A<sub>2A</sub> receptors decreases proinflammatory cytokine release and increases release of the potent anti-inflammatory cytokine IL-10. Activation of A<sub>2A</sub> receptors after intrathecal administration of A<sub>2A</sub> agonists may be a novel therapeutic approach for the treatment of neuropathic pain by increasing IL-10 in the immune cells of the CNS. However, to the best of our knowledge, there is no report in clinical trial where intrathecal administration is being used as a viable route of administration. One in vivo study shows CGS21680 (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) produced a long-duration reversal of mechanical allodynia and thermal hyperalgesia for prolonged time.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Cambridge Biotechnology and Ergomed are developing BVT115959 (structure not disclosed) as a new therapy for neuropathic pain. A phase I study demonstrated that BVT115959 is safe and well tolerated, and results of a phase II trial initiated in March 2012 are expected in mid-2013.</div></div><div id="sec6_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Other Therapeutic Areas</h4><div class="NLM_p last">In vivo studies with <b>21</b> indicate that A<sub>2A</sub> receptor agonists promote wound healing and reduce ulcer formation in normal and diabetic animals.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> A C2-ether derivative, 2-[2-(4-chlorophenyl)ethoxy]adenosine, also known as sonedenoson (also named MRE0094, <b>22</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 490 nM and 20-fold selective against A<sub>2B</sub> and A<sub>1</sub>) was under development by King Pharmaceuticals as a potential new therapy for diabetic foot ulcers.<a onclick="showRef(event, 'ref25 ref106'); return false;" href="javascript:void(0);" class="ref ref25 ref106">(25, 106)</a> However, clinical trials failed to demonstrate the desired clinical efficacy, and its development was discontinued. In addition, Forest Laboratories Inc. has been investigating A<sub>2A</sub> receptor agonists for the potential treatment of <i>Clostridium difficile</i> infection.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Zalicus Inc. has been using combinations of an A<sub>2A</sub> agonist with a Î²<sub>2</sub>-adrenergic receptor agonist for the potential treatment of B-cell malignancies such as multiple myeloma,<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> and Inotek Pharmaceutical Corporation investigated PJ1165 as a potential topical treatment for psoriasis and atopic dermatitis.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a></div></div></div><div id="sec6_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Partial Agonists</h3><div class="NLM_p last">Regadenoson behaves as a weak partial agonist causing cAMP accumulation in PC12 cells but as a full and potent agonist causing coronary vasodilation.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> In 2003, van Tilburg and co-workers reported that 2,8-disubstituted adenosine derivatives were adenosine receptor partial agonists.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Although both 2-(1-hexynyl)adenosine and 2-[(<i>E</i>)-1-hexenyl]adenosine have high binding affinities (<i>K</i><sub>i</sub> in the nanomolar range), they show submaximal levels of cAMP production in Chinese hamster ovary (CHO) cells expressing human A<sub>2A</sub> receptors, compared to the reference compound CGS21680. Introduction of 8-alkylamino substituents in most cases further reduces intrinsic activity. Most of these 8-alkylamino derivatives behave as partial agonists, with 8-propyl and 8-butylamino derivatives having the best intrinsic activity and behaving as full agonists.</div></div><div id="sec6_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Agonist Radioligands</h3><div class="NLM_p last">Both [<sup>3</sup>H]NECA and [<sup>3</sup>H]CGS21680 are used extensively as agonist radioligands to characterize A<sub>2</sub>-adenosine receptors in a variety of tissues. As we have seen previously, NECA is a highly potent agonist, but it is nonselective with regard to the four adenosine receptor subtypes. [<sup>3</sup>H]NECA has been successfully used to localize A<sub>2A</sub> adenosine receptors in rat striatal membranes.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> CGS21680 displays high A<sub>2A</sub> binding affinity (rA<sub>2A</sub><i>K</i><sub>i</sub> = 11 nM) and has more than 140-fold selectivity versus A<sub>1</sub> in rat striatal membranes.<a onclick="showRef(event, 'cit28b'); return false;" href="javascript:void(0);" class="ref cit28b">(28b)</a> In humans, it is highly selective versus A<sub>2B</sub> and exhibits a 10-fold selectivity versus A<sub>1,</sub> but it has similar potency at the A<sub>3</sub> receptor. The high affinity and degree of selectivity over A<sub>2B</sub> makes [<sup>3</sup>H]CGS21680 the current radiolabeled agonist of choice as a tool for many different experimental studies involving A<sub>2A</sub> receptors.</div></div><div id="sec6_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Allosteric Modulators</h3><div class="NLM_p">Allosteric modulators bind at a distinct site other than the natural ligand binding site (orthosteric site). They exert their effect only in the presence of the orthosteric ligand. A positive allosteric modulator (PAM) induces an enhancement of effects of the orthosteric ligand, while a negative allosteric modulator (NAM) attenuates those effects. Coumarin <b>23</b> (PD120918, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) enhances agonist radioligand binding to rat striatal A<sub>2A</sub> adenosine receptors, but no functional difference in activity was observed.<a onclick="showRef(event, 'ref112 ref113'); return false;" href="javascript:void(0);" class="ref ref112 ref113">(112, 113)</a> A<sub>2A</sub> adenosine receptors are allosterically modulated by sodium ions and the potassium-sparing diuretic amiloride (<b>24</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> In rat striatal membranes, both amiloride and its analogues increase, while sodium ions decrease, the dissociation rate of the antagonist [<sup>3</sup>H]ZM241385 from the A<sub>2A</sub> adenosine receptors in a concentration-dependent manner. However, amiloride, amiloride analogues, and sodium ions do not show any effect on the dissociation rate of the agonist [<sup>3</sup>H]CGS21680. In 2008, Giorgi and co-workers reported that the <i>N</i>6-1,3-diphenylurea derivative of 2-phenyl-9-benzyl-8-azadenine (<b>25</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>) acts as a positive binding-enhancer of agonist and antagonist radioligands at the A<sub>2A</sub> receptors (hA<sub>2A</sub><i>K</i><sub>i</sub> = 167 nM, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>).<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> The agonist-enhancing activity of <b>25</b> was demonstrated by a significantly higher vasodilating effect of CGS21680 when allosteric modulator <b>25</b> was present in the rat aortic ring assay. Although most of the efforts to modulate A<sub>2A</sub> receptors have been focused on the use of orthosteric ligands, the facts mentioned in this paragraph show that pharmacologic responses can also be fine-tuned using allosteric modulators.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. A<sub>2A</sub> allosteric modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Therapeutic Applications of A<sub>2A</sub> Receptor Antagonists</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_26122" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_26122" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Parkinsonâs Disease</h3><div class="NLM_p">Parkinsonâs disease (PD) is a neurodegenerative disorder named after James Parkinson, the English doctor who in 1817 first described its symptoms.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> PD is caused by a progressive loss of dopaminergic neurons in the substantia nigra region of the basal ganglia, which results in progressive impairment in motor functions (i.e., bradykinesia, resting tremor, muscle rigidity, and postural instability).<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> It is currently estimated to affect â¼1.5% of the world population over the age of 60.<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> The current treatment for PD is primarily based on dopamine replacement therapy. Levodopa (L-DOPA), a metabolic precursor of dopamine (DA), has been the gold standard treatment for decades.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> Other strategies used to elevate or maintain DA brain levels involve the use of DA agonists,<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> inhibitors of DA reuptake,<a onclick="showRef(event, 'ref121'); return false;" href="javascript:void(0);" class="ref ref121">(121)</a> or inhibitors of DA metabolizing enzymes such as monoamine oxidase B (MAO-B)<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> and catechol-<i>O</i>-methyltransferase (COMT).<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> However, with long-term treatment, these dopamine-targeted drugs carry the risk of undesirable side effects, including motor fluctuations (e.g., wearing-off, âonâoffâ phenomena, dyskinesia) and hallucinations.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Because of these significant limitations of dopamine replacement therapy, nondopaminergic strategies have been explored for potential PD treatment.<a onclick="showRef(event, 'ref125'); return false;" href="javascript:void(0);" class="ref ref125">(125)</a> Among nondopaminergic strategies, selective adenosine A<sub>2A</sub> and dual A<sub>1</sub>/A<sub>2A</sub> receptor antagonists have emerged in recent decades as potential therapeutic agents to treat the symptoms of PD.<a onclick="showRef(event, 'ref126'); return false;" href="javascript:void(0);" class="ref ref126">(126)</a></div><div class="NLM_p">As we mentioned earlier in this review, in the striatopallidal neurons at the striatum, adenosine A<sub>2A</sub> receptors are colocalized with dopamine D<sub>2</sub> receptors, and these two receptors exert opposite effects on motor behavior.<a onclick="showRef(event, 'ref127'); return false;" href="javascript:void(0);" class="ref ref127">(127)</a> For example, stimulation of the dopamine D<sub>2</sub> receptors with dopamine or other dopamine D<sub>2</sub> receptor agonists enhances motor activity, while activation of A<sub>2A</sub> receptors reduces this effect by inhibiting dopamine D<sub>2</sub> receptor signaling.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Therefore, antagonism of A<sub>2A</sub> receptors enhances D<sub>2</sub>-dependent signaling and improves motor disabilities in animal models of PD (e.g., 6-OHDA treated animal model (dopamine depleted);<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated non-human primate model).<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> Furthermore, it has been reported that blockade of A<sub>2A</sub> receptors results in remarkable therapeutic advantages, not only potentiating the effects of L-DOPA but also alleviating development of the dyskinesia normally associated with long-term L-DOPA treatment.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a></div><div class="NLM_p">Recently, a number of reviews related to A<sub>2A</sub> receptor antagonists have been published.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> As discussed in the historic A<sub>2A</sub> ligands section of this review, adenosine A<sub>2A</sub> receptor antagonists have been traditionally divided into xanthine-based and non-xanthine-based derivatives. Xanthine derivatives have several limitations as pharmacologic tools, such as poor water solubility.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> In addition, rapid photoisomerization of the side chain olefin of istradefylline after exposure to daylight in dilute solutions have been observed.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Consequently, the discovery of xanthine-based A<sub>2A</sub> receptor antagonists with desirable pharmacologic and physicochemical properties has remained a challenge, and research has become focused on the search for alternative non-xanthine-based heterocyclic derivatives.</div><div class="NLM_p">Non-xanthine-based adenosine A<sub>2A</sub> receptor antagonists have been generally classified, on the basis of their core structures, as monocyclic, fused bicyclic, and fused tricyclic derivatives (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). A number of monocyclic core derivatives are currently being evaluated as potential adenosine A<sub>2A</sub> receptor antagonists,<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> and a variety of fused bicyclic<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> and tricyclic compounds<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> structurally related to adenosine have been identified as A<sub>2A</sub> receptor antagonists. These antagonists contain an exocyclic amino group, and their potency and selectivity have been explored by the installation of various substituents onto each of these heterocyclic templates.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Overview of general core structures of A<sub>2A</sub> antagonists for the treatment of PD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">It is not clear yet which is a better approach toward treating the symptoms of PD: a selective A<sub>2A</sub> antagonist or a dual A<sub>1</sub>/A<sub>2A</sub> antagonist. On one hand, most research organizations are looking for selective A<sub>2A</sub> antagonists to minimize possible cardiovascular effects caused by interaction with the A<sub>1</sub> receptor.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> On the other hand, companies such as Astellas Pharma and Johnson & Johnson consider A<sub>1</sub> antagonism as a desirable feature because it enhanced cognition in rodents.<a onclick="showRef(event, 'ref137 ref138'); return false;" href="javascript:void(0);" class="ref ref137 ref138">(137, 138)</a> Herein, we provide a summary of the most relevant compounds organized by the different companies that have been actively working in the area of PD.</div><div id="sec7_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Merck/Schering-Plough</h4><div class="NLM_p">Merck & Co. (following its acquisition of Schering-Plough) has been very active in the adenosine A<sub>2A</sub> antagonist field, having advanced the compound preladenant (also named SCH420814, <b>28</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>)<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> to phase III in clinical trials. The core scaffold of preladenant had its origin in SCH58261 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), a pyrazolo[4,3-<i>e</i>]-1,2,4-triazolo[1,5-<i>c</i>]pyrimidine described in the historic A<sub>2A</sub> antagonists section of this review. Because of poor water solubility and the low oral bioavailability of SCH58261, researchers at Schering-Plough explored the SAR of the phenethyl side chain, replacing the phenyl ring with biaryl and fused heteroaryl substituents. The resulting methylquinoline analogue <b>26</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>) exhibited a potent A<sub>2A</sub> binding affinity (hA<sub>2A</sub><i>K</i><sub>i</sub> = 2.4 nM) and moderate selectivity over human A<sub>1</sub> (169-fold).<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> Notably, fused heteroaryl analogue <b>26</b> demonstrated a superior pharmacokinetic profile in rats (AUC = 1405 ngÂ·h/mL at 3 mg/kg, po) compared with SCH58261, having sustained plasma levels over 4 h and efficacy in the rat catalepsy model at 1 h (86% inhibition at 3 mg/kg, po) and 4 h (38% inhibition at 3 mg/kg, po) after dosing.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> In addition, efforts to replace the phenethyl side chain with an arylpiperazine scaffold delivered SCH412348 (<b>27</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), a very potent A<sub>2A</sub> antagonist (hA<sub>2A</sub><i>K</i><sub>i</sub> = 0.6 nM), with high selectivity over the human A<sub>1</sub> receptor (>1660-fold).<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Despite its excellent anticataleptic effect in rats (75% and 80% inhibition at 1 and 4 h, respectively, at 1 mg/kg dose, po), <b>27</b> was not developed further because of its poor water solubility. In order to improve solubility, a polar substituent (methoxyethoxy) was introduced at the para position of the aryl group to give preladenant, a compound that exhibited excellent A<sub>2A</sub> binding affinity (hA<sub>2A</sub><i>K</i><sub>i</sub> = 1.1 nM) and human A<sub>1</sub> selectivity (1340-fold). In the rat, preladenant displayed good plasma levels (AUC = 1560 ngÂ·h/mL at 3 mg/kg, po), adequate oral bioavailability (<i>F</i> = 57%), a relatively short half-life (<i>t</i><sub>1/2</sub> = 2.1 h at 1 mg/kg dose, iv), moderate clearance (Cl<sub>p</sub> = 37 mL min<sup>â1</sup> kg<sup>â1</sup>), and a brain-to-plasma ratio of 1. Preladenant demonstrated excellent dose-dependent in vivo efficacy in the haloperidol-induced rat catalepsy assay (77% and 70% inhibition at 1 and 4 h, respectively, at 1 mg/kg dose, po), with a minimum efficacious dose (MED) of 0.3 mg/kg at both 1 and 4 h time-points. Furthermore, preladenant reversed the hypolocomotion induced by treatment with the A<sub>2A</sub> agonist CGS21680 in rats and showed substantial striatal A<sub>2A</sub> receptor occupancy after oral doses of more than 0.1 mg/kg. In addition, preladenant showed a dose-dependent potentiation of L-DOPA-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats (0.03 to 1 mg/kg, po).<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> Although preladenant showed efficacy in one phase II clinical trial (P4501) at 2, 5, and 10 mg/kg (po,), on May 13, 2013, Merck announced that development of preladenant was discontinued because it failed to demonstrate efficacy versus placebo in three phase III clinical trials for PD.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Selected A<sub>2A</sub> antagonists from Merck/Schering-Plough.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further optimization of the preladenant structure was investigated by modifying the tricyclic core, replacing the furan ring, and modifying the side chains. Replacing the pyrazole ring with an imidazole on the tricyclic core provided compound <b>29</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>), a potent and highly selective analogue (hA<sub>2A</sub><i>K</i><sub>i</sub> = 0.9 nM, 669-fold over hA<sub>1</sub>). Compound <b>29</b> reversed haloperidol-induced rat catalepsy with 55% and 50% inhibition (1 mg/kg, po) at 1 and 4 h, respectively, but this imidazolopyrimidine series showed inferior selectivity and pharmacokinetic profiles and a lower in vivo efficacy than the pyrazolopyrimidine series.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> Numerous efforts have been made to replace the furan moiety; however, substitution of this critical structural functionality is a major challenge, and the corresponding aryl and heteroaryl analogues show a reduction in A<sub>2A</sub> potency and selectivity versus A<sub>1</sub> receptors (e.g., compound <b>30</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 12.6 nM, 108-fold over hA<sub>1</sub>).<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> As mentioned previously, analogues having an arylpiperazine-based tail are potent and selective A<sub>2A</sub> receptor antagonists, but all of the reported lead compounds possess poor water solubility. To address this issue, researchers at Schering-Plough have explored a variety of fused heterocyclic side chains containing amines. Compound <b>31</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 2 nM, 179-fold over hA<sub>1</sub>) shows excellent water solubility (100 Î¼M at pH 7.4), a good plasma level (AUC = 7980 ngÂ·h/mL at 3 mg/kg dose, po), a long half-life (<i>t</i><sub>1/2</sub> = 11.3 h), high oral bioavailability (<i>F</i> = 71%), and a low plasma clearance (4.7 mL min<sup>â1</sup> kg<sup>â1</sup>). It also showed a potent oral anticataleptic activity at doses of 3 mg/kg (80% inhibition at 1 h) and 1 mg/kg (65% inhibition at 1 h, â¼35% inhibition at 4 h) in the rat catalepsy model. Unfortunately, compound <b>31</b> was not further developed because of a lower selectivity versus the human A<sub>1</sub> receptor (179-fold) with respect to other compounds in this series.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a></div><div class="NLM_p last">During SAR exploration of A<sub>2A</sub> antagonists, researchers at Schering-Plough investigated a 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine series that lacks the pyrazole ring of the preladenant series and possesses the optimized arylpiperazine side chain. In general, these compounds demonstrate a high A<sub>2A</sub> binding affinity, good selectivity versus the A<sub>1</sub> receptor and significant rat plasma levels. Replacement of the furan moiety attached to the bicyclic scaffold by a 3-cyanophenyl group provided compound <b>32</b>, a very potent antagonist (hA<sub>2A</sub><i>K</i><sub>i</sub> = 1.8 nM) with good selectivity over the human A<sub>1</sub> receptor (620-fold) and desirable plasma exposure in rats (AUC = 1295 ngÂ·h/mL at 3 mg/kg dose, po).<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> Nevertheless, this series, including compound <b>32</b>, showed significantly lower rat catalepsy inhibiting activity compared with the corresponding analogues in the tricyclic series (<b>7</b>, 35% and 14% inhibition at 3 mg/kg, po). More recently, Merck/Schering-Plough has disclosed a series of novel pyrazolo[4,3-<i>e</i>]-1,2,4-triazolo[4,3-<i>c</i>]pyrimidin-3-one (core of compounds <b>33</b> and <b>34</b>) derivatives, which were developed to find a suitable replacement of the furan moiety and improve the solubility of preladenant. As discussed previously, incorporation of a basic nitrogen in the side chain of the preladenant series led to compounds with acceptable binding affinities and selectivity. On the basis of this observation, a morpholine and various other amines were introduced in the pyrazolo[4,3-<i>e</i>]-1,2,4-triazolo[4,3-<i>c</i>]pyrimidin-3-one core containing a 3-chlorobenzyl group instead of the furan. Relevant examples of this series are the dimethylamino analogue <b>33</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 5.2 nM, selectivity 269-fold over hA<sub>1</sub>) and the morpholine derivative <b>34</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 14.2 nM, selectivity 99-fold over hA<sub>1</sub>). As we have noted with other non-furan analogues, compounds in this series showed a significant lack of anticataleptic activity in the rat at 1 and 4 h (10 mg/kg, po).<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a></div></div><div id="sec7_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> Biotie/Roche</h4><div class="NLM_p">A research group from Hoffmann-La Roche has reported in the patent literature a series of potent and selective A<sub>2A</sub> antagonists derived from benzoxazole, thiazolopyridine, and benzothiophene cores. Earlier SAR studies of these series were highlighted in a preceding review and references therein.<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> Although the benzothiazole appears to be the most interesting core in this series, there are also patents claiming benzoxazoles and thiazolo[5,4-<i>c</i>]pyridines as adenosine A<sub>2A</sub> ligands.<a onclick="showRef(event, 'ref148 ref149'); return false;" href="javascript:void(0);" class="ref ref148 ref149">(148, 149)</a> Compounds <b>35</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 25 nM, 351-fold over hA<sub>1</sub>) and <b>36</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 5 nM, 420-fold over hA<sub>1</sub>) are representative examples of the benzoxazole and thiazolopyridine cores, respectively. However, no rat catalepsy data for these two compounds have been disclosed. More recent patent applications have claimed 4-morpholino-6-methoxybenzothiazoles containing a variety of urea and amide side chains as selective A<sub>2A</sub> antagonists. Among these analogues, Roche has identified tozadenant (also named SYN115, <b>37</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>), which exhibited potent A<sub>2A</sub> binding affinity (hA<sub>2A</sub><i>K</i><sub>i</sub> = 5 nM) and 270-fold selectivity over human A<sub>1</sub>.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> In a functional assay (cAMP), tozadenant showed over 4000-fold selectivity versus the human A<sub>1</sub> receptor. In the 2-[(2-aminoethylamino)carbonylethylphenylethylamino]-5â²-ethylcarboxamidoadenosine (APEC) induced hypolocomotion rat model, tozadenant significantly reduced motor deficits with ID<sub>50</sub> of 0.5 mg/kg and ID<sub>90</sub> of 3.4 mg/kg when dosed orally. In addition, tozadenant showed very good pharmacokinetic parameters in rat and dog [<i>t</i><sub>1/2</sub> = 4 (rat), 2.2 (dog) h; Cl<sub>p</sub> = 11 (rat), 8 (dog) mL min<sup>â1</sup> kg<sup>â1</sup>, <i>V</i><sub>d</sub> = 1.4 (rat), 1.2 (dog) L/kg; <i>F</i> = 77% (rat, 5 mg/kg, po), 88% (dog, 5 mg/kg, po)].<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Biotie Therapies (formerly Synosia Therapeutics) has a license agreement for tozadenant with Roche as a potential treatment of PD. Tozadenant is currently in phase IIb trials to evaluate its safety and efficacy. Biotie has granted UCB Pharma S.A. a license for exclusive, worldwide rights to tozadenant. Pending evaluation of the results of the ongoing study UCB Pharma will be responsible for conducting the phase III program and commercializing tozadenant (clinicaltrials.gov identifier NCT01283594).<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0011.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Selected A<sub>2A</sub> antagonists from Biotie/Roche and Vernalis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> Vernalis</h4><div class="NLM_p">While investigating side effects associated with the antimalarial drug mefloquine, researchers at Vernalis unexpectedly found that the (â)-(<i>R</i>,<i>S</i>)-isomer of mefloquine (<b>38</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) displayed moderate A<sub>2A</sub> receptor binding affinity (hA<sub>2A</sub><i>K</i><sub>i</sub> = 61 nM).<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> Although mefloquine had poor selectivity versus human A<sub>1</sub> receptor (4-fold) and was ineffective in rodent models in vivo, it inspired medicinal chemistry efforts to develop novel adenosine A<sub>2A</sub> receptor antagonists for the treatment of PD. From the initial screening of over 2000 compounds, a number of interesting series emerged. Thieno[3,2-<i>d</i>]pyrimidine <b>39</b> (also named VER6623, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) showed a high affinity for the human A<sub>2A</sub> receptor (hA<sub>2A</sub><i>K</i><sub>i</sub> = 1.4 nM) with moderate selectivity over the human A<sub>1</sub> receptor (148-fold) but low oral bioavailability (<i>F</i> = 5.8%).<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Further optimization of this series led to the novel triazolo[4,5-<i>d</i>]pyrimidine derivatives <b>40</b> and <b>41</b> (also named VER6947 and VER7835, respectively, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>), which showed extremely high affinities for the human A<sub>2A</sub> receptor (hA<sub>2A</sub><i>K</i><sub>i</sub> = 1.1 nM and hA<sub>2A</sub><i>K</i><sub>i</sub> = 1.7 nM, respectively), and 15- and 100-fold selectivity, respectively, over human A<sub>1</sub>. In particular, compound <b>41</b> was orally active in a haloperidol-induced hypolocomotion mouse model at a dose of 10 mg/kg.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Further development of these series was discontinued, however, because of low oral bioavailability and poor in vivo stability of these compounds in the rat. This liability was circumvented by substituting the urea moiety with a benzyl group to yield vipadenant (also named V2006/BIIB014, <b>42</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>).<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> Vipadenant exhibited high binding affinity for the human A<sub>2A</sub> receptor (<i>K</i><sub>i</sub> = 1.3 nM), moderately low selectivity versus human A<sub>1</sub> and A<sub>2B</sub> receptor subtypes (52- and 48-fold, respectively), and a high selectivity over the human A<sub>3</sub> receptor (773-fold). In haloperidol-induced hypolocomotion rodent models, vipadenant was highly efficacious with a MED of 0.1 mg/kg. In addition, vipadenant increased the number of contralateral rotations in 6-OHDA-lesioned rats when administered orally in combination with a subthreshold dose of the dopamine D<sub>1</sub> and D<sub>2</sub> agonist apomorphine at 3 and 10 mg/kg. Furthermore, in MPTP-lesioned marmosets pretreated with L-DOPA, vipadenant was efficacious with a MED of 5 mg/kg and showed none of the dyskinesias usually observed when L-DOPA is the sole treatment. In partnership with Biogen Idec, Vernalis initated clinical development of vipadenant for the treatment of PD. However, in spite of positive phase II results, development was stopped in July 2010 because of adverse findings in preclinical toxicology studies.<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a></div><div class="NLM_p">Vernalis is developing V81444 (structure not disclosed), an alternative compound that was also in development for the potential treatment of PD and other CNS disorders and that is currently in phase I trials. In December 2012, Vernalis announced successful positive results from a receptor occupancy study with this antagonist and plans for a phase IIa study to begin in the first half of 2013.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a></div><div class="NLM_p last">In addition to the development of the series just mentioned, Vernalis also explored pyrimidine-4-carboxamide, pyridine-4-carboxamide, and triazine-4-carboxamide derivatives as monocyclic adenosine A<sub>2A</sub> antagonists, in hope of obtaining improved aqueous solubility in comparison to the bicyclic and tricyclic analogues while maintaining A<sub>2A</sub> potency and selectivity.<a onclick="showRef(event, 'ref159 ref160'); return false;" href="javascript:void(0);" class="ref ref159 ref160">(159, 160)</a> Most of the compounds in this series showed a high in vitro A<sub>2A</sub> affinity, modest selectivity against A<sub>1</sub> receptors, and acceptable selectivity against A<sub>2B</sub> and A<sub>3</sub> receptors. Pyridine and triazine-based compounds had considerably lower binding affinities for the A<sub>2A</sub> receptor compared with the pyrimidine analogues. The 6-methoxymethyl-2-pyridyl analogue <b>43</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 1.7 nM, selectivity 25-fold over hA<sub>1</sub>) displayed excellent aqueous solubility (>450 Î¼M at pH 7.4), very high oral bioavailability in the rat (<i>F</i> = 90%), and a good brain/plasma ratio. It was efficacious in the haloperidol-induced hypolocomotion mouse model with a MED of 0.1 mg/kg. The 6-methyl-2-pyridyl analogue with a 5-methyl-2-furanyl moiety <b>44</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 2.5 nM, selectivity 53-fold over hA<sub>1</sub>) was also orally active in the hypolocomotion mouse model at 1 mg/kg dose, although it had a very low oral bioavailability (<i>F</i> = 3%). As was mentioned earlier, the structure of V81444 has not been disclosed, and it is not known if V81444 corresponds to the vipadenant series or whether Vernalis has been able to discover a monocyclic analogue with good in vivo efficacy in animal models and the superior aqueous solubility profile expected for monocyclic compounds.</div></div><div id="sec7_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Shire/Heptares Therapeutics</h4><div class="NLM_p">Shire, under license from Heptares Therapeutics, is currently investigating A<sub>2A</sub> receptor antagonists for the treatment of Parkinson disease and cognition and other CNS disorders. By performing a virtual screening of over 500K compounds, researchers at Heptares Therapeutics identified several novel compounds with high in vitro A<sub>2A</sub> antagonism, with CNS druglike properties, and lacking structural alerts such as the furan ring.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> The most interesting derivatives were those with the 1,3,5-triazine core (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>) which upon optimization led to the discovery of 1,2,4-triazine analogues <b>45</b>â<b>47</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) where the central ring mimics adenine, and ring A accesses the water pocket that is occupied by the ribose group of the natural ligand adenosine. Commercially available 5,6-diphenyl-1,2,4-triazine-3-amine <b>45</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) exhibited an antagonism at human A<sub>2A</sub> receptor (<i>K</i><sub>i</sub> = 115 nM) and basically no selectivity over human A<sub>1</sub> (2-fold). Additional SAR exploration in this series, such as replacement of the phenyl ring (ring A) of compound <b>45</b> with a 4-pyridyl group, resulted in the discovery of analogue <b>46</b>, which showed a substantial increase in potency at the human A<sub>2A</sub> receptor (<i>K</i><sub>i</sub> = 3.5 nM); however, the human A<sub>1</sub> selectivity continued to be low (8.8-fold). Heptares has reported that compound <b>46</b> displayed moderate clearance (Cl<sub>p</sub> = 42 mL min<sup>â1</sup> kg<sup>â1</sup>), a relatively high volume of distribution (4.6 L/kg), an acceptable half-life (<i>t</i><sub>1/2</sub> = 1.1 h), high bioavailability (<i>F</i> = 100%), and good plasma exposure (AUC = 846 ngÂ·h/mL at 2 mg/kg, po) in the rat. Compound <b>46</b> also demonstrated excellent brain penetration (ratio of brain/plasma of 3.2 at 0.5 h after iv dose). Moreover, compound <b>46</b> was found to significantly inhibit rat catalepsy induced by haloperidol, with ED<sub>50</sub> values of 0.2 mg/kg at both 1 and 2 h time-points. In a recent patent application, Heptares has claimed a variety of 5,6-disubstituted-1,2,4-triazine-3-amine derivatives as dual A<sub>1</sub>/A<sub>2A</sub> receptor antagonists.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Analysis of the X-ray crystal structure of <b>46</b> showed a hydrogen bond interaction between the 4-pyridyl nitrogen and water molecules in the A<sub>2A</sub> receptor binding pocket, and this inspired the synthesis of other ring-A-substituted analogues.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> Substitution at the para- and meta-positions of ring A can afford compounds with a slightly improved A<sub>1</sub> selectivity profile that also retain desirable A<sub>2A</sub> potency, especially when the aromatic A-ring contains a fluorine atom at the para-position. Compounds <b>47</b> and <b>48</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) are representative examples in which ring A is a cyclic amine. Replacement of the 3-dimethylpiperidine ring of <b>47</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 41 nM, 245-fold selective over hA<sub>1</sub>) with a 2,6-dimethylmorpholine gave analogue <b>48</b> in which the morpholine oxygen atom is believed to be responsible for its higher binding affinity (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 16 nM) with respect to analogue <b>47</b>. In addition, compound <b>48</b> showed excellent selectivity over the human A<sub>1</sub> receptor (617-fold). Compounds <b>47</b> and <b>48</b> possess an attractive preliminary in vitro profile, and it would be interesting to learn if these or similar monocyclic structures can be efficacious in in vivo animal models of PD.</div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0012.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Selected A<sub>2A</sub> antagonists from Shire Therapeutics, Domein Therapeutics, and Kyowa Hakko Kirin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> Domain Therapeutics</h4><div class="NLM_p last">According to the companyâs pipeline, Domain Therapeutics (formerly Faust Pharmaceuticals) is currently investigating the selective adenosine A<sub>2A</sub> receptor antagonist DT1133 (also named FP1133, structure not disclosed).<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> In a recent patent application containing very limited biological data, a variety of imidazo[1,2-<i>a</i>]pyridine derivatives are claimed.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> Only A<sub>2A</sub> receptor binding affinity is reported for selected compounds, and no A<sub>1</sub> receptor data have been released. Compound <b>49</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) displayed good human A<sub>2A</sub> receptor binding affinity (hA<sub>2A</sub><i>K</i><sub>i</sub> = 12 nM). When administered orally in the haloperidol-induced catalepsy mouse model, compound <b>49</b> showed a significant anticataleptic activity in a dose-dependent manner at 10 and 30 mg/kg doses. Replacement of the central phenyl ring of <b>49</b> with an indazole or a benzoxazole scaffold gave compounds <b>50</b> and <b>51</b>, which exhibited very high affinities at the human A<sub>2A</sub> receptor (hA<sub>2A</sub><i>K</i><sub>i</sub> = 3 nM and hA<sub>2A</sub><i>K</i><sub>i</sub> = 4 nM, respectively).</div></div><div id="sec7_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Kyowa Hakko Kirin</h4><div class="NLM_p last">As discussed in the historic A<sub>2A</sub> receptor antagonists section of this review, investigators at Kyowa Hakko Kirin (formerly Kyowa Hakko Kogyo) developed the xanthine derivative istradefylline (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Despite completion of phase III clinical trials in 2008, it was not approved in the U.S. by the FDA because of a lack of efficacy; however, in March of 2013, Kyowa Hakko Kirin received approval to market istradefylline in Japan as Nouriast (20 mg tablets).<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> Recently, Kyowa Hakko Kirin has reported the synthesis and SAR studies of the non-xanthine benzofuran derivatives <b>52</b>â<b>54</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>) as adenosine A<sub>2A</sub> receptor antagonists.<a onclick="showRef(event, 'ref167 ref168'); return false;" href="javascript:void(0);" class="ref ref167 ref168">(167, 168)</a> These antagonists have a fused 5â6 heterocyclic structure similar to the Biotie/Rocheâs benzothiazoles <b>36</b> and tozadenant (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>). The morpholine-substituted amide <b>52</b> (hA<sub>2A</sub> %Â inh = 39 at 10 nM, hA<sub>1</sub> %Â inh = 37 at 1 Î¼M) was efficacious in the mouse CGS21680-induced catalepsy model (78% at 10 mg/kg, po). The 4-morpholinebenzofuran analogue <b>53</b> also displayed good in vitro potency (hA<sub>2A</sub> %Â inh = 30 at 10 nM) and an excellent selectivity profile (hA<sub>1</sub> %Â inh = 4, A<sub>2B</sub> %Â inh = 21, both at 1 Î¼M). Compound <b>53</b> showed efficacy in the mouse CGS21680-induced catalepsy model (76% at 10 mg/kg, po). Methyl carbamate <b>54</b> showed a similar in vitro potency (hA<sub>2A</sub> %Â inh = 28 at 10 nM) to compound <b>53</b> and also remarkably reversed rat catalepsy (86% at 10 mg/kg, po). In this series, 4-morpholine derivatives such as compound <b>53</b> have superior aqueous solubility and pharmacokinetic profiles compared with their 4-phenyl analogues.</div></div><div id="sec7_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> Biogen Idec</h4><div class="NLM_p">The Biogen Idec research group has reported on a variety of fused bicyclic cores derived from the known non-xanthine A<sub>2A</sub> receptor antagonist ZM241385 (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). As mentioned in the historic antagonist section of this review, ZM241385 has a low oral bioavailability and limited brain penetration. With the aim of avoiding these liabilities, researchers at Biogen Idec have explored the SAR of the side chain. Adding the arylpiperazine tail discovered at Merck/Schering-Plough resulted in compound <b>55</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>), a bicyclic analogue of <b>32</b> with a core 1,2,4-triazolo[1,5-<i>c</i>]triazine instead of 1,2,4-triazolo[1,5-<i>c</i>]pyrimidine.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Compound <b>55</b>, which showed potent rat A<sub>2A</sub> receptor binding affinity (rA<sub>2A</sub><i>K</i><sub>i</sub> = 4 nM) and a good selectivity over the rat A<sub>1</sub> receptor (205-fold), was orally active in the mouse catalepsy model at 3 mg/kg. Compound <b>56</b> (rA<sub>2A</sub><i>K</i><sub>i</sub> = 4 nM, 63-fold over rA<sub>1</sub>) is a representative example of a novel potent and selective series of A<sub>2A</sub> antagonists that contain a (<i>R</i>)-2-(aminomethyl)pyrrolidine as the side chain.<a onclick="showRef(event, 'cit135b'); return false;" href="javascript:void(0);" class="ref cit135b">(135b)</a> Compound <b>56</b> was orally active in the mouse catalepsy model at 10 mg/kg (po). Replacement of the triazolotriazine core with a triazolopyrimidine scaffold reduced A<sub>2A</sub> receptor binding affinity and selectivity over the A<sub>1</sub> receptor, but interestingly in vivo efficacy was improved. Further attempts to optimize the side chain resulted in the discovery of novel fused bicyclic piperazine derivatives (e.g., compound <b>57</b>),<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> which can be viewed as constrained analogues of the 2-(aminomethyl)pyrrolidine linker as exemplified by compound <b>56</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>). In general, constrained analogues of <b>57</b> showed a reduced A<sub>2A</sub> potency at the rat A<sub>2A</sub> receptor. Triazolopyrimidine <b>57</b> (rA<sub>2A</sub><i>K</i><sub>i</sub> = 63 nM, 17-fold over rA<sub>1</sub>) exhibited greater than 50% reduction of haloperidol-induced rat catalepsy within 30 min after oral administration, and this effect lasted for more than 120 min at a dose of 3 mg/kg (po). Compounds with the <i>R</i> stereochemistry in these novel pyrrolidine and fused piperazine-based side chains have greater in vitro potency and in vivo efficacy than the <i>S</i>. Novel alkynyl-substituted derivatives of the triazolopyrazine core were also reported. A representative analogue, compound <b>58</b> (rA<sub>2A</sub><i>K</i><sub>i</sub> = 12 nM, 3.4-fold over rA<sub>1</sub>), was orally active at 3 mg/kg in both the mouse catalepsy and the 6-OHDA-lesioned rat model.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a></div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0013.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Selected A<sub>2A</sub> antagonists from Biogen Idec, Sigma-Tau, and Astellas Pharma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> Sigma-Tau</h4><div class="NLM_p last">The Sigma-Tau research group has been exploring the possibility of substituting the furan ring with a triazole using a pyrimidoimidazo core derived from ZM241385. In this series, Sigma-Tau investigators identified ST1535 (<b>59</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>)<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> as a lead candidate for the treatment of PD. Antagonist <b>59</b> displayed potent A<sub>2A</sub> receptor binding affinity (hA<sub>2A</sub><i>K</i><sub>i</sub> = 6.6 nM), 12-fold and 59-fold selectivity versus human A<sub>1</sub> and A<sub>2B</sub> receptors, respectively, and was orally active at doses of 5 and 1.25 mg/kg in hypolocomotion and haloperidol-induced catalepsy models in rodents. It also potentiated L-DOPA activity in 6-OHDA-lesioned rats and MPTP-treated marmosets. Interestingly, it is reported that when dosed at 20 mg/kg in combination with L-DOPA (2.5 mg/kg), compound <b>59</b> significantly reversed motor disability compared with 20 mg/kg <b>59</b> alone.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Although <b>59</b> has been studied in phase I clinical trials, it is no longer listed on Sigma-Tauâs pipeline. According to a recent patent application, ST3932 and ST4206 (<b>60</b> and <b>61</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>) are active oxidized metabolites of <b>59</b> with similar in vitro potencies (hA<sub>2A</sub><i>K</i><sub>i</sub> = 8 nM and <i>K</i><sub>i</sub> = 12 nM, respectively) and human A<sub>1</sub> selectivity (3- and 16-fold, respectively).<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> Antagonists <b>60</b> and <b>61</b> were orally active at 10, 20, and 40 mg/kg doses in haloperidol-induced catalepsy in mice. Additionally, these two compounds showed an increase in contralateral turning behavior induced by L-DOPA in rats (3 mg/kg dose).<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> This series of compounds possesses many good characteristics, but low selectivity over the A<sub>1</sub> receptor and possible stability issues with the triazole (a good leaving group) may be possible reasons for Sigma-Tau to decide to halt development.</div></div><div id="sec7_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Astellas Pharma</h4><div class="NLM_p last">The monocyclic aminopyrazine derivative ASP5854 (<b>62</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>) was developed by the Astellas Pharma research group. It has a structure very similar to the structures of the Shire/Heptares A<sub>2A</sub> antagonists discussed previously.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> Compound <b>62</b> is a potent human A<sub>2A</sub> (<i>K</i><sub>i</sub> = 1.8 nM) and A<sub>1</sub> receptor (<i>K</i><sub>i</sub> = 9 nM) dual antagonist that reversed haloperidol-induced rat catalepsy with a MED of 0.1 mg/kg. In addition, <b>62</b> significantly potentiated L-DOPA-induced rotational behavior in unilaterally 6-OHDA-lesioned rats with a MED of 0.03 mg/kg when dosed orally.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> In non-human primates, the anticataleptic effect of <b>62</b> was achieved at more than 85% striatal A<sub>2A</sub> receptor occupancy, and the compound reversed motor disability in MPTP-lesioned marmoset models at doses higher than 1 mg/kg dose, po.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> In the rat passive avoidance test, <b>62</b> significantly reversed scopolamine-induced memory deficits at 0.3 mg/kg po and was efficacious in reversing the scopolamine-induced impairment of spontaneous alternation in the mouse Y-maze test at 0.1 mg/kg, po. In contrast, the specific adenosine A<sub>2A</sub> receptor antagonist istradefylline was not efficacious in either of these tests. Importantly, these results demonstrate that the orally active dual adenosine A<sub>2A</sub> and A<sub>1</sub> receptor antagonist <b>62</b> can repair motor impairments via A<sub>2A</sub> receptor antagonism. It is noteworthy to mention that via A<sub>1</sub> receptor antagonism, <b>62</b> also showed an improved cognitive function in animal cognition models; however, this subject is outside the scope of this review.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> Because Astellas has not reported any recent development of <b>62</b>, it is assumed that this program has been discontinued.</div></div><div id="sec7_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> Johnson & Johnson</h4><div class="NLM_p">Researchers at Johnson & Johnson have developed a novel arylindenopyrimidine scaffold from initial screening hits.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> The initial lead, compound <b>63</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>), had superior functional in vitro activity (no binding affinity has been reported for this class of compounds) in both human A<sub>2A</sub> and A<sub>1</sub> receptors (hA<sub>2A</sub> cAMP <i>K</i><sub>i</sub> = 0.1 nM, hA<sub>1</sub> cAMP <i>K</i><sub>i</sub> = 0.4 nM) and reversed haloperidol-induced catalepsy in mice with an ED<sub>50</sub> of 5 mg/kg (po). However, compound <b>63</b> had poor aqueous solubility and was Ames positive.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> In order to attempt to address these two liabilities, the furan ring of <b>63</b> was replaced by a phenyl ring, and a variety of amines were incorporated at the 8 and 9 positions of the arylindenopyrimidine scaffold. These efforts resulted in the discovery of compound <b>64</b>, a promising dual A<sub>2A</sub> and A<sub>1</sub> receptor antagonist that showed potent functional in vitro activities (hA<sub>2A</sub> cAMP <i>K</i><sub>i</sub> = 4.1 nM; hA<sub>1</sub> cAMP <i>K</i><sub>i</sub> = 17 nM), had a good pharmacokinetic profile, and achieved desirable brain levels. Compound <b>64</b> also exhibited good in vivo efficacy with ED<sub>50</sub> values of 0.2 and 0.5 mg/kg (po) in the mouse and rat catalepsy models, respectively. In addition, compound <b>64</b> demonstrated excellent in vivo efficacy in the reserpine-induced akinesia mouse model at 1 mg/kg (po), the 6-OHDA-lesioned rat model at 1 mg/kg (po), and the reversing motor disability model in MPTP-treated marmosets at 10 mg/kg (po).<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Nevertheless, further development of compound <b>64</b> was discontinued because of its genotoxicity in both the Ames test and the mouse lymphoma L5178Y assay. Metabolic identification studies showed that after oxidative metabolism, two reactive metabolites were produced, one with an endocyclic iminium ion in the pyrrolidine ring and another containing an arylaldehyde, both of which are known to cause genotoxicity. Therefore, these analogues were further modified to yield compounds <b>65</b> and <b>66</b>, ether and amino analogues, respectively, that do not contain a benzylic hot spot for oxidative metabolism. Both compounds <b>65</b> (hA<sub>2A</sub> cAMP <i>K</i><sub>i</sub> = 6.5 nM; hA<sub>1</sub> cAMP <i>K</i><sub>i</sub> = 48.2 nM) and <b>66</b> (hA<sub>2A</sub> cAMP <i>K</i><sub>i</sub> = 4.4 nM; hA<sub>1</sub> cAMP <i>K</i><sub>i</sub> = 32.7 nM) maintained functional in vitro potency and were very efficacious in the mouse catalepsy model with ED<sub>50</sub> < 0.1 mg/kg, po. In particular, compound <b>65</b> was effective in reversing haloperidol-induced catalepsy with an ED<sub>50</sub> value of 0.3 mg/kg, po, in mouse/rat models of reserpine-induced akinesia at 1 mg/kg.<a onclick="showRef(event, 'ref180 ref181'); return false;" href="javascript:void(0);" class="ref ref180 ref181">(180, 181)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0014.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Selected A<sub>2A</sub> antagonists from Johnson & Johnson and Neurocrine Biosciences.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Recently Johnson & Johnson has reported a series of aminothieno[2,3-<i>d</i>]pyrimidines, exemplified by compounds <b>67</b>â<b>69</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>), that were potent adenosine A<sub>2A</sub> receptor antagonists with varying degrees of selectivity over A<sub>1</sub> receptors. A number of cyclic and acyclic amines were explored as side chains, and some interesting SAR results were obtained. The less basic the amino group incorporated, the higher are the in vitro and in vivo activities of the compound bearing this group. For example, compounds containing very basic amines such as pyrrolidines (calcd p<i>K</i><sub>a</sub> = 8.2) and piperidines (calcd p<i>K</i><sub>a</sub> = 8.5) showed good in vitro potency but did not reverse catalepsy in vivo; however, compounds with a reduced basic amine, such as morpholine (calcd p<i>K</i><sub>a</sub> = 6.5) in compound <b>67</b> (hA<sub>2A</sub> cAMP <i>K</i><sub>i</sub> = 29 nM; hA<sub>1</sub> cAMP <i>K</i><sub>i</sub> = 1680 nM), were potent in vivo with an ED<sub>50</sub> for compound <b>67</b> of 1.3 mg/kg, po, in the mouse catalepsy model. Compound <b>68</b> containing a difluorinated piperidine (calcd p<i>K</i><sub>a</sub> = 4.7) was significantly more potent in vitro (hA<sub>2A</sub> cAMP <i>K</i><sub>i</sub> = 6.6 nM; hA<sub>1</sub> cAMP <i>K</i><sub>i</sub> = 290 nM) than <b>67</b> and also very active in vivo, with ED<sub>50</sub> < 1 mg/kg, po, in the mouse catalepsy model. Attempts to avoid metabolic oxidation at the benzylic carbon led to compound <b>69</b>, where steric hindrance is provided by the methyl groups of a <i>cis</i>-2,6-dimethylpiperidine. Compound <b>69</b> is the most potent analogue of this series (hA<sub>2A</sub> cAMP <i>K</i><sub>i</sub> = 5.3 nM; hA<sub>1</sub> cAMP <i>K</i><sub>i</sub> = 100 nM) and showed a robust in vivo efficacy in the mouse catalepsy model at 10 mg/kg, po.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> It would be particularly interesting to develop one of these molecules to investigate the effects of a dual A<sub>2A</sub>/A<sub>1</sub> antagonist in treating the motor and cognitive symptoms of PD.</div></div><div id="sec7_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Neurocrine Biosciences</h4><div class="NLM_p last">Neurocrine Biosciences has reported that a series of trisubstituted pyrimidines act as adenosine A<sub>2A</sub> receptor antagonists.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> The initial 4-acylaminopyrimidine lead compound <b>70</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>, hA<sub>2A</sub><i>K</i><sub>i</sub> = 0.6 nM) suffered from a lack of selectivity over the human A<sub>1</sub> receptors (17-fold), and its furan moiety had the potential for metabolic instability. Simultaneous optimization of the acetamide moiety and the pyrazole and furan rings of <b>70</b> led to compound <b>71</b>. This analogue maintained a high binding affinity (hA<sub>2A</sub><i>K</i><sub>i</sub> = 9.0 nM) and had an improved selectivity versus the human A<sub>1</sub> receptor (222-fold selectivity); however, it showed a weak inhibition of CYP3A4 (IC<sub>50</sub> = 13 Î¼M).<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a> Most of the piperazine derivatives such as compound <b>71</b> were found to be potent inhibitors of the hERG channel. In an effort to address this liability, replacement of the piperazine moiety was explored. As a result, compound <b>72</b>, which is a potent adenosine A<sub>2A</sub> receptor antagonist (hA<sub>2A</sub><i>K</i><sub>i</sub> = 0.4 nM) with good selectivity over the human A<sub>1</sub> receptor (100-fold), showed a clean hERG profile (patch-clamp IC<sub>50</sub> = 1200 nM) and good aqueous solubility (0.21 mg/mL, pH 5). Although the pharmacokinetic profile of compound <b>72</b> displayed rapid plasma clearance (330 mL min<sup>â1</sup> kg<sup>â1</sup>), the brain levels were high, even after 4 h (360 ng/g). In line with the in vivo data, compound <b>72</b> exhibited significant oral activity with a MED of 10 mg/kg in the rat haloperiodol-induced catalepsy model.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a> Further development of this series led to the discovery of compound <b>73</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a>), an analogue that showed potent and selective A<sub>2A</sub> antagonism (hA<sub>2A</sub><i>K</i><sub>i</sub> = 0.4 nM, 193-fold over hA<sub>1</sub>). Despite its moderate solubility (30 Î¼g/mL at pH 7.4), compound <b>73</b> was efficacious at an oral dose of 1 mg/kg in the haloperidol-induced rat catalepsy model and exhibited 88% inhibition of catalepsy at 10 mg/kg, a dose at which plasma exposure (150 ng/mL) was moderately low but brain exposure (560 ng/g) was relatively high. Oral administration of compound <b>73</b> also potentiated L-DOPA-induced rotational behavioral in unilaterally 6-OHDA-lesioned rats with a MED of 3 mg/kg (po).<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a> In order to improve the solubility of this series, a number of different small cyclic amines were incorporated at the pyridyl A-ring of <b>73</b>; however, most of these analogues showed much lower levels of in vitro potency and A<sub>1</sub> selectivity.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a></div></div><div id="sec7_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Miscellaneous Series of A<sub>2A</sub> Receptor Antagonists</h4><div class="NLM_p">Palobiofarma is currently developing a non-furan adenosine A<sub>2A</sub> receptor antagonist PBF509 (structure not disclosed) for the treatment of PD. According to Palobiofarmaâs pipeline, PBF509 is currently in phase I clinical trials.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> A recent patent application from this company claimed 4-aminopyrimidine derivatives such as <b>74</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>) as adenosine A<sub>2A</sub> receptor antagonists. Interestingly, A<sub>2A</sub> binding affinities were shown only for selected intermediates and no data for final targets were reported.<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a></div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0015.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Other known A<sub>2A</sub> antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In addition to the companies mentioned in this section, other research groups have also reported SAR studies of A<sub>2A</sub> receptor antagonists as potential agents to treat PD. These include Kissei Pharmaceutical (<b>75</b>, benzofurans/pyridofurans, patent applications only),<a onclick="showRef(event, 'ref190 ref191'); return false;" href="javascript:void(0);" class="ref ref190 ref191">(190, 191)</a> University of Delhi (<b>76</b>, thiazolotriazolopyrimidines),<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> Ligand Pharmaceuticals/Pharmacopiea, Inc. (<b>77</b>, 2-aminoimidazopyridines),<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> and Ligand Pharmaceuticals (<b>78</b>, trisubstituted purinones).<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> Although in general these derivatives (shown in Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a>) have a desirable in vitro A<sub>2A</sub> binding affinity and selectivity profile, no in vivo results have been reported.</div><div class="NLM_p last">As we have seen in this section, the design of novel and orally active A<sub>2A</sub> antagonists has been focused on two different strategies. First, to avoid the formation of reactive metabolites, many non-furan-containing aryl and heteroaryl analogues have been prepared. Second, to improve the low aqueous solubility found in most of these polycyclic ligands, introduction of polar substituents and the development of novel monocyclic and bicyclic cores have been extensively studied.</div></div></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Other Therapeutic Areas</h3><div class="NLM_p">According to Thompson Pharma, CV Therapeutics (acquired by Gilead Sciences Inc.) is conducting preclinical studies with a series of A<sub>2A</sub> antagonists for the potential treatment of chemical dependence.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> In addition, Agenus Inc. and NewVac LLC are investigating analogues of istradefylline as selective A<sub>2A</sub> adenosine receptor antagonists as adjuvants for use with oncovaccines and adoptive immunotherapy in potential personalized cancer vaccines.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a></div><div class="NLM_p last">Despite the vast number of publications regarding the utility of historic A<sub>2A</sub> antagonists for many different therapeutic applications, the current ongoing clinical trials involving A<sub>2A</sub> antagonists show that the focus of big pharma is currently confined to Parkinson disease.</div></div><div id="sec7_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> Antagonist Radioligands</h3><div class="NLM_p">A number of radioligands have been studied over the past few decades. Not only are they useful for mapping the A<sub>2A</sub> receptors, but they are also of paramount importance for determining binding affinities and the relationships between dose, plasma levels, and receptor occupancy, critical information for the development of centrally acting drugs.</div><div class="NLM_p">Various radioligands of the xanthine type of A<sub>2A</sub> antagonists have been evaluated. In most cases these molecules have been labeled with <sup>3</sup>H or <sup>11</sup>C to study binding to A<sub>2A</sub> receptors in human platelets and rat striatal membranes or for use as PET radioligands to map A<sub>2A</sub> receptors in the heart and brain. Most of these efforts have been focused on finding a good PET ligand that specifically binds to the A<sub>2A</sub> receptors in the brain. This is not an easy task, and the major challenges that have been observed are compound accumulation and nonspecific binding (the compound is in the brain but not at the target receptors). On the basis of the literature, the most suitable radioligand of the xanthine type is <b>79</b> ([<sup>11</sup>C]TMSX, Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>), a compound developed by Mishina et al. as a PET ligand to map the A<sub>2A</sub> receptors in the brain of PD patients.<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> However, because of the susceptibility of xanthine <b>79</b> to photoisomerization, more suitable radioligands of the non-xanthine type have been developed.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0016.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. A<sub>2A</sub> antagonists radioligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A number of studies using [<sup>125</sup>I]ZM241385 and [<sup>3</sup>H]ZM241385 (both from <b>16</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) have been published, but the applications of these radioligands have been limited, since these compounds also have a high binding affinity at the A<sub>2B</sub> receptor. In 1996, Zocchi et al. were the first to document a specific, saturable, and reversible binding of [<sup>3</sup>H]SCH58261 in rat striatal membranes (h<i>K</i><sub>d</sub> = 0.70 nM).<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a> Calculation of the binding of different agonists and antagonists was based on displacement from the A<sub>2A</sub> receptor of [<sup>3</sup>H]SCH58261, which proved to be an excellent probe for studying the A<sub>2A</sub> receptor subtype in mammalian brain. [<sup>3</sup>H]SCH58261 has also been successfully used to develop binding assays in porcine coronary arteries, porcine striatum, and PC12 cells.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> Furthermore, successful [<sup>3</sup>H]SCH58261 labeling of adenosine A<sub>2A</sub> receptors in human platelets and in human neutrophil membranes has also been accomplished.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> In addition, [<sup>3</sup>H]SCH58261 has been used to characterize the A<sub>2A</sub> receptors in human lymphocyte membranes<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> and proven to be a useful tool in autoradiographic studies in rats.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a></div><div class="NLM_p last">Fazio et al. have developed [<sup>11</sup>C]SCH442416 (<b>80</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a>) as a suitable PET tracer.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a> Its parent compound (SCH442416) possesses a methoxy group to allow a fast and easy chemical approach to the radiosynthesis of the labeled form and a high specific radioactivity of the final product by direct alkylation of the phenolic function with [<sup>11</sup>C]CH<sub>3</sub>I. Radioligand <b>80</b> has a high binding affinity at the adenosine A<sub>2A</sub> receptor (h<i>K</i><sub>d</sub> = 0.048 nM) and is the first non-xanthine radioligand applicable for the in vivo PET imaging of adenosine A<sub>2A</sub> receptors due its adequate regional distribution in the brain and the periphery, a good signal-to-noise ratio observed between 5 and 15 min after injection, and the low occurrence of radioactive metabolites. Papapetropoulos et al. successfully used <b>80</b> as a PET radiotracer to investigate the relationships between dose, steady-state plasma levels, and receptor occupancy of vipadenant (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) in healthy male volunteers.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a></div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41822" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41822" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Following the discovery of adenosine, almost a century of intense research on adenosine receptors has led to the selection of the adenosine A<sub>2A</sub> receptor as a research target for developing small molecules in the treatment of various medical conditions.</div><div class="NLM_p">The vast store of knowledge and numerous research tools available make the A<sub>2A</sub> receptor a fascinating target for the medicinal chemist to explore. Not only does knowledge about receptor distribution combined with the availability of selective ligands allow us to obtain critical information such as receptor occupancy, but insight into its structure, particularly that coming from X-ray crystal structures, also serves to inspire the design of novel potent and selective A<sub>2A</sub> ligands.</div><div class="NLM_p">On the basis of a large number of publications in the literature, A<sub>2A</sub> ligands have therapeutic potential for a wide spectrum of medical conditions. One of these applications, the vasodilating effect of an A<sub>2A</sub> agonist, has been validated, and adenosine and regadenoson are currently being marketed for myocardial perfussion imaging. Furthermore, A<sub>2A</sub> agonists are being investigated as agents to treat a number of conditions such as asthma, COPD, neuropathic pain, and diabetic foot ulcers.</div><div class="NLM_p last">The potential therapeutic use of an A<sub>2A</sub> antagonist still remains to be validated. As we have seen in this review, most of the efforts in this area are focused on treating the symptoms of Parkinson disease. Unfortunately the lack of efficacy in phase III studies of istradefylline, and recently of preladenant, constitutes a major setback and raises questions about the therapeutic validity of this mechanism in humans. In our opinion, the main question that needs to be answered is whether the lack of efficacy of istradefylline and preladenant is due to a particular intrinsic feature of these compounds or to the complexity involved in designing these types of clinical studies, such as appropriate dose selection and recruitment of the correct patient populations. It is also possible that the commonly assumed connection between A<sub>2A</sub> receptors and the symptoms of PD is invalid because in vivo efficacy does not translate from animal models to humans, a situation unfortunately often observed in CNS programs. The current vigorous stream of research and development, including ongoing clinical trials with tozadenant in phase IIb and V81444 in phase IIa studies, may enable us to reach a conclusion about the possible connection between the A<sub>2A</sub> mechanism and PD in the near future.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/jm4011669" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46366" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46366" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Manuel de Lera Ruiz</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical Research, Merck Research Laboratories, 770 Sumneytown Pike, West Point, Pennsylvania 19486, United States</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6f020e011a0a03411d1a06152f020a1d0c04410c0002"><span class="__cf_email__" data-cfemail="c5a8a4abb0a0a9ebb7b0acbf85a8a0b7a6aeeba6aaa8">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yeon-Hee Lim</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical Research, Merck Research Laboratories, 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Junying Zheng</span> - <span class="hlFld-Affiliation affiliation">Department
of Chemical Research, Merck Research Laboratories, 126 E. Lincoln Avenue, Rahway, New Jersey 07065, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The author declares no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Manuel de Lera Ruiz</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=BIO-d693e5801-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Manuel de Lera Ruiz</b> received his B.Sc. in Chemistry from the University AutÃ³noma of Madrid, Spain, in 1997. After completion of his Ph.D. in 2001 from the University of Nottingham, U.K., he joined Professor Leo A. Paquetteâs research laboratories as a Postdoctoral Fellow. In 2003, he started a career in medicinal chemistry at Schering-Plough Research Institute, and currently, he is an Associate Principal Scientist with Merck Research Laboratories in West Point, PA.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Yeon-Hee Lim</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=BIO-d693e5806-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Yeon-Hee Lim</b> received her B.Sc. in Chemistry from the Pusan National University, South Korea, in 1997 and her M.Sc. in Chemistry from the Korea Advanced Institute of Technology (KAIST), South Korea, in 1999. After completion of her Ph.D. in 2005 from SUNY at Stony Brook, NY, under the direction of Professors Kathlyn A. Parker and Scott McN. Sieburth, she joined Professor M. G. Finnâs group at the Scripps Research Institute, CA, as a Postdoctoral Fellow. In 2008, she started her career in medicinal chemistry at Schering-Plough Research Institute, and currently, she is an Associate Principal Scientist with Merck Research Laboratories in Rahway, NJ.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Junying Zheng</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=BIO-d693e5811-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Junying Zheng</b> received his B.Sc. in Chemistry from Nanjing University, China, and M.Sc. in Organic Chemistry from the University of Alabama in 1998. He then did his Ph.D study in organic synthesis under the direction of Professor Amos B. Smith, III, at the University of Pennsylvania. After obtaining his Ph.D degree in 2003, he started his career in the pharmaceutical industry as a medicinal chemist at Schering-Plough Research Institute. Currently, he is an Associate Principal Scientist at Merck Research Laboratory in Rahway, NJ.</p></figure></div><div class="ack" id="ACK-d693e5816-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17414" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17414" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. Amjad Ali, Dr. Robert Hodgson, Dr. Andrew Stamford, and Dr. Pauline Ting for their comments and suggestions. Editing support from Philippa Solomon is greatly acknowledged. Dr. Kate Holloway is thanked for graphic images.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_51041" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_51041" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 204 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Druri, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szent-GyÃ¶rgy, A.</span><span> </span><span class="NLM_article-title">The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart</span> <span class="citation_source-journal">J. Physiol. (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1929</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">â</span> <span class="NLM_lpage">237</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1929&pages=213-237&author=A.+N.+Druriauthor=A.+Szent-Gy%C3%B6rgy&title=The+physiological+activity+of+adenine+compounds+with+especial+reference+to+their+action+upon+the+mammalian+heart"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDruri%26aufirst%3DA.%2BN.%26aulast%3DSzent-Gy%25C3%25B6rgy%26aufirst%3DA.%26atitle%3DThe%2520physiological%2520activity%2520of%2520adenine%2520compounds%2520with%2520especial%2520reference%2520to%2520their%2520action%2520upon%2520the%2520mammalian%2520heart%26jtitle%3DJ.%2520Physiol.%2520%2528London%2529%26date%3D1929%26volume%3D68%26spage%3D213%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Cobbin, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, M. H.</span><span> </span><span class="NLM_article-title">Studies on the coronary dilator actions of some adenosine analogs</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">â</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1111%2Fj.1476-5381.1974.tb09589.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=4362949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaE2cXktleht7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1974&pages=25-33&author=L.+B.+Cobbinauthor=R.+Einsteinauthor=M.+H.+McGuire&title=Studies+on+the+coronary+dilator+actions+of+some+adenosine+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Coronary dilator actions of adenosine analogs</span></div><div class="casAuthors">Cobbin, L. B.; Einstein, Rosemarie; Maguire, M. Helen</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-33</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Of 23 adenosine (I) [58-61-7] analogs, 22 stimulated coronary blood flow, with potencies which were not related to their durations of action, and durations which were not related to their substrate specificities for adenosine deaminase [9026-93-1] or adenosine kinase [9027-72-9].  Five of the analogs, which were injected intraatrially into anesthetized open thorax dogs, had potencies equal to or greater than that of I, and 4 potentiated the coronary dilator action of I.  The duration of this activity may be governed by the rate of tissue uptake of each analog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjwZ-Jcnn3hbVg90H21EOLACvtfcHk0ljAqywMj7wrbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXktleht7w%253D&md5=9b9ccedb0a7462c1d82273d6f90ad8f4</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1974.tb09589.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1974.tb09589.x%26sid%3Dliteratum%253Aachs%26aulast%3DCobbin%26aufirst%3DL.%2BB.%26aulast%3DEinstein%26aufirst%3DR.%26aulast%3DMcGuire%26aufirst%3DM.%2BH.%26atitle%3DStudies%2520on%2520the%2520coronary%2520dilator%2520actions%2520of%2520some%2520adenosine%2520analogs%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1974%26volume%3D50%26spage%3D25%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">De Gubareff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleator, W.</span><span> </span><span class="NLM_article-title">Effects of caffeine on mammalian atrial muscle, and its interaction with adenosine and calcium</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">â</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=14301011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaF2MXktVGqsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=1965&pages=202-214&author=T.+De+Gubareffauthor=W.+Sleator&title=Effects+of+caffeine+on+mammalian+atrial+muscle%2C+and+its+interaction+with+adenosine+and+calcium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of caffeine on mammalian atrial muscle and its interaction with adenosine and calcium</span></div><div class="casAuthors">De Gubareff, Taisija; Sleator, William, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-14</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Caffeine (I), at 0.25-1.5 mM, exerted a pos. inotropic effect on isolated guinea pig atrium, while at higher concns. the contraction decreased.  The increased duration of transmembranal action potentials induced by I was proportional to drug concn., and at 2.5 mM was twice normal.  I probably releases catechol amines from the normal heart, but not following pretreatment with reserpine; however, the inotropic activity of I is not via this process.  The marked effect of I on the duration of the action potential as well as on contraction was dependent upon Ca in the medium, such that when both are present the strength of contraction and duration of action potential increase at a low frequency of elec. stimulation.  I antagonized the depressant effect of adenosine on contraction and action potential of the guinea pig and human atria, probably by altering the functions of Ca within the muscle cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphQKAWx4q3t7Vg90H21EOLACvtfcHk0lggowPD54AAKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXktVGqsrY%253D&md5=0ae31bc64f3f2a047e6be43a8d0a184a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGubareff%26aufirst%3DT.%26aulast%3DSleator%26aufirst%3DW.%26atitle%3DEffects%2520of%2520caffeine%2520on%2520mammalian%2520atrial%2520muscle%252C%2520and%2520its%2520interaction%2520with%2520adenosine%2520and%2520calcium%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1965%26volume%3D148%26spage%3D202%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Sattin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rall, T. W.</span><span> </span><span class="NLM_article-title">The effect of adenosine and adenine nucleotides on the cyclic adenosine 3â²,5â²-phosphate content of guinea pig cerebral cortex slides</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">â</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1970&pages=13-23&author=A.+Sattinauthor=T.+W.+Rall&title=The+effect+of+adenosine+and+adenine+nucleotides+on+the+cyclic+adenosine+3%E2%80%B2%2C5%E2%80%B2-phosphate+content+of+guinea+pig+cerebral+cortex+slides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSattin%26aufirst%3DA.%26aulast%3DRall%26aufirst%3DT.%2BW.%26atitle%3DThe%2520effect%2520of%2520adenosine%2520and%2520adenine%2520nucleotides%2520on%2520the%2520cyclic%2520adenosine%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-phosphate%2520content%2520of%2520guinea%2520pig%2520cerebral%2520cortex%2520slides%26jtitle%3DMol.%2520Pharmacol.%26date%3D1970%26volume%3D6%26spage%3D13%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">Are methylxanthines effects due to antagonism of endogenous adenosine?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">â</span> <span class="NLM_lpage">132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1980&pages=129-132&author=B.+B.+Fredholm&title=Are+methylxanthines+effects+due+to+antagonism+of+endogenous+adenosine%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DAre%2520methylxanthines%2520effects%2520due%2520to%2520antagonism%2520of%2520endogenous%2520adenosine%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1980%26volume%3D1%26spage%3D129%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Van Calker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, B.</span><span> </span><span class="NLM_article-title">Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">999</span><span class="NLM_x">â</span> <span class="NLM_lpage">1005</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1111%2Fj.1471-4159.1979.tb05236.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=228008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaL3cXht1aitrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1979&pages=999-1005&author=D.+Van+Calkerauthor=M.+Mullerauthor=B.+Hamprecht&title=Adenosine+regulates+via+two+different+types+of+receptors%2C+the+accumulation+of+cyclic+AMP+in+cultured+brain+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells</span></div><div class="casAuthors">Van Calker, Dietrich; Mueller, Margarete; Hamprecht, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">999-1005</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">In cultured mouse brain cells of glial character, the increase in intracellular concns. of cyclic AMP  [60-92-4] caused by Î²-adrenoceptor agonists was inhibited by <Î¼M concns. of adenosine  [58-61-7], whereas at concns. >Î¼M adenosine stimulated cyclic AMP concns. (EC50 â¼50 Î¼M).  Both effects of adenosine were antagonized by methylxanthines but not by blockage of adenosine uptake (100 Î¼M dipyridamol) or inhibition of cyclic AMP phosphodiesterase.  The activities depended on the integrity of the ribose moiety of the nucleotide; substituents of the purine system were tolerated comparatively well.  The order of potency of adenosine analogs was different for the 2 effects.  The 2 effects are probably mediated, therefore, by different adenosine receptors on the outer cell surface; the receptors mediating the inhibition and stimulation of cyclic AMP accumulation were termed A1 and A2, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9LOZV9yRbdrVg90H21EOLACvtfcHk0lggowPD54AAKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXht1aitrY%253D&md5=87028348a598749438cba570b2a077ce</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1979.tb05236.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1979.tb05236.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BCalker%26aufirst%3DD.%26aulast%3DMuller%26aufirst%3DM.%26aulast%3DHamprecht%26aufirst%3DB.%26atitle%3DAdenosine%2520regulates%2520via%2520two%2520different%2520types%2520of%2520receptors%252C%2520the%2520accumulation%2520of%2520cyclic%2520AMP%2520in%2520cultured%2520brain%2520cells%26jtitle%3DJ.%2520Neurochem.%26date%3D1979%26volume%3D33%26spage%3D999%26epage%3D1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Daly, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pamela, B.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padgett, W.</span><span> </span><span class="NLM_article-title">Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">â</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2FBF00734999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=6309393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaL3sXkvVantbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1983&pages=69-80&author=J.+W.+Dalyauthor=B.-T.+Pamelaauthor=W.+Padgett&title=Subclasses+of+adenosine+receptors+in+the+central+nervous+system%3A+interaction+with+caffeine+and+related+methylxanthines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Subclasses of adenosine receptors in the central nervous system:  interaction with caffeine and related methylxanthines</span></div><div class="casAuthors">Daly, John W.; Butts-Lamb, Pamela; Padgett, William</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-80</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    </div><div class="casAbstract">The potencies of caffeine (I)  [58-08-2] and related methylxanthines as adenosine antagonists were assessed with respect to 3 apparent subtypes of adenosine receptors in rat brain prepns.: (1) the A1-adenosine receptor which binds with a very high affinity the ligand [3H]cyclohexyladenosine in rat brain membranes; (2) a ubiquitous low-affinity A2-adenosine receptor which activates cyclic AMP  [60-92-4] accumulation in rat brain slices, and (3) a relatively high-affinity A2-adenosine receptor which activates adenylate cyclase  [9012-42-4] in rat striatal membranes (this A2-adenosine system is present in striatal but not in cerebral cortical membranes).  Caffeine and other methylxanthines, thus, antagonize effectively both A1- and A2-adenosine receptors in brain prepns.  Theobromine  [83-67-0] appears less effective vs. A2-receptors than vs. A1-receptors.  The functional significance of antagonism of such adenosine receptors by caffeine in situ will depend both on the local levels of adenosine and on the affinity for adenosine for the receptor, since antagonism by xanthines is competitive in nature.  In addn., the functional significance of xanthine action will depend on the degree of inhibition of adenosine input which is required to alter the output signal.  For a stimulatory input to adenylate cyclase via an A2-adenosine receptor, profound antagonism by methylxanthines is probably required to alter the cyclic AMP-mediated output signal, while for inhibitory input to adenylate cyclase via an A1-adenosine receptor, presumably a lesser degree of antagonism by methylamines may be required to alter the cyclic AMP-mediated output signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDacfOvNrNcbVg90H21EOLACvtfcHk0lggowPD54AAKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXkvVantbs%253D&md5=94132d6b898b052e58f965cd417889b2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2FBF00734999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00734999%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DPamela%26aufirst%3DB.-T.%26aulast%3DPadgett%26aufirst%3DW.%26atitle%3DSubclasses%2520of%2520adenosine%2520receptors%2520in%2520the%2520central%2520nervous%2520system%253A%2520interaction%2520with%2520caffeine%2520and%2520related%2520methylxanthines%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D1983%26volume%3D3%26spage%3D69%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span> </span><span class="NLM_article-title">Adenosine receptors as therapeutic targets</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1038%2Fnrd1983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=16518376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=247-264&author=K.+A.+Jacobsonauthor=Z.+G.+Gao&title=Adenosine+receptors+as+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors as therapeutic targets</span></div><div class="casAuthors">Jacobson, Kenneth A.; Gao, Zhan-Guo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-264</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the world.  There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischemic diseases, sleep disorders, immune and inflammatory disorders and cancer.  After more than three decades of medicinal chem. research, a considerable no. of selective agonists and antagonists of adenosine receptors have been discovered, and some have been clin. evaluated, although none has yet received regulatory approval.  However, recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, as discussed in this review, have brought the goal of therapeutic application of adenosine receptor modulators considerably closer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoG29EyQFoSbVg90H21EOLACvtfcHk0lg9nrF5x-hpQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr4%253D&md5=85ad553154bd61f24a6bb594f960f9bc</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrd1983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1983%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26atitle%3DAdenosine%2520receptors%2520as%2520therapeutic%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D247%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">â</span> <span class="NLM_lpage">552</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1211%2F0022357011775631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=11734617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVOltQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=527-552&author=B.+B.+Fredholmauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobsonauthor=K.-N.+Klotzauthor=J.+Linden&title=International+Union+of+Pharmacology.+XXV.+Nomenclature+and+classification+of+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors</span></div><div class="casAuthors">Fredholm, Bertil B.; IJzerman, Adriaan P.; Jacobson, Kenneth A.; Klotz, Karl-Norbert; Linden, Joel</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-552</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Four adenosine receptors have been cloned and characterized from several mammalian species.  The receptors are named adenosine A1, A2A, A2B, and A3.  The A2A and A2B receptors preferably interact with members of the Gs family of G proteins and the A1 and A3 receptors with Gi/o proteins.  However, other G protein interactions have also been described.  Adenosine is the preferred endogenous agonist at all these receptors, but inosine can also activate the A3 receptor.  The levels of adenosine seen under basal conditions are sufficient to cause some activation of all the receptors, at least where they are abundantly expressed.  Adenosine levels during, e.g., ischemia can activate all receptors even when expressed in low abundance.  Accordingly, expts. with receptor antagonists and mice with targeted disruption of adenosine A1, A2A, and A3 expression reveal roles for these receptors under physiol. and particularly pathophysiol. conditions.  There are pharmacol. tools that can be used to classify A1, A2A, and A3 receptors but few drugs that interact selectively with A2B receptors.  Testable models of the interaction of these drugs with their receptors have been generated by site-directed mutagenesis and homol.-based modeling.  Both agonists and antagonists are being developed as potential drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJOCrJphTwDrVg90H21EOLACvtfcHk0lg9nrF5x-hpQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVOltQ%253D%253D&md5=060ea8a3d7b07fdc4b2c8acc3b4d4745</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1211%2F0022357011775631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357011775631%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XXV.%2520Nomenclature%2520and%2520classification%2520of%2520adenosine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2001%26volume%3D53%26spage%3D527%26epage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Maenhaut, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Sande, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramowicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderhaegen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffmann, S.</span><span> </span><span class="NLM_article-title">RDC8 codes for an adenosine A2 receptor with physiological constitutive activity</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">1169</span><span class="NLM_x">â</span> <span class="NLM_lpage">1178</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=1990&pages=1169-1178&author=C.+Maenhautauthor=J.+Van+Sandeauthor=F.+Libertauthor=M.+Abramowiczauthor=M.+Parmentierauthor=J.+J.+Vanderhaegenauthor=J.+E.+Dumontauthor=G.+Vassanauthor=S.+Schiffmann&title=RDC8+codes+for+an+adenosine+A2+receptor+with+physiological+constitutive+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaenhaut%26aufirst%3DC.%26aulast%3DVan%2BSande%26aufirst%3DJ.%26aulast%3DLibert%26aufirst%3DF.%26aulast%3DAbramowicz%26aufirst%3DM.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DVanderhaegen%26aufirst%3DJ.%2BJ.%26aulast%3DDumont%26aufirst%3DJ.%2BE.%26aulast%3DVassan%26aufirst%3DG.%26aulast%3DSchiffmann%26aufirst%3DS.%26atitle%3DRDC8%2520codes%2520for%2520an%2520adenosine%2520A2%2520receptor%2520with%2520physiological%2520constitutive%2520activity%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1990%26volume%3D173%26spage%3D1169%26epage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Chem, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, H.</span><span> </span><span class="NLM_article-title">Molecular cloning of a novel adenosine receptor gene from rat brain</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">â</span> <span class="NLM_lpage">309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1992&pages=304-309&author=Y.+Chemauthor=K.+Kingauthor=H.+Lai&title=Molecular+cloning+of+a+novel+adenosine+receptor+gene+from+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChem%26aufirst%3DY.%26aulast%3DKing%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DH.%26atitle%3DMolecular%2520cloning%2520of%2520a%2520novel%2520adenosine%2520receptor%2520gene%2520from%2520rat%2520brain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1992%26volume%3D185%26spage%3D304%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Furlong, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selbie, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shine, J.</span><span> </span><span class="NLM_article-title">Molecular characterization of a human brain adenosine A<sub>2</sub> receptor</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">â</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2F0169-328X%2892%2990152-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK3sXit1Kiu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1992&pages=62-66&author=T.+J.+Furlongauthor=K.+D.+Pierceauthor=L.+A.+Selbieauthor=J.+Shine&title=Molecular+characterization+of+a+human+brain+adenosine+A2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of a human brain adenosine A2 receptor</span></div><div class="casAuthors">Furlong, Timothy J.; Pierce, Kerrie D.; Selbie, Lisa A.; Shine, John</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">62-6</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    </div><div class="casAbstract">A cDNA encoding a G protein-coupled receptor of unknown ligand specificity was isolated from a human hippocampal cDNA library by virtue of the high degree of structural homol. between members of this receptor family.  The cloned receptor DNA was transfected into human embryonic kidney 293 cells.  Stably transfected cell lines bound a variety of adenosine agonists and antagonists with affinities characteristic of a brain adenosine A2a receptor.  The A2a specific agonist CGS21680 stimulated cAMP prodn. but did not alter intracellular calcium concns. in transfected 293 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLrHo7yhb7dLVg90H21EOLACvtfcHk0lg9nrF5x-hpQw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1Kiu7s%253D&md5=7074217779407edb8a93652462529fd6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2F0169-328X%2892%2990152-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0169-328X%252892%252990152-2%26sid%3Dliteratum%253Aachs%26aulast%3DFurlong%26aufirst%3DT.%2BJ.%26aulast%3DPierce%26aufirst%3DK.%2BD.%26aulast%3DSelbie%26aufirst%3DL.%2BA.%26aulast%3DShine%26aufirst%3DJ.%26atitle%3DMolecular%2520characterization%2520of%2520a%2520human%2520brain%2520adenosine%2520A2%2520receptor%26jtitle%3DBrain%2520Res.%26date%3D1992%26volume%3D15%26spage%3D62%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Ledent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaugeois, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffmann, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrazzini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Yacoubi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderhaeghen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costentin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.</span><span> </span><span class="NLM_article-title">Aggressiveness hypoalgesia and high blood pressure in mice lacking the adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">â</span> <span class="NLM_lpage">678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=1997&pages=674-678&author=C.+Ledentauthor=J.+M.+Vaugeoisauthor=S.+N.+Schiffmannauthor=T.+Pedrazziniauthor=M.+El+Yacoubiauthor=J.+J.+Vanderhaeghenauthor=J.+Costentinauthor=J.+K.+Heathauthor=G.+Vassartauthor=M.+Parmentier&title=Aggressiveness+hypoalgesia+and+high+blood+pressure+in+mice+lacking+the+adenosine+A2A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DVaugeois%26aufirst%3DJ.%2BM.%26aulast%3DSchiffmann%26aufirst%3DS.%2BN.%26aulast%3DPedrazzini%26aufirst%3DT.%26aulast%3DEl%2BYacoubi%26aufirst%3DM.%26aulast%3DVanderhaeghen%26aufirst%3DJ.%2BJ.%26aulast%3DCostentin%26aufirst%3DJ.%26aulast%3DHeath%26aufirst%3DJ.%2BK.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DParmentier%26aufirst%3DM.%26atitle%3DAggressiveness%2520hypoalgesia%2520and%2520high%2520blood%2520pressure%2520in%2520mice%2520lacking%2520the%2520adenosine%2520A2A%2520receptor%26jtitle%3DNature%26date%3D1997%26volume%3D388%26spage%3D674%26epage%3D678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Meng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akil, H.</span><span> </span><span class="NLM_article-title">Cloning and expression of the A<sub>2A</sub> adenosine receptor from guinea pig brain</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">â</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2FBF00971338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=8065518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK2cXltVSgur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1994&pages=613-621&author=F.+Mengauthor=G.+Xieauthor=D.+Chalmersauthor=C.+Morganauthor=S.+J.+Watsonauthor=H.+Akil&title=Cloning+and+expression+of+the+A2A+adenosine+receptor+from+guinea+pig+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and expression of the A2a adenosine receptor from guinea pig brain</span></div><div class="casAuthors">Meng, Fan; Xie, Guo Xi; Chalmers, Derek; Morgan, Caurnel; Watson, Stanley, J.,Jr.; Akil, Huda</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">613-21</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    </div><div class="casAbstract">A full-length complementary DNA (cDNA) clone encoding the guinea pig brain A2 adenosine receptor has been isolated by polymerase chain reaction (PCR) and low-stringency-hybridization screening lof a guinea pig brain cDNA library.  This cDNA contains a long open reading frame encoding a 409-amino acid-residue protein which is highly homologous to the A2 adenosine receptors previously cloned from other species.  Hydrophobicity anal. of the deduced protein sequence reveals seven hydrophobic regions, characteristic of a member of the G-protein-coupled receptor superfamily.  Radioligand binding assay and functional (GTPase and cAMP) assays of the receptor, transiently expressed in mammalian cells, demonstrate typical characteristics of the A2 type adenosine receptor.  The mRNA (mRNA) of this A2 receptor is found in the brain, heart, kidney and spleen.  Receptor autoradiog. with [3H]CGS21680, a specific A2 agonist, and in situ hybridization with A2 cRNA probe in guinea pig brain indicate that the receptor is expressed exclusively in the caudate nucleus.  The pharmacol. profile and anatomical distribution of this receptor indicate that it is of the A2a subtype.  This work represents the first cloning of an A2a receptor in a rodent species, offers a complete pharmacol. characterization of the receptor and provides an anatomical comparison between the binding profile and gene expression of the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkrT474qsxYrVg90H21EOLACvtfcHk0ljsMbh-HTQUkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltVSgur8%253D&md5=8610b2c03708fafccc1d579cb5638e6f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2FBF00971338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00971338%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DXie%26aufirst%3DG.%26aulast%3DChalmers%26aufirst%3DD.%26aulast%3DMorgan%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DS.%2BJ.%26aulast%3DAkil%26aufirst%3DH.%26atitle%3DCloning%2520and%2520expression%2520of%2520the%2520A2A%2520adenosine%2520receptor%2520from%2520guinea%2520pig%2520brain%26jtitle%3DNeurochem.%2520Res.%26date%3D1994%26volume%3D19%26spage%3D613%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Fuxe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FerrÃ©, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torvinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasmaa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staines, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnati, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> and dopamine D<sub>2</sub> heteromeric receptor complexes and their function</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">2â3</span><span class="NLM_x">) </span> <span class="NLM_fpage">209</span><span class="NLM_x">â</span> <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1385%2FJMN%3A26%3A2-3%3A209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=16012194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtl2ksrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=209-220&issue=2%E2%80%933&author=K.+Fuxeauthor=S.+Ferr%C3%A9author=M.+Canalsauthor=M.+Torvinenauthor=A.+Terasmaaauthor=D.+Marcellinoauthor=S.+R.+Goldbergauthor=W.+Stainesauthor=K.+X.+Jacobsenauthor=C.+Lluisauthor=A.+S.+Woodsauthor=L.+F.+Agnatiauthor=R.+Franco&title=Adenosine+A2A+and+dopamine+D2+heteromeric+receptor+complexes+and+their+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function</span></div><div class="casAuthors">Fuxe, Kjell; Ferre, Sergi; Canals, Meritxell; Torvinen, Maria; Terasmaa, Anton; Marcellino, Daniel; Goldberg, Steven R.; Staines, William; Jacobsen, Kirsten X.; Lluis, Carmen; Woods, Amina S.; Agnati, Luigi F.; Franco, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">209-220</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  The existence of A2A-D2 heteromeric complexes is based on coimmunopptn. studies and on fluorescence resonance energy transfer and bioluminescence resonance energy transfer analyses.  It has now become possible to show that A2A and D2 receptors also coimmunoppt. in striatal tissue, giving evidence for the existence of A2A-D2 heteromeric receptor complexes also in rat striatal tissue.  The anal. gives evidence that these heteromers are constitutive, as they are obsd. in the absence of A2A and D2 agonists.  The A2A-D2 heteromers could either be A2A-D2 heterodimers and/or higher-order A2A-D2 hetero-oligomers.  In striatal neurons there are probably A2A-D2 heteromeric complexes, together with A2A-D2 homomeric complexes in the neuronal surface membrane.  Their stoichiometry in various microdomains will have a major role in detg. A2A and D2 signaling in the striatopallidal GABA neurons.  Through the use of D2/D1 chimeras, evidence has been obtained that the fifth transmembrane (TM) domain and/or the I3 of the D2 receptor are part of the A2A-D2 receptor interface, where electrostatic epitope-epitope interactions involving the N-terminal part of I3 of the D2 receptor (arginine-rich epitope) play a major role, interacting with the C-terminus of the A2A receptor.  Computerized modeling of A2A-D2 heteromers are in line with these findings.  It seems likely that A2A receptor-induced redn. of D2 receptor recognition, G protein coupling, and signaling, as well as the existence of A2A-D2 co-trafficking, are the consequence of the existence of an A2A-D2 receptor heteromer.  The relevance of A2A-D2 heteromeric receptor complexes for Parkinson's disease and schizophrenia is emphasized as well as for the treatment of these diseases.  Finally, recent evidence for the existence of antagonistic A2A-D3 heteromeric receptor complexes in cotransfected cell lines has been summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW6Kc8Z4sX5LVg90H21EOLACvtfcHk0ljsMbh-HTQUkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtl2ksrc%253D&md5=f6df5d2a1da7b132e203562db77f8449</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1385%2FJMN%3A26%3A2-3%3A209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FJMN%253A26%253A2-3%253A209%26sid%3Dliteratum%253Aachs%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DTorvinen%26aufirst%3DM.%26aulast%3DTerasmaa%26aufirst%3DA.%26aulast%3DMarcellino%26aufirst%3DD.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DStaines%26aufirst%3DW.%26aulast%3DJacobsen%26aufirst%3DK.%2BX.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DWoods%26aufirst%3DA.%2BS.%26aulast%3DAgnati%26aufirst%3DL.%2BF.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DAdenosine%2520A2A%2520and%2520dopamine%2520D2%2520heteromeric%2520receptor%2520complexes%2520and%2520their%2520function%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2005%26volume%3D26%26issue%3D2%25E2%2580%25933%26spage%3D209%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Torvinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnati, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor and dopamine D<sub>3</sub> heteromeric complexes</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">400</span><span class="NLM_x">â</span> <span class="NLM_lpage">407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=400-407&issue=2&author=M.+Torvinenauthor=D.+Marcellinoauthor=M.+Canalsauthor=L.+F.+Agnatiauthor=C.+Lluisauthor=R.+Francoauthor=K.+Fuxe&title=Adenosine+A2A+receptor+and+dopamine+D3+heteromeric+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorvinen%26aufirst%3DM.%26aulast%3DMarcellino%26aufirst%3DD.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DAgnati%26aufirst%3DL.%2BF.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DFuxe%26aufirst%3DK.%26atitle%3DAdenosine%2520A2A%2520receptor%2520and%2520dopamine%2520D3%2520heteromeric%2520complexes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26issue%3D2%26spage%3D400%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">FerrÃ©, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span> </span><span class="NLM_article-title">Looking for the role of cannabinoid receptor heteromers in striatal function</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">S1</span><span class="NLM_x">) </span> <span class="NLM_fpage">226</span><span class="NLM_x">â</span> <span class="NLM_lpage">234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2009&pages=226-234&issue=S1&author=S.+Ferr%C3%A9author=S.+R.+Goldbergauthor=C.+Lluisauthor=R.+Franco&title=Looking+for+the+role+of+cannabinoid+receptor+heteromers+in+striatal+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DLooking%2520for%2520the%2520role%2520of%2520cannabinoid%2520receptor%2520heteromers%2520in%2520striatal%2520function%26jtitle%3DNeuropharmacology%26date%3D2009%26volume%3D56%26issue%3DS1%26spage%3D226%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">FerrÃ©, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karcz-Kubicha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casado, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciruela, F.</span><span> </span><span class="NLM_article-title">Synergistic interaction between adenosine A<sub>2A</sub> and glutamate mGlu5 receptors: implications for striatal neuronal function</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">11940</span><span class="NLM_x">â</span> <span class="NLM_lpage">11945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11940-11945&author=S.+Ferr%C3%A9author=M.+Karcz-Kubichaauthor=B.+T.+Hopeauthor=P.+Popoliauthor=J.+Burguenoauthor=M.+A.+Gutierrezauthor=V.+Casadoauthor=K.+Fuxeauthor=S.+R.+Goldbergauthor=C.+Lluisauthor=R.+Francoauthor=F.+Ciruela&title=Synergistic+interaction+between+adenosine+A2A+and+glutamate+mGlu5+receptors%3A+implications+for+striatal+neuronal+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DKarcz-Kubicha%26aufirst%3DM.%26aulast%3DHope%26aufirst%3DB.%2BT.%26aulast%3DPopoli%26aufirst%3DP.%26aulast%3DBurgueno%26aufirst%3DJ.%26aulast%3DGutierrez%26aufirst%3DM.%2BA.%26aulast%3DCasado%26aufirst%3DV.%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DCiruela%26aufirst%3DF.%26atitle%3DSynergistic%2520interaction%2520between%2520adenosine%2520A2A%2520and%2520glutamate%2520mGlu5%2520receptors%253A%2520implications%2520for%2520striatal%2520neuronal%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D11940%26epage%3D11945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Navarro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carriba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GandÃ­a, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciruela, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">CasadÃ³, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">CortÃ©s, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallol, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canela, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span> </span><span class="NLM_article-title">Detection of heteromers formed by cannabinoid CB<sub>1</sub>, dopamine D<sub>2</sub> and adenosine A<sub>2A</sub> G-protein coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer</span> <span class="citation_source-journal">TheScientificWorldJournal</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1088</span><span class="NLM_x">â</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1088-1097&author=G.+Navarroauthor=P.+Carribaauthor=J.+Gand%C3%ADaauthor=F.+Ciruelaauthor=V.+Casad%C3%B3author=A.+Cort%C3%A9sauthor=J.+Mallolauthor=E.+I.+Canelaauthor=C.+Lluisauthor=R.+Franco&title=Detection+of+heteromers+formed+by+cannabinoid+CB1%2C+dopamine+D2+and+adenosine+A2A+G-protein+coupled+receptors+by+combining+bimolecular+fluorescence+complementation+and+bioluminescence+energy+transfer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNavarro%26aufirst%3DG.%26aulast%3DCarriba%26aufirst%3DP.%26aulast%3DGand%25C3%25ADa%26aufirst%3DJ.%26aulast%3DCiruela%26aufirst%3DF.%26aulast%3DCasad%25C3%25B3%26aufirst%3DV.%26aulast%3DCort%25C3%25A9s%26aufirst%3DA.%26aulast%3DMallol%26aufirst%3DJ.%26aulast%3DCanela%26aufirst%3DE.%2BI.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DDetection%2520of%2520heteromers%2520formed%2520by%2520cannabinoid%2520CB1%252C%2520dopamine%2520D2%2520and%2520adenosine%2520A2A%2520G-protein%2520coupled%2520receptors%2520by%2520combining%2520bimolecular%2520fluorescence%2520complementation%2520and%2520bioluminescence%2520energy%2520transfer%26jtitle%3DTheScientificWorldJournal%26date%3D2008%26volume%3D8%26spage%3D1088%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span>What Is Lexiscan? <a href="https://www.lexiscaninfo.com/lexiscan/aslex_web_aboutlexiscan.html?kw=lexiscan&amp;c=710002" class="extLink">https://www.lexiscaninfo.com/lexiscan/aslex_web_aboutlexiscan.html?kw=lexiscan&c=710002</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=What+Is+Lexiscan%3F+https%3A%2F%2Fwww.lexiscaninfo.com%2Flexiscan%2Faslex_web_aboutlexiscan.html%3Fkw%3Dlexiscan%26c%3D710002."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenningsson, P.</span><span> </span><span class="NLM_article-title">Pharmacology of adenosine A<sub>2A</sub> receptors and therapeutic applications</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">â</span> <span class="NLM_lpage">426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.2174%2F1568026033392200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=413-426&author=B.+B.+Fredholmauthor=R.+A.+Cunhaauthor=P.+Svenningsson&title=Pharmacology+of+adenosine+A2A+receptors+and+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F1568026033392200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392200%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DCunha%26aufirst%3DR.%2BA.%26aulast%3DSvenningsson%26aufirst%3DP.%26atitle%3DPharmacology%2520of%2520adenosine%2520A2A%2520receptors%2520and%2520therapeutic%2520applications%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D3%26spage%3D413%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Kull, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenningsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptors are colocalized with and activate G<sub>olf</sub> in rat striatum</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">â</span> <span class="NLM_lpage">777</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=771-777&author=B.+Kullauthor=P.+Svenningssonauthor=B.+B.+Fredholm&title=Adenosine+A2A+receptors+are+colocalized+with+and+activate+Golf+in+rat+striatum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKull%26aufirst%3DB.%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DAdenosine%2520A2A%2520receptors%2520are%2520colocalized%2520with%2520and%2520activate%2520Golf%2520in%2520rat%2520striatum%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D771%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Schulte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">Human adenosine A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub> and A<sub>3</sub> receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">â</span> <span class="NLM_lpage">482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=477-482&author=G.+Schulteauthor=B.+B.+Fredholm&title=Human+adenosine+A1%2C+A2A%2C+A2B+and+A3+receptors+expressed+in+Chinese+hamster+ovary+cells+all+mediate+the+phosphorylation+of+extracellular-regulated+kinase+1%2F2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DG.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DHuman%2520adenosine%2520A1%252C%2520A2A%252C%2520A2B%2520and%2520A3%2520receptors%2520expressed%2520in%2520Chinese%2520hamster%2520ovary%2520cells%2520all%2520mediate%2520the%2520phosphorylation%2520of%2520extracellular-regulated%2520kinase%25201%252F2%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D477%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span>For more information about the A<sub>2A</sub> signaling pathway, visit <a href="http://www.genego.com/map_643.php" class="extLink">http://www.genego.com/map_643.php</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+more+information+about+the+A2A+signaling+pathway%2C+visit+http%3A%2F%2Fwww.genego.com%2Fmap_643.php."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Valls, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronstein, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montesinos, M. C.</span><span> </span><span class="NLM_article-title">Adenosine receptor agonists for promotion of dermal wound healing</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">â</span> <span class="NLM_lpage">1124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.bcp.2008.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=19041853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVGgsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=1117-1124&author=M.+D.+Vallsauthor=B.+N.+Cronsteinauthor=M.+C.+Montesinos&title=Adenosine+receptor+agonists+for+promotion+of+dermal+wound+healing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptor agonists for promotion of dermal wound healing</span></div><div class="casAuthors">Valls, Maria D.; Cronstein, Bruce N.; Montesinos, M. Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1117-1124</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Wound healing is a dynamic and complex process that involves a well-coordinated, highly regulated series of events including inflammation, tissue formation, revascularization and tissue remodeling.  However, this orderly sequence is impaired in certain pathophysiol. conditions such as diabetes mellitus, venous insufficiency, chronic glucocorticoid use, aging and malnutrition.  Together with proper wound care, promotion of the healing process is the primary objective in the management of chronic poorly healing wounds.  Recent studies have demonstrated that A2A adenosine receptor agonists promote wound healing in normal and diabetic animals and one such agonist, Sonedenoson, is currently being evaluated as a prospective new therapy of diabetic foot ulcers.  We will review the mechanisms by which adenosine receptor activation affects the function of the cells and tissues that participate in wound healing, emphasizing the potential beneficial impact of adenosine receptor agonists in diabetic impaired healing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLlM4GeFS-t7Vg90H21EOLACvtfcHk0lhWStA2N2dI4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVGgsLk%253D&md5=a0c6d7f74a61e316919c04069c63b422</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2008.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2008.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DValls%26aufirst%3DM.%2BD.%26aulast%3DCronstein%26aufirst%3DB.%2BN.%26aulast%3DMontesinos%26aufirst%3DM.%2BC.%26atitle%3DAdenosine%2520receptor%2520agonists%2520for%2520promotion%2520of%2520dermal%2520wound%2520healing%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D77%26spage%3D1117%26epage%3D1124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camaioni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Pharmacology of the highly selective A<sub>1</sub> adenosine receptor agonist 2-chloro-<i>N</i>6-cyclopentyladenosine</span> <span class="citation_source-journal">Arzneimittelforschung</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1305</span><span class="NLM_x">â</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1994&pages=1305-1312&author=A.+Monopoliauthor=A.+Contiauthor=S.+Dionisottiauthor=C.+Casatiauthor=E.+Camaioniauthor=G.+Cristalliauthor=E.+Ongini&title=Pharmacology+of+the+highly+selective+A1+adenosine+receptor+agonist+2-chloro-N6-cyclopentyladenosine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DConti%26aufirst%3DA.%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DCasati%26aufirst%3DC.%26aulast%3DCamaioni%26aufirst%3DE.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DPharmacology%2520of%2520the%2520highly%2520selective%2520A1%2520adenosine%2520receptor%2520agonist%25202-chloro-N6-cyclopentyladenosine%26jtitle%3DArzneimittelforschung%26date%3D1994%26volume%3D44%26spage%3D1305%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Bruns, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugsley, T. A.</span><span> </span><span class="NLM_article-title">Characterization of the A<sub>2</sub> adenosine receptor labeled by [<sup>3</sup>H]-NECA in rat striatal membranes</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">â</span> <span class="NLM_lpage">346</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=331-346&author=R.+F.+Brunsauthor=G.+H.+Luauthor=T.+A.+Pugsley&title=Characterization+of+the+A2+adenosine+receptor+labeled+by+%5B3H%5D-NECA+in+rat+striatal+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26aulast%3DLu%26aufirst%3DG.%2BH.%26aulast%3DPugsley%26aufirst%3DT.%2BA.%26atitle%3DCharacterization%2520of%2520the%2520A2%2520adenosine%2520receptor%2520labeled%2520by%2520%255B3H%255D-NECA%2520in%2520rat%2520striatal%2520membranes%26jtitle%3DMol.%2520Pharmacol.%26date%3D1986%26volume%3D29%26spage%3D331%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hutchison, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oei, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghai, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiliams, M.</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">47</span><span class="NLM_x">â</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=2795469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK3cXjtVertw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hutchison%2C+A.+J.%3B+Webb%2C+R.+L.%3B+Oei%2C+H.+H.%3B+Ghai%2C+G.+R.%3B+Zimmerman%2C+M.+B.%3B+Wiliams%2C+M.J.+Pharmacol.+Exp.+Ther.+1989%2C+251+%281%29+47%E2%80%9355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity</span></div><div class="casAuthors">Hutchison, Alan J.; Webb, Randy L.; Oei, Howard H.; Ghai, Geetha R.; Zimmerman, Mark B.; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-55</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">CGS 21680C (I) and the related analog CGS 21577 (II) have high in vitro affinity for brain striatal adenosine A2 receptors; IC50 values 22 and 13 nM, resp.  Both compds. were considerably less active at A1 receptors with CGS 21577 and CGS 21680C having resp. IC50 values of 0.76 and 3.1 Î¼M.  The former compd. was thus 59-fold selective for A2 receptors whereas CGS 21680C was 140-fold selective.  In contrast, the ref. A2 selective ligand, CV 1808 (2-phenylaminoadenosine), showed only 8-fold selectivity as an A2 ligand, having an IC50 of 115 nM in the [3H]-5'-N-ethylcarboxamide adenosine assay and an IC50 of 910 nM at the N6-[3H]cyclohexyladenosine site.  Further examn. of CGS 21680C showed that the compd. was without effect on binding to 17 other putative neurotransmitter/neuromodulator sites indicating its selectivity as an adenosine receptor ligand.  In an isolated perfused working rat heart model, CGS 21680C effectively increased coronary flow with an ED25 value of 1.8 nM.  The corresponding value for CGS 21577 was 3 nM whereas that for CV 1808 was 110 nM.  The EC25 for eliciting bradycardia for all three compds. was >1000 nM.  The effects of all three compds. could be reversed by treatment with the xanthine adenosine antagonist, xanthine amine congener.  Given i.v., CGS 21680A, the HCl salt of CGS 21680 (III), and CGS 21577 reduced blood pressure in an anesthetized normotensive rat model with ED50 values of 9 Î¼g/kg (19 nmol) and 1.8 Î¼g/kg (4.2 nmol).  CV 1808 had an ED50 of 28 Î¼g/kg (78 nmol).  All three adenosine analogs increased heart rate by up to 15%, the latter effect probably reflecting a reflex tachycardia occurring as a result of the obsd. decrease in blood pressure.  CGS 21680A, CGS 21577 and CV 1808 were active p.o. in the spontaneously hypertensive rat at a dose of 10 mg/kg with efficacy for up to 24 h.  CGS 21680A caused a transient (60 min) increase in heart rate.  A similar response was noted with CV 1808.  However, CGS 21577 caused a marked increase in heart rate (140 bpm) which was sustained at 70 bpm for up to 24 h.  CGS 21680C, although more potent and selective as an A2 receptor agonist than CV 1808, shows no apparent difference in its ability to lower blood pressure and affect heart rate in the spontaneous hypertensive rat than the latter compd.  CGS 21577, because of its profound and prolonged effects on heart rate is unlikely to merit further attention as a potential hypotensive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrBiFb7nA-7rVg90H21EOLACvtfcHk0lhWStA2N2dI4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXjtVertw%253D%253D&md5=26d92ec79024d4cb01e87a727a753eb2</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutchison%26aufirst%3DA.%2BJ.%26aulast%3DWebb%26aufirst%3DR.%2BL.%26aulast%3DOei%26aufirst%3DH.%2BH.%26aulast%3DGhai%26aufirst%3DG.%2BR.%26aulast%3DZimmerman%26aufirst%3DM.%2BB.%26aulast%3DWiliams%26aufirst%3DM.%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1989%26volume%3D251%26issue%3D1%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jarvis, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sills, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]-CGS21680, a selective A<sub>2</sub> adenosine receptor agonist directly labels A<sub>2</sub> receptors in rat brain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">888</span><span class="NLM_x">â</span> <span class="NLM_lpage">893</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=2600819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK3cXhtFamur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1989&pages=888-893&author=M.+F.+Jarvisauthor=R.+Schulzauthor=A.+J.+Hutchisonauthor=U.+H.+Doauthor=M.+A.+Sillsauthor=M.+Williams&title=%5B3H%5D-CGS21680%2C+a+selective+A2+adenosine+receptor+agonist+directly+labels+A2+receptors+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain</span></div><div class="casAuthors">Jarvis, Michael F.; Schulz, Rainer; Hutchison, Alan J.; Do, Un Hoi; Sills, Matthew A.; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">888-93</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Characterization of the adenosine A2 receptor has been limited due to the lack of available ligands which have high affinity and selectivity for this adenosine receptor subtype.  In the present study, the binding of a highly A2-selective agonist radioligand, [3H]CGS 21680 (I) is described.  [3H]CGS 21680 specific binding to rat striatal membranes was saturable, reversible, and dependent on protein concn.  Satn. studies revealed that [3H]CGS 21680 bound with high affinity (Kd =15.5 nM) and limited capacity (apparent Bmax = 375 fmol/mg protein) to a single class of recognition sites.  Ests. of ligand affinity (16 nM) detd. from assocn. and dissocn. kinetic expts. were in close agreement with the results from the satn. studies.  [3H]CGS 21680 binding was greatest in striatal membranes with negligible specific binding obtained in rat cortical membranes.  Adenosine agonists ligands competed for the binding of 5 nM [3H]CGS 21680 to striatal membranes with the following order of activity; CGS 21680 = 5'-N-ethylcarboxamidoadenosine > 2-phenylaminoadenosine (CV-1808) ; 5'-N-methylcarboxamidoadenosine = 2-chloroadenosine > R-phenylisopropyladenosine > N6-cyclohexyladenosine > N6-cyclopentyltheophylline > S-phenylisopropyladenosine.  The nonxanthine adenosine antagonist, CGS 15943A, was the most active compd. in inhibiting the binding of [3H]CGS 21680.  Other adenosine antagonists inhibited binding in the following order; xanthine amine congener = (1,3-dipropyl-8-(2-amino-4-chloro)phenylxanthine > 1,3-dipropyl-8-cyclopentylxanthine > 1,3-diethyl-8-phenylxanthine > 8-phenyltheophylline > 8-cyclopentyltheophylline = xanthine carboxylic acid congener > 8-parasulfophenyltheophylline > theophylline > caffeine.  The pharmacol. profile of both adenosine agonist and antagonist compds. to compete for the binding of [3H]CGS 21680 was consistent with a selective interaction at the high affinity adenosine A2 receptor.  A high pos. correlation was obsd. between the pharmacol. profile of adenosine ligands to inhibit the binding of [3H]CGS 21680 and the selective binding of [3H]NECA (+50 nM CPA) to high affinity A2 receptors.  However, some differences between these assays were found for compds. which have moderate affinity and nonselective actions at both the A1 and A2 adenosine receptor subtypes.  Unlike data obtained with nonselective adenosine ligands, the present results indicate that [3H]CGS 21680 directly labels the high affinity A2 receptor in rat brain without the need to block binding activity at the A1 receptor.  The high degree of selectivity (>170-fold) and high affinity of [3H]CGS 21680 make this the current ligand of choice for the in vitro characterization of high affinity A2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF9YARcmgaFrVg90H21EOLACvtfcHk0lhWStA2N2dI4w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtFamur4%253D&md5=fc1961da1f86a5592fa6142878952fa9</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DM.%2BF.%26aulast%3DSchulz%26aufirst%3DR.%26aulast%3DHutchison%26aufirst%3DA.%2BJ.%26aulast%3DDo%26aufirst%3DU.%2BH.%26aulast%3DSills%26aufirst%3DM.%2BA.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3D%255B3H%255D-CGS21680%252C%2520a%2520selective%2520A2%2520adenosine%2520receptor%2520agonist%2520directly%2520labels%2520A2%2520receptors%2520in%2520rat%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1989%26volume%3D251%26spage%3D888%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfrogna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosea, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewc, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Deusen, J.</span><span> </span><span class="NLM_article-title">Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1443</span><span class="NLM_x">â</span> <span class="NLM_lpage">1447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1124%2Fdmd.105.008201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=16760229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Sksrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1443-1447&author=X.+Liuauthor=B.+J.+Smithauthor=C.+Chenauthor=E.+Callegariauthor=S.+L.+Beckerauthor=X.+Chenauthor=J.+Cianfrognaauthor=A.+C.+Doranauthor=S.+D.+Doranauthor=J.+P.+Gibbsauthor=N.+Hoseaauthor=J.+Liuauthor=F.+R.+Nelsonauthor=M.+A.+Szewcauthor=J.+Van+Deusen&title=Evaluation+of+cerebrospinal+fluid+concentration+and+plasma+free+concentration+as+a+surrogate+measurement+for+brain+free+concentration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration</span></div><div class="casAuthors">Liu, Xingrong; Smith, Bill J.; Chen, Cuiping; Callegari, Ernesto; Becker, Stacey L.; Chen, Xi; Cianfrogna, Julie; Doran, Angela C.; Doran, Shawn D.; Gibbs, John P.; Hosea, Natilie; Liu, Jianhua; Nelson, Frederick R.; Szewc, Mark A.; Van Deusen, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1443-1447</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study was designed to evaluate the use of cerebrospinal fluid (CSF) drug concn. and plasma unbound concn. (Cu,plasma) to predict brain unbound concn. (Cu,brain).  The concn.-time profiles in CSF, plasma, and brain of seven model compds. were detd. after s.c. administration in rats.  The Cu,brain was estd. from the product of total brain concns. and unbound fractions, which were detd. using brain tissue slice and brain homogenate methods.  For theobromine, theophylline, caffeine, fluoxetine, and propranolol, which represent rapid brain penetration compds. with a simple diffusion mechanism, the ratios of the area under the curve of Cu,brain/CCSF and Cu,brain/Cu,plasma were 0.27 to 1.5 and 0.29 to 2.1, resp., using the brain slice method, and were 0.27 to 2.9 and 0.36 to 3.9, resp., using the brain homogenate method.  A P-glycoprotein substrate, CP-141938 (methoxy-3-[(2-phenyl-piperidinyl-3-amino)-methyl]-phenyl-N-methyl-methane-sulfonamide), had Cu,brain/CCSF and Cu,brain/Cu,plasma ratios of 0.57 and 0.066, using the brain slice method, and 1.1 and 0.13, using the brain homogenate method, resp.  The slow brain-penetrating compd., N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine, had Cu,brain/CCSF and Cu,brain/Cu,plasma ratios of 0.94 and 0.12 using the brain slice method and 0.15 and 0.018 using the brain homogenate method, resp.  Therefore, for quick brain penetration with simple diffusion mechanism compds., CCSF and Cu,plasma represent Cu,brain equally well; for efflux substrates or slow brain penetration compds., CCSF appears to be equiv. to or more accurate than Cu,plasma to represent Cu,brain.  Thus, we hypothesize that CCSF is equiv. to or better than Cu,plasma to predict Cu,brain.  This hypothesis is supported by the literature data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw43dRkq9lx7Vg90H21EOLACvtfcHk0ljMJKUrFPGMQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Sksrc%253D&md5=cef079e1a667dbddf9d5a2f7d01889e8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.008201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.008201%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DHosea%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DSzewc%26aufirst%3DM.%2BA.%26aulast%3DVan%2BDeusen%26aufirst%3DJ.%26atitle%3DEvaluation%2520of%2520cerebrospinal%2520fluid%2520concentration%2520and%2520plasma%2520free%2520concentration%2520as%2520a%2520surrogate%2520measurement%2520for%2520brain%2520free%2520concentration%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D1443%26epage%3D1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kull, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span> </span><span class="NLM_article-title">Comparative pharmacology of human adenosine receptor subtypesâcharacterization of stably transfected receptors in CHO cells</span> <span class="citation_source-journal">Naunyn-Schmiedebergâs Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2FPL00005131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9459566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlKltw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=1998&pages=1-9&author=K.+N.+Klotzauthor=J.+Hesslingauthor=J.+Heglerauthor=C.+Owmanauthor=B.+Kullauthor=B.+B.+Fredholmauthor=M.+J.+Lohse&title=Comparative+pharmacology+of+human+adenosine+receptor+subtypes%E2%80%94characterization+of+stably+transfected+receptors+in+CHO+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells</span></div><div class="casAuthors">Klotz, K.-N.; Hessling, J.; Hegler, J.; Owman, C.; Kull, B.; Fredholm, B. B.; Lohse, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Four adenosine receptor subtypes of the family of G protein-coupled receptors, designated A1, A2A, A2B and A3 are currently known.  In this study all human subtypes were stably transfected into Chinese hamster ovary (CHO) cells to be able to study their pharmacol. profile in an identical cellular background utilizing radioligand binding studies (A1, A2A, A3) or adenylyl cyclase activity assays (A2B).  The A1 subtype showed the typical pharmacol. profile with 2-chloro-N6-cyclopentyladenosine (CCPA) as the agonist with the highest affinity and a marked stereoselectivity for the N6-phenylisopropyladenosine (PIA) diastereomers.  In competition with antagonist radioligand biphasic curves were obsd. for agonists.  In the presence of GTP all receptors were converted to a single low affinity state indicating functional coupling to endogenous G proteins.  For A2A adenosine receptors CGS 21680 (2-[p-(2-carboxyethyl)phenylethylamino]-5'-N-ethylcarboxamidoadenosine) and N-ethylcarboxamidoadenosine (NECA) were found to be the most potent agonists followed by R- and S-PIA with minor stereoselectivity.  The relative potencies of agonists for the A2B adenosine receptor could only be tested by measurement of receptor-stimulated adenylyl cyclase activity.  NECA was the most potent agonist with an EC50-value of 2.3 Î¼M, whereas all other compds. tested were active at concns. in the high micromolar range.  Inhibition of NECA-stimulated adenylyl cyclase identified xanthine amino congener (XAC; 8-[4-[[[[(2-aminoethyl)amino]carbonyl]methyl]oxy]phenyl]-1,3-dipropylxanthine) as the most potent antagonist at this receptor subtype.  The A3 receptor was characterized utilizing the nonselective agonist [3H]NECA.  The N6-benzyl substituted derivs. of adenosine-5'-N-methyluronamide (MECA) turned out to be the most potent agonists.  The notion of xanthine-insensitivity of the A3 receptor should be dropped at least for the human receptor as xanthines with submicromolar affinity were found.  Overall, the pharmacol. characteristics of the human receptors are similar to other species with some species-specific characteristics.  In this study the authors present for the first time the comparative pharmacol. of all known human adenosine receptor subtypes.  The CHO cells with stably transfected adenosine receptors provide an identical cellular background for such a pharmacol. characterization.  These cells are valuable systems for further characterization of specific receptor subtypes and for the development of new ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyUbgRii47RrVg90H21EOLACvtfcHk0ljMJKUrFPGMQQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlKltw%253D%253D&md5=3bfa5a636309e935eea0e43dd2878d05</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FPL00005131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00005131%26sid%3Dliteratum%253Aachs%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DHessling%26aufirst%3DJ.%26aulast%3DHegler%26aufirst%3DJ.%26aulast%3DOwman%26aufirst%3DC.%26aulast%3DKull%26aufirst%3DB.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26atitle%3DComparative%2520pharmacology%2520of%2520human%2520adenosine%2520receptor%2520subtypes%25E2%2580%2594characterization%2520of%2520stably%2520transfected%2520receptors%2520in%2520CHO%2520cells%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1998%26volume%3D357%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Sauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurinsh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FÃ¼lle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¼ller, C. E.</span><span> </span><span class="NLM_article-title">Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A<sub>2A</sub> selective adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">â</span> <span class="NLM_lpage">448</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9911480" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=440-448&author=R.+Sauerauthor=J.+Maurinshauthor=U.+Reithauthor=F.+F%C3%BClleauthor=K.+N.+Klotzauthor=C.+E.+M%C3%BCller&title=Water-soluble+phosphate+prodrugs+of+1-propargyl-8-styrylxanthine+derivatives%2C+A2A+selective+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm9911480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9911480%26sid%3Dliteratum%253Aachs%26aulast%3DSauer%26aufirst%3DR.%26aulast%3DMaurinsh%26aufirst%3DJ.%26aulast%3DReith%26aufirst%3DU.%26aulast%3DF%25C3%25BClle%26aufirst%3DF.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DWater-soluble%2520phosphate%2520prodrugs%2520of%25201-propargyl-8-styrylxanthine%2520derivatives%252C%2520A2A%2520selective%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D440%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Le Witt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guttman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tetrud, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuite, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, N. M.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonist istradefylline (KW6002) reduces off time in Parkinsonâs disease: a double-blind, randomized, multicenter clinical trial (6002-US-005)</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">295</span><span class="NLM_x">â</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1002%2Fana.21315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=18306243" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2008&pages=295-302&issue=3&author=P.+A.+Le+Wittauthor=M.+Guttmanauthor=J.+W.+Tetrudauthor=P.+J.+Tuiteauthor=A.+Moriauthor=P.+Chaikinauthor=N.+M.+Sussman&title=Adenosine+A2A+receptor+antagonist+istradefylline+%28KW6002%29+reduces+off+time+in+Parkinson%E2%80%99s+disease%3A+a+double-blind%2C+randomized%2C+multicenter+clinical+trial+%286002-US-005%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1002%2Fana.21315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21315%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BWitt%26aufirst%3DP.%2BA.%26aulast%3DGuttman%26aufirst%3DM.%26aulast%3DTetrud%26aufirst%3DJ.%2BW.%26aulast%3DTuite%26aufirst%3DP.%2BJ.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DChaikin%26aufirst%3DP.%26aulast%3DSussman%26aufirst%3DN.%2BM.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonist%2520istradefylline%2520%2528KW6002%2529%2520reduces%2520off%2520time%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520double-blind%252C%2520randomized%252C%2520multicenter%2520clinical%2520trial%2520%25286002-US-005%2529%26jtitle%3DAnn.%2520Neurol.%26date%3D2008%26volume%3D63%26issue%3D3%26spage%3D295%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Manera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccomanni, G.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> receptor ligands: past present and future trends</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">â</span> <span class="NLM_lpage">922</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.2174%2F156802610791268765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=20370660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVegsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=902-922&author=C.+Maneraauthor=G.+Saccomanni&title=A2A+receptor+ligands%3A+past+present+and+future+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">A2A receptor ligands: past, present and future trends</span></div><div class="casAuthors">Manera, C.; Saccomanni, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">902-922</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The adenosine A2A receptor is a member of the G protein-coupled receptor family and mediates multiple physiol. effects of adenosine, both at the central nervous system and at peripheral tissues.  Increasing evidence relates the A2A receptor with several pathol. conditions such as neurodegenerative disorders, inflammation, pharmacol. stress, and wound healing renewing the interest in A2A receptor agonists and antagonists as promising leads for drugs.  However some of them initially tested in clin. trials presented several side effects, short half-life, lower soly., and in some cases a lack of effects, perhaps attributable to receptor desensitization or to low receptor d. in the targeted tissue.  For these reasons it is evident that addnl. rational chem. modifications of the existing A2A receptor ligands to improve their affinity/selectivity and bioavailability as well as further studies to get new template for A2AAR ligands are necessary.  The purpose of this review is to analyze and summarize the past and the present aspects related to the medicinal chem. of A2A receptor ligands.  Moreover their current and possible therapeutic applications have been also highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnLx7COhHSYLVg90H21EOLACvtfcHk0ljMNSAqYWrhYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVegsLo%253D&md5=17c6c4a3178313e73f25f8c1a76708ac</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.2174%2F156802610791268765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610791268765%26sid%3Dliteratum%253Aachs%26aulast%3DManera%26aufirst%3DC.%26aulast%3DSaccomanni%26aufirst%3DG.%26atitle%3DA2A%2520receptor%2520ligands%253A%2520past%2520present%2520and%2520future%2520trends%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D902%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, R. K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> antagonist: a novel antiparkisonian agent that does not provoke dyskinesia in parkinsonian monkeys</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">â</span> <span class="NLM_lpage">513</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1002%2Fana.410430415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9546333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1cXisFyisbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=507-513&author=T.+Kandaauthor=M.+J.+Jacksonauthor=L.+A.+Smithauthor=R.+K.+B.+Pearceauthor=J.+Nakamuraauthor=H.+Kaseauthor=Y.+Kuwanaauthor=P.+Jenner&title=Adenosine+A2A+antagonist%3A+a+novel+antiparkisonian+agent+that+does+not+provoke+dyskinesia+in+parkinsonian+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys</span></div><div class="casAuthors">Kanda, Tomoyuki; Jackson, Michael J.; Smith, Lance A.; Pearce, Ronald K. B.; Nakamura, Joji; Kase, Hiroshi; Kuwana, Yoshihisa; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">507-513</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">Treatment of Parkinson's disease with L-DOPA therapy leads to long-term complications, including loss of drug efficacy and the onset of dyskinesia.  Adenosine A2A receptors in the striatum are selectively localized to GABAergic output neurons of the striato-pallidal pathway and may avoid such problems.  The novel adenosine A2A receptor antagonist KW-6002 was examd. for antiparkinsonian activity in MPTP-treated primates.  Oral administration of KW-6002 reversed motor disability in MPTP-treated common marmosets in a dose-dependent manner.  However, KW-6002 only modestly increased overall locomotor activity and did not cause abnormal movement, such as stereotypy.  The ability of KW-6002 to reverse motor disability was maintained on repeated daily administration for 21 days, and no tolerance was obsd.  KW-6002 induced little or no dyskinesia in MPTP-treated primates previously primed to exhibit dyskinesia by prior exposure to L-DOPA.  Thus, selective adenosine A2A receptor antagonists represent a new class of antiparkinsonian agents that do not produce hyperactivity or induce dyskinesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouQ20y4EvPvLVg90H21EOLACvtfcHk0ljMNSAqYWrhYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFyisbw%253D&md5=36af21fdde02b63c588e3ca03785dafe</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fana.410430415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410430415%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DPearce%26aufirst%3DR.%2BK.%2BB.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DKase%26aufirst%3DH.%26aulast%3DKuwana%26aufirst%3DY.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DAdenosine%2520A2A%2520antagonist%253A%2520a%2520novel%2520antiparkisonian%2520agent%2520that%2520does%2520not%2520provoke%2520dyskinesia%2520in%2520parkinsonian%2520monkeys%26jtitle%3DAnn.%2520Neurol.%26date%3D1998%26volume%3D43%26spage%3D507%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Hockemeyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burbiel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¼ller, C. E.</span><span> </span><span class="NLM_article-title">Multigram-scale synthesis, stability and photoreactions of A<sub>2A</sub> adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinsonâs disease</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">3308</span><span class="NLM_x">â</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0358574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=3308-3318&issue=10&author=J.+Hockemeyerauthor=J.+Burbielauthor=C.+E.+M%C3%BCller&title=Multigram-scale+synthesis%2C+stability+and+photoreactions+of+A2A+adenosine+receptor+antagonists+with+8-styrylxanthine+structure%3A+potential+drugs+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo0358574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0358574%26sid%3Dliteratum%253Aachs%26aulast%3DHockemeyer%26aufirst%3DJ.%26aulast%3DBurbiel%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMultigram-scale%2520synthesis%252C%2520stability%2520and%2520photoreactions%2520of%2520A2A%2520adenosine%2520receptor%2520antagonists%2520with%25208-styrylxanthine%2520structure%253A%2520potential%2520drugs%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26issue%3D10%26spage%3D3308%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunwalder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Psychoyos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cash, W. D.</span><span> </span><span class="NLM_article-title">Biochemical characterization of the triazoloquinazoline, CGS15943, a novel, non-xanthine adenosine antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">241</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">â</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=2883298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaL2sXksFWrtLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=1987&pages=415-420&author=M.+Williamsauthor=J.+Francisauthor=G.+Ghaiauthor=A.+Braunwalderauthor=S.+Psychoyosauthor=G.+A.+Stoneauthor=W.+D.+Cash&title=Biochemical+characterization+of+the+triazoloquinazoline%2C+CGS15943%2C+a+novel%2C+non-xanthine+adenosine+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical characterization of the triazoloquinazoline CGS 15943A, a novel, nonxanthine adenosine antagonist</span></div><div class="casAuthors">Williams, Michael; Francis, John; Ghai, Geetha; Braunwalder, Albert; Psychoyos, Stacy; Stone, George A.; Cash, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">415-20</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">CGS 15943A (I), a triazoloquinazoline, is a potent and selective adenosine receptor antagonist as assessed by its effects on radioligand binding and adenosine-stimulated adenylate cyclase activity in guinea pig synaptoneurosomes.  At the adenosine A-1 receptor labeled with [3H]cyclohexyladenosine, I had an IC50 value of 20 nM.  At the striatal A-2 receptor labeled with [3H]5'-N-ethylcarboxamidoadenosine (in the presence of a low concn. of cyclopentyladenosine to block A-1 receptors labeled by this nonselective adenosine agonist), I had an IC50 value of 3 nM, indicating that the compd. had some degree of selectivity for the A-2 receptor.  Anal. of the effect of the compd. on the satn. isotherms for each of the receptors indicated that it was a competitive antagonist at the brain A-1 receptor but that it was noncompetitive at the striatal A-2 receptor.  I was a potent adenosine antagonist in the adenosine-stimulated adenylate cyclase system in guinea pig synaptoneurosomes, where the compd. was found to have an IC50 value of 30 to 70 nM against the increase in cAMP evoked by 5 Î¼M adenosine.  I had no effect on the binding of [3H]nitrobenzylthioinosine, a ligand thought to bind to adenosine uptake sites, and, at a concn. of 10 Î¼M, had no effect on beef heart type III phosphodiesterase activity.  In assessing its activity in binding assays for 21 other putative neurotransmitters, I showed no appreciable activity at concns. up to 10 Î¼M, although it was able to inhibit the binding of [3H]flunitrazepam to the central benzodiazepine receptor with an IC50 value of 1020 nM.  I is a potent adenosine antagonist.  Since it is not a xanthine with the underlying assocn. of phosphodiesterase-inhibitory properties, it may be useful in evaluating the role of adenosine in mammalian tissue function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7D611Hdrm6rVg90H21EOLACvtfcHk0ljMNSAqYWrhYg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXksFWrtLc%253D&md5=15287d69f1c5ae5a413f665c137353a7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DFrancis%26aufirst%3DJ.%26aulast%3DGhai%26aufirst%3DG.%26aulast%3DBraunwalder%26aufirst%3DA.%26aulast%3DPsychoyos%26aufirst%3DS.%26aulast%3DStone%26aufirst%3DG.%2BA.%26aulast%3DCash%26aufirst%3DW.%2BD.%26atitle%3DBiochemical%2520characterization%2520of%2520the%2520triazoloquinazoline%252C%2520CGS15943%252C%2520a%2520novel%252C%2520non-xanthine%2520adenosine%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1987%26volume%3D241%26spage%3D415%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">de Mendoca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastiao, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, J. A.</span><span> </span><span class="NLM_article-title">Adenosine: Does it have a neuroprotective role after all?</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">2â3</span><span class="NLM_x">) </span> <span class="NLM_fpage">258</span><span class="NLM_x">â</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2FS0165-0173%2800%2900033-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=11011069" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=258-274&issue=2%E2%80%933&author=A.+de+Mendocaauthor=A.+M.+Sebastiaoauthor=J.+A.+Ribeiro&title=Adenosine%3A+Does+it+have+a+neuroprotective+role+after+all%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1016%2FS0165-0173%2800%2900033-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-0173%252800%252900033-3%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMendoca%26aufirst%3DA.%26aulast%3DSebastiao%26aufirst%3DA.%2BM.%26aulast%3DRibeiro%26aufirst%3DJ.%2BA.%26atitle%3DAdenosine%253A%2520Does%2520it%2520have%2520a%2520neuroprotective%2520role%2520after%2520all%253F%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2000%26volume%3D33%26issue%3D2%25E2%2580%25933%26spage%3D258%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ismayilova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crossman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhratsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J.</span><span> </span><span class="NLM_article-title">Effects of adenosine A<sub>2</sub>, dopamine D<sub>1</sub> and metabotropic glutamate 5 receptor-modulating agents on locomotion of the reserpinised rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">497</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">187</span><span class="NLM_x">â</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.ejphar.2004.06.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=15306204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslCjurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=497&publication_year=2004&pages=187-195&issue=2&author=N.+Ismayilovaauthor=A.+Crossmanauthor=A.+Verkhratskyauthor=J.+Brotchie&title=Effects+of+adenosine+A2%2C+dopamine+D1+and+metabotropic+glutamate+5+receptor-modulating+agents+on+locomotion+of+the+reserpinised+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of adenosine A1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised rats</span></div><div class="casAuthors">Ismayilova, Naila; Crossman, Alan; Verkhratsky, Alexei; Brotchie, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">497</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-195</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The pathophysiol. of Parkinson's disease and -3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia are characterized by an imbalance between activity of the direct and indirect pathways regulated by dopamine D1 and D2 receptors, resp.  In this study, we investigated the effects of treatments combining adenosine A1 and metabotropic glutamate 5 (mGlu5) receptors modulators on locomotion induced by dopamine D1 receptor activation in the reserpine-treated rats.  Administration of the adenosine A1 receptor agonist and mGlu5 receptor antagonist resulted in the significant redn. of dopamine D1 receptor agonist-induced locomotion.  The combination of adenosine A1 receptor agonist with mGlu5 receptor antagonist had no greater effect than these compds. alone.  However, the adenosine A1 receptor antagonist attenuated the inhibitory effect of mGlu5 receptor antagonist.  The data suggest that the effect of mGlu5 receptor blockade on locomotion elicited by dopamine D1 receptor stimulation involves activation of adenosine A1 receptors.  This interaction can improve our understanding of pathophysiol. of L-DOPA-induced dyskinesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH52gtRJBUubVg90H21EOLACvtfcHk0ljzmRGSXw9SUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslCjurk%253D&md5=09a735642d457d41adda90ac5a3b8cdd</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.06.030%26sid%3Dliteratum%253Aachs%26aulast%3DIsmayilova%26aufirst%3DN.%26aulast%3DCrossman%26aufirst%3DA.%26aulast%3DVerkhratsky%26aufirst%3DA.%26aulast%3DBrotchie%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520adenosine%2520A2%252C%2520dopamine%2520D1%2520and%2520metabotropic%2520glutamate%25205%2520receptor-modulating%2520agents%2520on%2520locomotion%2520of%2520the%2520reserpinised%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D497%26issue%3D2%26spage%3D187%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Gatta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionsotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Synthesis of imidazo[1,2-<i>c</i>]pyrazolo[4,3-<i>e</i>]pyrimidines, pyrazolo[4,3-<i>e</i>]1,2,4-triazolo[1,5-<i>c</i>]pyrimidines and triazolo[5,1-<i>i</i>]purines: new potent A<sub>2</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">â</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1993&pages=569-576&author=F.+Gattaauthor=M.+R.+Del+Giudiceauthor=A.+Borioniauthor=P.+A.+Boreaauthor=S.+Dionsottiauthor=E.+Ongini&title=Synthesis+of+imidazo%5B1%2C2-c%5Dpyrazolo%5B4%2C3-e%5Dpyrimidines%2C+pyrazolo%5B4%2C3-e%5D1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidines+and+triazolo%5B5%2C1-i%5Dpurines%3A+new+potent+A2+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGatta%26aufirst%3DF.%26aulast%3DDel%2BGiudice%26aufirst%3DM.%2BR.%26aulast%3DBorioni%26aufirst%3DA.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DDionsotti%26aufirst%3DS.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DSynthesis%2520of%2520imidazo%255B1%252C2-c%255Dpyrazolo%255B4%252C3-e%255Dpyrimidines%252C%2520pyrazolo%255B4%252C3-e%255D1%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidines%2520and%2520triazolo%255B5%252C1-i%255Dpurines%253A%2520new%2520potent%2520A2%2520adenosine%2520receptor%2520antagonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1993%26volume%3D28%26spage%3D569%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zappaterra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Synthesis of new pyrazolo [4,3-<i>e</i>]-1,2,4-triazolo[1,5-<i>c</i>] pyrimidine and 1,2,3-triazolo [1,5-<i>c</i>] pyrimidine displaying potent and selective activity as A<sub>2A</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2539</span><span class="NLM_x">â</span> <span class="NLM_lpage">2544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=2539-2544&author=P.+G.+Baraldiauthor=S.+Manfrediniauthor=D.+Simoniauthor=L.+Zappaterraauthor=C.+Zocchiauthor=S.+Dionisottiauthor=E.+Ongini&title=Synthesis+of+new+pyrazolo+%5B4%2C3-e%5D-1%2C2%2C4-triazolo%5B1%2C5-c%5D+pyrimidine+and+1%2C2%2C3-triazolo+%5B1%2C5-c%5D+pyrimidine+displaying+potent+and+selective+activity+as+A2A+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DManfredini%26aufirst%3DS.%26aulast%3DSimoni%26aufirst%3DD.%26aulast%3DZappaterra%26aufirst%3DL.%26aulast%3DZocchi%26aufirst%3DC.%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DSynthesis%2520of%2520new%2520pyrazolo%2520%255B4%252C3-e%255D-1%252C2%252C4-triazolo%255B1%252C5-c%255D%2520pyrimidine%2520and%25201%252C2%252C3-triazolo%2520%255B1%252C5-c%255D%2520pyrimidine%2520displaying%2520potent%2520and%2520selective%2520activity%2520as%2520A2A%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D2539%26epage%3D2544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forlani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Cardiovascular pharmacology of the A<sub>2A</sub> adenosine receptor antagonist, SCH58261, in rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">â</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9535988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1cXisVCrt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1998&pages=9-15&author=A.+Monopoliauthor=C.+Casatiauthor=G.+Lozzaauthor=A.+Forlaniauthor=E.+Ongini&title=Cardiovascular+pharmacology+of+the+A2A+adenosine+receptor+antagonist%2C+SCH58261%2C+in+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat</span></div><div class="casAuthors">Monopoli, Angela; Casati, Carlo; Lozza, Gianluca; Forlani, Angelo; Ongini, Ennio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-15</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">We characterized the in vivo cardiovascular profile of SCH 58261, 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidine, a selective A2A adenosine receptor antagonist, in conscious, freely moving rats by use of the telemetry system.  In normotensive rats, SCH 58261, at 10 mg/kg i.p., significantly (P < .05) inhibited hypotension and tachycardia induced by the A2A receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine (0.01 mg/kg i.p.), but not the bradycardic effect caused by the A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (0.03 mg/kg i.p.).  SCH 58261, when administered alone, at 0.1 and 1 mg/kg i.p., did not induce significant hemodynamic changes, but at 10 mg/kg i.p., it slightly increased both systolic blood pressure (SBP) and diastolic blood pressure (DBP) (+19 Â± 3 and +16 Â± 2 mm Hg, resp.; P < .01) and heart rate (HR) (+85 Â± 5 beats/min; P < .01).  These effects were inhibited by adrenergic blockade with propranolol (30 mg/kg i.p.) and phentolamine (10 mg/kg i.p.): -5 Â± 3 mm Hg on DBP and -12 Â± 11 beats/min on HR (P < .01).  In spontaneously hypertensive rats, SCH 58261, at 3 and 10 mg/kg i.p., increased weakly both SBP (+19 Â± 5 mm Hg and +25 Â± 4 mm Hg) and DBP (+14 Â± 4 mm Hg and +23 Â± 4 mm Hg) vs. vehicle (P < .01) and HR (+45 Â± 17 and +64 Â± 18 beats/min vs. vehicle, resp.; P < .01).  The data indicate that SCH 58261 retains A2A selective receptor antagonist properties in vivo.  Its effect on cardiovascular sympathetic outflow further suggests that endogenous adenosine exerts a tonic vascular regulation through A2A receptors.  Therefore, SCH 58261 can be a useful pharmacol. tool for clarifying A2A-mediated cardiovascular actions of adenosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6AOfPNETfJLVg90H21EOLACvtfcHk0ljzmRGSXw9SUQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisVCrt7g%253D&md5=7c747920f3448d2e81f4bdc3a2fa1224</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DCasati%26aufirst%3DC.%26aulast%3DLozza%26aufirst%3DG.%26aulast%3DForlani%26aufirst%3DA.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DCardiovascular%2520pharmacology%2520of%2520the%2520A2A%2520adenosine%2520receptor%2520antagonist%252C%2520SCH58261%252C%2520in%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D285%26spage%3D9%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Caulkett, P. W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPartlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renshaw, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, B.</span><span> </span><span class="NLM_article-title">Adenine isosteres with bridgehead nitrogen. Part 1. Two independent syntheses of the [1,2,4]triazolo[1,5-<i>a</i>][1,3,5]triazine ring system leading to a range of substituents in the 2, 5 and 7 positions</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">â</span> <span class="NLM_lpage">808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=801-808&author=P.+W.+R.+Caulkettauthor=G.+Jonesauthor=M.+McPartlinauthor=N.+D.+Renshawauthor=S.+K.+Stewartauthor=B.+Wright&title=Adenine+isosteres+with+bridgehead+nitrogen.+Part+1.+Two+independent+syntheses+of+the+%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5D%5B1%2C3%2C5%5Dtriazine+ring+system+leading+to+a+range+of+substituents+in+the+2%2C+5+and+7+positions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaulkett%26aufirst%3DP.%2BW.%2BR.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DMcPartlin%26aufirst%3DM.%26aulast%3DRenshaw%26aufirst%3DN.%2BD.%26aulast%3DStewart%26aufirst%3DS.%2BK.%26aulast%3DWright%26aufirst%3DB.%26atitle%3DAdenine%2520isosteres%2520with%2520bridgehead%2520nitrogen.%2520Part%25201.%2520Two%2520independent%2520syntheses%2520of%2520the%2520%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255D%255B1%252C3%252C5%255Dtriazine%2520ring%2520system%2520leading%2520to%2520a%2520range%2520of%2520substituents%2520in%2520the%25202%252C%25205%2520and%25207%2520positions%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1995%26spage%3D801%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moratalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standaert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskowitz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> adenosine receptor deficiency attenuates brain injury induced by transient local ischemia in mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">9192</span><span class="NLM_x">â</span> <span class="NLM_lpage">9200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=10531422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1MXnslyisLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=9192-9200&author=J.+F.+Chenauthor=Z.+Huangauthor=J.+Maauthor=J.+Zhuauthor=R.+Moratallaauthor=D.+Standaertauthor=M.+A.+Moskowitzauthor=J.+S.+Finkauthor=M.+A.+Schwarzschild&title=A2A+adenosine+receptor+deficiency+attenuates+brain+injury+induced+by+transient+local+ischemia+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice</span></div><div class="casAuthors">Chen, Jiang-Fan; Huang, Zhihong; Ma, Jianya; Zhu, JinMin; Moratalla, Rosario; Standaert, David; Moskowitz, Michael A.; Fink, J. Stephen; Schwarzschild, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9192-9200</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Extracellular adenosine critically modulates ischemic brain injury, at least in part through activation of the A1 adenosine receptor.  However, the role played by the A2A receptor has been obscured by intrinsic limitations of A2A adenosinergic agents.  To overcome these pharmacol. limitations, the authors explored the consequences of deleting the A2A adenosine receptor on brain damage after transient focal ischemia.  Cerebral morphol., as well as vascular and physiol. measures (before, during, and after ischemia) did not differ between A2A receptor knock-out and wild-type littermates.  The vol. of cerebral infarction, as well as the assocd. neurol. deficit induced by transient filament occlusion of the middle cerebral artery, were significantly attenuated in A2A receptor knock-out mice.  This neuroprotective phenotype of A2A receptor-deficient mice was obsd. in different genetic backgrounds, confirming A2A receptor disruption as its cause.  Together with complementary pharmacol. studies, these data suggest that A2A receptors play a prominent role in the development of ischemic injury within brain and demonstrate the potential for anatomical and functional neuroprotection against stroke by A2A receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLSE_1cO_jVLVg90H21EOLACvtfcHk0lgRhJj47BOxpA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslyisLc%253D&md5=54d19e3ba26fcbd7cf3a963b381c204f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DMoratalla%26aufirst%3DR.%26aulast%3DStandaert%26aufirst%3DD.%26aulast%3DMoskowitz%26aufirst%3DM.%2BA.%26aulast%3DFink%26aufirst%3DJ.%2BS.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26atitle%3DA2A%2520adenosine%2520receptor%2520deficiency%2520attenuates%2520brain%2520injury%2520induced%2520by%2520transient%2520local%2520ischemia%2520in%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D9192%26epage%3D9200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span>The Jackson Laboratory. <a href="http://jaxmice.jax.org/strain/010685.html" class="extLink">http://jaxmice.jax.org/strain/010685.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Jackson+Laboratory.+http%3A%2F%2Fjaxmice.jax.org%2Fstrain%2F010685.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Effects of selective agonists and antagonists for A<sub>1</sub> or A<sub>2A</sub> adenosine receptors on sleep-waking patterns in rats</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">â</span> <span class="NLM_lpage">72</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=65-72&author=R.+Bertorelliauthor=N.+Ferriauthor=M.+Adamiauthor=E.+Ongini&title=Effects+of+selective+agonists+and+antagonists+for+A1+or+A2A+adenosine+receptors+on+sleep-waking+patterns+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DFerri%26aufirst%3DN.%26aulast%3DAdami%26aufirst%3DM.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DEffects%2520of%2520selective%2520agonists%2520and%2520antagonists%2520for%2520A1%2520or%2520A2A%2520adenosine%2520receptors%2520on%2520sleep-waking%2520patterns%2520in%2520rats%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1996%26volume%3D37%26spage%3D65%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">FerrÃ©, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Euler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span> </span><span class="NLM_article-title">Stimulation of high affinity adenosine A<sub>2</sub> receptors decreases the affinity of dopamine D<sub>2</sub> receptors in rat striatal membranes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">7238</span><span class="NLM_x">â</span> <span class="NLM_lpage">7241</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=7238-7241&author=S.+Ferr%C3%A9author=G.+Von+Eulerauthor=B.+Johanssonauthor=B.+Fredholmauthor=K.+Fuxe&title=Stimulation+of+high+affinity+adenosine+A2+receptors+decreases+the+affinity+of+dopamine+D2+receptors+in+rat+striatal+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DVon%2BEuler%26aufirst%3DG.%26aulast%3DJohansson%26aufirst%3DB.%26aulast%3DFredholm%26aufirst%3DB.%26aulast%3DFuxe%26aufirst%3DK.%26atitle%3DStimulation%2520of%2520high%2520affinity%2520adenosine%2520A2%2520receptors%2520decreases%2520the%2520affinity%2520of%2520dopamine%2520D2%2520receptors%2520in%2520rat%2520striatal%2520membranes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1991%26volume%3D88%26spage%3D7238%26epage%3D7241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Dasgupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FerrÃ©, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kull, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finnman, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arenas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor modulates the binding characteristics of dopamine D<sub>2</sub> receptors in stably cotransfected fibroblast cells</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">â</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2FS0014-2999%2896%2900665-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=8982704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1Krsbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=1996&pages=325-331&author=S.+Dasguptaauthor=S.+Ferr%C3%A9author=B.+Kullauthor=P.+B.+Hedlundauthor=U.+B.+Finnmanauthor=S.+Ahlbergauthor=E.+Arenasauthor=B.+B.+Fredholmauthor=K.+Fuxe&title=Adenosine+A2A+receptor+modulates+the+binding+characteristics+of+dopamine+D2+receptors+in+stably+cotransfected+fibroblast+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells</span></div><div class="casAuthors">Dasgupta, Sarmila; Ferre, Sergi; Kull, Bjoern; Hedlund, Peter B.; Finnman, Ulla-Britt; Ahlberg, Susanne; Arenas, Ernest; Fredholm, Bertil B.; Fuxe, Kjell</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">325-331</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In membrane prepns. from rat striatum, where adenosine A2A and dopamine D2 receptors are coexpressed, stimulation of adenosine A2A receptors was found to decrease the affinity of dopamine D2 receptors for dopamine agonists.  We now demonstrate the existence of this antagonistic interaction in a fibroblast cell line (Ltk-) stably transfected with the human dopamine D2 (long-form) receptor and the dog adenosine A2A receptor cDNAs (A2A-D2 cells).  In A2A-D2 cells, but not in control cells only contg. dopamine D2 receptors (D2 cells), the selective adenosine A2A agonist CGS 21680 induced a 2-3-fold decrease in the affinity of dopamine D2 receptors for dopamine, as shown in competition expts. with dopamine vs. the selective dopamine D2 antagonist [3H]raclopride.  By contrast, activation of the constitutively expressed adenosine A2B receptors with 5'-N-ethyl-carboxamidoadenosine (NECA) did not modify dopamine D2 receptor binding.  In A2A-D2 cells CGS 21680 failed to induce or induced only a small increase in cAMP accumulation.  In D2 cells NECA- or forskolin-induced adenylyl cyclase activation was not assocd. with any change in dopamine D2 receptor binding.  These results indicate that adenylyl cyclase activation is not involved in the adenosine A2A receptor-mediated modulation of the binding characteristics of the dopamine D2 (long-form) receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmB5ZLTykPzrVg90H21EOLACvtfcHk0lgRhJj47BOxpA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1Krsbk%253D&md5=bfd7889f6f1d076ea7d5740dbc41f12d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2896%2900665-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252896%252900665-6%26sid%3Dliteratum%253Aachs%26aulast%3DDasgupta%26aufirst%3DS.%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DKull%26aufirst%3DB.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26aulast%3DFinnman%26aufirst%3DU.%2BB.%26aulast%3DAhlberg%26aufirst%3DS.%26aulast%3DArenas%26aufirst%3DE.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DFuxe%26aufirst%3DK.%26atitle%3DAdenosine%2520A2A%2520receptor%2520modulates%2520the%2520binding%2520characteristics%2520of%2520dopamine%2520D2%2520receptors%2520in%2520stably%2520cotransfected%2520fibroblast%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D316%26spage%3D325%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Pollack, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, J. S.</span><span> </span><span class="NLM_article-title">Adenosine antagonists potentiate D<sub>2</sub>-dopamine-dependent activation of Fos in the striopallidal pathway</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">â</span> <span class="NLM_lpage">728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1995&pages=721-728&author=A.+E.+Pollackauthor=J.+S.+Fink&title=Adenosine+antagonists+potentiate+D2-dopamine-dependent+activation+of+Fos+in+the+striopallidal+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPollack%26aufirst%3DA.%2BE.%26aulast%3DFink%26aufirst%3DJ.%2BS.%26atitle%3DAdenosine%2520antagonists%2520potentiate%2520D2-dopamine-dependent%2520activation%2520of%2520Fos%2520in%2520the%2520striopallidal%2520pathway%26jtitle%3DNeuroscience%26date%3D1995%26volume%3D68%26spage%3D721%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Popoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">PÃ¨zola, A.</span><span> </span><span class="NLM_article-title">Effects of SCH58261, an adenosine A<sub>2A</sub> receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats: lack of tolerance after chronic caffeine intake</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">522</span><span class="NLM_x">â</span> <span class="NLM_lpage">529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2000&pages=522-529&issue=5&author=P.+Popoliauthor=R.+Reggioauthor=A.+P%C3%A8zola&title=Effects+of+SCH58261%2C+an+adenosine+A2A+receptor+antagonist%2C+on+quinpirole-induced+turning+in+6-hydroxydopamine-lesioned+rats%3A+lack+of+tolerance+after+chronic+caffeine+intake"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPopoli%26aufirst%3DP.%26aulast%3DReggio%26aufirst%3DR.%26aulast%3DP%25C3%25A8zola%26aufirst%3DA.%26atitle%3DEffects%2520of%2520SCH58261%252C%2520an%2520adenosine%2520A2A%2520receptor%2520antagonist%252C%2520on%2520quinpirole-induced%2520turning%2520in%25206-hydroxydopamine-lesioned%2520rats%253A%2520lack%2520of%2520tolerance%2520after%2520chronic%2520caffeine%2520intake%26jtitle%3DNeuropsychopharmacology%26date%3D2000%26volume%3D22%26issue%3D5%26spage%3D522%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">FerrÃ©, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimondini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D<sub>2</sub> receptors in the rat striatum</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">â</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=129-140&author=S.+Ferr%C3%A9author=P.+Popoliauthor=R.+Rimondiniauthor=R.+Reggioauthor=J.+Kehrauthor=K.+Fuxe&title=Adenosine+A2A+and+group+I+metabotropic+glutamate+receptors+synergistically+modulate+the+binding+characteristics+of+dopamine+D2+receptors+in+the+rat+striatum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DPopoli%26aufirst%3DP.%26aulast%3DRimondini%26aufirst%3DR.%26aulast%3DReggio%26aufirst%3DR.%26aulast%3DKehr%26aufirst%3DJ.%26aulast%3DFuxe%26aufirst%3DK.%26atitle%3DAdenosine%2520A2A%2520and%2520group%2520I%2520metabotropic%2520glutamate%2520receptors%2520synergistically%2520modulate%2520the%2520binding%2520characteristics%2520of%2520dopamine%2520D2%2520receptors%2520in%2520the%2520rat%2520striatum%26jtitle%3DNeuropharmacology%26date%3D1999%26volume%3D38%26spage%3D129%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">El Yacoubi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costentin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaugeois, J.-M.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonists are potential antidepressants: evidence based on pharmacology and A<sub>2A</sub> receptor knock out mice</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">â</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1038%2Fsj.bjp.0704240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=11522598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVyrurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=68-77&author=M.+El+Yacoubiauthor=C.+Ledentauthor=M.+Parmentierauthor=R.+Bertorelliauthor=E.+Onginiauthor=J.+Costentinauthor=J.-M.+Vaugeois&title=Adenosine+A2A+receptor+antagonists+are+potential+antidepressants%3A+evidence+based+on+pharmacology+and+A2A+receptor+knock+out+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice</span></div><div class="casAuthors">El Yacoubi, Malika; Ledent, Catherine; Parmentier, Marc; Bertorelli, Rosalia; Ongini, Ennio; Costentin, Jean; Vaugeois, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-77</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adenosine, an ubiquitous neuromodulator, and its analogs have been shown to produce "depressant" effects in animal models believed to be relevant to depressive disorders, while adenosine receptor antagonists have been found to reverse adenosine-mediated "depressant" effect.  We have designed studies to assess whether adenosine A2A receptor antagonists, or genetic inactivation of the receptor would be effective in established screening procedures, such as tail suspension and forced swim tests, which are predictive of clin. antidepressant activity.  Adenosine A2A receptor knockout mice were found to be less sensitive to "depressant" challenges than their wild-type littermates.  Consistently, the adenosine A2A receptor blockers SCH 58261 (1-10 mg kg-1, i.p.) and KW 6002 (0.1-10 mg kg-1, p.o.) reduced the total immobility time in the tail suspension test.  The efficacy of adenosine A2A receptor antagonists in reducing immobility time in the tail suspension test was confirmed and extended in two groups of mice.  Specifically, SCH 58261 (1-10 mg kg-1) and ZM 241385 (15-60 mg kg-1) were effective in mice previously screened for having high immobility time, while SCH 58261 at 10 mg kg-1 reduced immobility of mice that were selectively bred for their spontaneous "helplessness" in this assay.  Addnl. expts. were carried out using the forced swim test.  SCH 58261 at 10 mg kg-1 reduced the immobility time by 61%, while KW 6002 decreased the total immobility time at the doses of 1 and 10 mg kg-1 by 75 and 79%, resp.  Administration of the dopamine D2 receptor antagonist haloperidol (50-200 Î¼g kg-1 i.p.) prevented the antidepressant-like effects elicited by SCH 58261 (10 mg kg-1 i.p.) in forced swim test whereas it left unaltered its stimulant motor effects.  In conclusion, these data support the hypothesis that A2A receptor antagonists prolong escape-directed behavior in two screening tests for antidepressants.  Altogether the results support the hypothesis that blockade of the adenosine A2A receptor might be an interesting target for the development of effective antidepressant agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXnF2LXC3z7rVg90H21EOLACvtfcHk0lgZQyWowAYHmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVyrurc%253D&md5=b000017916296c89c1e71875ecd887e5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704240%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BYacoubi%26aufirst%3DM.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DCostentin%26aufirst%3DJ.%26aulast%3DVaugeois%26aufirst%3DJ.-M.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonists%2520are%2520potential%2520antidepressants%253A%2520evidence%2520based%2520on%2520pharmacology%2520and%2520A2A%2520receptor%2520knock%2520out%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D134%26spage%3D68%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Popoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pintor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenici, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebano, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">PÃ¨zzola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarchilli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quarta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malchiodi-Albedi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massotti, M.</span><span> </span><span class="NLM_article-title">Blockade of striatal adenosine A<sub>2A</sub> receptors reduces quinolinic acid-induced excitotoxicity</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1967</span><span class="NLM_x">â</span> <span class="NLM_lpage">1975</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=11880527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvVaktbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=1967-1975&issue=5&author=P.+Popoliauthor=A.+Pintorauthor=M.+R.+Domeniciauthor=C.+Frankauthor=M.+T.+Tebanoauthor=A.+P%C3%A8zzolaauthor=L.+Scarchilliauthor=D.+Quartaauthor=R.+Reggioauthor=F.+Malchiodi-Albediauthor=M.+Falchiauthor=M.+Massotti&title=Blockade+of+striatal+adenosine+A2A+receptors+reduces+quinolinic+acid-induced+excitotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum</span></div><div class="casAuthors">Popoli, Patrizia; Pintor, Annita; Domenici, Maria Rosaria; Frank, Claudio; Tebano, Maria Teresa; Pezzola, Antonella; Scarchilli, Laura; Quarta, Davide; Reggio, Rosaria; Malchiodi-Albedi, Fiorella; Falchi, Mario; Massotti, Marino</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1967-1975</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The aim of the present study was to evaluate whether, and by means of which mechanisms, the adenosine A2A receptor antagonist SCH 58261 [5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine] exerted neuroprotective effects in a rat model of Huntington's disease.  In a first set of expts., SCH 58261 (0.01 and 1 mg/kg) was administered i.p. to Wistar rats 20 min before the bilateral striatal injection of quinolinic acid (QA) (300 nmol/1 Î¼l).  SCH 58261 (0.01 but not 1 mg/kg, i.p.) did reduce significantly the effects of QA on motor activity, electroencephalog. changes, and striatal gliosis.  Because QA acts by both increasing glutamate outflow and directly stimulating NMDA receptors, a second set of expts. was performed to evaluate whether SCH 58261 acted by preventing the presynaptic and/or the postsynaptic effects of QA.  In microdialysis expts. in naive rats, striatal perfusion with QA (5 mN) enhanced glutamate levels by â¼500%.  Such an effect of QA was completely antagonized by pretreatment with SCH 58261 (0.01 but not 1 mg/kg, i.p.).  In primary striatal cultures, bath application of QA (900 AM) significantly increased intracellular calcium levels, an effect prevented by the NMDA receptor antagonist MK-801 [(Â±)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate].  In this model, bath application of SCH 58261 (15-200 nM) tended to potentiate QA-induced calcium increase.  We conclude the following: (1) the adenosine A2A receptor antagonist SCH 58261 has neuroprotective effects, although only at low doses, in an excitotoxic rat model of HD, and (2) the inhibition of QA-evoked glutamate outflow seems to be the major mechanism underlying the neuroprotective effects of SCH 58261.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjomGSUPCO0LVg90H21EOLACvtfcHk0lgZQyWowAYHmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvVaktbc%253D&md5=4111a81928fac5c23b9a85c7f1f6b14d</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPopoli%26aufirst%3DP.%26aulast%3DPintor%26aufirst%3DA.%26aulast%3DDomenici%26aufirst%3DM.%2BR.%26aulast%3DFrank%26aufirst%3DC.%26aulast%3DTebano%26aufirst%3DM.%2BT.%26aulast%3DP%25C3%25A8zzola%26aufirst%3DA.%26aulast%3DScarchilli%26aufirst%3DL.%26aulast%3DQuarta%26aufirst%3DD.%26aulast%3DReggio%26aufirst%3DR.%26aulast%3DMalchiodi-Albedi%26aufirst%3DF.%26aulast%3DFalchi%26aufirst%3DM.%26aulast%3DMassotti%26aufirst%3DM.%26atitle%3DBlockade%2520of%2520striatal%2520adenosine%2520A2A%2520receptors%2520reduces%2520quinolinic%2520acid-induced%2520excitotoxicity%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26issue%3D5%26spage%3D1967%26epage%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Paterniti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipriani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mello, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramanti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzocrea, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedata, F.</span><span> </span><span class="NLM_article-title">Selective adenosine A<sub>2A</sub> receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">â</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1186%2F1742-2094-8-31" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=21486435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVamsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=31-44&author=I.+Paternitiauthor=A.+Melaniauthor=S.+Ciprianiauthor=F.+Cortiauthor=T.+Melloauthor=E.+Mazzonauthor=E.+Espositoauthor=P.+Bramantiauthor=S.+Cuzzocreaauthor=F.+Pedata&title=Selective+adenosine+A2A+receptor+agonists+and+antagonists+protect+against+spinal+cord+injury+through+peripheral+and+central+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects</span></div><div class="casAuthors">Paterniti, Irene; Melani, Alessia; Cipriani, Sara; Corti, Francesca; Mello, Tommaso; Mazzon, Emanuela; Esposito, Emanuela; Bramanti, Placido; Cuzzocrea, Salvatore; Pedata, Felicita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Permanent functional deficits following spinal cord injury (SCI) arise both from mech. injury and from secondary tissue reactions involving inflammation.  Enhanced release of adenosine and glutamate soon after SCI represents a component in the sequelae that may be responsible for resulting functional deficits.  The role of adenosine A2A receptor in central ischemia/trauma is still to be elucidated.  In our previous studies we have demonstrated that the adenosine A2A receptor-selective agonist CGS21680, systemically administered after SCI, protects from tissue damage, locomotor dysfunction and different inflammatory readouts.  In this work we studied the effect of the adenosine A2A receptor antagonist SCH58261, systemically administered after SCI, on the same parameters.  We investigated the hypothesis that the main action mechanism of agonists and antagonists is at peripheral or central sites.  Methods: Spinal trauma was induced by extradural compression of SC exposed via a four-level T5-T8 laminectomy in mouse.  Three drug-dosing protocols were utilized: a short-term systemic administration by i.p. injection, a chronic administration via osmotic minipump, and direct injection into the spinal cord.  Results: SCH58261, systemically administered (0.01 mg/kg i.p. 1, 6 and 10 h after SCI), reduced demyelination and levels of TNF-Î±, Fas-L, PAR, Bax expression and activation of JNK mitogen-activated protein kinase (MAPK) 24 h after SCI.  Chronic SCH58261 administration, by mini-osmotic pump delivery for 10 days, improved the neurol. deficit up to 10 days after SCI.  Adenosine A2A receptors are physiol. expressed in the spinal cord by astrocytes, microglia and oligodendrocytes.  Soon after SCI (24 h), these receptors showed enhanced expression in neurons.  Both the A2A agonist and antagonist, administered i.p., reduced expression of the A2A receptor, ruling out the possibility that the neuroprotective effects of the A2A agonist are due to A2A receptor desensitization.  When the A2A antagonist and agonist were centrally injected into injured SC, only SCH58261 appeared neuroprotective, while CGS21680 was ineffective.  Conclusions: Our results indicate that the A2A antagonist protects against SCI by acting on centrally located A2A receptors.  It is likely that blockade of A2A receptors reduces excitotoxicity.  In contrast, neuroprotection afforded by the A2A agonist may be primarily due to peripheral effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH4aBI5clJBbVg90H21EOLACvtfcHk0lgZQyWowAYHmw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVamsL8%253D&md5=cee045c88a97571e1c0f4b836da9dc90</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-8-31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-8-31%26sid%3Dliteratum%253Aachs%26aulast%3DPaterniti%26aufirst%3DI.%26aulast%3DMelani%26aufirst%3DA.%26aulast%3DCipriani%26aufirst%3DS.%26aulast%3DCorti%26aufirst%3DF.%26aulast%3DMello%26aufirst%3DT.%26aulast%3DMazzon%26aufirst%3DE.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DBramanti%26aufirst%3DP.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DPedata%26aufirst%3DF.%26atitle%3DSelective%2520adenosine%2520A2A%2520receptor%2520agonists%2520and%2520antagonists%2520protect%2520against%2520spinal%2520cord%2520injury%2520through%2520peripheral%2520and%2520central%2520effects%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2011%26volume%3D8%26spage%3D31%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Mohamed, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agha, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nassar, N. N.</span><span> </span><span class="NLM_article-title">SCH58261 the selective adenosine A<sub>2A</sub> receptor blocker modulates ischemia reperfusion injury following bilateral carotid occlusion: role of inflammatory mediators</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">538</span><span class="NLM_x">â</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2Fs11064-011-0640-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=22071908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVektrrO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=538-547&issue=3&author=R.+A.+Mohamedauthor=A.+M.+Aghaauthor=N.+N.+Nassar&title=SCH58261+the+selective+adenosine+A2A+receptor+blocker+modulates+ischemia+reperfusion+injury+following+bilateral+carotid+occlusion%3A+role+of+inflammatory+mediators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">SCH58261 the Selective Adenosine A2A Receptor Blocker Modulates Ischemia Reperfusion Injury Following Bilateral Carotid Occlusion: Role of Inflammatory Mediators</span></div><div class="casAuthors">Mohamed, R. A.; Agha, A. M.; Nassar, N. N.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">538-547</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In the present study, the effects of SCH58261, a selective adenosine A2A receptor antagonist that crosses the blood brain barrier (BBB) and 8-(4-sulfophenyl) theophylline (8-SPT), a non-selective adenosine receptor antagonist that acts peripherally, were investigated on cerebral ischemia reperfusion injury (IR).  Male Wistar rats (200-250 g) were divided into four groups: (1) sham-operated (SO), IR pretreated with either (2) vehicle (DMSO); (3) SCH58261 (0.01 mg/kg); (4) 8-SPT (2.5 mg/kg).  Animals were anesthetized and submitted to occlusion of both carotid arteries for 45 min.  All treatments were administered i.p. post carotid occlusion prior to exposure to a 24 h reperfusion period.  Ischemic rats showed increased infarct size compared to their control counterparts that corroborated with histopathol. changes as well as increased lactate dehydrogenase (LDH) activity in the hippocampus.  Moreover, ischemic animals showed habituation deficit, increased anxiety and locomotor activity.  IR increased hippocampal glutamate (Glu), GABA, glycine (Gly) and aspartate (ASP).  SCH58261 significantly reversed these effects while 8-SPT elicited minimal change.  IR raised myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-Î±), nitric oxide (NO), prostaglandin E2 (PGE2) accompanied by a decrease in interleukin-10 (IL-10), effects that were again reversed by SCH58261, but 8-SPT elicited less changes.  Results from the present study point towards the importance of central blockade of adenosine A2A receptor in ameliorating hippocampal damage following IR injury by halting inflammatory cascades as well as modulating excitotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP6EgOLW89JbVg90H21EOLACvtfcHk0lixZYJdFgEbEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVektrrO&md5=9dec8f6dacd131ea7a24d347f8e91d48</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs11064-011-0640-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-011-0640-x%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DR.%2BA.%26aulast%3DAgha%26aufirst%3DA.%2BM.%26aulast%3DNassar%26aufirst%3DN.%2BN.%26atitle%3DSCH58261%2520the%2520selective%2520adenosine%2520A2A%2520receptor%2520blocker%2520modulates%2520ischemia%2520reperfusion%2520injury%2520following%2520bilateral%2520carotid%2520occlusion%253A%2520role%2520of%2520inflammatory%2520mediators%26jtitle%3DNeurochem.%2520Res.%26date%3D2012%26volume%3D37%26issue%3D3%26spage%3D538%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tikhonova, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure and function of G protein-coupled receptors studied using sequence analysis, molecular modeling and receptor engineering: adenosine receptors</span> <span class="citation_source-journal">Front. Drug Des. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">â</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWlur3N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=63-79&author=S.+Costanziauthor=A.+A.+Ivanovauthor=I.+G.+Tikhonovaauthor=K.+A.+Jacobson&title=Structure+and+function+of+G+protein-coupled+receptors+studied+using+sequence+analysis%2C+molecular+modeling+and+receptor+engineering%3A+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of G protein-coupled receptors studied using sequence analysis, molecular modeling and receptor engineering: adenosine receptors</span></div><div class="casAuthors">Costanzi, Stefano; Ivanov, Andrei A.; Tikhonova, Irina G.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Drug Design and Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-79</span>CODEN:
                <span class="NLM_cas:coden">FDDDBZ</span>;
        ISSN:<span class="NLM_cas:issn">1574-0889</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Rhodopsin is the only member of the G protein-coupled receptors (GPCRs) superfamily for which crystallog. data are available.  Thus, the study of the structure-function relationships of most GPCRs relies on bioinformatics, rhodopsin-based homol. modeling, and docking expts. conducted in an iterative manner utilizing site-directed mutagenesis and chem. modification of the ligands.  Adenosine receptors (ARs) are presented as a case study to illustrate this indirect composite approach relying on an intimate combination of computational and exptl. techniques.  In the first section we discuss the phylogenesis of the ARs from an evolutionary perspective.  Furthermore, we review sequence comparison studies from the perspective of similarities with other GPCRs, chemogenomics, and coupling to G proteins.  In the second section, we review various rhodopsin-based homol. models of the ARs and docking studies of agonists and antagonists.  As reported for other GPCRs, several different modes have been hypothesized for ligands binding to ARs.  Here, we critically review the proposed binding modes of agonists and antagonists in light of the available matagenesis data and the structure-activity relationships of ligands.  Lastly, we review an exptl.-supported strategy for validating theor. binding hypotheses based on the complementary reengineering of receptors and ligands (neoceptors and neoligands).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAswktiw8RYbVg90H21EOLACvtfcHk0lixZYJdFgEbEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWlur3N&md5=c631351430d3703fbfa31efb487d8388</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DIvanov%26aufirst%3DA.%2BA.%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure%2520and%2520function%2520of%2520G%2520protein-coupled%2520receptors%2520studied%2520using%2520sequence%2520analysis%252C%2520molecular%2520modeling%2520and%2520receptor%2520engineering%253A%2520adenosine%2520receptors%26jtitle%3DFront.%2520Drug%2520Des.%2520Discovery%26date%3D2007%26volume%3D3%26spage%3D63%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> adenosine receptors and its modulators: overview on a druggable GPCR and on SAR analysis and binding requirements of agonists and antagonists</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">â</span> <span class="NLM_lpage">1552</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.2174%2F138161208784480081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=18537675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1ymsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1525-1552&author=G.+Cristalliauthor=C.+Lambertucciauthor=G.+Marucciauthor=R.+Volpiniauthor=D.+Dal+Ben&title=A2A+adenosine+receptors+and+its+modulators%3A+overview+on+a+druggable+GPCR+and+on+SAR+analysis+and+binding+requirements+of+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists</span></div><div class="casAuthors">Cristalli, G.; Lambertucci, C.; Marucci, G.; Volpini, R.; Dal Ben, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1525-1552</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the biol. effects of adenosine, the development of potent and selective agonists and antagonists of adenosine receptors has been the subject of medicinal chem. research for several decades, even if their clin. evaluation has been discontinued.  Main problems include side effects due to the ubiquity of the receptors and the possibility of side effects, or to low brain penetration (in particular for the targeting of CNS diseases), short half-life of compds., lack of effects.  Furthermore, species differences in the affinity of ligands make difficult preclin. testing in animal models.  Nevertheless, adenosine receptors continue to represent promising drug targets.  A2A receptor has proved to be a promising pharmacol. target for small synthetic ligands, and while A2A agonists are undergoing clin. trials for myocardial perfusion imaging and as anti-inflammatory agents, A2A antagonists represent an attractive field of research to discover new drugs for the treatment of neurodegenerative disorders, such as Parkinson's disease.  Furthermore, the information coming from bioinformatics and mol. modeling studies for the A2A receptor has made easier the understanding of ligand-target interaction and the rational design of agonists and antagonists for this subtype.  The aim of this review is to show an overview of the most significant steps and progresses in developing A2A adenosine receptor agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLD7b3gsaCZrVg90H21EOLACvtfcHk0lixZYJdFgEbEA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1ymsrk%253D&md5=3b8c004d9a1fbff02c0a0ee1b476fcea</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F138161208784480081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208784480081%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DDal%2BBen%26aufirst%3DD.%26atitle%3DA2A%2520adenosine%2520receptors%2520and%2520its%2520modulators%253A%2520overview%2520on%2520a%2520druggable%2520GPCR%2520and%2520on%2520SAR%2520analysis%2520and%2520binding%2520requirements%2520of%2520agonists%2520and%2520antagonists%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D1525%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Jaakola, V.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, E. Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">The 2.6 angstrom crystal structure of a human A<sub>2A</sub> adenosine receptor bound to an antagonist</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">â</span> <span class="NLM_lpage">1217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1126%2Fscience.1164772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=18832607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyqtbfN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2008&pages=1211-1217&author=V.-P.+Jaakolaauthor=M.+Griffithauthor=M.+A.+Hansonauthor=V.+Cherezovauthor=E.+Y.+T.+Chienauthor=J.+R.+Laneauthor=A.+P.+Ijzermanauthor=R.+C.+Stevens&title=The+2.6+angstrom+crystal+structure+of+a+human+A2A+adenosine+receptor+bound+to+an+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist</span></div><div class="casAuthors">Jaakola, Veli-Pekka; Griffith, Mark T.; Hanson, Michael A.; Cherezov, Vadim; Chien, Ellen Y. T.; Lane, J. Robert; IJzerman, Adriaan P.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">5905</span>),
    <span class="NLM_cas:pages">1211-1217</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The adenosine class of heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) mediates the important role of extracellular adenosine in many physiol. processes and is antagonized by caffeine.  The authors have detd. the crystal structure of the human A2A adenosine receptor, in complex with a high-affinity subtype-selective antagonist, ZM241385, to 2.6 angstrom resoln.  Four disulfide bridges in the extracellular domain, combined with a subtle repacking of the transmembrane helixes relative to the adrenergic and rhodopsin receptor structures, define a pocket distinct from that of other structurally detd. GPCRs.  The arrangement allows for the binding of the antagonist in an extended conformation, perpendicular to the membrane plane.  The binding site highlights an integral role for the extracellular loops, together with the helical core, in ligand recognition by this class of GPCRs and suggests a role for ZM241385 in restricting the movement of a tryptophan residue important in the activation mechanism of the class A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7QL4wN4TdhrVg90H21EOLACvtfcHk0ljs_mHP2lLJyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyqtbfN&md5=5bdb862b41f345c244f3c162e058206b</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1126%2Fscience.1164772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1164772%26sid%3Dliteratum%253Aachs%26aulast%3DJaakola%26aufirst%3DV.-P.%26aulast%3DGriffith%26aufirst%3DM.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DThe%25202.6%2520angstrom%2520crystal%2520structure%2520of%2520a%2520human%2520A2A%2520adenosine%2520receptor%2520bound%2520to%2520an%2520antagonist%26jtitle%3DScience%26date%3D2008%26volume%3D322%26spage%3D1211%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Lebon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, C. G.</span><span> </span><span class="NLM_article-title">Agonist-bound adenosine A<sub>2A</sub> receptor structures reveal common features of GPCR activation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">474</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">â</span> <span class="NLM_lpage">525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1038%2Fnature10136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=21593763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFyqsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=474&publication_year=2011&pages=521-525&author=G.+Lebonauthor=T.+Warneauthor=P.+C.+Edwardsauthor=K.+Bennettauthor=C.+J.+Langmeadauthor=A.+G.+W.+Leslieauthor=C.+G.+Tate&title=Agonist-bound+adenosine+A2A+receptor+structures+reveal+common+features+of+GPCR+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation</span></div><div class="casAuthors">Lebon, Guillaume; Warne, Tony; Edwards, Patricia C.; Bennett, Kirstie; Langmead, Christopher J.; Leslie, Andrew G. W.; Tate, Christopher G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">474</span>
        (<span class="NLM_cas:issue">7352</span>),
    <span class="NLM_cas:pages">521-525</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adenosine receptors and Î²-adrenoceptors are G-protein-coupled receptors (GPCRs) that activate intracellular G proteins on binding the agonists adenosine or noradrenaline, resp.  GPCRs have similar structures consisting of seven transmembrane helixes that contain well-conserved sequence motifs, indicating that they are probably activated by a common mechanism.  Recent structures of Î²-adrenoceptors highlight residues in transmembrane region 5 that initially bind specifically to agonists rather than to antagonists, indicating that these residues have an important role in agonist-induced activation of receptors.  Here we present two crystal structures of the thermostabilized human adenosine A2A receptor (A2AR-GL31) bound to its endogenous agonist adenosine and the synthetic agonist NECA.  The structures represent an intermediate conformation between the inactive and active states, because they share all the features of GPCRs that are thought to be in a fully activated state, except that the cytoplasmic end of transmembrane helix 6 partially occludes the G-protein-binding site.  The adenine substituent of the agonists binds in a similar fashion to the chem. related region of the inverse agonist ZM241385 (ref. 8).  Both agonists contain a ribose group, not found in ZM241385, which extends deep into the ligand-binding pocket where it makes polar interactions with conserved residues in H7 (Ser 2777.42 and His 2787.43; superscripts refer to Ballesteros-Weinstein numbering) and non-polar interactions with residues in H3.  In contrast, the inverse agonist ZM241385 does not interact with any of these residues and comparison with the agonist-bound structures indicates that ZM241385 sterically prevents the conformational change in H5 and therefore it acts as an inverse agonist.  Comparison of the agonist-bound structures of A2AR with the agonist-bound structures of Î²-adrenoceptors indicates that the contraction of the ligand-binding pocket caused by the inward motion of helixes 3, 5 and 7 may be a common feature in the activation of all GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1rCKkCsE9CrVg90H21EOLACvtfcHk0ljs_mHP2lLJyw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFyqsrg%253D&md5=1b8161216b878db48ad33d7e8e007dc7</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnature10136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10136%26sid%3Dliteratum%253Aachs%26aulast%3DLebon%26aufirst%3DG.%26aulast%3DWarne%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DP.%2BC.%26aulast%3DBennett%26aufirst%3DK.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DTate%26aufirst%3DC.%2BG.%26atitle%3DAgonist-bound%2520adenosine%2520A2A%2520receptor%2520structures%2520reveal%2520common%2520features%2520of%2520GPCR%2520activation%26jtitle%3DNature%26date%3D2011%26volume%3D474%26spage%3D521%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhukov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Errey, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span> </span><span class="NLM_article-title">Biophysical mapping of the adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">4312</span><span class="NLM_x">â</span> <span class="NLM_lpage">4323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2003798" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4312-4323&issue=13&author=A.+Zhukovauthor=S.+P.+Andrewsauthor=J.+C.+Erreyauthor=N.+Robertsonauthor=B.+Tehanauthor=J.+S.+Masonauthor=F.+H.+Marshallauthor=M.+Weirauthor=M.+Congreve&title=Biophysical+mapping+of+the+adenosine+A2A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57a&amp;dbid=16384&amp;doi=10.1021%2Fjm2003798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2003798%26sid%3Dliteratum%253Aachs%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DRobertson%26aufirst%3DN.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DCongreve%26aufirst%3DM.%26atitle%3DBiophysical%2520mapping%2520of%2520the%2520adenosine%2520A2A%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D13%26spage%3D4312%26epage%3D4323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit57b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yasuda, M.; Harada, H.; Miyazawa, S.; Kobayashi, S.; Harada, K.; Hida, T.; Shibata, H.; Yasuda, N.; Asano, O.; Kotake, Y.</span><span> </span><span class="NLM_article-title">Pharmaceutical Composition Promoting Defecation</span>. U.S. Pat. Appl. Publ. US20060270674 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Yasuda&author=H.+Harada&author=S.+Miyazawa&author=S.+Kobayashi&author=K.+Harada&author=T.+Hida&author=H.+Shibata&author=N.+Yasuda&author=O.+Asano&author=Y.+Kotake&title=Pharmaceutical+Composition+Promoting+Defecation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DM.%26atitle%3DPharmaceutical%2520Composition%2520Promoting%2520Defecation%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaakola, V.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeager, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span> </span><span class="NLM_article-title">Structure-based discovery of novel chemotypes for adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1799</span><span class="NLM_x">â</span> <span class="NLM_lpage">1809</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901647p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlKqsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1799-1809&author=V.+Katritchauthor=V.-P.+Jaakolaauthor=J.+R.+Laneauthor=J.+Linauthor=A.+P.+Ijzermanauthor=I.+K.+Yeagerauthor=I.+Kufarevaauthor=R.+C.+Stevensauthor=R.+Abagyan&title=Structure-based+discovery+of+novel+chemotypes+for+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of Novel Chemotypes for Adenosine A2A Receptor Antagonists</span></div><div class="casAuthors">Katritch, Vsevolod; Jaakola, Veli-Pekka; Lane, J. Robert; Lin, Judy; IJzerman, Adriaan P.; Yeager, Mark; Kufareva, Irina; Stevens, Raymond C.; Abagyan, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1799-1809</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent progress in crystallog. of G-protein coupled receptors opens an unprecedented venue for structure-based GPCR drug discovery.  To test efficiency of the structure-based approach, we performed mol. docking and virtual ligand screening (VLS) of more than 4 million com. available "drug-like" and "lead-like" compds. against the A2AAR 2.6 Ã resoln. crystal structure.  Out of 56 high ranking compds. tested in A2AAR binding assays, 23 showed affinities under 10 Î¼M, 11 of those had sub-Î¼M affinities and two compds. had affinities under 60 nM.  The identified hits represent at least 9 different chem. scaffolds and are characterized by very high ligand efficiency (0.3-0.5 kcal/mol per heavy atom).  Significant A2AAR antagonist activities were confirmed for 10 out of 13 ligands tested in functional assays.  High success rate, novelty, and diversity of the chem. scaffolds and strong ligand efficiency of the A2AAR antagonists identified in this study suggest practical applicability of receptor-based VLS in GPCR drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX-YAwoEVzEbVg90H21EOLACvtfcHk0lh09KRgRiyCsg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlKqsw%253D%253D&md5=5a54df43f6edd20d83e7e5942e2f9811</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm901647p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901647p%26sid%3Dliteratum%253Aachs%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DJaakola%26aufirst%3DV.-P.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DYeager%26aufirst%3DI.%2BK.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DAbagyan%26aufirst%3DR.%26atitle%3DStructure-based%2520discovery%2520of%2520novel%2520chemotypes%2520for%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1799%26epage%3D1809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Klotz, K.-N.</span><span> </span><span class="NLM_article-title">Adenosine receptors and their ligands</span> <span class="citation_source-journal">Naunyn-Schmiedebergâs Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">â</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2Fs002100000315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=11111832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFCru7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2000&pages=382-391&author=K.-N.+Klotz&title=Adenosine+receptors+and+their+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors and their ligands</span></div><div class="casAuthors">Klotz, Karl-Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">382-391</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review with 65 refs.  The regulatory actions of adenosine are mediated via four subtypes of G protein-coupled receptors distinguished as A1, A2A, A2B and A3 receptors.  Their presence on basically every cell makes them an interesting target for the pharmacol. intervention in many pathophysiol. situations.  A large no. of ligands have been synthesized over the last two decades and provide agonists and antagonists that are more or less selective for the known receptor subtypes.  In addn., many radioligands are available in tritiated or radioiodinated form.  The comparative pharmacol. characterization of all four human adenosine receptor subtypes revealed that some of the compds. thought to be selective from data in other species have unexpected potencies at human receptors.  As a result, compds. that exhibit high affinity to only one subtype are an exception.  Although the selection of ligands is immense, it is less than satisfying for most subtypes of adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsGzhFkL72vbVg90H21EOLACvtfcHk0lh09KRgRiyCsg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFCru7Y%253D&md5=56b1c3ef50390d3c9bfc874da65baf58</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs002100000315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002100000315%26sid%3Dliteratum%253Aachs%26aulast%3DKlotz%26aufirst%3DK.-N.%26atitle%3DAdenosine%2520receptors%2520and%2520their%2520ligands%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2000%26volume%3D362%26spage%3D382%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taffi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of adenosine A<sub>2A</sub> receptor agonists</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">â</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.2174%2F1568026033392282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=12570757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGjuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=387-401&author=G.+Cristalliauthor=C.+Lambertucciauthor=S.+Taffiauthor=S.+Vittoriauthor=R.+Volpini&title=Medicinal+chemistry+of+adenosine+A2A+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of adenosine A2A receptor agonists</span></div><div class="casAuthors">Cristalli, Gloria; Lambertucci, Catia; Taffi, Sara; Vittori, Sauro; Volpini, Rosaria</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The search for potent and selective A2A adenosine receptor agonists has been particularly fruitful in the early nineties.  A series of 2-amino, 2-alkoxy, 2-alkythio-, 2-alkynyl-, and 2-alkenyl-derivs. of adenosine (Ado, 1) and N-ethylcarboxamidoadenosine (NECA, 30) have been synthesized and tested mainly on different model of rat A1 and A2A receptor subtypes.  From these studies some ligands, such as CGS 21680 (33), HENECA (42), and (S)-PHPNECA (46b), showed to possess high A2A affinity combined with good A2A vs A1 selectivity.  More detailed characterization of these ligands at the four cloned human adenosine receptor subtypes revealed that none of the prototypical adenosine receptor agonists exhibits at the same time high affinity and selectivity for the human A2AAR subtype.  Both NECA and CGS 21680, which are available as radioligands for this subtype, have lower affinity at human than at rat receptor.  The 2-alkynylNECA derivs. HENECA an PHPNECA showed high affinity also at human A3 receptors.  In particular, (S)-PHPNECA displayed Kis in the low nanomolar range at A1, A2A, and A3 subtypes and an EC50 of 220 nM at human A2B receptor.  It is now well known that the coronary vasodilation induced by Ado in different species is mediated by activation of A2AAR and a compd. capable of producing coronary vasodilation through activation of A2AAR, but that is devoid of A1-and A3-agonist activity would have advantage over Ado for use in myocardial perfusion imaging studies.  Other potential therapeutic applications of selective A2AAR agonists are as anti-aggregatory, anti-inflammatory, anti-psychotic, and anti-Huntington's disease agents.  This review is aimed at presenting a complete overview of the medicinal chem. development of A2A adenosine receptor agonists and at stressing the strong need for more selective ligands at A2A human subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZ9WytCwyQLVg90H21EOLACvtfcHk0ljCfk5_PiSS6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGjuw%253D%253D&md5=4d2aef4b8cb3f1f30efe8d4f839e01d1</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F1568026033392282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392282%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DTaffi%26aufirst%3DS.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DVolpini%26aufirst%3DR.%26atitle%3DMedicinal%2520chemistry%2520of%2520adenosine%2520A2A%2520receptor%2520agonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2003%26volume%3D3%26spage%3D387%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span> </span><span class="NLM_article-title">Recent developments in adenosine A<sub>2A</sub> receptor ligands</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">â</span> <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2F978-3-540-89615-9_3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=19639279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2009&pages=59-98&author=G.+Cristalliauthor=C.+E.+Mullerauthor=R.+Volpini&title=Recent+developments+in+adenosine+A2A+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in adenosine A2A receptor ligands</span></div><div class="casAuthors">Cristalli, Gloria; Muller, Christa E.; Volpini, Rosaria</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">Adenosine Receptors in Health and Disease</span>),
    <span class="NLM_cas:pages">59-98</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The development of potent and selective agonists and antagonists of adenosine receptors (ARs) has been a target of medicinal chem. research for several decades, and recently the US Food and Drug Administration has approved Lexiscan, an adenosine deriv. substituted at the 2 position, for use as a pharmacol. stress agent in radionuclide myocardial perfusion imaging.  Currently, some other adenosine A2A receptor (A2AAR) agonists and antagonists are undergoing preclin. testing and clin. trials.  While agonists are potent antiinflammatory agents also showing hypotensive effects, antagonists are being developed for the treatment of Parkinson's disease.  However, since there are still major problems in this field, including side effects, low brain penetration (for the targeting of CNS diseases), short half-life, or lack of in vivo effects, the design and development of new AR ligands is a hot research topic.  This review presents an update on the medicinal chem. of A2AAR agonists and antagonists, and stresses the strong need for more selective ligands at the human A2AAR subtype, in particular in the case of agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZlneM0HaH4rVg90H21EOLACvtfcHk0ljCfk5_PiSS6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr7E&md5=95c3e8fde30c9094d81cea882987ae64</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-89615-9_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-540-89615-9_3%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DMuller%26aufirst%3DC.%2BE.%26aulast%3DVolpini%26aufirst%3DR.%26atitle%3DRecent%2520developments%2520in%2520adenosine%2520A2A%2520receptor%2520ligands%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2009%26volume%3D193%26spage%3D59%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Mueller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Recent developments in adenosine receptor ligands and their potential as novel drugs</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1808</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1290</span><span class="NLM_x">â</span> <span class="NLM_lpage">1308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.bbamem.2010.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=21185259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1808&publication_year=2011&pages=1290-1308&issue=5&author=C.+E.+Muellerauthor=K.+A.+Jacobson&title=Recent+developments+in+adenosine+receptor+ligands+and+their+potential+as+novel+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in adenosine receptor ligands and their potential as novel drugs</span></div><div class="casAuthors">Mueller, Christa E.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1808</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1290-1308</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Medicinal chem. approaches have been applied to all four of the adenosine receptor (AR) subtypes (A1, A2A, A2B, and A3) to create selective agonists and antagonists for each.  The most recent class of selective AR ligands to be reported is the class of A2BAR agonists.  The availability of these selective ligands has facilitated research on therapeutic applications of modulating the ARs and in some cases has provided clin. candidates.  Prodrug approaches have been developed which improve the bioavailability of the drugs, reduce side-effects, and/or may lead to site-selective effects.  The A2A agonist regadenoson (Lexiscan), a diagnostic drug for myocardial perfusion imaging, is the first selective AR agonist to be approved.  Other selective agonists and antagonists are or were undergoing clin. trials for a broad range of indications, including capadenoson and tecadenoson (A1 agonists) for atrial fibrillation, or paroxysmal supraventricular tachycardia, resp., apadenoson and binodenoson (A2A agonists) for myocardial perfusion imaging, preladenant (A2A antagonist) for the treatment of Parkinson's disease, and CF101 and CF102 (A3 agonists) for inflammatory diseases and cancer, resp.  This article is part of a Special Issue entitled: "Adenosine Receptors".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8Cuch7XkT7Vg90H21EOLACvtfcHk0ljCfk5_PiSS6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrsr8%253D&md5=f143d2424c178c0a75e956ffb6b8320a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2010.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2010.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DC.%2BE.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DRecent%2520developments%2520in%2520adenosine%2520receptor%2520ligands%2520and%2520their%2520potential%2520as%2520novel%2520drugs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2011%26volume%3D1808%26issue%3D5%26spage%3D1290%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Siddiqi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esker, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist Iii, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneller, S. W.</span><span> </span><span class="NLM_article-title">Search for new purine-and ribose-modified adenosine analogs as selective agonists and antagonists at adenosine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1174</span><span class="NLM_x">â</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00007a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1174-1188&author=S.+M.+Siddiqiauthor=K.+A.+Jacobsonauthor=J.+L.+Eskerauthor=M.+E.+Olahauthor=X.+Jiauthor=N.+Melmanauthor=K.+N.+Tiwariauthor=J.+A.+Secrist+Iiiauthor=S.+W.+Schneller&title=Search+for+new+purine-and+ribose-modified+adenosine+analogs+as+selective+agonists+and+antagonists+at+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm00007a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00007a014%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqi%26aufirst%3DS.%2BM.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DEsker%26aufirst%3DJ.%2BL.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DTiwari%26aufirst%3DK.%2BN.%26aulast%3DSecrist%2BIii%26aufirst%3DJ.%2BA.%26aulast%3DSchneller%26aufirst%3DS.%2BW.%26atitle%3DSearch%2520for%2520new%2520purine-and%2520ribose-modified%2520adenosine%2520analogs%2520as%2520selective%2520agonists%2520and%2520antagonists%2520at%2520adenosine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1174%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burbiel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maass, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, C. E.</span><span> </span><span class="NLM_article-title">Adenosine receptor agonists: from basic medicinal chemistry to clinical development</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">â</span> <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1517%2F14728214.8.2.537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=14662005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFOqug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=537-576&author=L.+Yanauthor=J.+C.+Burbielauthor=A.+Maassauthor=C.+E.+Mueller&title=Adenosine+receptor+agonists%3A+from+basic+medicinal+chemistry+to+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptor agonists: from basic medicinal chemistry to clinical development</span></div><div class="casAuthors">Yan, Luo; Burbiel, Joachim C.; Maass, Astrid; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">537-576</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Adenosine is a physiol. nucleoside which acts as an autocoid and activates G protein-coupled membrane receptors, designated A1, A2A, A2B and A3.  Adenosine plays an important role in many (patho)physiol. conditions in the CNS as well as in peripheral organs and tissues.  Adenosine receptors are present on virtually every cell.  However, receptor subtype distribution and densities vary greatly.  Adenosine itself is used as a therapeutic agent for the treatment of supraventricular paroxysmal tachycardia and arrhythmias and as a vasodilatatory agent in cardiac imaging.  During the past 20 yr, a no. of selective agonists for A1, A2A and A3 adenosine receptors have been developed, all of them structurally derived from adenosine.  Several such compds. are currently undergoing clin. trials for the treatment of cardiovascular diseases (A1 and A2A), pain (A1), wound healing (A2A), diabetic foot ulcers (A2A), colorectal cancer (A3) and rheumatoid arthritis (A3).  Clin. evaluation of some A1, and A2A adenosine receptor agonists has been discontinued.  Major problems include side effects due to the wide distribution of adenosine receptors; low brain penetration, which is important for the targeting of CNS diseases; short half-lives of compds.; or a lack of effects, in some cases perhaps due to receptor desensitization or to low receptor d. in the targeted tissue.  Partial agonists, inhibitors of adenosine metab. (adenosine kinase and deaminase inhibitors) or allosteric activators of adenosine receptors may be advantageous for certain indications, as they may exhibit fewer side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCnhX_DnCYs7Vg90H21EOLACvtfcHk0lgAOpd6YgJGXA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFOqug%253D%253D&md5=d695e919750ae509a9e7a7b87c108382</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1517%2F14728214.8.2.537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.8.2.537%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DBurbiel%26aufirst%3DJ.%2BC.%26aulast%3DMaass%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DC.%2BE.%26atitle%3DAdenosine%2520receptor%2520agonists%253A%2520from%2520basic%2520medicinal%2520chemistry%2520to%2520clinical%2520development%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2003%26volume%3D8%26spage%3D537%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">van Tilburg, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gremmen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Frijtag Drabbe KÃ¼nzel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groote, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">2,8-Disubstituted adenosine derivatives as partial agonists for the adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2183</span><span class="NLM_x">â</span> <span class="NLM_lpage">2192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2183-2192&author=E.+W.+van+Tilburgauthor=M.+Gremmenauthor=J.+von+Frijtag+Drabbe+K%C3%BCnzelauthor=M.+de+Grooteauthor=A.+P.+Ijzerman&title=2%2C8-Disubstituted+adenosine+derivatives+as+partial+agonists+for+the+adenosine+A2A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BTilburg%26aufirst%3DE.%2BW.%26aulast%3DGremmen%26aufirst%3DM.%26aulast%3Dvon%2BFrijtag%2BDrabbe%2BK%25C3%25BCnzel%26aufirst%3DJ.%26aulast%3Dde%2BGroote%26aufirst%3DM.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3D2%252C8-Disubstituted%2520adenosine%2520derivatives%2520as%2520partial%2520agonists%2520for%2520the%2520adenosine%2520A2A%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2183%26epage%3D2192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Prasad, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bariana, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tietje, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brondyk, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, R. S.</span><span> </span><span class="NLM_article-title">Modification of the 5â²position of purine nucleosides. 2. Synthesis and some cardiovascular properties of adenosine-5â²-(N-substituted) carboxamides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">â</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00177a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1980&pages=313-319&author=R.+N.+Prasadauthor=D.+S.+Barianaauthor=A.+Fungauthor=M.+Savicauthor=K.+Tietjeauthor=H.+H.+Steinauthor=H.+Brondykauthor=R.+S.+Egan&title=Modification+of+the+5%E2%80%B2position+of+purine+nucleosides.+2.+Synthesis+and+some+cardiovascular+properties+of+adenosine-5%E2%80%B2-%28N-substituted%29+carboxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm00177a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00177a021%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DR.%2BN.%26aulast%3DBariana%26aufirst%3DD.%2BS.%26aulast%3DFung%26aufirst%3DA.%26aulast%3DSavic%26aufirst%3DM.%26aulast%3DTietje%26aufirst%3DK.%26aulast%3DStein%26aufirst%3DH.%2BH.%26aulast%3DBrondyk%26aufirst%3DH.%26aulast%3DEgan%26aufirst%3DR.%2BS.%26atitle%3DModification%2520of%2520the%25205%25E2%2580%25B2position%2520of%2520purine%2520nucleosides.%25202.%2520Synthesis%2520and%2520some%2520cardiovascular%2520properties%2520of%2520adenosine-5%25E2%2580%25B2-%2528N-substituted%2529%2520carboxamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1980%26volume%3D23%26spage%3D313%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccomanni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span> </span><span class="NLM_article-title">Adenosine receptor modelling. A<sub>1</sub>/A<sub>2A</sub> selectivity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">â</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=321-329&author=T.+Tuccinardiauthor=G.+Ortoreauthor=C.+Maneraauthor=G.+Saccomanniauthor=A.+Martinelli&title=Adenosine+receptor+modelling.+A1%2FA2A+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DOrtore%26aufirst%3DG.%26aulast%3DManera%26aufirst%3DC.%26aulast%3DSaccomanni%26aufirst%3DG.%26aulast%3DMartinelli%26aufirst%3DA.%26atitle%3DAdenosine%2520receptor%2520modelling.%2520A1%252FA2A%2520selectivity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D321%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">de Zwart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kourounakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooijman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spek, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Frijtag Drabbe KÃ¼nzel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">5â²-N-substituted carboxamidoadenosines as agonists for adenosine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1384</span><span class="NLM_x">â</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9804984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1384-1392&author=M.+de+Zwartauthor=A.+Kourounakisauthor=H.+Kooijmanauthor=A.+L.+Spekauthor=R.+Linkauthor=J.+K.+von+Frijtag+Drabbe+K%C3%BCnzelauthor=A.+P.+Ijzerman&title=5%E2%80%B2-N-substituted+carboxamidoadenosines+as+agonists+for+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm9804984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9804984%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BZwart%26aufirst%3DM.%26aulast%3DKourounakis%26aufirst%3DA.%26aulast%3DKooijman%26aufirst%3DH.%26aulast%3DSpek%26aufirst%3DA.%2BL.%26aulast%3DLink%26aufirst%3DR.%26aulast%3Dvon%2BFrijtag%2BDrabbe%2BK%25C3%25BCnzel%26aufirst%3DJ.%2BK.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3D5%25E2%2580%25B2-N-substituted%2520carboxamidoadenosines%2520as%2520agonists%2520for%2520adenosine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1384%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleuteri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span> </span><span class="NLM_article-title">2-Alkynyl derivatives of adenosine and adenosine-5â²-<i>N</i>-ethyluronamide as selective agonists at A<sub>2</sub> adenosine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2363</span><span class="NLM_x">â</span> <span class="NLM_lpage">2368</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00091a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2363-2368&author=G.+Cristalliauthor=A.+Eleuteriauthor=S.+Vittoriauthor=R.+Volpiniauthor=M.+J.+Lohseauthor=K.+N.+Klotz&title=2-Alkynyl+derivatives+of+adenosine+and+adenosine-5%E2%80%B2-N-ethyluronamide+as+selective+agonists+at+A2+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm00091a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00091a003%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DEleuteri%26aufirst%3DA.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26atitle%3D2-Alkynyl%2520derivatives%2520of%2520adenosine%2520and%2520adenosine-5%25E2%2580%25B2-N-ethyluronamide%2520as%2520selective%2520agonists%2520at%2520A2%2520adenosine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2363%26epage%3D2368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Mantell, S.-J.; Stephenson, P.-T.</span><span> </span><span class="NLM_article-title">Purine Derivatives </span>. PCT Int. Appl. Publ. WO2002022630 A1,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=S.-J.+Mantell&author=P.-T.+Stephenson&title=Purine+Derivatives+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMantell%26aufirst%3DS.-J.%26atitle%3DPurine%2520Derivatives%2520%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">de Zwart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Frijtag Drabbe KÃ¼nzel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend-Nicholson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">A functional screening of adenosine analogs at the adenosine A<sub>2B</sub> receptor: a search for potent agonists</span> <span class="citation_source-journal">Nucleosides Nucleotides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">969</span><span class="NLM_x">â</span> <span class="NLM_lpage">985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1080%2F07328319808004215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9708319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1cXjt12ju7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=969-985&author=M.+de+Zwartauthor=R.+Linkauthor=J.+K.+von+Frijtag+Drabbe+K%C3%BCnzelauthor=G.+Cristalliauthor=K.+A.+Jacobsonauthor=A.+Townsend-Nicholsonauthor=A.+P.+Ijzerman&title=A+functional+screening+of+adenosine+analogs+at+the+adenosine+A2B+receptor%3A+a+search+for+potent+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">A functional screening of adenosine analogs at the adenosine A2B receptor: a search for potent agonists</span></div><div class="casAuthors">De Zwart, Maarten; Link, Regina; Von Frijtag Drabbe Kunzel, Jacobien K.; Cristalli, Gloria; Jacobson, Kenneth A.; Townsend-Nicholson, Andrea; Ijzerman, Ad P.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides & Nucleotides</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">969-985</span>CODEN:
                <span class="NLM_cas:coden">NUNUD5</span>;
        ISSN:<span class="NLM_cas:issn">0732-8311</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Various adenosine analogs were tested at the adenosine A2B receptor.  Agonist potencies were detd. by measuring the cAMP prodn. in Chinese Hamster Ovary cells expressing human A2B receptors.  5'-N-Substituted carboxamidoadenosines were most potent.  5'-N-Ethylcarboxamidoadenosine (NECA) was most active with an EC50 value of 3.1 Î¼M.  Other ribose modified derivs. displayed low to negligible activity.  Potency was reduced by substitution on the exocyclic amino function (N6) of the purine ring system.  The most active N6-substituted deriv. N6-methyl-NECA was 5 fold less potent than NECA.  C8- and most C2-substituted analogs were virtually inactive.  1-Deaza-analogs had a reduced potency, 3- and 7- deazaanalogues were not active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3wpgJtobi6LVg90H21EOLACvtfcHk0li5siFW29bqbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjt12ju7s%253D&md5=0cb26d515a13257b6309e3d5e6a146e9</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1080%2F07328319808004215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07328319808004215%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BZwart%26aufirst%3DM.%26aulast%3DLink%26aufirst%3DR.%26aulast%3Dvon%2BFrijtag%2BDrabbe%2BK%25C3%25BCnzel%26aufirst%3DJ.%2BK.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DTownsend-Nicholson%26aufirst%3DA.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DA%2520functional%2520screening%2520of%2520adenosine%2520analogs%2520at%2520the%2520adenosine%2520A2B%2520receptor%253A%2520a%2520search%2520for%2520potent%2520agonists%26jtitle%3DNucleosides%2520Nucleotides%26date%3D1998%26volume%3D17%26spage%3D969%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Daly, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padgett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secunda, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R. A.</span><span> </span><span class="NLM_article-title">Structureâactivity relationships for 2-substituted adenosines at A<sub>1</sub> and A<sub>2</sub> adenosine receptors</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">â</span> <span class="NLM_lpage">100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=91-100&author=J.+W.+Dalyauthor=W.+L.+Padgettauthor=S.+I.+Secundaauthor=R.+D.+Thompsonauthor=R.+A.+Olsson&title=Structure%E2%80%93activity+relationships+for+2-substituted+adenosines+at+A1+and+A2+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DSecunda%26aufirst%3DS.%2BI.%26aulast%3DThompson%26aufirst%3DR.%2BD.%26aulast%3DOlsson%26aufirst%3DR.%2BA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520for%25202-substituted%2520adenosines%2520at%2520A1%2520and%2520A2%2520adenosine%2520receptors%26jtitle%3DPharmacology%26date%3D1993%26volume%3D46%26spage%3D91%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">Matova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacheva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boicheva, S.</span><span> </span><span class="NLM_article-title">QSAR analysis of 2-alkyloxy and 2-aralkyloxy adenosine A<sub>1</sub> and A<sub>2</sub> agonists</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">â</span> <span class="NLM_lpage">513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1997&pages=505-513&author=M.+Matovaauthor=R.+Nachevaauthor=S.+Boicheva&title=QSAR+analysis+of+2-alkyloxy+and+2-aralkyloxy+adenosine+A1+and+A2+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatova%26aufirst%3DM.%26aulast%3DNacheva%26aufirst%3DR.%26aulast%3DBoicheva%26aufirst%3DS.%26atitle%3DQSAR%2520analysis%2520of%25202-alkyloxy%2520and%25202-aralkyloxy%2520adenosine%2520A1%2520and%2520A2%2520agonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1997%26volume%3D32%26spage%3D505%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Hasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, P. C.</span><span> </span><span class="NLM_article-title">2-Substituted thioadenine nucleoside and nucleotide analogs: synthesis and receptor subtype binding affinities</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">â</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc00028a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK2cXkslejtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=364-369&author=A.+Hasanauthor=T.+Hussainauthor=S.+J.+Mustafaauthor=P.+C.+Srivastava&title=2-Substituted+thioadenine+nucleoside+and+nucleotide+analogs%3A+synthesis+and+receptor+subtype+binding+affinities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted Thioadenine Nucleoside and Nucleotide Analogs: Synthesis and Receptor Subtype Binding Affinities</span></div><div class="casAuthors">Hasan, Ahmad; Hussain, Tahir; Mustafa, S. Jamal; Srivastava, Prem C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">364-9</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    </div><div class="casAbstract">The design, synthesis, and receptor subtype binding affinities of several 2-substituted thioadenosine nucleoside and nucleotide analogs are described.  The analogs were evaluated for their affinities toward A1 and A2 adenosine receptors in rat brain cortex and striatum, resp. using [3H]DPCPX and [3H]CGS 21680 as ligands.  Four of the nucleotide analogs inhibited binding of [3H]DPCPX by 10-20% and of [3H]CGS 21680 by 40-50% at a concn. of 100 Î¼M suggesting weak affinity toward adenosine receptors.  Six of the nucleoside analogs inhibited the A2 receptor binding of [3H]CGS 21680 with Ki values of 1.2-3.67Î¼M, while A1 receptor binding of [3H]DPCPX was inhibited with Ki values 10-17 Î¼M.  The A1/A2 ratios suggest 4-8-fold A2 receptor selectivity.  Obsd. binding affinities indicate that introduction of the S atom at the C-2 position of adenine does not contribute toward the affinity or selectivity of these compds.  However, the presence of a hydrophobic group at the C-2 position appears to increase the A2 receptor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCmoulkjC0_7Vg90H21EOLACvtfcHk0li5siFW29bqbw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslejtL0%253D&md5=12963518bb296a1deeb72dfd3c58f1ba</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fbc00028a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc00028a014%26sid%3Dliteratum%253Aachs%26aulast%3DHasan%26aufirst%3DA.%26aulast%3DHussain%26aufirst%3DT.%26aulast%3DMustafa%26aufirst%3DS.%2BJ.%26aulast%3DSrivastava%26aufirst%3DP.%2BC.%26atitle%3D2-Substituted%2520thioadenine%2520nucleoside%2520and%2520nucleotide%2520analogs%253A%2520synthesis%2520and%2520receptor%2520subtype%2520binding%2520affinities%26jtitle%3DBioconjugate%2520Chem.%26date%3D1994%26volume%3D5%26spage%3D364%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title">2-Thioether A<sub>2A</sub> Receptor Agonists</span>. PCT Int. Appl. Publ. WO2001062768A1,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=G.+Cristalli&title=2-Thioether+A2A+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3D2-Thioether%2520A2A%2520Receptor%2520Agonists%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Francis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghai, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskal, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeJesus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovinski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contardo, N.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Highly selective adenosine A<sub>2</sub> receptor agonists in a series of N-alkylated 2-aminoadenosines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2570</span><span class="NLM_x">â</span> <span class="NLM_lpage">2579</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00112a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=2570-2579&author=J.+E.+Francisauthor=R.+L.+Webbauthor=G.+R.+Ghaiauthor=A.+J.+Hutchisonauthor=M.+A.+Moskalauthor=R.+DeJesusauthor=R.+Yokoyamaauthor=S.+L.+Rovinskiauthor=N.+Contardo&title=Highly+selective+adenosine+A2+receptor+agonists+in+a+series+of+N-alkylated+2-aminoadenosines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm00112a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00112a035%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DJ.%2BE.%26aulast%3DWebb%26aufirst%3DR.%2BL.%26aulast%3DGhai%26aufirst%3DG.%2BR.%26aulast%3DHutchison%26aufirst%3DA.%2BJ.%26aulast%3DMoskal%26aufirst%3DM.%2BA.%26aulast%3DDeJesus%26aufirst%3DR.%26aulast%3DYokoyama%26aufirst%3DR.%26aulast%3DRovinski%26aufirst%3DS.%2BL.%26aulast%3DContardo%26aufirst%3DN.%26atitle%3DHighly%2520selective%2520adenosine%2520A2%2520receptor%2520agonists%2520in%2520a%2520series%2520of%2520N-alkylated%25202-aminoadenosines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D2570%26epage%3D2579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Ohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchilibon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2995</span><span class="NLM_x">â</span> <span class="NLM_lpage">3007</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2995-3007&author=M.+Ohnoauthor=Z.-G.+Gaoauthor=R.+P.+Vanauthor=S.+Tchilibonauthor=S.-K.+Kimauthor=B.+A.+Harrisauthor=A.+S.+Grossauthor=H.+T.+Duongauthor=C.+S.+Vanauthor=K.+A.+Jacobson&title=Modulation+of+adenosine+receptor+affinity+and+intrinsic+efficacy+in+adenine+nucleosides+substituted+at+the+2-position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DVan%26aufirst%3DR.%2BP.%26aulast%3DTchilibon%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.-K.%26aulast%3DHarris%26aufirst%3DB.%2BA.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DVan%26aufirst%3DC.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DModulation%2520of%2520adenosine%2520receptor%2520affinity%2520and%2520intrinsic%2520efficacy%2520in%2520adenine%2520nucleosides%2520substituted%2520at%2520the%25202-position%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2995%26epage%3D3007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taffi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title"><i>N</i>6-Alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A<sub>3</sub> receptor and a starting point for searching A<sub>2B</sub> ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3271</span><span class="NLM_x">â</span> <span class="NLM_lpage">3279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0109762" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3271-3279&author=R.+Volpiniauthor=S.+Costanziauthor=C.+Lambertucciauthor=S.+Taffiauthor=S.+Vittoriauthor=K.-N.+Klotzauthor=G.+Cristalli&title=N6-Alkyl-2-alkynyl+derivatives+of+adenosine+as+potent+and+selective+agonists+at+the+human+adenosine+A3+receptor+and+a+starting+point+for+searching+A2B+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm0109762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0109762%26sid%3Dliteratum%253Aachs%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DTaffi%26aufirst%3DS.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DN6-Alkyl-2-alkynyl%2520derivatives%2520of%2520adenosine%2520as%2520potent%2520and%2520selective%2520agonists%2520at%2520the%2520human%2520adenosine%2520A3%2520receptor%2520and%2520a%2520starting%2520point%2520for%2520searching%2520A2B%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3271%26epage%3D3279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Niiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvia, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueeda, M.</span><span> </span><span class="NLM_article-title">2-(<i>N</i>â²-alkylidenehydrazino)adenosines: potent and selective coronary vasodilators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">4557</span><span class="NLM_x">â</span> <span class="NLM_lpage">4561</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00102a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=4557-4561&author=K.+Niiyaauthor=R.+A.+Olssonauthor=R.+D.+Thompsonauthor=S.+K.+Silviaauthor=M.+Ueeda&title=2-%28N%E2%80%B2-alkylidenehydrazino%29adenosines%3A+potent+and+selective+coronary+vasodilators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm00102a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00102a007%26sid%3Dliteratum%253Aachs%26aulast%3DNiiya%26aufirst%3DK.%26aulast%3DOlsson%26aufirst%3DR.%2BA.%26aulast%3DThompson%26aufirst%3DR.%2BD.%26aulast%3DSilvia%26aufirst%3DS.%2BK.%26aulast%3DUeeda%26aufirst%3DM.%26atitle%3D2-%2528N%25E2%2580%25B2-alkylidenehydrazino%2529adenosines%253A%2520potent%2520and%2520selective%2520coronary%2520vasodilators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D4557%26epage%3D4561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Niiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvia, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R. A.</span><span> </span><span class="NLM_article-title">2-(<i>N</i>â²-aralkylidenehydrazino)adenosines: potent and selective coronary vasodilators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">4562</span><span class="NLM_x">â</span> <span class="NLM_lpage">4566</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00102a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=4562-4566&author=K.+Niiyaauthor=R.+D.+Thompsonauthor=S.+K.+Silviaauthor=R.+A.+Olsson&title=2-%28N%E2%80%B2-aralkylidenehydrazino%29adenosines%3A+potent+and+selective+coronary+vasodilators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm00102a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00102a008%26sid%3Dliteratum%253Aachs%26aulast%3DNiiya%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DR.%2BD.%26aulast%3DSilvia%26aufirst%3DS.%2BK.%26aulast%3DOlsson%26aufirst%3DR.%2BA.%26atitle%3D2-%2528N%25E2%2580%25B2-aralkylidenehydrazino%2529adenosines%253A%2520potent%2520and%2520selective%2520coronary%2520vasodilators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D4562%26epage%3D4566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Viziano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seminati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pocar, D.</span><span> </span><span class="NLM_article-title">2-[<i>N</i>â²-(3-Arylallylidene)hydrazino]adenosines showing A<sub>2A</sub> adenosine agonist properties and vasodilation activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3581</span><span class="NLM_x">â</span> <span class="NLM_lpage">3585</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00018a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3581-3585&author=M.+Vizianoauthor=E.+Onginiauthor=A.+Contiauthor=C.+Zocchiauthor=M.+Seminatiauthor=D.+Pocar&title=2-%5BN%E2%80%B2-%283-Arylallylidene%29hydrazino%5Dadenosines+showing+A2A+adenosine+agonist+properties+and+vasodilation+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm00018a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00018a017%26sid%3Dliteratum%253Aachs%26aulast%3DViziano%26aufirst%3DM.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DConti%26aufirst%3DA.%26aulast%3DZocchi%26aufirst%3DC.%26aulast%3DSeminati%26aufirst%3DM.%26aulast%3DPocar%26aufirst%3DD.%26atitle%3D2-%255BN%25E2%2580%25B2-%25283-Arylallylidene%2529hydrazino%255Dadenosines%2520showing%2520A2A%2520adenosine%2520agonist%2520properties%2520and%2520vasodilation%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3581%26epage%3D3585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Daly, J. W.</span><span> </span><span class="NLM_article-title">Adenosine receptors: targets for future drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">â</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00345a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=197-207&author=J.+W.+Daly&title=Adenosine+receptors%3A+targets+for+future+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm00345a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00345a001%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DAdenosine%2520receptors%253A%2520targets%2520for%2520future%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26spage%3D197%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J.</span><span> </span><span class="NLM_article-title">A<sub>1</sub> adenosine receptor agonists and their potential therapeutic applications</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1901</span><span class="NLM_x">â</span> <span class="NLM_lpage">1910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1901-1910&author=E.+Elzeinauthor=J.+Zablocki&title=A1+adenosine+receptor+agonists+and+their+potential+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DA1%2520adenosine%2520receptor%2520agonists%2520and%2520their%2520potential%2520therapeutic%2520applications%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1901%26epage%3D1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Morrison, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquart, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palle, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenk, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varkhedkar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lustig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J. A.</span><span> </span><span class="NLM_article-title">Structureâaffinity relationships of 5â²-aromatic ethers and 5â²-aromatic sulfides as partial A<sub>1</sub> adenosine agonists, potential supraventricular anti-arrhythmic agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3793</span><span class="NLM_x">â</span> <span class="NLM_lpage">3797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3793-3797&author=C.+F.+Morrisonauthor=E.+Elzeinauthor=B.+Jiangauthor=P.+N.+Ibrahimauthor=T.+Marquartauthor=V.+Palleauthor=K.+D.+Shenkauthor=V.+Varkhedkarauthor=T.+Maaauthor=L.+Wuauthor=Y.+Wuauthor=D.+Zengauthor=I.+Fongauthor=D.+Lustigauthor=K.+Leungauthor=J.+A.+Zablocki&title=Structure%E2%80%93affinity+relationships+of+5%E2%80%B2-aromatic+ethers+and+5%E2%80%B2-aromatic+sulfides+as+partial+A1+adenosine+agonists%2C+potential+supraventricular+anti-arrhythmic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DC.%2BF.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DMarquart%26aufirst%3DT.%26aulast%3DPalle%26aufirst%3DV.%26aulast%3DShenk%26aufirst%3DK.%2BD.%26aulast%3DVarkhedkar%26aufirst%3DV.%26aulast%3DMaa%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DFong%26aufirst%3DI.%26aulast%3DLustig%26aufirst%3DD.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26atitle%3DStructure%25E2%2580%2593affinity%2520relationships%2520of%25205%25E2%2580%25B2-aromatic%2520ethers%2520and%25205%25E2%2580%25B2-aromatic%2520sulfides%2520as%2520partial%2520A1%2520adenosine%2520agonists%252C%2520potential%2520supraventricular%2520anti-arrhythmic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3793%26epage%3D3797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Brand, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, G.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor dynamics studied with the novel fluorescent agonist Alexa488-APEC</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">590</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">â</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.ejphar.2008.05.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=18603240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt1Kntbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=590&publication_year=2008&pages=36-42&author=F.+Brandauthor=A.+M.+Klutzauthor=K.+A.+Jacobsonauthor=B.+B.+Fredholmauthor=G.+Schulte&title=Adenosine+A2A+receptor+dynamics+studied+with+the+novel+fluorescent+agonist+Alexa488-APEC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A receptor dynamics studied with the novel fluorescent agonist Alexa488-APEC</span></div><div class="casAuthors">Brand, Frank; Klutz, Athena M.; Jacobson, Kenneth A.; Fredholm, Bertil B.; Schulte, Gunnar</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">590</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">36-42</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">G protein-coupled receptors, such as the adenosine A2A receptor, are dynamic proteins, which undergo agonist-dependent redistribution from the cell surface to intracellular membranous compartments, such as endosomes.  In order to study the kinetics of adenosine A2A receptor redistribution in living cells, we synthesized a novel fluorescent agonist, Alexa488-APEC.  Alexa488-APEC binds to adenosine A2A (Ki = 149 nM) as well as A3 receptors (Ki = 240 nM) but not to adenosine A1 receptors.  Further, we characterized the dose-dependent increase in Alexa488-APEC-induced cAMP prodn. as well as cAMP response element binding (CREB) protein phosphorylation, verifying the ligand's functionality at adenosine A2A but not A2B receptors.  In live-cell imaging studies, Alexa488-APEC-induced adenosine A2A receptor internalization, which was blocked by the competitive reversible antagonist ZM 241385 and hyperosmolaric sucrose.  Further, internalized adenosine A2A receptors colocalized with clathrin and Rab5, indicating that agonist stimulation promotes adenosine A2A receptor uptake through a clathrin-dependent mechanism to Rab5-pos. endosomes.  The basic characterization of Alexa488-APEC described here showed that it provides a useful tool for tracing adenosine A2A receptors in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLrhh1rC3xF7Vg90H21EOLACvtfcHk0li0yxrL8IXckg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt1Kntbo%253D&md5=70669d999975108a80e1448081265331</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.05.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.05.036%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DF.%26aulast%3DKlutz%26aufirst%3DA.%2BM.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DSchulte%26aufirst%3DG.%26atitle%3DAdenosine%2520A2A%2520receptor%2520dynamics%2520studied%2520with%2520the%2520novel%2520fluorescent%2520agonist%2520Alexa488-APEC%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D590%26spage%3D36%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Hendel, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wackers, F. J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ficaro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depuey, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerqueira, M.</span><span> </span><span class="NLM_article-title">Reporting of radionuclide myocardial perfusion imaging studies</span> <span class="citation_source-journal">J. Nucl. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">â</span> <span class="NLM_lpage">708</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.nuclcard.2003.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=14668786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslWjsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=705-708&author=R.+C.+Hendelauthor=F.+J.+T.+Wackersauthor=D.+S.+Bermanauthor=E.+Ficaroauthor=E.+G.+Depueyauthor=L.+Kleinauthor=M.+Cerqueira&title=Reporting+of+radionuclide+myocardial+perfusion+imaging+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">American society of nuclear cardiology consensus statement: reporting of radionuclide myocardial perfusion imaging studies</span></div><div class="casAuthors">Hendel Robert C; Wackers Frans J Th; Berman Daniel S; Ficaro Edward; Depuey E Gordon; Klein Larry; Cerqueira Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">705-8</span>
        ISSN:<span class="NLM_cas:issn">1071-3581</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8lvAgqb2vdc5fW6udTcc2ebm5YzbsGqhubntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslWjsA%253D%253D&md5=ccb4e1d2100216bd6cb0be215992eaad</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.nuclcard.2003.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nuclcard.2003.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DHendel%26aufirst%3DR.%2BC.%26aulast%3DWackers%26aufirst%3DF.%2BJ.%2BT.%26aulast%3DBerman%26aufirst%3DD.%2BS.%26aulast%3DFicaro%26aufirst%3DE.%26aulast%3DDepuey%26aufirst%3DE.%2BG.%26aulast%3DKlein%26aufirst%3DL.%26aulast%3DCerqueira%26aufirst%3DM.%26atitle%3DReporting%2520of%2520radionuclide%2520myocardial%2520perfusion%2520imaging%2520studies%26jtitle%3DJ.%2520Nucl.%2520Cardiol.%26date%3D2003%26volume%3D10%26spage%3D705%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Hendel, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamil, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. K.</span><span> </span><span class="NLM_article-title">Pharmacologic stress testing: new methods and new agents</span> <span class="citation_source-journal">J. Nucl. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">â</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1067%2Fmnc.2003.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=12673185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADC%252BD3s7lsleksQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=197-204&author=R.+C.+Hendelauthor=T.+Jamilauthor=D.+K.+Glover&title=Pharmacologic+stress+testing%3A+new+methods+and+new+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic stress testing: new methods and new agents</span></div><div class="casAuthors">Hendel Robert C; Jamil Tariq; Glover David K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-204</span>
        ISSN:<span class="NLM_cas:issn">1071-3581</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQeUH2h_3phmgRQsDqrjW_fW6udTcc2eaSVsy-zQoREbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7lsleksQ%253D%253D&md5=429807f2eababdcb2d779b8b1f99e64a</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1067%2Fmnc.2003.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmnc.2003.5%26sid%3Dliteratum%253Aachs%26aulast%3DHendel%26aufirst%3DR.%2BC.%26aulast%3DJamil%26aufirst%3DT.%26aulast%3DGlover%26aufirst%3DD.%2BK.%26atitle%3DPharmacologic%2520stress%2520testing%253A%2520new%2520methods%2520and%2520new%2520agents%26jtitle%3DJ.%2520Nucl.%2520Cardiol.%26date%3D2003%26volume%3D10%26spage%3D197%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Cerqueira, M.</span><span> </span><span class="NLM_article-title">Advances in pharmacologic agents in imaging: new A<sub>2A</sub> receptor agonists</span> <span class="citation_source-journal">Curr. Cardiol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2Fs11886-006-0022-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=16524538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADC%252BD287jslSlug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=119-122&author=M.+Cerqueira&title=Advances+in+pharmacologic+agents+in+imaging%3A+new+A2A+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in pharmacologic agents in imaging: new A2A receptor agonists</span></div><div class="casAuthors">Cerqueira Manuel D</div><div class="citationInfo"><span class="NLM_cas:title">Current cardiology reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-22</span>
        ISSN:<span class="NLM_cas:issn">1523-3782</span>.
    </div><div class="casAbstract">Pharmacologic stress myocardial perfusion imaging is being performed with increasing frequency over exercise stress.  Dipyridamole and adenosine have a high side-effect profile, provide higher than needed coronary artery flow rates, and use a relatively complicated method of administration.  Based on preclinical animal work, three selective adenosine A2A receptor agonists, regadenoson (CVT3146), binodenoson (MRE0470 or WRC0470), and apadenoson (BMS068645 or ATL146e), may overcome these limitations and are now in Phase III studies as pharmacologic stress agents.  For single-photon emission CT imaging, binodenoson and regadenoson were concordant with adenosine images for detection and quantitation of ischemia.  Despite the high A2A selectivity of binodenoson and regadenoson in preclinical studies, subjective side effects attributable to other adenosine receptor subtypes were still observed in human studies and are similar to or slightly lower than adenosine.  There have been no reports of atrioventricular block or bronchospasm with either regadenoson or binodenoson in published trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzqtNn0TVk3VHFYivNCdPRfW6udTcc2eaSVsy-zQoREbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287jslSlug%253D%253D&md5=cfc18ab073625cd546a9f32f32fb9a37</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1007%2Fs11886-006-0022-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11886-006-0022-1%26sid%3Dliteratum%253Aachs%26aulast%3DCerqueira%26aufirst%3DM.%26atitle%3DAdvances%2520in%2520pharmacologic%2520agents%2520in%2520imaging%253A%2520new%2520A2A%2520receptor%2520agonists%26jtitle%3DCurr.%2520Cardiol.%2520Rep.%26date%3D2006%26volume%3D8%26spage%3D119%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Cerqueira, M.</span><span> </span><span class="NLM_article-title">The future of pharmacologic stress: selective A<sub>2A</sub> adenosine receptor agonists</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">33D</span><span class="NLM_x">â</span> <span class="NLM_lpage">40D</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2004&pages=33D-40D&author=M.+Cerqueira&title=The+future+of+pharmacologic+stress%3A+selective+A2A+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCerqueira%26aufirst%3DM.%26atitle%3DThe%2520future%2520of%2520pharmacologic%2520stress%253A%2520selective%2520A2A%2520adenosine%2520receptor%2520agonists%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2004%26volume%3D94%26spage%3D33D%26epage%3D40D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Moorman, A.; OâNeil, M.</span><span> </span><span class="NLM_article-title">Crystal forms of 2-(2-[(Cyclohexyl)methylene]hydrazino)adenosine</span>. Eur. Pat. EP2257162 A2,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=A.+Moorman&author=M.+O%E2%80%99Neil&title=Crystal+forms+of+2-%282-%5B%28Cyclohexyl%29methylene%5Dhydrazino%29adenosine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoorman%26aufirst%3DA.%26atitle%3DCrystal%2520forms%2520of%25202-%25282-%255B%2528Cyclohexyl%2529methylene%255Dhydrazino%2529adenosine%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Barrett, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. B.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers</span> <span class="citation_source-journal">J. Nucl. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">â</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.nuclcard.2004.12.294" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=15812370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADC%252BD2M7nvFKmtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=166-171&author=R.+J.+Barrettauthor=M.+J.+Lamsonauthor=J.+Johnsonauthor=W.+B.+Smith&title=Pharmacokinetics+and+safety+of+binodenoson+after+intravenous+dose+escalation+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers</span></div><div class="casAuthors">Barrett Richard J; Lamson Michael J; Johnson James; Smith William B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">166-71</span>
        ISSN:<span class="NLM_cas:issn">1071-3581</span>.
    </div><div class="casAbstract">BACKGROUND:  Binodenoson, a highly selective agonist of the adenosine A 2A receptor, is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging.  This study was designed to assess the single-dose pharmacokinetics, safety, and tolerability of intravenous binodenoson.  METHODS AND RESULTS:  This was a single-center, open-label, nonrandomized, dose-escalation study in 24 healthy volunteers.  Each subject received 3 successive intravenous doses of binodenoson (0.1, 0.2, 0.4, 0.6, 1, 2, 3, 4, 5, and 6 microg/kg), each infused over a period of 10 minutes and separated by washout periods of at least 120 minutes.  Generally, binodenoson was well tolerated.  There were no serious adverse events.  However, there was a dose-related increase in adverse events (e.g., headache, nausea, vasodilation, chest pain), consistent with the pharmacology of the drug.  Binodenoson exhibited linear pharmacokinetics as indicated by a dose-proportional increase in peak concentration (C max ) and area under the concentration-time curve (AUC).  Systemic clearance was independent of dose but was correlated with body weight.  The mean terminal half-life of binodenoson across all doses was 10 +/- 4 minutes.  CONCLUSIONS:  Overall, binodenoson was well tolerated and exhibited linear pharmacokinetics when administered intravenously over a 60-fold dose range from 0.1 to 6 microg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfBXzTWL8C0vcsfMJQC1ZdfW6udTcc2eaSVsy-zQoREbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7nvFKmtQ%253D%253D&md5=60ec7a94b653100b804791e52145b7e2</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.nuclcard.2004.12.294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nuclcard.2004.12.294%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DR.%2BJ.%26aulast%3DLamson%26aufirst%3DM.%2BJ.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DW.%2BB.%26atitle%3DPharmacokinetics%2520and%2520safety%2520of%2520binodenoson%2520after%2520intravenous%2520dose%2520escalation%2520in%2520healthy%2520volunteers%26jtitle%3DJ.%2520Nucl.%2520Cardiol.%26date%3D2005%26volume%3D12%26spage%3D166%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Murphree, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span> </span><span class="NLM_article-title">Human A<sub>2A</sub> adenosine receptors: high-affinity agonist binding to receptor-G protein complexes containing GÎ²4</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">â</span> <span class="NLM_lpage">462</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=455-462&author=L.+J.+Murphreeauthor=M.+A.+Marshallauthor=J.+M.+Riegerauthor=T.+L.+MacDonaldauthor=J.+Linden&title=Human+A2A+adenosine+receptors%3A+high-affinity+agonist+binding+to+receptor-G+protein+complexes+containing+G%CE%B24"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurphree%26aufirst%3DL.%2BJ.%26aulast%3DMarshall%26aufirst%3DM.%2BA.%26aulast%3DRieger%26aufirst%3DJ.%2BM.%26aulast%3DMacDonald%26aufirst%3DT.%2BL.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DHuman%2520A2A%2520adenosine%2520receptors%253A%2520high-affinity%2520agonist%2520binding%2520to%2520receptor-G%2520protein%2520complexes%2520containing%2520G%25CE%25B24%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D61%26spage%3D455%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Garnock-Jones, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, M. P.</span><span> </span><span class="NLM_article-title">Regadenoson</span> <span class="citation_source-journal">Am. J. Cardiovasc. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">65</span><span class="NLM_x">â</span> <span class="NLM_lpage">71</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=65-71&issue=1&author=K.+P.+Garnock-Jonesauthor=M.+P.+Curran&title=Regadenoson"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarnock-Jones%26aufirst%3DK.%2BP.%26aulast%3DCurran%26aufirst%3DM.%2BP.%26atitle%3DRegadenoson%26jtitle%3DAm.%2520J.%2520Cardiovasc.%2520Drugs%26date%3D2010%26volume%3D10%26issue%3D1%26spage%3D65%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Palle, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elzein, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gothe, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J. A.</span><span> </span><span class="NLM_article-title">Structureâaffinity relationships of the affinity of 2-pyrazolyl adenosine analogs for the adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2935</span><span class="NLM_x">â</span> <span class="NLM_lpage">2939</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2935-2939&author=V.+P.+Palleauthor=E.+O.+Elzeinauthor=S.+A.+Gotheauthor=Z.+Liauthor=Z.+Gaoauthor=S.+Meyerauthor=B.+Blackburnauthor=J.+A.+Zablocki&title=Structure%E2%80%93affinity+relationships+of+the+affinity+of+2-pyrazolyl+adenosine+analogs+for+the+adenosine+A2A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalle%26aufirst%3DV.%2BP.%26aulast%3DElzein%26aufirst%3DE.%2BO.%26aulast%3DGothe%26aufirst%3DS.%2BA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DBlackburn%26aufirst%3DB.%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26atitle%3DStructure%25E2%2580%2593affinity%2520relationships%2520of%2520the%2520affinity%2520of%25202-pyrazolyl%2520adenosine%2520analogs%2520for%2520the%2520adenosine%2520A2A%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2935%26epage%3D2939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Gordi, T.; Olmsted, A. W.; Lieu, H. D.; Belardinelli, L.</span><span> </span><span class="NLM_article-title">Use of A<sub>2A</sub> Adenosine Receptor Agonists</span>. PCT Int. Appl. Publ. US20060084625A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=T.+Gordi&author=A.+W.+Olmsted&author=H.+D.+Lieu&author=L.+Belardinelli&title=Use+of+A2A+Adenosine+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGordi%26aufirst%3DT.%26atitle%3DUse%2520of%2520A2A%2520Adenosine%2520Receptor%2520Agonists%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Lappas, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> agonists in development for the treatment of inflammation</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">797</span><span class="NLM_x">â</span> <span class="NLM_lpage">806</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=797-806&issue=7&author=C.+M.+Lappasauthor=G.+W.+Sullivanauthor=J.+Linden&title=Adenosine+A2A+agonists+in+development+for+the+treatment+of+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLappas%26aufirst%3DC.%2BM.%26aulast%3DSullivan%26aufirst%3DG.%2BW.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DAdenosine%2520A2A%2520agonists%2520in%2520development%2520for%2520the%2520treatment%2520of%2520inflammation%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26issue%3D7%26spage%3D797%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Hasko, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deitch, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vizi, E. S.</span><span> </span><span class="NLM_article-title">Shaping of monocyte and macrophage function by adenosine receptors</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">264</span><span class="NLM_x">â</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.pharmthera.2006.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=17056121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCgt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2007&pages=264-275&author=G.+Haskoauthor=P.+Pacherauthor=E.+A.+Deitchauthor=E.+S.+Vizi&title=Shaping+of+monocyte+and+macrophage+function+by+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Shaping of monocyte and macrophage function by adenosine receptors</span></div><div class="casAuthors">Hasko, Gyoergy; Pacher, Pal; Deitch, Edwin A.; Vizi, E. Sylvester</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">264-275</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Adenosine is an endogenous purine nucleoside that, following its release into the extracellular space, binds to specific adenosine receptors expressed on the cell surface.  Adenosine appears in the extracellular space under metabolically stressful conditions, which are assocd. with ischemia, inflammation, and cell damage.  There are 4 types of adenosine receptors (A1, A2A, A2B and A3) and all adenosine receptors are members of the G protein-coupled family of receptors.  Adenosine receptors are expressed on monocytes and macrophages and through these receptors adenosine modulates monocyte and macrophage function.  Since monocytes and macrophages are activated by the same danger signals that cause accumulation of extracellular adenosine, adenosine receptors expressed on macrophages represent a sensor system that provide monocytes and macrophages with information about the stressful environment.  Adenosine receptors, thus, allow monocytes and macrophages to fine-tune their responses to stressful stimuli.  Here, the authors review the consequences of adenosine receptor activation on monocyte/macrophage function.  The authors will detail the effect of stimulating the various adenosine receptor subtypes on macrophage differentiation/proliferation, phagocytosis, and tissue factor (TF) expression.  The authors will also summarize their knowledge of how adenosine impacts the prodn. of extracellular mediators secreted by monocytes and macrophages in response to Toll-like receptor (TLR) ligands and other inflammatory stimuli.  Specifically, the authors will delineate how adenosine affects the prodn. of superoxide, nitric oxide (NO), tumor necrosis factor-Î±, interleukin (IL)-12, IL-10, and vascular endothelial growth factor (VEGF).  A deeper insight into the regulation of monocyte and macrophage function by adenosine receptors should assist in developing new therapies for inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0pqyGpq9YMbVg90H21EOLACvtfcHk0liWSFnCeu0AOw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCgt7o%253D&md5=d793caeb6be4cc48ca6b7d465827919f</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2006.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2006.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DHasko%26aufirst%3DG.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DDeitch%26aufirst%3DE.%2BA.%26aulast%3DVizi%26aufirst%3DE.%2BS.%26atitle%3DShaping%2520of%2520monocyte%2520and%2520macrophage%2520function%2520by%2520adenosine%2520receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D113%26spage%3D264%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Cohen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheld, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diduch, D. R.</span><span> </span><span class="NLM_article-title">Reducing joint destruction due to septic arthrosis using an adenosine A<sub>2A</sub> receptor agonist</span> <span class="citation_source-journal">J. Orthop. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">â</span> <span class="NLM_lpage">435</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.orthres.2003.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=15013106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVGgtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=427-435&author=S.+B.+Cohenauthor=S.+S.+Gillauthor=G.+S.+Baerauthor=B.+M.+Leoauthor=W.+M.+Scheldauthor=D.+R.+Diduch&title=Reducing+joint+destruction+due+to+septic+arthrosis+using+an+adenosine+A2A+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing joint destruction due to septic arthrosis using an adenosine2A receptor agonist</span></div><div class="casAuthors">Cohen, Steven B.; Gill, Sanjitpal S.; Baer, Geoffrey S.; Leo, Brian M.; Scheld, W. Michael; Diduch, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Orthopaedic Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">427-435</span>CODEN:
                <span class="NLM_cas:coden">JOREDR</span>;
        ISSN:<span class="NLM_cas:issn">0736-0266</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We assessed the efficacy of a new adenosine A2A agonist ATL146e, a potent inhibitor of white blood cell chemotaxis, to reduce cartilage damage in the treatment of septic arthrosis.  A live septic arthrosis model was created using Staphylococcus aureus in rabbit knees.  Animals were divided into five treatment groups: (1) untreated infected control, (2) antibiotics control, and antibiotics plus ATL146e for (3) 24, (4) 48, or (5) 72 h and assessed at 1, 4, and 7 days.  Knees in all ATL146e treated animals exhibited no detectable effusion, and histol. examn. revealed near normal cartilage and diminished synovial inflammatory response.  Synovial WBC counts decreased with the addn. of ATL146e when compared to infected and antibiotic controls.  Histol. grading of osteochondral specimens demonstrated improved scores for animals treated with ATL146e compared to infected (p<0.00004) and antibiotics controls (p<0.05).  Anal. of glycosaminoglycan content revealed significantly decreased loss of articular cartilage following infection in the ATL146e groups when compared to infected (p<0.03) and antibiotics controls (p<0.05).  Addn. of an adenosine A2A agonist to antibiotic therapy decreases joint inflammation and articular cartilage destruction without compromising bacterial clearance in rabbit knees following intraarticular bacterial infection.  The use of adenosine agonists selective to the A2A receptor to augment conventional treatment of joint sepsis may be chondroprotective and ultimately help prevent arthrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqnOZVcK_D8bVg90H21EOLACvtfcHk0liWSFnCeu0AOw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVGgtw%253D%253D&md5=ff66293fba4f68136acdfe1a77408109</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.orthres.2003.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.orthres.2003.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%2BB.%26aulast%3DGill%26aufirst%3DS.%2BS.%26aulast%3DBaer%26aufirst%3DG.%2BS.%26aulast%3DLeo%26aufirst%3DB.%2BM.%26aulast%3DScheld%26aufirst%3DW.%2BM.%26aulast%3DDiduch%26aufirst%3DD.%2BR.%26atitle%3DReducing%2520joint%2520destruction%2520due%2520to%2520septic%2520arthrosis%2520using%2520an%2520adenosine%2520A2A%2520receptor%2520agonist%26jtitle%3DJ.%2520Orthop.%2520Res.%26date%3D2004%26volume%3D22%26spage%3D427%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Beattie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brearley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fozard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meja, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neef, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, H.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of two series of 4â²-aza-carbocyclic nucleosides as adenosine A<sub>2A</sub> receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1219</span><span class="NLM_x">â</span> <span class="NLM_lpage">1224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1219-1224&issue=3&author=D.+Beattieauthor=A.+Brearleyauthor=Z.+Brownauthor=S.+J.+Charltonauthor=B.+Coxauthor=R.+A.+Fairhurstauthor=J.+R.+Fozardauthor=P.+Gedeckauthor=P.+Kirkhamauthor=K.+Mejaauthor=L.+Nansonauthor=J.+Neefauthor=H.+Oakmanauthor=G.+Spoonerauthor=R.+J.+Taylorauthor=R.+J.+Turnerauthor=R.+Westauthor=H.+Woodward&title=Synthesis+and+evaluation+of+two+series+of+4%E2%80%B2-aza-carbocyclic+nucleosides+as+adenosine+A2A+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeattie%26aufirst%3DD.%26aulast%3DBrearley%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DZ.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26aulast%3DCox%26aufirst%3DB.%26aulast%3DFairhurst%26aufirst%3DR.%2BA.%26aulast%3DFozard%26aufirst%3DJ.%2BR.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DKirkham%26aufirst%3DP.%26aulast%3DMeja%26aufirst%3DK.%26aulast%3DNanson%26aufirst%3DL.%26aulast%3DNeef%26aufirst%3DJ.%26aulast%3DOakman%26aufirst%3DH.%26aulast%3DSpooner%26aufirst%3DG.%26aulast%3DTaylor%26aufirst%3DR.%2BJ.%26aulast%3DTurner%26aufirst%3DR.%2BJ.%26aulast%3DWest%26aufirst%3DR.%26aulast%3DWoodward%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520two%2520series%2520of%25204%25E2%2580%25B2-aza-carbocyclic%2520nucleosides%2520as%2520adenosine%2520A2A%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D3%26spage%3D1219%26epage%3D1224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Bosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niubo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero, A.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of new potential agonists for the human adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4041</span><span class="NLM_x">â</span> <span class="NLM_lpage">4053</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031143%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4041-4053&author=M.+P.+Boschauthor=F.+Camposauthor=I.+Niuboauthor=G.+Rosellauthor=J.+L.+Diazauthor=J.+Breaauthor=M.+I.+Lozaauthor=A.+Guerrero&title=Synthesis+and+biological+activity+of+new+potential+agonists+for+the+human+adenosine+A2A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm031143%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031143%252B%26sid%3Dliteratum%253Aachs%26aulast%3DBosch%26aufirst%3DM.%2BP.%26aulast%3DCampos%26aufirst%3DF.%26aulast%3DNiubo%26aufirst%3DI.%26aulast%3DRosell%26aufirst%3DG.%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DGuerrero%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520new%2520potential%2520agonists%2520for%2520the%2520human%2520adenosine%2520A2A%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4041%26epage%3D4053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Folkesson, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzenko, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthay, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, M. A.</span><span> </span><span class="NLM_article-title">The adenosine A<sub>2A</sub> receptor agonist GW328267C improves lung function after acute lung injury in rats</span> <span class="citation_source-journal">Am. J. Physiol.: Lung Cell. Mol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">L259</span><span class="NLM_x">â</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2012&pages=L259-271&issue=3&author=H.+G.+Folkessonauthor=S.+R.+Kuzenkoauthor=D.+A.+Lipsonauthor=M.+A.+Matthayauthor=M.+A.+Simmons&title=The+adenosine+A2A+receptor+agonist+GW328267C+improves+lung+function+after+acute+lung+injury+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkesson%26aufirst%3DH.%2BG.%26aulast%3DKuzenko%26aufirst%3DS.%2BR.%26aulast%3DLipson%26aufirst%3DD.%2BA.%26aulast%3DMatthay%26aufirst%3DM.%2BA.%26aulast%3DSimmons%26aufirst%3DM.%2BA.%26atitle%3DThe%2520adenosine%2520A2A%2520receptor%2520agonist%2520GW328267C%2520improves%2520lung%2520function%2520after%2520acute%2520lung%2520injury%2520in%2520rats%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Lung%2520Cell.%2520Mol.%2520Physiol.%26date%3D2012%26volume%3D303%26issue%3D3%26spage%3DL259%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Mantell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaghan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maw, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevethick, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeadon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozze, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavaroche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaitre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitlock, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macintyre, F.</span><span> </span><span class="NLM_article-title">SAR of a series of inhaled A<sub>2A</sub> agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4471</span><span class="NLM_x">â</span> <span class="NLM_lpage">4475</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4471-4475&author=S.+J.+Mantellauthor=P.+T.+Stephensonauthor=S.+M.+Monaghanauthor=G.+N.+Mawauthor=M.+A.+Trevethickauthor=M.+Yeadonauthor=D.+K.+Walkerauthor=M.+D.+Selbyauthor=D.+V.+Batchelorauthor=S.+Rozzeauthor=H.+Chavarocheauthor=A.+Lemaitreauthor=K.+N.+Wrightauthor=L.+Whitlockauthor=E.+F.+Stuartauthor=P.+A.+Wrightauthor=F.+Macintyre&title=SAR+of+a+series+of+inhaled+A2A+agonists+and+comparison+of+inhaled+pharmacokinetics+in+a+preclinical+model+with+clinical+pharmacokinetic+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMantell%26aufirst%3DS.%2BJ.%26aulast%3DStephenson%26aufirst%3DP.%2BT.%26aulast%3DMonaghan%26aufirst%3DS.%2BM.%26aulast%3DMaw%26aufirst%3DG.%2BN.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26aulast%3DSelby%26aufirst%3DM.%2BD.%26aulast%3DBatchelor%26aufirst%3DD.%2BV.%26aulast%3DRozze%26aufirst%3DS.%26aulast%3DChavaroche%26aufirst%3DH.%26aulast%3DLemaitre%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DK.%2BN.%26aulast%3DWhitlock%26aufirst%3DL.%26aulast%3DStuart%26aufirst%3DE.%2BF.%26aulast%3DWright%26aufirst%3DP.%2BA.%26aulast%3DMacintyre%26aufirst%3DF.%26atitle%3DSAR%2520of%2520a%2520series%2520of%2520inhaled%2520A2A%2520agonists%2520and%2520comparison%2520of%2520inhaled%2520pharmacokinetics%2520in%2520a%2520preclinical%2520model%2520with%2520clinical%2520pharmacokinetic%2520data%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4471%26epage%3D4475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Rieger, J. M.; Kimpel, D. L.; Linden, J. M.; Sullivan, G. W.</span><span> </span><span class="NLM_article-title">Method To Reduce an Inflammatory Response from Arthritis</span>. U.S. Pat. Appl. Publ. US20060100169 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+M.+Rieger&author=D.+L.+Kimpel&author=J.+M.+Linden&author=G.+W.+Sullivan&title=Method+To+Reduce+an+Inflammatory+Response+from+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRieger%26aufirst%3DJ.%2BM.%26atitle%3DMethod%2520To%2520Reduce%2520an%2520Inflammatory%2520Response%2520from%2520Arthritis%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Impagnatiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span> </span><span class="NLM_article-title">Adenosine receptors in neurological disorders</span> <span class="citation_source-journal">Emerging Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">â</span> <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1517%2F14728222.4.5.635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1ynt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2000&pages=635-664&author=F.+Impagnatielloauthor=E.+Bastiaauthor=E.+Onginiauthor=A.+Monopoli&title=Adenosine+receptors+in+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors in neurological disorders</span></div><div class="casAuthors">Impagnatiello, Francesco; Bastia, Elena; Ongini, Ennio; Monopoli, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Therapeutic Targets</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">635-664</span>CODEN:
                <span class="NLM_cas:coden">ETTAF7</span>;
        ISSN:<span class="NLM_cas:issn">1460-0412</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review, with 165 refs.  Adenosine is present in the extracellular space of organs and tissues in the mammalian organism where it modulates a variety of physiol. processes through specific cell membrane receptors which have been identified as members of the G-protein coupled receptors (GPCRs).  Currently, four receptors have been cloned and characterized, namely A1, A2A, A2B, A3 adenosine receptors.  The different distribution of receptor populations in organs and tissues together with their importance in normal and altered conditions make each individual adenosine receptor an attractive target for the discovery of new pharmacol. agents.  Major efforts have involved the A1 and A2A receptors with the central nervous (and cardiovascular) systems being the medical areas of highest interest.  Thus, a variety of selective receptor agonists and antagonists have been discovered and some are currently under development for the treatment of neurol. disorders.  Treatment of pain, neurodegenerative diseases, such as Parkinson's (PD) and Huntington's disease (HD), cognitive impairment and epilepsy are all potential therapy areas of future drug development.  This review describes the scientific background information currently available together with the rationale underlying the innovative strategies assocd. with the modulation of each individual adenosine receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCK9lAExzYK7Vg90H21EOLACvtfcHk0lh47E6kWCWCkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1ynt74%253D&md5=9fe39b62c530a99532d16af67316f2c3</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1517%2F14728222.4.5.635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.4.5.635%26sid%3Dliteratum%253Aachs%26aulast%3DImpagnatiello%26aufirst%3DF.%26aulast%3DBastia%26aufirst%3DE.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DMonopoli%26aufirst%3DA.%26atitle%3DAdenosine%2520receptors%2520in%2520neurological%2520disorders%26jtitle%3DEmerging%2520Ther.%2520Targets%26date%3D2000%26volume%3D4%26spage%3D635%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group">Loram, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloane, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sholar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkelhammer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coats, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poole, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, L. R.</span><span> </span><span class="NLM_article-title">Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine A<sub>2A</sub> receptor agonists: a novel therapy for neuropathic pain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">14015</span><span class="NLM_x">â</span> <span class="NLM_lpage">14025</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1523%2FJNEUROSCI.3447-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=19890011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSmsbnE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=14015-14025&author=L.+C.+Loramauthor=J.+A.+Harrisonauthor=E.+M.+Sloaneauthor=M.+R.+Hutchinsonauthor=P.+Sholarauthor=F.+R.+Taylorauthor=D.+Berkelhammerauthor=B.+D.+Coatsauthor=S.+Pooleauthor=E.+D.+Milliganauthor=S.+F.+Maierauthor=J.+Riegerauthor=L.+R.+Watkins&title=Enduring+reversal+of+neuropathic+pain+by+a+single+intrathecal+injection+of+adenosine+A2A+receptor+agonists%3A+a+novel+therapy+for+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain</span></div><div class="casAuthors">Loram, Lisa C.; Harrison, Jacqueline A.; Sloane, Evan M.; Hutchinson, Mark R.; Sholar, Paige; Taylor, Frederick R.; Berkelhammer, Debra; Coats, Benjamen D.; Poole, Stephen; Milligan, Erin D.; Maier, Steven F.; Rieger, Jayson; Watkins, Linda R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">14015-14025</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Previous studies of peripheral immune cells have documented that activation of adenosine 2A receptors (A2ARs) decrease proinflammatory cytokine release and increase release of the potent anti-inflammatory cytokine, interleukin-10 (IL-10).  Given the growing literature supporting that glial proinflammatory cytokines importantly contribute to neuropathic pain and that IL-10 can suppress such pain, we evaluated the effects of intrathecally administered A2AR agonists on neuropathic pain using the chronic constriction injury (CCI) model.  A single intrathecal injection of the A2AR agonists 4-(3-(6-amino-9-(5-cyclopropylcarbamoyl-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-2-yl)prop-2-ynyl)piperidine-1-carboxylic acid Me ester (ATL313) or 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamido adenosine HCl (CGS21680), 10-14 d after CCI vs. sham surgery, produced a long-duration reversal of mech. allodynia and thermal hyperalgesia for at least 4 wk.  Neither drug altered the nociceptive responses of sham-operated controls.  An A2AR antagonist [ZM241385 (4-(2-[7-amino-2-(2-furyl)(1,2,4)triazolo(2,3-a)(1,3,5)triazin-5-ylamino]ethyl)phenol)] coadministered intrathecally with ATL313 abolished the action of ATL313 in rats with neuropathy-induced allodynia but had no effect on allodynia in the absence of the A2AR agonist.  ATL313 attenuated CCI-induced upregulation of spinal cord activation markers for microglia and astrocytes in the L4-L6 spinal cord segments both 1 and 4 wk after a single intrathecal ATL313 administration.  Neutralizing IL-10 antibodies administered intrathecally transiently abolished the effect of ATL313 on neuropathic pain.  In addn., IL-10 mRNA was significantly elevated in the CSF cells collected from the lumbar region.  Activation of A2ARs after intrathecal administration may be a novel, therapeutic approach for the treatment of neuropathic pain by increasing IL-10 in the immunocompetent cells of the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYa7OimtQi_LVg90H21EOLACvtfcHk0lh47E6kWCWCkw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSmsbnE&md5=ccdf1c9331bb1337e25ed372e9013df0</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3447-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3447-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DLoram%26aufirst%3DL.%2BC.%26aulast%3DHarrison%26aufirst%3DJ.%2BA.%26aulast%3DSloane%26aufirst%3DE.%2BM.%26aulast%3DHutchinson%26aufirst%3DM.%2BR.%26aulast%3DSholar%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DF.%2BR.%26aulast%3DBerkelhammer%26aufirst%3DD.%26aulast%3DCoats%26aufirst%3DB.%2BD.%26aulast%3DPoole%26aufirst%3DS.%26aulast%3DMilligan%26aufirst%3DE.%2BD.%26aulast%3DMaier%26aufirst%3DS.%2BF.%26aulast%3DRieger%26aufirst%3DJ.%26aulast%3DWatkins%26aufirst%3DL.%2BR.%26atitle%3DEnduring%2520reversal%2520of%2520neuropathic%2520pain%2520by%2520a%2520single%2520intrathecal%2520injection%2520of%2520adenosine%2520A2A%2520receptor%2520agonists%253A%2520a%2520novel%2520therapy%2520for%2520neuropathic%2520pain%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D14015%26epage%3D14025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group">Mantell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevethick, M.</span><span> </span><span class="NLM_article-title">Design and application of locally delivered agonists of the adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">Expert Rev. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">â</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1586%2Fecp.09.57" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=22111533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFyiur7N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=55-72&author=S.+Mantellauthor=R.+Jonesauthor=M.+Trevethick&title=Design+and+application+of+locally+delivered+agonists+of+the+adenosine+A2A+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Design and application of locally delivered agonists of the adenosine A2A receptor</span></div><div class="casAuthors">Mantell, Simon; Jones, Rhys; Trevethick, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-72</span>CODEN:
                <span class="NLM_cas:coden">ERCPAG</span>;
        ISSN:<span class="NLM_cas:issn">1751-2433</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  The broad spectrum anti-inflammatory actions of adenosine A2A receptor agonists are well described.  The wide distribution of this receptor, however, suggests that the therapeutic potential of these agents is likely to reside in topical treatments to avoid systemic side effects assocd. with oral administration.  Adenosine A2A receptor agonists have been assessed as topical agents: GW328267X (GSK; allergic rhinitis and asthma), UK-432097 (Pfizer; chronic obstructive pulmonary disease [COPD]) and Sonedenoson (MRE0094, King Pharmaceuticals; wound healing).  All trials failed to achieve effects against the desired clin. end points.  This broad-based review will discuss general principles of chem. design of topically applied agents and potential therapeutic topical applications of current adenosine A2A receptor agonists.  Potential factors contributing to the lack of efficacy in the above clin. trials will be discussed together with design principles, which may influence efficacy in disease states.  Our anal. suggests that adenosine A2A receptor agonists have a wide therapeutic potential as topical agents in a wide variety of diseases, such as neutrophil-dependent lung diseases (acute lung injury, exacerbations in asthma and COPD), allergic rhinitis, glaucoma and wound repair.  Factors that will influence topical activity include formulation, tissue retention, compd. potency, receptor kinetics and pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq1S7ZYIysqbVg90H21EOLACvtfcHk0lgDPrB6g45nsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFyiur7N&md5=570bbb72a3670b0b317c4f4dbe1a9b00</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1586%2Fecp.09.57&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fecp.09.57%26sid%3Dliteratum%253Aachs%26aulast%3DMantell%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DTrevethick%26aufirst%3DM.%26atitle%3DDesign%2520and%2520application%2520of%2520locally%2520delivered%2520agonists%2520of%2520the%2520adenosine%2520A2A%2520receptor%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Pharmacol.%26date%3D2010%26volume%3D3%26spage%3D55%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group">Warren, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlowski, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figler, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, P. B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, R. L.</span><span> </span><span class="NLM_article-title">Effects of adenosine A<sub>2A</sub> receptor activation and alanyl-glutamine in <i>Clostridium difficile</i> toxin-induced ileitis in rabbits and cecitis in mice</span> <span class="citation_source-journal">BMC Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1186%2F1471-2334-12-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=22214291" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1-13&author=C.+A.+Warrenauthor=G.+M.+Calabreseauthor=Y.+Liauthor=S.+W.+Pawlowskiauthor=R.+A.+Figlerauthor=P.+B.+E.+Riegerauthor=J.+Lindenauthor=R.+L.+Guerrant&title=Effects+of+adenosine+A2A+receptor+activation+and+alanyl-glutamine+in+Clostridium+difficile+toxin-induced+ileitis+in+rabbits+and+cecitis+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1186%2F1471-2334-12-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2334-12-13%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DC.%2BA.%26aulast%3DCalabrese%26aufirst%3DG.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPawlowski%26aufirst%3DS.%2BW.%26aulast%3DFigler%26aufirst%3DR.%2BA.%26aulast%3DRieger%26aufirst%3DP.%2BB.%2BE.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DGuerrant%26aufirst%3DR.%2BL.%26atitle%3DEffects%2520of%2520adenosine%2520A2A%2520receptor%2520activation%2520and%2520alanyl-glutamine%2520in%2520Clostridium%2520difficile%2520toxin-induced%2520ileitis%2520in%2520rabbits%2520and%2520cecitis%2520in%2520mice%26jtitle%3DBMC%2520Infect.%2520Dis.%26date%3D2012%26volume%3D12%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group">Rickles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, T. P.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farwell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMillin, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Necheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navrocki, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carew, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borisy, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> and beta-2 adrenergic receptor agonists: novel selective and synergistic multiple myeloma targets discovered through systematic combination screening</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1432</span><span class="NLM_x">â</span> <span class="NLM_lpage">1442</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1158%2F1535-7163.MCT-11-0925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=22474168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVKrtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1432-1442&issue=7&author=R.+J.+Ricklesauthor=W.+F.+Tamauthor=T.+P.+Giordanoauthor=L.+T.+Pierceauthor=M.+Farwellauthor=D.+W.+McMillinauthor=A.+Nechevaauthor=D.+Croweauthor=M.+Chenauthor=W.+Averyauthor=V.+Kansraauthor=S.+T.+Navrockiauthor=J.+S.+Carewauthor=F.+J.+Gilesauthor=C.+S.+Mitsiadesauthor=A.+A.+Borisyauthor=K.+C.+Andersonauthor=M.+S.+Lee&title=Adenosine+A2A+and+beta-2+adrenergic+receptor+agonists%3A+novel+selective+and+synergistic+multiple+myeloma+targets+discovered+through+systematic+combination+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A and Beta-2 Adrenergic Receptor Agonists: Novel Selective and Synergistic Multiple Myeloma Targets Discovered through Systematic Combination Screening</span></div><div class="casAuthors">Rickles, Richard J.; Tam, Winnie F.; Giordano, Thomas P., III; Pierce, Laura T.; Farwell, Melissa; McMillin, Douglas W.; Necheva, Antoaneta; Crowe, David; Chen, Mei; Avery, William; Kansra, Vikram; Nawrocki, Steffan T.; Carew, Jennifer S.; Giles, Francis J.; Mitsiades, Constantine S.; Borisy, Alexis A.; Anderson, Kenneth C.; Lee, Margaret S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1432-1442</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The use of combination drug regimens has dramatically improved the clin. outcome for patients with multiple myeloma.  However, to date, combination treatments have been limited to approved drugs and a small no. of emerging agents.  Using a systematic approach to identify synergistic drug combinations, combination high-throughput screening (cHTS) technol., adenosine A2A and Î²-2 adrenergic receptor (Î²2AR) agonists were shown to be highly synergistic, selective, and novel agents that enhance glucocorticoid activity in B-cell malignancies.  Unexpectedly, A2A and Î²2AR agonists also synergize with melphalan, lenalidomide, bortezomib, and doxorubicin.  An anal. of agonists, in combination with dexamethasone or melphalan in 83 cell lines, reveals substantial activity in multiple myeloma and diffuse large B-cell lymphoma cell lines.  Combination effects are also obsd. with dexamethasone as well as bortezomib, using multiple myeloma patient samples and mouse multiple myeloma xenograft assays.  Our results provide compelling evidence in support of development of A2A and Î²2AR agonists for use in multi-drug combination therapy for multiple myeloma.  Furthermore, use of cHTS for the discovery and evaluation of new targets and combination therapies has the potential to improve cancer treatment paradigms and patient outcomes.  Mol Cancer Ther; 11(7); 1432-42. Â©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-1C5c76NcrVg90H21EOLACvtfcHk0lgDPrB6g45nsA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVKrtLk%253D&md5=9334b1b241d21b084f89b617a68cf86d</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0925%26sid%3Dliteratum%253Aachs%26aulast%3DRickles%26aufirst%3DR.%2BJ.%26aulast%3DTam%26aufirst%3DW.%2BF.%26aulast%3DGiordano%26aufirst%3DT.%2BP.%26aulast%3DPierce%26aufirst%3DL.%2BT.%26aulast%3DFarwell%26aufirst%3DM.%26aulast%3DMcMillin%26aufirst%3DD.%2BW.%26aulast%3DNecheva%26aufirst%3DA.%26aulast%3DCrowe%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DAvery%26aufirst%3DW.%26aulast%3DKansra%26aufirst%3DV.%26aulast%3DNavrocki%26aufirst%3DS.%2BT.%26aulast%3DCarew%26aufirst%3DJ.%2BS.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26aulast%3DBorisy%26aufirst%3DA.%2BA.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DLee%26aufirst%3DM.%2BS.%26atitle%3DAdenosine%2520A2A%2520and%2520beta-2%2520adrenergic%2520receptor%2520agonists%253A%2520novel%2520selective%2520and%2520synergistic%2520multiple%2520myeloma%2520targets%2520discovered%2520through%2520systematic%2520combination%2520screening%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26issue%3D7%26spage%3D1432%26epage%3D1442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group">Linden, J. M.; Rieger, J. M.; Mcdonald, T. L.; Sullivan, G. W.; Murphree, L. J.; Figler, R. A.</span><span> </span><span class="NLM_article-title">2-Propynyl Adenosine Analogs Having A<sub>2A</sub> Agonist Activity and Compositions Thereof</span>. U.S. Pat. Appl. US7737127 B2,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Linden&author=J.+M.+Rieger&author=T.+L.+Mcdonald&author=G.+W.+Sullivan&author=L.+J.+Murphree&author=R.+A.+Figler&title=2-Propynyl+Adenosine+Analogs+Having+A2A+Agonist+Activity+and+Compositions+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLinden%26aufirst%3DJ.%2BM.%26atitle%3D2-Propynyl%2520Adenosine%2520Analogs%2520Having%2520A2A%2520Agonist%2520Activity%2520and%2520Compositions%2520Thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasley, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palle, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span> </span><span class="NLM_article-title">Novel short-acting A<sub>2A</sub> adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A<sub>2A</sub> agonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">â</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=11408544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFChtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2001&pages=209-218&author=Z.+Gaoauthor=Z.+Liauthor=S.+P.+Bakerauthor=R.+D.+Lasleyauthor=S.+Meyerauthor=E.+Elzeinauthor=V.+Palleauthor=J.+A.+Zablockiauthor=B.+Blackburnauthor=L.+Belardinelli&title=Novel+short-acting+A2A+adenosine+receptor+agonists+for+coronary+vasodilation%3A+inverse+relationship+between+affinity+and+duration+of+action+of+A2A+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists</span></div><div class="casAuthors">Gao, Zhenhai; Li, Zhihe; Baker, Stephen P.; Lasley, Robert D.; Meyer, Stephanie; Elzein, Elfatih; Palle, Venkata; Zablocki, Jeff A.; Blackburn, Brent; Belardinelli, Luiz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">209-218</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Several potent and selective A2A adenosine receptor agonists are currently available.  These compds. have a high affinity for the A2A receptor and a long duration of action.  However, in situations where a short duration of action is desired, currently available A2A receptor agonists are less than ideal.  From a series of recently synthesized A2A receptor agonists, two agonists (CVT-3146 and CVT-3033) with low affinity were selected for further characterization as selective and short-acting coronary vasodilators.  Both compds. were selective for the A2A adenosine receptor (AdoR) vs. the A1, A2B, and A3AdoR in binding and functional studies.  CVT-3146 and CVT-3033 appeared to be weak partial agonists to cause cAMP accumulation in PC12 cells, but were full and potent agonists to cause coronary vasodilation, a response that has a very large A2A receptor reserve.  However, the durations of action of CVT-3146 and CVT-3033 were remarkably shorter than those of the high-affinity agonists CGS21680 or WRC0470, presumably due to the relative lower affinity of CVT-3146 and CVT-3033 for the A2A receptor.  Indeed, an inverse relation was found between the affinity of the various agonists for the A2A receptor and the duration of their actions.  These data indicate that low-affinity agonists can produce a response that is of equiv. magnitude but more rapid in termination than that caused by a high-affinity agonist.  Hence, the low-affinity A2A agonists CVT-3146 and CVT-3033 may prove to be superior to currently available high-affinity agonists as coronary vasodilators during myocardial imaging with radionuclide agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrHUi8guQpTbVg90H21EOLACvtfcHk0lgLNNH26lIoNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFChtbk%253D&md5=737a2ee654cd919208e12b5043ab2349</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBaker%26aufirst%3DS.%2BP.%26aulast%3DLasley%26aufirst%3DR.%2BD.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DPalle%26aufirst%3DV.%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26aulast%3DBlackburn%26aufirst%3DB.%26aulast%3DBelardinelli%26aufirst%3DL.%26atitle%3DNovel%2520short-acting%2520A2A%2520adenosine%2520receptor%2520agonists%2520for%2520coronary%2520vasodilation%253A%2520inverse%2520relationship%2520between%2520affinity%2520and%2520duration%2520of%2520action%2520of%2520A2A%2520agonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D298%26spage%3D209%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group">Kirk, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. J.</span><span> </span><span class="NLM_article-title">Further characterization of [<sup>3</sup>H]-CGS21680 binding sites in the rat striatum and cortex</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">â</span> <span class="NLM_lpage">543</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1111%2Fj.1476-5381.1995.tb13260.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=7881753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK2MXjt12ltb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1995&pages=537-543&author=I.+P.+Kirkauthor=P.+J.+Richardson&title=Further+characterization+of+%5B3H%5D-CGS21680+binding+sites+in+the+rat+striatum+and+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Further characterization of [3H]-CGS 2168 binding sites in the rat striatum and cortex</span></div><div class="casAuthors">Kirk, Ian P.; Richardson, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">537-43</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The putative high affinity binding site for the adenosine A2A receptor agonist 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine (CGS 21680) in the rat cerebral cortex was characterized by use of a no. of selective A1 and A2 adenosine receptor ligands, and compared to the characteristics of the more abundant striatal A2A receptor.  The binding of [3H]-CGS 21680 to cortical membranes was performed at pH 5.5, to increase the amt. of specific binding.  Redn. of the pH from 7.4 to 5.5 increased the apparent affinity of the striatal binding side for both agonists and antagonists.  The relative order of potencies of both groups of ligands were the same at both pH values, and were consistent with binding to the A2A receptor.  There was no observable change in the Bmax, the values being 415 and 446 fmol mg-1 protein at pH 5.5 and 7.4 resp.  The cortical binding site yielded a Bmax value of 117 fmol mg-1 protein.  The relative order of potencies of the adenosine receptor ligands obsd. at this binding site were not the same as those obsd. in the striatum, exhibiting a profile with both A1 and A2 characteristics.  Further characterization of this cortical binding site in the presence of A1 selective antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) revealed a more typical A2A profile.  This indicated that under these conditions used there were two components of [3H]-CGS 21680 binding, approx. 20% of the A1 receptor and 80% to the A2A receptor.  It is concluded that in the cerebral cortex there is a CGS 21680 binding site showing the characteristic properties of the striatal A2A receptor, and no evidence was obtained for the existence of a novel A2A-like binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolg_eJ8W4ya7Vg90H21EOLACvtfcHk0lgLNNH26lIoNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjt12ltb0%253D&md5=97de90da9dcf054bb52ce92a0f847ace</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb13260.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb13260.x%26sid%3Dliteratum%253Aachs%26aulast%3DKirk%26aufirst%3DI.%2BP.%26aulast%3DRichardson%26aufirst%3DP.%2BJ.%26atitle%3DFurther%2520characterization%2520of%2520%255B3H%255D-CGS21680%2520binding%2520sites%2520in%2520the%2520rat%2520striatum%2520and%2520cortex%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D114%26spage%3D537%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goblyos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">Allosteric modulation of purine and pyrimidine receptors</span> <span class="citation_source-journal">Adv. Pharmacol. (San Diego, CA, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">â</span> <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2FB978-0-12-385526-8.00007-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=21586360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsVKmsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=187-220&author=K.+A.+Jacobsonauthor=Z.-G.+Gaoauthor=A.+Goblyosauthor=A.+P.+Ijzerman&title=Allosteric+modulation+of+purine+and+pyrimidine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of purine and pyrimidine receptors</span></div><div class="casAuthors">Jacobson, Kenneth A.; Gao, Zhan-Guo; Goblyos, Aniko; Ijzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">Pharmacology of Purine and Pyrimidine Receptors</span>),
    <span class="NLM_cas:pages">187-220</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Among the purine and pyrimidine receptors, the discovery of small mol. allosteric modulators has been most highly advanced for the A1 and A3 adenosine receptors (ARs).  These AR modulators have allosteric effects that are structurally sepd. from the orthosteric effects in SAR studies.  The benzoylthiophene derivs. tend to act as allosteric agonists as well as selective pos. allosteric modulators (PAMs) of the A1 AR.  A 2-amino-3-aroylthiophene deriv. T-62 has been under development as a PAM of the A1 AR for the treatment of chronic pain.  Several structurally distinct classes of allosteric modulators of the human A3 AR have been reported: 3-(2-pyridinyl)isoquinolines, 2,4-disubstituted quinolines, 1H-imidazo-[4,5-c]quinolin-4-amines, endocannabinoid 2-arachidonylglycerol, and the food dye Brilliant Black BN.  Site-directed mutagenesis of A1 and A3 ARs has identified residues assocd. with the allosteric effect, distinct from those that affect orthosteric binding.  A few small mol. allosteric modulators have been reported for several of the P2X ligand-gated ion channels and the G protein-coupled P2Y receptor nucleotides.  Metal ion modulation of the P2X receptors has been extensively explored.  The allosteric approach to modulation of purine and pyrimidine receptors looks promising for development of drugs that are event and site specific in action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf8nqRx1ZoQ7Vg90H21EOLACvtfcHk0lgLNNH26lIoNQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsVKmsL4%253D&md5=418a4cd16efc876f25597cca2189cc34</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-385526-8.00007-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-385526-8.00007-2%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DGoblyos%26aufirst%3DA.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DAllosteric%2520modulation%2520of%2520purine%2520and%2520pyrimidine%2520receptors%26jtitle%3DAdv.%2520Pharmacol.%2520%2528San%2520Diego%252C%2520CA%252C%2520U.%2520S.%2529%26date%3D2011%26volume%3D61%26spage%3D187%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group">Gao, Z.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Allosteric modulation of the adenosine family of receptors</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">â</span> <span class="NLM_lpage">553</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=545-553&author=Z.-G.+Gaoauthor=S.-K.+Kimauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Allosteric+modulation+of+the+adenosine+family+of+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DKim%26aufirst%3DS.-K.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DAllosteric%2520modulation%2520of%2520the%2520adenosine%2520family%2520of%2520receptors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D545%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">Allosteric modulation of A<sub>2A</sub> adenosine receptors by amiloride analogs and sodium ions</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">â</span> <span class="NLM_lpage">676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=669-676&author=Z.+G.+Gaoauthor=A.+P.+Ijzerman&title=Allosteric+modulation+of+A2A+adenosine+receptors+by+amiloride+analogs+and+sodium+ions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DAllosteric%2520modulation%2520of%2520A2A%2520adenosine%2520receptors%2520by%2520amiloride%2520analogs%2520and%2520sodium%2520ions%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2000%26volume%3D60%26spage%3D669%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group">Giorgi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianucci, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderone, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martelli, A.</span><span> </span><span class="NLM_article-title"><i>N</i>6-1,3-Diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: synthesis and biological evaluation as allosteric modulators of A<sub>2A</sub> adenosine receptors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1639</span><span class="NLM_x">â</span> <span class="NLM_lpage">1647</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1639-1647&author=I.+Giorgiauthor=G.+Biagiauthor=A.+M.+Bianucciauthor=A.+Borghiniauthor=O.+Liviauthor=M.+Leonardiauthor=D.+Pietraauthor=V.+Calderoneauthor=A.+Martelli&title=N6-1%2C3-Diphenylurea+derivatives+of+2-phenyl-9-benzyladenines+and+8-azaadenines%3A+synthesis+and+biological+evaluation+as+allosteric+modulators+of+A2A+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiorgi%26aufirst%3DI.%26aulast%3DBiagi%26aufirst%3DG.%26aulast%3DBianucci%26aufirst%3DA.%2BM.%26aulast%3DBorghini%26aufirst%3DA.%26aulast%3DLivi%26aufirst%3DO.%26aulast%3DLeonardi%26aufirst%3DM.%26aulast%3DPietra%26aufirst%3DD.%26aulast%3DCalderone%26aufirst%3DV.%26aulast%3DMartelli%26aufirst%3DA.%26atitle%3DN6-1%252C3-Diphenylurea%2520derivatives%2520of%25202-phenyl-9-benzyladenines%2520and%25208-azaadenines%253A%2520synthesis%2520and%2520biological%2520evaluation%2520as%2520allosteric%2520modulators%2520of%2520A2A%2520adenosine%2520receptors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1639%26epage%3D1647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group">Parkinson, J.</span><span> </span><span class="NLM_article-title">An essay on the shaking palsy</span> <span class="citation_source-journal">J. Neurosychiatry Clin. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">â</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1176%2Fappi.neuropsych.14.2.223" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2002&pages=223-236&issue=2&author=J.+Parkinson&title=An+essay+on+the+shaking+palsy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1176%2Fappi.neuropsych.14.2.223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.neuropsych.14.2.223%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DJ.%26atitle%3DAn%2520essay%2520on%2520the%2520shaking%2520palsy%26jtitle%3DJ.%2520Neurosychiatry%2520Clin.%2520Neurosci.%26date%3D2002%26volume%3D14%26issue%3D2%26spage%3D223%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">The original article was published as a short monograph in an assay on the shaking palsy. London, 1817.</p></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">The pathogenesis of cell death in Parkinsonâs disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 10)</span><span class="NLM_x">) </span> <span class="NLM_fpage">S24</span><span class="NLM_x">â</span> <span class="NLM_lpage">S36</span><div class="note"><p class="first last">and references therein.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=S24-S36&issue=Suppl.+10%29&author=P.+Jennerauthor=C.+W.+Olanow&title=The+pathogenesis+of+cell+death+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DThe%2520pathogenesis%2520of%2520cell%2520death%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D2006%26volume%3D66%26issue%3DSuppl.%252010%2529%26spage%3DS24%26epage%3DS36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group">Lozano, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostrovsky, J. O.</span><span> </span><span class="NLM_article-title">New developments in understanding the etiology of Parkinsonâs disease and in its treatment</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">â</span> <span class="NLM_lpage">790</span><div class="note"><p class="first last">and Parkinsonâs disease, National Parkinson Foundation, Miami, FL, U.S., <a href="http://www.parkinson.org/parkinson-s-disease.aspx" class="extLink">www.parkinson.org/parkinson-s-disease.aspx</a></p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=783-790&author=A.+M.+Lozanoauthor=A.+E.+Langauthor=W.+D.+Hutchisonauthor=J.+O.+Dostrovsky&title=New+developments+in+understanding+the+etiology+of+Parkinson%E2%80%99s+disease+and+in+its+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLozano%26aufirst%3DA.%2BM.%26aulast%3DLang%26aufirst%3DA.%2BE.%26aulast%3DHutchison%26aufirst%3DW.%2BD.%26aulast%3DDostrovsky%26aufirst%3DJ.%2BO.%26atitle%3DNew%2520developments%2520in%2520understanding%2520the%2520etiology%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520in%2520its%2520treatment%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D1998%26volume%3D8%26spage%3D783%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group">Mercuri, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardi, G.</span><span> </span><span class="NLM_article-title">The âmagicâ of L-dopa: Why is it the gold standard Parkinsonâs disease therapy?</span> <span class="citation_source-journal">Trends Pharmacol. Sci</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">341</span><span class="NLM_x">â</span> <span class="NLM_lpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=341-344&issue=7&author=N.+B.+Mercuriauthor=G.+Bernardi&title=The+%E2%80%9Cmagic%E2%80%9D+of+L-dopa%3A+Why+is+it+the+gold+standard+Parkinson%E2%80%99s+disease+therapy%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMercuri%26aufirst%3DN.%2BB.%26aulast%3DBernardi%26aufirst%3DG.%26atitle%3DThe%2520%25E2%2580%259Cmagic%25E2%2580%259D%2520of%2520L-dopa%253A%2520Why%2520is%2520it%2520the%2520gold%2520standard%2520Parkinson%25E2%2580%2599s%2520disease%2520therapy%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci%26date%3D2005%26volume%3D26%26issue%3D7%26spage%3D341%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Dopamine agonists in Parkinsonâs disease</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">â</span> <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1586%2F14737175.8.4.671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=18416667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFSht70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=671-677&author=M.+Yamamotoauthor=A.+H.+V.+Schapira&title=Dopamine+agonists+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine agonists in Parkinson's disease</span></div><div class="casAuthors">Yamamoto, Mitsutoshi; Schapira, Anthony H. V.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">671-677</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Dopamine agonists are established as effective drugs for the symptomatic treatment of Parkinson's disease (PD) throughout its course.  As monotherapy, they produce effective control of motor symptoms and combine this with a low risk for motor complications.  As an adjunct to levodopa, they improve motor control and limit the need for levodopa in those patients in whom this may be considered relevant.  The non-ergot dopamine agonists in particular have a good safety profile, although as with other agonists, sedation, and cognitive and behavioral problems may be limiting in some patients.  Pramipexole has shown benefit in improving depressive symptoms in PD.  Ropinirole and pramipexole have both demonstrated a redn. in the rate of loss of nigrostriatal innervation as detd. by imaging in PD patients, when compared with levodopa.  Thus, dopamine agonists contribute to several dimensions of the management of PD and have become an integral part of the disease treatment algorithm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxVM_IekUXprVg90H21EOLACvtfcHk0liY2zYX7tPfgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFSht70%253D&md5=9a145ab9c49de374322fb02fe543d4ad</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1586%2F14737175.8.4.671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.8.4.671%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DDopamine%2520agonists%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2008%26volume%3D8%26spage%3D671%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group">Hansard, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheetam, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Dopamine, but not norepinephrine or serotonin reuptake inhibition reverse motor deficts in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">â</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1124%2Fjpet.102.039743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=12438514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD38Xptlamt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=952-958&author=M.+J.+Hansardauthor=L.+A.+Smithauthor=M.+J.+Jacksonauthor=S.+C.+Cheetamauthor=P.+Jenner&title=Dopamine%2C+but+not+norepinephrine+or+serotonin+reuptake+inhibition+reverse+motor+deficts+in+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine-treated+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates</span></div><div class="casAuthors">Hansard, Matthew J.; Smith, Lance A.; Jackson, Michael J.; Cheetham, Sharon C.; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">952-958</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Monoamine reuptake inhibitors that do not discriminate between the transporters for dopamine (DA), norepinephrine (NE), or 5-hydroxytryptamine (5-HT, serotonin) can reverse locomotor deficits and motor disability in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosets.  DA reuptake inhibition is presumed to be primarily responsible, but the role played by inhibition of NE and 5-HT reuptake is unknown.  This work evaluated the efficacy of a range of monoamine reuptake inhibitors either alone or in combination in MPTP-treated common marmosets to det. the actions required for effective antiparkinsonian activity.  Monoamine reuptake inhibitors not discriminating between the DA, NE, and 5-HT transporters [1-[1-(3,4-dichlororphenyl)cyclobutyl]-2-(3-diaminethylaminopropylthio)ethanone monocitrate (BTS 74 398) and nomifensine] reversed locomotor deficits and motor disability in MPTP-treated marmosets but bupropion was without effect.  The selective DA reuptake inhibitor 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride (GBR 12909) also reversed these motor deficits.  The relative efficacy of the compds. (BTS 74 398 > GBR 12909 > nomifensine Â» bupropion) paralleled their previously detd. potency in inhibiting DA uptake in vitro and in vivo.  In contrast, the selective NE reuptake inhibitor nisoxetine and the 5-HT reuptake inhibitor sertraline administered alone failed to improve motor function and tended to worsen the deficits.  Coadministration of nisoxetine attenuated the improvement in motor deficits produced by GBR 12909.  Coadministration of sertraline also abolished the reversal of motor deficits produced by GBR 12909.  Coadministration of both sertraline and nisoxetine similarly abolished the improvement of motor deficits produced by GBR 12909.  Mols. possessing potent DA reuptake inhibitory activity may be useful in the treatment of the motor symptoms of Parkinson's disease.  In contrast, there seems to be no role for NE or 5-HT reuptake inhibitors, and they may impair antiparkinsonian activity mediated through dopaminergic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprkAiG5hgKS7Vg90H21EOLACvtfcHk0liY2zYX7tPfgA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xptlamt7g%253D&md5=f5b88eadd0c931fe318d49b4701b8760</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039743%26sid%3Dliteratum%253Aachs%26aulast%3DHansard%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DCheetam%26aufirst%3DS.%2BC.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DDopamine%252C%2520but%2520not%2520norepinephrine%2520or%2520serotonin%2520reuptake%2520inhibition%2520reverse%2520motor%2520deficts%2520in%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine-treated%2520primates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D952%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">MAO-B inhibitors in Parkinsonâs disease</span> <span class="citation_source-journal">Adv. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">â</span> <span class="NLM_lpage">671</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=8420207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK3sXktF2lurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1993&pages=666-671&author=C.+W.+Olanow&title=MAO-B+inhibitors+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">MAO-B inhibitors in Parkinson's disease</span></div><div class="casAuthors">Olanow, C. Warren</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Parkinson's Disease</span>),
    <span class="NLM_cas:pages">666-71</span>CODEN:
                <span class="NLM_cas:coden">ADNRA3</span>;
        ISSN:<span class="NLM_cas:issn">0091-3952</span>.
    </div><div class="casAbstract">A review with 46 ref.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQFDRpN_SkdrVg90H21EOLACvtfcHk0ljs3lHOVfEkFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktF2lurw%253D&md5=e90fcc306d9c58991fe71c94a48e5fba</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DMAO-B%2520inhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAdv.%2520Neurol.%26date%3D1993%26volume%3D60%26spage%3D666%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span> </span><span class="NLM_article-title">Clinical pharmacology and therapeutic use of COMT inhibition in Parkinsonâs disease</span> <span class="citation_source-journal">J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">IV/37</span><span class="NLM_x">â</span> <span class="NLM_lpage">IV/48</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2007&pages=IV%2F37-IV%2F48&author=A.+Gordinauthor=D.+J.+Brooks&title=Clinical+pharmacology+and+therapeutic+use+of+COMT+inhibition+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3DClinical%2520pharmacology%2520and%2520therapeutic%2520use%2520of%2520COMT%2520inhibition%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%26date%3D2007%26volume%3D254%26spage%3DIV%252F37%26epage%3DIV%252F48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethi, K.</span><span> </span><span class="NLM_article-title">The scientific and clinical basis for the treatment of Parkinson disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">21, Suppl. 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">S1</span><span class="NLM_x">â</span> <span class="NLM_lpage">S136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2009&pages=S1-S136&issue=21%2C+Suppl.+4&author=C.+W.+Olanowauthor=M.+B.+Sternauthor=K.+Sethi&title=The+scientific+and+clinical+basis+for+the+treatment+of+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DStern%26aufirst%3DM.%2BB.%26aulast%3DSethi%26aufirst%3DK.%26atitle%3DThe%2520scientific%2520and%2520clinical%2520basis%2520for%2520the%2520treatment%2520of%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D2009%26volume%3D72%26issue%3D21%252C%2520Suppl.%25204%26spage%3DS1%26epage%3DS136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit124b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Antonini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clilia, R.</span><span> </span><span class="NLM_article-title">Behavioural adverse effects of dopaminergic treatments in Parkinsonâs disease: incidence, neurobiological basis, management and prevention</span> <span class="citation_source-journal">Drug Safety</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">â</span> <span class="NLM_lpage">488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=475-488&author=A.+Antoniniauthor=R.+Clilia&title=Behavioural+adverse+effects+of+dopaminergic+treatments+in+Parkinson%E2%80%99s+disease%3A+incidence%2C+neurobiological+basis%2C+management+and+prevention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAntonini%26aufirst%3DA.%26aulast%3DClilia%26aufirst%3DR.%26atitle%3DBehavioural%2520adverse%2520effects%2520of%2520dopaminergic%2520treatments%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520incidence%252C%2520neurobiological%2520basis%252C%2520management%2520and%2520prevention%26jtitle%3DDrug%2520Safety%26date%3D2009%26volume%3D32%26spage%3D475%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group">Bonuccelli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Dotto, P.</span><span> </span><span class="NLM_article-title">New pharmacologic horizons in the treatment of Parkinson disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">7, Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S30</span><span class="NLM_x">â</span> <span class="NLM_lpage">S38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=S30-S38&issue=7%2C+Suppl.+2&author=U.+Bonuccelliauthor=P.+Del+Dotto&title=New+pharmacologic+horizons+in+the+treatment+of+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonuccelli%26aufirst%3DU.%26aulast%3DDel%2BDotto%26aufirst%3DP.%26atitle%3DNew%2520pharmacologic%2520horizons%2520in%2520the%2520treatment%2520of%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D2006%26volume%3D67%26issue%3D7%252C%2520Suppl.%25202%26spage%3DS30%26epage%3DS38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, M.</span><span> </span><span class="NLM_article-title">Targeting adenosine A<sub>2A</sub> receptors in Parkinsonâs disease</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">647</span><span class="NLM_x">â</span> <span class="NLM_lpage">654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=647-654&issue=11&author=M.+A.+Schwarzschildauthor=L.+Agnatiauthor=K.+Fuxeauthor=J.+F.+Chenauthor=M.+Morelli&title=Targeting+adenosine+A2A+receptors+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DAgnati%26aufirst%3DL.%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DMorelli%26aufirst%3DM.%26atitle%3DTargeting%2520adenosine%2520A2A%2520receptors%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26issue%3D11%26spage%3D647%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit126b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Salamone, J. D.</span><span> </span><span class="NLM_article-title">Facing dyskinesia in Parkinsonâs disease: nondopaminergic approaches</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">â</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1358%2Fdof.2010.035.07.1516041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlems7nJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=567-573&author=J.+D.+Salamone&title=Facing+dyskinesia+in+Parkinson%E2%80%99s+disease%3A+nondopaminergic+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126bR"><div class="casContent"><span class="casTitleNuber">126b</span><div class="casTitle"><span class="NLM_cas:atitle">Facing dyskinesia in Parkinson's disease: nondopaminergic approaches</span></div><div class="casAuthors">Salamone, J. D.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">567-573</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  L-DOPA has been the gold std. for the treatment of Parkinson's disease for the last 5 decades.  Nevertheless, problems with long-term use, such as motor fluctuations and dyskinesias, have led investigators to search for alternative therapies and for various approaches designed to minimize or ameliorate dyskinesias.  Dopaminergic strategies are being studied, including continuous drug infusion.  Moreover, non-dopaminergic approaches such as serotonergic agents, adenosine A2A receptor antagonists and amantadine are also being investigated.  Serotonin 5-HT2A receptor antagonists and 5-HT1A receptor agonists have been studied for their antidyskinetic effects.  Adenosine A2A receptor antagonists exert antiparkinsonian effects in animal models and several candidates have progressed to phase II or III clin. testing.  Generally, these agents have been shown to decrease L-DOPA "off" time and increase "on" time, without worsening L-DOPA-induced dyskinesias.  Of all the drugs tested so far, amantadine appears to produce the most consistent antidyskinetic actions.  In conclusion, numerous approaches appear to offer promise for the management of dyskinesias, one of the most troubling aspects of the current treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfZky7YUA737Vg90H21EOLACvtfcHk0ljs3lHOVfEkFQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlems7nJ&md5=3a61e4d753eb2c3d0c57acde5f2e6e8a</span></div><a href="/servlet/linkout?suffix=cit126b&amp;dbid=16384&amp;doi=10.1358%2Fdof.2010.035.07.1516041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2010.035.07.1516041%26sid%3Dliteratum%253Aachs%26aulast%3DSalamone%26aufirst%3DJ.%2BD.%26atitle%3DFacing%2520dyskinesia%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520nondopaminergic%2520approaches%26jtitle%3DDrugs%2520Future%26date%3D2010%26volume%3D35%26spage%3D567%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group">Fink, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivkees, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterfreund, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reppert, S. M.</span><span> </span><span class="NLM_article-title">Molecular cloning of the rat A<sub>2</sub> adenosine receptor: selective co-expression with D<sub>2</sub> dopamine receptors in rat striatum</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">â</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2F0169-328X%2892%2990173-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=1279342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVelt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1992&pages=186-195&author=J.+S.+Finkauthor=D.+R.+Weaverauthor=S.+A.+Rivkeesauthor=R.+A.+Peterfreundauthor=A.+E.+Pollackauthor=E.+M.+Adlerauthor=S.+M.+Reppert&title=Molecular+cloning+of+the+rat+A2+adenosine+receptor%3A+selective+co-expression+with+D2+dopamine+receptors+in+rat+striatum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum</span></div><div class="casAuthors">Fink, J. Stephen; Weaver, David R.; Rivkees, Scott A.; Peterfreund, Robert A.; Pollack, Alexia E.; Adler, Elizabeth M.; Reppert, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-95</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    </div><div class="casAbstract">A cDNA fragment homologous to other G protein-coupled receptors was isolated from rat brain using the PCR method and demonstrated to be abundantly expressed in striatum.  Using this fragment as a probe, a 2.1 kb full-length cDNA was isolated from a rat striatal cDNA library.  This cDNA encodes a protein of 410 amino acids and is highly homologous to previously isolated adenosine receptor cDNA.  Expression of this cDNA in COS cells revealed high affinity (Kd = 38.6 nM) and saturable binding of the A2 adenosine receptor-selective ligand [3H]CGS 21680.  Agonist displacement profile of [3H]CGS 21680 binding was consistent with an adenosine receptor of the A2 subtype (NECA > (R)-PIA > CPA > (S)-PIA).  In situ hybridization demonstrated that rat A2 adenosine receptor mRNA was co-expressed in the same striatal neurons as D2 dopamine receptor mRNA, and never co-expressed with striatal D1 dopamine receptor mRNA.  Several lines of evidence have previously suggested that dopamine-induced changes in motor behavior can be modulated by adenosine analogs acting at the A2 subtype of adenosine receptor in the forebrain.  The co-expression of D2 dopamine and A2 adenosine receptors in a subset of striatal cells provides an anatomical basis for dopaminergic-adenosinergic interactions on motor behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Daq1pagx8bVg90H21EOLACvtfcHk0lghkAbaW9D5-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVelt7o%253D&md5=c625968121ce9599d80d0d7cad3e1b56</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2F0169-328X%2892%2990173-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0169-328X%252892%252990173-9%26sid%3Dliteratum%253Aachs%26aulast%3DFink%26aufirst%3DJ.%2BS.%26aulast%3DWeaver%26aufirst%3DD.%2BR.%26aulast%3DRivkees%26aufirst%3DS.%2BA.%26aulast%3DPeterfreund%26aufirst%3DR.%2BA.%26aulast%3DPollack%26aufirst%3DA.%2BE.%26aulast%3DAdler%26aufirst%3DE.%2BM.%26aulast%3DReppert%26aufirst%3DS.%2BM.%26atitle%3DMolecular%2520cloning%2520of%2520the%2520rat%2520A2%2520adenosine%2520receptor%253A%2520selective%2520co-expression%2520with%2520D2%2520dopamine%2520receptors%2520in%2520rat%2520striatum%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D1992%26volume%3D14%26spage%3D186%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group">Ungerstedt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbuthnott, G. W.</span><span> </span><span class="NLM_article-title">Quantitative recording of rotational behavior in rats after 6-hyroxy-dopamine lesions of the nigrostriatal dopamine system</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">â</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2F0006-8993%2870%2990187-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=5494536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADyaE3M%252Fotl2msA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1970&pages=485-493&author=U.+Ungerstedtauthor=G.+W.+Arbuthnott&title=Quantitative+recording+of+rotational+behavior+in+rats+after+6-hyroxy-dopamine+lesions+of+the+nigrostriatal+dopamine+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system</span></div><div class="casAuthors">Ungerstedt U; Arbuthnott G W</div><div class="citationInfo"><span class="NLM_cas:title">Brain research</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">485-93</span>
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxWjpxbmSViUg6wdEZmT2rfW6udTcc2ebRqVpBUbzLk7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3M%252Fotl2msA%253D%253D&md5=e31a2eee4f4fff68329c0ab8a8a62788</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2870%2990187-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252870%252990187-3%26sid%3Dliteratum%253Aachs%26aulast%3DUngerstedt%26aufirst%3DU.%26aulast%3DArbuthnott%26aufirst%3DG.%2BW.%26atitle%3DQuantitative%2520recording%2520of%2520rotational%2520behavior%2520in%2520rats%2520after%25206-hyroxy-dopamine%2520lesions%2520of%2520the%2520nigrostriatal%2520dopamine%2520system%26jtitle%3DBrain%2520Res.%26date%3D1970%26volume%3D24%26spage%3D485%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group">Campos-Romo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojeda-Flores, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Briseno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernadez-Ruiz, J.</span><span> </span><span class="NLM_article-title">Quantitative evaluation of MPTP-treated nonhuman pakinsonian primates in the hallway task</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">â</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.jneumeth.2008.10.026" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2009&pages=36-368&author=A.+Campos-Romoauthor=R.+Ojeda-Floresauthor=P.+Moreno-Brisenoauthor=J.+Fernadez-Ruiz&title=Quantitative+evaluation+of+MPTP-treated+nonhuman+pakinsonian+primates+in+the+hallway+task"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2008.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2008.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DCampos-Romo%26aufirst%3DA.%26aulast%3DOjeda-Flores%26aufirst%3DR.%26aulast%3DMoreno-Briseno%26aufirst%3DP.%26aulast%3DFernadez-Ruiz%26aufirst%3DJ.%26atitle%3DQuantitative%2520evaluation%2520of%2520MPTP-treated%2520nonhuman%2520pakinsonian%2520primates%2520in%2520the%2520hallway%2520task%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2009%26volume%3D177%26spage%3D36%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group">Bara-Jimenez, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherzai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouradian, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonist treatment of Parkinsonâs disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">â</span> <span class="NLM_lpage">296</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=293-296&author=W.+Bara-Jimenezauthor=A.+Sherzaiauthor=T.+Dimitrovaauthor=A.+Favitauthor=F.+Bibbianiauthor=M.+Gillespieauthor=M.+J.+Morrisauthor=M.+M.+Mouradianauthor=T.+N.+Chase&title=Adenosine+A2A+receptor+antagonist+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBara-Jimenez%26aufirst%3DW.%26aulast%3DSherzai%26aufirst%3DA.%26aulast%3DDimitrova%26aufirst%3DT.%26aulast%3DFavit%26aufirst%3DA.%26aulast%3DBibbiani%26aufirst%3DF.%26aulast%3DGillespie%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26aulast%3DChase%26aufirst%3DT.%2BN.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonist%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D293%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">jackson, P. F.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonists and Parkinsonâs disease</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">â</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn2000537" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref131/cit131a&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosVSrsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=555-567&author=B.+C.+Shookauthor=P.+F.+jackson&title=Adenosine+A2A+receptor+antagonists+and+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131aR"><div class="casContent"><span class="casTitleNuber">131a</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A Receptor Antagonists and Parkinson's Disease</span></div><div class="casAuthors">Shook, Brian C.; Jackson, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">555-567</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This Review summarizes and updates the work on adenosine A2A receptor antagonists for Parkinson's disease from 2006 to the present.  There have been numerous publications, patent applications, and press releases within this time frame that highlight new medicinal chem. approaches to this attractive and promising target to treat Parkinson's disease.  The Review is broken down by scaffold type and will discuss the efforts to optimize particular scaffolds for activity, pharmacokinetics, and other drug discovery parameters.  The majority of approaches focus on prepg. selective A2A antagonists, but a few approaches to dual A2A/A1 antagonists will also be highlighted.  The in vivo profiles of compds. will be highlighted and discussed to compare activities across different chem. series.  A clin. report and update will be given on compds. that have entered clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9jbqVC-a6P7Vg90H21EOLACvtfcHk0lghkAbaW9D5-g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosVSrsrc%253D&md5=81746259f96dd1a270f12c3cb2dbe1d3</span></div><a href="/servlet/linkout?suffix=cit131a&amp;dbid=16384&amp;doi=10.1021%2Fcn2000537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn2000537%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3Djackson%26aufirst%3DP.%2BF.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonists%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D555%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit131b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Armentero, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanciego, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span> </span><span class="NLM_article-title">Past, present and future of A<sub>2A</sub> adenosine receptor antagonists in the therapy of Parkinsonâs disease</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">â</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.pharmthera.2011.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=21810444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2ntrzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2011&pages=280-299&author=M.+T.+Armenteroauthor=A.+Pinnaauthor=S.+Ferreauthor=J.+L.+Lanciegoauthor=C.+E.+Mullerauthor=R.+Franco&title=Past%2C+present+and+future+of+A2A+adenosine+receptor+antagonists+in+the+therapy+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131bR"><div class="casContent"><span class="casTitleNuber">131b</span><div class="casTitle"><span class="NLM_cas:atitle">Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease</span></div><div class="casAuthors">Armentero, Marie Therese; Pinna, Annalisa; Ferre, Sergi; Lanciego, Jose Luis; Mueller, Christa E.; Franco, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">280-299</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Several selective antagonists for adenosine A2A receptors (A2AR) are currently under evaluation in clin. trials (phases I to III) to treat Parkinson's disease, and they will probably soon reach the market.  The usefulness of these antagonists has been deduced from studies demonstrating functional interactions between dopamine D2 and adenosine A2A receptors in the basal ganglia.  At present it is believed that A2AR antagonists can be used in combination with the dopamine precursor L-DOPA to minimize the motor symptoms of Parkinson's patients.  However, a considerable body of data indicates that in addn. to ameliorating motor symptoms, adenosine A2AR antagonists may also prevent neurodegeneration.  Despite these promising indications, one further issue must be considered in order to develop fully optimized antiparkinsonian drug therapy, namely the existence of (hetero)dimers/oligomers of G protein-coupled receptors, a topic that is currently the focus of intense debate within the scientific community.  Dopamine D2 receptors (D2Rs) expressed in the striatum are known to form heteromers with A2A adenosine receptors.  Thus, the development of heteromer-specific A2A receptor antagonists represents a promising strategy for the identification of more selective and safer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2pOYdmdfQMLVg90H21EOLACvtfcHk0li1LhYDoLtmZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2ntrzP&md5=39fa871338516f7574deb7845029e624</span></div><a href="/servlet/linkout?suffix=cit131b&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2011.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2011.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DArmentero%26aufirst%3DM.%2BT.%26aulast%3DPinna%26aufirst%3DA.%26aulast%3DFerre%26aufirst%3DS.%26aulast%3DLanciego%26aufirst%3DJ.%2BL.%26aulast%3DMuller%26aufirst%3DC.%2BE.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DPast%252C%2520present%2520and%2520future%2520of%2520A2A%2520adenosine%2520receptor%2520antagonists%2520in%2520the%2520therapy%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2011%26volume%3D132%26spage%3D280%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit131c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Shah, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span> </span><span class="NLM_article-title">Recent progress in the discovery of adenosine A<sub>2A</sub> receptor antagonists for the treatment of Parkinsonâs disease</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">â</span> <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131c&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=20597030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131c&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSju7zK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=466-480&author=U.+Shahauthor=R.+Hodgson&title=Recent+progress+in+the+discovery+of+adenosine+A2A+receptor+antagonists+for+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131cR"><div class="casContent"><span class="casTitleNuber">131c</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery of adenosine A2A receptor antagonists for the treatment of Parkinson's disease</span></div><div class="casAuthors">Shah, Unmesh; Hodgson, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">466-480</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Antagonism of the A2A receptor has emerged as a promising non-dopaminergic approach for the potential treatment of Parkinson's disease (PD).  Several pharmaceutical and academic institutions have ongoing research programs in this area, and orally efficacious A2A receptor antagonists were advanced into clin. development.  Traditionally, antagonists of the A2A receptor are classified as xanthine and non-xanthine derivs.  This review provides a detailed summary of the recent SAR development that has led to the discovery of promising non-xanthine-based A2A receptor antagonists.  The current clin. status and the potential utility of A2A receptor antagonists in indications other than PD are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouWpTRXO9ll7Vg90H21EOLACvtfcHk0li1LhYDoLtmZg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSju7zK&md5=1e9fb4644949ab0efeb9a208bdb1d3d7</span></div><a href="/servlet/linkout?suffix=cit131c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DU.%26aulast%3DHodgson%26aufirst%3DR.%26atitle%3DRecent%2520progress%2520in%2520the%2520discovery%2520of%2520adenosine%2520A2A%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D466%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit131d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span> </span><span class="NLM_article-title">Adenosine, adenosine A<sub>2A</sub> antagonists, and Parkinsonâs disease</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">â</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131d&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.parkreldis.2008.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131d&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=19446490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131d&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADC%252BD1MvksVWnsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=406-413&author=P.+Jennerauthor=A.+Moriauthor=R.+Hauserauthor=M.+Morelliauthor=B.+B.+Fredholmauthor=J.+F.+Chen&title=Adenosine%2C+adenosine+A2A+antagonists%2C+and+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131dR"><div class="casContent"><span class="casTitleNuber">131d</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine, adenosine A 2A antagonists, and Parkinson's disease</span></div><div class="casAuthors">Jenner P; Mori A; Hauser R; Morelli M; Fredholm B B; Chen J F</div><div class="citationInfo"><span class="NLM_cas:title">Parkinsonism & related disorders</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">406-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Adenosine derived from the degradation of ATP/AMP functions as a signalling molecule in the nervous system through the occupation of A1, A2, and A3 adenosine receptors.  Adenosine A(2A) receptors have a selective localization to the basal ganglia and specifically to the indirect output pathway, and as a consequence offer a unique opportunity to modulate the output from the striatum that is believed critical to the occurrence of motor components of PD.  Indeed, the ability of A(2A) antagonists to modulate basal ganglia neurotransmission has been shown to be associated with improved motor function in experimental models of PD.  This suggests that A(2A) antagonists would be effective as a symptomatic treatment in humans without provoking marked dyskinesia.  Indeed, the A(2A) antagonist istradefylline reduces OFF time in moderate- to late-stage patients with PD already receiving dopaminergic therapy, with an increase in non-troublesome dyskinesia.  Adenosine and adenosine receptors also exert actions relevant to pathogenesis in PD, raising the possibility of their use as neuroprotective agents.  Both epidemiologic evidence and the current preclinical data strongly support a role for A(2A) antagonists in protecting dopaminergic neurons and influencing the onset and progression of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQsdd-F41SVOmBAiYWy6n3SfW6udTcc2ebWH60eXvU17bntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvksVWnsg%253D%253D&md5=3c823d672ed66ea92ef6876eedf544a5</span></div><a href="/servlet/linkout?suffix=cit131d&amp;dbid=16384&amp;doi=10.1016%2Fj.parkreldis.2008.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.parkreldis.2008.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DHauser%26aufirst%3DR.%26aulast%3DMorelli%26aufirst%3DM.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26atitle%3DAdenosine%252C%2520adenosine%2520A2A%2520antagonists%252C%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2009%26volume%3D15%26spage%3D406%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit131e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">238</span><span class="NLM_x">â</span> <span class="NLM_lpage">263</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0682195" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=238-263&issue=1&author=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Gessiauthor=P.+A.+Borea&title=Adenosine+receptor+antagonists%3A+translating+medicinal+chemistry+and+pharmacology+into+clinical+utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131e&amp;dbid=16384&amp;doi=10.1021%2Fcr0682195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0682195%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520receptor%2520antagonists%253A%2520translating%2520medicinal%2520chemistry%2520and%2520pharmacology%2520into%2520clinical%2520utility%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26issue%3D1%26spage%3D238%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit131f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Muller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferre, S.</span><span> </span><span class="NLM_article-title">Blocking striatal adenosine A<sub>2A</sub> receptors: a new strategy basal ganglia disorder</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">21</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1-21&author=C.+E.+Mullerauthor=S.+Ferre&title=Blocking+striatal+adenosine+A2A+receptors%3A+a+new+strategy+basal+ganglia+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DC.%2BE.%26aulast%3DFerre%26aufirst%3DS.%26atitle%3DBlocking%2520striatal%2520adenosine%2520A2A%2520receptors%253A%2520a%2520new%2520strategy%2520basal%2520ganglia%2520disorder%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D1%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group">Jackson, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzer, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, F.</span><span> </span><span class="NLM_article-title">KF17837 is an A<sub>2</sub> adenosine receptor antagonist in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">â</span> <span class="NLM_lpage">1310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=8263794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKisr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1993&pages=1304-1310&author=E.+K.+Jacksonauthor=W.+A.+Herzerauthor=F.+Suzuki&title=KF17837+is+an+A2+adenosine+receptor+antagonist+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">KF17837 is an A2 adenosine receptor antagonist in vivo</span></div><div class="casAuthors">Jackson, Edwin K.; Herzer, William A.; Suzuki, Fumio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1304-10</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The goal of this study was to det. whether KF17837 (I) is a useful pharmacol. probe for investigating in the rat the in vivo physiol. roles of A2 adenosine receptors.  In anesthetized rats, bradycardic responses to N6-cyclopentyladenosine and hypotensive responses to 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamido adenosine (CGS21680C) were used to assess A1 receptor and A2 receptor activation, resp.  After obtaining control responses to N6-cyclopentyladenosine and CGS21680C, the rats received infusions of either vehicle or one of two dosage levels of KF17837, a compd. recently demonstrated to be a potent and selective A2 receptor antagonist in vitro.  KF17837 was infused for 4 h and, at various times during the infusions, bradycardic and hypotensive responses to N6-cyclopentyladenosine and CGS21680C, resp., were elicited.  Infusion of either 10 or 30 Î¼g kg-1 min-1 (2.4 or 7.4 mg kg-1 4 h-1) of KF17837 did not significantly affect the bradycardic responses to N6-cyclopentyladenosine.  By contrast, 10 Î¼g kg-1 min-1 of KF17837 attenuated and 30 Î¼g kg-1 min-1 of KF17837 nearly abolished hypotensive responses to CGS21680C.  In a second study, pretreatment with KF17837 (30 Î¼g kg-1 min-1) did not affect the hypotensive response to either PGI2 (3 Î¼g kg-1 min-1) or acetylcholine (100 Î¼g kg-1 min-1); however, it attenuated the hypotensive response to adenosine (300 Î¼g kg-1 min-1).  In a third study, hypotension was induced and maintained with an infusion of adenosine (300 Î¼g kg-1 min-1).  Subsequent initiation of an infusion of KF17837 (30 Î¼g kg-1 min-1) completely reversed the adenosine-induced hypotension.  This study suggests that in vivo KF17837 has relative selectivity for the A2 receptor and may be a useful pharmacol. probe for elucidating the role of endogenous adenosine-A2 receptor interactions in vivo in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN9ejyWlCCqrVg90H21EOLACvtfcHk0ljE67o545Yicw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKisr0%253D&md5=9477b07493ca01f4141bcfc0d1ecbb54</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DE.%2BK.%26aulast%3DHerzer%26aufirst%3DW.%2BA.%26aulast%3DSuzuki%26aufirst%3DF.%26atitle%3DKF17837%2520is%2520an%2520A2%2520adenosine%2520receptor%2520antagonist%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D267%26spage%3D1304%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, F.</span><span> </span><span class="NLM_article-title">Photoisomerization of a potent and selective adenosine A<sub>2</sub> antagonist, (<i>E</i>)-1,3-dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3731</span><span class="NLM_x">â</span> <span class="NLM_lpage">3733</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00075a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=3731-3733&author=Y.+Nonakaauthor=J.+Shimadaauthor=H.+Nonakaauthor=N.+Koikeauthor=N.+Aokiauthor=H.+Kobayashiauthor=H.+Kaseauthor=K.+Yamaguchiauthor=F.+Suzuki&title=Photoisomerization+of+a+potent+and+selective+adenosine+A2+antagonist%2C+%28E%29-1%2C3-dipropyl-8-%283%2C4-dimethoxystyryl%29-7-methylxanthine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fjm00075a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00075a031%26sid%3Dliteratum%253Aachs%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DKoike%26aufirst%3DN.%26aulast%3DAoki%26aufirst%3DN.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DKase%26aufirst%3DH.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DF.%26atitle%3DPhotoisomerization%2520of%2520a%2520potent%2520and%2520selective%2520adenosine%2520A2%2520antagonist%252C%2520%2528E%2529-1%252C3-dipropyl-8-%25283%252C4-dimethoxystyryl%2529-7-methylxanthine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D3731%26epage%3D3733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="note"><p class="first last">Representitive monocyclic core examples:</p></div><div class="NLM_citation" id="cit134a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alanine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anselm, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vifian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groaning, M. D.</span><span> </span><span class="NLM_article-title">Synthesis and SAR evaluation of 1,2,4-triazoles as A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">â</span> <span class="NLM_lpage">821</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=817-821&author=A.+Alanineauthor=L.+Anselmauthor=L.+Stewardauthor=S.+Thomiauthor=W.+Vifianauthor=M.+D.+Groaning&title=Synthesis+and+SAR+evaluation+of+1%2C2%2C4-triazoles+as+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlanine%26aufirst%3DA.%26aulast%3DAnselm%26aufirst%3DL.%26aulast%3DSteward%26aufirst%3DL.%26aulast%3DThomi%26aufirst%3DS.%26aulast%3DVifian%26aufirst%3DW.%26aulast%3DGroaning%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520and%2520SAR%2520evaluation%2520of%25201%252C2%252C4-triazoles%2520as%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D817%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit134b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Richardson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellwood, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span> </span><span class="NLM_article-title">Identification of non-furan containing A<sub>2A</sub> antagonists using databasemining and molecular similarity approaches</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5993</span><span class="NLM_x">â</span> <span class="NLM_lpage">5997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5993-5997&author=C.+M.+Richardsonauthor=R.+J.+Gillespieauthor=D.+S.+Williamsonauthor=A.+M.+Jordanauthor=A.+Finkauthor=A.+R.+Knightauthor=D.+W.+Sellwoodauthor=A.+Misra&title=Identification+of+non-furan+containing+A2A+antagonists+using+databasemining+and+molecular+similarity+approaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DC.%2BM.%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DKnight%26aufirst%3DA.%2BR.%26aulast%3DSellwood%26aufirst%3DD.%2BW.%26aulast%3DMisra%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520non-furan%2520containing%2520A2A%2520antagonists%2520using%2520databasemining%2520and%2520molecular%2520similarity%2520approaches%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5993%26epage%3D5997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit134c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sams, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torup, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang-Andersen, B.</span><span> </span><span class="NLM_article-title">Hit-to-lead optimization of a series of carboxamides of ethyl 2-amino-4-phenylthiazole-5-carboxylates as novel adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">â</span> <span class="NLM_lpage">5244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5241-5244&author=A.+G.+Samsauthor=G.+K.+Mikkelsenauthor=M.+Larsenauthor=L.+Torupauthor=L.+T.+Brennumauthor=T.+J.+Schroderauthor=B.+Bang-Andersen&title=Hit-to-lead+optimization+of+a+series+of+carboxamides+of+ethyl+2-amino-4-phenylthiazole-5-carboxylates+as+novel+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSams%26aufirst%3DA.%2BG.%26aulast%3DMikkelsen%26aufirst%3DG.%2BK.%26aulast%3DLarsen%26aufirst%3DM.%26aulast%3DTorup%26aufirst%3DL.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DSchroder%26aufirst%3DT.%2BJ.%26aulast%3DBang-Andersen%26aufirst%3DB.%26atitle%3DHit-to-lead%2520optimization%2520of%2520a%2520series%2520of%2520carboxamides%2520of%2520ethyl%25202-amino-4-phenylthiazole-5-carboxylates%2520as%2520novel%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5241%26epage%3D5244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="note"><p class="first last">Representative bicyclic core examples:</p></div><div class="NLM_citation" id="cit135a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Manera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannaccini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccomanni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraini, P. L.</span><span> </span><span class="NLM_article-title">1,8-Naphthyridine-4-one derivatives as new ligands of A<sub>2A</sub> adenosine receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4604</span><span class="NLM_x">â</span> <span class="NLM_lpage">4610</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4604-4610&author=C.+Maneraauthor=L.+Bettiauthor=T.+Cavalliniauthor=G.+Giannacciniauthor=A.+Martinelliauthor=G.+Ortoreauthor=G.+Saccomanniauthor=L.+Trincavelliauthor=T.+Tuccinardiauthor=P.+L.+Ferraini&title=1%2C8-Naphthyridine-4-one+derivatives+as+new+ligands+of+A2A+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManera%26aufirst%3DC.%26aulast%3DBetti%26aufirst%3DL.%26aulast%3DCavallini%26aufirst%3DT.%26aulast%3DGiannaccini%26aufirst%3DG.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DOrtore%26aufirst%3DG.%26aulast%3DSaccomanni%26aufirst%3DG.%26aulast%3DTrincavelli%26aufirst%3DL.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DFerraini%26aufirst%3DP.%2BL.%26atitle%3D1%252C8-Naphthyridine-4-one%2520derivatives%2520as%2520new%2520ligands%2520of%2520A2A%2520adenosine%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4604%26epage%3D4610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit135b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smits, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phadke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span> </span><span class="NLM_article-title">Novel diaminoderivatives of [1,2,4]triazolo[1,5-<i>a</i>][1,3,5]triazine as potent and selective adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2009</span><span class="NLM_x">â</span> <span class="NLM_lpage">2018</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0498396" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2009-2018&author=C.+B.+Vuauthor=D.+Panauthor=B.+Pengauthor=G.+Kumaravelauthor=G.+Smitsauthor=X.+Jinauthor=D.+Phadkeauthor=T.+Engberauthor=C.+Huangauthor=J.+Reillyauthor=S.+Tamauthor=D.+Grantauthor=G.+Hetuauthor=R.+C.+Petter&title=Novel+diaminoderivatives+of+%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5D%5B1%2C3%2C5%5Dtriazine+as+potent+and+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135b&amp;dbid=16384&amp;doi=10.1021%2Fjm0498396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0498396%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DC.%2BB.%26aulast%3DPan%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DSmits%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DPhadke%26aufirst%3DD.%26aulast%3DEngber%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DReilly%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DGrant%26aufirst%3DD.%26aulast%3DHetu%26aufirst%3DG.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26atitle%3DNovel%2520diaminoderivatives%2520of%2520%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255D%255B1%252C3%252C5%255Dtriazine%2520as%2520potent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2009%26epage%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit135c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Holschbach, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuesgen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wutz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sihver, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coenen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R. A.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 7-amino-2-(2(3)-furyl)-5-phenylethylamino-oxazolo[5,4-<i>d</i>]pyrimidines as potential A<sub>2A</sub> adenosine receptor antagonists for positron emission tomography (PET)</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">â</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=7-15&author=M.+H.+Holschbachauthor=D.+Bierauthor=S.+Stuesgenauthor=W.+Wutzauthor=W.+Sihverauthor=H.+H.+Coenenauthor=R.+A.+Olsson&title=Synthesis+and+evaluation+of+7-amino-2-%282%283%29-furyl%29-5-phenylethylamino-oxazolo%5B5%2C4-d%5Dpyrimidines+as+potential+A2A+adenosine+receptor+antagonists+for+positron+emission+tomography+%28PET%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolschbach%26aufirst%3DM.%2BH.%26aulast%3DBier%26aufirst%3DD.%26aulast%3DStuesgen%26aufirst%3DS.%26aulast%3DWutz%26aufirst%3DW.%26aulast%3DSihver%26aufirst%3DW.%26aulast%3DCoenen%26aufirst%3DH.%2BH.%26aulast%3DOlsson%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25207-amino-2-%25282%25283%2529-furyl%2529-5-phenylethylamino-oxazolo%255B5%252C4-d%255Dpyrimidines%2520as%2520potential%2520A2A%2520adenosine%2520receptor%2520antagonists%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D7%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit135d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccioni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachare, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title">8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A<sub>2A</sub> and A<sub>2B</sub> receptors ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2812</span><span class="NLM_x">â</span> <span class="NLM_lpage">2822</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2812-2822&author=C.+Lambertucciauthor=I.+Antoniniauthor=M.+Buccioniauthor=D.+Dal+Benauthor=D.+D.+Kachareauthor=R.+Volpiniauthor=K.-N.+Klotzauthor=G.+Cristalli&title=8-Bromo-9-alkyl+adenine+derivatives+as+tools+for+developing+new+adenosine+A2A+and+A2B+receptors+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DAntonini%26aufirst%3DI.%26aulast%3DBuccioni%26aufirst%3DM.%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DKachare%26aufirst%3DD.%2BD.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3D8-Bromo-9-alkyl%2520adenine%2520derivatives%2520as%2520tools%2520for%2520developing%2520new%2520adenosine%2520A2A%2520and%2520A2B%2520receptors%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2812%26epage%3D2822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="note"><p class="first last">Representative tricyclic core examples:</p></div><div class="NLM_citation" id="cit136a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moorman, A. R.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> Receptor Antagonists</span>. PCT Int. Appl. WO2008121748,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=A.+R.+Moorman&title=Adenosine+A2A+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26atitle%3DAdenosine%2520A2A%2520Receptor%2520Antagonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit136b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of A<sub>2A</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">â</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.2174%2F1568026033392183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=12570758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGisg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=403-411&author=B.+Cacciariauthor=G.+Pastorinauthor=G.+Spalluto&title=Medicinal+chemistry+of+A2A+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136bR"><div class="casContent"><span class="casTitleNuber">136b</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of A2A adenosine receptor antagonists</span></div><div class="casAuthors">Cacciari, Barbara; Pastorin, Giorgia; Spalluto, Giampiero</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-411</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Due to the clearly demonstrated receptor-receptor interaction between adenosine A2A and dopamine D2 receptors in the basal ganglia, the discovery and development of potent and selective A2A adenosine receptor antagonists became, in the last ten years, an attractive field of research to discovery new drugs for the treatment of neurodegenerative disorders, such as Parkinsons disease.  Different compds. have been deeply investigated as A2A adenosine receptor antagonists, which could be classified in two great families: xanthine derivs. and nitrogen polyheterocyclic systems.  These studies led to the discovery of some highly potent and selective A2A adenosine receptor antagonists such as ZM241385, SCH58261 and some xanthine derivs. (KW6002), which have been used as pharmacol. tools for studying this receptor subtype.  However, those compds. showed some problems that do not permit their use in clin. studies, such as poor water soly. (SCH58261, and xanthine derivs.) or good affinity for A2B adenosine receptor subtype (ZM241385).  In the last few years great efforts have been made to overcome these problems, trying to optimize not only the pharmacol. profile but also the pharmacokinetic character of this class of compds.  The aim of this report is to briefly summarize the recent progress made in this attractive field of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Js9jSgCJ7LVg90H21EOLACvtfcHk0ljj3sDew1_tAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGisg%253D%253D&md5=28a5cf572c5400ec56ab33b2120e717f</span></div><a href="/servlet/linkout?suffix=cit136b&amp;dbid=16384&amp;doi=10.2174%2F1568026033392183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392183%26sid%3Dliteratum%253Aachs%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DPastorin%26aufirst%3DG.%26aulast%3DSpalluto%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520A2A%2520adenosine%2520receptor%2520antagonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D403%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit136c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teran, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadavid, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segarra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotelo, E.</span><span> </span><span class="NLM_article-title">Synthesis, adenosine receptor binding and 3D-QSAR of 4-ubstituted 2-(2â²-furyl)-1,2,4-triazolo[1,5-<i>a</i>]quinoxalines</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2103</span><span class="NLM_x">â</span> <span class="NLM_lpage">2113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2103-2113&author=A.+Martinezauthor=H.+G.+Teranauthor=J.+Breaauthor=E.+Ravinaauthor=M.+I.+Lozaauthor=M.+I.+Cadavidauthor=F.+Sanzauthor=B.+Vidalauthor=V.+Segarraauthor=E.+Sotelo&title=Synthesis%2C+adenosine+receptor+binding+and+3D-QSAR+of+4-ubstituted+2-%282%E2%80%B2-furyl%29-1%2C2%2C4-triazolo%5B1%2C5-a%5Dquinoxalines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DTeran%26aufirst%3DH.%2BG.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DRavina%26aufirst%3DE.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DSanz%26aufirst%3DF.%26aulast%3DVidal%26aufirst%3DB.%26aulast%3DSegarra%26aufirst%3DV.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DSynthesis%252C%2520adenosine%2520receptor%2520binding%2520and%25203D-QSAR%2520of%25204-ubstituted%25202-%25282%25E2%2580%25B2-furyl%2529-1%252C2%252C4-triazolo%255B1%252C5-a%255Dquinoxalines%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D2103%26epage%3D2113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group">Maemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahane, A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of FR194921, a new potent, selective, and orally active antagonist for central adenosine A<sub>1</sub> receptors</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">â</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1254%2Fjphs.FP0040359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=15351792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFyjs78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2004&pages=42-52&author=T.+Maemotoauthor=M.+Tadaauthor=T.+Miharaauthor=N.+Ueyamaauthor=H.+Matsuokaauthor=K.+Haradaauthor=T.+Yamajiauthor=K.+Shirakawaauthor=S.+Kurodaauthor=A.+Akahane&title=Pharmacological+characterization+of+FR194921%2C+a+new+potent%2C+selective%2C+and+orally+active+antagonist+for+central+adenosine+A1+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of FR194921, a new potent, selective, and orally active antagonist for central adenosine A1 receptors</span></div><div class="casAuthors">Maemoto, Takuya; Tada, Miho; Mihara, Takuma; Ueyama, Noriko; Matsuoka, Hideaki; Harada, Katsuya; Yamaji, Takayuki; Shirakawa, Kiyoharu; Kuroda, Satoru; Akahane, Atsushi; Iwashita, Akinori; Matsuoka, Nobuya; Mutoh, Seitaro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-52</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Adenosine A1 receptors in the brain are believed to play an important role in brain functioning.  We have discovered a novel adenosine A1 receptor antagonist, FR194921 (2-(1-methyl-4-piperidinyl)-6-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-3(2H)-pyridazinone), and characterized the pharmacol. activity in the present study.  FR194921 showed potent and selective affinity for the adenosine A1 receptor without affinity for A2A and A3 receptors and did not show any species differences in binding affinity profile among human, rat, and mouse.  Pharmacokinetic study in rats revealed that FR194921 was orally active and highly brain penetrable.  Oral administration of FR194921 dose-dependently ameliorated the hypolocomotion induced by the A1 receptor agonist N6-cyclopentyladenosine in rats, indicating this compd. exerts A1-antagonistic action in vivo.  In the passive avoidance test, scopolamine (1 mg/kg)-induced memory deficits were significantly ameliorated by FR194921 (0.32, 1 mg/kg).  In two animal models of anxiety, the social interaction test and elevated plus maze, FR194921 showed specific anxiolytic activity without significantly influencing general behavior.  In contrast, FR194921 did not show antidepressant activity even at a dose of 32 mg/kg in the rat forced swimming test.  These results indicate that the novel, potent, and selective adenosine A1 receptor antagonist FR194921 exerts both cognitive-enhancing and anxiolytic activity, suggesting the therapeutic potential of this compd. for dementia and anxiety disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpor8cuLg5xVrVg90H21EOLACvtfcHk0ljj3sDew1_tAQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFyjs78%253D&md5=1828b4e7afe4c25a61aa0fa094f64c38</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FP0040359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FP0040359%26sid%3Dliteratum%253Aachs%26aulast%3DMaemoto%26aufirst%3DT.%26aulast%3DTada%26aufirst%3DM.%26aulast%3DMihara%26aufirst%3DT.%26aulast%3DUeyama%26aufirst%3DN.%26aulast%3DMatsuoka%26aufirst%3DH.%26aulast%3DHarada%26aufirst%3DK.%26aulast%3DYamaji%26aufirst%3DT.%26aulast%3DShirakawa%26aufirst%3DK.%26aulast%3DKuroda%26aufirst%3DS.%26aulast%3DAkahane%26aufirst%3DA.%26atitle%3DPharmacological%2520characterization%2520of%2520FR194921%252C%2520a%2520new%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520antagonist%2520for%2520central%2520adenosine%2520A1%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D96%26spage%3D42%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupert, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heintzelman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullington, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">In vivo characterization of a dual adenosine A<sub>2A</sub>/A<sub>1</sub> receptor antagonist in animal models of Parkinsonâs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8104</span><span class="NLM_x">â</span> <span class="NLM_lpage">8115</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100971t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8104-8115&author=B.+C.+Shookauthor=S.+Rassnickauthor=M.+C.+Osborneauthor=S.+Davisauthor=L.+Westoverauthor=J.+Bouletauthor=D.+Hallauthor=K.+C.+Rupertauthor=G.+R.+Heintzelmanauthor=K.+Hansenauthor=D.+Chakravartyauthor=J.+L.+Bullingtonauthor=R.+Russellauthor=S.+Branumauthor=K.+M.+Wellsauthor=S.+Damonauthor=S.+Youellsauthor=X.+Liauthor=D.+A.+Beauchampauthor=D.+Palmerauthor=M.+Reyesauthor=K.+Demarestauthor=Y.-T.+Tangauthor=K.+Rhodesauthor=P.+F.+Jackson&title=In+vivo+characterization+of+a+dual+adenosine+A2A%2FA1+receptor+antagonist+in+animal+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm100971t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100971t%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DOsborne%26aufirst%3DM.%2BC.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DBoulet%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHeintzelman%26aufirst%3DG.%2BR.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DBullington%26aufirst%3DJ.%2BL.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBranum%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DK.%2BM.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DYouells%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBeauchamp%26aufirst%3DD.%2BA.%26aulast%3DPalmer%26aufirst%3DD.%26aulast%3DReyes%26aufirst%3DM.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DY.-T.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DIn%2520vivo%2520characterization%2520of%2520a%2520dual%2520adenosine%2520A2A%252FA1%2520receptor%2520antagonist%2520in%2520animal%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8104%26epage%3D8115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group">Shah, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowics, J. E.</span><span> </span><span class="NLM_article-title">Biaryl and heteroaryl derivatives of SCH58261 as potent and selective adenosine A<sub>2A</sub> receptor antagonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4199</span><span class="NLM_x">â</span> <span class="NLM_lpage">4203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4199-4203&issue=14&author=U.+Shahauthor=C.+D.+Boyleauthor=S.+Chackalamannilauthor=B.+R.+Neustadtauthor=N.+Lindoauthor=W.+J.+Greenleeauthor=C.+Fosterauthor=L.+Arikauthor=Y.+Zhaiauthor=K.+Ngauthor=S.+Wangauthor=A.+Monopoliauthor=J.+E.+Lachowics&title=Biaryl+and+heteroaryl+derivatives+of+SCH58261+as+potent+and+selective+adenosine+A2A+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DU.%26aulast%3DBoyle%26aufirst%3DC.%2BD.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DLindo%26aufirst%3DN.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DArik%26aufirst%3DL.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DNg%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DLachowics%26aufirst%3DJ.%2BE.%26atitle%3DBiaryl%2520and%2520heteroaryl%2520derivatives%2520of%2520SCH58261%2520as%2520potent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D14%26spage%3D4199%26epage%3D4203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, K.-I.</span><span> </span><span class="NLM_article-title">Potent, selective and orally active adenosine A<sub>2A</sub> receptor antagonist: arylpiperazine derivatives of pyrazolo[4,3-<i>e</i>]-1,2,4-triazolo[1,5-<i>c</i>]pyrimidines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1376</span><span class="NLM_x">â</span> <span class="NLM_lpage">1380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1376-1380&issue=5&author=B.+R.+Neustadtauthor=J.+Haoauthor=N.+Lindoauthor=W.+J.+Greenleeauthor=A.+W.+Stamfordauthor=D.+Tulshianauthor=E.+Onginiauthor=J.+Hunterauthor=A.+Monopoliauthor=R.+Berorelliauthor=C.+Fosterauthor=L.+Arikauthor=J.+Lachowiczauthor=K.+Ngauthor=K.-I.+Feng&title=Potent%2C+selective+and+orally+active+adenosine+A2A+receptor+antagonist%3A+arylpiperazine+derivatives+of+pyrazolo%5B4%2C3-e%5D-1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DLindo%26aufirst%3DN.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DTulshian%26aufirst%3DD.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DHunter%26aufirst%3DJ.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DBerorelli%26aufirst%3DR.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DArik%26aufirst%3DL.%26aulast%3DLachowicz%26aufirst%3DJ.%26aulast%3DNg%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DK.-I.%26atitle%3DPotent%252C%2520selective%2520and%2520orally%2520active%2520adenosine%2520A2A%2520receptor%2520antagonist%253A%2520arylpiperazine%2520derivatives%2520of%2520pyrazolo%255B4%252C3-e%255D-1%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D5%26spage%3D1376%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group">Hodgson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forlani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredduzzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Impagnatiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolussi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span> </span><span class="NLM_article-title">Characterization of the potent and highly selective A<sub>2A</sub> receptor antagonists preladenant and SCH412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7<i>H</i>-pyrazolo[4,3-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidin-5-amine] in rodent models of movement disorders and depression</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">294</span><span class="NLM_x">â</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1124%2Fjpet.108.149617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=19332567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFeluro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=294-303&issue=1&author=R.+A.+Hodgsonauthor=R.+Bertorelliauthor=G.+B.+Vartyauthor=J.+E.+Lachowiczauthor=A.+Forlaniauthor=S.+Fredduzziauthor=M.+E.+Cohen-Williamsauthor=G.+A.+Higginsauthor=F.+Impagnatielloauthor=E.+Nicolussiauthor=L.+E.+Parraauthor=C.+Fosterauthor=Y.+Zhaiauthor=B.+R.+Neustadtauthor=A.+W.+Stamfordauthor=E.+M.+Parkerauthor=A.+Reggianiauthor=J.+C.+Hunter&title=Characterization+of+the+potent+and+highly+selective+A2A+receptor+antagonists+preladenant+and+SCH412348+%5B7-%5B2-%5B4-2%2C4-difluorophenyl%5D-1-piperazinyl%5Dethyl%5D-2-%282-furanyl%29-7H-pyrazolo%5B4%2C3-e%5D%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-c%5Dpyrimidin-5-amine%5D+in+rodent+models+of+movement+disorders+and+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression</span></div><div class="casAuthors">Hodgson, Robert A.; Bertorelli, Rosalia; Varty, Geoffrey B.; Lachowicz, Jean E.; Forlani, Angelo; Fredduzzi, Silva; Cohen-Williams, Mary E.; Higgins, Guy A.; Impagnatiello, Francesco; Nicolussi, Elisa; Parra, Leonard E.; Foster, Carolyn; Zhai, Ying; Neustadt, Bernie R.; Stamford, Andrew W.; Parker, Eric M.; Reggiani, Angelo; Hunter, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">294-303</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The adenosine A2A receptor has been implicated in the underlying biol. of various neurol. and psychiatric disorders, including Parkinson's disease (PD) and depression.  Preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] are potent competitive antagonists of the human A2A receptor (Ki = 1.1 and 0.6 nM, resp.) and have > 1000-fold selectivity over all other adenosine receptors, making these compds. the most selective A2A receptor antagonists reported to date.  Both compds. attenuate hypolocomotion induced by the A2A receptor agonist CGS-21680 [2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine], suggesting that they inhibit A2A receptor activity in vivo.  Their high degree of selectivity and robust in vivo activity make preladenant and SCH 412348 useful tools to investigate the role of the A2A receptor system in animal models of PD and depression.  Oral administration of preladenant and SCH 412348 (0.1-1 mg/kg) to rats potentiated 3,4-dihydroxy-L-phenylalanine (L-Dopa)-induced contralateral rotations after 6-hydroxydopamine lesions in the medial forebrain bundle and potently attenuated the cataleptic effects of haloperidol.  Preladenant (1 mg/kg) inhibited L-Dopa-induced behavioral sensitization after repeated daily administration, which suggests a reduced risk of the development of dyskinesias.  Finally, preladenant and SCH 412348 exhibited antidepressant-like profiles in models of behavioral despair, namely the mouse tail suspension test and the mouse and rat forced swim test.  These studies demonstrate that preladenant and SCH 412348 are potent and selective A2A receptor antagonists and provide further evidence of the potential therapeutic benefits of A2A receptor inhibition in PD (with reduced risk of dyskinesias) and depression (one of the primary nonmotor symptoms of PD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNkJMOfNlLc7Vg90H21EOLACvtfcHk0li2EfsuRBkJ-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFeluro%253D&md5=b8ce809c2d57a994d201ecca4daa39a3</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.149617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.149617%26sid%3Dliteratum%253Aachs%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DVarty%26aufirst%3DG.%2BB.%26aulast%3DLachowicz%26aufirst%3DJ.%2BE.%26aulast%3DForlani%26aufirst%3DA.%26aulast%3DFredduzzi%26aufirst%3DS.%26aulast%3DCohen-Williams%26aufirst%3DM.%2BE.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DImpagnatiello%26aufirst%3DF.%26aulast%3DNicolussi%26aufirst%3DE.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26atitle%3DCharacterization%2520of%2520the%2520potent%2520and%2520highly%2520selective%2520A2A%2520receptor%2520antagonists%2520preladenant%2520and%2520SCH412348%2520%255B7-%255B2-%255B4-2%252C4-difluorophenyl%255D-1-piperazinyl%255Dethyl%255D-2-%25282-furanyl%2529-7H-pyrazolo%255B4%252C3-e%255D%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-c%255Dpyrimidin-5-amine%255D%2520in%2520rodent%2520models%2520of%2520movement%2520disorders%2520and%2520depression%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26issue%3D1%26spage%3D294%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span>Thomson Reuters Pharma. <a href="https://www.thomson-pharma.com/portal/page/portal/Popups/NEWS%20ARTICLE%20DETAILS?_dummy=&#xA;y&amp;referenceid=1427557&amp;dbsource=Iddb" class="extLink">https://www.thomson-pharma.com/portal/page/portal/Popups/NEWS%20ARTICLE%20DETAILS?_dummy= y&referenceid=1427557&dbsource=Iddb</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomson+Reuters+Pharma.+https%3A%2F%2Fwww.thomson-pharma.com%2Fportal%2Fpage%2Fportal%2FPopups%2FNEWS%2520ARTICLE%2520DETAILS%3F_dummy%3D+y%26referenceid%3D1427557%26dbsource%3DIddb."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group">Silverman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiselgof, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matasi, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">3H-[1,2,4]-triazolo[5,1-<i>i</i>]purin-5-amine derivatives as adenosine A<sub>2A</sub> antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1659</span><span class="NLM_x">â</span> <span class="NLM_lpage">1662</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1659-1662&issue=6&author=L.+S.+Silvermanauthor=J.+P.+Caldwellauthor=W.+J.+Greenleeauthor=E.+Kiselgofauthor=J.+J.+Matasiauthor=D.+B.+Tulshianauthor=L.+Arikauthor=C.+Fosterauthor=R.+Bertorelliauthor=A.+Monopoliauthor=E.+Ongini&title=3H-%5B1%2C2%2C4%5D-triazolo%5B5%2C1-i%5Dpurin-5-amine+derivatives+as+adenosine+A2A+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DL.%2BS.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DKiselgof%26aufirst%3DE.%26aulast%3DMatasi%26aufirst%3DJ.%2BJ.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DArik%26aufirst%3DL.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3D3H-%255B1%252C2%252C4%255D-triazolo%255B5%252C1-i%255Dpurin-5-amine%2520derivatives%2520as%2520adenosine%2520A2A%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D6%26spage%3D1659%26epage%3D1662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group">Shah, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lankin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J. E.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluations of fused heterocyclic analogs of SCH58261 as adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4204</span><span class="NLM_x">â</span> <span class="NLM_lpage">4209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4204-4209&issue=14&author=U.+Shahauthor=C.+M.+Lankinauthor=C.+D.+Boyleauthor=S.+Chackalamannilauthor=W.+J.+Greenleeauthor=B.+R.+Neustadtauthor=M.+E.+Cohen-Williamsauthor=G.+A.+higginsauthor=K.+Ngauthor=G.+B.+Vartyauthor=H.+Zhangauthor=J.+E.+Lachowicz&title=Design%2C+synthesis%2C+and+evaluations+of+fused+heterocyclic+analogs+of+SCH58261+as+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DU.%26aulast%3DLankin%26aufirst%3DC.%2BM.%26aulast%3DBoyle%26aufirst%3DC.%2BD.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DCohen-Williams%26aufirst%3DM.%2BE.%26aulast%3Dhiggins%26aufirst%3DG.%2BA.%26aulast%3DNg%26aufirst%3DK.%26aulast%3DVarty%26aufirst%3DG.%2BB.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLachowicz%26aufirst%3DJ.%2BE.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluations%2520of%2520fused%2520heterocyclic%2520analogs%2520of%2520SCH58261%2520as%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D14%26spage%3D4204%26epage%3D4209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredduzzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span> </span><span class="NLM_article-title">Potent and selective adenosine A<sub>2A</sub> receptor antagonists: 1,2,4-triazolo[1,5-<i>c</i>]pyrimidines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">â</span> <span class="NLM_lpage">971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=967-971&author=B.+R.+Neustadtauthor=H.+Liuauthor=J.+Haoauthor=W.+J.+Greenleeauthor=A.+Stamfordauthor=C.+Fosterauthor=L.+Arikauthor=J.+Lachowiczauthor=H.+Zhangauthor=R.+Bertorelliauthor=S.+Fredduzziauthor=G.+Vartyauthor=M.+Cohen-Williamsauthor=K.+Ng&title=Potent+and+selective+adenosine+A2A+receptor+antagonists%3A+1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DArik%26aufirst%3DL.%26aulast%3DLachowicz%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DFredduzzi%26aufirst%3DS.%26aulast%3DVarty%26aufirst%3DG.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DNg%26aufirst%3DK.%26atitle%3DPotent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%253A%25201%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D967%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group">Harris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">lachowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Potent and selective adenosine A<sub>2A</sub> receptor antagonists: [1,2,4]-triazolo[4,3-<i>c</i>]pyrimidin-3-ones</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2497</span><span class="NLM_x">â</span> <span class="NLM_lpage">2501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2497-2501&author=J.+M.+Harrisauthor=B.+R.+Neustadtauthor=H.+Zhangauthor=J.+lachowiczauthor=M.+Cohen-Williamsauthor=G.+Vartyauthor=J.+Haoauthor=A.+W.+Stamford&title=Potent+and+selective+adenosine+A2A+receptor+antagonists%3A+%5B1%2C2%2C4%5D-triazolo%5B4%2C3-c%5Dpyrimidin-3-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DJ.%2BM.%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3Dlachowicz%26aufirst%3DJ.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DVarty%26aufirst%3DG.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DPotent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%253A%2520%255B1%252C2%252C4%255D-triazolo%255B4%252C3-c%255Dpyrimidin-3-ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D21%26spage%3D2497%26epage%3D2501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group">Vu, C. B.</span><span> </span><span class="NLM_article-title">Recent advances in the design and optimization of adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">458</span><span class="NLM_x">â</span> <span class="NLM_lpage">468</span><div class="note"><p class="first last">and references therein.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=458-468&issue=4&author=C.+B.+Vu&title=Recent+advances+in+the+design+and+optimization+of+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DC.%2BB.%26atitle%3DRecent%2520advances%2520in%2520the%2520design%2520and%2520optimization%2520of%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2005%26volume%3D8%26issue%3D4%26spage%3D458%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group">Norcross, R. D.</span><span> </span><span class="NLM_article-title">Benzoxazole Derivatives and Their Use as Adenosine Receptor Ligands</span>. PCT Int. Appl. WO2004063177,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+D.+Norcross&title=Benzoxazole+Derivatives+and+Their+Use+as+Adenosine+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNorcross%26aufirst%3DR.%2BD.%26atitle%3DBenzoxazole%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Adenosine%2520Receptor%2520Ligands%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group">Norcross, R. D.</span><span> </span><span class="NLM_article-title">Thiazolopyridine</span>. U.S. Pat. Appl. Publ. US20050065151,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+D.+Norcross&title=Thiazolopyridine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNorcross%26aufirst%3DR.%2BD.%26atitle%3DThiazolopyridine%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group">Flohr, A.; Moreau, J.-L.; Poli, S. M.; Riemer, C.; Steward, L.</span><span> </span><span class="NLM_article-title">4-Hydroxy-4-methyl-piperidine-1-carboxylic Acid (4-Methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide</span>. U.S. Pat. Appl. Publ. US20050261289 A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+Flohr&author=J.-L.+Moreau&author=S.+M.+Poli&author=C.+Riemer&author=L.+Steward&title=4-Hydroxy-4-methyl-piperidine-1-carboxylic+Acid+%284-Methoxy-7-morpholin-4-yl-benzothiazol-2-yl%29-amide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFlohr%26aufirst%3DA.%26atitle%3D4-Hydroxy-4-methyl-piperidine-1-carboxylic%2520Acid%2520%25284-Methoxy-7-morpholin-4-yl-benzothiazol-2-yl%2529-amide%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group">Woiwode, T.; Moran, M.</span><span> </span><span class="NLM_article-title">4-Hydroxy-4-methyl-piperidine-1-carboxylic Acid (4-Methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide for the Treatment of Post-Traumatic Stress Disorder</span>. PCT Int. Appl. WO2009015236 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=T.+Woiwode&author=M.+Moran&title=4-Hydroxy-4-methyl-piperidine-1-carboxylic+Acid+%284-Methoxy-7-morpholin-4-yl-benzothiazol-2-yl%29-amide+for+the+Treatment+of+Post-Traumatic+Stress+Disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWoiwode%26aufirst%3DT.%26atitle%3D4-Hydroxy-4-methyl-piperidine-1-carboxylic%2520Acid%2520%25284-Methoxy-7-morpholin-4-yl-benzothiazol-2-yl%2529-amide%2520for%2520the%2520Treatment%2520of%2520Post-Traumatic%2520Stress%2520Disorder%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span>Biotie Therapies: Biotieâs Tozadenant (SYN115) Meets Primary and Multiple Secondary Endpoints in Phase 2b Study in Parkinsonâs Disease. Press Release, December 11,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Biotie+Therapies%3A+Biotie%E2%80%99s+Tozadenant+%28SYN115%29+Meets+Primary+and+Multiple+Secondary+Endpoints+in+Phase+2b+Study+in+Parkinson%E2%80%99s+Disease.+Press+Release%2C+December+11%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group">Weiss, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benwell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerpiniere, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dourish, C. T.</span><span> </span><span class="NLM_article-title">Discovery of nonxanthine adenosine A<sub>2A</sub> receptor antagonists for the treatment of Parkinsonâs disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">S101</span><span class="NLM_x">â</span> <span class="NLM_lpage">S106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=S101-S106&author=S.+M.+Weissauthor=K.+Benwellauthor=I.+A.+Cliffeauthor=R.+J.+Gillespieauthor=A.+R.+Knightauthor=J.+Lerpiniereauthor=A.+Misraauthor=R.+M.+Prattauthor=D.+Revellauthor=R.+Uptonauthor=C.+T.+Dourish&title=Discovery+of+nonxanthine+adenosine+A2A+receptor+antagonists+for+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DS.%2BM.%26aulast%3DBenwell%26aufirst%3DK.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26aulast%3DKnight%26aufirst%3DA.%2BR.%26aulast%3DLerpiniere%26aufirst%3DJ.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DPratt%26aufirst%3DR.%2BM.%26aulast%3DRevell%26aufirst%3DD.%26aulast%3DUpton%26aufirst%3DR.%26aulast%3DDourish%26aufirst%3DC.%2BT.%26atitle%3DDiscovery%2520of%2520nonxanthine%2520adenosine%2520A2A%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3DS101%26epage%3DS106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soohoo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soelaiman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabiocki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shryock, J. C.</span><span> </span><span class="NLM_article-title">Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Naunyn-Schmiedebergâs Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">â</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2Fs00210-007-0135-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=17310264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVamurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2007&pages=133-144&author=M.+Yangauthor=D.+Soohooauthor=S.+Soelaimanauthor=R.+Kallaauthor=J.+Zabiockiauthor=N.+Chuauthor=K.+Leungauthor=L.+Yaoauthor=I.+Diamondauthor=L.+Belardinelliauthor=J.+C.+Shryock&title=Characterization+of+the+potency%2C+selectivity%2C+and+pharmacokinetic+profile+for+six+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists</span></div><div class="casAuthors">Yang, Ming; Soohoo, Daniel; Soelaiman, Sandriyana; Kalla, Rao; Zablocki, Jeff; Chu, Nancy; Leung, Kwan; Yao, Lina; Diamond, Ivan; Belardinelli, Luiz; Shryock, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">375</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-144</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Antagonists of adenosine A2A receptors (A2A-antagonists) with different chem. structures have been developed by several pharmaceutical companies for the potential treatment of Parkinson's disease.  Pharmacol. characterization of these antagonists was incomplete, and different assay conditions were used in different labs.  Therefore, we characterized the potencies, selectivities, and pharmacokinetic profiles of six prototypical A2A-antagonists.  Displacements of [3H]MSX-2 and of [3H]CGS21680 binding to the human cloned and rat A2A receptors were performed.  The rank order of potency of antagonists to displace [3H]MSX-2 binding to the human A2A was SCH58261 â¥ Biogen-34 â¥ Ver-6623 â¥ MSX-2 > KW-6002 > > DMPX.  For the rat striatal A2A, the order of potency was Biogen-34 â¥ SCH58261 â¥ Ver-6623 â¥ MSX-2 â¥ KW-6002 > > DMPX.  SCH58261 was the most potent antagonist of the human A2A with a K i value of 4 nM, whereas Biogen-34 was the most potent antagonist of the rat A2A with a K i value of 1.2 nM.  Similar results were obtained from cAMP assays.  Selectivities of A2A-antagonists were detd. using radioligands [3H]DPCPX, [3H]ZM241385, and [125I]-AB-MECA for A1, A2B, and A3 receptors, resp.  KW-6002 and Biogen-34 exhibited the highest selectivity for A2A vs A1 (human and rat), resp.  The pharmacokinetic profiles of antagonists were evaluated in vivo in rats.  DMPX and KW-6002 had the greatest oral bioavailability.  In contrast, SCH58261, MSX-2, and Ver-6623 had low or poor oral bioavailability.  In summary, SCH58261, Biogen-34, MSX-2, and Ver-6623 had high affinities for both human and rat A2A receptors, with reasonable selectivity for A2A over A1 and A2B receptors.  They are suitable as A2A-antagonists for in vitro pharmacol. studies.  Among the six A2A-antagonists, KW-6002 is the best for use in in vivo animal studies, particularly for a CNS target, based on its bioavailability, half life, and brain penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAzTTwucKRCrVg90H21EOLACvtfcHk0lhrcbhnLh5rKQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVamurk%253D&md5=0d31392603956cc9e016123edd88d5ea</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1007%2Fs00210-007-0135-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-007-0135-0%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.%26aulast%3DSoohoo%26aufirst%3DD.%26aulast%3DSoelaiman%26aufirst%3DS.%26aulast%3DKalla%26aufirst%3DR.%26aulast%3DZabiocki%26aufirst%3DJ.%26aulast%3DChu%26aufirst%3DN.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DDiamond%26aufirst%3DI.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DShryock%26aufirst%3DJ.%2BC.%26atitle%3DCharacterization%2520of%2520the%2520potency%252C%2520selectivity%252C%2520and%2520pharmacokinetic%2520profile%2520for%2520six%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2007%26volume%3D375%26spage%3D133%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group">Gillespie, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dourish, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerpiniere, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roffey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. S.</span><span> </span><span class="NLM_article-title">Antagonists of the human adenosine A<sub>2A</sub> receptor. Part 3: Design and synthesis of pyrazolo[3,4-<i>d</i>]pyrimidines, pyrrolo[2,3-<i>d</i>]pyrdimidines and 6-arylpurines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2924</span><span class="NLM_x">â</span> <span class="NLM_lpage">2929</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2924-2929&author=R.+J.+Gillespieauthor=I.+A.+Cliffeauthor=C.+E.+Dawsonauthor=C.+T.+Dourishauthor=S.+Gaurauthor=A.+M.+Jordanauthor=A.+R.+Knightauthor=J.+Lerpiniereauthor=A.+Misraauthor=R.+M.+Prattauthor=J.+Roffeyauthor=G.+C.+Strattonauthor=R.+Uptonauthor=S.+M.+Weissauthor=D.+S.+Williamson&title=Antagonists+of+the+human+adenosine+A2A+receptor.+Part+3%3A+Design+and+synthesis+of+pyrazolo%5B3%2C4-d%5Dpyrimidines%2C+pyrrolo%5B2%2C3-d%5Dpyrdimidines+and+6-arylpurines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DDawson%26aufirst%3DC.%2BE.%26aulast%3DDourish%26aufirst%3DC.%2BT.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DKnight%26aufirst%3DA.%2BR.%26aulast%3DLerpiniere%26aufirst%3DJ.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DPratt%26aufirst%3DR.%2BM.%26aulast%3DRoffey%26aufirst%3DJ.%26aulast%3DStratton%26aufirst%3DG.%2BC.%26aulast%3DUpton%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DS.%2BM.%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26atitle%3DAntagonists%2520of%2520the%2520human%2520adenosine%2520A2A%2520receptor.%2520Part%25203%253A%2520Design%2520and%2520synthesis%2520of%2520pyrazolo%255B3%252C4-d%255Dpyrimidines%252C%2520pyrrolo%255B2%252C3-d%255Dpyrdimidines%2520and%25206-arylpurines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2924%26epage%3D2929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group">Gillespie, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botting, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerpiniere, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightowler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAteer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reece, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selwood, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruston, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, S. M.</span><span> </span><span class="NLM_article-title">Antagonist of the human A<sub>2A</sub> adenosine receptor. 4. Design, synthesis, and preclinical evaluations of 7-aryltriazolo[4,5-<i>d</i>]pyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">â</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800961g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=33-47&author=R.+J.+Gillespieauthor=S.+J.+Bamfordauthor=R.+Bottingauthor=M.+Comerauthor=S.+Dennyauthor=S.+Gaurauthor=M.+Griffinauthor=A.+M.+Jordanauthor=A.+R.+Knightauthor=J.+Lerpiniereauthor=S.+Leonardiauthor=S.+Lightowlerauthor=S.+McAteerauthor=A.+Merrettauthor=A.+Misraauthor=A.+Padfieldauthor=M.+Reeceauthor=M.+Saadiauthor=D.+L.+Selwoodauthor=G.+C.+Strattonauthor=D.+Surryauthor=R.+Toddauthor=X.+Tongauthor=V.+Rustonauthor=R.+Uptonauthor=S.+M.+Weiss&title=Antagonist+of+the+human+A2A+adenosine+receptor.+4.+Design%2C+synthesis%2C+and+preclinical+evaluations+of+7-aryltriazolo%5B4%2C5-d%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fjm800961g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800961g%26sid%3Dliteratum%253Aachs%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26aulast%3DBamford%26aufirst%3DS.%2BJ.%26aulast%3DBotting%26aufirst%3DR.%26aulast%3DComer%26aufirst%3DM.%26aulast%3DDenny%26aufirst%3DS.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DM.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DKnight%26aufirst%3DA.%2BR.%26aulast%3DLerpiniere%26aufirst%3DJ.%26aulast%3DLeonardi%26aufirst%3DS.%26aulast%3DLightowler%26aufirst%3DS.%26aulast%3DMcAteer%26aufirst%3DS.%26aulast%3DMerrett%26aufirst%3DA.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DPadfield%26aufirst%3DA.%26aulast%3DReece%26aufirst%3DM.%26aulast%3DSaadi%26aufirst%3DM.%26aulast%3DSelwood%26aufirst%3DD.%2BL.%26aulast%3DStratton%26aufirst%3DG.%2BC.%26aulast%3DSurry%26aufirst%3DD.%26aulast%3DTodd%26aufirst%3DR.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DRuston%26aufirst%3DV.%26aulast%3DUpton%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DS.%2BM.%26atitle%3DAntagonist%2520of%2520the%2520human%2520A2A%2520adenosine%2520receptor.%25204.%2520Design%252C%2520synthesis%252C%2520and%2520preclinical%2520evaluations%2520of%25207-aryltriazolo%255B4%252C5-d%255Dpyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D33%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span>Vernalis: Vernalis Announces A<sub>2A</sub> Receptor Antagonist Programme for Parkinsonâs Disease Continues with Next Generation Compound. Press Release, July 16,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vernalis%3A+Vernalis+Announces+A2A+Receptor+Antagonist+Programme+for+Parkinson%E2%80%99s+Disease+Continues+with+Next+Generation+Compound.+Press+Release%2C+July+16%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span>Vernalis: Positive Results Achieved in Vernalisâ Receptor Occupancy Study of V81444 for Parkinsonâs Disease and Other CNS Indications. Press Release, December 12,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vernalis%3A+Positive+Results+Achieved+in+Vernalis%E2%80%99+Receptor+Occupancy+Study+of+V81444+for+Parkinson%E2%80%99s+Disease+and+Other+CNS+Indications.+Press+Release%2C+December+12%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group">Gillespie, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerpiniere, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansell, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, G. C.</span><span> </span><span class="NLM_article-title">Antagonists of the human A<sub>2A</sub> receptor. Part 5: Highly bio-available pyrimidine-4-carboxamides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2664</span><span class="NLM_x">â</span> <span class="NLM_lpage">2667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2664-2667&author=R.+J.+Gillespieauthor=S.+J.+Bamfordauthor=S.+Gaurauthor=A.+M.+Jordanauthor=J.+Lerpiniereauthor=H.+L.+Mansellauthor=G.+C.+Stratton&title=Antagonists+of+the+human+A2A+receptor.+Part+5%3A+Highly+bio-available+pyrimidine-4-carboxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26aulast%3DBamford%26aufirst%3DS.%2BJ.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLerpiniere%26aufirst%3DJ.%26aulast%3DMansell%26aufirst%3DH.%2BL.%26aulast%3DStratton%26aufirst%3DG.%2BC.%26atitle%3DAntagonists%2520of%2520the%2520human%2520A2A%2520receptor.%2520Part%25205%253A%2520Highly%2520bio-available%2520pyrimidine-4-carboxamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2664%26epage%3D2667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group">Gillespie, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haymes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klenke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansell, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmonite, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yule, I. A.</span><span> </span><span class="NLM_article-title">Antagonists of the human A<sub>2A</sub> receptor. Part 6: Further optimization of pyridmidine-4-carboxamides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6590</span><span class="NLM_x">â</span> <span class="NLM_lpage">6605</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6590-6605&author=R.+J.+Gillespieauthor=S.+J.+Bamfordauthor=A.+Clayauthor=S.+Gaurauthor=T.+Haymesauthor=P.+S.+Jacksonauthor=A.+M.+Jordanauthor=B.+Klenkeauthor=S.+Leonardiauthor=J.+Liuauthor=H.+L.+Mansellauthor=S.+Ngauthor=M.+Saadiauthor=H.+Simmoniteauthor=G.+C.+Strattonauthor=R.+S.+Toddauthor=D.+S.+Williamsonauthor=I.+A.+Yule&title=Antagonists+of+the+human+A2A+receptor.+Part+6%3A+Further+optimization+of+pyridmidine-4-carboxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26aulast%3DBamford%26aufirst%3DS.%2BJ.%26aulast%3DClay%26aufirst%3DA.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DHaymes%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DP.%2BS.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DKlenke%26aufirst%3DB.%26aulast%3DLeonardi%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMansell%26aufirst%3DH.%2BL.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DSaadi%26aufirst%3DM.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DStratton%26aufirst%3DG.%2BC.%26aulast%3DTodd%26aufirst%3DR.%2BS.%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26aulast%3DYule%26aufirst%3DI.%2BA.%26atitle%3DAntagonists%2520of%2520the%2520human%2520A2A%2520receptor.%2520Part%25206%253A%2520Further%2520optimization%2520of%2520pyridmidine-4-carboxamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D17%26spage%3D6590%26epage%3D6605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Errey, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurrell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhukov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, M.</span><span> </span><span class="NLM_article-title">Identification of novel adenosine A<sub>2A</sub> receptor antagonists by virtual screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1904</span><span class="NLM_x">â</span> <span class="NLM_lpage">1909</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201455y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVOqug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1904-1909&author=C.+J.+Langmeadauthor=S.+P.+Andrewsauthor=M.+Congreveauthor=J.+C.+Erreyauthor=E.+Hurrellauthor=F.+H.+Marshallauthor=J.+S.+Masonauthor=C.+M.+Richardsonauthor=N.+Robertsonauthor=A.+Zhukovauthor=M.+Weir&title=Identification+of+novel+adenosine+A2A+receptor+antagonists+by+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Novel Adenosine A2A Receptor Antagonists by Virtual Screening</span></div><div class="casAuthors">Langmead, Christopher J.; Andrews, Stephen P.; Congreve, Miles; Errey, James C.; Hurrell, Edward; Marshall, Fiona H.; Mason, Jonathan S.; Richardson, Christine M.; Robertson, Nathan; Zhukov, Andrei; Weir, Malcolm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1904-1909</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Virtual screening was performed against exptl. enabled homol. models of the adenosine A2A receptor, identifying a diverse range of ligand efficient antagonists (hit rate 9%).  By use of ligand docking and Biophys. Mapping (BPM), hits 1 and 5 were optimized to potent and selective lead mols. (11-13 from 5, pKI = 7.5-8.5, 13- to >100-fold selective vs. adenosine A1; 14-16 from 1, pKI = 7.9-9.0, 19- to 59-fold selective).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroN2ZrmhhzurVg90H21EOLACvtfcHk0lh9UmHqeIX2tg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVOqug%253D%253D&md5=89f18c8a19339aeb6d082bbb8bb0c830</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Fjm201455y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201455y%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DHurrell%26aufirst%3DE.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DC.%2BM.%26aulast%3DRobertson%26aufirst%3DN.%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DWeir%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520novel%2520adenosine%2520A2A%2520receptor%2520antagonists%2520by%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1904%26epage%3D1909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group">Congreve, M. S.; Andrews, S. P.; Mason, J. S.; Richardson, C. M.; Brown, G. A.</span><span> </span><span class="NLM_article-title">1,2,4-Triazine-4-amine Derivatives</span>. PCT Int. Appl. WO2011095625 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+S.+Congreve&author=S.+P.+Andrews&author=J.+S.+Mason&author=C.+M.+Richardson&author=G.+A.+Brown&title=1%2C2%2C4-Triazine-4-amine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%2BS.%26atitle%3D1%252C2%252C4-Triazine-4-amine%2520Derivatives%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dore, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenstein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurrell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhukov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span> </span><span class="NLM_article-title">Discovery of 1,2,4-triazine derivatives as adenosine A<sub>2A</sub> antagonists using structure based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1898</span><span class="NLM_x">â</span> <span class="NLM_lpage">1903</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201376w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVGqsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1898-1903&author=M.+Congreveauthor=S.+P.+Andrewsauthor=A.+S.+Doreauthor=K.+Hollensteinauthor=E.+Hurrellauthor=C.+J.+Langmeadauthor=J.+S.+Masonauthor=I.+W.+Ngauthor=B.+Tehanauthor=A.+Zhukovauthor=M.+Weirauthor=F.+H.+Marshall&title=Discovery+of+1%2C2%2C4-triazine+derivatives+as+adenosine+A2A+antagonists+using+structure+based+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design</span></div><div class="casAuthors">Congreve, Miles; Andrews, Stephen P.; Dore, Andrew S.; Hollenstein, Kaspar; Hurrell, Edward; Langmead, Christopher J.; Mason, Jonathan S.; Ng, Irene W.; Tehan, Benjamin; Zhukov, Andrei; Weir, Malcolm; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1898-1903</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, ligand efficient, selective, and orally efficacious 1,2,4-triazine derivs. have been identified using structure based drug design approaches as antagonists of the adenosine A2A receptor.  The X-ray crystal structures of compds. 4e and 4g (I) bound to the GPCR illustrate that the mols. bind deeply inside the orthosteric binding cavity.  In vivo pharmacokinetic and efficacy data for compd. 4k are presented, demonstrating the potential of this series of compds. for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpddydZvtRPv7Vg90H21EOLACvtfcHk0lh9UmHqeIX2tg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVGqsw%253D%253D&md5=71d76db8a22bf82f11d3632d2917e155</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fjm201376w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201376w%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DDore%26aufirst%3DA.%2BS.%26aulast%3DHollenstein%26aufirst%3DK.%26aulast%3DHurrell%26aufirst%3DE.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DNg%26aufirst%3DI.%2BW.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DDiscovery%2520of%25201%252C2%252C4-triazine%2520derivatives%2520as%2520adenosine%2520A2A%2520antagonists%2520using%2520structure%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1898%26epage%3D1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span>DT-1133 was listed on the Domain Therapeutics Web site <a href="http://www.domaintherapeutics.com/" class="extLink">http://www.domaintherapeutics.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DT-1133+was+listed+on+the+Domain+Therapeutics+Web+site+http%3A%2F%2Fwww.domaintherapeutics.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group">Mayer, S.; Schann, S.</span><span> </span><span class="NLM_article-title">New Adenosine Receptor Ligands and Uses Thereof</span>. PCT Int. Appl. WO2010084425 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+Mayer&author=S.+Schann&title=New+Adenosine+Receptor+Ligands+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DS.%26atitle%3DNew%2520Adenosine%2520Receptor%2520Ligands%2520and%2520Uses%2520Thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span>Kyowa Kirin: News Releases. <a href="http://www.kyowa-kirin.com/news_releases/2013/e20130325_04.html" class="extLink">http://www.kyowa-kirin.com/news_releases/2013/e20130325_04.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kyowa+Kirin%3A+News+Releases.+http%3A%2F%2Fwww.kyowa-kirin.com%2Fnews_releases%2F2013%2Fe20130325_04.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group">Saku, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurosawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takizawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uesaka, N.</span><span> </span><span class="NLM_article-title">Synthetic studies on selective adenosine A<sub>2A</sub> receptor antagonists: synthesis and structureâactivity relationships of novel benzofuran derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1090</span><span class="NLM_x">â</span> <span class="NLM_lpage">1093</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1090-1093&author=O.+Sakuauthor=M.+Sakiauthor=M.+Kurosawaauthor=K.+Ikedaauthor=T.+Takizawaauthor=N.+Uesaka&title=Synthetic+studies+on+selective+adenosine+A2A+receptor+antagonists%3A+synthesis+and+structure%E2%80%93activity+relationships+of+novel+benzofuran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaku%26aufirst%3DO.%26aulast%3DSaki%26aufirst%3DM.%26aulast%3DKurosawa%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DTakizawa%26aufirst%3DT.%26aulast%3DUesaka%26aufirst%3DN.%26atitle%3DSynthetic%2520studies%2520on%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520novel%2520benzofuran%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1090%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group">Saku, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takizawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uesaka, N.</span><span> </span><span class="NLM_article-title">Synthetic studies on selective adenosine A<sub>2A</sub> receptor antagonists. Part II: Synthesis and structureâactivity relationships of novel benzofuran derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3768</span><span class="NLM_x">â</span> <span class="NLM_lpage">3771</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3768-3771&author=O.+Sakuauthor=M.+Sakiauthor=M.+Kurokawaauthor=K.+Ikedaauthor=S.-L.+Uchidaauthor=T.+Takizawaauthor=N.+Uesaka&title=Synthetic+studies+on+selective+adenosine+A2A+receptor+antagonists.+Part+II%3A+Synthesis+and+structure%E2%80%93activity+relationships+of+novel+benzofuran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaku%26aufirst%3DO.%26aulast%3DSaki%26aufirst%3DM.%26aulast%3DKurokawa%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DUchida%26aufirst%3DS.-L.%26aulast%3DTakizawa%26aufirst%3DT.%26aulast%3DUesaka%26aufirst%3DN.%26atitle%3DSynthetic%2520studies%2520on%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists.%2520Part%2520II%253A%2520Synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520novel%2520benzofuran%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3768%26epage%3D3771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group">Vu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shields, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phadke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayyub, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span> </span><span class="NLM_article-title">Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4835</span><span class="NLM_x">â</span> <span class="NLM_lpage">4838</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4835-4838&author=C.+B.+Vuauthor=P.+Shieldsauthor=B.+Pengauthor=G.+Kumaravelauthor=X.+Jinauthor=D.+Phadkeauthor=J.+Wangauthor=T.+Engberauthor=E.+Ayyubauthor=R.+C.+Petter&title=Triamino+derivatives+of+triazolotriazine+and+triazolopyrimidine+as+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DC.%2BB.%26aulast%3DShields%26aufirst%3DP.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DPhadke%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DEngber%26aufirst%3DT.%26aulast%3DAyyub%26aufirst%3DE.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26atitle%3DTriamino%2520derivatives%2520of%2520triazolotriazine%2520and%2520triazolopyrimidine%2520as%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4835%26epage%3D4838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sha, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Vlijmen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohnert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ensinger, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalley, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span> </span><span class="NLM_article-title">Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6218</span><span class="NLM_x">â</span> <span class="NLM_lpage">6229</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0494321" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6218-6229&author=H.+Pengauthor=G.+Kumaravelauthor=G.+Yaoauthor=L.+Shaauthor=J.+Wangauthor=V.+Van+Vlijmenauthor=T.+Bohnertauthor=C.+Huangauthor=C.+B.+Vuauthor=C.+L.+Ensingerauthor=H.+Changauthor=T.+M.+Engberauthor=E.+T.+Whalleyauthor=R.+C.+Petter&title=Novel+bicyclic+piperazine+derivatives+of+triazolotriazine+and+triazolopyrimidines+as+highly+potent+and+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Fjm0494321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0494321%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DYao%26aufirst%3DG.%26aulast%3DSha%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DVan%2BVlijmen%26aufirst%3DV.%26aulast%3DBohnert%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DVu%26aufirst%3DC.%2BB.%26aulast%3DEnsinger%26aufirst%3DC.%2BL.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DEngber%26aufirst%3DT.%2BM.%26aulast%3DWhalley%26aufirst%3DE.%2BT.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26atitle%3DNovel%2520bicyclic%2520piperazine%2520derivatives%2520of%2520triazolotriazine%2520and%2520triazolopyrimidines%2520as%2520highly%2520potent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6218%26epage%3D6229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group">Yao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haque, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sha, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalley, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conlon, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiesman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span> </span><span class="NLM_article-title">Synthesis of alkyne derivatives of a novel triazolopyrazine as A<sub>2A</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">â</span> <span class="NLM_lpage">515</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=511-515&author=G.+Yaoauthor=S.+Haqueauthor=L.+Shaauthor=G.+Kumaravelauthor=J.+Wangauthor=T.+M.+Engberauthor=E.+T.+Whalleyauthor=P.+R.+Conlonauthor=H.+Changauthor=W.+F.+Kiesmanauthor=R.+C.+Petter&title=Synthesis+of+alkyne+derivatives+of+a+novel+triazolopyrazine+as+A2A+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DG.%26aulast%3DHaque%26aufirst%3DS.%26aulast%3DSha%26aufirst%3DL.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DEngber%26aufirst%3DT.%2BM.%26aulast%3DWhalley%26aufirst%3DE.%2BT.%26aulast%3DConlon%26aufirst%3DP.%2BR.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DKiesman%26aufirst%3DW.%2BF.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%2520of%2520alkyne%2520derivatives%2520of%2520a%2520novel%2520triazolopyrazine%2520as%2520A2A%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D511%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group">Minetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinti, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carminati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castorina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cesare, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Serio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghirardi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piersanti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoccini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span> </span><span class="NLM_article-title">2-<i>n</i>-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9<i>H</i>-purin-6-ylamine and analogs as A<sub>2A</sub> adenosine receptor antagonists. Design, synthesis, and pharmacological characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6887</span><span class="NLM_x">â</span> <span class="NLM_lpage">6896</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058018d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6887-6896&author=P.+Minettiauthor=M.+O.+Tintiauthor=P.+Carminatiauthor=M.+Castorinaauthor=M.+A.+Di+Cesareauthor=S.+Di+Serioauthor=G.+Galloauthor=O.+Ghirardiauthor=F.+Giorgiauthor=L.+Giorgiauthor=G.+Piersantiauthor=F.+Bartocciniauthor=G.+Tarzia&title=2-n-Butyl-9-methyl-8-%5B1%2C2%2C3%5Dtriazol-2-yl-9H-purin-6-ylamine+and+analogs+as+A2A+adenosine+receptor+antagonists.+Design%2C+synthesis%2C+and+pharmacological+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fjm058018d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058018d%26sid%3Dliteratum%253Aachs%26aulast%3DMinetti%26aufirst%3DP.%26aulast%3DTinti%26aufirst%3DM.%2BO.%26aulast%3DCarminati%26aufirst%3DP.%26aulast%3DCastorina%26aufirst%3DM.%26aulast%3DDi%2BCesare%26aufirst%3DM.%2BA.%26aulast%3DDi%2BSerio%26aufirst%3DS.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DGhirardi%26aufirst%3DO.%26aulast%3DGiorgi%26aufirst%3DF.%26aulast%3DGiorgi%26aufirst%3DL.%26aulast%3DPiersanti%26aufirst%3DG.%26aulast%3DBartoccini%26aufirst%3DF.%26aulast%3DTarzia%26aufirst%3DG.%26atitle%3D2-n-Butyl-9-methyl-8-%255B1%252C2%252C3%255Dtriazol-2-yl-9H-purin-6-ylamine%2520and%2520analogs%2520as%2520A2A%2520adenosine%2520receptor%2520antagonists.%2520Design%252C%2520synthesis%252C%2520and%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6887%26epage%3D6896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stasi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borisini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cesare, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghirardi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carminati, P.</span><span> </span><span class="NLM_article-title">ST 1535: a preferential A<sub>2A</sub> adenosine receptor antagonist</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">575</span><span class="NLM_x">â</span> <span class="NLM_lpage">584</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173a&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1017%2FS1461145705006188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173a&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=16867213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173a&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKku7rJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=575-584&issue=5&author=M.+A.+Stasiauthor=F.+Borisiniauthor=K.+Varaniauthor=F.+Vincenziauthor=M.+A.+Di+Cesareauthor=P.+Minettiauthor=O.+Ghirardiauthor=P.+Carminati&title=ST+1535%3A+a+preferential+A2A+adenosine+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173aR"><div class="casContent"><span class="casTitleNuber">173a</span><div class="casTitle"><span class="NLM_cas:atitle">ST 1535: a preferential A2A adenosine receptor antagonist</span></div><div class="casAuthors">Stasi, Maria Antonietta; Borsini, Franco; Varani, Katia; Vincenzi, Fabrizio; Di Cesare, Maria Assunta; Minetti, Patrizia; Ghirardi, Orlando; Carminati, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">575-584</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Antagonism of the A2A adenosine function has proved beneficial in the treatment of Parkinson's disease, in that it increases L-dopa therapeutical effects without concomitant worsening of its side-effects.  In this paper we describe a preferential A2A adenosine antagonist, ST 1535, with long-lasting pharmacodynamic effects.  It competitively antagonizes the effects of the A2A adenosine agonist NECA on cAMP in cells cloned with the human A2A adenosine receptor (IC50=353Â±30 nM), and the effects of the A1 adenosine agonist CHA on cAMP in cells cloned with the human A1 adenosine receptor (IC50=510Â±38 nM).  ST 1535, at oral doses of 5 and 10 mg/kg, antagonizes catalepsy induced by intracerebroventricular administration of the A2A adenosine agonist CGS 21680 (10 Î¼g/5 Î¼l) in mice.  At oral doses ranging between 5 and 20 mg/kg, ST 1535 induces hypermotility and antagonizes haloperidol-induced catalepsy in mice up to 7 h.  Oral ST 1535, at 1.25 and 2.5 mg/kg, potentiates L-dopa effects in reducing haloperidol-induced catalepsy.  ST 1535 represents a potential new compd., with long-lasting activity, for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK-eQmf_KyF7Vg90H21EOLACvtfcHk0li_wg6KU882yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKku7rJ&md5=937d0a67ece946a9b8c6cea4edb2a8ca</span></div><a href="/servlet/linkout?suffix=cit173a&amp;dbid=16384&amp;doi=10.1017%2FS1461145705006188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145705006188%26sid%3Dliteratum%253Aachs%26aulast%3DStasi%26aufirst%3DM.%2BA.%26aulast%3DBorisini%26aufirst%3DF.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DDi%2BCesare%26aufirst%3DM.%2BA.%26aulast%3DMinetti%26aufirst%3DP.%26aulast%3DGhirardi%26aufirst%3DO.%26aulast%3DCarminati%26aufirst%3DP.%26atitle%3DST%25201535%253A%2520a%2520preferential%2520A2A%2520adenosine%2520receptor%2520antagonist%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2006%26volume%3D9%26issue%3D5%26spage%3D575%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit173b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay Croft, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, p.</span><span> </span><span class="NLM_article-title">The novel adenosine A<sub>2A</sub> antagonist ST1535 potentiates the effects of a threshold dose of L-dopa in unilaterally 6-OHDA-lesioned rats</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1133</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">110</span><span class="NLM_x">â</span> <span class="NLM_lpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.brainres.2006.10.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=17196564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvV2msQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1133&publication_year=2007&pages=110-114&issue=1&author=S.+Roseauthor=N.+Ramsay+Croftauthor=p.+Jenner&title=The+novel+adenosine+A2A+antagonist+ST1535+potentiates+the+effects+of+a+threshold+dose+of+L-dopa+in+unilaterally+6-OHDA-lesioned+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173bR"><div class="casContent"><span class="casTitleNuber">173b</span><div class="casTitle"><span class="NLM_cas:atitle">The novel adenosine A2a antagonist ST1535 potentiates the effects of a threshold dose of L-dopa in unilaterally 6-OHDA-lesioned rats</span></div><div class="casAuthors">Rose, Sarah; Ramsay Croft, Neil; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-114</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Adenosine A2a antagonists can modulate dopamine-mediated motor behaviors, however, their ability to induce rotational behavior in 6-hydroxydopamine (6-OHDA)-lesioned rats and to potentiate the effects of L-dopa differs.  We now report on the effects of the novel A2a antagonist ST1535 on rotational responses in this model.  When administered alone, ST1535 (2.5-40 mg/kg po) enhanced exploratory behavior and produced a dose-related increase in ipsilateral rotation in rats with a unilateral 6-OHDA lesion of the nigro-striatal pathway.  Administration of ST1535 (40 mg/kg po) in combination with a high dose of L-dopa (12 mg/kg i.p.) caused marked contraversive rotation but did not alter the rotational response produced by L-dopa alone.  In contrast, when administered in combination with L-dopa (7 mg/kg i.p.) that alone produced a submaximal circling response, ST1535 enhanced the intensity and duration of rotation.  These results suggest that ST1535 is able to alter dopamine-mediated behavior when given alone and to potentiate the effects of submaximal doses of L-dopa.  ST1535 may be useful in the treatment of Parkinson's disease and effective in reducing the use of L-dopa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMcs-c9bnjzLVg90H21EOLACvtfcHk0lgEIbCHKsbpnw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvV2msQ%253D%253D&md5=d6ed93e51c36589221e7a42e33c29c4f</span></div><a href="/servlet/linkout?suffix=cit173b&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2006.10.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2006.10.038%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DS.%26aulast%3DRamsay%2BCroft%26aufirst%3DN.%26aulast%3DJenner%26aufirst%3Dp.%26atitle%3DThe%2520novel%2520adenosine%2520A2A%2520antagonist%2520ST1535%2520potentiates%2520the%2520effects%2520of%2520a%2520threshold%2520dose%2520of%2520L-dopa%2520in%2520unilaterally%25206-OHDA-lesioned%2520rats%26jtitle%3DBrain%2520Res.%26date%3D2007%26volume%3D1133%26issue%3D1%26spage%3D110%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit173c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carminati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">The novel adenosine A<sub>2A</sub> receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">546</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">â</span> <span class="NLM_lpage">87</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173c&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.ejphar.2006.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173c&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=16925991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173c&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVWqu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2006&pages=82-87&author=S.+Roseauthor=M.+J.+Jacksonauthor=L.+A.+Smithauthor=K.+Stockwellauthor=L.+Johnsonauthor=P.+Carminatiauthor=P.+Jenner&title=The+novel+adenosine+A2A+receptor+antagonist+ST1535+potentiates+the+effects+of+a+threshold+dose+of+L-DOPA+in+MPTP+treated+common+marmosets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173cR"><div class="casContent"><span class="casTitleNuber">173c</span><div class="casTitle"><span class="NLM_cas:atitle">The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets</span></div><div class="casAuthors">Rose, Sarah; Jackson, Michael J.; Smith, Lance A.; Stockwell, Kim; Johnson, Louisa; Carminati, Paolo; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">82-87</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adenosine A2a receptor antagonists may represent a novel non-dopaminergic approach to the treatment of Parkinson's disease.  However, there is little information available on their ability to reverse motor deficits in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine hydrochloride (MPTP)-treated primates.  We have studied the effects of the novel A2a receptor antagonist 2-butyl-9-methyl-8-(2H-1,2,3-triazol 2-yl)-9 H-purin-6-ylamine (ST1535) alone and in combination with L-3,4-dihydroxyphenylalanine (L-DOPA) in MPTP-treated common marmosets.  ST1535 (10, 20 and 40 mg/kg, p.o.) when administered alone to MPTP-treated common marmosets produced a dose related increase in locomotor motor activity and tended to reverse motor disability.  Treatment with a threshold dose of L-DOPA (2.5 mg/kg, p.o.) produced an increase in locomotor activity and again tended to reverse motor disability.  When L-DOPA (2.5 mg/kg, p.o.) was administered in combination with ST1535 (20 mg/kg, p.o.), there was an enhancement in the intensity and duration of the effect of L-DOPA (2.5 mg/kg, p.o.) in reversing motor deficits as shown by both a further increase in locomotor activity and reversal of motor disability.  The combination of L-DOPA (2.5 mg/kg, p.o.) plus ST1535 (20 mg/kg, p.o.) significantly increased "on time" in these animals.  These data substantiate the evidence that adenosine A2a receptor antagonists are able to reverse motor deficits in a highly predictive model of clin. efficacy in Parkinson's disease.  The data suggests that ST1535 will be an effective anti-parkinsonian agent in combination with L-DOPA and allow a redn. in L-DOPA usage in the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqIOO5uXa6zbVg90H21EOLACvtfcHk0lgEIbCHKsbpnw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVWqu7s%253D&md5=fd99e0204761e4c667df8e561a89b084</span></div><a href="/servlet/linkout?suffix=cit173c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DStockwell%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DCarminati%26aufirst%3DP.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DThe%2520novel%2520adenosine%2520A2A%2520receptor%2520antagonist%2520ST1535%2520potentiates%2520the%2520effects%2520of%2520a%2520threshold%2520dose%2520of%2520L-DOPA%2520in%2520MPTP%2520treated%2520common%2520marmosets%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D546%26spage%3D82%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group">Cabri, W.; Minetti, P.; Piersanti, G.; Tarsia, G.</span><span> </span><span class="NLM_article-title">Oxidated Derivatives of Triazolypurines Useful as Ligands of the Adenosine A<sub>2A</sub> Receptor and Their Use as Medicaments</span>. PCT Int. Appl. WO2010106145 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=W.+Cabri&author=P.+Minetti&author=G.+Piersanti&author=G.+Tarsia&title=Oxidated+Derivatives+of+Triazolypurines+Useful+as+Ligands+of+the+Adenosine+A2A+Receptor+and+Their+Use+as+Medicaments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCabri%26aufirst%3DW.%26atitle%3DOxidated%2520Derivatives%2520of%2520Triazolypurines%2520Useful%2520as%2520Ligands%2520of%2520the%2520Adenosine%2520A2A%2520Receptor%2520and%2520Their%2520Use%2520as%2520Medicaments%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group">Akahane, A.; Aoki, S.; Matsushima, Y.; Yonishi, S.</span><span> </span><span class="NLM_article-title">Pyrazine Derivatives and Pharmaceutical Use Thereof</span>. PCT Int. Appl. WO2005040151 A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+Akahane&author=S.+Aoki&author=Y.+Matsushima&author=S.+Yonishi&title=Pyrazine+Derivatives+and+Pharmaceutical+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAkahane%26aufirst%3DA.%26atitle%3DPyrazine%2520Derivatives%2520and%2520Pharmaceutical%2520Use%2520Thereof%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group">Mihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyoshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, N.</span><span> </span><span class="NLM_article-title">Brain adenosine A2A receptor occupancy by a novel A<sub>1</sub>/A<sub>2A</sub> receptor antagonist, ASP5854, in rhesus monkeys: relationship to anticataleptic effect</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">â</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=1183-1188&author=T.+Miharaauthor=A.+Nodaauthor=H.+Araiauthor=K.+Miharaauthor=A.+Iwashitaauthor=Y.+Murakamiauthor=T.+Matsuyaauthor=S.+Miyoshiauthor=S.+Nishimuraauthor=N.+Matsuoka&title=Brain+adenosine+A2A+receptor+occupancy+by+a+novel+A1%2FA2A+receptor+antagonist%2C+ASP5854%2C+in+rhesus+monkeys%3A+relationship+to+anticataleptic+effect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMihara%26aufirst%3DT.%26aulast%3DNoda%26aufirst%3DA.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DMihara%26aufirst%3DK.%26aulast%3DIwashita%26aufirst%3DA.%26aulast%3DMurakami%26aufirst%3DY.%26aulast%3DMatsuya%26aufirst%3DT.%26aulast%3DMiyoshi%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DMatsuoka%26aufirst%3DN.%26atitle%3DBrain%2520adenosine%2520A2A%2520receptor%2520occupancy%2520by%2520a%2520novel%2520A1%252FA2A%2520receptor%2520antagonist%252C%2520ASP5854%252C%2520in%2520rhesus%2520monkeys%253A%2520relationship%2520to%2520anticataleptic%2520effect%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2008%26volume%3D49%26spage%3D1183%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group">Mihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, M.</span><span> </span><span class="NLM_article-title">A novel adenosine A<sub>1</sub> and A<sub>2A</sub> receptor antagonist ASP5854 ameliorates motor impairment in MPTP-treated marmosets: comparison with existing anti-Parkinsonâs disease drugs</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">â</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2008&pages=152-161&author=T.+Miharaauthor=A.+Iwashitaauthor=M.+Matsuoka&title=A+novel+adenosine+A1+and+A2A+receptor+antagonist+ASP5854+ameliorates+motor+impairment+in+MPTP-treated+marmosets%3A+comparison+with+existing+anti-Parkinson%E2%80%99s+disease+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMihara%26aufirst%3DT.%26aulast%3DIwashita%26aufirst%3DA.%26aulast%3DMatsuoka%26aufirst%3DM.%26atitle%3DA%2520novel%2520adenosine%2520A1%2520and%2520A2A%2520receptor%2520antagonist%2520ASP5854%2520ameliorates%2520motor%2520impairment%2520in%2520MPTP-treated%2520marmosets%253A%2520comparison%2520with%2520existing%2520anti-Parkinson%25E2%2580%2599s%2520disease%2520drugs%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2008%26volume%3D194%26spage%3D152%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group">Mihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarimizu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, N.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of a novel, potent adenosine A<sub>1</sub> and A<sub>2A</sub> receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1<i>H</i>)-one (ASP5854), in models of Parkinsonâs disease and cognition</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">708</span><span class="NLM_x">â</span> <span class="NLM_lpage">719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1124%2Fjpet.107.121962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=17684118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsb%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=708-719&author=T.+Miharaauthor=K.+Miharaauthor=J.+Yarimizuauthor=Y.+Mitaniauthor=R.+Matsudaauthor=H.+Yamamotoauthor=S.+Aokiauthor=A.+Akahaneauthor=A.+Iwashitaauthor=N.+Matsuda&title=Pharmacological+characterization+of+a+novel%2C+potent+adenosine+A1+and+A2A+receptor+dual+antagonist%2C+5-%5B5-amino-3-%284-fluorophenyl%29pyrazin-2-yl%5D-1-isopropylpyridine-2%281H%29-one+%28ASP5854%29%2C+in+models+of+Parkinson%E2%80%99s+disease+and+cognition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition</span></div><div class="casAuthors">Mihara, Takuma; Mihara, Kayoko; Yarimizu, Junko; Mitani, Yasuyuki; Matsuda, Ritsuko; Yamamoto, Hiroko; Aoki, Satoshi; Akahane, Atsushi; Iwashita, Akinori; Matsuoka, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">708-719</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Central adenosine A2A receptor is a promising target for drugs to treat Parkinson's disease (PD), and the central blockade of adenosine A1 receptor improves cognitive function.  In the present study, we investigated the effect of a novel adenosine A1 and A2A dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one(ASP5854),in animal models of PD and cognition.  The binding affinities of ASP5854 for human A1 and A2A receptors were 9.03 and 1.76 nM, resp., with higher specificity and no species differences.  ASP5854 also showed antagonistic action on A1 and A2A agonist-induced increases of intracellular Ca2+ concn.  ASP5854 ameliorated A2A agonist 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680)- and haloperidol-induced catalepsy in mice, with the min. EDs of 0.32 and 0.1 mg/kg, resp., and it also improved haloperidol-induced catalepsy in rats at doses higher than 0.1 mg/kg.  In unilateral 6-hydroxydopamine-lesioned rats, ASP5854 significantly potentiated 7-dihydroxyphenylalanine (L-DOPA)-induced rotational behavior at doses higher than 0.032 mg/kg.  ASP5854 also significantly restored the striatal dopamine content reduced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment in mice at doses higher than 0.1 mg/kg.  Furthermore, in the rat passive avoidance test, ASP5854 significantly reversed the scopolamine-induced memory deficits, whereas the specific adenosine A2A antagonist 8-((E)-2-(3,4-dimethoxyphenyl)ethenyl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione (KW-6002; istradefylline) did not.  Scopolamine- or 5H-dibenzo[a,d]cyclohepten-5,10-imine (dizocilpine maleate) (MK-801)-induced impairment of spontaneous alternation in the mouse Y-maze test was ameliorated by ASP5854, whereas KW-6002 did not exert improvement at therapeutically relevant dosages.  These results demonstrate that the novel, selective, and orally active dual adenosine A1 and A2A receptors antagonist ASP5854 improves motor impairments, is neuroprotective via A2A antagonism, and also enhances cognitive function through A1 antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKhOITDQ8dxrVg90H21EOLACvtfcHk0ljGDq8oRLDybg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsb%252FF&md5=2d9770179a47a228d825a49feab70ef2</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.121962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.121962%26sid%3Dliteratum%253Aachs%26aulast%3DMihara%26aufirst%3DT.%26aulast%3DMihara%26aufirst%3DK.%26aulast%3DYarimizu%26aufirst%3DJ.%26aulast%3DMitani%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DR.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DS.%26aulast%3DAkahane%26aufirst%3DA.%26aulast%3DIwashita%26aufirst%3DA.%26aulast%3DMatsuda%26aufirst%3DN.%26atitle%3DPharmacological%2520characterization%2520of%2520a%2520novel%252C%2520potent%2520adenosine%2520A1%2520and%2520A2A%2520receptor%2520dual%2520antagonist%252C%25205-%255B5-amino-3-%25284-fluorophenyl%2529pyrazin-2-yl%255D-1-isopropylpyridine-2%25281H%2529-one%2520%2528ASP5854%2529%252C%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520cognition%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D708%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupert, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heintzelman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullington, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osbourne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Methylene amine substituted arylindenopyrimidines as potent adenosine A<sub>2A</sub>/A<sub>1</sub> antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2864</span><span class="NLM_x">â</span> <span class="NLM_lpage">2867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2864-2867&author=B.+C.+Shookauthor=S.+Rassnickauthor=D.+Hallauthor=K.+C.+Rupertauthor=G.+R.+Heintzelmanauthor=K.+Hansenauthor=D.+Chakravartyauthor=J.+L.+Bullingtonauthor=R.+H.+Scannevinauthor=B.+Magliaroauthor=L.+Westoverauthor=K.+Carrollauthor=L.+Lampronauthor=R.+Russellauthor=S.+Branumauthor=K.+Wellsauthor=S.+Damonauthor=S.+Youellsauthor=X.+Liauthor=M.+Osbourneauthor=K.+Demarestauthor=Y.+Tangauthor=K.+Rhodesauthor=P.+F.+Jackson&title=Methylene+amine+substituted+arylindenopyrimidines+as+potent+adenosine+A2A%2FA1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHeintzelman%26aufirst%3DG.%2BR.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DBullington%26aufirst%3DJ.%2BL.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DMagliaro%26aufirst%3DB.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DLampron%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBranum%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DK.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DYouells%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DOsbourne%26aufirst%3DM.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DMethylene%2520amine%2520substituted%2520arylindenopyrimidines%2520as%2520potent%2520adenosine%2520A2A%252FA1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2864%26epage%3D2867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbay, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alford, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupert, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heintzeman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullington, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Optimization of arylindenopyridimidines as potent adenosine A<sub>2A</sub>/A<sub>1</sub> antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2868</span><span class="NLM_x">â</span> <span class="NLM_lpage">2871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2868-2871&author=B.+C.+Shookauthor=S.+Rassnickauthor=D.+Chakravartyauthor=N.+Wallaceauthor=M.+Aultauthor=J.+Crookeauthor=J.+K.+Barbayauthor=A.+Wangauthor=K.+Leonardauthor=M.+T.+Powellauthor=V.+Alfordauthor=D.+Hallauthor=K.+C.+Rupertauthor=G.+R.+Heintzemanauthor=K.+Hansenauthor=J.+L.+Bullingtonauthor=R.+H.+Scannevinauthor=K.+Carrollauthor=L.+Lampronauthor=L.+Westoverauthor=R.+Russellauthor=S.+Branumauthor=K.+Wellsauthor=S.+Damonauthor=S.+Youellsauthor=D.+Beauchampauthor=X.+Liauthor=K.+Rhodesauthor=P.+F.+Jackson&title=Optimization+of+arylindenopyridimidines+as+potent+adenosine+A2A%2FA1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DWallace%26aufirst%3DN.%26aulast%3DAult%26aufirst%3DM.%26aulast%3DCrooke%26aufirst%3DJ.%26aulast%3DBarbay%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DPowell%26aufirst%3DM.%2BT.%26aulast%3DAlford%26aufirst%3DV.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHeintzeman%26aufirst%3DG.%2BR.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DBullington%26aufirst%3DJ.%2BL.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DLampron%26aufirst%3DL.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBranum%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DK.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DYouells%26aufirst%3DS.%26aulast%3DBeauchamp%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DOptimization%2520of%2520arylindenopyridimidines%2520as%2520potent%2520adenosine%2520A2A%252FA1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2868%26epage%3D2871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbay, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alford, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Design and characterization of optimized adenosine A<sub>2A</sub>/A<sub>1</sub> receptor antagonists for the treatment of Parkinsonâs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1402</span><span class="NLM_x">â</span> <span class="NLM_lpage">1417</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201640m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1402-1417&author=B.+C.+Shookauthor=S.+Rassnickauthor=N.+Wallaceauthor=J.+Crookeauthor=M.+Aultauthor=D.+Chakravartyauthor=J.+K.+Barbayauthor=A.+Wangauthor=M.+T.+Powellauthor=K.+Leonardauthor=V.+Alfordauthor=R.+H.+Scannevinauthor=K.+Carrollauthor=L.+Lampronauthor=L.+Westoverauthor=H.-K.+Limauthor=R.+Russellauthor=S.+Branumauthor=K.+M.+Wellsauthor=S.+Damonauthor=S.+Youellsauthor=X.+Liauthor=D.+A.+Beauchampauthor=K.+Rhodesauthor=P.+F.+Jackson&title=Design+and+characterization+of+optimized+adenosine+A2A%2FA1+receptor+antagonists+for+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1021%2Fjm201640m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201640m%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DWallace%26aufirst%3DN.%26aulast%3DCrooke%26aufirst%3DJ.%26aulast%3DAult%26aufirst%3DM.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DBarbay%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DM.%2BT.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DAlford%26aufirst%3DV.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DLampron%26aufirst%3DL.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DH.-K.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBranum%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DK.%2BM.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DYouells%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBeauchamp%26aufirst%3DD.%2BA.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DDesign%2520and%2520characterization%2520of%2520optimized%2520adenosine%2520A2A%252FA1%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1402%26epage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charavarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbay, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alford, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Aminomethyl substituted thieno[2,3-<i>d</i>]pyrimidines as adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">950</span><span class="NLM_x">â</span> <span class="NLM_lpage">965</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1039%2Fc1md00082a" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=950-965&author=B.+C.+Shookauthor=D.+Charavartyauthor=J.+K.+Barbayauthor=A.+Wangauthor=K.+Leonardauthor=V.+Alfordauthor=M.+Powellauthor=D.+A.+Beauchampauthor=S.+Rassnickauthor=R.+Scannevinauthor=K.+Carrollauthor=N.+Wallaceauthor=J.+Crookeauthor=M.+Aultauthor=L.+Lampronauthor=L.+Westoverauthor=K.+Rhodesauthor=P.+F.+Jackson&title=Aminomethyl+substituted+thieno%5B2%2C3-d%5Dpyrimidines+as+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1039%2Fc1md00082a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00082a%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DCharavarty%26aufirst%3DD.%26aulast%3DBarbay%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DAlford%26aufirst%3DV.%26aulast%3DPowell%26aufirst%3DM.%26aulast%3DBeauchamp%26aufirst%3DD.%2BA.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DScannevin%26aufirst%3DR.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DWallace%26aufirst%3DN.%26aulast%3DCrooke%26aufirst%3DJ.%26aulast%3DAult%26aufirst%3DM.%26aulast%3DLampron%26aufirst%3DL.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DAminomethyl%2520substituted%2520thieno%255B2%252C3-d%255Dpyrimidines%2520as%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D950%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâBrien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">Identification of novel, water-soluble, 2-amino-<i>N</i>-pyrimidine-4-yl acetamides as A<sub>2A</sub> receptor antagonists with in vivo efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">â</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070623o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=400-406&author=D.+H.+Sleeauthor=X.+Zhangauthor=M.+Moorjaniauthor=E.+Linauthor=M.+C.+Lanierauthor=Y.+Chenauthor=J.+K.+Rueterauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=S.+Malanyauthor=T.+Joswigauthor=M.+Santosauthor=R.+S.+Grossauthor=J.+P.+Williamsauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Wenauthor=Z.+O%E2%80%99Brienauthor=J.+Saunders&title=Identification+of+novel%2C+water-soluble%2C+2-amino-N-pyrimidine-4-yl+acetamides+as+A2A+receptor+antagonists+with+in+vivo+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1021%2Fjm070623o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070623o%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520novel%252C%2520water-soluble%252C%25202-amino-N-pyrimidine-4-yl%2520acetamides%2520as%2520A2A%2520receptor%2520antagonists%2520with%2520in%2520vivo%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D400%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen., Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">2-Amino-<i>N</i>-pyrimidin-4-ylacetamides as A<sub>2A</sub> receptor antagonists: 1. Structureâactivity relationships and optimization of heterocyclic substituents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">â</span> <span class="NLM_lpage">1729</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701185v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1719-1729&author=D.+H.+Sleeauthor=Y.+Chen.author=X.+Zhangauthor=M.+Moorjaniauthor=E.+Linauthor=M.+C.+Lanierauthor=E.+Linauthor=J.+K.+Rueterauthor=J.+P.+Williamsauthor=S.+M.+Pechnerauthor=S.+Markisonauthor=S.+Malanyauthor=M.+Santosauthor=R.+S.+Grossauthor=K.+Jalaliauthor=Y.+Saiauthor=Z.+Zuoauthor=C.+Yangauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Saunders&title=2-Amino-N-pyrimidin-4-ylacetamides+as+A2A+receptor+antagonists%3A+1.+Structure%E2%80%93activity+relationships+and+optimization+of+heterocyclic+substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1021%2Fjm701185v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701185v%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DChen.%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DPechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DZuo%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3D2-Amino-N-pyrimidin-4-ylacetamides%2520as%2520A2A%2520receptor%2520antagonists%253A%25201.%2520Structure%25E2%2580%2593activity%2520relationships%2520and%2520optimization%2520of%2520heterocyclic%2520substituents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1719%26epage%3D1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecher, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, D. H.</span><span> </span><span class="NLM_article-title">Synthesis of <i>N</i>-pyrimidinyl-2-phenoxyacetamides as adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1778</span><span class="NLM_x">â</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1778-1783&author=X.+Zhangauthor=J.+K.+Rueterauthor=Y.+Chenauthor=M.+Moorjaniauthor=M.+C.+Lanierauthor=E.+Linauthor=R.+S.+Grossauthor=J.+E.+Tellewauthor=J.+P.+Williamsauthor=S.+M.+Lecherauthor=S.+Markisonauthor=T.+Joswigauthor=S.+Malanyauthor=M.+Santosauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Saundersauthor=D.+H.+Slee&title=Synthesis+of+N-pyrimidinyl-2-phenoxyacetamides+as+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DLecher%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DSlee%26aufirst%3DD.%2BH.%26atitle%3DSynthesis%2520of%2520N-pyrimidinyl-2-phenoxyacetamides%2520as%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1778%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâBrien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stotz, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, D. H.</span><span> </span><span class="NLM_article-title">Lead optimization of 4-acetylamino-2-(3,5-dimetylpyrazol-1yl)-6-pyridylpyrimidines as A<sub>2A</sub> adenosine receptor antagonists for the treatment of Parkinsonâs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7099</span><span class="NLM_x">â</span> <span class="NLM_lpage">7110</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800851u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7099-7110&author=X.+Zhangauthor=J.+E.+Tellewauthor=Z.+Luoauthor=M.+Moorjaniauthor=E.+Linauthor=M.+C.+Lanierauthor=Y.+Chenauthor=J.+P.+Williamsauthor=J.+Saundersauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=T.+Joswigauthor=R.+Petroskiauthor=J.+Pierceyauthor=W.+Kargoauthor=S.+Malanyauthor=M.+Santosauthor=R.+S.+Grossauthor=J.+Wenauthor=K.+Jalaliauthor=Z.+O%E2%80%99Brienauthor=C.+E.+Stotzauthor=M.+I.+Crespoauthor=J.-L.+Diazauthor=D.+H.+Slee&title=Lead+optimization+of+4-acetylamino-2-%283%2C5-dimetylpyrazol-1yl%29-6-pyridylpyrimidines+as+A2A+adenosine+receptor+antagonists+for+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1021%2Fjm800851u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800851u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DPiercey%26aufirst%3DJ.%26aulast%3DKargo%26aufirst%3DW.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DStotz%26aufirst%3DC.%2BE.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSlee%26aufirst%3DD.%2BH.%26atitle%3DLead%2520optimization%2520of%25204-acetylamino-2-%25283%252C5-dimetylpyrazol-1yl%2529-6-pyridylpyrimidines%2520as%2520A2A%2520adenosine%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7099%26epage%3D7110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâBrien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, D. H.</span><span> </span><span class="NLM_article-title"><i>N</i>-[6-Amino-2-(heteroaryl)pyrimidine-4-yl]aceamides as A<sub>2A</sub> receptor antagonists with improved druglike properties and in vivo efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">â</span> <span class="NLM_lpage">717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800908d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=709-717&author=M.+C.+Lanierauthor=M.+Moorjaniauthor=Z.+Luoauthor=Y.+Chenauthor=E.+Linauthor=J.+E.+Tellewauthor=X.+Zhangauthor=J.+P.+Willamsauthor=R.+S.+Grossauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=T.+Joswigauthor=W.+Kargoauthor=J.+Pierceyauthor=M.+Santosauthor=S.+Malanyauthor=M.+Zhaoauthor=R.+Petroskiauthor=M.+I.+Crespoauthor=J.-L.+Diazauthor=J.+Saundersauthor=J.+Wenauthor=Z.+O%E2%80%99Brienauthor=K.+Jalaliauthor=A.+Madanauthor=D.+H.+Slee&title=N-%5B6-Amino-2-%28heteroaryl%29pyrimidine-4-yl%5Daceamides+as+A2A+receptor+antagonists+with+improved+druglike+properties+and+in+vivo+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1021%2Fjm800908d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800908d%26sid%3Dliteratum%253Aachs%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWillams%26aufirst%3DJ.%2BP.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DKargo%26aufirst%3DW.%26aulast%3DPiercey%26aufirst%3DJ.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DMadan%26aufirst%3DA.%26aulast%3DSlee%26aufirst%3DD.%2BH.%26atitle%3DN-%255B6-Amino-2-%2528heteroaryl%2529pyrimidine-4-yl%255Daceamides%2520as%2520A2A%2520receptor%2520antagonists%2520with%2520improved%2520druglike%2520properties%2520and%2520in%2520vivo%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D709%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span>In June, 2012, on the pipeline Web site, PBF509 was listed as being in phase I development as an adenosine A<sub>2A</sub> antagonist for the potential treatment of Parkinsonâs disease. <a href="http://www.palobiofarma.com" class="extLink">http://www.palobiofarma.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=In+June%2C+2012%2C+on+the+pipeline+Web+site%2C+PBF509+was+listed+as+being+in+phase+I+development+as+an+adenosine+A2A+antagonist+for+the+potential+treatment+of+Parkinson%E2%80%99s+disease.+http%3A%2F%2Fwww.palobiofarma.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group">Camacho Gomez, J. A.; Castro-Palomino Laria, J. C.</span><span> </span><span class="NLM_article-title">4-Aminopyrimidine Derivatives and Their Use as Adenosine A2a Receptor Antagonists</span>. PCT Int. Appl. WO2011121418 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+A.+Camacho+Gomez&author=J.+C.+Castro-Palomino+Laria&title=4-Aminopyrimidine+Derivatives+and+Their+Use+as+Adenosine+A2a+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCamacho%2BGomez%26aufirst%3DJ.%2BA.%26atitle%3D4-Aminopyrimidine%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Adenosine%2520A2a%2520Receptor%2520Antagonists%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group">Shiohara, H.; Nakamura, T.; Kobayashi, S.</span><span> </span><span class="NLM_article-title">Novel Benzofuran Derivative, Pharmaceutical Composition Comprising the Same, and Use of the Derivative or Composition</span>. PCT Int. Appl. WO2006115134 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=H.+Shiohara&author=T.+Nakamura&author=S.+Kobayashi&title=Novel+Benzofuran+Derivative%2C+Pharmaceutical+Composition+Comprising+the+Same%2C+and+Use+of+the+Derivative+or+Composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShiohara%26aufirst%3DH.%26atitle%3DNovel%2520Benzofuran%2520Derivative%252C%2520Pharmaceutical%2520Composition%2520Comprising%2520the%2520Same%252C%2520and%2520Use%2520of%2520the%2520Derivative%2520or%2520Composition%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group">Shiohara, H.; Nakamura, T.; Mukaiyama, H.; Kobayashi, S.; Jo, K.</span><span> </span><span class="NLM_article-title">Novel Furopyridine Derivative, Pharmaceutical Composition Comprising the Derivative, and Use of the Derivative or Composition</span>. PCT Int. Appl. WO2006137350 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=H.+Shiohara&author=T.+Nakamura&author=H.+Mukaiyama&author=S.+Kobayashi&author=K.+Jo&title=Novel+Furopyridine+Derivative%2C+Pharmaceutical+Composition+Comprising+the+Derivative%2C+and+Use+of+the+Derivative+or+Composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShiohara%26aufirst%3DH.%26atitle%3DNovel%2520Furopyridine%2520Derivative%252C%2520Pharmaceutical%2520Composition%2520Comprising%2520the%2520Derivative%252C%2520and%2520Use%2520of%2520the%2520Derivative%2520or%2520Composition%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group">Mishra, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barodia, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prakash, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, J. B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthra, P. M.</span><span> </span><span class="NLM_article-title">Novel 8-(furan-2-yl)-3-substituted thiazolo[5,4-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidine-2(3<i>H</i>)-thio derivatives as potential adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2491</span><span class="NLM_x">â</span> <span class="NLM_lpage">2500</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2491-2500&author=C.+B.+Mishraauthor=S.+K.+Barodiaauthor=A.+Prakashauthor=J.+B.+S.+Kumarauthor=P.+M.+Luthra&title=Novel+8-%28furan-2-yl%29-3-substituted+thiazolo%5B5%2C4-e%5D%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-c%5Dpyrimidine-2%283H%29-thio+derivatives+as+potential+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DC.%2BB.%26aulast%3DBarodia%26aufirst%3DS.%2BK.%26aulast%3DPrakash%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DJ.%2BB.%2BS.%26aulast%3DLuthra%26aufirst%3DP.%2BM.%26atitle%3DNovel%25208-%2528furan-2-yl%2529-3-substituted%2520thiazolo%255B5%252C4-e%255D%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-c%255Dpyrimidine-2%25283H%2529-thio%2520derivatives%2520as%2520potential%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2491%26epage%3D2500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group">McGinness, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brescia, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokosz, L. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannava, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimble, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wines, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadros, E.</span><span> </span><span class="NLM_article-title">Discovery of 2-aminoimidazopyridine adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6845</span><span class="NLM_x">â</span> <span class="NLM_lpage">6849</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6845-6849&author=B.+F.+McGinnessauthor=A.+G.+Coleauthor=G.+Dongauthor=M.-R.+Bresciaauthor=Y.+Shaoauthor=I.+Hendersonauthor=L.+L+Rokoszauthor=T.+M.+Staufferauthor=N.+Mannavaauthor=E.+F.+Kimbleauthor=C.+Hicksauthor=N.+Whiteauthor=P.+G.+Winesauthor=E.+Quadros&title=Discovery+of+2-aminoimidazopyridine+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGinness%26aufirst%3DB.%2BF.%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DBrescia%26aufirst%3DM.-R.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DHenderson%26aufirst%3DI.%26aulast%3DRokosz%26aufirst%3DL.%2BL%26aulast%3DStauffer%26aufirst%3DT.%2BM.%26aulast%3DMannava%26aufirst%3DN.%26aulast%3DKimble%26aufirst%3DE.%2BF.%26aulast%3DHicks%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DN.%26aulast%3DWines%26aufirst%3DP.%2BG.%26aulast%3DQuadros%26aufirst%3DE.%26atitle%3DDiscovery%2520of%25202-aminoimidazopyridine%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6845%26epage%3D6849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group">Shao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brescia, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokosz, L. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuniiess, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, L.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of trisubsituted purinones as potent and selective adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">â</span> <span class="NLM_lpage">1402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1399-1402&author=Y.+Shaoauthor=A.+G.+Coleauthor=M.-R.+Bresciaauthor=L.-Y.+Qinauthor=J.+Duoauthor=T.+M.+Staufferauthor=L.+L+Rokoszauthor=B.+F.+McGuniiessauthor=L.+Henderson&title=Synthesis+and+SAR+studies+of+trisubsituted+purinones+as+potent+and+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DY.%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DBrescia%26aufirst%3DM.-R.%26aulast%3DQin%26aufirst%3DL.-Y.%26aulast%3DDuo%26aufirst%3DJ.%26aulast%3DStauffer%26aufirst%3DT.%2BM.%26aulast%3DRokosz%26aufirst%3DL.%2BL%26aulast%3DMcGuniiess%26aufirst%3DB.%2BF.%26aulast%3DHenderson%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520trisubsituted%2520purinones%2520as%2520potent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1399%26epage%3D1402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span>Thomson Reuters Pharma. <a href="https://www.thomson-pharma.com/portal/page/portal/Reports/DRUG%20TABBED%20REPORT?_dummy&#xA;=y&amp;" class="extLink">https://www.thomson-pharma.com/portal/page/portal/Reports/DRUG%20TABBED%20REPORT?_dummy =y&</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomson+Reuters+Pharma.+https%3A%2F%2Fwww.thomson-pharma.com%2Fportal%2Fpage%2Fportal%2FReports%2FDRUG%2520TABBED%2520REPORT%3F_dummy+%3Dy%26."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196a"><span><span class="NLM_label">(a) </span>Thomson Reuters Pharma. <a href="https://www.thomson-pharma.com/portal/page/portal/Reports/DRUG%20TABBED%20REPORT?_&#xA;dummy=y&amp;" class="extLink">https://www.thomson-pharma.com/portal/page/portal/Reports/DRUG%20TABBED%20REPORT?_ dummy=y&</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomson+Reuters+Pharma.+https%3A%2F%2Fwww.thomson-pharma.com%2Fportal%2Fpage%2Fportal%2FReports%2FDRUG%2520TABBED%2520REPORT%3F_+dummy%3Dy%26."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit196b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ivachtchenko, A. V.; Mitkin, O. D.; Kadieva, M. G.; Okun, I. M.</span><span> </span><span class="NLM_article-title">Substituted Phenoxyacetic Acids and Esters and Amides Thereof, Comprising a 2,6-Dioxo-2,3,6,7-tetrahydro-1<i>H</i>-purine-8-yl fragment and constituting A<sub>2A</sub> Adenosine Receptor Antagonists, and the Use Thereof</span>. PCT Int. Appl. WO2013058681 A2,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+V.+Ivachtchenko&author=O.+D.+Mitkin&author=M.+G.+Kadieva&author=I.+M.+Okun&title=Substituted+Phenoxyacetic+Acids+and+Esters+and+Amides+Thereof%2C+Comprising+a+2%2C6-Dioxo-2%2C3%2C6%2C7-tetrahydro-1H-purine-8-yl+fragment+and+constituting+A2A+Adenosine+Receptor+Antagonists%2C+and+the+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DIvachtchenko%26aufirst%3DA.%2BV.%26atitle%3DSubstituted%2520Phenoxyacetic%2520Acids%2520and%2520Esters%2520and%2520Amides%2520Thereof%252C%2520Comprising%2520a%25202%252C6-Dioxo-2%252C3%252C6%252C7-tetrahydro-1H-purine-8-yl%2520fragment%2520and%2520constituting%2520A2A%2520Adenosine%2520Receptor%2520Antagonists%252C%2520and%2520the%2520Use%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mishina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naganawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, K.</span><span> </span><span class="NLM_article-title">Evaluation of distribution of adenosine A<sub>2A</sub> receptors in normal human brain measured with [<sup>11</sup>C]-TMSX PET</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">â</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=778-784&author=M.+Mishinaauthor=K.+Ishiwataauthor=Y.+Kimuraauthor=M.+Naganawaauthor=K.+Odaauthor=S.+Kobayashiauthor=Y.+Katayamaauthor=K.+Ishii&title=Evaluation+of+distribution+of+adenosine+A2A+receptors+in+normal+human+brain+measured+with+%5B11C%5D-TMSX+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMishina%26aufirst%3DM.%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DNaganawa%26aufirst%3DM.%26aulast%3DOda%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DKatayama%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DK.%26atitle%3DEvaluation%2520of%2520distribution%2520of%2520adenosine%2520A2A%2520receptors%2520in%2520normal%2520human%2520brain%2520measured%2520with%2520%255B11C%255D-TMSX%2520PET%26jtitle%3DSynapse%26date%3D2007%26volume%3D61%26spage%3D778%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit197b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mishina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naganawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, K.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptors measured with [<sup>11</sup>C]-TMSX PET in the striata of Parkinsonâs disease patients</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">e17338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e17338&issue=2&author=M.+Mishinaauthor=K.+Ishiwataauthor=Y.+Kimuraauthor=M.+Naganawaauthor=S.+Kitamuraauthor=M.+Suzukiauthor=M.+Hashimotoauthor=K.+Ishibashiauthor=K.+Odaauthor=M.+Sakataauthor=M.+Hamamotoauthor=S.+Kobayashiauthor=Y.+Katayamaauthor=K.+Ishii&title=Adenosine+A2A+receptors+measured+with+%5B11C%5D-TMSX+PET+in+the+striata+of+Parkinson%E2%80%99s+disease+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMishina%26aufirst%3DM.%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DNaganawa%26aufirst%3DM.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DIshibashi%26aufirst%3DK.%26aulast%3DOda%26aufirst%3DK.%26aulast%3DSakata%26aufirst%3DM.%26aulast%3DHamamoto%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DKatayama%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DK.%26atitle%3DAdenosine%2520A2A%2520receptors%2520measured%2520with%2520%255B11C%255D-TMSX%2520PET%2520in%2520the%2520striata%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D2%26spage%3De17338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group">Zocchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span> </span><span class="NLM_article-title">Binding of the radioligand [<sup>3</sup>H]-SCH58261, a new non-xanthine A<sub>2A</sub> adenosine receptor antagonist, to rat striatal membranes</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">â</span> <span class="NLM_lpage">1386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1111%2Fj.1476-5381.1996.tb15296.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=8730729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK28XisFensbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1996&pages=1381-1386&author=C.+Zocchiauthor=E.+Onginiauthor=S.+Ferraraauthor=P.+G.+Baraldiauthor=S.+Dionisotti&title=Binding+of+the+radioligand+%5B3H%5D-SCH58261%2C+a+new+non-xanthine+A2A+adenosine+receptor+antagonist%2C+to+rat+striatal+membranes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes</span></div><div class="casAuthors">Zocchi, Cristina; Ongini, Ennio; Ferrara, Silvia; Baraldi, Pier Giovanni; Dionisotti, Silvio</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1381-6</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The present study describes the binding to rat striatal A2A adenosine receptors of the new potent and selective antagonist radioligand, [3H]-5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine, [3H]-SCH 58261.  [3H]-SCH 58261 specific binding to rat striatal membranes (>90%) was saturable, reversible and dependent upon protein concn.  Satn. expts. revealed that [3H]-SCH 58261 labeled a single class of recognition sites with high affinity (Kd = 0.70 nM) and limited capacity (apparent Bmax = 971 fmol mg-1 of protein).  The presence of 100 Î¼M GTP in the incubation mixt. did not modify [3H]-SCH 58261 binding parameters.  Competition expts. showed that [3H]-SCH 58261 binding is consistent with the labeling of A2A striatal receptors.  Adenosine receptor agonists competed with the binding of 0.2 nM [3H]-SCH 58261 with the following order of potency: 2-hexynyl-5'-ethylcarboxamidoadenosine (2HE-NECA)>5'-N-ethylcarboxamidoadenosine (NECA)>2-[4-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine (CGS 21680)>2-phenylaminoadenosine (CV 1808)>R-N6-phenylisopropyladenosine (R-PIA)>N6-cyclohexyladenosine (CCPA)>S-N6-phenylisopropyladenosine (S-PIA).  Adenosine antagonists inhibited [3H]-SCH 58261 binding in the following order: 5-amino-9-chloro-2-(furyl)-[1,2,4]-triazolo[1,5-c]quinazoline (CGS 15943)>5-amino-8-(4-fluorobenzyl)-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine (8FB-PTP)=SCH 58261>xanthine amine congener (XAC)=(E,18%-Z,82%)7-methyl-8-(3,4-dimethoxystyryl)-1,3-dipropylxanthine (KF 17837S)>8-cyclopentyl-1,3-dipropylxanthine (DPCPX)â¥8-phenyltheophylline (8-PT).  The Ki values for adenosine antagonists were similar to those labeled with the A2A agonist [3H]-CGS 21680.  Affinities of agonists were generally lower.  The A1-selective agonist, R-PIA, was found to be about 9 fold more potent than its stereoisomer, S-PIA, thus showing the stereoselectivity of [3H]-SCH 58261 binding.  Except for 8-PT, the adenosine agonists and antagonists examd. inhibited [3H]-SCH 58261 binding with Hill coeffs. not significantly different from unity.  The present results indicate that [3H]-SCH 58261 is the first non-xanthine adenosine antagonist radioligand which directly labels A2A striatal receptors.  High receptor affinity, good selectivity and very low non-specific binding make [3H]-SCH 58261 an excellent probe for studying the A2A adenosine receptor subtype in mammalian brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv6NZsS5vYirVg90H21EOLACvtfcHk0lhG_pwE1pTj0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisFensbY%253D&md5=4908046838559424aea1aa319bd33167</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb15296.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb15296.x%26sid%3Dliteratum%253Aachs%26aulast%3DZocchi%26aufirst%3DC.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DFerrara%26aufirst%3DS.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DDionisotti%26aufirst%3DS.%26atitle%3DBinding%2520of%2520the%2520radioligand%2520%255B3H%255D-SCH58261%252C%2520a%2520new%2520non-xanthine%2520A2A%2520adenosine%2520receptor%2520antagonist%252C%2520to%2520rat%2520striatal%2520membranes%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D117%26spage%3D1381%26epage%3D1386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shryok, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruble, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. P.</span><span> </span><span class="NLM_article-title">Binding of the novel nonxanthine A<sub>2A</sub> adenosine receptor antagonist [<sup>3</sup>H]-SCH58261 to coronary artery membranes</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1153</span><span class="NLM_x">â</span> <span class="NLM_lpage">1160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1996&pages=1153-1160&author=L.+Belardinelliauthor=J.+C.+Shryokauthor=J.+Rubleauthor=A.+Monopoliauthor=S.+Dionisottiauthor=E.+Onginiauthor=D.+M.+Dennisauthor=S.+P.+Baker&title=Binding+of+the+novel+nonxanthine+A2A+adenosine+receptor+antagonist+%5B3H%5D-SCH58261+to+coronary+artery+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DShryok%26aufirst%3DJ.%2BC.%26aulast%3DRuble%26aufirst%3DJ.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DDennis%26aufirst%3DD.%2BM.%26aulast%3DBaker%26aufirst%3DS.%2BP.%26atitle%3DBinding%2520of%2520the%2520novel%2520nonxanthine%2520A2A%2520adenosine%2520receptor%2520antagonist%2520%255B3H%255D-SCH58261%2520to%2520coronary%2520artery%2520membranes%26jtitle%3DCirc.%2520Res.%26date%3D1996%26volume%3D79%26spage%3D1153%26epage%3D1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Labeling of A<sub>2A</sub> adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [<sup>3</sup>H]-SCH58261</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1209</span><span class="NLM_x">â</span> <span class="NLM_lpage">1214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200a&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=8819504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200a&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADyaK28vhs1Ojuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1996&pages=1209-1214&issue=3&author=S.+Dionisottiauthor=S.+Ferraraauthor=C.+Moltaauthor=C.+Zocchiauthor=E.+Ongini&title=Labeling+of+A2A+adenosine+receptors+in+human+platelets+by+use+of+the+new+nonxanthine+antagonist+radioligand+%5B3H%5D-SCH58261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200aR"><div class="casContent"><span class="casTitleNuber">200a</span><div class="casTitle"><span class="NLM_cas:atitle">Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261</span></div><div class="casAuthors">Dionisotti S; Ferrara S; Molta C; Zocchi C; Ongini E</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1209-14</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The present study describes the binding to human platelet A2A adenosine receptors of the new potent and selective antagonist radioligand [3H]5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-e]-1,2,4-triazolo [1,5-c] pyrimidine ([3H]SCH 58261).  Saturation experiments revealed that [3H]SCH 58261 labels a single class of recognition sites with high affinity (Kd = 0.85 nM), limited capacity (apparent Bmax = 85 fmol/mg of protein) and good specific binding (about 60%). [3H]SCH 58261 binding was not modulated by either the divalent cation Mg(+2) or guanine nucleotides.  In competition experiments, a series of both adenosine agonists and antagonists inhibited [3H]SCH 58261 binding to A2A platelet receptors with rank order of potency and affinity similar to those observed in rat striatal membranes with the same radioligand.  This confirms that the platelet A2A receptor is similar to that labeled in the brain striatum.  Binding data were also found to be in good agreement with the results from functional studies such as A2A agonist-induced stimulation of adenylate cyclase or platelet aggregation inhibition.  The present findings indicate that [3H]SCH 58261 is the first radioligand available for the characterization of the A2A receptor subtype in platelets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSaFsw8-qb6flw2ofyr07jXfW6udTcc2eazIwYukw4Htbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28vhs1Ojuw%253D%253D&md5=36316e4a277567d4697c2a86fc93e2d8</span></div><a href="/servlet/linkout?suffix=cit200a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DFerrara%26aufirst%3DS.%26aulast%3DMolta%26aufirst%3DC.%26aulast%3DZocchi%26aufirst%3DC.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DLabeling%2520of%2520A2A%2520adenosine%2520receptors%2520in%2520human%2520platelets%2520by%2520use%2520of%2520the%2520new%2520nonxanthine%2520antagonist%2520radioligand%2520%255B3H%255D-SCH58261%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1996%26volume%3D278%26issue%3D3%26spage%3D1209%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit200b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]-SCH58261 labeling of functional A<sub>2A</sub> adenosine receptors in human neutrophil membranes</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1723</span><span class="NLM_x">â</span> <span class="NLM_lpage">1731</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1038%2Fsj.bjp.0701758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9605581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1cXislarsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1998&pages=1723-1731&issue=8&author=K.+Varaniauthor=S.+Gessiauthor=S.+Dionisottiauthor=E.+Onginiauthor=P.+A.+Borea&title=%5B3H%5D-SCH58261+labeling+of+functional+A2A+adenosine+receptors+in+human+neutrophil+membranes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200bR"><div class="casContent"><span class="casTitleNuber">200b</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]-SCH 58261 labeling of functional A2A adenosine receptors in human neutrophil membranes</span></div><div class="casAuthors">Varani, Katia; Gessi, Stefania; Dionisotti, Silvio; Ongini, Ennio; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1723-1731</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The present study describes the direct labeling of A2A adenosine receptors in human neutrophil membranes with the potent and selective antagonist radioligand, [3H]-SCH 58261.  In addn., both receptor affinity and potency of a no. of adenosine receptor agonists and antagonists were detd. in binding, adenylyl cyclase and superoxide anion prodn. assays.  Satn. expts. revealed a single class of binding sites with Kd and Bmax values of 1.34 nM and 75 fmol mg-1 protein, resp.  Adenosine receptor ligands competed for the binding of 1 nM [3H]-SCH 58261 to human neutrophil membranes, with a rank order of potency consistent with that typically found for interactions with the A2A adenosine receptors.  In the adenylyl cyclase and in the superoxide anion prodn. assays the same compds. exhibited a rank order of potency identical to that obsd. in binding expts.  Thermodn. data indicated that [3H]-SCH 58261 binding to human neutrophils is entropy and enthalpy-driven.  This finding is in agreement with the thermodn. behavior of antagonists binding to rat striatal A2A adenosine receptors.  It was concluded that in human neutrophil membranes, [3H]-SCH 58261 directly labels binding sites with pharmacol. properties similar to those of A2A adenosine receptors of other tissues.  The receptors labeled by [3H]-SCH 58261 mediated the effects of adenosine and adenosine receptor agonists to stimulate cAMP accumulation and inhibition of superoxide anion prodn. in human neutrophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWvXET6hg7irVg90H21EOLACvtfcHk0lhG_pwE1pTj0A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislarsbg%253D&md5=442232e102df7b0dec587c2cbc49600c</span></div><a href="/servlet/linkout?suffix=cit200b&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0701758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0701758%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3D%255B3H%255D-SCH58261%2520labeling%2520of%2520functional%2520A2A%2520adenosine%2520receptors%2520in%2520human%2520neutrophil%2520membranes%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D123%26issue%3D8%26spage%3D1723%26epage%3D1731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalpiaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Characterization of A<sub>2A</sub> adenosine receptors in human lymphocyte membranes by . [<sup>3</sup>H]-SCH58261 binding</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">386</span><span class="NLM_x">â</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1038%2Fsj.bjp.0701378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9313951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK2sXmtlyqsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1997&pages=386-392&issue=2&author=K.+Varaniauthor=S.+Gessiauthor=A.+Dalpiazauthor=E.+Onginiauthor=P.+A.+Borea&title=Characterization+of+A2A+adenosine+receptors+in+human+lymphocyte+membranes+by+.+%5B3H%5D-SCH58261+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding</span></div><div class="casAuthors">Varani, Katia; Gessi, Stefania; Dalpiaz, Alessandro; Ongini, Ennio; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">386-392</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The present study describes for the first time the characterization of the adenosine A2A receptor in human lymphocyte membranes with the new potent and selective antagonist radioligand, [3H]-5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine, ([3H]-SCH 58261).  In addn., both receptor affinity and potency of ref. adenosine receptor agonists and antagonists were detd. in binding and adenylyl cyclase studies.  Satn. expts. revealed a single class of binding sites with Kd and Bmax values of 0.85 nM and 35 fmol mg-1 protein, resp.  A series of adenosine receptor ligands were found to compete for the binding of 0.8 nM [3H]-SCH 58261 to human lymphocyte membranes with a rank order of potency consistent with that typically found for interactions with the A2A-adenosine receptor.  In the adenylyl cyclase assay the same compds. exhibited a rank order of potency similar to that obsd. in binding expts.  Thermodn. data indicate that [3H]-SCH 57251 binding to human lymphocytes is entropy and enthalpy-driven, a finding in agreement with the thermodn. behavior of antagonists for rat striatal A2A-adenosine receptors.  It is concluded that in human lymphocyte membranes [3H]-SCH 58261 directly labels binding sites showing the characteristic properties of the adenosine A2A-receptor.  The presence of A2A-receptors in peripheral tissue such as human lymphocytes strongly suggests an important role for adenosine in modulating immune and inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn-wwjaPvaerVg90H21EOLACvtfcHk0lhPNdir5jXayQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtlyqsL0%253D&md5=9187e79f45b951159585f617291f5463</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0701378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0701378%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DDalpiaz%26aufirst%3DA.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DCharacterization%2520of%2520A2A%2520adenosine%2520receptors%2520in%2520human%2520lymphocyte%2520membranes%2520by%2520.%2520%255B3H%255D-SCH58261%2520binding%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D122%26issue%3D2%26spage%3D386%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]-SCH58261, a selective adenosine A<sub>2A</sub> receptor antagonist, is a useful ligand in autoradiographic studies</span> <span class="citation_source-journal">Neurochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1210</span><span class="NLM_x">â</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1046%2Fj.1471-4159.1998.70031210.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9489743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1cXht1yru74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1998&pages=1210-1216&issue=3&author=B.+B.+Fredholmauthor=K.+Lindstromauthor=S.+Dionisottiauthor=E.+Ongini&title=%5B3H%5D-SCH58261%2C+a+selective+adenosine+A2A+receptor+antagonist%2C+is+a+useful+ligand+in+autoradiographic+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]SCH 58261, a selective adenosine A2A receptor antagonist, is a useful ligand in autoradiographic studies</span></div><div class="casAuthors">Fredholm, Bertil B.; Lindstrom, Karin; Dionisotti, Silvio; Ongini, Ennio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1210-1216</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">We have characterized the new potent and selective nonxanthine adenosine A2A receptor antagonist SCH 58261 as a new radioligand for receptor autoradiog.  In autoradiog. studies using agonist radioligands for A2A receptors ([3H] CGS 21680) or A1 receptors (N6-[3H]cyclohexyladenosine), it was found that SCH 58261 is close to 800-fold selective for rat brain A2A vs. A1 receptors (Ki values of 1.2 nM vs. 0.8 Î¼M).  Moreover, receptor autoradiog. showed that [3H]SCH 58261, in concns. below 2 nM, binds only to the dopamine-rich regions of the rat brain, with a KD value of 1.4 (0.8-1.8) nM.  The maximal no. of binding sites was 310 fmol/mg of protein in the striatum.  Below concns. of 3 nM, the nonspecific binding was <15%.  Three adenosine analogs displaced all specific binding of [3H]SCH 58261 with the following estd. Ki values (nM): 2-hex-1-ynyl-5'-N-ethylcarboxamidoadenosine, 3.9 (1.8-8.4); CGS 21680, 130 (42-405); N6-cyclohexyladenosine, 9,985 (3,169-31,462).  The binding of low concns. of SCH 58261 was not influenced by either GTP (100 Î¼M) or Mg2+ (10 mM).  The present results show that in its tritium-labeled form, SCH 58261 appears to be a good radioligand for autoradiog. studies, because it does not suffer from some of the problems encountered with the currently used agonist radioligand [3H]CGS 21680.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq_GQSALPBwLVg90H21EOLACvtfcHk0lhPNdir5jXayQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXht1yru74%253D&md5=f3364bca00ef72a19d29b86596a31046</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1998.70031210.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1998.70031210.x%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DLindstrom%26aufirst%3DK.%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3D%255B3H%255D-SCH58261%252C%2520a%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonist%252C%2520is%2520a%2520useful%2520ligand%2520in%2520autoradiographic%2520studies%26jtitle%3DNeurochemistry%26date%3D1998%26volume%3D70%26issue%3D3%26spage%3D1210%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group">Todde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moresco, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matarrese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienle, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, F.</span><span> </span><span class="NLM_article-title">Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A<sub>2A</sub> receptor system using positron emmision tomography</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">4359</span><span class="NLM_x">â</span> <span class="NLM_lpage">4362</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0009843" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4359-4362&issue=23&author=S.+Toddeauthor=R.+M.+Morescoauthor=P.+Simonelliauthor=P.+G.+Baraldiauthor=B.+Cacciariauthor=G.+Spallutoauthor=K.+Varaniauthor=A.+Monopoliauthor=M.+Matarreseauthor=A.+Carpinelliauthor=F.+Magniauthor=M.+G.+Kienleauthor=F.+Fazio&title=Design%2C+radiosynthesis%2C+and+biodistribution+of+a+new+potent+and+selective+ligand+for+in+vivo+imaging+of+the+adenosine+A2A+receptor+system+using+positron+emmision+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1021%2Fjm0009843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0009843%26sid%3Dliteratum%253Aachs%26aulast%3DTodde%26aufirst%3DS.%26aulast%3DMoresco%26aufirst%3DR.%2BM.%26aulast%3DSimonelli%26aufirst%3DP.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DMatarrese%26aufirst%3DM.%26aulast%3DCarpinelli%26aufirst%3DA.%26aulast%3DMagni%26aufirst%3DF.%26aulast%3DKienle%26aufirst%3DM.%2BG.%26aulast%3DFazio%26aufirst%3DF.%26atitle%3DDesign%252C%2520radiosynthesis%252C%2520and%2520biodistribution%2520of%2520a%2520new%2520potent%2520and%2520selective%2520ligand%2520for%2520in%2520vivo%2520imaging%2520of%2520the%2520adenosine%2520A2A%2520receptor%2520system%2520using%2520positron%2520emmision%2520tomography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D23%26spage%3D4359%26epage%3D4362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group">Brooks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papapetropoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenhende, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâNeill, G.</span><span> </span><span class="NLM_article-title">An open-label, positron emission tomography study to assess adenosine A<sub>2A</sub> brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">55</span><span class="NLM_x">â</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=55-60&issue=2&author=D.+J.+Brooksauthor=S.+Papapetropoulosauthor=F.+Vandenhendeauthor=D.+Tomicauthor=A.+Coppellauthor=G.+O%E2%80%99Neill&title=An+open-label%2C+positron+emission+tomography+study+to+assess+adenosine+A2A+brain+receptor+occupancy+of+vipadenant+%28BIIB014%29+at+steady-state+levels+in+healthy+male+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DPapapetropoulos%26aufirst%3DS.%26aulast%3DVandenhende%26aufirst%3DF.%26aulast%3DTomic%26aufirst%3DD.%26aulast%3DCoppell%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DG.%26atitle%3DAn%2520open-label%252C%2520positron%2520emission%2520tomography%2520study%2520to%2520assess%2520adenosine%2520A2A%2520brain%2520receptor%2520occupancy%2520of%2520vipadenant%2520%2528BIIB014%2529%2520at%2520steady-state%2520levels%2520in%2520healthy%2520male%2520volunteers%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2010%26volume%3D33%26issue%3D2%26spage%3D55%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28a','cit28b'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36a','cit36b'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57a','cit57b'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124a','cit124b'],'ref125':['cit125'],'ref126':['cit126a','cit126b'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131a','cit131b','cit131c','cit131d','cit131e','cit131f'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134a','cit134b','cit134c'],'ref135':['cit135a','cit135b','cit135c','cit135d'],'ref136':['cit136a','cit136b','cit136c'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173a','cit173b','cit173c'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196a','cit196b'],'ref197':['cit197a','cit197b'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200a','cit200b'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 161 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yan Lu, Hongyue Liu, Dehua Yang, Li Zhong, Ye Xin, Suwen Zhao, Ming-Wei Wang, Qingtong Zhou, <span class="NLM_string-name hlFld-ContribAuthor">Wenqing Shui</span>. </span><span class="cited-content_cbyCitation_article-title">Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A2A Receptor Targeting the Sodium Ion Pocket. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2021,</strong> <em>16 </em>
                                    (6)
                                     , 991-1002. <a href="https://doi.org/10.1021/acschembio.0c00899" title="DOI URL">https://doi.org/10.1021/acschembio.0c00899</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.0c00899&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.0c00899%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DAffinity%252BMass%252BSpectrometry-Based%252BFragment%252BScreening%252BIdentified%252Ba%252BNew%252BNegative%252BAllosteric%252BModulator%252Bof%252Bthe%252BAdenosine%252BA2A%252BReceptor%252BTargeting%252Bthe%252BSodium%252BIon%252BPocket%26aulast%3DLu%26aufirst%3DYan%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D21112020%26date%3D29042021%26date%3D28052021%26volume%3D16%26issue%3D6%26spage%3D991%26epage%3D1002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Giuseppe Faudone, Silvia Arifi, <span class="NLM_string-name hlFld-ContribAuthor">Daniel Merk</span>. </span><span class="cited-content_cbyCitation_article-title">The Medicinal Chemistry of Caffeine. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7156-7178. <a href="https://doi.org/10.1021/acs.jmedchem.1c00261" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00261</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00261%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BMedicinal%252BChemistry%252Bof%252BCaffeine%26aulast%3DFaudone%26aufirst%3DGiuseppe%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D09022021%26date%3D21052021%26volume%3D64%26issue%3D11%26spage%3D7156%26epage%3D7178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yuta Takamura, <span class="NLM_string-name hlFld-ContribAuthor">Hiroki Kakuta</span>. </span><span class="cited-content_cbyCitation_article-title">In Vivo Receptor Visualization and Evaluation of Receptor Occupancy with Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (9)
                                     , 5226-5251. <a href="https://doi.org/10.1021/acs.jmedchem.0c01714" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01714</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01714&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01714%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIn%252BVivo%252BReceptor%252BVisualization%252Band%252BEvaluation%252Bof%252BReceptor%252BOccupancy%252Bwith%252BPositron%252BEmission%252BTomography%26aulast%3DTakamura%26aufirst%3DYuta%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D30092020%26date%3D27042021%26volume%3D64%26issue%3D9%26spage%3D5226%26epage%3D5251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jin Cheng, Maozi Chen, Siyi Wang, Tianjian Liang, Hui Chen, Chih-Jung Chen, Zhiwei Feng, <span class="NLM_string-name hlFld-ContribAuthor">Xiang-Qun Xie</span>. </span><span class="cited-content_cbyCitation_article-title">Binding Characterization of Agonists and Antagonists by MCCS: A Case Study from Adenosine A2A Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2021,</strong> <em>12 </em>
                                    (9)
                                     , 1606-1620. <a href="https://doi.org/10.1021/acschemneuro.1c00082" title="DOI URL">https://doi.org/10.1021/acschemneuro.1c00082</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.1c00082&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.1c00082%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DBinding%252BCharacterization%252Bof%252BAgonists%252Band%252BAntagonists%252Bby%252BMCCS%25253A%252BA%252BCase%252BStudy%252Bfrom%252BAdenosine%252BA2A%252BReceptor%26aulast%3DCheng%26aufirst%3DJin%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D10022021%26date%3D31032021%26date%3D15042021%26volume%3D12%26issue%3D9%26spage%3D1606%26epage%3D1620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Fazhi Yu, Chenyu Zhu, Qiong Xie, <span class="NLM_string-name hlFld-ContribAuthor">Yonghui Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine A2A Receptor Antagonists for Cancer Immunotherapy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (21)
                                     , 12196-12212. <a href="https://doi.org/10.1021/acs.jmedchem.0c00237" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00237</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00237%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAdenosine%252BA2A%252BReceptor%252BAntagonists%252Bfor%252BCancer%252BImmunotherapy%26aulast%3DYu%26aufirst%3DFazhi%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D10022020%26date%3D30072020%26date%3D15072020%26volume%3D63%26issue%3D21%26spage%3D12196%26epage%3D12212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Ana Mallo-Abreu, RubÃ©n Prieto-DÃ­az, Willem Jespers, Jhonny Azuaje, Maria Majellaro, Carmen Velando, Xerardo GarcÃ­a-Mera, Olga CaamaÃ±o, JosÃ© Brea, MarÃ­a I. Loza, Hugo GutiÃ©rrez-de-TerÃ¡n, <span class="NLM_string-name hlFld-ContribAuthor">Eddy Sotelo</span>. </span><span class="cited-content_cbyCitation_article-title">Nitrogen-Walk Approach to Explore Bioisosteric Replacements in a Series of Potent A2B Adenosine Receptor Antagonists. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (14)
                                     , 7721-7739. <a href="https://doi.org/10.1021/acs.jmedchem.0c00564" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00564</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c00564%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNitrogen-Walk%252BApproach%252Bto%252BExplore%252BBioisosteric%252BReplacements%252Bin%252Ba%252BSeries%252Bof%252BPotent%252BA2B%252BAdenosine%252BReceptor%252BAntagonists%26aulast%3DMallo-Abreu%26aufirst%3DAna%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D06042020%26date%3D07072020%26date%3D23062020%26volume%3D63%26issue%3D14%26spage%3D7721%26epage%3D7739" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Eleonora Comeo, Nicholas D. Kindon, Mark Soave, Leigh A. Stoddart, Laura E. Kilpatrick, Peter J. Scammells, Stephen J. Hill, <span class="NLM_string-name hlFld-ContribAuthor">Barrie Kellam</span>. </span><span class="cited-content_cbyCitation_article-title">Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A2A Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (5)
                                     , 2656-2672. <a href="https://doi.org/10.1021/acs.jmedchem.9b01856" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01856</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01856&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01856%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSubtype-Selective%252BFluorescent%252BLigands%252Bas%252BPharmacological%252BResearch%252BTools%252Bfor%252Bthe%252BHuman%252BAdenosine%252BA2A%252BReceptor%26aulast%3DComeo%26aufirst%3DEleonora%26date%3D2020%26date%3D2019%26date%3D2019%26date%3D08112019%26date%3D09012020%26date%3D30122019%26volume%3D63%26issue%3D5%26spage%3D2656%26epage%3D2672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jinan Wang, <span class="NLM_string-name hlFld-ContribAuthor">Yinglong Miao</span>. </span><span class="cited-content_cbyCitation_article-title">Mechanistic Insights into Specific G Protein Interactions with Adenosine Receptors. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Physical Chemistry B</span><span> <strong>2019,</strong> <em>123 </em>
                                    (30)
                                     , 6462-6473. <a href="https://doi.org/10.1021/acs.jpcb.9b04867" title="DOI URL">https://doi.org/10.1021/acs.jpcb.9b04867</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jpcb.9b04867&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jpcb.9b04867%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Physical%2520Chemistry%2520B%26atitle%3DMechanistic%252BInsights%252Binto%252BSpecific%252BG%252BProtein%252BInteractions%252Bwith%252BAdenosine%252BReceptors%26aulast%3DWang%26aufirst%3DJinan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D22052019%26date%3D22062019%26date%3D22072019%26date%3D08072019%26volume%3D123%26issue%3D30%26spage%3D6462%26epage%3D6473" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yan Lu, Shanshan Qin, Bingjie Zhang, Antao Dai, Xiaoqing Cai, Mengna Ma, Zhan-Guo Gao, Dehua Yang, Raymond C. Stevens, Kenneth A. Jacobson, Ming-Wei Wang, <span class="NLM_string-name hlFld-ContribAuthor">Wenqing Shui</span>. </span><span class="cited-content_cbyCitation_article-title">Accelerating the Throughput of Affinity Mass Spectrometry-Based Ligand Screening toward a G Protein-Coupled Receptor. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2019,</strong> <em>91 </em>
                                    (13)
                                     , 8162-8169. <a href="https://doi.org/10.1021/acs.analchem.9b00477" title="DOI URL">https://doi.org/10.1021/acs.analchem.9b00477</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.9b00477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.9b00477%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DAccelerating%252Bthe%252BThroughput%252Bof%252BAffinity%252BMass%252BSpectrometry-Based%252BLigand%252BScreening%252Btoward%252Ba%252BG%252BProtein-Coupled%252BReceptor%26aulast%3DLu%26aufirst%3DYan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D26012019%26date%3D16052019%26date%3D12062019%26date%3D16052019%26volume%3D91%26issue%3D13%26spage%3D8162%26epage%3D8169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Dongxiang Xue, Jingjing Wang, Xiyong Song, Wei Wang, Tao Hu, Lintao Ye, Yang Liu, Qingtong Zhou, Fang Zhou, Zhong-Xing Jiang, Zhi-Jie Liu, <span class="NLM_string-name hlFld-ContribAuthor">Houchao Tao</span>. </span><span class="cited-content_cbyCitation_article-title">A Chemical Strategy for Amphiphile Replacement in Membrane Protein Research. </span><span class="cited-content_cbyCitation_journal-name">Langmuir</span><span> <strong>2019,</strong> <em>35 </em>
                                    (12)
                                     , 4319-4327. <a href="https://doi.org/10.1021/acs.langmuir.8b04072" title="DOI URL">https://doi.org/10.1021/acs.langmuir.8b04072</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.langmuir.8b04072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.langmuir.8b04072%26sid%3Dliteratum%253Aachs%26jtitle%3DLangmuir%26atitle%3DA%252BChemical%252BStrategy%252Bfor%252BAmphiphile%252BReplacement%252Bin%252BMembrane%252BProtein%252BResearch%26aulast%3DXue%26aufirst%3DDongxiang%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D2019%26date%3D07122018%26date%3D10022019%26date%3D12032019%26date%3D19022019%26volume%3D35%26issue%3D12%26spage%3D4319%26epage%3D4327" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiyue Zheng, Xiaohu Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Xuechu Zhen</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Adenosine A2A Receptor Antagonists for the Treatment of Parkinsonâs Disease: A Recent Update and Challenge. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (2)
                                     , 783-791. <a href="https://doi.org/10.1021/acschemneuro.8b00313" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00313</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00313&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00313%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDevelopment%252Bof%252BAdenosine%252BA2A%252BReceptor%252BAntagonists%252Bfor%252Bthe%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%25253A%252BA%252BRecent%252BUpdate%252Band%252BChallenge%26aulast%3DZheng%26aufirst%3DJiyue%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26062018%26date%3D10092018%26date%3D21092018%26date%3D10092018%26volume%3D10%26issue%3D2%26spage%3D783%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Benjamin
J. Buckley, Ashraf Aboelela, Elahe Minaei, Longguang X. Jiang, Zhihong Xu, Umar Ali, Karen Fildes, Chen-Yi Cheung, Simon M. Cook, Darren C. Johnson, Daniel A. Bachovchin, Gregory M. Cook, Minoti Apte, Mingdong Huang, Marie Ranson, <span class="NLM_string-name hlFld-ContribAuthor">Michael J. Kelso</span>. </span><span class="cited-content_cbyCitation_article-title">6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (18)
                                     , 8299-8320. <a href="https://doi.org/10.1021/acs.jmedchem.8b00838" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00838</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00838%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3D6-Substituted%252BHexamethylene%252BAmiloride%252B%252528HMA%252529%252BDerivatives%252Bas%252BPotent%252Band%252BSelective%252BInhibitors%252Bof%252Bthe%252BHuman%252BUrokinase%252BPlasminogen%252BActivator%252Bfor%252BUse%252Bin%252BCancer%26aulast%3DBuckley%26aufirst%3DBenjamin%2BJ.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27052018%26date%3D07092018%26date%3D21082018%26volume%3D61%26issue%3D18%26spage%3D8299%26epage%3D8320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Panagiotis Lagarias, Eleni Vrontaki, George Lambrinidis, Dimitrios Stamatis, Marino Convertino, Gabriella Ortore, Thomas Mavromoustakos, Karl-Norbert Klotz, <span class="NLM_string-name hlFld-ContribAuthor">Antonios Kolocouris</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Adenosine Receptor Antagonists through a Combined Structure- and Ligand-Based Approach Followed by Molecular Dynamics Investigation of Ligand Binding Mode. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2018,</strong> <em>58 </em>
                                    (4)
                                     , 794-815. <a href="https://doi.org/10.1021/acs.jcim.7b00455" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00455</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00455&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00455%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BNovel%252BAdenosine%252BReceptor%252BAntagonists%252Bthrough%252Ba%252BCombined%252BStructure-%252Band%252BLigand-Based%252BApproach%252BFollowed%252Bby%252BMolecular%252BDynamics%252BInvestigation%252Bof%252BLigand%252BBinding%252BMode%26aulast%3DLagarias%26aufirst%3DPanagiotis%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D29072017%26date%3D19032018%26date%3D27022018%26volume%3D58%26issue%3D4%26spage%3D794%26epage%3D815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheng  Tian</span>, <span class="hlFld-ContribAuthor ">Xu  Wang</span>, <span class="hlFld-ContribAuthor ">Linlang  Li</span>, <span class="hlFld-ContribAuthor ">Xiaohu  Zhang</span>, <span class="hlFld-ContribAuthor ">Youyong  Li</span>, <span class="hlFld-ContribAuthor ">Feng  Zhu</span>, <span class="hlFld-ContribAuthor ">Tingjun  Hou</span>, and <span class="hlFld-ContribAuthor ">Xuechu  Zhen</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel and Selective Adenosine A2A Receptor Antagonists for Treating Parkinsonâs Disease through Comparative Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2017,</strong> <em>57 </em>
                                    (6)
                                     , 1474-1487. <a href="https://doi.org/10.1021/acs.jcim.7b00188" title="DOI URL">https://doi.org/10.1021/acs.jcim.7b00188</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.7b00188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.7b00188%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BNovel%252Band%252BSelective%252BAdenosine%252BA2A%252BReceptor%252BAntagonists%252Bfor%252BTreating%252BParkinson%2525E2%252580%252599s%252BDisease%252Bthrough%252BComparative%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DTian%26aufirst%3DSheng%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04042017%26date%3D15052017%26date%3D26062017%26date%3D02052017%26volume%3D57%26issue%3D6%26spage%3D1474%26epage%3D1487" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hideyuki  Muranaka</span>, <span class="hlFld-ContribAuthor ">Takaki  Momose</span>, <span class="hlFld-ContribAuthor ">Chiaki  Handa</span>, and <span class="hlFld-ContribAuthor ">Tomonaga  Ozawa</span>  . </span><span class="cited-content_cbyCitation_article-title">Photoaffinity Labeling of the Human A2A Adenosine Receptor and Cross-link Position Analysis by Mass Spectrometry. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>8 </em>
                                    (6)
                                     , 660-665. <a href="https://doi.org/10.1021/acsmedchemlett.7b00138" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.7b00138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.7b00138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.7b00138%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPhotoaffinity%252BLabeling%252Bof%252Bthe%252BHuman%252BA2A%252BAdenosine%252BReceptor%252Band%252BCross-link%252BPosition%252BAnalysis%252Bby%252BMass%252BSpectrometry%26aulast%3DMuranaka%26aufirst%3DHideyuki%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D28032017%26date%3D17052017%26date%3D22052017%26date%3D08062017%26date%3D17052017%26volume%3D8%26issue%3D6%26spage%3D660%26epage%3D665" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sujay  Basu</span>, <span class="hlFld-ContribAuthor ">Dinesh A.  Barawkar</span>, <span class="hlFld-ContribAuthor ">Sachin  Thorat</span>, <span class="hlFld-ContribAuthor ">Yogesh D.  Shejul</span>, <span class="hlFld-ContribAuthor ">Meena  Patel</span>, <span class="hlFld-ContribAuthor ">Minakshi  Naykodi</span>, <span class="hlFld-ContribAuthor ">Vaibhav  Jain</span>, <span class="hlFld-ContribAuthor ">Yogesh  Salve</span>, <span class="hlFld-ContribAuthor ">Vandna  Prasad</span>, <span class="hlFld-ContribAuthor ">Sumit  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Indraneel  Ghosh</span>, <span class="hlFld-ContribAuthor ">Ganesh  Bhat</span>, <span class="hlFld-ContribAuthor ">Azfar  Quraishi</span>, <span class="hlFld-ContribAuthor ">Harish  Patil</span>, <span class="hlFld-ContribAuthor ">Shariq  Ansari</span>, <span class="hlFld-ContribAuthor ">Suraj  Menon</span>, <span class="hlFld-ContribAuthor ">Vishal  Unadkat</span>, <span class="hlFld-ContribAuthor ">Rhishikesh  Thakare</span>, <span class="hlFld-ContribAuthor ">Madhav S.  Seervi</span>, <span class="hlFld-ContribAuthor ">Ashwinkumar V.  Meru</span>, <span class="hlFld-ContribAuthor ">Siddhartha  De</span>, <span class="hlFld-ContribAuthor ">Ravi K.  Bhamidipati</span>, <span class="hlFld-ContribAuthor ">Sreekanth R.  Rouduri</span>, <span class="hlFld-ContribAuthor ">Venkata P.  Palle</span>, <span class="hlFld-ContribAuthor ">Anita  Chug</span>, and <span class="hlFld-ContribAuthor ">Kasim A.  Mookhtiar</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A2A Receptor Antagonists and Their Biological Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (2)
                                     , 681-694. <a href="https://doi.org/10.1021/acs.jmedchem.6b01584" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b01584</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b01584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b01584%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%252Bof%252BNovel%25252C%252BPotent%25252C%252BSelective%25252C%252BOrally%252BBioavailable%252BAdenosine%252BA2A%252BReceptor%252BAntagonists%252Band%252BTheir%252BBiological%252BEvaluation%26aulast%3DBasu%26aufirst%3DSujay%26date%3D2017%26date%3D2017%26date%3D2016%26date%3D25102016%26date%3D17012017%26date%3D26012017%26date%3D05012017%26volume%3D60%26issue%3D2%26spage%3D681%26epage%3D694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaohui  Yang</span>, <span class="hlFld-ContribAuthor ">Linlang  Li</span>, <span class="hlFld-ContribAuthor ">Jiyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Haikuo  Ma</span>, <span class="hlFld-ContribAuthor ">Sheng  Tian</span>, <span class="hlFld-ContribAuthor ">Jiajun  Li</span>, <span class="hlFld-ContribAuthor ">Hongjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Xuechu  Zhen</span>, and <span class="hlFld-ContribAuthor ">Xiaohu  Zhang</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of a New Series of Potent Adenosine A2A Receptor Antagonists Based on 4-Amino-5-carbonitrile Pyrimidine Template for the Treatment of Parkinsonâs Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2016,</strong> <em>7 </em>
                                    (11)
                                     , 1575-1584. <a href="https://doi.org/10.1021/acschemneuro.6b00218" title="DOI URL">https://doi.org/10.1021/acschemneuro.6b00218</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.6b00218&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.6b00218%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DIdentification%252Bof%252Ba%252BNew%252BSeries%252Bof%252BPotent%252BAdenosine%252BA2A%252BReceptor%252BAntagonists%252BBased%252Bon%252B4-Amino-5-carbonitrile%252BPyrimidine%252BTemplate%252Bfor%252Bthe%252BTreatment%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DYang%26aufirst%3DZhaohui%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D26072016%26date%3D28082016%26date%3D09092016%26date%3D16112016%26date%3D28082016%26volume%3D7%26issue%3D11%26spage%3D1575%26epage%3D1584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandip B.  Bharate</span>, <span class="hlFld-ContribAuthor ">Baljinder  Singh</span>, <span class="hlFld-ContribAuthor ">Sonja  Kachler</span>, <span class="hlFld-ContribAuthor ">Ana  Oliveira</span>, <span class="hlFld-ContribAuthor ">Vikas  Kumar</span>, <span class="hlFld-ContribAuthor ">Sonali S.  Bharate</span>, <span class="hlFld-ContribAuthor ">Ram A.  Vishwakarma</span>, <span class="hlFld-ContribAuthor ">Karl-Norbert  Klotz</span>, and <span class="hlFld-ContribAuthor ">Hugo  GutiÃ©rrez de TerÃ¡n</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 7-(Prolinol-N-yl)-2-phenylamino-thiazolo[5,4-d]pyrimidines as Novel Non-Nucleoside Partial Agonists for the A2A Adenosine Receptor: Prediction from Molecular Modeling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (12)
                                     , 5922-5928. <a href="https://doi.org/10.1021/acs.jmedchem.6b00552" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00552%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B7-%252528Prolinol-N-yl%252529-2-phenylamino-thiazolo%25255B5%25252C4-d%25255Dpyrimidines%252Bas%252BNovel%252BNon-Nucleoside%252BPartial%252BAgonists%252Bfor%252Bthe%252BA2A%252BAdenosine%252BReceptor%25253A%252BPrediction%252Bfrom%252BMolecular%252BModeling%26aulast%3DBharate%26aufirst%3DSandip%2BB.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D12042016%26date%3D07062016%26date%3D23062016%26date%3D26052016%26volume%3D59%26issue%3D12%26spage%3D5922%26epage%3D5928" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Delia  Preti</span>, <span class="hlFld-ContribAuthor ">Pier Giovanni  Baraldi</span>, <span class="hlFld-ContribAuthor ">Giulia  Saponaro</span>, <span class="hlFld-ContribAuthor ">Romeo  Romagnoli</span>, <span class="hlFld-ContribAuthor ">Mojgan  Aghazadeh Tabrizi</span>, <span class="hlFld-ContribAuthor ">Stefania  Baraldi</span>, <span class="hlFld-ContribAuthor ">Sandro  Cosconati</span>, <span class="hlFld-ContribAuthor ">Agostino  Bruno</span>, <span class="hlFld-ContribAuthor ">Ettore  Novellino</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Vincenzi</span>, <span class="hlFld-ContribAuthor ">Annalisa  Ravani</span>, <span class="hlFld-ContribAuthor ">Pier Andrea  Borea</span>, and <span class="hlFld-ContribAuthor ">Katia  Varani</span>  . </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Novel 2-((2-(4-(Substituted)phenylpiperazin-1-yl)ethyl)amino)-5â²-N-ethylcarboxamidoadenosines as Potent and Selective Agonists of the A2A Adenosine Receptor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (7)
                                     , 3253-3267. <a href="https://doi.org/10.1021/acs.jmedchem.5b00215" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00215</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00215%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BNovel%252B2-%252528%2525282-%2525284-%252528Substituted%252529phenylpiperazin-1-yl%252529ethyl%252529amino%252529-5%2525E2%252580%2525B2-N-ethylcarboxamidoadenosines%252Bas%252BPotent%252Band%252BSelective%252BAgonists%252Bof%252Bthe%252BA2A%252BAdenosine%252BReceptor%26aulast%3DPreti%26aufirst%3DDelia%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D05022015%26date%3D25032015%26date%3D09042015%26date%3D17032015%26volume%3D58%26issue%3D7%26spage%3D3253%26epage%3D3267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoyun  Zhou</span>, <span class="hlFld-ContribAuthor ">Shivashankar  Khanapur</span>, <span class="hlFld-ContribAuthor ">Anja P.  Huizing</span>, <span class="hlFld-ContribAuthor ">Rolf  Zijlma</span>, <span class="hlFld-ContribAuthor ">Marianne  Schepers</span>, <span class="hlFld-ContribAuthor ">Rudi A. J. O.  Dierckx</span>, <span class="hlFld-ContribAuthor ">Aren  van Waarde</span>, <span class="hlFld-ContribAuthor ">Erik F. J.  de Vries</span>, and <span class="hlFld-ContribAuthor ">Philip H.  Elsinga</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Preclinical Evaluation of 2-(2-Furanyl)-7-[2-[4-[4-(2-[11C]methoxyethoxy)phenyl]-1-piperazinyl]ethyl]7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine-5-amine ([11C]Preladenant) as a PET Tracer for the Imaging of Cerebral Adenosine A2A Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (21)
                                     , 9204-9210. <a href="https://doi.org/10.1021/jm501065t" title="DOI URL">https://doi.org/10.1021/jm501065t</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501065t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501065t%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252BPreclinical%252BEvaluation%252Bof%252B2-%2525282-Furanyl%252529-7-%25255B2-%25255B4-%25255B4-%2525282-%25255B11C%25255Dmethoxyethoxy%252529phenyl%25255D-1-piperazinyl%25255Dethyl%25255D7H-pyrazolo%25255B4%25252C3-e%25255D%25255B1%25252C2%25252C4%25255Dtriazolo%25255B1%25252C5-c%25255Dpyrimidine-5-amine%252B%252528%25255B11C%25255DPreladenant%252529%252Bas%252Ba%252BPET%252BTracer%252Bfor%252Bthe%252BImaging%252Bof%252BCerebral%252BAdenosine%252BA2A%252BReceptors%26aulast%3DZhou%26aufirst%3DXiaoyun%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D16072014%26date%3D15102014%26date%3D13112014%26date%3D03102014%26volume%3D57%26issue%3D21%26spage%3D9204%26epage%3D9210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuwen  He</span>, <span class="hlFld-ContribAuthor ">Qingmei  Hong</span>, <span class="hlFld-ContribAuthor ">Zhong  Lai</span>, <span class="hlFld-ContribAuthor ">David X.  Yang</span>, <span class="hlFld-ContribAuthor ">Pauline C.  Ting</span>, <span class="hlFld-ContribAuthor ">Jeffrey T.  Kuethe</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Cernak</span>, <span class="hlFld-ContribAuthor ">Kevin D.  Dykstra</span>, <span class="hlFld-ContribAuthor ">Donald M.  Sperbeck</span>, <span class="hlFld-ContribAuthor ">Zhicai  Wu</span>, <span class="hlFld-ContribAuthor ">Yang  Yu</span>, <span class="hlFld-ContribAuthor ">Ginger X.  Yang</span>, <span class="hlFld-ContribAuthor ">Tianying  Jian</span>, <span class="hlFld-ContribAuthor ">Jian  Liu</span>, <span class="hlFld-ContribAuthor ">Deodial  Guiadeen</span>, <span class="hlFld-ContribAuthor ">Arto D.  Krikorian</span>, <span class="hlFld-ContribAuthor ">Lisa M.  Sonatore</span>, <span class="hlFld-ContribAuthor ">Judyann  Wiltsie</span>, <span class="hlFld-ContribAuthor ">Jinqi  Liu</span>, <span class="hlFld-ContribAuthor ">Judith N.  Gorski</span>, <span class="hlFld-ContribAuthor ">Christine C.  Chung</span>, <span class="hlFld-ContribAuthor ">Jack T.  Gibson</span>, <span class="hlFld-ContribAuthor ">JeanMarie  Lisnock</span>, <span class="hlFld-ContribAuthor ">Jianying  Xiao</span>, <span class="hlFld-ContribAuthor ">Michael  Wolff</span>, <span class="hlFld-ContribAuthor ">Sharon X.  Tong</span>, <span class="hlFld-ContribAuthor ">Maria  Madeira</span>, <span class="hlFld-ContribAuthor ">Bindhu V.  Karanam</span>, <span class="hlFld-ContribAuthor ">Dong-Ming  Shen</span>, <span class="hlFld-ContribAuthor ">James M.  Balkovec</span>, <span class="hlFld-ContribAuthor ">Shirly  Pinto</span>, <span class="hlFld-ContribAuthor ">Ravi P.  Nargund</span>, and <span class="hlFld-ContribAuthor ">Robert J.  DeVita</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent and Selective DGAT1 Inhibitor with a Piperidinyl-oxy-cyclohexanecarboxylic Acid Moiety. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (10)
                                     , 1082-1087. <a href="https://doi.org/10.1021/ml5003426" title="DOI URL">https://doi.org/10.1021/ml5003426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml5003426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml5003426%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252Band%252BSelective%252BDGAT1%252BInhibitor%252Bwith%252Ba%252BPiperidinyl-oxy-cyclohexanecarboxylic%252BAcid%252BMoiety%26aulast%3DHe%26aufirst%3DShuwen%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D09022014%26date%3D08092014%26date%3D11092014%26date%3D09102014%26date%3D08092014%26volume%3D5%26issue%3D10%26spage%3D1082%26epage%3D1087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven M.  Moss</span>, <span class="hlFld-ContribAuthor ">P. Suresh  Jayasekara</span>, <span class="hlFld-ContribAuthor ">Silvia  Paoletta</span>, <span class="hlFld-ContribAuthor ">Zhan-Guo  Gao</span>, and <span class="hlFld-ContribAuthor ">Kenneth A.  Jacobson</span>  . </span><span class="cited-content_cbyCitation_article-title">Structure-Based Design of Reactive Nucleosides for Site-Specific Modification of the A2A Adenosine Receptor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>5 </em>
                                    (9)
                                     , 1043-1048. <a href="https://doi.org/10.1021/ml5002486" title="DOI URL">https://doi.org/10.1021/ml5002486</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml5002486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml5002486%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-Based%252BDesign%252Bof%252BReactive%252BNucleosides%252Bfor%252BSite-Specific%252BModification%252Bof%252Bthe%252BA2A%252BAdenosine%252BReceptor%26aulast%3DMoss%26aufirst%3DSteven%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D11062014%26date%3D11072014%26date%3D15072014%26date%3D11092014%26date%3D11072014%26volume%3D5%26issue%3D9%26spage%3D1043%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shivashankar  Khanapur</span>, <span class="hlFld-ContribAuthor ">Soumen  Paul</span>, <span class="hlFld-ContribAuthor ">Anup  Shah</span>, <span class="hlFld-ContribAuthor ">Suresh  Vatakuti</span>, <span class="hlFld-ContribAuthor ">Michel J. B.  Koole</span>, <span class="hlFld-ContribAuthor ">Rolf  Zijlma</span>, <span class="hlFld-ContribAuthor ">Rudi A. J. O.  Dierckx</span>, <span class="hlFld-ContribAuthor ">Gert  Luurtsema</span>, <span class="hlFld-ContribAuthor ">Prabha  Garg</span>, <span class="hlFld-ContribAuthor ">Aren  van Waarde</span>, and <span class="hlFld-ContribAuthor ">Philip H.  Elsinga</span>  . </span><span class="cited-content_cbyCitation_article-title">Development of [18F]-Labeled Pyrazolo[4,3-e]-1,2,4- triazolo[1,5-c]pyrimidine (SCH442416) Analogs for the Imaging of Cerebral Adenosine A2A Receptors with Positron Emission Tomography. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (15)
                                     , 6765-6780. <a href="https://doi.org/10.1021/jm500700y" title="DOI URL">https://doi.org/10.1021/jm500700y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500700y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500700y%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDevelopment%252Bof%252B%25255B18F%25255D-Labeled%252BPyrazolo%25255B4%25252C3-e%25255D-1%25252C2%25252C4-%252Btriazolo%25255B1%25252C5-c%25255Dpyrimidine%252B%252528SCH442416%252529%252BAnalogs%252Bfor%252Bthe%252BImaging%252Bof%252BCerebral%252BAdenosine%252BA2A%252BReceptors%252Bwith%252BPositron%252BEmission%252BTomography%26aulast%3DKhanapur%26aufirst%3DShivashankar%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D23052014%26date%3D04082014%26date%3D14082014%26date%3D25072014%26volume%3D57%26issue%3D15%26spage%3D6765%26epage%3D6780" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephanie  Federico</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciancetta</span>, <span class="hlFld-ContribAuthor ">Nicola  Porta</span>, <span class="hlFld-ContribAuthor ">Sara  Redenti</span>, <span class="hlFld-ContribAuthor ">Giorgia  Pastorin</span>, <span class="hlFld-ContribAuthor ">Barbara  Cacciari</span>, <span class="hlFld-ContribAuthor ">Karl Norbert  Klotz</span>, <span class="hlFld-ContribAuthor ">Stefano  Moro</span>, and <span class="hlFld-ContribAuthor ">Giampiero  Spalluto</span>  . </span><span class="cited-content_cbyCitation_article-title">Scaffold Decoration at Positions 5 and 8 of 1,2,4-Triazolo[1,5-c]Pyrimidines to Explore the Antagonist Profiling on Adenosine Receptors: A Preliminary StructureâActivity Relationship Study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (14)
                                     , 6210-6225. <a href="https://doi.org/10.1021/jm500752h" title="DOI URL">https://doi.org/10.1021/jm500752h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500752h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500752h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DScaffold%252BDecoration%252Bat%252BPositions%252B5%252Band%252B8%252Bof%252B1%25252C2%25252C4-Triazolo%25255B1%25252C5-c%25255DPyrimidines%252Bto%252BExplore%252Bthe%252BAntagonist%252BProfiling%252Bon%252BAdenosine%252BReceptors%25253A%252BA%252BPreliminary%252BStructure%2525E2%252580%252593Activity%252BRelationship%252BStudy%26aulast%3DFederico%26aufirst%3DStephanie%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D15052014%26date%3D11072014%26date%3D24072014%26date%3D27062014%26volume%3D57%26issue%3D14%26spage%3D6210%26epage%3D6225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xihui  Gao</span>, <span class="hlFld-ContribAuthor ">Jun  Qian</span>, <span class="hlFld-ContribAuthor ">Shuyan  Zheng</span>, <span class="hlFld-ContribAuthor ">Yinzhi  Changyi</span>, <span class="hlFld-ContribAuthor ">Jianping  Zhang</span>, <span class="hlFld-ContribAuthor ">Shenghong  Ju</span>, <span class="hlFld-ContribAuthor ">Jianhua  Zhu</span>, and <span class="hlFld-ContribAuthor ">Cong  Li</span>  . </span><span class="cited-content_cbyCitation_article-title">Overcoming the BloodâBrain Barrier for Delivering Drugs into the Brain by Using Adenosine Receptor Nanoagonist. </span><span class="cited-content_cbyCitation_journal-name">ACS Nano</span><span> <strong>2014,</strong> <em>8 </em>
                                    (4)
                                     , 3678-3689. <a href="https://doi.org/10.1021/nn5003375" title="DOI URL">https://doi.org/10.1021/nn5003375</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/nn5003375&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fnn5003375%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Nano%26atitle%3DOvercoming%252Bthe%252BBlood%2525E2%252580%252593Brain%252BBarrier%252Bfor%252BDelivering%252BDrugs%252Binto%252Bthe%252BBrain%252Bby%252BUsing%252BAdenosine%252BReceptor%252BNanoagonist%26aulast%3DGao%26aufirst%3DXihui%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D18012014%26date%3D27032014%26date%3D03042014%26date%3D22042014%26date%3D27032014%26volume%3D8%26issue%3D4%26spage%3D3678%26epage%3D3689" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng-Jung  Chiang</span>, <span class="hlFld-ContribAuthor ">Marc A.  Holbert</span>, <span class="hlFld-ContribAuthor ">Jay H.  Kalin</span>, <span class="hlFld-ContribAuthor ">Young-Hoon  Ahn</span>, <span class="hlFld-ContribAuthor ">John  Giddens</span>, <span class="hlFld-ContribAuthor ">Mohammed N.  Amin</span>, <span class="hlFld-ContribAuthor ">Martin S.  Taylor</span>, <span class="hlFld-ContribAuthor ">Samuel L.  Collins</span>, <span class="hlFld-ContribAuthor ">Yee  Chan-Li</span>, <span class="hlFld-ContribAuthor ">Adam  Waickman</span>, <span class="hlFld-ContribAuthor ">Po-Yuan  Hsiao</span>, <span class="hlFld-ContribAuthor ">David  Bolduc</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Leahy</span>, <span class="hlFld-ContribAuthor ">Maureen R.  Horton</span>, <span class="hlFld-ContribAuthor ">Lai-Xi  Wang</span>, <span class="hlFld-ContribAuthor ">Jonathan D.  Powell</span>, and <span class="hlFld-ContribAuthor ">Philip A.  Cole</span>  . </span><span class="cited-content_cbyCitation_article-title">An Fc Domain ProteinâSmall Molecule Conjugate as an Enhanced Immunomodulator. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2014,</strong> <em>136 </em>
                                    (9)
                                     , 3370-3373. <a href="https://doi.org/10.1021/ja5006674" title="DOI URL">https://doi.org/10.1021/ja5006674</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ja5006674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fja5006674%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DAn%252BFc%252BDomain%252BProtein%2525E2%252580%252593Small%252BMolecule%252BConjugate%252Bas%252Ban%252BEnhanced%252BImmunomodulator%26aulast%3DChiang%26aufirst%3DMeng-Jung%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D21012014%26date%3D24022014%26date%3D05032014%26date%3D17022014%26volume%3D136%26issue%3D9%26spage%3D3370%26epage%3D3373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dennis D.  Fernandes</span>, <span class="hlFld-ContribAuthor ">Chris  Neale</span>, <span class="hlFld-ContribAuthor ">Gregory-Neal W.  Gomes</span>, <span class="hlFld-ContribAuthor ">Yuchong  Li</span>, <span class="hlFld-ContribAuthor ">Aimen  Malik</span>, <span class="hlFld-ContribAuthor ">Aditya  Pandey</span>, <span class="hlFld-ContribAuthor ">Alexander P.  Orazietti</span>, <span class="hlFld-ContribAuthor ">Xudong  Wang</span>, <span class="hlFld-ContribAuthor ">Libin  Ye</span>, <span class="hlFld-ContribAuthor ">R.  Scott Prosser</span>, <span class="hlFld-ContribAuthor ">Claudiu C.  Gradinaru</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand modulation of the conformational dynamics of the A2A adenosine receptor revealed by single-molecule fluorescence. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2021,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-021-84069-0" title="DOI URL">https://doi.org/10.1038/s41598-021-84069-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-021-84069-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-021-84069-0%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DLigand%252Bmodulation%252Bof%252Bthe%252Bconformational%252Bdynamics%252Bof%252Bthe%252BA2A%252Badenosine%252Breceptor%252Brevealed%252Bby%252Bsingle-molecule%252Bfluorescence%26aulast%3DFernandes%26aufirst%3DDennis%2BD.%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aleksandra  Szopa</span>, <span class="hlFld-ContribAuthor ">Katarzyna  SocaÅa</span>, <span class="hlFld-ContribAuthor ">Anna  Serefko</span>, <span class="hlFld-ContribAuthor ">Urszula  Doboszewska</span>, <span class="hlFld-ContribAuthor ">Andrzej  WrÃ³bel</span>, <span class="hlFld-ContribAuthor ">Ewa  Poleszak</span>, <span class="hlFld-ContribAuthor ">Piotr  WlaÅº</span>. </span><span class="cited-content_cbyCitation_article-title">Purinergic transmission in depressive disorders. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2021,</strong> <em>224 </em>, 107821. <a href="https://doi.org/10.1016/j.pharmthera.2021.107821" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2021.107821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2021.107821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2021.107821%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DPurinergic%252Btransmission%252Bin%252Bdepressive%252Bdisorders%26aulast%3DSzopa%26aufirst%3DAleksandra%26date%3D2021%26volume%3D224%26spage%3D107821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chrisna  Matthee</span>, <span class="hlFld-ContribAuthor ">Gisella  TerreâBlanche</span>, <span class="hlFld-ContribAuthor ">Lesetja J.  Legoabe</span>, <span class="hlFld-ContribAuthor ">Helena D.  Janse van Rensburg</span>. </span><span class="cited-content_cbyCitation_article-title">Exploration of chalcones and related heterocycle compounds as ligands of adenosine receptors: therapeutics development. </span><span class="cited-content_cbyCitation_journal-name">Molecular Diversity</span><span> <strong>2021,</strong> <em>16 </em><a href="https://doi.org/10.1007/s11030-021-10257-9" title="DOI URL">https://doi.org/10.1007/s11030-021-10257-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11030-021-10257-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11030-021-10257-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Diversity%26atitle%3DExploration%252Bof%252Bchalcones%252Band%252Brelated%252Bheterocycle%252Bcompounds%252Bas%252Bligands%252Bof%252Badenosine%252Breceptors%25253A%252Btherapeutics%252Bdevelopment%26aulast%3DMatthee%26aufirst%3DChrisna%26date%3D2021%26date%3D2021%26volume%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oliwia  KoszÅa</span>, <span class="hlFld-ContribAuthor ">Piotr  StÄpnicki</span>, <span class="hlFld-ContribAuthor ">Agata  ZiÄba</span>, <span class="hlFld-ContribAuthor ">Angelika  GrudziÅska</span>, <span class="hlFld-ContribAuthor ">Dariusz  Matosiuk</span>, <span class="hlFld-ContribAuthor ">Agnieszka A.  Kaczor</span>. </span><span class="cited-content_cbyCitation_article-title">Current Approaches and Tools Used in Drug Development against Parkinsonâs Disease. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 897. <a href="https://doi.org/10.3390/biom11060897" title="DOI URL">https://doi.org/10.3390/biom11060897</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom11060897&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom11060897%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DCurrent%252BApproaches%252Band%252BTools%252BUsed%252Bin%252BDrug%252BDevelopment%252Bagainst%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DKosz%25C5%2582a%26aufirst%3DOliwia%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D6%26spage%3D897" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Overduin</span>, <span class="hlFld-ContribAuthor ">Catharine  Trieber</span>, <span class="hlFld-ContribAuthor ">R. Scott  Prosser</span>, <span class="hlFld-ContribAuthor ">Louis-Philippe  Picard</span>, <span class="hlFld-ContribAuthor ">Joey G.  Sheff</span>. </span><span class="cited-content_cbyCitation_article-title">Structures and Dynamics of Native-State Transmembrane Protein Targets and Bound Lipids. </span><span class="cited-content_cbyCitation_journal-name">Membranes</span><span> <strong>2021,</strong> <em>11 </em>
                                    (6)
                                     , 451. <a href="https://doi.org/10.3390/membranes11060451" title="DOI URL">https://doi.org/10.3390/membranes11060451</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/membranes11060451&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmembranes11060451%26sid%3Dliteratum%253Aachs%26jtitle%3DMembranes%26atitle%3DStructures%252Band%252BDynamics%252Bof%252BNative-State%252BTransmembrane%252BProtein%252BTargets%252Band%252BBound%252BLipids%26aulast%3DOverduin%26aufirst%3DMichael%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D6%26spage%3D451" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Toyoshi  Umezu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel target molecules of l-menthol. </span><span class="cited-content_cbyCitation_journal-name">Heliyon</span><span> <strong>2021,</strong> <em>7 </em>
                                    (6)
                                     , e07329. <a href="https://doi.org/10.1016/j.heliyon.2021.e07329" title="DOI URL">https://doi.org/10.1016/j.heliyon.2021.e07329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.heliyon.2021.e07329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.heliyon.2021.e07329%26sid%3Dliteratum%253Aachs%26jtitle%3DHeliyon%26atitle%3DIdentification%252Bof%252Bnovel%252Btarget%252Bmolecules%252Bof%252Bl-menthol%26aulast%3DUmezu%26aufirst%3DToyoshi%26date%3D2021%26volume%3D7%26issue%3D6%26spage%3De07329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jingyu  Zhang</span>, <span class="hlFld-ContribAuthor ">Yu  Zhang</span>, <span class="hlFld-ContribAuthor ">Bingxue  Qu</span>, <span class="hlFld-ContribAuthor ">Haiyan  Yang</span>, <span class="hlFld-ContribAuthor ">Shengquan  Hu</span>, <span class="hlFld-ContribAuthor ">Xiaowu  Dong</span>. </span><span class="cited-content_cbyCitation_article-title">If small molecules immunotherapy comes, can the prime be far behind?. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113356. <a href="https://doi.org/10.1016/j.ejmech.2021.113356" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113356</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113356&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113356%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIf%252Bsmall%252Bmolecules%252Bimmunotherapy%252Bcomes%25252C%252Bcan%252Bthe%252Bprime%252Bbe%252Bfar%252Bbehind%25253F%26aulast%3DZhang%26aufirst%3DJingyu%26date%3D2021%26volume%3D218%26spage%3D113356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linzhen  Hu</span>, <span class="hlFld-ContribAuthor ">Shuying  Tian</span>, <span class="hlFld-ContribAuthor ">Rongrong  Wu</span>, <span class="hlFld-ContribAuthor ">Zhou  Tong</span>, <span class="hlFld-ContribAuthor ">Wen  Jiang</span>, <span class="hlFld-ContribAuthor ">Ping  Hu</span>, <span class="hlFld-ContribAuthor ">Xueyang  Xiao</span>, <span class="hlFld-ContribAuthor ">Xueke  Zhang</span>, <span class="hlFld-ContribAuthor ">Hui  Zhou</span>, <span class="hlFld-ContribAuthor ">Qingyi  Tong</span>, <span class="hlFld-ContribAuthor ">Yuanyuan  Lu</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Huang</span>, <span class="hlFld-ContribAuthor ">Yong  Chen</span>, <span class="hlFld-ContribAuthor ">Yonghui  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of antiâParkinson's Disease Lead Compounds from
              Aspergillus ochraceus
              Targeting Adenosin Receptors A
              2A. </span><span class="cited-content_cbyCitation_journal-name">ChemistryOpen</span><span> <strong>2021,</strong> <em>10 </em>
                                    (6)
                                     , 630-638. <a href="https://doi.org/10.1002/open.202100022" title="DOI URL">https://doi.org/10.1002/open.202100022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/open.202100022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fopen.202100022%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistryOpen%26atitle%3DIdentification%252Bof%252Banti%2525E2%252580%252590Parkinson%252527s%252BDisease%252BLead%252BCompounds%252Bfrom%252BAspergillus%252Bochraceus%252BTargeting%252BAdenosin%252BReceptors%252BA%252B2A%26aulast%3DHu%26aufirst%3DLinzhen%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D6%26spage%3D630%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manting  Huang</span>, <span class="hlFld-ContribAuthor ">Li  Yong</span>, <span class="hlFld-ContribAuthor ">Jie  Xu</span>, <span class="hlFld-ContribAuthor ">Yanqiu  Zuo</span>, <span class="hlFld-ContribAuthor ">Zhongsheng  Yi</span>, <span class="hlFld-ContribAuthor ">Hongyan  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Determinants of Adenosine A
              2A
              ReceptorsâPerfluoroalkyl Sulfonates Complex: MultiâSpectroscopic and Molecular Dynamics Simulation Study. </span><span class="cited-content_cbyCitation_journal-name">ChemistrySelect</span><span> <strong>2021,</strong> <em>6 </em>
                                    (19)
                                     , 4633-4644. <a href="https://doi.org/10.1002/slct.202100863" title="DOI URL">https://doi.org/10.1002/slct.202100863</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/slct.202100863&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fslct.202100863%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistrySelect%26atitle%3DDeterminants%252Bof%252BAdenosine%252BA%252B2A%252BReceptors%2525E2%252580%252590Perfluoroalkyl%252BSulfonates%252BComplex%25253A%252BMulti%2525E2%252580%252590Spectroscopic%252Band%252BMolecular%252BDynamics%252BSimulation%252BStudy%26aulast%3DHuang%26aufirst%3DManting%26date%3D2021%26date%3D2021%26volume%3D6%26issue%3D19%26spage%3D4633%26epage%3D4644" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xin  Qin</span>, <span class="hlFld-ContribAuthor ">Michael G.  Zaki</span>, <span class="hlFld-ContribAuthor ">Zhicheng  Chen</span>, <span class="hlFld-ContribAuthor ">Elisabet  Jakova</span>, <span class="hlFld-ContribAuthor ">Zhi  Ming</span>, <span class="hlFld-ContribAuthor ">Francisco S.  Cayabyab</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine Signaling and Clathrin-Mediated Endocytosis of Glutamate AMPA Receptors in Delayed Hypoxic Injury in Rat Hippocampus: Role of Casein Kinase 2. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurobiology</span><span> <strong>2021,</strong> <em>58 </em>
                                    (5)
                                     , 1932-1951. <a href="https://doi.org/10.1007/s12035-020-02246-0" title="DOI URL">https://doi.org/10.1007/s12035-020-02246-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12035-020-02246-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12035-020-02246-0%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurobiology%26atitle%3DAdenosine%252BSignaling%252Band%252BClathrin-Mediated%252BEndocytosis%252Bof%252BGlutamate%252BAMPA%252BReceptors%252Bin%252BDelayed%252BHypoxic%252BInjury%252Bin%252BRat%252BHippocampus%25253A%252BRole%252Bof%252BCasein%252BKinase%252B2%26aulast%3DQin%26aufirst%3DXin%26date%3D2021%26date%3D2021%26volume%3D58%26issue%3D5%26spage%3D1932%26epage%3D1951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuesong  Wang</span>, <span class="hlFld-ContribAuthor ">Gerard J.P.  van Westen</span>, <span class="hlFld-ContribAuthor ">Laura H.  Heitman</span>, <span class="hlFld-ContribAuthor ">Adriaan P.  IJzerman</span>. </span><span class="cited-content_cbyCitation_article-title">G protein-coupled receptors expressed and studied in yeast. The adenosine receptor as a prime example. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Pharmacology</span><span> <strong>2021,</strong> <em>187 </em>, 114370. <a href="https://doi.org/10.1016/j.bcp.2020.114370" title="DOI URL">https://doi.org/10.1016/j.bcp.2020.114370</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bcp.2020.114370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bcp.2020.114370%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Pharmacology%26atitle%3DG%252Bprotein-coupled%252Breceptors%252Bexpressed%252Band%252Bstudied%252Bin%252Byeast.%252BThe%252Badenosine%252Breceptor%252Bas%252Ba%252Bprime%252Bexample%26aulast%3DWang%26aufirst%3DXuesong%26date%3D2021%26volume%3D187%26spage%3D114370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helena D.  Janse van Rensburg</span>, <span class="hlFld-ContribAuthor ">Lesetja J.  Legoabe</span>, <span class="hlFld-ContribAuthor ">Gisella  TerreâBlanche</span>. </span><span class="cited-content_cbyCitation_article-title">C3 amino-substituted chalcone derivative with selective adenosine rA1 receptor affinity in the micromolar range. </span><span class="cited-content_cbyCitation_journal-name">Chemical Papers</span><span> <strong>2021,</strong> <em>75 </em>
                                    (4)
                                     , 1581-1605. <a href="https://doi.org/10.1007/s11696-020-01414-9" title="DOI URL">https://doi.org/10.1007/s11696-020-01414-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11696-020-01414-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11696-020-01414-9%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Papers%26atitle%3DC3%252Bamino-substituted%252Bchalcone%252Bderivative%252Bwith%252Bselective%252Badenosine%252BrA1%252Breceptor%252Baffinity%252Bin%252Bthe%252Bmicromolar%252Brange%26aulast%3DJanse%2Bvan%2BRensburg%26aufirst%3DHelena%2BD.%26date%3D2021%26date%3D2020%26volume%3D75%26issue%3D4%26spage%3D1581%26epage%3D1605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuya Kate  Huang</span>, <span class="hlFld-ContribAuthor ">Aditya  Pandey</span>, <span class="hlFld-ContribAuthor ">Duy Phuoc  Tran</span>, <span class="hlFld-ContribAuthor ">Nicolas L.  Villanueva</span>, <span class="hlFld-ContribAuthor ">Akio  Kitao</span>, <span class="hlFld-ContribAuthor ">Roger K.  Sunahara</span>, <span class="hlFld-ContribAuthor ">Adnan  Sljoka</span>, <span class="hlFld-ContribAuthor ">R. Scott  Prosser</span>. </span><span class="cited-content_cbyCitation_article-title">Delineating the conformational landscape of the adenosine A2A receptor during G protein coupling. </span><span class="cited-content_cbyCitation_journal-name">Cell</span><span> <strong>2021,</strong> <em>184 </em>
                                    (7)
                                     , 1884-1894.e14. <a href="https://doi.org/10.1016/j.cell.2021.02.041" title="DOI URL">https://doi.org/10.1016/j.cell.2021.02.041</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cell.2021.02.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cell.2021.02.041%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%26atitle%3DDelineating%252Bthe%252Bconformational%252Blandscape%252Bof%252Bthe%252Badenosine%252BA2A%252Breceptor%252Bduring%252BG%252Bprotein%252Bcoupling%26aulast%3DHuang%26aufirst%3DShuya%2BKate%26date%3D2021%26volume%3D184%26issue%3D7%26spage%3D1884%26epage%3D1894.e14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dana R.  Renk</span>, <span class="hlFld-ContribAuthor ">Marcel  Skraban</span>, <span class="hlFld-ContribAuthor ">Dirk  Bier</span>, <span class="hlFld-ContribAuthor ">Annette  Schulze</span>, <span class="hlFld-ContribAuthor ">Erika  Wabbals</span>, <span class="hlFld-ContribAuthor ">Franziska  Wedekind</span>, <span class="hlFld-ContribAuthor ">Felix  Neumaier</span>, <span class="hlFld-ContribAuthor ">Bernd  Neumaier</span>, <span class="hlFld-ContribAuthor ">Marcus  Holschbach</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of Tozadenant analogues as adenosine A2A receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>214 </em>, 113214. <a href="https://doi.org/10.1016/j.ejmech.2021.113214" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113214</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113214%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BTozadenant%252Banalogues%252Bas%252Badenosine%252BA2A%252Breceptor%252Bligands%26aulast%3DRenk%26aufirst%3DDana%2BR.%26date%3D2021%26volume%3D214%26spage%3D113214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eleonora  Spinozzi</span>, <span class="hlFld-ContribAuthor ">Cecilia  Baldassarri</span>, <span class="hlFld-ContribAuthor ">Laura  Acquaticci</span>, <span class="hlFld-ContribAuthor ">Fabio  Del Bello</span>, <span class="hlFld-ContribAuthor ">Mario  Grifantini</span>, <span class="hlFld-ContribAuthor ">Loredana  Cappellacci</span>, <span class="hlFld-ContribAuthor ">Petrelli  Riccardo</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine receptors as promising targets for the management of ocular diseases. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (2)
                                     , 353-370. <a href="https://doi.org/10.1007/s00044-021-02704-x" title="DOI URL">https://doi.org/10.1007/s00044-021-02704-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-021-02704-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-021-02704-x%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DAdenosine%252Breceptors%252Bas%252Bpromising%252Btargets%252Bfor%252Bthe%252Bmanagement%252Bof%252Bocular%252Bdiseases%26aulast%3DSpinozzi%26aufirst%3DEleonora%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D2%26spage%3D353%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. Lakshma  Reddy</span>, <span class="hlFld-ContribAuthor ">Rupam  Sarma</span>, <span class="hlFld-ContribAuthor ">Shuhao  Liu</span>, <span class="hlFld-ContribAuthor ">Weifeng  Huang</span>, <span class="hlFld-ContribAuthor ">Jinping  Lei</span>, <span class="hlFld-ContribAuthor ">Jiasheng  Fu</span>, <span class="hlFld-ContribAuthor ">Wenhao  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of novel scaffold benzo[4,5]imidazo [1,2-a]pyrazin-1-amine: Towards adenosine A2A receptor (A2A AR) antagonist. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>210 </em>, 113040. <a href="https://doi.org/10.1016/j.ejmech.2020.113040" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113040%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bscaffold%252Bbenzo%25255B4%25252C5%25255Dimidazo%252B%25255B1%25252C2-a%25255Dpyrazin-1-amine%25253A%252BTowards%252Badenosine%252BA2A%252Breceptor%252B%252528A2A%252BAR%252529%252Bantagonist%26aulast%3DReddy%26aufirst%3DG.%2BLakshma%26date%3D2021%26volume%3D210%26spage%3D113040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Abhinav R.  Jain</span>, <span class="hlFld-ContribAuthor ">Claire  McGraw</span>, <span class="hlFld-ContribAuthor ">Anne S.  Robinson</span>. </span><span class="cited-content_cbyCitation_article-title">The Specificity of Downstream Signaling for A1 and A2AR Does Not Depend on the C-Terminus, Despite the Importance of This Domain in Downstream Signaling Strength. </span><span class="cited-content_cbyCitation_journal-name">Biomedicines</span><span> <strong>2020,</strong> <em>8 </em>
                                    (12)
                                     , 603. <a href="https://doi.org/10.3390/biomedicines8120603" title="DOI URL">https://doi.org/10.3390/biomedicines8120603</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biomedicines8120603&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiomedicines8120603%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicines%26atitle%3DThe%252BSpecificity%252Bof%252BDownstream%252BSignaling%252Bfor%252BA1%252Band%252BA2AR%252BDoes%252BNot%252BDepend%252Bon%252Bthe%252BC-Terminus%25252C%252BDespite%252Bthe%252BImportance%252Bof%252BThis%252BDomain%252Bin%252BDownstream%252BSignaling%252BStrength%26aulast%3DJain%26aufirst%3DAbhinav%2BR.%26date%3D2020%26date%3D2020%26volume%3D8%26issue%3D12%26spage%3D603" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nisha  Chandran</span>, <span class="hlFld-ContribAuthor ">Mahalaxmi  Iyer</span>, <span class="hlFld-ContribAuthor ">Zothan  Siama</span>, <span class="hlFld-ContribAuthor ">Balachandar  Vellingiri</span>, <span class="hlFld-ContribAuthor ">Arul  Narayanasamy</span>. </span><span class="cited-content_cbyCitation_article-title">Purinergic signalling pathway: therapeutic target in ovarian cancer. </span><span class="cited-content_cbyCitation_journal-name">Egyptian Journal of Medical Human Genetics</span><span> <strong>2020,</strong> <em>21 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s43042-020-00059-3" title="DOI URL">https://doi.org/10.1186/s43042-020-00059-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s43042-020-00059-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs43042-020-00059-3%26sid%3Dliteratum%253Aachs%26jtitle%3DEgyptian%2520Journal%2520of%2520Medical%2520Human%2520Genetics%26atitle%3DPurinergic%252Bsignalling%252Bpathway%25253A%252Btherapeutic%252Btarget%252Bin%252Bovarian%252Bcancer%26aulast%3DChandran%26aufirst%3DNisha%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paulo C. T.  Souza</span>, <span class="hlFld-ContribAuthor ">Sebastian  Thallmair</span>, <span class="hlFld-ContribAuthor ">Paolo  Conflitti</span>, <span class="hlFld-ContribAuthor ">Carlos  RamÃ­rez-Palacios</span>, <span class="hlFld-ContribAuthor ">Riccardo  Alessandri</span>, <span class="hlFld-ContribAuthor ">Stefano  Raniolo</span>, <span class="hlFld-ContribAuthor ">Vittorio  Limongelli</span>, <span class="hlFld-ContribAuthor ">Siewert J.  Marrink</span>. </span><span class="cited-content_cbyCitation_article-title">Proteinâligand binding with the coarse-grained Martini model. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2020,</strong> <em>11 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-020-17437-5" title="DOI URL">https://doi.org/10.1038/s41467-020-17437-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-020-17437-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-020-17437-5%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DProtein%2525E2%252580%252593ligand%252Bbinding%252Bwith%252Bthe%252Bcoarse-grained%252BMartini%252Bmodel%26aulast%3DSouza%26aufirst%3DPaulo%2BC.%2BT.%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dirk  Bier</span>, <span class="hlFld-ContribAuthor ">Annette  Schulze</span>, <span class="hlFld-ContribAuthor ">Marcus  Holschbach</span>, <span class="hlFld-ContribAuthor ">Bernd  Neumaier</span>, <span class="hlFld-ContribAuthor ">Arnd  Baumann</span>. </span><span class="cited-content_cbyCitation_article-title">Development and Evaluation of a Versatile Receptor-Ligand Binding Assay Using Cell Membrane Preparations Embedded in an Agarose Gel Matrix and Evaluation with the Human Adenosine A
              1
              Receptor. </span><span class="cited-content_cbyCitation_journal-name">ASSAY and Drug Development Technologies</span><span> <strong>2020,</strong> <em>18 </em>
                                    (7)
                                     , 328-340. <a href="https://doi.org/10.1089/adt.2020.991" title="DOI URL">https://doi.org/10.1089/adt.2020.991</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/adt.2020.991&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fadt.2020.991%26sid%3Dliteratum%253Aachs%26jtitle%3DASSAY%2520and%2520Drug%2520Development%2520Technologies%26atitle%3DDevelopment%252Band%252BEvaluation%252Bof%252Ba%252BVersatile%252BReceptor-Ligand%252BBinding%252BAssay%252BUsing%252BCell%252BMembrane%252BPreparations%252BEmbedded%252Bin%252Ban%252BAgarose%252BGel%252BMatrix%252Band%252BEvaluation%252Bwith%252Bthe%252BHuman%252BAdenosine%252BA%252B1%252BReceptor%26aulast%3DBier%26aufirst%3DDirk%26date%3D2020%26volume%3D18%26issue%3D7%26spage%3D328%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen B  Willingham</span>, <span class="hlFld-ContribAuthor ">Andrew N  Hotson</span>, <span class="hlFld-ContribAuthor ">Richard A  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the A2AR in cancer; early lessons from the clinic. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2020,</strong> <em>53 </em>, 126-133. <a href="https://doi.org/10.1016/j.coph.2020.08.003" title="DOI URL">https://doi.org/10.1016/j.coph.2020.08.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2020.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2020.08.003%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DTargeting%252Bthe%252BA2AR%252Bin%252Bcancer%25253B%252Bearly%252Blessons%252Bfrom%252Bthe%252Bclinic%26aulast%3DWillingham%26aufirst%3DStephen%2BB%26date%3D2020%26volume%3D53%26spage%3D126%26epage%3D133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Luca  Soattin</span>, <span class="hlFld-ContribAuthor ">Anniek Frederike  Lubberding</span>, <span class="hlFld-ContribAuthor ">Bo Hjorth  Bentzen</span>, <span class="hlFld-ContribAuthor ">Torsten  Christ</span>, <span class="hlFld-ContribAuthor ">Thomas  Jespersen</span>. </span><span class="cited-content_cbyCitation_article-title">Inhibition of Adenosine Pathway Alters Atrial Electrophysiology and Prevents Atrial Fibrillation. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Physiology</span><span> <strong>2020,</strong> <em>11 </em><a href="https://doi.org/10.3389/fphys.2020.00493" title="DOI URL">https://doi.org/10.3389/fphys.2020.00493</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphys.2020.00493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphys.2020.00493%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Physiology%26atitle%3DInhibition%252Bof%252BAdenosine%252BPathway%252BAlters%252BAtrial%252BElectrophysiology%252Band%252BPrevents%252BAtrial%252BFibrillation%26aulast%3DSoattin%26aufirst%3DLuca%26date%3D2020%26date%3D2020%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Diego  Dal Ben</span>, <span class="hlFld-ContribAuthor ">Luca  Antonioli</span>, <span class="hlFld-ContribAuthor ">Catia  Lambertucci</span>, <span class="hlFld-ContribAuthor ">Andrea  Spinaci</span>, <span class="hlFld-ContribAuthor ">Matteo  Fornai</span>, <span class="hlFld-ContribAuthor ">Vanessa  DâAntongiovanni</span>, <span class="hlFld-ContribAuthor ">Carolina  Pellegrini</span>, <span class="hlFld-ContribAuthor ">Corrado  Blandizzi</span>, <span class="hlFld-ContribAuthor ">Rosaria  Volpini</span>. </span><span class="cited-content_cbyCitation_article-title">Approaches for designing and discovering purinergic drugs for gastrointestinal diseases. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2020,</strong> <em>15 </em>
                                    (6)
                                     , 687-703. <a href="https://doi.org/10.1080/17460441.2020.1743673" title="DOI URL">https://doi.org/10.1080/17460441.2020.1743673</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2020.1743673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2020.1743673%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DApproaches%252Bfor%252Bdesigning%252Band%252Bdiscovering%252Bpurinergic%252Bdrugs%252Bfor%252Bgastrointestinal%252Bdiseases%26aulast%3DDal%2BBen%26aufirst%3DDiego%26date%3D2020%26date%3D2020%26volume%3D15%26issue%3D6%26spage%3D687%26epage%3D703" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabio C.  Tescarollo</span>, <span class="hlFld-ContribAuthor ">Diogo M.  Rombo</span>, <span class="hlFld-ContribAuthor ">Lindsay K.  DeLiberto</span>, <span class="hlFld-ContribAuthor ">Denise E.  Fedele</span>, <span class="hlFld-ContribAuthor ">Enmar  Alharfoush</span>, <span class="hlFld-ContribAuthor ">Ãngelo R.  TomÃ©</span>, <span class="hlFld-ContribAuthor ">Rodrigo A.  Cunha</span>, <span class="hlFld-ContribAuthor ">Ana M.  SebastiÃ£o</span>, <span class="hlFld-ContribAuthor ">Detlev  Boison</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Adenosine in Epilepsy and Seizures. </span><span class="cited-content_cbyCitation_journal-name">Journal of Caffeine and Adenosine Research</span><span> <strong>2020,</strong> <em>10 </em>
                                    (2)
                                     , 45-60. <a href="https://doi.org/10.1089/caff.2019.0022" title="DOI URL">https://doi.org/10.1089/caff.2019.0022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/caff.2019.0022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fcaff.2019.0022%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Caffeine%2520and%2520Adenosine%2520Research%26atitle%3DRole%252Bof%252BAdenosine%252Bin%252BEpilepsy%252Band%252BSeizures%26aulast%3DTescarollo%26aufirst%3DFabio%2BC.%26date%3D2020%26volume%3D10%26issue%3D2%26spage%3D45%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucile  Lecas</span>, <span class="hlFld-ContribAuthor ">Lucie  Hartmann</span>, <span class="hlFld-ContribAuthor ">Lydia  Caro</span>, <span class="hlFld-ContribAuthor ">Sarah  Mohamed-Bouteben</span>, <span class="hlFld-ContribAuthor ">Claire  Raingeval</span>, <span class="hlFld-ContribAuthor ">Isabelle  Krimm</span>, <span class="hlFld-ContribAuthor ">Renaud  Wagner</span>, <span class="hlFld-ContribAuthor ">Vincent  Dugas</span>, <span class="hlFld-ContribAuthor ">Claire  Demesmay</span>. </span><span class="cited-content_cbyCitation_article-title">Miniaturized weak affinity chromatography for ligand identification of nanodiscs-embedded G-protein coupled receptors. </span><span class="cited-content_cbyCitation_journal-name">Analytica Chimica Acta</span><span> <strong>2020,</strong> <em>1113 </em>, 26-35. <a href="https://doi.org/10.1016/j.aca.2020.03.062" title="DOI URL">https://doi.org/10.1016/j.aca.2020.03.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.aca.2020.03.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.aca.2020.03.062%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytica%2520Chimica%2520Acta%26atitle%3DMiniaturized%252Bweak%252Baffinity%252Bchromatography%252Bfor%252Bligand%252Bidentification%252Bof%252Bnanodiscs-embedded%252BG-protein%252Bcoupled%252Breceptors%26aulast%3DLecas%26aufirst%3DLucile%26date%3D2020%26volume%3D1113%26spage%3D26%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernard J C  Macatangay</span>, <span class="hlFld-ContribAuthor ">Edwin K  Jackson</span>, <span class="hlFld-ContribAuthor ">Kaleab Z  Abebe</span>, <span class="hlFld-ContribAuthor ">Diane  Comer</span>, <span class="hlFld-ContribAuthor ">Joshua  Cyktor</span>, <span class="hlFld-ContribAuthor ">Cynthia  Klamar-Blain</span>, <span class="hlFld-ContribAuthor ">Luann  Borowski</span>, <span class="hlFld-ContribAuthor ">Delbert G  Gillespie</span>, <span class="hlFld-ContribAuthor ">John W  Mellors</span>, <span class="hlFld-ContribAuthor ">Charles R  Rinaldo</span>, <span class="hlFld-ContribAuthor ">Sharon A  Riddler</span>. </span><span class="cited-content_cbyCitation_article-title">A Randomized, Placebo-Controlled, Pilot Clinical Trial of Dipyridamole to Decrease Human Immunodeficiency VirusâAssociated Chronic Inflammation. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Infectious Diseases</span><span> <strong>2020,</strong> <em>221 </em>
                                    (10)
                                     , 1598-1606. <a href="https://doi.org/10.1093/infdis/jiz344" title="DOI URL">https://doi.org/10.1093/infdis/jiz344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/infdis/jiz344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Finfdis%2Fjiz344%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Infectious%2520Diseases%26atitle%3DA%252BRandomized%25252C%252BPlacebo-Controlled%25252C%252BPilot%252BClinical%252BTrial%252Bof%252BDipyridamole%252Bto%252BDecrease%252BHuman%252BImmunodeficiency%252BVirus%2525E2%252580%252593Associated%252BChronic%252BInflammation%26aulast%3DMacatangay%26aufirst%3DBernard%2BJ%2BC%26date%3D2020%26date%3D2019%26volume%3D221%26issue%3D10%26spage%3D1598%26epage%3D1606" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">AgustÃ­n  Bruzzese</span>, <span class="hlFld-ContribAuthor ">James A. R.  Dalton</span>, <span class="hlFld-ContribAuthor ">JesÃºs  Giraldo</span>, . </span><span class="cited-content_cbyCitation_article-title">Insights into adenosine A2AÂ receptor activation through cooperative modulation of agonist and allosteric lipid interactions. </span><span class="cited-content_cbyCitation_journal-name">PLOS Computational Biology</span><span> <strong>2020,</strong> <em>16 </em>
                                    (4)
                                     , e1007818. <a href="https://doi.org/10.1371/journal.pcbi.1007818" title="DOI URL">https://doi.org/10.1371/journal.pcbi.1007818</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pcbi.1007818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pcbi.1007818%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Computational%2520Biology%26atitle%3DInsights%252Binto%252Badenosine%252BA2A%2525C2%2525A0receptor%252Bactivation%252Bthrough%252Bcooperative%252Bmodulation%252Bof%252Bagonist%252Band%252Ballosteric%252Blipid%252Binteractions%26aulast%3DBruzzese%26aufirst%3DAgust%25C3%25ADn%26date%3D2020%26date%3D2020%26volume%3D16%26issue%3D4%26spage%3De1007818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Khalid Bashir  Dar</span>, <span class="hlFld-ContribAuthor ">Aashiq Hussain  Bhat</span>, <span class="hlFld-ContribAuthor ">Shajrul  Amin</span>, <span class="hlFld-ContribAuthor ">Bilal Ahmad  Reshi</span>, <span class="hlFld-ContribAuthor ">Mohammad Afzal  Zargar</span>, <span class="hlFld-ContribAuthor ">Akbar  Masood</span>, <span class="hlFld-ContribAuthor ">Showkat Ahmad  Ganie</span>. </span><span class="cited-content_cbyCitation_article-title">Elucidating Critical Proteinopathic Mechanisms and Potential Drug Targets in Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Cellular and Molecular Neurobiology</span><span> <strong>2020,</strong> <em>40 </em>
                                    (3)
                                     , 313-345. <a href="https://doi.org/10.1007/s10571-019-00741-0" title="DOI URL">https://doi.org/10.1007/s10571-019-00741-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10571-019-00741-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10571-019-00741-0%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520and%2520Molecular%2520Neurobiology%26atitle%3DElucidating%252BCritical%252BProteinopathic%252BMechanisms%252Band%252BPotential%252BDrug%252BTargets%252Bin%252BNeurodegeneration%26aulast%3DDar%26aufirst%3DKhalid%2BBashir%26date%3D2020%26date%3D2019%26volume%3D40%26issue%3D3%26spage%3D313%26epage%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu  Wang</span>, <span class="hlFld-ContribAuthor ">Yan-Jiao  Chen</span>, <span class="hlFld-ContribAuthor ">Cheng  Xiang</span>, <span class="hlFld-ContribAuthor ">Guang-Wei  Jiang</span>, <span class="hlFld-ContribAuthor ">Yu-Dong  Xu</span>, <span class="hlFld-ContribAuthor ">Lei-Miao  Yin</span>, <span class="hlFld-ContribAuthor ">Dong-Dong  Zhou</span>, <span class="hlFld-ContribAuthor ">Yan-Yan  Liu</span>, <span class="hlFld-ContribAuthor ">Yong-Qing  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of potential asthma targets based on the clinical efficacy of Traditional Chinese Medicine formulas. </span><span class="cited-content_cbyCitation_journal-name">Journal of Ethnopharmacology</span><span> <strong>2020,</strong> <em>252 </em>, 112635. <a href="https://doi.org/10.1016/j.jep.2020.112635" title="DOI URL">https://doi.org/10.1016/j.jep.2020.112635</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jep.2020.112635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jep.2020.112635%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Ethnopharmacology%26atitle%3DDiscovery%252Bof%252Bpotential%252Basthma%252Btargets%252Bbased%252Bon%252Bthe%252Bclinical%252Befficacy%252Bof%252BTraditional%252BChinese%252BMedicine%252Bformulas%26aulast%3DWang%26aufirst%3DYu%26date%3D2020%26volume%3D252%26spage%3D112635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qi  Mao</span>, <span class="hlFld-ContribAuthor ">Wang-zhi  Qin</span>, <span class="hlFld-ContribAuthor ">Ao  Zhang</span>, <span class="hlFld-ContribAuthor ">Na  Ye</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances in dopaminergic strategies for the treatment of Parkinsonâs disease. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2020,</strong> <em>41 </em>
                                    (4)
                                     , 471-482. <a href="https://doi.org/10.1038/s41401-020-0365-y" title="DOI URL">https://doi.org/10.1038/s41401-020-0365-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-020-0365-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-020-0365-y%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DRecent%252Badvances%252Bin%252Bdopaminergic%252Bstrategies%252Bfor%252Bthe%252Btreatment%252Bof%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DMao%26aufirst%3DQi%26date%3D2020%26date%3D2020%26volume%3D41%26issue%3D4%26spage%3D471%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Susann  SchrÃ¶der</span>, <span class="hlFld-ContribAuthor ">Thu Hang  Lai</span>, <span class="hlFld-ContribAuthor ">Magali  Toussaint</span>, <span class="hlFld-ContribAuthor ">Mathias  Kranz</span>, <span class="hlFld-ContribAuthor ">Alexandra  Chovsepian</span>, <span class="hlFld-ContribAuthor ">Qi  Shang</span>, <span class="hlFld-ContribAuthor ">Sladjana  DukiÄ-StefanoviÄ</span>, <span class="hlFld-ContribAuthor ">Winnie  Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Teodoro</span>, <span class="hlFld-ContribAuthor ">Barbara  Wenzel</span>, <span class="hlFld-ContribAuthor ">RareÅ-Petru  Moldovan</span>, <span class="hlFld-ContribAuthor ">Francisco  Pan-Montojo</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>. </span><span class="cited-content_cbyCitation_article-title">PET Imaging of the Adenosine A2A Receptor in the Rotenone-Based Mouse Model of Parkinsonâs Disease with [18F]FESCH Synthesized by a Simplified Two-Step One-Pot Radiolabeling Strategy. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (7)
                                     , 1633. <a href="https://doi.org/10.3390/molecules25071633" title="DOI URL">https://doi.org/10.3390/molecules25071633</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25071633&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25071633%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DPET%252BImaging%252Bof%252Bthe%252BAdenosine%252BA2A%252BReceptor%252Bin%252Bthe%252BRotenone-Based%252BMouse%252BModel%252Bof%252BParkinson%2525E2%252580%252599s%252BDisease%252Bwith%252B%25255B18F%25255DFESCH%252BSynthesized%252Bby%252Ba%252BSimplified%252BTwo-Step%252BOne-Pot%252BRadiolabeling%252BStrategy%26aulast%3DSchr%25C3%25B6der%26aufirst%3DSusann%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D7%26spage%3D1633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takuya  Mizumura</span>, <span class="hlFld-ContribAuthor ">Keita  Kondo</span>, <span class="hlFld-ContribAuthor ">Masatoshi  Kurita</span>, <span class="hlFld-ContribAuthor ">Yutaka  Kofuku</span>, <span class="hlFld-ContribAuthor ">Mei  Natsume</span>, <span class="hlFld-ContribAuthor ">Shunsuke  Imai</span>, <span class="hlFld-ContribAuthor ">Yutaro  Shiraishi</span>, <span class="hlFld-ContribAuthor ">Takumi  Ueda</span>, <span class="hlFld-ContribAuthor ">Ichio  Shimada</span>. </span><span class="cited-content_cbyCitation_article-title">Activation of adenosine A
              2A
              receptor by lipids from docosahexaenoic acid revealed by NMR. </span><span class="cited-content_cbyCitation_journal-name">Science Advances</span><span> <strong>2020,</strong> <em>6 </em>
                                    (12)
                                     , eaay8544. <a href="https://doi.org/10.1126/sciadv.aay8544" title="DOI URL">https://doi.org/10.1126/sciadv.aay8544</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/sciadv.aay8544&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fsciadv.aay8544%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Advances%26atitle%3DActivation%252Bof%252Badenosine%252BA%252B2A%252Breceptor%252Bby%252Blipids%252Bfrom%252Bdocosahexaenoic%252Bacid%252Brevealed%252Bby%252BNMR%26aulast%3DMizumura%26aufirst%3DTakuya%26date%3D2020%26date%3D2020%26volume%3D6%26issue%3D12%26spage%3Deaay8544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francesco  Bartoli</span>, <span class="hlFld-ContribAuthor ">Geoffrey  Burnstock</span>, <span class="hlFld-ContribAuthor ">Cristina  Crocamo</span>, <span class="hlFld-ContribAuthor ">Giuseppe  CarrÃ </span>. </span><span class="cited-content_cbyCitation_article-title">Purinergic Signaling and Related Biomarkers in Depression. </span><span class="cited-content_cbyCitation_journal-name">Brain Sciences</span><span> <strong>2020,</strong> <em>10 </em>
                                    (3)
                                     , 160. <a href="https://doi.org/10.3390/brainsci10030160" title="DOI URL">https://doi.org/10.3390/brainsci10030160</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/brainsci10030160&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbrainsci10030160%26sid%3Dliteratum%253Aachs%26jtitle%3DBrain%2520Sciences%26atitle%3DPurinergic%252BSignaling%252Band%252BRelated%252BBiomarkers%252Bin%252BDepression%26aulast%3DBartoli%26aufirst%3DFrancesco%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D3%26spage%3D160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wiwin Is  Effendi</span>, <span class="hlFld-ContribAuthor ">Tatsuya  Nagano</span>, <span class="hlFld-ContribAuthor ">Kazuyuki  Kobayashi</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Nishimura</span>. </span><span class="cited-content_cbyCitation_article-title">Focusing on Adenosine Receptors as a Potential Targeted Therapy in Human Diseases. </span><span class="cited-content_cbyCitation_journal-name">Cells</span><span> <strong>2020,</strong> <em>9 </em>
                                    (3)
                                     , 785. <a href="https://doi.org/10.3390/cells9030785" title="DOI URL">https://doi.org/10.3390/cells9030785</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cells9030785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcells9030785%26sid%3Dliteratum%253Aachs%26jtitle%3DCells%26atitle%3DFocusing%252Bon%252BAdenosine%252BReceptors%252Bas%252Ba%252BPotential%252BTargeted%252BTherapy%252Bin%252BHuman%252BDiseases%26aulast%3DEffendi%26aufirst%3DWiwin%2BIs%26date%3D2020%26date%3D2020%26volume%3D9%26issue%3D3%26spage%3D785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Boghuma  Titanji</span>, <span class="hlFld-ContribAuthor ">Christina  Gavegnano</span>, <span class="hlFld-ContribAuthor ">Priscilla  Hsue</span>, <span class="hlFld-ContribAuthor ">Raymond  Schinazi</span>, <span class="hlFld-ContribAuthor ">Vincent C.  Marconi</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Heart Association</span><span> <strong>2020,</strong> <em>9 </em>
                                    (3)
                                     <a href="https://doi.org/10.1161/JAHA.119.014873" title="DOI URL">https://doi.org/10.1161/JAHA.119.014873</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1161/JAHA.119.014873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1161%2FJAHA.119.014873%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Heart%2520Association%26atitle%3DTargeting%252BInflammation%252Bto%252BReduce%252BAtherosclerotic%252BCardiovascular%252BRisk%252Bin%252BPeople%252BWith%252BHIV%252BInfection%26aulast%3DTitanji%26aufirst%3DBoghuma%26date%3D2020%26volume%3D9%26issue%3D3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pran Kishore  Deb</span>, <span class="hlFld-ContribAuthor ">Sarah Falah  Kokaz</span>, <span class="hlFld-ContribAuthor ">Sara Nidal  Abed</span>, <span class="hlFld-ContribAuthor ">Balakumar  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Wafa  Hourani</span>, <span class="hlFld-ContribAuthor ">Abdulmuttaleb Yousef  Jaber</span>, <span class="hlFld-ContribAuthor ">Raghu Prasad  Mailavaram</span>, <span class="hlFld-ContribAuthor ">Puneet  Kumar</span>, <span class="hlFld-ContribAuthor ">Katharigatta N.  Venugopala</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacology of Adenosine Receptors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 325-359. <a href="https://doi.org/10.1007/978-981-15-3556-7_10" title="DOI URL">https://doi.org/10.1007/978-981-15-3556-7_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-981-15-3556-7_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-981-15-3556-7_10%26sid%3Dliteratum%253Aachs%26atitle%3DPharmacology%252Bof%252BAdenosine%252BReceptors%26aulast%3DDeb%26aufirst%3DPran%2BKishore%26date%3D2020%26date%3D2020%26spage%3D325%26epage%3D359%26pub%3DSpringer%2520Singapore%26atitle%3DFrontiers%252Bin%252BPharmacology%252Bof%252BNeurotransmitters%26aulast%3DKumar%26aufirst%3DPuneet%26date%3D2020%26volume%3D50" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Helena D.  Janse van Rensburg</span>, <span class="hlFld-ContribAuthor ">Lesetja J.  Legoabe</span>, <span class="hlFld-ContribAuthor ">Gisella  Terre'Blanche</span>, <span class="hlFld-ContribAuthor ">Janine  Aucamp</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and evaluation of methoxy substituted 2-benzoyl-1-benzofuran derivatives as lead compounds for the development adenosine A1 and/or A2A receptor antagonists. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>94 </em>, 103459. <a href="https://doi.org/10.1016/j.bioorg.2019.103459" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103459</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103459%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%252Band%252Bevaluation%252Bof%252Bmethoxy%252Bsubstituted%252B2-benzoyl-1-benzofuran%252Bderivatives%252Bas%252Blead%252Bcompounds%252Bfor%252Bthe%252Bdevelopment%252Badenosine%252BA1%252Band%25252For%252BA2A%252Breceptor%252Bantagonists%26aulast%3DJanse%2Bvan%2BRensburg%26aufirst%3DHelena%2BD.%26date%3D2020%26volume%3D94%26spage%3D103459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalie Y.L.  Ngoi</span>, <span class="hlFld-ContribAuthor ">Jie Qing  Eu</span>, <span class="hlFld-ContribAuthor ">Jayshree  Hirpara</span>, <span class="hlFld-ContribAuthor ">Lingzhi  Wang</span>, <span class="hlFld-ContribAuthor ">Joline S.J.  Lim</span>, <span class="hlFld-ContribAuthor ">Soo-Chin  Lee</span>, <span class="hlFld-ContribAuthor ">Yaw-Chyn  Lim</span>, <span class="hlFld-ContribAuthor ">Shazib  Pervaiz</span>, <span class="hlFld-ContribAuthor ">Boon Cher  Goh</span>, <span class="hlFld-ContribAuthor ">Andrea L.A.  Wong</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Cell Metabolism as Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Antioxidants & Redox Signaling</span><span> <strong>2020,</strong> <em>32 </em>
                                    (5)
                                     , 285-308. <a href="https://doi.org/10.1089/ars.2019.7947" title="DOI URL">https://doi.org/10.1089/ars.2019.7947</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/ars.2019.7947&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fars.2019.7947%26sid%3Dliteratum%253Aachs%26jtitle%3DAntioxidants%2520%2526%2520Redox%2520Signaling%26atitle%3DTargeting%252BCell%252BMetabolism%252Bas%252BCancer%252BTherapy%26aulast%3DNgoi%26aufirst%3DNatalie%2BY.L.%26date%3D2020%26volume%3D32%26issue%3D5%26spage%3D285%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lawrence  Fong</span>, <span class="hlFld-ContribAuthor ">Andrew  Hotson</span>, <span class="hlFld-ContribAuthor ">John D.  Powderly</span>, <span class="hlFld-ContribAuthor ">Mario  Sznol</span>, <span class="hlFld-ContribAuthor ">Rebecca S.  Heist</span>, <span class="hlFld-ContribAuthor ">Toni K.  Choueiri</span>, <span class="hlFld-ContribAuthor ">Saby  George</span>, <span class="hlFld-ContribAuthor ">Brett G.M.  Hughes</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Hellmann</span>, <span class="hlFld-ContribAuthor ">Dale R.  Shepard</span>, <span class="hlFld-ContribAuthor ">Brian I.  Rini</span>, <span class="hlFld-ContribAuthor ">Shivaani  Kummar</span>, <span class="hlFld-ContribAuthor ">Amy M.  Weise</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Riese</span>, <span class="hlFld-ContribAuthor ">Ben  Markman</span>, <span class="hlFld-ContribAuthor ">Leisha A.  Emens</span>, <span class="hlFld-ContribAuthor ">Daruka  Mahadevan</span>, <span class="hlFld-ContribAuthor ">Jason J.  Luke</span>, <span class="hlFld-ContribAuthor ">Ginna  Laport</span>, <span class="hlFld-ContribAuthor ">Joshua D.  Brody</span>, <span class="hlFld-ContribAuthor ">Leonel  Hernandez-Aya</span>, <span class="hlFld-ContribAuthor ">Philip  Bonomi</span>, <span class="hlFld-ContribAuthor ">Jonathan W.  Goldman</span>, <span class="hlFld-ContribAuthor ">Lyudmyla  Berim</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Renouf</span>, <span class="hlFld-ContribAuthor ">Rachel A.  Goodwin</span>, <span class="hlFld-ContribAuthor ">Brian  Munneke</span>, <span class="hlFld-ContribAuthor ">Po Y.  Ho</span>, <span class="hlFld-ContribAuthor ">Jessica  Hsieh</span>, <span class="hlFld-ContribAuthor ">Ian  McCaffery</span>, <span class="hlFld-ContribAuthor ">Long  Kwei</span>, <span class="hlFld-ContribAuthor ">Stephen B.  Willingham</span>, <span class="hlFld-ContribAuthor ">Richard A.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine 2A Receptor Blockade as an Immunotherapy for Treatment-Refractory Renal Cell Cancer. </span><span class="cited-content_cbyCitation_journal-name">Cancer Discovery</span><span> <strong>2020,</strong> <em>10 </em>
                                    (1)
                                     , 40-53. <a href="https://doi.org/10.1158/2159-8290.CD-19-0980" title="DOI URL">https://doi.org/10.1158/2159-8290.CD-19-0980</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/2159-8290.CD-19-0980&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F2159-8290.CD-19-0980%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Discovery%26atitle%3DAdenosine%252B2A%252BReceptor%252BBlockade%252Bas%252Ban%252BImmunotherapy%252Bfor%252BTreatment-Refractory%252BRenal%252BCell%252BCancer%26aulast%3DFong%26aufirst%3DLawrence%26date%3D2020%26date%3D2019%26volume%3D10%26issue%3D1%26spage%3D40%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Karl B.  Alstadhaug</span>, <span class="hlFld-ContribAuthor ">Anna P.  Andreou</span>. </span><span class="cited-content_cbyCitation_article-title">Caffeine and Primary (Migraine) HeadachesâFriend or Foe?. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Neurology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fneur.2019.01275" title="DOI URL">https://doi.org/10.3389/fneur.2019.01275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fneur.2019.01275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffneur.2019.01275%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Neurology%26atitle%3DCaffeine%252Band%252BPrimary%252B%252528Migraine%252529%252BHeadaches%2525E2%252580%252594Friend%252Bor%252BFoe%25253F%26aulast%3DAlstadhaug%26aufirst%3DKarl%2BB.%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pedro  Renault</span>, <span class="hlFld-ContribAuthor ">Maxime  Louet</span>, <span class="hlFld-ContribAuthor ">Jacky  Marie</span>, <span class="hlFld-ContribAuthor ">Gilles  Labesse</span>, <span class="hlFld-ContribAuthor ">Nicolas  Floquet</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular Dynamics Simulations of the Allosteric Modulation of the Adenosine A2a Receptor by a Mini-G Protein. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2019,</strong> <em>9 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41598-019-41980-x" title="DOI URL">https://doi.org/10.1038/s41598-019-41980-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41598-019-41980-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41598-019-41980-x%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DMolecular%252BDynamics%252BSimulations%252Bof%252Bthe%252BAllosteric%252BModulation%252Bof%252Bthe%252BAdenosine%252BA2a%252BReceptor%252Bby%252Ba%252BMini-G%252BProtein%26aulast%3DRenault%26aufirst%3DPedro%26date%3D2019%26date%3D2019%26volume%3D9%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana Cristina de Bem  Alves</span>, <span class="hlFld-ContribAuthor ">Viviane JosÃ© de Oliveira  Bristot</span>, <span class="hlFld-ContribAuthor ">Mirieli Denardi  Limana</span>, <span class="hlFld-ContribAuthor ">Ana Elisa  Speck</span>, <span class="hlFld-ContribAuthor ">Leonardo Soares de  Barros</span>, <span class="hlFld-ContribAuthor ">Alexandre Francisco  Solano</span>, <span class="hlFld-ContribAuthor ">Aderbal S.  Aguiar</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Adenosine A
              2A
              Receptors in the Central Fatigue of Neurodegenerative Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Caffeine and Adenosine Research</span><span> <strong>2019,</strong> <em>9 </em>
                                    (4)
                                     , 145-156. <a href="https://doi.org/10.1089/caff.2019.0009" title="DOI URL">https://doi.org/10.1089/caff.2019.0009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1089/caff.2019.0009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1089%2Fcaff.2019.0009%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Caffeine%2520and%2520Adenosine%2520Research%26atitle%3DRole%252Bof%252BAdenosine%252BA%252B2A%252BReceptors%252Bin%252Bthe%252BCentral%252BFatigue%252Bof%252BNeurodegenerative%252BDiseases%26aulast%3DAlves%26aufirst%3DAna%2BCristina%2Bde%2BBem%26date%3D2019%26volume%3D9%26issue%3D4%26spage%3D145%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Catia  Lambertucci</span>, <span class="hlFld-ContribAuthor ">Andrea  Spinaci</span>, <span class="hlFld-ContribAuthor ">Michela  Buccioni</span>, <span class="hlFld-ContribAuthor ">Diego  Dal Ben</span>, <span class="hlFld-ContribAuthor ">Michael Alliance  Ngouadjeu Ngnintedem</span>, <span class="hlFld-ContribAuthor ">Sonja  Kachler</span>, <span class="hlFld-ContribAuthor ">Gabriella  Marucci</span>, <span class="hlFld-ContribAuthor ">Karl-Norbert  Klotz</span>, <span class="hlFld-ContribAuthor ">Rosaria  Volpini</span>. </span><span class="cited-content_cbyCitation_article-title">New A2A adenosine receptor antagonists: a structure-based upside-down interaction in the receptor cavity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>92 </em>, 103183. <a href="https://doi.org/10.1016/j.bioorg.2019.103183" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.103183</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.103183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.103183%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNew%252BA2A%252Badenosine%252Breceptor%252Bantagonists%25253A%252Ba%252Bstructure-based%252Bupside-down%252Binteraction%252Bin%252Bthe%252Breceptor%252Bcavity%26aulast%3DLambertucci%26aufirst%3DCatia%26date%3D2019%26volume%3D92%26spage%3D103183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yogendra  Pal</span>, <span class="hlFld-ContribAuthor ">Nabamita  Bandyopadhyay</span>, <span class="hlFld-ContribAuthor ">Rashmi S.  Pal</span>, <span class="hlFld-ContribAuthor ">Sarfaraz  Ahmed</span>, <span class="hlFld-ContribAuthor ">Shantanu  Bandopadhyay</span>. </span><span class="cited-content_cbyCitation_article-title">Perspective and Potential of A2A and A3 Adenosine Receptors as Therapeutic Targets for the Treatment of Rheumatoid Arthritis. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2019,</strong> <em>25 </em>
                                    (26)
                                     , 2859-2874. <a href="https://doi.org/10.2174/1381612825666190710111658" title="DOI URL">https://doi.org/10.2174/1381612825666190710111658</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612825666190710111658&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612825666190710111658%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DPerspective%252Band%252BPotential%252Bof%252BA2A%252Band%252BA3%252BAdenosine%252BReceptors%252Bas%252BTherapeutic%252BTargets%252Bfor%252Bthe%252BTreatment%252Bof%252BRheumatoid%252BArthritis%26aulast%3DPal%26aufirst%3DYogendra%26date%3D2019%26volume%3D25%26issue%3D26%26spage%3D2859%26epage%3D2874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sumit  Jamwal</span>, <span class="hlFld-ContribAuthor ">Ashish  Mittal</span>, <span class="hlFld-ContribAuthor ">Puneet  Kumar</span>, <span class="hlFld-ContribAuthor ">Dana M.  Alhayani</span>, <span class="hlFld-ContribAuthor ">Amal  Al-Aboudi</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Potential of Agonists and Antagonists of A1, A2a, A2b and A3 Adenosine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2019,</strong> <em>25 </em>
                                    (26)
                                     , 2892-2905. <a href="https://doi.org/10.2174/1381612825666190716112319" title="DOI URL">https://doi.org/10.2174/1381612825666190716112319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612825666190716112319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612825666190716112319%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DTherapeutic%252BPotential%252Bof%252BAgonists%252Band%252BAntagonists%252Bof%252BA1%25252C%252BA2a%25252C%252BA2b%252Band%252BA3%252BAdenosine%252BReceptors%26aulast%3DJamwal%26aufirst%3DSumit%26date%3D2019%26volume%3D25%26issue%3D26%26spage%3D2892%26epage%3D2905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Omar H.A.  Al-Attraqchi</span>, <span class="hlFld-ContribAuthor ">Mahesh  Attimarad</span>, <span class="hlFld-ContribAuthor ">Katharigatta N.  Venugopala</span>, <span class="hlFld-ContribAuthor ">Anroop  Nair</span>, <span class="hlFld-ContribAuthor ">Noor H.A.  Al-Attraqchi</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2019,</strong> <em>25 </em>
                                    (25)
                                     , 2716-2740. <a href="https://doi.org/10.2174/1381612825666190716113444" title="DOI URL">https://doi.org/10.2174/1381612825666190716113444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612825666190716113444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612825666190716113444%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DAdenosine%252BA2A%252BReceptor%252Bas%252Ba%252BPotential%252BDrug%252BTarget%252B-%252BCurrent%252BStatus%252Band%252BFuture%252BPerspectives%26aulast%3DAl-Attraqchi%26aufirst%3DOmar%2BH.A.%26date%3D2019%26volume%3D25%26issue%3D25%26spage%3D2716%26epage%3D2740" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Zhang</span>, <span class="hlFld-ContribAuthor ">Shiyong  Fan</span>, <span class="hlFld-ContribAuthor ">Xinbo  Zhou</span>, <span class="hlFld-ContribAuthor ">Fei  Xie</span>, <span class="hlFld-ContribAuthor ">Song  Li</span>, <span class="hlFld-ContribAuthor ">Wu  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 2-hydrazinyladenosine derivatives as A2A adenosine receptor ligands. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>179 </em>, 310-324. <a href="https://doi.org/10.1016/j.ejmech.2019.06.050" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.050%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B2-hydrazinyladenosine%252Bderivatives%252Bas%252BA2A%252Badenosine%252Breceptor%252Bligands%26aulast%3DZhang%26aufirst%3DMin%26date%3D2019%26volume%3D179%26spage%3D310%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">XiangJun  Kong</span>, <span class="hlFld-ContribAuthor ">Jun  Jiang</span>, <span class="hlFld-ContribAuthor ">Bo  Cheng</span>, <span class="hlFld-ContribAuthor ">Rui  Jiang</span>. </span><span class="cited-content_cbyCitation_article-title">Effect of low androgen status on the expression of adenosine A
              2A
              and A
              2B
              receptors in rat penile corpus cavernosum. </span><span class="cited-content_cbyCitation_journal-name">Andrologia</span><span> <strong>2019,</strong> <em>51 </em>
                                    (9)
                                     <a href="https://doi.org/10.1111/and.13344" title="DOI URL">https://doi.org/10.1111/and.13344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/and.13344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fand.13344%26sid%3Dliteratum%253Aachs%26jtitle%3DAndrologia%26atitle%3DEffect%252Bof%252Blow%252Bandrogen%252Bstatus%252Bon%252Bthe%252Bexpression%252Bof%252Badenosine%252BA%252B2A%252Band%252BA%252B2B%252Breceptors%252Bin%252Brat%252Bpenile%252Bcorpus%252Bcavernosum%26aulast%3DKong%26aufirst%3DXiangJun%26date%3D2019%26date%3D2019%26volume%3D51%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dongxiang  Xue</span>, <span class="hlFld-ContribAuthor ">Tiandan  Xu</span>, <span class="hlFld-ContribAuthor ">Huixia  Wang</span>, <span class="hlFld-ContribAuthor ">Meng  Wu</span>, <span class="hlFld-ContribAuthor ">Ya  Yuan</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">Qiwen  Tan</span>, <span class="hlFld-ContribAuthor ">Fei  Zhao</span>, <span class="hlFld-ContribAuthor ">Fang  Zhou</span>, <span class="hlFld-ContribAuthor ">Tao  Hu</span>, <span class="hlFld-ContribAuthor ">Zhongxing  Jiang</span>, <span class="hlFld-ContribAuthor ">ZhiâJie  Liu</span>, <span class="hlFld-ContribAuthor ">Suwen  Zhao</span>, <span class="hlFld-ContribAuthor ">Dongsheng  Liu</span>, <span class="hlFld-ContribAuthor ">Kurt  WÃ¼thrich</span>, <span class="hlFld-ContribAuthor ">Houchao  Tao</span>. </span><span class="cited-content_cbyCitation_article-title">DisulfideâContaining Detergents (DCDs) for the Structural Biology of Membrane Proteins. </span><span class="cited-content_cbyCitation_journal-name">Chemistry â A European Journal</span><span> <strong>2019,</strong> <em>25 </em>
                                    (50)
                                     , 11635-11640. <a href="https://doi.org/10.1002/chem.201903190" title="DOI URL">https://doi.org/10.1002/chem.201903190</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201903190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201903190%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DDisulfide%2525E2%252580%252590Containing%252BDetergents%252B%252528DCDs%252529%252Bfor%252Bthe%252BStructural%252BBiology%252Bof%252BMembrane%252BProteins%26aulast%3DXue%26aufirst%3DDongxiang%26date%3D2019%26date%3D2019%26volume%3D25%26issue%3D50%26spage%3D11635%26epage%3D11640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Saynaz A.  Choudhary</span>, <span class="hlFld-ContribAuthor ">Nikita  Bora</span>, <span class="hlFld-ContribAuthor ">Dipanjan  Banerjee</span>, <span class="hlFld-ContribAuthor ">Leena  Arora</span>, <span class="hlFld-ContribAuthor ">Anindhya Sundar  Das</span>, <span class="hlFld-ContribAuthor ">Rakesh  Yadav</span>, <span class="hlFld-ContribAuthor ">Karl-Norbert  Klotz</span>, <span class="hlFld-ContribAuthor ">Durba  Pal</span>, <span class="hlFld-ContribAuthor ">Anupam Nath  Jha</span>, <span class="hlFld-ContribAuthor ">Suman  Dasgupta</span>. </span><span class="cited-content_cbyCitation_article-title">A novel small molecule A2A adenosine receptor agonist, indirubin-3â²-monoxime, alleviates lipid-induced inflammation and insulin resistance in 3T3-L1 adipocytes. </span><span class="cited-content_cbyCitation_journal-name">Biochemical Journal</span><span> <strong>2019,</strong> <em>476 </em>
                                    (16)
                                     , 2371-2391. <a href="https://doi.org/10.1042/BCJ20190251" title="DOI URL">https://doi.org/10.1042/BCJ20190251</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1042/BCJ20190251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1042%2FBCJ20190251%26sid%3Dliteratum%253Aachs%26jtitle%3DBiochemical%2520Journal%26atitle%3DA%252Bnovel%252Bsmall%252Bmolecule%252BA2A%252Badenosine%252Breceptor%252Bagonist%25252C%252Bindirubin-3%2525E2%252580%2525B2-monoxime%25252C%252Balleviates%252Blipid-induced%252Binflammation%252Band%252Binsulin%252Bresistance%252Bin%252B3T3-L1%252Badipocytes%26aulast%3DChoudhary%26aufirst%3DSaynaz%2BA.%26date%3D2019%26date%3D2019%26volume%3D476%26issue%3D16%26spage%3D2371%26epage%3D2391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Widya  Dwi Aryati</span>, <span class="hlFld-ContribAuthor ">Nabilah  Nurtika Salamah</span>, <span class="hlFld-ContribAuthor ">Rezi  Riadhi Syahdi</span>, <span class="hlFld-ContribAuthor ">Arry  Yanuar</span>. </span><span class="cited-content_cbyCitation_article-title">The Role and Development of the Antagonist of Adenosine A
              2A
              in Parkinsonâs Disease. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.5772/intechopen.84272" title="DOI URL">https://doi.org/10.5772/intechopen.84272</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.5772/intechopen.84272&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.5772%2Fintechopen.84272%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BRole%252Band%252BDevelopment%252Bof%252Bthe%252BAntagonist%252Bof%252BAdenosine%252BA%252B2A%252Bin%252BParkinson%2525E2%252580%252599s%252BDisease%26aulast%3DDwi%2BAryati%26aufirst%3DWidya%26date%3D2019%26date%3D2019%26pub%3DIntechOpen%26atitle%3DNeuroprotection%26aulast%3DChuen-Chung%2BChang%26aufirst%3DRaymond%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pabitra Narayan  Samanta</span>, <span class="hlFld-ContribAuthor ">Supratik  Kar</span>, <span class="hlFld-ContribAuthor ">Jerzy  Leszczynski</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances of In-Silico Modeling of Potent Antagonists for the Adenosine Receptors. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2019,</strong> <em>25 </em>
                                    (7)
                                     , 750-773. <a href="https://doi.org/10.2174/1381612825666190304123545" title="DOI URL">https://doi.org/10.2174/1381612825666190304123545</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612825666190304123545&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612825666190304123545%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DRecent%252BAdvances%252Bof%252BIn-Silico%252BModeling%252Bof%252BPotent%252BAntagonists%252Bfor%252Bthe%252BAdenosine%252BReceptors%26aulast%3DSamanta%26aufirst%3DPabitra%2BNarayan%26date%3D2019%26volume%3D25%26issue%3D7%26spage%3D750%26epage%3D773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nikhil  Agrawal</span>, <span class="hlFld-ContribAuthor ">Balakumar  Chandrasekaran</span>, <span class="hlFld-ContribAuthor ">Amal  Al-Aboudi</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the In-silico Structure-based and Ligand-based Approaches for the Design and Discovery of Agonists and Antagonists of A2A Adenosine Receptor. </span><span class="cited-content_cbyCitation_journal-name">Current Pharmaceutical Design</span><span> <strong>2019,</strong> <em>25 </em>
                                    (7)
                                     , 774-782. <a href="https://doi.org/10.2174/1381612825666190306162006" title="DOI URL">https://doi.org/10.2174/1381612825666190306162006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/1381612825666190306162006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F1381612825666190306162006%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pharmaceutical%2520Design%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BIn-silico%252BStructure-based%252Band%252BLigand-based%252BApproaches%252Bfor%252Bthe%252BDesign%252Band%252BDiscovery%252Bof%252BAgonists%252Band%252BAntagonists%252Bof%252BA2A%252BAdenosine%252BReceptor%26aulast%3DAgrawal%26aufirst%3DNikhil%26date%3D2019%26volume%3D25%26issue%3D7%26spage%3D774%26epage%3D782" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Selena  Vigano</span>, <span class="hlFld-ContribAuthor ">Dimitrios  Alatzoglou</span>, <span class="hlFld-ContribAuthor ">Melita  Irving</span>, <span class="hlFld-ContribAuthor ">Christine  MÃ©nÃ©trier-Caux</span>, <span class="hlFld-ContribAuthor ">Christophe  Caux</span>, <span class="hlFld-ContribAuthor ">Pedro  Romero</span>, <span class="hlFld-ContribAuthor ">George  Coukos</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Immunology</span><span> <strong>2019,</strong> <em>10 </em><a href="https://doi.org/10.3389/fimmu.2019.00925" title="DOI URL">https://doi.org/10.3389/fimmu.2019.00925</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fimmu.2019.00925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffimmu.2019.00925%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Immunology%26atitle%3DTargeting%252BAdenosine%252Bin%252BCancer%252BImmunotherapy%252Bto%252BEnhance%252BT-Cell%252BFunction%26aulast%3DVigano%26aufirst%3DSelena%26date%3D2019%26date%3D2019%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Suman  Rohilla</span>, <span class="hlFld-ContribAuthor ">Ranju  Bansal</span>, <span class="hlFld-ContribAuthor ">Sonja  Kachler</span>, <span class="hlFld-ContribAuthor ">Karl-Norbert  Klotz</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and molecular modelling studies of 1,3,7,8-tetrasubstituted xanthines as potent and selective A2A AR ligands with in vivo efficacy against animal model of Parkinsonâs disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>87 </em>, 601-612. <a href="https://doi.org/10.1016/j.bioorg.2019.03.032" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.03.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.03.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.03.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodelling%252Bstudies%252Bof%252B1%25252C3%25252C7%25252C8-tetrasubstituted%252Bxanthines%252Bas%252Bpotent%252Band%252Bselective%252BA2A%252BAR%252Bligands%252Bwith%252Bin%252Bvivo%252Befficacy%252Bagainst%252Banimal%252Bmodel%252Bof%252BParkinson%2525E2%252580%252599s%252Bdisease%26aulast%3DRohilla%26aufirst%3DSuman%26date%3D2019%26volume%3D87%26spage%3D601%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maulik S.  Jani</span>, <span class="hlFld-ContribAuthor ">Aneesh T.  Veetil</span>, <span class="hlFld-ContribAuthor ">Yamuna  Krishnan</span>. </span><span class="cited-content_cbyCitation_article-title">Precision immunomodulation with synthetic nucleic acid technologies. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Materials</span><span> <strong>2019,</strong> <em>4 </em>
                                    (6)
                                     , 451-458. <a href="https://doi.org/10.1038/s41578-019-0105-4" title="DOI URL">https://doi.org/10.1038/s41578-019-0105-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41578-019-0105-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41578-019-0105-4%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Materials%26atitle%3DPrecision%252Bimmunomodulation%252Bwith%252Bsynthetic%252Bnucleic%252Bacid%252Btechnologies%26aulast%3DJani%26aufirst%3DMaulik%2BS.%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D6%26spage%3D451%26epage%3D458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rita C.  AcÃºrcio</span>, <span class="hlFld-ContribAuthor ">Anna  Scomparin</span>, <span class="hlFld-ContribAuthor ">Ronit  SatchiâFainaro</span>, <span class="hlFld-ContribAuthor ">Helena F.  Florindo</span>, <span class="hlFld-ContribAuthor ">Rita C.  Guedes</span>. </span><span class="cited-content_cbyCitation_article-title">Computerâaided drug design in new druggable targets for the next generation of immuneâoncology therapies. </span><span class="cited-content_cbyCitation_journal-name">Wiley Interdisciplinary Reviews: Computational Molecular Science</span><span> <strong>2019,</strong> <em>9 </em>
                                    (3)
                                     , e1397. <a href="https://doi.org/10.1002/wcms.1397" title="DOI URL">https://doi.org/10.1002/wcms.1397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/wcms.1397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fwcms.1397%26sid%3Dliteratum%253Aachs%26jtitle%3DWiley%2520Interdisciplinary%2520Reviews%253A%2520Computational%2520Molecular%2520Science%26atitle%3DComputer%2525E2%252580%252590aided%252Bdrug%252Bdesign%252Bin%252Bnew%252Bdruggable%252Btargets%252Bfor%252Bthe%252Bnext%252Bgeneration%252Bof%252Bimmune%2525E2%252580%252590oncology%252Btherapies%26aulast%3DAc%25C3%25BArcio%26aufirst%3DRita%2BC.%26date%3D2019%26date%3D2018%26volume%3D9%26issue%3D3%26spage%3De1397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maan T.  Khayat</span>, <span class="hlFld-ContribAuthor ">Ahmad  Hanif</span>, <span class="hlFld-ContribAuthor ">Werner J.  Geldenhuys</span>, <span class="hlFld-ContribAuthor ">Mohammed A.  Nayeem</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine Receptors and Drug Discovery in the Cardiovascular System. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 65-82. <a href="https://doi.org/10.2174/9781681083995118040004" title="DOI URL">https://doi.org/10.2174/9781681083995118040004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/9781681083995118040004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F9781681083995118040004%26sid%3Dliteratum%253Aachs%26atitle%3DAdenosine%252BReceptors%252Band%252BDrug%252BDiscovery%252Bin%252Bthe%252BCardiovascular%252BSystem%26aulast%3DKhayat%26aufirst%3DMaan%2BT.%26date%3D2019%26spage%3D65%26epage%3D82%26pub%3DBENTHAM%2520SCIENCE%2520PUBLISHERS%26atitle%3DFrontiers%252Bin%252BCardiovascular%252BDrug%252BDiscovery%25253A%252BVolume%252B4%26aulast%3DAtta-ur-Rahman%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Fontenas</span>, <span class="hlFld-ContribAuthor ">Taylor G.  Welsh</span>, <span class="hlFld-ContribAuthor ">Melanie  Piller</span>, <span class="hlFld-ContribAuthor ">Patricia  Coughenour</span>, <span class="hlFld-ContribAuthor ">Avni V.  Gandhi</span>, <span class="hlFld-ContribAuthor ">David A.  Prober</span>, <span class="hlFld-ContribAuthor ">Sarah  Kucenas</span>. </span><span class="cited-content_cbyCitation_article-title">The Neuromodulator Adenosine Regulates Oligodendrocyte Migration at Motor Exit Point Transition Zones. </span><span class="cited-content_cbyCitation_journal-name">Cell Reports</span><span> <strong>2019,</strong> <em>27 </em>
                                    (1)
                                     , 115-128.e5. <a href="https://doi.org/10.1016/j.celrep.2019.03.013" title="DOI URL">https://doi.org/10.1016/j.celrep.2019.03.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.celrep.2019.03.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.celrep.2019.03.013%26sid%3Dliteratum%253Aachs%26jtitle%3DCell%2520Reports%26atitle%3DThe%252BNeuromodulator%252BAdenosine%252BRegulates%252BOligodendrocyte%252BMigration%252Bat%252BMotor%252BExit%252BPoint%252BTransition%252BZones%26aulast%3DFontenas%26aufirst%3DLaura%26date%3D2019%26volume%3D27%26issue%3D1%26spage%3D115%26epage%3D128.e5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sangbae  Lee</span>, <span class="hlFld-ContribAuthor ">Anita K.  Nivedha</span>, <span class="hlFld-ContribAuthor ">Christopher G.  Tate</span>, <span class="hlFld-ContribAuthor ">Nagarajan  Vaidehi</span>. </span><span class="cited-content_cbyCitation_article-title">Dynamic Role of the G Protein in Stabilizing the Active State of the Adenosine A2A Receptor. </span><span class="cited-content_cbyCitation_journal-name">Structure</span><span> <strong>2019,</strong> <em>27 </em>
                                    (4)
                                     , 703-712.e3. <a href="https://doi.org/10.1016/j.str.2018.12.007" title="DOI URL">https://doi.org/10.1016/j.str.2018.12.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.str.2018.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.str.2018.12.007%26sid%3Dliteratum%253Aachs%26jtitle%3DStructure%26atitle%3DDynamic%252BRole%252Bof%252Bthe%252BG%252BProtein%252Bin%252BStabilizing%252Bthe%252BActive%252BState%252Bof%252Bthe%252BAdenosine%252BA2A%252BReceptor%26aulast%3DLee%26aufirst%3DSangbae%26date%3D2019%26volume%3D27%26issue%3D4%26spage%3D703%26epage%3D712.e3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Passarelli</span>, <span class="hlFld-ContribAuthor ">Marco  Tucci</span>, <span class="hlFld-ContribAuthor ">Francesco  Mannavola</span>, <span class="hlFld-ContribAuthor ">Claudia  Felici</span>, <span class="hlFld-ContribAuthor ">Francesco  Silvestris</span>. </span><span class="cited-content_cbyCitation_article-title">The metabolic milieu in melanoma: Role of immune suppression by CD73/adenosine. </span><span class="cited-content_cbyCitation_journal-name">Tumor Biology</span><span> <strong>2019,</strong> <em>41 </em>
                                    (4)
                                     , 101042831983713. <a href="https://doi.org/10.1177/1010428319837138" title="DOI URL">https://doi.org/10.1177/1010428319837138</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1010428319837138&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1010428319837138%26sid%3Dliteratum%253Aachs%26jtitle%3DTumor%2520Biology%26atitle%3DThe%252Bmetabolic%252Bmilieu%252Bin%252Bmelanoma%25253A%252BRole%252Bof%252Bimmune%252Bsuppression%252Bby%252BCD73%25252Fadenosine%26aulast%3DPassarelli%26aufirst%3DAnna%26date%3D2019%26date%3D2019%26volume%3D41%26issue%3D4%26spage%3D101042831983713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Byeong ill  Lee</span>, <span class="hlFld-ContribAuthor ">Min-Ho  Park</span>, <span class="hlFld-ContribAuthor ">Seok-Ho  Shin</span>, <span class="hlFld-ContribAuthor ">Jin-Ju  Byeon</span>, <span class="hlFld-ContribAuthor ">Yuri  Park</span>, <span class="hlFld-ContribAuthor ">Nahye  Kim</span>, <span class="hlFld-ContribAuthor ">Jangmi  Choi</span>, <span class="hlFld-ContribAuthor ">Young G.  Shin</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative Analysis of Tozadenant Using Liquid Chromatography-Mass Spectrometric Method in Rat Plasma and Its Human Pharmacokinetics Prediction Using Physiologically Based Pharmacokinetic Modeling. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (7)
                                     , 1295. <a href="https://doi.org/10.3390/molecules24071295" title="DOI URL">https://doi.org/10.3390/molecules24071295</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24071295&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24071295%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DQuantitative%252BAnalysis%252Bof%252BTozadenant%252BUsing%252BLiquid%252BChromatography-Mass%252BSpectrometric%252BMethod%252Bin%252BRat%252BPlasma%252Band%252BIts%252BHuman%252BPharmacokinetics%252BPrediction%252BUsing%252BPhysiologically%252BBased%252BPharmacokinetic%252BModeling%26aulast%3DLee%26aufirst%3DByeong%2Bill%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D7%26spage%3D1295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liming  Liu</span>, <span class="hlFld-ContribAuthor ">Qun  Chen</span>, <span class="hlFld-ContribAuthor ">Liewei  Wen</span>, <span class="hlFld-ContribAuthor ">Cong  Li</span>, <span class="hlFld-ContribAuthor ">Huan  Qin</span>, <span class="hlFld-ContribAuthor ">Da  Xing</span>. </span><span class="cited-content_cbyCitation_article-title">Photoacoustic Therapy for Precise Eradication of Glioblastoma with a Tumor Site Blood-Brain Barrier Permeability Upregulating Nanoparticle. </span><span class="cited-content_cbyCitation_journal-name">Advanced Functional Materials</span><span> <strong>2019,</strong> <em>29 </em>
                                    (11)
                                     , 1808601. <a href="https://doi.org/10.1002/adfm.201808601" title="DOI URL">https://doi.org/10.1002/adfm.201808601</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adfm.201808601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadfm.201808601%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Functional%2520Materials%26atitle%3DPhotoacoustic%252BTherapy%252Bfor%252BPrecise%252BEradication%252Bof%252BGlioblastoma%252Bwith%252Ba%252BTumor%252BSite%252BBlood-Brain%252BBarrier%252BPermeability%252BUpregulating%252BNanoparticle%26aulast%3DLiu%26aufirst%3DLiming%26date%3D2019%26date%3D2019%26volume%3D29%26issue%3D11%26spage%3D1808601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C.F.  Burgos</span>, <span class="hlFld-ContribAuthor ">C.  SanchÃ©z</span>, <span class="hlFld-ContribAuthor ">C.  SepÃºlveda</span>, <span class="hlFld-ContribAuthor ">E.  Fuentes</span>, <span class="hlFld-ContribAuthor ">I.  Palomo</span>, <span class="hlFld-ContribAuthor ">M.  AlarcÃ³n</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-aggregation effect on platelets of Indiplon a hypnotic sedative non-benzodiazepine drug. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2019,</strong> <em>111 </em>, 378-385. <a href="https://doi.org/10.1016/j.biopha.2018.12.087" title="DOI URL">https://doi.org/10.1016/j.biopha.2018.12.087</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2018.12.087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2018.12.087%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DAnti-aggregation%252Beffect%252Bon%252Bplatelets%252Bof%252BIndiplon%252Ba%252Bhypnotic%252Bsedative%252Bnon-benzodiazepine%252Bdrug%26aulast%3DBurgos%26aufirst%3DC.F.%26date%3D2019%26volume%3D111%26spage%3D378%26epage%3D385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Flavia  Varano</span>, <span class="hlFld-ContribAuthor ">Daniela  Catarzi</span>, <span class="hlFld-ContribAuthor ">Matteo  Falsini</span>, <span class="hlFld-ContribAuthor ">Diego  Dal Ben</span>, <span class="hlFld-ContribAuthor ">Michela  Buccioni</span>, <span class="hlFld-ContribAuthor ">Gabriella  Marucci</span>, <span class="hlFld-ContribAuthor ">Rosaria  Volpini</span>, <span class="hlFld-ContribAuthor ">Vittoria  Colotta</span>. </span><span class="cited-content_cbyCitation_article-title">Novel human adenosine receptor antagonists based on the 7-amino-thiazolo[5,4-d]pyrimidine scaffold. Structural investigations at the 2-, 5- and 7-positions to enhance affinity and tune selectivity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (4)
                                     , 563-569. <a href="https://doi.org/10.1016/j.bmcl.2018.12.062" title="DOI URL">https://doi.org/10.1016/j.bmcl.2018.12.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2018.12.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2018.12.062%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252Bhuman%252Badenosine%252Breceptor%252Bantagonists%252Bbased%252Bon%252Bthe%252B7-amino-thiazolo%25255B5%25252C4-d%25255Dpyrimidine%252Bscaffold.%252BStructural%252Binvestigations%252Bat%252Bthe%252B2-%25252C%252B5-%252Band%252B7-positions%252Bto%252Benhance%252Baffinity%252Band%252Btune%252Bselectivity%26aulast%3DVarano%26aufirst%3DFlavia%26date%3D2019%26volume%3D29%26issue%3D4%26spage%3D563%26epage%3D569" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Magdalena  Boncler</span>, <span class="hlFld-ContribAuthor ">Joanna  Wzorek</span>, <span class="hlFld-ContribAuthor ">Nina  Wolska</span>, <span class="hlFld-ContribAuthor ">Dawid  Polak</span>, <span class="hlFld-ContribAuthor ">Cezary  Watala</span>, <span class="hlFld-ContribAuthor ">Marcin  Rozalski</span>. </span><span class="cited-content_cbyCitation_article-title">Adenosine receptor agonists deepen the inhibition of platelet aggregation by P2Y12 antagonists. </span><span class="cited-content_cbyCitation_journal-name">Vascular Pharmacology</span><span> <strong>2019,</strong> <em>113 </em>, 47-56. <a href="https://doi.org/10.1016/j.vph.2018.11.005" title="DOI URL">https://doi.org/10.1016/j.vph.2018.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.vph.2018.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.vph.2018.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DVascular%2520Pharmacology%26atitle%3DAdenosine%252Breceptor%252Bagonists%252Bdeepen%252Bthe%252Binhibition%252Bof%252Bplatelet%252Baggregation%252Bby%252BP2Y12%252Bantagonists%26aulast%3DBoncler%26aufirst%3DMagdalena%26date%3D2019%26volume%3D113%26spage%3D47%26epage%3D56" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Antoni  CortÃ©s</span>, <span class="hlFld-ContribAuthor ">VerÃ²nica  CasadÃ³-Anguera</span>, <span class="hlFld-ContribAuthor ">EstefanÃ­a  Moreno</span>, <span class="hlFld-ContribAuthor ">Vicent  CasadÃ³</span>. </span><span class="cited-content_cbyCitation_article-title">The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 37-78. <a href="https://doi.org/10.1016/bs.apha.2019.01.001" title="DOI URL">https://doi.org/10.1016/bs.apha.2019.01.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.apha.2019.01.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.apha.2019.01.001%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252Bheterotetrameric%252Bstructure%252Bof%252Bthe%252Badenosine%252BA1-dopamine%252BD1%252Breceptor%252Bcomplex%25253A%252BPharmacological%252Bimplication%252Bfor%252Brestless%252Blegs%252Bsyndrome%26aulast%3DCort%25C3%25A9s%26aufirst%3DAntoni%26date%3D2019%26spage%3D37%26epage%3D78%26pub%3DElsevier%26atitle%3DPharmacology%252Bof%252BRestless%252BLegs%252BSyndrome%252B%252528RLS%252529%26date%3D2019%26volume%3D84" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mustafa  Korkutata</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Saitoh</span>, <span class="hlFld-ContribAuthor ">Yoan  Cherasse</span>, <span class="hlFld-ContribAuthor ">Shuji  Ioka</span>, <span class="hlFld-ContribAuthor ">Feng  Duo</span>, <span class="hlFld-ContribAuthor ">Rujie  Qin</span>, <span class="hlFld-ContribAuthor ">Nobuyuki  Murakoshi</span>, <span class="hlFld-ContribAuthor ">Shinya  Fujii</span>, <span class="hlFld-ContribAuthor ">Xuzhao  Zhou</span>, <span class="hlFld-ContribAuthor ">Fumihiro  Sugiyama</span>, <span class="hlFld-ContribAuthor ">Jiang-Fan  Chen</span>, <span class="hlFld-ContribAuthor ">Hidetoshi  Kumagai</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Nagase</span>, <span class="hlFld-ContribAuthor ">Michael  Lazarus</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancing endogenous adenosine A2A receptor signaling induces slow-wave sleep without affecting body temperature and cardiovascular function. </span><span class="cited-content_cbyCitation_journal-name">Neuropharmacology</span><span> <strong>2019,</strong> <em>144 </em>, 122-132. <a href="https://doi.org/10.1016/j.neuropharm.2018.10.022" title="DOI URL">https://doi.org/10.1016/j.neuropharm.2018.10.022</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neuropharm.2018.10.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neuropharm.2018.10.022%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropharmacology%26atitle%3DEnhancing%252Bendogenous%252Badenosine%252BA2A%252Breceptor%252Bsignaling%252Binduces%252Bslow-wave%252Bsleep%252Bwithout%252Baffecting%252Bbody%252Btemperature%252Band%252Bcardiovascular%252Bfunction%26aulast%3DKorkutata%26aufirst%3DMustafa%26date%3D2019%26volume%3D144%26spage%3D122%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristian A.  Haanes</span>, <span class="hlFld-ContribAuthor ">Alejandro  Labastida-RamÃ­rez</span>, <span class="hlFld-ContribAuthor ">Kayi Y.  Chan</span>, <span class="hlFld-ContribAuthor ">RenÃ©  de Vries</span>, <span class="hlFld-ContribAuthor ">Brian  Shook</span>, <span class="hlFld-ContribAuthor ">Paul  Jackson</span>, <span class="hlFld-ContribAuthor ">Jimmy  Zhang</span>, <span class="hlFld-ContribAuthor ">Christopher M.  Flores</span>, <span class="hlFld-ContribAuthor ">Alexander H. J.  Danser</span>, <span class="hlFld-ContribAuthor ">Carlos M.  VillalÃ³n</span>, <span class="hlFld-ContribAuthor ">Antoinette  MaassenVanDenBrink</span>. </span><span class="cited-content_cbyCitation_article-title">Characterization of the trigeminovascular actions of several adenosine A2A receptor antagonists in an in vivo rat model of migraine. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Headache and Pain</span><span> <strong>2018,</strong> <em>19 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s10194-018-0867-x" title="DOI URL">https://doi.org/10.1186/s10194-018-0867-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s10194-018-0867-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs10194-018-0867-x%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Headache%2520and%2520Pain%26atitle%3DCharacterization%252Bof%252Bthe%252Btrigeminovascular%252Bactions%252Bof%252Bseveral%252Badenosine%252BA2A%252Breceptor%252Bantagonists%252Bin%252Ban%252Bin%252Bvivo%252Brat%252Bmodel%252Bof%252Bmigraine%26aulast%3DHaanes%26aufirst%3DKristian%2BA.%26date%3D2018%26date%3D2018%26volume%3D19%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yu-Ting  Weng</span>, <span class="hlFld-ContribAuthor ">Ting  Chien</span>, <span class="hlFld-ContribAuthor ">I-I  Kuan</span>, <span class="hlFld-ContribAuthor ">Yijuang  Chern</span>. </span><span class="cited-content_cbyCitation_article-title">The TRAX, DISC1, and GSK3 complex in mental disorders and therapeutic interventions. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomedical Science</span><span> <strong>2018,</strong> <em>25 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s12929-018-0473-x" title="DOI URL">https://doi.org/10.1186/s12929-018-0473-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s12929-018-0473-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs12929-018-0473-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomedical%2520Science%26atitle%3DThe%252BTRAX%25252C%252BDISC1%25252C%252Band%252BGSK3%252Bcomplex%252Bin%252Bmental%252Bdisorders%252Band%252Btherapeutic%252Binterventions%26aulast%3DWeng%26aufirst%3DYu-Ting%26date%3D2018%26date%3D2018%26volume%3D25%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seok-Ho  Shin</span>, <span class="hlFld-ContribAuthor ">Min-Ho  Park</span>, <span class="hlFld-ContribAuthor ">Jin-Ju  Byeon</span>, <span class="hlFld-ContribAuthor ">Byeong  Lee</span>, <span class="hlFld-ContribAuthor ">Yuri  Park</span>, <span class="hlFld-ContribAuthor ">Nahye  Kim</span>, <span class="hlFld-ContribAuthor ">Jangmi  Choi</span>, <span class="hlFld-ContribAuthor ">Young  Shin</span>. </span><span class="cited-content_cbyCitation_article-title">Analysis of Vipadenant and Its In Vitro and In Vivo Metabolites via Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometry. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutics</span><span> <strong>2018,</strong> <em>10 </em>
                                    (4)
                                     , 260. <a href="https://doi.org/10.3390/pharmaceutics10040260" title="DOI URL">https://doi.org/10.3390/pharmaceutics10040260</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/pharmaceutics10040260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fpharmaceutics10040260%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutics%26atitle%3DAnalysis%252Bof%252BVipadenant%252Band%252BIts%252BIn%252BVitro%252Band%252BIn%252BVivo%252BMetabolites%252Bvia%252BLiquid%252BChromatography-Quadrupole-Time-of-Flight%252BMass%252BSpectrometry%26aulast%3DShin%26aufirst%3DSeok-Ho%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D4%26spage%3D260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Miles  Congreve</span>, <span class="hlFld-ContribAuthor ">Giles A.  Brown</span>, <span class="hlFld-ContribAuthor ">Alexandra  Borodovsky</span>, <span class="hlFld-ContribAuthor ">Michelle L.  Lamb</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting adenosine A
              2A
              receptor antagonism for treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2018,</strong> <em>13 </em>
                                    (11)
                                     , 997-1003. <a href="https://doi.org/10.1080/17460441.2018.1534825" title="DOI URL">https://doi.org/10.1080/17460441.2018.1534825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2018.1534825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2018.1534825%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DTargeting%252Badenosine%252BA%252B2A%252Breceptor%252Bantagonism%252Bfor%252Btreatment%252Bof%252Bcancer%26aulast%3DCongreve%26aufirst%3DMiles%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D11%26spage%3D997%26epage%3D1003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stephen B.  Willingham</span>, <span class="hlFld-ContribAuthor ">Po Y.  Ho</span>, <span class="hlFld-ContribAuthor ">Andrew  Hotson</span>, <span class="hlFld-ContribAuthor ">Craig  Hill</span>, <span class="hlFld-ContribAuthor ">Emily C.  Piccione</span>, <span class="hlFld-ContribAuthor ">Jessica  Hsieh</span>, <span class="hlFld-ContribAuthor ">Liang  Liu</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Buggy</span>, <span class="hlFld-ContribAuthor ">Ian  McCaffery</span>, <span class="hlFld-ContribAuthor ">Richard A.  Miller</span>. </span><span class="cited-content_cbyCitation_article-title">A2AR Antagonism with CPI-444 Induces Antitumor Responses and Augments Efficacy to AntiâPD-(L)1 and AntiâCTLA-4 in Preclinical Models. </span><span class="cited-content_cbyCitation_journal-name">Cancer Immunology Research</span><span> <strong>2018,</strong> <em>6 </em>
                                    (10)
                                     , 1136-1149. <a href="https://doi.org/10.1158/2326-6066.CIR-18-0056" title="DOI URL">https://doi.org/10.1158/2326-6066.CIR-18-0056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/2326-6066.CIR-18-0056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F2326-6066.CIR-18-0056%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Immunology%2520Research%26atitle%3DA2AR%252BAntagonism%252Bwith%252BCPI-444%252BInduces%252BAntitumor%252BResponses%252Band%252BAugments%252BEfficacy%252Bto%252BAnti%2525E2%252580%252593PD-%252528L%2525291%252Band%252BAnti%2525E2%252580%252593CTLA-4%252Bin%252BPreclinical%252BModels%26aulast%3DWillingham%26aufirst%3DStephen%2BB.%26date%3D2018%26date%3D2018%26volume%3D6%26issue%3D10%26spage%3D1136%26epage%3D1149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rajaa  Boulahjar</span>, <span class="hlFld-ContribAuthor ">Angela  Rincon Arias</span>, <span class="hlFld-ContribAuthor ">RaphaÃ«l  Bolteau</span>, <span class="hlFld-ContribAuthor ">Nicolas  Renault</span>, <span class="hlFld-ContribAuthor ">Mathilde  Coevoet</span>, <span class="hlFld-ContribAuthor ">AmÃ©lie  Barczyk</span>, <span class="hlFld-ContribAuthor ">Romain  Duroux</span>, <span class="hlFld-ContribAuthor ">SaÃ¯d  Yous</span>, <span class="hlFld-ContribAuthor ">Patricia  Melnyk</span>, <span class="hlFld-ContribAuthor ">Laurence  Agouridas</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of 2,6-disubstituted-8-amino imidazo[1,2a]pyridines, a promising privileged structure. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2018,</strong> <em>26 </em>
                                    (12)
                                     , 3296-3307. <a href="https://doi.org/10.1016/j.bmc.2018.04.057" title="DOI URL">https://doi.org/10.1016/j.bmc.2018.04.057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2018.04.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2018.04.057%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B2%25252C6-disubstituted-8-amino%252Bimidazo%25255B1%25252C2a%25255Dpyridines%25252C%252Ba%252Bpromising%252Bprivileged%252Bstructure%26aulast%3DBoulahjar%26aufirst%3DRajaa%26date%3D2018%26volume%3D26%26issue%3D12%26spage%3D3296%26epage%3D3307" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm4011669&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm4011669%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-9&amp;citedByCount=161&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="âtrueâ" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_null" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0017.gif" alt="" id="_i1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=f_null"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Adenosine A<sub>2A</sub> receptor historical agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Adenosine A<sub>2A</sub> receptor historical antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Adenosine A<sub>2A</sub> receptor location (black), cell or tissue function (red), and possible therapeutic applications (blue).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Crystal structure of the A<sub>2A</sub> receptor. (B) Overlap between the crystal structure of the agonist adenosine <b>1</b> (yellow) and the antagonist ZM241385 <b>16</b> (cyan).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Binding interactions at the adenosine A<sub>2A</sub> receptor: (A) antagonist ZM241385; (B) agonist NECA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Structures of therapeutically relevant A<sub>2A</sub> agonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. A<sub>2A</sub> allosteric modulators.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Overview of general core structures of A<sub>2A</sub> antagonists for the treatment of PD.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Selected A<sub>2A</sub> antagonists from Merck/Schering-Plough.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0011.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Selected A<sub>2A</sub> antagonists from Biotie/Roche and Vernalis.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0012.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Selected A<sub>2A</sub> antagonists from Shire Therapeutics, Domein Therapeutics, and Kyowa Hakko Kirin.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0013.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Selected A<sub>2A</sub> antagonists from Biogen Idec, Sigma-Tau, and Astellas Pharma.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0014.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Selected A<sub>2A</sub> antagonists from Johnson & Johnson and Neurocrine Biosciences.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0015.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Other known A<sub>2A</sub> antagonists.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/medium/jm-2013-011669_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0016.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. A<sub>2A</sub> antagonists radioligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-9/jm4011669/production/images/large/jm-2013-011669_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4011669&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i42">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27721" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27721" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 204 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Druri, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szent-GyÃ¶rgy, A.</span><span> </span><span class="NLM_article-title">The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart</span> <span class="citation_source-journal">J. Physiol. (London)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1929</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">â</span> <span class="NLM_lpage">237</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1929&pages=213-237&author=A.+N.+Druriauthor=A.+Szent-Gy%C3%B6rgy&title=The+physiological+activity+of+adenine+compounds+with+especial+reference+to+their+action+upon+the+mammalian+heart"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDruri%26aufirst%3DA.%2BN.%26aulast%3DSzent-Gy%25C3%25B6rgy%26aufirst%3DA.%26atitle%3DThe%2520physiological%2520activity%2520of%2520adenine%2520compounds%2520with%2520especial%2520reference%2520to%2520their%2520action%2520upon%2520the%2520mammalian%2520heart%26jtitle%3DJ.%2520Physiol.%2520%2528London%2529%26date%3D1929%26volume%3D68%26spage%3D213%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Cobbin, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Einstein, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuire, M. H.</span><span> </span><span class="NLM_article-title">Studies on the coronary dilator actions of some adenosine analogs</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">â</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1111%2Fj.1476-5381.1974.tb09589.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=4362949" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaE2cXktleht7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1974&pages=25-33&author=L.+B.+Cobbinauthor=R.+Einsteinauthor=M.+H.+McGuire&title=Studies+on+the+coronary+dilator+actions+of+some+adenosine+analogs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Coronary dilator actions of adenosine analogs</span></div><div class="casAuthors">Cobbin, L. B.; Einstein, Rosemarie; Maguire, M. Helen</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1974</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-33</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    </div><div class="casAbstract">Of 23 adenosine (I) [58-61-7] analogs, 22 stimulated coronary blood flow, with potencies which were not related to their durations of action, and durations which were not related to their substrate specificities for adenosine deaminase [9026-93-1] or adenosine kinase [9027-72-9].  Five of the analogs, which were injected intraatrially into anesthetized open thorax dogs, had potencies equal to or greater than that of I, and 4 potentiated the coronary dilator action of I.  The duration of this activity may be governed by the rate of tissue uptake of each analog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjwZ-Jcnn3hbVg90H21EOLACvtfcHk0lijvsXsoQ9qTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE2cXktleht7w%253D&md5=9b9ccedb0a7462c1d82273d6f90ad8f4</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1974.tb09589.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1974.tb09589.x%26sid%3Dliteratum%253Aachs%26aulast%3DCobbin%26aufirst%3DL.%2BB.%26aulast%3DEinstein%26aufirst%3DR.%26aulast%3DMcGuire%26aufirst%3DM.%2BH.%26atitle%3DStudies%2520on%2520the%2520coronary%2520dilator%2520actions%2520of%2520some%2520adenosine%2520analogs%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1974%26volume%3D50%26spage%3D25%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">De Gubareff, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sleator, W.</span><span> </span><span class="NLM_article-title">Effects of caffeine on mammalian atrial muscle, and its interaction with adenosine and calcium</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1965</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">202</span><span class="NLM_x">â</span> <span class="NLM_lpage">214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=14301011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaF2MXktVGqsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=1965&pages=202-214&author=T.+De+Gubareffauthor=W.+Sleator&title=Effects+of+caffeine+on+mammalian+atrial+muscle%2C+and+its+interaction+with+adenosine+and+calcium"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of caffeine on mammalian atrial muscle and its interaction with adenosine and calcium</span></div><div class="casAuthors">De Gubareff, Taisija; Sleator, William, Jr.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1965</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">202-14</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Caffeine (I), at 0.25-1.5 mM, exerted a pos. inotropic effect on isolated guinea pig atrium, while at higher concns. the contraction decreased.  The increased duration of transmembranal action potentials induced by I was proportional to drug concn., and at 2.5 mM was twice normal.  I probably releases catechol amines from the normal heart, but not following pretreatment with reserpine; however, the inotropic activity of I is not via this process.  The marked effect of I on the duration of the action potential as well as on contraction was dependent upon Ca in the medium, such that when both are present the strength of contraction and duration of action potential increase at a low frequency of elec. stimulation.  I antagonized the depressant effect of adenosine on contraction and action potential of the guinea pig and human atria, probably by altering the functions of Ca within the muscle cell.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphQKAWx4q3t7Vg90H21EOLACvtfcHk0lijvsXsoQ9qTg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2MXktVGqsrY%253D&md5=0ae31bc64f3f2a047e6be43a8d0a184a</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDe%2BGubareff%26aufirst%3DT.%26aulast%3DSleator%26aufirst%3DW.%26atitle%3DEffects%2520of%2520caffeine%2520on%2520mammalian%2520atrial%2520muscle%252C%2520and%2520its%2520interaction%2520with%2520adenosine%2520and%2520calcium%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1965%26volume%3D148%26spage%3D202%26epage%3D214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Sattin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rall, T. W.</span><span> </span><span class="NLM_article-title">The effect of adenosine and adenine nucleotides on the cyclic adenosine 3â²,5â²-phosphate content of guinea pig cerebral cortex slides</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">13</span><span class="NLM_x">â</span> <span class="NLM_lpage">23</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1970&pages=13-23&author=A.+Sattinauthor=T.+W.+Rall&title=The+effect+of+adenosine+and+adenine+nucleotides+on+the+cyclic+adenosine+3%E2%80%B2%2C5%E2%80%B2-phosphate+content+of+guinea+pig+cerebral+cortex+slides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSattin%26aufirst%3DA.%26aulast%3DRall%26aufirst%3DT.%2BW.%26atitle%3DThe%2520effect%2520of%2520adenosine%2520and%2520adenine%2520nucleotides%2520on%2520the%2520cyclic%2520adenosine%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-phosphate%2520content%2520of%2520guinea%2520pig%2520cerebral%2520cortex%2520slides%26jtitle%3DMol.%2520Pharmacol.%26date%3D1970%26volume%3D6%26spage%3D13%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">Are methylxanthines effects due to antagonism of endogenous adenosine?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">â</span> <span class="NLM_lpage">132</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=1980&pages=129-132&author=B.+B.+Fredholm&title=Are+methylxanthines+effects+due+to+antagonism+of+endogenous+adenosine%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DAre%2520methylxanthines%2520effects%2520due%2520to%2520antagonism%2520of%2520endogenous%2520adenosine%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D1980%26volume%3D1%26spage%3D129%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Van Calker, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamprecht, B.</span><span> </span><span class="NLM_article-title">Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1979</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x">, </span> <span class="NLM_fpage">999</span><span class="NLM_x">â</span> <span class="NLM_lpage">1005</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1111%2Fj.1471-4159.1979.tb05236.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=228008" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaL3cXht1aitrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1979&pages=999-1005&author=D.+Van+Calkerauthor=M.+Mullerauthor=B.+Hamprecht&title=Adenosine+regulates+via+two+different+types+of+receptors%2C+the+accumulation+of+cyclic+AMP+in+cultured+brain+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine regulates via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells</span></div><div class="casAuthors">Van Calker, Dietrich; Mueller, Margarete; Hamprecht, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1979</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">999-1005</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">In cultured mouse brain cells of glial character, the increase in intracellular concns. of cyclic AMP  [60-92-4] caused by Î²-adrenoceptor agonists was inhibited by <Î¼M concns. of adenosine  [58-61-7], whereas at concns. >Î¼M adenosine stimulated cyclic AMP concns. (EC50 â¼50 Î¼M).  Both effects of adenosine were antagonized by methylxanthines but not by blockage of adenosine uptake (100 Î¼M dipyridamol) or inhibition of cyclic AMP phosphodiesterase.  The activities depended on the integrity of the ribose moiety of the nucleotide; substituents of the purine system were tolerated comparatively well.  The order of potency of adenosine analogs was different for the 2 effects.  The 2 effects are probably mediated, therefore, by different adenosine receptors on the outer cell surface; the receptors mediating the inhibition and stimulation of cyclic AMP accumulation were termed A1 and A2, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9LOZV9yRbdrVg90H21EOLACvtfcHk0ljoExFPyp76Vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXht1aitrY%253D&md5=87028348a598749438cba570b2a077ce</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1979.tb05236.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1979.tb05236.x%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BCalker%26aufirst%3DD.%26aulast%3DMuller%26aufirst%3DM.%26aulast%3DHamprecht%26aufirst%3DB.%26atitle%3DAdenosine%2520regulates%2520via%2520two%2520different%2520types%2520of%2520receptors%252C%2520the%2520accumulation%2520of%2520cyclic%2520AMP%2520in%2520cultured%2520brain%2520cells%26jtitle%3DJ.%2520Neurochem.%26date%3D1979%26volume%3D33%26spage%3D999%26epage%3D1005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Daly, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pamela, B.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padgett, W.</span><span> </span><span class="NLM_article-title">Subclasses of adenosine receptors in the central nervous system: interaction with caffeine and related methylxanthines</span> <span class="citation_source-journal">Cell. Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">69</span><span class="NLM_x">â</span> <span class="NLM_lpage">80</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2FBF00734999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=6309393" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaL3sXkvVantbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1983&pages=69-80&author=J.+W.+Dalyauthor=B.-T.+Pamelaauthor=W.+Padgett&title=Subclasses+of+adenosine+receptors+in+the+central+nervous+system%3A+interaction+with+caffeine+and+related+methylxanthines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Subclasses of adenosine receptors in the central nervous system:  interaction with caffeine and related methylxanthines</span></div><div class="casAuthors">Daly, John W.; Butts-Lamb, Pamela; Padgett, William</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Neurobiology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">69-80</span>CODEN:
                <span class="NLM_cas:coden">CMNEDI</span>;
        ISSN:<span class="NLM_cas:issn">0272-4340</span>.
    </div><div class="casAbstract">The potencies of caffeine (I)  [58-08-2] and related methylxanthines as adenosine antagonists were assessed with respect to 3 apparent subtypes of adenosine receptors in rat brain prepns.: (1) the A1-adenosine receptor which binds with a very high affinity the ligand [3H]cyclohexyladenosine in rat brain membranes; (2) a ubiquitous low-affinity A2-adenosine receptor which activates cyclic AMP  [60-92-4] accumulation in rat brain slices, and (3) a relatively high-affinity A2-adenosine receptor which activates adenylate cyclase  [9012-42-4] in rat striatal membranes (this A2-adenosine system is present in striatal but not in cerebral cortical membranes).  Caffeine and other methylxanthines, thus, antagonize effectively both A1- and A2-adenosine receptors in brain prepns.  Theobromine  [83-67-0] appears less effective vs. A2-receptors than vs. A1-receptors.  The functional significance of antagonism of such adenosine receptors by caffeine in situ will depend both on the local levels of adenosine and on the affinity for adenosine for the receptor, since antagonism by xanthines is competitive in nature.  In addn., the functional significance of xanthine action will depend on the degree of inhibition of adenosine input which is required to alter the output signal.  For a stimulatory input to adenylate cyclase via an A2-adenosine receptor, profound antagonism by methylxanthines is probably required to alter the cyclic AMP-mediated output signal, while for inhibitory input to adenylate cyclase via an A1-adenosine receptor, presumably a lesser degree of antagonism by methylamines may be required to alter the cyclic AMP-mediated output signal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDacfOvNrNcbVg90H21EOLACvtfcHk0ljoExFPyp76Vg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXkvVantbs%253D&md5=94132d6b898b052e58f965cd417889b2</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2FBF00734999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00734999%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DPamela%26aufirst%3DB.-T.%26aulast%3DPadgett%26aufirst%3DW.%26atitle%3DSubclasses%2520of%2520adenosine%2520receptors%2520in%2520the%2520central%2520nervous%2520system%253A%2520interaction%2520with%2520caffeine%2520and%2520related%2520methylxanthines%26jtitle%3DCell.%2520Mol.%2520Neurobiol.%26date%3D1983%26volume%3D3%26spage%3D69%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z. G.</span><span> </span><span class="NLM_article-title">Adenosine receptors as therapeutic targets</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1038%2Fnrd1983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=16518376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=247-264&author=K.+A.+Jacobsonauthor=Z.+G.+Gao&title=Adenosine+receptors+as+therapeutic+targets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors as therapeutic targets</span></div><div class="casAuthors">Jacobson, Kenneth A.; Gao, Zhan-Guo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">247-264</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Adenosine receptors are major targets of caffeine, the most commonly consumed drug in the world.  There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischemic diseases, sleep disorders, immune and inflammatory disorders and cancer.  After more than three decades of medicinal chem. research, a considerable no. of selective agonists and antagonists of adenosine receptors have been discovered, and some have been clin. evaluated, although none has yet received regulatory approval.  However, recent advances in the understanding of the roles of the various adenosine receptor subtypes, and in the development of selective and potent ligands, as discussed in this review, have brought the goal of therapeutic application of adenosine receptor modulators considerably closer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoG29EyQFoSbVg90H21EOLACvtfcHk0ljbXGJnvw6Zaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhvFOlsr4%253D&md5=85ad553154bd61f24a6bb594f960f9bc</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnrd1983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1983%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.%2BG.%26atitle%3DAdenosine%2520receptors%2520as%2520therapeutic%2520targets%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D247%26epage%3D264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span> </span><span class="NLM_article-title">International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors</span> <span class="citation_source-journal">Pharmacol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">527</span><span class="NLM_x">â</span> <span class="NLM_lpage">552</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1211%2F0022357011775631" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=11734617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD38XltVOltQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=527-552&author=B.+B.+Fredholmauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobsonauthor=K.-N.+Klotzauthor=J.+Linden&title=International+Union+of+Pharmacology.+XXV.+Nomenclature+and+classification+of+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">International union of pharmacology. XXV. Nomenclature and classification of adenosine receptors</span></div><div class="casAuthors">Fredholm, Bertil B.; IJzerman, Adriaan P.; Jacobson, Kenneth A.; Klotz, Karl-Norbert; Linden, Joel</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Reviews</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">527-552</span>CODEN:
                <span class="NLM_cas:coden">PAREAQ</span>;
        ISSN:<span class="NLM_cas:issn">0031-6997</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A review.  Four adenosine receptors have been cloned and characterized from several mammalian species.  The receptors are named adenosine A1, A2A, A2B, and A3.  The A2A and A2B receptors preferably interact with members of the Gs family of G proteins and the A1 and A3 receptors with Gi/o proteins.  However, other G protein interactions have also been described.  Adenosine is the preferred endogenous agonist at all these receptors, but inosine can also activate the A3 receptor.  The levels of adenosine seen under basal conditions are sufficient to cause some activation of all the receptors, at least where they are abundantly expressed.  Adenosine levels during, e.g., ischemia can activate all receptors even when expressed in low abundance.  Accordingly, expts. with receptor antagonists and mice with targeted disruption of adenosine A1, A2A, and A3 expression reveal roles for these receptors under physiol. and particularly pathophysiol. conditions.  There are pharmacol. tools that can be used to classify A1, A2A, and A3 receptors but few drugs that interact selectively with A2B receptors.  Testable models of the interaction of these drugs with their receptors have been generated by site-directed mutagenesis and homol.-based modeling.  Both agonists and antagonists are being developed as potential drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJOCrJphTwDrVg90H21EOLACvtfcHk0ljbXGJnvw6Zaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XltVOltQ%253D%253D&md5=060ea8a3d7b07fdc4b2c8acc3b4d4745</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1211%2F0022357011775631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1211%252F0022357011775631%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DInternational%2520Union%2520of%2520Pharmacology.%2520XXV.%2520Nomenclature%2520and%2520classification%2520of%2520adenosine%2520receptors%26jtitle%3DPharmacol.%2520Rev.%26date%3D2001%26volume%3D53%26spage%3D527%26epage%3D552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Maenhaut, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Sande, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libert, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abramowicz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderhaegen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dumont, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffmann, S.</span><span> </span><span class="NLM_article-title">RDC8 codes for an adenosine A2 receptor with physiological constitutive activity</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">173</span><span class="NLM_x">, </span> <span class="NLM_fpage">1169</span><span class="NLM_x">â</span> <span class="NLM_lpage">1178</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=1990&pages=1169-1178&author=C.+Maenhautauthor=J.+Van+Sandeauthor=F.+Libertauthor=M.+Abramowiczauthor=M.+Parmentierauthor=J.+J.+Vanderhaegenauthor=J.+E.+Dumontauthor=G.+Vassanauthor=S.+Schiffmann&title=RDC8+codes+for+an+adenosine+A2+receptor+with+physiological+constitutive+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMaenhaut%26aufirst%3DC.%26aulast%3DVan%2BSande%26aufirst%3DJ.%26aulast%3DLibert%26aufirst%3DF.%26aulast%3DAbramowicz%26aufirst%3DM.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DVanderhaegen%26aufirst%3DJ.%2BJ.%26aulast%3DDumont%26aufirst%3DJ.%2BE.%26aulast%3DVassan%26aufirst%3DG.%26aulast%3DSchiffmann%26aufirst%3DS.%26atitle%3DRDC8%2520codes%2520for%2520an%2520adenosine%2520A2%2520receptor%2520with%2520physiological%2520constitutive%2520activity%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1990%26volume%3D173%26spage%3D1169%26epage%3D1178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Chem, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">King, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lai, H.</span><span> </span><span class="NLM_article-title">Molecular cloning of a novel adenosine receptor gene from rat brain</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">185</span><span class="NLM_x">, </span> <span class="NLM_fpage">304</span><span class="NLM_x">â</span> <span class="NLM_lpage">309</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=185&publication_year=1992&pages=304-309&author=Y.+Chemauthor=K.+Kingauthor=H.+Lai&title=Molecular+cloning+of+a+novel+adenosine+receptor+gene+from+rat+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChem%26aufirst%3DY.%26aulast%3DKing%26aufirst%3DK.%26aulast%3DLai%26aufirst%3DH.%26atitle%3DMolecular%2520cloning%2520of%2520a%2520novel%2520adenosine%2520receptor%2520gene%2520from%2520rat%2520brain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1992%26volume%3D185%26spage%3D304%26epage%3D309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Furlong, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selbie, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shine, J.</span><span> </span><span class="NLM_article-title">Molecular characterization of a human brain adenosine A<sub>2</sub> receptor</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">62</span><span class="NLM_x">â</span> <span class="NLM_lpage">66</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2F0169-328X%2892%2990152-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK3sXit1Kiu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1992&pages=62-66&author=T.+J.+Furlongauthor=K.+D.+Pierceauthor=L.+A.+Selbieauthor=J.+Shine&title=Molecular+characterization+of+a+human+brain+adenosine+A2+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular characterization of a human brain adenosine A2 receptor</span></div><div class="casAuthors">Furlong, Timothy J.; Pierce, Kerrie D.; Selbie, Lisa A.; Shine, John</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">62-6</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    </div><div class="casAbstract">A cDNA encoding a G protein-coupled receptor of unknown ligand specificity was isolated from a human hippocampal cDNA library by virtue of the high degree of structural homol. between members of this receptor family.  The cloned receptor DNA was transfected into human embryonic kidney 293 cells.  Stably transfected cell lines bound a variety of adenosine agonists and antagonists with affinities characteristic of a brain adenosine A2a receptor.  The A2a specific agonist CGS21680 stimulated cAMP prodn. but did not alter intracellular calcium concns. in transfected 293 cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLrHo7yhb7dLVg90H21EOLACvtfcHk0ljbXGJnvw6Zaw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXit1Kiu7s%253D&md5=7074217779407edb8a93652462529fd6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2F0169-328X%2892%2990152-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0169-328X%252892%252990152-2%26sid%3Dliteratum%253Aachs%26aulast%3DFurlong%26aufirst%3DT.%2BJ.%26aulast%3DPierce%26aufirst%3DK.%2BD.%26aulast%3DSelbie%26aufirst%3DL.%2BA.%26aulast%3DShine%26aufirst%3DJ.%26atitle%3DMolecular%2520characterization%2520of%2520a%2520human%2520brain%2520adenosine%2520A2%2520receptor%26jtitle%3DBrain%2520Res.%26date%3D1992%26volume%3D15%26spage%3D62%26epage%3D66" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Ledent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaugeois, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiffmann, S. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedrazzini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">El Yacoubi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanderhaeghen, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costentin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heath, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vassart, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.</span><span> </span><span class="NLM_article-title">Aggressiveness hypoalgesia and high blood pressure in mice lacking the adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">674</span><span class="NLM_x">â</span> <span class="NLM_lpage">678</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=1997&pages=674-678&author=C.+Ledentauthor=J.+M.+Vaugeoisauthor=S.+N.+Schiffmannauthor=T.+Pedrazziniauthor=M.+El+Yacoubiauthor=J.+J.+Vanderhaeghenauthor=J.+Costentinauthor=J.+K.+Heathauthor=G.+Vassartauthor=M.+Parmentier&title=Aggressiveness+hypoalgesia+and+high+blood+pressure+in+mice+lacking+the+adenosine+A2A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DVaugeois%26aufirst%3DJ.%2BM.%26aulast%3DSchiffmann%26aufirst%3DS.%2BN.%26aulast%3DPedrazzini%26aufirst%3DT.%26aulast%3DEl%2BYacoubi%26aufirst%3DM.%26aulast%3DVanderhaeghen%26aufirst%3DJ.%2BJ.%26aulast%3DCostentin%26aufirst%3DJ.%26aulast%3DHeath%26aufirst%3DJ.%2BK.%26aulast%3DVassart%26aufirst%3DG.%26aulast%3DParmentier%26aufirst%3DM.%26atitle%3DAggressiveness%2520hypoalgesia%2520and%2520high%2520blood%2520pressure%2520in%2520mice%2520lacking%2520the%2520adenosine%2520A2A%2520receptor%26jtitle%3DNature%26date%3D1997%26volume%3D388%26spage%3D674%26epage%3D678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Meng, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xie, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akil, H.</span><span> </span><span class="NLM_article-title">Cloning and expression of the A<sub>2A</sub> adenosine receptor from guinea pig brain</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">613</span><span class="NLM_x">â</span> <span class="NLM_lpage">621</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2FBF00971338" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=8065518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK2cXltVSgur8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1994&pages=613-621&author=F.+Mengauthor=G.+Xieauthor=D.+Chalmersauthor=C.+Morganauthor=S.+J.+Watsonauthor=H.+Akil&title=Cloning+and+expression+of+the+A2A+adenosine+receptor+from+guinea+pig+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Cloning and expression of the A2a adenosine receptor from guinea pig brain</span></div><div class="casAuthors">Meng, Fan; Xie, Guo Xi; Chalmers, Derek; Morgan, Caurnel; Watson, Stanley, J.,Jr.; Akil, Huda</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">613-21</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    </div><div class="casAbstract">A full-length complementary DNA (cDNA) clone encoding the guinea pig brain A2 adenosine receptor has been isolated by polymerase chain reaction (PCR) and low-stringency-hybridization screening lof a guinea pig brain cDNA library.  This cDNA contains a long open reading frame encoding a 409-amino acid-residue protein which is highly homologous to the A2 adenosine receptors previously cloned from other species.  Hydrophobicity anal. of the deduced protein sequence reveals seven hydrophobic regions, characteristic of a member of the G-protein-coupled receptor superfamily.  Radioligand binding assay and functional (GTPase and cAMP) assays of the receptor, transiently expressed in mammalian cells, demonstrate typical characteristics of the A2 type adenosine receptor.  The mRNA (mRNA) of this A2 receptor is found in the brain, heart, kidney and spleen.  Receptor autoradiog. with [3H]CGS21680, a specific A2 agonist, and in situ hybridization with A2 cRNA probe in guinea pig brain indicate that the receptor is expressed exclusively in the caudate nucleus.  The pharmacol. profile and anatomical distribution of this receptor indicate that it is of the A2a subtype.  This work represents the first cloning of an A2a receptor in a rodent species, offers a complete pharmacol. characterization of the receptor and provides an anatomical comparison between the binding profile and gene expression of the receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkrT474qsxYrVg90H21EOLACvtfcHk0lhhG1Eb8aYnMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXltVSgur8%253D&md5=8610b2c03708fafccc1d579cb5638e6f</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1007%2FBF00971338&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00971338%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DXie%26aufirst%3DG.%26aulast%3DChalmers%26aufirst%3DD.%26aulast%3DMorgan%26aufirst%3DC.%26aulast%3DWatson%26aufirst%3DS.%2BJ.%26aulast%3DAkil%26aufirst%3DH.%26atitle%3DCloning%2520and%2520expression%2520of%2520the%2520A2A%2520adenosine%2520receptor%2520from%2520guinea%2520pig%2520brain%26jtitle%3DNeurochem.%2520Res.%26date%3D1994%26volume%3D19%26spage%3D613%26epage%3D621" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Fuxe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FerrÃ©, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torvinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasmaa, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Staines, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woods, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnati, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> and dopamine D<sub>2</sub> heteromeric receptor complexes and their function</span> <span class="citation_source-journal">J. Mol. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">2â3</span><span class="NLM_x">) </span> <span class="NLM_fpage">209</span><span class="NLM_x">â</span> <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1385%2FJMN%3A26%3A2-3%3A209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=16012194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmtl2ksrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=209-220&issue=2%E2%80%933&author=K.+Fuxeauthor=S.+Ferr%C3%A9author=M.+Canalsauthor=M.+Torvinenauthor=A.+Terasmaaauthor=D.+Marcellinoauthor=S.+R.+Goldbergauthor=W.+Stainesauthor=K.+X.+Jacobsenauthor=C.+Lluisauthor=A.+S.+Woodsauthor=L.+F.+Agnatiauthor=R.+Franco&title=Adenosine+A2A+and+dopamine+D2+heteromeric+receptor+complexes+and+their+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A and dopamine D2 heteromeric receptor complexes and their function</span></div><div class="casAuthors">Fuxe, Kjell; Ferre, Sergi; Canals, Meritxell; Torvinen, Maria; Terasmaa, Anton; Marcellino, Daniel; Goldberg, Steven R.; Staines, William; Jacobsen, Kirsten X.; Lluis, Carmen; Woods, Amina S.; Agnati, Luigi F.; Franco, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Neuroscience</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">209-220</span>CODEN:
                <span class="NLM_cas:coden">JMNEES</span>;
        ISSN:<span class="NLM_cas:issn">0895-8696</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  The existence of A2A-D2 heteromeric complexes is based on coimmunopptn. studies and on fluorescence resonance energy transfer and bioluminescence resonance energy transfer analyses.  It has now become possible to show that A2A and D2 receptors also coimmunoppt. in striatal tissue, giving evidence for the existence of A2A-D2 heteromeric receptor complexes also in rat striatal tissue.  The anal. gives evidence that these heteromers are constitutive, as they are obsd. in the absence of A2A and D2 agonists.  The A2A-D2 heteromers could either be A2A-D2 heterodimers and/or higher-order A2A-D2 hetero-oligomers.  In striatal neurons there are probably A2A-D2 heteromeric complexes, together with A2A-D2 homomeric complexes in the neuronal surface membrane.  Their stoichiometry in various microdomains will have a major role in detg. A2A and D2 signaling in the striatopallidal GABA neurons.  Through the use of D2/D1 chimeras, evidence has been obtained that the fifth transmembrane (TM) domain and/or the I3 of the D2 receptor are part of the A2A-D2 receptor interface, where electrostatic epitope-epitope interactions involving the N-terminal part of I3 of the D2 receptor (arginine-rich epitope) play a major role, interacting with the C-terminus of the A2A receptor.  Computerized modeling of A2A-D2 heteromers are in line with these findings.  It seems likely that A2A receptor-induced redn. of D2 receptor recognition, G protein coupling, and signaling, as well as the existence of A2A-D2 co-trafficking, are the consequence of the existence of an A2A-D2 receptor heteromer.  The relevance of A2A-D2 heteromeric receptor complexes for Parkinson's disease and schizophrenia is emphasized as well as for the treatment of these diseases.  Finally, recent evidence for the existence of antagonistic A2A-D3 heteromeric receptor complexes in cotransfected cell lines has been summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoW6Kc8Z4sX5LVg90H21EOLACvtfcHk0lhhG1Eb8aYnMg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmtl2ksrc%253D&md5=f6df5d2a1da7b132e203562db77f8449</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1385%2FJMN%3A26%3A2-3%3A209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1385%252FJMN%253A26%253A2-3%253A209%26sid%3Dliteratum%253Aachs%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DTorvinen%26aufirst%3DM.%26aulast%3DTerasmaa%26aufirst%3DA.%26aulast%3DMarcellino%26aufirst%3DD.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DStaines%26aufirst%3DW.%26aulast%3DJacobsen%26aufirst%3DK.%2BX.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DWoods%26aufirst%3DA.%2BS.%26aulast%3DAgnati%26aufirst%3DL.%2BF.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DAdenosine%2520A2A%2520and%2520dopamine%2520D2%2520heteromeric%2520receptor%2520complexes%2520and%2520their%2520function%26jtitle%3DJ.%2520Mol.%2520Neurosci.%26date%3D2005%26volume%3D26%26issue%3D2%25E2%2580%25933%26spage%3D209%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Torvinen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marcellino, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canals, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnati, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor and dopamine D<sub>3</sub> heteromeric complexes</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">400</span><span class="NLM_x">â</span> <span class="NLM_lpage">407</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2005&pages=400-407&issue=2&author=M.+Torvinenauthor=D.+Marcellinoauthor=M.+Canalsauthor=L.+F.+Agnatiauthor=C.+Lluisauthor=R.+Francoauthor=K.+Fuxe&title=Adenosine+A2A+receptor+and+dopamine+D3+heteromeric+complexes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTorvinen%26aufirst%3DM.%26aulast%3DMarcellino%26aufirst%3DD.%26aulast%3DCanals%26aufirst%3DM.%26aulast%3DAgnati%26aufirst%3DL.%2BF.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DFuxe%26aufirst%3DK.%26atitle%3DAdenosine%2520A2A%2520receptor%2520and%2520dopamine%2520D3%2520heteromeric%2520complexes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2005%26volume%3D67%26issue%3D2%26spage%3D400%26epage%3D407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">FerrÃ©, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span> </span><span class="NLM_article-title">Looking for the role of cannabinoid receptor heteromers in striatal function</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x"> (</span><span class="NLM_issue">S1</span><span class="NLM_x">) </span> <span class="NLM_fpage">226</span><span class="NLM_x">â</span> <span class="NLM_lpage">234</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2009&pages=226-234&issue=S1&author=S.+Ferr%C3%A9author=S.+R.+Goldbergauthor=C.+Lluisauthor=R.+Franco&title=Looking+for+the+role+of+cannabinoid+receptor+heteromers+in+striatal+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DLooking%2520for%2520the%2520role%2520of%2520cannabinoid%2520receptor%2520heteromers%2520in%2520striatal%2520function%26jtitle%3DNeuropharmacology%26date%3D2009%26volume%3D56%26issue%3DS1%26spage%3D226%26epage%3D234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">FerrÃ©, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karcz-Kubicha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hope, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burgueno, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gutierrez, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casado, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciruela, F.</span><span> </span><span class="NLM_article-title">Synergistic interaction between adenosine A<sub>2A</sub> and glutamate mGlu5 receptors: implications for striatal neuronal function</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">99</span><span class="NLM_x">, </span> <span class="NLM_fpage">11940</span><span class="NLM_x">â</span> <span class="NLM_lpage">11945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=11940-11945&author=S.+Ferr%C3%A9author=M.+Karcz-Kubichaauthor=B.+T.+Hopeauthor=P.+Popoliauthor=J.+Burguenoauthor=M.+A.+Gutierrezauthor=V.+Casadoauthor=K.+Fuxeauthor=S.+R.+Goldbergauthor=C.+Lluisauthor=R.+Francoauthor=F.+Ciruela&title=Synergistic+interaction+between+adenosine+A2A+and+glutamate+mGlu5+receptors%3A+implications+for+striatal+neuronal+function"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DKarcz-Kubicha%26aufirst%3DM.%26aulast%3DHope%26aufirst%3DB.%2BT.%26aulast%3DPopoli%26aufirst%3DP.%26aulast%3DBurgueno%26aufirst%3DJ.%26aulast%3DGutierrez%26aufirst%3DM.%2BA.%26aulast%3DCasado%26aufirst%3DV.%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DGoldberg%26aufirst%3DS.%2BR.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DCiruela%26aufirst%3DF.%26atitle%3DSynergistic%2520interaction%2520between%2520adenosine%2520A2A%2520and%2520glutamate%2520mGlu5%2520receptors%253A%2520implications%2520for%2520striatal%2520neuronal%2520function%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2002%26volume%3D99%26spage%3D11940%26epage%3D11945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Navarro, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carriba, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GandÃ­a, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciruela, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">CasadÃ³, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">CortÃ©s, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallol, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Canela, E. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lluis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span> </span><span class="NLM_article-title">Detection of heteromers formed by cannabinoid CB<sub>1</sub>, dopamine D<sub>2</sub> and adenosine A<sub>2A</sub> G-protein coupled receptors by combining bimolecular fluorescence complementation and bioluminescence energy transfer</span> <span class="citation_source-journal">TheScientificWorldJournal</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1088</span><span class="NLM_x">â</span> <span class="NLM_lpage">1097</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=1088-1097&author=G.+Navarroauthor=P.+Carribaauthor=J.+Gand%C3%ADaauthor=F.+Ciruelaauthor=V.+Casad%C3%B3author=A.+Cort%C3%A9sauthor=J.+Mallolauthor=E.+I.+Canelaauthor=C.+Lluisauthor=R.+Franco&title=Detection+of+heteromers+formed+by+cannabinoid+CB1%2C+dopamine+D2+and+adenosine+A2A+G-protein+coupled+receptors+by+combining+bimolecular+fluorescence+complementation+and+bioluminescence+energy+transfer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNavarro%26aufirst%3DG.%26aulast%3DCarriba%26aufirst%3DP.%26aulast%3DGand%25C3%25ADa%26aufirst%3DJ.%26aulast%3DCiruela%26aufirst%3DF.%26aulast%3DCasad%25C3%25B3%26aufirst%3DV.%26aulast%3DCort%25C3%25A9s%26aufirst%3DA.%26aulast%3DMallol%26aufirst%3DJ.%26aulast%3DCanela%26aufirst%3DE.%2BI.%26aulast%3DLluis%26aufirst%3DC.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DDetection%2520of%2520heteromers%2520formed%2520by%2520cannabinoid%2520CB1%252C%2520dopamine%2520D2%2520and%2520adenosine%2520A2A%2520G-protein%2520coupled%2520receptors%2520by%2520combining%2520bimolecular%2520fluorescence%2520complementation%2520and%2520bioluminescence%2520energy%2520transfer%26jtitle%3DTheScientificWorldJournal%26date%3D2008%26volume%3D8%26spage%3D1088%26epage%3D1097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span>What Is Lexiscan? <a href="https://www.lexiscaninfo.com/lexiscan/aslex_web_aboutlexiscan.html?kw=lexiscan&amp;c=710002" class="extLink">https://www.lexiscaninfo.com/lexiscan/aslex_web_aboutlexiscan.html?kw=lexiscan&c=710002</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=What+Is+Lexiscan%3F+https%3A%2F%2Fwww.lexiscaninfo.com%2Flexiscan%2Faslex_web_aboutlexiscan.html%3Fkw%3Dlexiscan%26c%3D710002."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cunha, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenningsson, P.</span><span> </span><span class="NLM_article-title">Pharmacology of adenosine A<sub>2A</sub> receptors and therapeutic applications</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">â</span> <span class="NLM_lpage">426</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.2174%2F1568026033392200" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2002&pages=413-426&author=B.+B.+Fredholmauthor=R.+A.+Cunhaauthor=P.+Svenningsson&title=Pharmacology+of+adenosine+A2A+receptors+and+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F1568026033392200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392200%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DCunha%26aufirst%3DR.%2BA.%26aulast%3DSvenningsson%26aufirst%3DP.%26atitle%3DPharmacology%2520of%2520adenosine%2520A2A%2520receptors%2520and%2520therapeutic%2520applications%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2002%26volume%3D3%26spage%3D413%26epage%3D426" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Kull, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Svenningsson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptors are colocalized with and activate G<sub>olf</sub> in rat striatum</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">771</span><span class="NLM_x">â</span> <span class="NLM_lpage">777</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=771-777&author=B.+Kullauthor=P.+Svenningssonauthor=B.+B.+Fredholm&title=Adenosine+A2A+receptors+are+colocalized+with+and+activate+Golf+in+rat+striatum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKull%26aufirst%3DB.%26aulast%3DSvenningsson%26aufirst%3DP.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DAdenosine%2520A2A%2520receptors%2520are%2520colocalized%2520with%2520and%2520activate%2520Golf%2520in%2520rat%2520striatum%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D771%26epage%3D777" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Schulte, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span> </span><span class="NLM_article-title">Human adenosine A<sub>1</sub>, A<sub>2A</sub>, A<sub>2B</sub> and A<sub>3</sub> receptors expressed in Chinese hamster ovary cells all mediate the phosphorylation of extracellular-regulated kinase 1/2</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">477</span><span class="NLM_x">â</span> <span class="NLM_lpage">482</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=477-482&author=G.+Schulteauthor=B.+B.+Fredholm&title=Human+adenosine+A1%2C+A2A%2C+A2B+and+A3+receptors+expressed+in+Chinese+hamster+ovary+cells+all+mediate+the+phosphorylation+of+extracellular-regulated+kinase+1%2F2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchulte%26aufirst%3DG.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26atitle%3DHuman%2520adenosine%2520A1%252C%2520A2A%252C%2520A2B%2520and%2520A3%2520receptors%2520expressed%2520in%2520Chinese%2520hamster%2520ovary%2520cells%2520all%2520mediate%2520the%2520phosphorylation%2520of%2520extracellular-regulated%2520kinase%25201%252F2%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D477%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span>For more information about the A<sub>2A</sub> signaling pathway, visit <a href="http://www.genego.com/map_643.php" class="extLink">http://www.genego.com/map_643.php</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=For+more+information+about+the+A2A+signaling+pathway%2C+visit+http%3A%2F%2Fwww.genego.com%2Fmap_643.php."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Valls, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronstein, B. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montesinos, M. C.</span><span> </span><span class="NLM_article-title">Adenosine receptor agonists for promotion of dermal wound healing</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x">, </span> <span class="NLM_fpage">1117</span><span class="NLM_x">â</span> <span class="NLM_lpage">1124</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.bcp.2008.11.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=19041853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVGgsLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2009&pages=1117-1124&author=M.+D.+Vallsauthor=B.+N.+Cronsteinauthor=M.+C.+Montesinos&title=Adenosine+receptor+agonists+for+promotion+of+dermal+wound+healing"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptor agonists for promotion of dermal wound healing</span></div><div class="casAuthors">Valls, Maria D.; Cronstein, Bruce N.; Montesinos, M. Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1117-1124</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Wound healing is a dynamic and complex process that involves a well-coordinated, highly regulated series of events including inflammation, tissue formation, revascularization and tissue remodeling.  However, this orderly sequence is impaired in certain pathophysiol. conditions such as diabetes mellitus, venous insufficiency, chronic glucocorticoid use, aging and malnutrition.  Together with proper wound care, promotion of the healing process is the primary objective in the management of chronic poorly healing wounds.  Recent studies have demonstrated that A2A adenosine receptor agonists promote wound healing in normal and diabetic animals and one such agonist, Sonedenoson, is currently being evaluated as a prospective new therapy of diabetic foot ulcers.  We will review the mechanisms by which adenosine receptor activation affects the function of the cells and tissues that participate in wound healing, emphasizing the potential beneficial impact of adenosine receptor agonists in diabetic impaired healing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLlM4GeFS-t7Vg90H21EOLACvtfcHk0lj8lD8oqqw9Dw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVGgsLk%253D&md5=a0c6d7f74a61e316919c04069c63b422</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2008.11.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2008.11.002%26sid%3Dliteratum%253Aachs%26aulast%3DValls%26aufirst%3DM.%2BD.%26aulast%3DCronstein%26aufirst%3DB.%2BN.%26aulast%3DMontesinos%26aufirst%3DM.%2BC.%26atitle%3DAdenosine%2520receptor%2520agonists%2520for%2520promotion%2520of%2520dermal%2520wound%2520healing%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2009%26volume%3D77%26spage%3D1117%26epage%3D1124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Camaioni, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Pharmacology of the highly selective A<sub>1</sub> adenosine receptor agonist 2-chloro-<i>N</i>6-cyclopentyladenosine</span> <span class="citation_source-journal">Arzneimittelforschung</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x">, </span> <span class="NLM_fpage">1305</span><span class="NLM_x">â</span> <span class="NLM_lpage">1312</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1994&pages=1305-1312&author=A.+Monopoliauthor=A.+Contiauthor=S.+Dionisottiauthor=C.+Casatiauthor=E.+Camaioniauthor=G.+Cristalliauthor=E.+Ongini&title=Pharmacology+of+the+highly+selective+A1+adenosine+receptor+agonist+2-chloro-N6-cyclopentyladenosine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DConti%26aufirst%3DA.%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DCasati%26aufirst%3DC.%26aulast%3DCamaioni%26aufirst%3DE.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DPharmacology%2520of%2520the%2520highly%2520selective%2520A1%2520adenosine%2520receptor%2520agonist%25202-chloro-N6-cyclopentyladenosine%26jtitle%3DArzneimittelforschung%26date%3D1994%26volume%3D44%26spage%3D1305%26epage%3D1312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Bruns, R. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pugsley, T. A.</span><span> </span><span class="NLM_article-title">Characterization of the A<sub>2</sub> adenosine receptor labeled by [<sup>3</sup>H]-NECA in rat striatal membranes</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">331</span><span class="NLM_x">â</span> <span class="NLM_lpage">346</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=331-346&author=R.+F.+Brunsauthor=G.+H.+Luauthor=T.+A.+Pugsley&title=Characterization+of+the+A2+adenosine+receptor+labeled+by+%5B3H%5D-NECA+in+rat+striatal+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBruns%26aufirst%3DR.%2BF.%26aulast%3DLu%26aufirst%3DG.%2BH.%26aulast%3DPugsley%26aufirst%3DT.%2BA.%26atitle%3DCharacterization%2520of%2520the%2520A2%2520adenosine%2520receptor%2520labeled%2520by%2520%255B3H%255D-NECA%2520in%2520rat%2520striatal%2520membranes%26jtitle%3DMol.%2520Pharmacol.%26date%3D1986%26volume%3D29%26spage%3D331%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hutchison, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oei, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghai, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zimmerman, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiliams, M.</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">47</span><span class="NLM_x">â</span> <span class="NLM_lpage">55</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=2795469" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28a&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK3cXjtVertw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hutchison%2C+A.+J.%3B+Webb%2C+R.+L.%3B+Oei%2C+H.+H.%3B+Ghai%2C+G.+R.%3B+Zimmerman%2C+M.+B.%3B+Wiliams%2C+M.J.+Pharmacol.+Exp.+Ther.+1989%2C+251+%281%29+47%E2%80%9355"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28aR"><div class="casContent"><span class="casTitleNuber">28a</span><div class="casTitle"><span class="NLM_cas:atitle">CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity</span></div><div class="casAuthors">Hutchison, Alan J.; Webb, Randy L.; Oei, Howard H.; Ghai, Geetha R.; Zimmerman, Mark B.; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">47-55</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">CGS 21680C (I) and the related analog CGS 21577 (II) have high in vitro affinity for brain striatal adenosine A2 receptors; IC50 values 22 and 13 nM, resp.  Both compds. were considerably less active at A1 receptors with CGS 21577 and CGS 21680C having resp. IC50 values of 0.76 and 3.1 Î¼M.  The former compd. was thus 59-fold selective for A2 receptors whereas CGS 21680C was 140-fold selective.  In contrast, the ref. A2 selective ligand, CV 1808 (2-phenylaminoadenosine), showed only 8-fold selectivity as an A2 ligand, having an IC50 of 115 nM in the [3H]-5'-N-ethylcarboxamide adenosine assay and an IC50 of 910 nM at the N6-[3H]cyclohexyladenosine site.  Further examn. of CGS 21680C showed that the compd. was without effect on binding to 17 other putative neurotransmitter/neuromodulator sites indicating its selectivity as an adenosine receptor ligand.  In an isolated perfused working rat heart model, CGS 21680C effectively increased coronary flow with an ED25 value of 1.8 nM.  The corresponding value for CGS 21577 was 3 nM whereas that for CV 1808 was 110 nM.  The EC25 for eliciting bradycardia for all three compds. was >1000 nM.  The effects of all three compds. could be reversed by treatment with the xanthine adenosine antagonist, xanthine amine congener.  Given i.v., CGS 21680A, the HCl salt of CGS 21680 (III), and CGS 21577 reduced blood pressure in an anesthetized normotensive rat model with ED50 values of 9 Î¼g/kg (19 nmol) and 1.8 Î¼g/kg (4.2 nmol).  CV 1808 had an ED50 of 28 Î¼g/kg (78 nmol).  All three adenosine analogs increased heart rate by up to 15%, the latter effect probably reflecting a reflex tachycardia occurring as a result of the obsd. decrease in blood pressure.  CGS 21680A, CGS 21577 and CV 1808 were active p.o. in the spontaneously hypertensive rat at a dose of 10 mg/kg with efficacy for up to 24 h.  CGS 21680A caused a transient (60 min) increase in heart rate.  A similar response was noted with CV 1808.  However, CGS 21577 caused a marked increase in heart rate (140 bpm) which was sustained at 70 bpm for up to 24 h.  CGS 21680C, although more potent and selective as an A2 receptor agonist than CV 1808, shows no apparent difference in its ability to lower blood pressure and affect heart rate in the spontaneous hypertensive rat than the latter compd.  CGS 21577, because of its profound and prolonged effects on heart rate is unlikely to merit further attention as a potential hypotensive agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrBiFb7nA-7rVg90H21EOLACvtfcHk0ljBbH7EWK5qUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXjtVertw%253D%253D&md5=26d92ec79024d4cb01e87a727a753eb2</span></div><a href="/servlet/linkout?suffix=cit28a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutchison%26aufirst%3DA.%2BJ.%26aulast%3DWebb%26aufirst%3DR.%2BL.%26aulast%3DOei%26aufirst%3DH.%2BH.%26aulast%3DGhai%26aufirst%3DG.%2BR.%26aulast%3DZimmerman%26aufirst%3DM.%2BB.%26aulast%3DWiliams%26aufirst%3DM.%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1989%26volume%3D251%26issue%3D1%26spage%3D47%26epage%3D55" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit28b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Jarvis, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulz, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sills, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]-CGS21680, a selective A<sub>2</sub> adenosine receptor agonist directly labels A<sub>2</sub> receptors in rat brain</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">251</span><span class="NLM_x">, </span> <span class="NLM_fpage">888</span><span class="NLM_x">â</span> <span class="NLM_lpage">893</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=2600819" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK3cXhtFamur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=251&publication_year=1989&pages=888-893&author=M.+F.+Jarvisauthor=R.+Schulzauthor=A.+J.+Hutchisonauthor=U.+H.+Doauthor=M.+A.+Sillsauthor=M.+Williams&title=%5B3H%5D-CGS21680%2C+a+selective+A2+adenosine+receptor+agonist+directly+labels+A2+receptors+in+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28bR"><div class="casContent"><span class="casTitleNuber">28b</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain</span></div><div class="casAuthors">Jarvis, Michael F.; Schulz, Rainer; Hutchison, Alan J.; Do, Un Hoi; Sills, Matthew A.; Williams, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">251</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">888-93</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">Characterization of the adenosine A2 receptor has been limited due to the lack of available ligands which have high affinity and selectivity for this adenosine receptor subtype.  In the present study, the binding of a highly A2-selective agonist radioligand, [3H]CGS 21680 (I) is described.  [3H]CGS 21680 specific binding to rat striatal membranes was saturable, reversible, and dependent on protein concn.  Satn. studies revealed that [3H]CGS 21680 bound with high affinity (Kd =15.5 nM) and limited capacity (apparent Bmax = 375 fmol/mg protein) to a single class of recognition sites.  Ests. of ligand affinity (16 nM) detd. from assocn. and dissocn. kinetic expts. were in close agreement with the results from the satn. studies.  [3H]CGS 21680 binding was greatest in striatal membranes with negligible specific binding obtained in rat cortical membranes.  Adenosine agonists ligands competed for the binding of 5 nM [3H]CGS 21680 to striatal membranes with the following order of activity; CGS 21680 = 5'-N-ethylcarboxamidoadenosine > 2-phenylaminoadenosine (CV-1808) ; 5'-N-methylcarboxamidoadenosine = 2-chloroadenosine > R-phenylisopropyladenosine > N6-cyclohexyladenosine > N6-cyclopentyltheophylline > S-phenylisopropyladenosine.  The nonxanthine adenosine antagonist, CGS 15943A, was the most active compd. in inhibiting the binding of [3H]CGS 21680.  Other adenosine antagonists inhibited binding in the following order; xanthine amine congener = (1,3-dipropyl-8-(2-amino-4-chloro)phenylxanthine > 1,3-dipropyl-8-cyclopentylxanthine > 1,3-diethyl-8-phenylxanthine > 8-phenyltheophylline > 8-cyclopentyltheophylline = xanthine carboxylic acid congener > 8-parasulfophenyltheophylline > theophylline > caffeine.  The pharmacol. profile of both adenosine agonist and antagonist compds. to compete for the binding of [3H]CGS 21680 was consistent with a selective interaction at the high affinity adenosine A2 receptor.  A high pos. correlation was obsd. between the pharmacol. profile of adenosine ligands to inhibit the binding of [3H]CGS 21680 and the selective binding of [3H]NECA (+50 nM CPA) to high affinity A2 receptors.  However, some differences between these assays were found for compds. which have moderate affinity and nonselective actions at both the A1 and A2 adenosine receptor subtypes.  Unlike data obtained with nonselective adenosine ligands, the present results indicate that [3H]CGS 21680 directly labels the high affinity A2 receptor in rat brain without the need to block binding activity at the A1 receptor.  The high degree of selectivity (>170-fold) and high affinity of [3H]CGS 21680 make this the current ligand of choice for the in vitro characterization of high affinity A2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrF9YARcmgaFrVg90H21EOLACvtfcHk0ljBbH7EWK5qUA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtFamur4%253D&md5=fc1961da1f86a5592fa6142878952fa9</span></div><a href="/servlet/linkout?suffix=cit28b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJarvis%26aufirst%3DM.%2BF.%26aulast%3DSchulz%26aufirst%3DR.%26aulast%3DHutchison%26aufirst%3DA.%2BJ.%26aulast%3DDo%26aufirst%3DU.%2BH.%26aulast%3DSills%26aufirst%3DM.%2BA.%26aulast%3DWilliams%26aufirst%3DM.%26atitle%3D%255B3H%255D-CGS21680%252C%2520a%2520selective%2520A2%2520adenosine%2520receptor%2520agonist%2520directly%2520labels%2520A2%2520receptors%2520in%2520rat%2520brain%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1989%26volume%3D251%26spage%3D888%26epage%3D893" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Callegari, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianfrogna, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doran, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hosea, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewc, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Deusen, J.</span><span> </span><span class="NLM_article-title">Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1443</span><span class="NLM_x">â</span> <span class="NLM_lpage">1447</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1124%2Fdmd.105.008201" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=16760229" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpt1Sksrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2006&pages=1443-1447&author=X.+Liuauthor=B.+J.+Smithauthor=C.+Chenauthor=E.+Callegariauthor=S.+L.+Beckerauthor=X.+Chenauthor=J.+Cianfrognaauthor=A.+C.+Doranauthor=S.+D.+Doranauthor=J.+P.+Gibbsauthor=N.+Hoseaauthor=J.+Liuauthor=F.+R.+Nelsonauthor=M.+A.+Szewcauthor=J.+Van+Deusen&title=Evaluation+of+cerebrospinal+fluid+concentration+and+plasma+free+concentration+as+a+surrogate+measurement+for+brain+free+concentration"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration</span></div><div class="casAuthors">Liu, Xingrong; Smith, Bill J.; Chen, Cuiping; Callegari, Ernesto; Becker, Stacey L.; Chen, Xi; Cianfrogna, Julie; Doran, Angela C.; Doran, Shawn D.; Gibbs, John P.; Hosea, Natilie; Liu, Jianhua; Nelson, Frederick R.; Szewc, Mark A.; Van Deusen, Jeffrey</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1443-1447</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">This study was designed to evaluate the use of cerebrospinal fluid (CSF) drug concn. and plasma unbound concn. (Cu,plasma) to predict brain unbound concn. (Cu,brain).  The concn.-time profiles in CSF, plasma, and brain of seven model compds. were detd. after s.c. administration in rats.  The Cu,brain was estd. from the product of total brain concns. and unbound fractions, which were detd. using brain tissue slice and brain homogenate methods.  For theobromine, theophylline, caffeine, fluoxetine, and propranolol, which represent rapid brain penetration compds. with a simple diffusion mechanism, the ratios of the area under the curve of Cu,brain/CCSF and Cu,brain/Cu,plasma were 0.27 to 1.5 and 0.29 to 2.1, resp., using the brain slice method, and were 0.27 to 2.9 and 0.36 to 3.9, resp., using the brain homogenate method.  A P-glycoprotein substrate, CP-141938 (methoxy-3-[(2-phenyl-piperidinyl-3-amino)-methyl]-phenyl-N-methyl-methane-sulfonamide), had Cu,brain/CCSF and Cu,brain/Cu,plasma ratios of 0.57 and 0.066, using the brain slice method, and 1.1 and 0.13, using the brain homogenate method, resp.  The slow brain-penetrating compd., N[3-(4'-fluorophenyl)-3-(4'-phenylphenoxy)propyl]sarcosine, had Cu,brain/CCSF and Cu,brain/Cu,plasma ratios of 0.94 and 0.12 using the brain slice method and 0.15 and 0.018 using the brain homogenate method, resp.  Therefore, for quick brain penetration with simple diffusion mechanism compds., CCSF and Cu,plasma represent Cu,brain equally well; for efflux substrates or slow brain penetration compds., CCSF appears to be equiv. to or more accurate than Cu,plasma to represent Cu,brain.  Thus, we hypothesize that CCSF is equiv. to or better than Cu,plasma to predict Cu,brain.  This hypothesis is supported by the literature data.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw43dRkq9lx7Vg90H21EOLACvtfcHk0lj085DUYbMWug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpt1Sksrc%253D&md5=cef079e1a667dbddf9d5a2f7d01889e8</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1124%2Fdmd.105.008201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.105.008201%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DSmith%26aufirst%3DB.%2BJ.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DCallegari%26aufirst%3DE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DCianfrogna%26aufirst%3DJ.%26aulast%3DDoran%26aufirst%3DA.%2BC.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DGibbs%26aufirst%3DJ.%2BP.%26aulast%3DHosea%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DSzewc%26aufirst%3DM.%2BA.%26aulast%3DVan%2BDeusen%26aufirst%3DJ.%26atitle%3DEvaluation%2520of%2520cerebrospinal%2520fluid%2520concentration%2520and%2520plasma%2520free%2520concentration%2520as%2520a%2520surrogate%2520measurement%2520for%2520brain%2520free%2520concentration%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2006%26volume%3D34%26spage%3D1443%26epage%3D1447" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hessling, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hegler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kull, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span> </span><span class="NLM_article-title">Comparative pharmacology of human adenosine receptor subtypesâcharacterization of stably transfected receptors in CHO cells</span> <span class="citation_source-journal">Naunyn-Schmiedebergâs Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">357</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">9</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2FPL00005131" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9459566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1cXmtlKltw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=1998&pages=1-9&author=K.+N.+Klotzauthor=J.+Hesslingauthor=J.+Heglerauthor=C.+Owmanauthor=B.+Kullauthor=B.+B.+Fredholmauthor=M.+J.+Lohse&title=Comparative+pharmacology+of+human+adenosine+receptor+subtypes%E2%80%94characterization+of+stably+transfected+receptors+in+CHO+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells</span></div><div class="casAuthors">Klotz, K.-N.; Hessling, J.; Hegler, J.; Owman, C.; Kull, B.; Fredholm, B. B.; Lohse, M. J.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Four adenosine receptor subtypes of the family of G protein-coupled receptors, designated A1, A2A, A2B and A3 are currently known.  In this study all human subtypes were stably transfected into Chinese hamster ovary (CHO) cells to be able to study their pharmacol. profile in an identical cellular background utilizing radioligand binding studies (A1, A2A, A3) or adenylyl cyclase activity assays (A2B).  The A1 subtype showed the typical pharmacol. profile with 2-chloro-N6-cyclopentyladenosine (CCPA) as the agonist with the highest affinity and a marked stereoselectivity for the N6-phenylisopropyladenosine (PIA) diastereomers.  In competition with antagonist radioligand biphasic curves were obsd. for agonists.  In the presence of GTP all receptors were converted to a single low affinity state indicating functional coupling to endogenous G proteins.  For A2A adenosine receptors CGS 21680 (2-[p-(2-carboxyethyl)phenylethylamino]-5'-N-ethylcarboxamidoadenosine) and N-ethylcarboxamidoadenosine (NECA) were found to be the most potent agonists followed by R- and S-PIA with minor stereoselectivity.  The relative potencies of agonists for the A2B adenosine receptor could only be tested by measurement of receptor-stimulated adenylyl cyclase activity.  NECA was the most potent agonist with an EC50-value of 2.3 Î¼M, whereas all other compds. tested were active at concns. in the high micromolar range.  Inhibition of NECA-stimulated adenylyl cyclase identified xanthine amino congener (XAC; 8-[4-[[[[(2-aminoethyl)amino]carbonyl]methyl]oxy]phenyl]-1,3-dipropylxanthine) as the most potent antagonist at this receptor subtype.  The A3 receptor was characterized utilizing the nonselective agonist [3H]NECA.  The N6-benzyl substituted derivs. of adenosine-5'-N-methyluronamide (MECA) turned out to be the most potent agonists.  The notion of xanthine-insensitivity of the A3 receptor should be dropped at least for the human receptor as xanthines with submicromolar affinity were found.  Overall, the pharmacol. characteristics of the human receptors are similar to other species with some species-specific characteristics.  In this study the authors present for the first time the comparative pharmacol. of all known human adenosine receptor subtypes.  The CHO cells with stably transfected adenosine receptors provide an identical cellular background for such a pharmacol. characterization.  These cells are valuable systems for further characterization of specific receptor subtypes and for the development of new ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyUbgRii47RrVg90H21EOLACvtfcHk0lj085DUYbMWug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXmtlKltw%253D%253D&md5=3bfa5a636309e935eea0e43dd2878d05</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1007%2FPL00005131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FPL00005131%26sid%3Dliteratum%253Aachs%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DHessling%26aufirst%3DJ.%26aulast%3DHegler%26aufirst%3DJ.%26aulast%3DOwman%26aufirst%3DC.%26aulast%3DKull%26aufirst%3DB.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26atitle%3DComparative%2520pharmacology%2520of%2520human%2520adenosine%2520receptor%2520subtypes%25E2%2580%2594characterization%2520of%2520stably%2520transfected%2520receptors%2520in%2520CHO%2520cells%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D1998%26volume%3D357%26spage%3D1%26epage%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Sauer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurinsh, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FÃ¼lle, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¼ller, C. E.</span><span> </span><span class="NLM_article-title">Water-soluble phosphate prodrugs of 1-propargyl-8-styrylxanthine derivatives, A<sub>2A</sub> selective adenosine receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">440</span><span class="NLM_x">â</span> <span class="NLM_lpage">448</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9911480" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=440-448&author=R.+Sauerauthor=J.+Maurinshauthor=U.+Reithauthor=F.+F%C3%BClleauthor=K.+N.+Klotzauthor=C.+E.+M%C3%BCller&title=Water-soluble+phosphate+prodrugs+of+1-propargyl-8-styrylxanthine+derivatives%2C+A2A+selective+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm9911480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9911480%26sid%3Dliteratum%253Aachs%26aulast%3DSauer%26aufirst%3DR.%26aulast%3DMaurinsh%26aufirst%3DJ.%26aulast%3DReith%26aufirst%3DU.%26aulast%3DF%25C3%25BClle%26aufirst%3DF.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DWater-soluble%2520phosphate%2520prodrugs%2520of%25201-propargyl-8-styrylxanthine%2520derivatives%252C%2520A2A%2520selective%2520adenosine%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D440%26epage%3D448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Le Witt, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guttman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tetrud, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuite, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikin, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sussman, N. M.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonist istradefylline (KW6002) reduces off time in Parkinsonâs disease: a double-blind, randomized, multicenter clinical trial (6002-US-005)</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">295</span><span class="NLM_x">â</span> <span class="NLM_lpage">302</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1002%2Fana.21315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=18306243" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2008&pages=295-302&issue=3&author=P.+A.+Le+Wittauthor=M.+Guttmanauthor=J.+W.+Tetrudauthor=P.+J.+Tuiteauthor=A.+Moriauthor=P.+Chaikinauthor=N.+M.+Sussman&title=Adenosine+A2A+receptor+antagonist+istradefylline+%28KW6002%29+reduces+off+time+in+Parkinson%E2%80%99s+disease%3A+a+double-blind%2C+randomized%2C+multicenter+clinical+trial+%286002-US-005%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1002%2Fana.21315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.21315%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BWitt%26aufirst%3DP.%2BA.%26aulast%3DGuttman%26aufirst%3DM.%26aulast%3DTetrud%26aufirst%3DJ.%2BW.%26aulast%3DTuite%26aufirst%3DP.%2BJ.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DChaikin%26aufirst%3DP.%26aulast%3DSussman%26aufirst%3DN.%2BM.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonist%2520istradefylline%2520%2528KW6002%2529%2520reduces%2520off%2520time%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520a%2520double-blind%252C%2520randomized%252C%2520multicenter%2520clinical%2520trial%2520%25286002-US-005%2529%26jtitle%3DAnn.%2520Neurol.%26date%3D2008%26volume%3D63%26issue%3D3%26spage%3D295%26epage%3D302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Manera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccomanni, G.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> receptor ligands: past present and future trends</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">902</span><span class="NLM_x">â</span> <span class="NLM_lpage">922</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.2174%2F156802610791268765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=20370660" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptVegsLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=902-922&author=C.+Maneraauthor=G.+Saccomanni&title=A2A+receptor+ligands%3A+past+present+and+future+trends"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32bR"><div class="casContent"><span class="casTitleNuber">32b</span><div class="casTitle"><span class="NLM_cas:atitle">A2A receptor ligands: past, present and future trends</span></div><div class="casAuthors">Manera, C.; Saccomanni, G.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">902-922</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The adenosine A2A receptor is a member of the G protein-coupled receptor family and mediates multiple physiol. effects of adenosine, both at the central nervous system and at peripheral tissues.  Increasing evidence relates the A2A receptor with several pathol. conditions such as neurodegenerative disorders, inflammation, pharmacol. stress, and wound healing renewing the interest in A2A receptor agonists and antagonists as promising leads for drugs.  However some of them initially tested in clin. trials presented several side effects, short half-life, lower soly., and in some cases a lack of effects, perhaps attributable to receptor desensitization or to low receptor d. in the targeted tissue.  For these reasons it is evident that addnl. rational chem. modifications of the existing A2A receptor ligands to improve their affinity/selectivity and bioavailability as well as further studies to get new template for A2AAR ligands are necessary.  The purpose of this review is to analyze and summarize the past and the present aspects related to the medicinal chem. of A2A receptor ligands.  Moreover their current and possible therapeutic applications have been also highlighted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnLx7COhHSYLVg90H21EOLACvtfcHk0ljcDTFMk7H36Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptVegsLo%253D&md5=17c6c4a3178313e73f25f8c1a76708ac</span></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=10.2174%2F156802610791268765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610791268765%26sid%3Dliteratum%253Aachs%26aulast%3DManera%26aufirst%3DC.%26aulast%3DSaccomanni%26aufirst%3DG.%26atitle%3DA2A%2520receptor%2520ligands%253A%2520past%2520present%2520and%2520future%2520trends%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D902%26epage%3D922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kanda, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, R. K. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuwana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> antagonist: a novel antiparkisonian agent that does not provoke dyskinesia in parkinsonian monkeys</span> <span class="citation_source-journal">Ann. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">507</span><span class="NLM_x">â</span> <span class="NLM_lpage">513</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1002%2Fana.410430415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9546333" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1cXisFyisbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1998&pages=507-513&author=T.+Kandaauthor=M.+J.+Jacksonauthor=L.+A.+Smithauthor=R.+K.+B.+Pearceauthor=J.+Nakamuraauthor=H.+Kaseauthor=Y.+Kuwanaauthor=P.+Jenner&title=Adenosine+A2A+antagonist%3A+a+novel+antiparkisonian+agent+that+does+not+provoke+dyskinesia+in+parkinsonian+monkeys"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A antagonist: a novel antiparkinsonian agent that does not provoke dyskinesia in parkinsonian monkeys</span></div><div class="casAuthors">Kanda, Tomoyuki; Jackson, Michael J.; Smith, Lance A.; Pearce, Ronald K. B.; Nakamura, Joji; Kase, Hiroshi; Kuwana, Yoshihisa; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Neurology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">507-513</span>CODEN:
                <span class="NLM_cas:coden">ANNED3</span>;
        ISSN:<span class="NLM_cas:issn">0364-5134</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">Treatment of Parkinson's disease with L-DOPA therapy leads to long-term complications, including loss of drug efficacy and the onset of dyskinesia.  Adenosine A2A receptors in the striatum are selectively localized to GABAergic output neurons of the striato-pallidal pathway and may avoid such problems.  The novel adenosine A2A receptor antagonist KW-6002 was examd. for antiparkinsonian activity in MPTP-treated primates.  Oral administration of KW-6002 reversed motor disability in MPTP-treated common marmosets in a dose-dependent manner.  However, KW-6002 only modestly increased overall locomotor activity and did not cause abnormal movement, such as stereotypy.  The ability of KW-6002 to reverse motor disability was maintained on repeated daily administration for 21 days, and no tolerance was obsd.  KW-6002 induced little or no dyskinesia in MPTP-treated primates previously primed to exhibit dyskinesia by prior exposure to L-DOPA.  Thus, selective adenosine A2A receptor antagonists represent a new class of antiparkinsonian agents that do not produce hyperactivity or induce dyskinesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouQ20y4EvPvLVg90H21EOLACvtfcHk0lgjwguCapbQMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisFyisbw%253D&md5=36af21fdde02b63c588e3ca03785dafe</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1002%2Fana.410430415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fana.410430415%26sid%3Dliteratum%253Aachs%26aulast%3DKanda%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DPearce%26aufirst%3DR.%2BK.%2BB.%26aulast%3DNakamura%26aufirst%3DJ.%26aulast%3DKase%26aufirst%3DH.%26aulast%3DKuwana%26aufirst%3DY.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DAdenosine%2520A2A%2520antagonist%253A%2520a%2520novel%2520antiparkisonian%2520agent%2520that%2520does%2520not%2520provoke%2520dyskinesia%2520in%2520parkinsonian%2520monkeys%26jtitle%3DAnn.%2520Neurol.%26date%3D1998%26volume%3D43%26spage%3D507%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Hockemeyer, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burbiel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¼ller, C. E.</span><span> </span><span class="NLM_article-title">Multigram-scale synthesis, stability and photoreactions of A<sub>2A</sub> adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinsonâs disease</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">69</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">3308</span><span class="NLM_x">â</span> <span class="NLM_lpage">3318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo0358574" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2004&pages=3308-3318&issue=10&author=J.+Hockemeyerauthor=J.+Burbielauthor=C.+E.+M%C3%BCller&title=Multigram-scale+synthesis%2C+stability+and+photoreactions+of+A2A+adenosine+receptor+antagonists+with+8-styrylxanthine+structure%3A+potential+drugs+for+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo0358574&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo0358574%26sid%3Dliteratum%253Aachs%26aulast%3DHockemeyer%26aufirst%3DJ.%26aulast%3DBurbiel%26aufirst%3DJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DC.%2BE.%26atitle%3DMultigram-scale%2520synthesis%252C%2520stability%2520and%2520photoreactions%2520of%2520A2A%2520adenosine%2520receptor%2520antagonists%2520with%25208-styrylxanthine%2520structure%253A%2520potential%2520drugs%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2004%26volume%3D69%26issue%3D10%26spage%3D3308%26epage%3D3318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghai, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Braunwalder, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Psychoyos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stone, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cash, W. D.</span><span> </span><span class="NLM_article-title">Biochemical characterization of the triazoloquinazoline, CGS15943, a novel, non-xanthine adenosine antagonist</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">241</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span><span class="NLM_x">â</span> <span class="NLM_lpage">420</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=2883298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaL2sXksFWrtLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=241&publication_year=1987&pages=415-420&author=M.+Williamsauthor=J.+Francisauthor=G.+Ghaiauthor=A.+Braunwalderauthor=S.+Psychoyosauthor=G.+A.+Stoneauthor=W.+D.+Cash&title=Biochemical+characterization+of+the+triazoloquinazoline%2C+CGS15943%2C+a+novel%2C+non-xanthine+adenosine+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Biochemical characterization of the triazoloquinazoline CGS 15943A, a novel, nonxanthine adenosine antagonist</span></div><div class="casAuthors">Williams, Michael; Francis, John; Ghai, Geetha; Braunwalder, Albert; Psychoyos, Stacy; Stone, George A.; Cash, William D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">241</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">415-20</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">CGS 15943A (I), a triazoloquinazoline, is a potent and selective adenosine receptor antagonist as assessed by its effects on radioligand binding and adenosine-stimulated adenylate cyclase activity in guinea pig synaptoneurosomes.  At the adenosine A-1 receptor labeled with [3H]cyclohexyladenosine, I had an IC50 value of 20 nM.  At the striatal A-2 receptor labeled with [3H]5'-N-ethylcarboxamidoadenosine (in the presence of a low concn. of cyclopentyladenosine to block A-1 receptors labeled by this nonselective adenosine agonist), I had an IC50 value of 3 nM, indicating that the compd. had some degree of selectivity for the A-2 receptor.  Anal. of the effect of the compd. on the satn. isotherms for each of the receptors indicated that it was a competitive antagonist at the brain A-1 receptor but that it was noncompetitive at the striatal A-2 receptor.  I was a potent adenosine antagonist in the adenosine-stimulated adenylate cyclase system in guinea pig synaptoneurosomes, where the compd. was found to have an IC50 value of 30 to 70 nM against the increase in cAMP evoked by 5 Î¼M adenosine.  I had no effect on the binding of [3H]nitrobenzylthioinosine, a ligand thought to bind to adenosine uptake sites, and, at a concn. of 10 Î¼M, had no effect on beef heart type III phosphodiesterase activity.  In assessing its activity in binding assays for 21 other putative neurotransmitters, I showed no appreciable activity at concns. up to 10 Î¼M, although it was able to inhibit the binding of [3H]flunitrazepam to the central benzodiazepine receptor with an IC50 value of 1020 nM.  I is a potent adenosine antagonist.  Since it is not a xanthine with the underlying assocn. of phosphodiesterase-inhibitory properties, it may be useful in evaluating the role of adenosine in mammalian tissue function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7D611Hdrm6rVg90H21EOLACvtfcHk0lgjwguCapbQMw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXksFWrtLc%253D&md5=15287d69f1c5ae5a413f665c137353a7</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DFrancis%26aufirst%3DJ.%26aulast%3DGhai%26aufirst%3DG.%26aulast%3DBraunwalder%26aufirst%3DA.%26aulast%3DPsychoyos%26aufirst%3DS.%26aulast%3DStone%26aufirst%3DG.%2BA.%26aulast%3DCash%26aufirst%3DW.%2BD.%26atitle%3DBiochemical%2520characterization%2520of%2520the%2520triazoloquinazoline%252C%2520CGS15943%252C%2520a%2520novel%252C%2520non-xanthine%2520adenosine%2520antagonist%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1987%26volume%3D241%26spage%3D415%26epage%3D420" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">de Mendoca, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sebastiao, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ribeiro, J. A.</span><span> </span><span class="NLM_article-title">Adenosine: Does it have a neuroprotective role after all?</span> <span class="citation_source-journal">Brain Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">2â3</span><span class="NLM_x">) </span> <span class="NLM_fpage">258</span><span class="NLM_x">â</span> <span class="NLM_lpage">274</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2FS0165-0173%2800%2900033-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36a&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=11011069" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=258-274&issue=2%E2%80%933&author=A.+de+Mendocaauthor=A.+M.+Sebastiaoauthor=J.+A.+Ribeiro&title=Adenosine%3A+Does+it+have+a+neuroprotective+role+after+all%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36a&amp;dbid=16384&amp;doi=10.1016%2FS0165-0173%2800%2900033-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0165-0173%252800%252900033-3%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BMendoca%26aufirst%3DA.%26aulast%3DSebastiao%26aufirst%3DA.%2BM.%26aulast%3DRibeiro%26aufirst%3DJ.%2BA.%26atitle%3DAdenosine%253A%2520Does%2520it%2520have%2520a%2520neuroprotective%2520role%2520after%2520all%253F%26jtitle%3DBrain%2520Res.%2520Rev.%26date%3D2000%26volume%3D33%26issue%3D2%25E2%2580%25933%26spage%3D258%26epage%3D274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit36b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ismayilova, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crossman, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhratsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brotchie, J.</span><span> </span><span class="NLM_article-title">Effects of adenosine A<sub>2</sub>, dopamine D<sub>1</sub> and metabotropic glutamate 5 receptor-modulating agents on locomotion of the reserpinised rats</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">497</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">187</span><span class="NLM_x">â</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.ejphar.2004.06.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=15306204" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmslCjurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=497&publication_year=2004&pages=187-195&issue=2&author=N.+Ismayilovaauthor=A.+Crossmanauthor=A.+Verkhratskyauthor=J.+Brotchie&title=Effects+of+adenosine+A2%2C+dopamine+D1+and+metabotropic+glutamate+5+receptor-modulating+agents+on+locomotion+of+the+reserpinised+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36bR"><div class="casContent"><span class="casTitleNuber">36b</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of adenosine A1, dopamine D1 and metabotropic glutamate 5 receptors-modulating agents on locomotion of the reserpinised rats</span></div><div class="casAuthors">Ismayilova, Naila; Crossman, Alan; Verkhratsky, Alexei; Brotchie, Jonathan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">497</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">187-195</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The pathophysiol. of Parkinson's disease and -3,4-dihydroxyphenylalanine (L-DOPA)-induced dyskinesia are characterized by an imbalance between activity of the direct and indirect pathways regulated by dopamine D1 and D2 receptors, resp.  In this study, we investigated the effects of treatments combining adenosine A1 and metabotropic glutamate 5 (mGlu5) receptors modulators on locomotion induced by dopamine D1 receptor activation in the reserpine-treated rats.  Administration of the adenosine A1 receptor agonist and mGlu5 receptor antagonist resulted in the significant redn. of dopamine D1 receptor agonist-induced locomotion.  The combination of adenosine A1 receptor agonist with mGlu5 receptor antagonist had no greater effect than these compds. alone.  However, the adenosine A1 receptor antagonist attenuated the inhibitory effect of mGlu5 receptor antagonist.  The data suggest that the effect of mGlu5 receptor blockade on locomotion elicited by dopamine D1 receptor stimulation involves activation of adenosine A1 receptors.  This interaction can improve our understanding of pathophysiol. of L-DOPA-induced dyskinesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH52gtRJBUubVg90H21EOLACvtfcHk0lheWNCdptZQ5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmslCjurk%253D&md5=09a735642d457d41adda90ac5a3b8cdd</span></div><a href="/servlet/linkout?suffix=cit36b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2004.06.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2004.06.030%26sid%3Dliteratum%253Aachs%26aulast%3DIsmayilova%26aufirst%3DN.%26aulast%3DCrossman%26aufirst%3DA.%26aulast%3DVerkhratsky%26aufirst%3DA.%26aulast%3DBrotchie%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520adenosine%2520A2%252C%2520dopamine%2520D1%2520and%2520metabotropic%2520glutamate%25205%2520receptor-modulating%2520agents%2520on%2520locomotion%2520of%2520the%2520reserpinised%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2004%26volume%3D497%26issue%3D2%26spage%3D187%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Gatta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Giudice, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borioni, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionsotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Synthesis of imidazo[1,2-<i>c</i>]pyrazolo[4,3-<i>e</i>]pyrimidines, pyrazolo[4,3-<i>e</i>]1,2,4-triazolo[1,5-<i>c</i>]pyrimidines and triazolo[5,1-<i>i</i>]purines: new potent A<sub>2</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">569</span><span class="NLM_x">â</span> <span class="NLM_lpage">576</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1993&pages=569-576&author=F.+Gattaauthor=M.+R.+Del+Giudiceauthor=A.+Borioniauthor=P.+A.+Boreaauthor=S.+Dionsottiauthor=E.+Ongini&title=Synthesis+of+imidazo%5B1%2C2-c%5Dpyrazolo%5B4%2C3-e%5Dpyrimidines%2C+pyrazolo%5B4%2C3-e%5D1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidines+and+triazolo%5B5%2C1-i%5Dpurines%3A+new+potent+A2+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGatta%26aufirst%3DF.%26aulast%3DDel%2BGiudice%26aufirst%3DM.%2BR.%26aulast%3DBorioni%26aufirst%3DA.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26aulast%3DDionsotti%26aufirst%3DS.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DSynthesis%2520of%2520imidazo%255B1%252C2-c%255Dpyrazolo%255B4%252C3-e%255Dpyrimidines%252C%2520pyrazolo%255B4%252C3-e%255D1%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidines%2520and%2520triazolo%255B5%252C1-i%255Dpurines%253A%2520new%2520potent%2520A2%2520adenosine%2520receptor%2520antagonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1993%26volume%3D28%26spage%3D569%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manfredini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zappaterra, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Synthesis of new pyrazolo [4,3-<i>e</i>]-1,2,4-triazolo[1,5-<i>c</i>] pyrimidine and 1,2,3-triazolo [1,5-<i>c</i>] pyrimidine displaying potent and selective activity as A<sub>2A</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">2539</span><span class="NLM_x">â</span> <span class="NLM_lpage">2544</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=1994&pages=2539-2544&author=P.+G.+Baraldiauthor=S.+Manfrediniauthor=D.+Simoniauthor=L.+Zappaterraauthor=C.+Zocchiauthor=S.+Dionisottiauthor=E.+Ongini&title=Synthesis+of+new+pyrazolo+%5B4%2C3-e%5D-1%2C2%2C4-triazolo%5B1%2C5-c%5D+pyrimidine+and+1%2C2%2C3-triazolo+%5B1%2C5-c%5D+pyrimidine+displaying+potent+and+selective+activity+as+A2A+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DManfredini%26aufirst%3DS.%26aulast%3DSimoni%26aufirst%3DD.%26aulast%3DZappaterra%26aufirst%3DL.%26aulast%3DZocchi%26aufirst%3DC.%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DSynthesis%2520of%2520new%2520pyrazolo%2520%255B4%252C3-e%255D-1%252C2%252C4-triazolo%255B1%252C5-c%255D%2520pyrimidine%2520and%25201%252C2%252C3-triazolo%2520%255B1%252C5-c%255D%2520pyrimidine%2520displaying%2520potent%2520and%2520selective%2520activity%2520as%2520A2A%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1994%26volume%3D4%26spage%3D2539%26epage%3D2544" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casati, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozza, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forlani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Cardiovascular pharmacology of the A<sub>2A</sub> adenosine receptor antagonist, SCH58261, in rat</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">9</span><span class="NLM_x">â</span> <span class="NLM_lpage">15</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9535988" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1cXisVCrt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1998&pages=9-15&author=A.+Monopoliauthor=C.+Casatiauthor=G.+Lozzaauthor=A.+Forlaniauthor=E.+Ongini&title=Cardiovascular+pharmacology+of+the+A2A+adenosine+receptor+antagonist%2C+SCH58261%2C+in+rat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiovascular pharmacology of the A2A adenosine receptor antagonist, SCH 58261, in the rat</span></div><div class="casAuthors">Monopoli, Angela; Casati, Carlo; Lozza, Gianluca; Forlani, Angelo; Ongini, Ennio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9-15</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">Williams & Wilkins</span>)
        </div><div class="casAbstract">We characterized the in vivo cardiovascular profile of SCH 58261, 7-(2-phenylethyl)-5-amino-2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c] pyrimidine, a selective A2A adenosine receptor antagonist, in conscious, freely moving rats by use of the telemetry system.  In normotensive rats, SCH 58261, at 10 mg/kg i.p., significantly (P < .05) inhibited hypotension and tachycardia induced by the A2A receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine (0.01 mg/kg i.p.), but not the bradycardic effect caused by the A1 receptor agonist 2-chloro-N6-cyclopentyladenosine (0.03 mg/kg i.p.).  SCH 58261, when administered alone, at 0.1 and 1 mg/kg i.p., did not induce significant hemodynamic changes, but at 10 mg/kg i.p., it slightly increased both systolic blood pressure (SBP) and diastolic blood pressure (DBP) (+19 Â± 3 and +16 Â± 2 mm Hg, resp.; P < .01) and heart rate (HR) (+85 Â± 5 beats/min; P < .01).  These effects were inhibited by adrenergic blockade with propranolol (30 mg/kg i.p.) and phentolamine (10 mg/kg i.p.): -5 Â± 3 mm Hg on DBP and -12 Â± 11 beats/min on HR (P < .01).  In spontaneously hypertensive rats, SCH 58261, at 3 and 10 mg/kg i.p., increased weakly both SBP (+19 Â± 5 mm Hg and +25 Â± 4 mm Hg) and DBP (+14 Â± 4 mm Hg and +23 Â± 4 mm Hg) vs. vehicle (P < .01) and HR (+45 Â± 17 and +64 Â± 18 beats/min vs. vehicle, resp.; P < .01).  The data indicate that SCH 58261 retains A2A selective receptor antagonist properties in vivo.  Its effect on cardiovascular sympathetic outflow further suggests that endogenous adenosine exerts a tonic vascular regulation through A2A receptors.  Therefore, SCH 58261 can be a useful pharmacol. tool for clarifying A2A-mediated cardiovascular actions of adenosine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6AOfPNETfJLVg90H21EOLACvtfcHk0lheWNCdptZQ5A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXisVCrt7g%253D&md5=7c747920f3448d2e81f4bdc3a2fa1224</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DCasati%26aufirst%3DC.%26aulast%3DLozza%26aufirst%3DG.%26aulast%3DForlani%26aufirst%3DA.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DCardiovascular%2520pharmacology%2520of%2520the%2520A2A%2520adenosine%2520receptor%2520antagonist%252C%2520SCH58261%252C%2520in%2520rat%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1998%26volume%3D285%26spage%3D9%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Caulkett, P. W. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McPartlin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renshaw, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, B.</span><span> </span><span class="NLM_article-title">Adenine isosteres with bridgehead nitrogen. Part 1. Two independent syntheses of the [1,2,4]triazolo[1,5-<i>a</i>][1,3,5]triazine ring system leading to a range of substituents in the 2, 5 and 7 positions</span> <span class="citation_source-journal">J. Chem. Soc., Perkin Trans. 1</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_fpage">801</span><span class="NLM_x">â</span> <span class="NLM_lpage">808</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1995&pages=801-808&author=P.+W.+R.+Caulkettauthor=G.+Jonesauthor=M.+McPartlinauthor=N.+D.+Renshawauthor=S.+K.+Stewartauthor=B.+Wright&title=Adenine+isosteres+with+bridgehead+nitrogen.+Part+1.+Two+independent+syntheses+of+the+%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5D%5B1%2C3%2C5%5Dtriazine+ring+system+leading+to+a+range+of+substituents+in+the+2%2C+5+and+7+positions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaulkett%26aufirst%3DP.%2BW.%2BR.%26aulast%3DJones%26aufirst%3DG.%26aulast%3DMcPartlin%26aufirst%3DM.%26aulast%3DRenshaw%26aufirst%3DN.%2BD.%26aulast%3DStewart%26aufirst%3DS.%2BK.%26aulast%3DWright%26aufirst%3DB.%26atitle%3DAdenine%2520isosteres%2520with%2520bridgehead%2520nitrogen.%2520Part%25201.%2520Two%2520independent%2520syntheses%2520of%2520the%2520%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255D%255B1%252C3%252C5%255Dtriazine%2520ring%2520system%2520leading%2520to%2520a%2520range%2520of%2520substituents%2520in%2520the%25202%252C%25205%2520and%25207%2520positions%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Perkin%2520Trans.%25201%26date%3D1995%26spage%3D801%26epage%3D808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moratalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Standaert, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskowitz, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> adenosine receptor deficiency attenuates brain injury induced by transient local ischemia in mice</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">9192</span><span class="NLM_x">â</span> <span class="NLM_lpage">9200</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=10531422" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1MXnslyisLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=9192-9200&author=J.+F.+Chenauthor=Z.+Huangauthor=J.+Maauthor=J.+Zhuauthor=R.+Moratallaauthor=D.+Standaertauthor=M.+A.+Moskowitzauthor=J.+S.+Finkauthor=M.+A.+Schwarzschild&title=A2A+adenosine+receptor+deficiency+attenuates+brain+injury+induced+by+transient+local+ischemia+in+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">A2A adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice</span></div><div class="casAuthors">Chen, Jiang-Fan; Huang, Zhihong; Ma, Jianya; Zhu, JinMin; Moratalla, Rosario; Standaert, David; Moskowitz, Michael A.; Fink, J. Stephen; Schwarzschild, Michael A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9192-9200</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Extracellular adenosine critically modulates ischemic brain injury, at least in part through activation of the A1 adenosine receptor.  However, the role played by the A2A receptor has been obscured by intrinsic limitations of A2A adenosinergic agents.  To overcome these pharmacol. limitations, the authors explored the consequences of deleting the A2A adenosine receptor on brain damage after transient focal ischemia.  Cerebral morphol., as well as vascular and physiol. measures (before, during, and after ischemia) did not differ between A2A receptor knock-out and wild-type littermates.  The vol. of cerebral infarction, as well as the assocd. neurol. deficit induced by transient filament occlusion of the middle cerebral artery, were significantly attenuated in A2A receptor knock-out mice.  This neuroprotective phenotype of A2A receptor-deficient mice was obsd. in different genetic backgrounds, confirming A2A receptor disruption as its cause.  Together with complementary pharmacol. studies, these data suggest that A2A receptors play a prominent role in the development of ischemic injury within brain and demonstrate the potential for anatomical and functional neuroprotection against stroke by A2A receptor antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoLSE_1cO_jVLVg90H21EOLACvtfcHk0lhpqSDUJy5UCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslyisLc%253D&md5=54d19e3ba26fcbd7cf3a963b381c204f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DZhu%26aufirst%3DJ.%26aulast%3DMoratalla%26aufirst%3DR.%26aulast%3DStandaert%26aufirst%3DD.%26aulast%3DMoskowitz%26aufirst%3DM.%2BA.%26aulast%3DFink%26aufirst%3DJ.%2BS.%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26atitle%3DA2A%2520adenosine%2520receptor%2520deficiency%2520attenuates%2520brain%2520injury%2520induced%2520by%2520transient%2520local%2520ischemia%2520in%2520mice%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D9192%26epage%3D9200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span>The Jackson Laboratory. <a href="http://jaxmice.jax.org/strain/010685.html" class="extLink">http://jaxmice.jax.org/strain/010685.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+Jackson+Laboratory.+http%3A%2F%2Fjaxmice.jax.org%2Fstrain%2F010685.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferri, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Effects of selective agonists and antagonists for A<sub>1</sub> or A<sub>2A</sub> adenosine receptors on sleep-waking patterns in rats</span> <span class="citation_source-journal">Drug Dev. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">65</span><span class="NLM_x">â</span> <span class="NLM_lpage">72</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1996&pages=65-72&author=R.+Bertorelliauthor=N.+Ferriauthor=M.+Adamiauthor=E.+Ongini&title=Effects+of+selective+agonists+and+antagonists+for+A1+or+A2A+adenosine+receptors+on+sleep-waking+patterns+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DFerri%26aufirst%3DN.%26aulast%3DAdami%26aufirst%3DM.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DEffects%2520of%2520selective%2520agonists%2520and%2520antagonists%2520for%2520A1%2520or%2520A2A%2520adenosine%2520receptors%2520on%2520sleep-waking%2520patterns%2520in%2520rats%26jtitle%3DDrug%2520Dev.%2520Res.%26date%3D1996%26volume%3D37%26spage%3D65%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">FerrÃ©, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Von Euler, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johansson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span> </span><span class="NLM_article-title">Stimulation of high affinity adenosine A<sub>2</sub> receptors decreases the affinity of dopamine D<sub>2</sub> receptors in rat striatal membranes</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x">, </span> <span class="NLM_fpage">7238</span><span class="NLM_x">â</span> <span class="NLM_lpage">7241</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=1991&pages=7238-7241&author=S.+Ferr%C3%A9author=G.+Von+Eulerauthor=B.+Johanssonauthor=B.+Fredholmauthor=K.+Fuxe&title=Stimulation+of+high+affinity+adenosine+A2+receptors+decreases+the+affinity+of+dopamine+D2+receptors+in+rat+striatal+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DVon%2BEuler%26aufirst%3DG.%26aulast%3DJohansson%26aufirst%3DB.%26aulast%3DFredholm%26aufirst%3DB.%26aulast%3DFuxe%26aufirst%3DK.%26atitle%3DStimulation%2520of%2520high%2520affinity%2520adenosine%2520A2%2520receptors%2520decreases%2520the%2520affinity%2520of%2520dopamine%2520D2%2520receptors%2520in%2520rat%2520striatal%2520membranes%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1991%26volume%3D88%26spage%3D7238%26epage%3D7241" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Dasgupta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FerrÃ©, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kull, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedlund, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finnman, U. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahlberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arenas, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor modulates the binding characteristics of dopamine D<sub>2</sub> receptors in stably cotransfected fibroblast cells</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">316</span><span class="NLM_x">, </span> <span class="NLM_fpage">325</span><span class="NLM_x">â</span> <span class="NLM_lpage">331</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2FS0014-2999%2896%2900665-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=8982704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK28Xnt1Krsbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=316&publication_year=1996&pages=325-331&author=S.+Dasguptaauthor=S.+Ferr%C3%A9author=B.+Kullauthor=P.+B.+Hedlundauthor=U.+B.+Finnmanauthor=S.+Ahlbergauthor=E.+Arenasauthor=B.+B.+Fredholmauthor=K.+Fuxe&title=Adenosine+A2A+receptor+modulates+the+binding+characteristics+of+dopamine+D2+receptors+in+stably+cotransfected+fibroblast+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A receptors modulate the binding characteristics of dopamine D2 receptors in stably cotransfected fibroblast cells</span></div><div class="casAuthors">Dasgupta, Sarmila; Ferre, Sergi; Kull, Bjoern; Hedlund, Peter B.; Finnman, Ulla-Britt; Ahlberg, Susanne; Arenas, Ernest; Fredholm, Bertil B.; Fuxe, Kjell</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">316</span>
        (<span class="NLM_cas:issue">2/3</span>),
    <span class="NLM_cas:pages">325-331</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">In membrane prepns. from rat striatum, where adenosine A2A and dopamine D2 receptors are coexpressed, stimulation of adenosine A2A receptors was found to decrease the affinity of dopamine D2 receptors for dopamine agonists.  We now demonstrate the existence of this antagonistic interaction in a fibroblast cell line (Ltk-) stably transfected with the human dopamine D2 (long-form) receptor and the dog adenosine A2A receptor cDNAs (A2A-D2 cells).  In A2A-D2 cells, but not in control cells only contg. dopamine D2 receptors (D2 cells), the selective adenosine A2A agonist CGS 21680 induced a 2-3-fold decrease in the affinity of dopamine D2 receptors for dopamine, as shown in competition expts. with dopamine vs. the selective dopamine D2 antagonist [3H]raclopride.  By contrast, activation of the constitutively expressed adenosine A2B receptors with 5'-N-ethyl-carboxamidoadenosine (NECA) did not modify dopamine D2 receptor binding.  In A2A-D2 cells CGS 21680 failed to induce or induced only a small increase in cAMP accumulation.  In D2 cells NECA- or forskolin-induced adenylyl cyclase activation was not assocd. with any change in dopamine D2 receptor binding.  These results indicate that adenylyl cyclase activation is not involved in the adenosine A2A receptor-mediated modulation of the binding characteristics of the dopamine D2 (long-form) receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmB5ZLTykPzrVg90H21EOLACvtfcHk0lhpqSDUJy5UCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xnt1Krsbk%253D&md5=bfd7889f6f1d076ea7d5740dbc41f12d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2FS0014-2999%2896%2900665-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0014-2999%252896%252900665-6%26sid%3Dliteratum%253Aachs%26aulast%3DDasgupta%26aufirst%3DS.%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DKull%26aufirst%3DB.%26aulast%3DHedlund%26aufirst%3DP.%2BB.%26aulast%3DFinnman%26aufirst%3DU.%2BB.%26aulast%3DAhlberg%26aufirst%3DS.%26aulast%3DArenas%26aufirst%3DE.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DFuxe%26aufirst%3DK.%26atitle%3DAdenosine%2520A2A%2520receptor%2520modulates%2520the%2520binding%2520characteristics%2520of%2520dopamine%2520D2%2520receptors%2520in%2520stably%2520cotransfected%2520fibroblast%2520cells%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D316%26spage%3D325%26epage%3D331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Pollack, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, J. S.</span><span> </span><span class="NLM_article-title">Adenosine antagonists potentiate D<sub>2</sub>-dopamine-dependent activation of Fos in the striopallidal pathway</span> <span class="citation_source-journal">Neuroscience</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">68</span><span class="NLM_x">, </span> <span class="NLM_fpage">721</span><span class="NLM_x">â</span> <span class="NLM_lpage">728</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=68&publication_year=1995&pages=721-728&author=A.+E.+Pollackauthor=J.+S.+Fink&title=Adenosine+antagonists+potentiate+D2-dopamine-dependent+activation+of+Fos+in+the+striopallidal+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPollack%26aufirst%3DA.%2BE.%26aulast%3DFink%26aufirst%3DJ.%2BS.%26atitle%3DAdenosine%2520antagonists%2520potentiate%2520D2-dopamine-dependent%2520activation%2520of%2520Fos%2520in%2520the%2520striopallidal%2520pathway%26jtitle%3DNeuroscience%26date%3D1995%26volume%3D68%26spage%3D721%26epage%3D728" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Popoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">PÃ¨zola, A.</span><span> </span><span class="NLM_article-title">Effects of SCH58261, an adenosine A<sub>2A</sub> receptor antagonist, on quinpirole-induced turning in 6-hydroxydopamine-lesioned rats: lack of tolerance after chronic caffeine intake</span> <span class="citation_source-journal">Neuropsychopharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">522</span><span class="NLM_x">â</span> <span class="NLM_lpage">529</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2000&pages=522-529&issue=5&author=P.+Popoliauthor=R.+Reggioauthor=A.+P%C3%A8zola&title=Effects+of+SCH58261%2C+an+adenosine+A2A+receptor+antagonist%2C+on+quinpirole-induced+turning+in+6-hydroxydopamine-lesioned+rats%3A+lack+of+tolerance+after+chronic+caffeine+intake"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPopoli%26aufirst%3DP.%26aulast%3DReggio%26aufirst%3DR.%26aulast%3DP%25C3%25A8zola%26aufirst%3DA.%26atitle%3DEffects%2520of%2520SCH58261%252C%2520an%2520adenosine%2520A2A%2520receptor%2520antagonist%252C%2520on%2520quinpirole-induced%2520turning%2520in%25206-hydroxydopamine-lesioned%2520rats%253A%2520lack%2520of%2520tolerance%2520after%2520chronic%2520caffeine%2520intake%26jtitle%3DNeuropsychopharmacology%26date%3D2000%26volume%3D22%26issue%3D5%26spage%3D522%26epage%3D529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">FerrÃ©, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rimondini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kehr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D<sub>2</sub> receptors in the rat striatum</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">129</span><span class="NLM_x">â</span> <span class="NLM_lpage">140</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1999&pages=129-140&author=S.+Ferr%C3%A9author=P.+Popoliauthor=R.+Rimondiniauthor=R.+Reggioauthor=J.+Kehrauthor=K.+Fuxe&title=Adenosine+A2A+and+group+I+metabotropic+glutamate+receptors+synergistically+modulate+the+binding+characteristics+of+dopamine+D2+receptors+in+the+rat+striatum"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFerr%25C3%25A9%26aufirst%3DS.%26aulast%3DPopoli%26aufirst%3DP.%26aulast%3DRimondini%26aufirst%3DR.%26aulast%3DReggio%26aufirst%3DR.%26aulast%3DKehr%26aufirst%3DJ.%26aulast%3DFuxe%26aufirst%3DK.%26atitle%3DAdenosine%2520A2A%2520and%2520group%2520I%2520metabotropic%2520glutamate%2520receptors%2520synergistically%2520modulate%2520the%2520binding%2520characteristics%2520of%2520dopamine%2520D2%2520receptors%2520in%2520the%2520rat%2520striatum%26jtitle%3DNeuropharmacology%26date%3D1999%26volume%3D38%26spage%3D129%26epage%3D140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">El Yacoubi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ledent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costentin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vaugeois, J.-M.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonists are potential antidepressants: evidence based on pharmacology and A<sub>2A</sub> receptor knock out mice</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">134</span><span class="NLM_x">, </span> <span class="NLM_fpage">68</span><span class="NLM_x">â</span> <span class="NLM_lpage">77</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1038%2Fsj.bjp.0704240" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=11522598" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD3MXmvVyrurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2001&pages=68-77&author=M.+El+Yacoubiauthor=C.+Ledentauthor=M.+Parmentierauthor=R.+Bertorelliauthor=E.+Onginiauthor=J.+Costentinauthor=J.-M.+Vaugeois&title=Adenosine+A2A+receptor+antagonists+are+potential+antidepressants%3A+evidence+based+on+pharmacology+and+A2A+receptor+knock+out+mice"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice</span></div><div class="casAuthors">El Yacoubi, Malika; Ledent, Catherine; Parmentier, Marc; Bertorelli, Rosalia; Ongini, Ennio; Costentin, Jean; Vaugeois, Jean-Marie</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">68-77</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adenosine, an ubiquitous neuromodulator, and its analogs have been shown to produce "depressant" effects in animal models believed to be relevant to depressive disorders, while adenosine receptor antagonists have been found to reverse adenosine-mediated "depressant" effect.  We have designed studies to assess whether adenosine A2A receptor antagonists, or genetic inactivation of the receptor would be effective in established screening procedures, such as tail suspension and forced swim tests, which are predictive of clin. antidepressant activity.  Adenosine A2A receptor knockout mice were found to be less sensitive to "depressant" challenges than their wild-type littermates.  Consistently, the adenosine A2A receptor blockers SCH 58261 (1-10 mg kg-1, i.p.) and KW 6002 (0.1-10 mg kg-1, p.o.) reduced the total immobility time in the tail suspension test.  The efficacy of adenosine A2A receptor antagonists in reducing immobility time in the tail suspension test was confirmed and extended in two groups of mice.  Specifically, SCH 58261 (1-10 mg kg-1) and ZM 241385 (15-60 mg kg-1) were effective in mice previously screened for having high immobility time, while SCH 58261 at 10 mg kg-1 reduced immobility of mice that were selectively bred for their spontaneous "helplessness" in this assay.  Addnl. expts. were carried out using the forced swim test.  SCH 58261 at 10 mg kg-1 reduced the immobility time by 61%, while KW 6002 decreased the total immobility time at the doses of 1 and 10 mg kg-1 by 75 and 79%, resp.  Administration of the dopamine D2 receptor antagonist haloperidol (50-200 Î¼g kg-1 i.p.) prevented the antidepressant-like effects elicited by SCH 58261 (10 mg kg-1 i.p.) in forced swim test whereas it left unaltered its stimulant motor effects.  In conclusion, these data support the hypothesis that A2A receptor antagonists prolong escape-directed behavior in two screening tests for antidepressants.  Altogether the results support the hypothesis that blockade of the adenosine A2A receptor might be an interesting target for the development of effective antidepressant agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXnF2LXC3z7rVg90H21EOLACvtfcHk0lhL2zoxRZLtnw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXmvVyrurc%253D&md5=b000017916296c89c1e71875ecd887e5</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704240&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704240%26sid%3Dliteratum%253Aachs%26aulast%3DEl%2BYacoubi%26aufirst%3DM.%26aulast%3DLedent%26aufirst%3DC.%26aulast%3DParmentier%26aufirst%3DM.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DCostentin%26aufirst%3DJ.%26aulast%3DVaugeois%26aufirst%3DJ.-M.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonists%2520are%2520potential%2520antidepressants%253A%2520evidence%2520based%2520on%2520pharmacology%2520and%2520A2A%2520receptor%2520knock%2520out%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D134%26spage%3D68%26epage%3D77" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Popoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pintor, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Domenici, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frank, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tebano, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">PÃ¨zzola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scarchilli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quarta, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggio, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malchiodi-Albedi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Falchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Massotti, M.</span><span> </span><span class="NLM_article-title">Blockade of striatal adenosine A<sub>2A</sub> receptors reduces quinolinic acid-induced excitotoxicity</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1967</span><span class="NLM_x">â</span> <span class="NLM_lpage">1975</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=11880527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvVaktbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2002&pages=1967-1975&issue=5&author=P.+Popoliauthor=A.+Pintorauthor=M.+R.+Domeniciauthor=C.+Frankauthor=M.+T.+Tebanoauthor=A.+P%C3%A8zzolaauthor=L.+Scarchilliauthor=D.+Quartaauthor=R.+Reggioauthor=F.+Malchiodi-Albediauthor=M.+Falchiauthor=M.+Massotti&title=Blockade+of+striatal+adenosine+A2A+receptors+reduces+quinolinic+acid-induced+excitotoxicity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Blockade of striatal adenosine A2A receptor reduces, through a presynaptic mechanism, quinolinic acid-induced excitotoxicity: possible relevance to neuroprotective interventions in neurodegenerative diseases of the striatum</span></div><div class="casAuthors">Popoli, Patrizia; Pintor, Annita; Domenici, Maria Rosaria; Frank, Claudio; Tebano, Maria Teresa; Pezzola, Antonella; Scarchilli, Laura; Quarta, Davide; Reggio, Rosaria; Malchiodi-Albedi, Fiorella; Falchi, Mario; Massotti, Marino</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1967-1975</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">The aim of the present study was to evaluate whether, and by means of which mechanisms, the adenosine A2A receptor antagonist SCH 58261 [5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine] exerted neuroprotective effects in a rat model of Huntington's disease.  In a first set of expts., SCH 58261 (0.01 and 1 mg/kg) was administered i.p. to Wistar rats 20 min before the bilateral striatal injection of quinolinic acid (QA) (300 nmol/1 Î¼l).  SCH 58261 (0.01 but not 1 mg/kg, i.p.) did reduce significantly the effects of QA on motor activity, electroencephalog. changes, and striatal gliosis.  Because QA acts by both increasing glutamate outflow and directly stimulating NMDA receptors, a second set of expts. was performed to evaluate whether SCH 58261 acted by preventing the presynaptic and/or the postsynaptic effects of QA.  In microdialysis expts. in naive rats, striatal perfusion with QA (5 mN) enhanced glutamate levels by â¼500%.  Such an effect of QA was completely antagonized by pretreatment with SCH 58261 (0.01 but not 1 mg/kg, i.p.).  In primary striatal cultures, bath application of QA (900 AM) significantly increased intracellular calcium levels, an effect prevented by the NMDA receptor antagonist MK-801 [(Â±)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine maleate].  In this model, bath application of SCH 58261 (15-200 nM) tended to potentiate QA-induced calcium increase.  We conclude the following: (1) the adenosine A2A receptor antagonist SCH 58261 has neuroprotective effects, although only at low doses, in an excitotoxic rat model of HD, and (2) the inhibition of QA-evoked glutamate outflow seems to be the major mechanism underlying the neuroprotective effects of SCH 58261.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjomGSUPCO0LVg90H21EOLACvtfcHk0lhL2zoxRZLtnw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvVaktbc%253D&md5=4111a81928fac5c23b9a85c7f1f6b14d</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPopoli%26aufirst%3DP.%26aulast%3DPintor%26aufirst%3DA.%26aulast%3DDomenici%26aufirst%3DM.%2BR.%26aulast%3DFrank%26aufirst%3DC.%26aulast%3DTebano%26aufirst%3DM.%2BT.%26aulast%3DP%25C3%25A8zzola%26aufirst%3DA.%26aulast%3DScarchilli%26aufirst%3DL.%26aulast%3DQuarta%26aufirst%3DD.%26aulast%3DReggio%26aufirst%3DR.%26aulast%3DMalchiodi-Albedi%26aufirst%3DF.%26aulast%3DFalchi%26aufirst%3DM.%26aulast%3DMassotti%26aufirst%3DM.%26atitle%3DBlockade%2520of%2520striatal%2520adenosine%2520A2A%2520receptors%2520reduces%2520quinolinic%2520acid-induced%2520excitotoxicity%26jtitle%3DJ.%2520Neurosci.%26date%3D2002%26volume%3D22%26issue%3D5%26spage%3D1967%26epage%3D1975" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Paterniti, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cipriani, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mello, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzon, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esposito, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bramanti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cuzzocrea, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pedata, F.</span><span> </span><span class="NLM_article-title">Selective adenosine A<sub>2A</sub> receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects</span> <span class="citation_source-journal">J. Neuroinflammation</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">31</span><span class="NLM_x">â</span> <span class="NLM_lpage">44</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1186%2F1742-2094-8-31" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=21486435" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXlsVamsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2011&pages=31-44&author=I.+Paternitiauthor=A.+Melaniauthor=S.+Ciprianiauthor=F.+Cortiauthor=T.+Melloauthor=E.+Mazzonauthor=E.+Espositoauthor=P.+Bramantiauthor=S.+Cuzzocreaauthor=F.+Pedata&title=Selective+adenosine+A2A+receptor+agonists+and+antagonists+protect+against+spinal+cord+injury+through+peripheral+and+central+effects"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Selective adenosine A2A receptor agonists and antagonists protect against spinal cord injury through peripheral and central effects</span></div><div class="casAuthors">Paterniti, Irene; Melani, Alessia; Cipriani, Sara; Corti, Francesca; Mello, Tommaso; Mazzon, Emanuela; Esposito, Emanuela; Bramanti, Placido; Cuzzocrea, Salvatore; Pedata, Felicita</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroinflammation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">31</span>CODEN:
                <span class="NLM_cas:coden">JNOEB3</span>;
        ISSN:<span class="NLM_cas:issn">1742-2094</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Permanent functional deficits following spinal cord injury (SCI) arise both from mech. injury and from secondary tissue reactions involving inflammation.  Enhanced release of adenosine and glutamate soon after SCI represents a component in the sequelae that may be responsible for resulting functional deficits.  The role of adenosine A2A receptor in central ischemia/trauma is still to be elucidated.  In our previous studies we have demonstrated that the adenosine A2A receptor-selective agonist CGS21680, systemically administered after SCI, protects from tissue damage, locomotor dysfunction and different inflammatory readouts.  In this work we studied the effect of the adenosine A2A receptor antagonist SCH58261, systemically administered after SCI, on the same parameters.  We investigated the hypothesis that the main action mechanism of agonists and antagonists is at peripheral or central sites.  Methods: Spinal trauma was induced by extradural compression of SC exposed via a four-level T5-T8 laminectomy in mouse.  Three drug-dosing protocols were utilized: a short-term systemic administration by i.p. injection, a chronic administration via osmotic minipump, and direct injection into the spinal cord.  Results: SCH58261, systemically administered (0.01 mg/kg i.p. 1, 6 and 10 h after SCI), reduced demyelination and levels of TNF-Î±, Fas-L, PAR, Bax expression and activation of JNK mitogen-activated protein kinase (MAPK) 24 h after SCI.  Chronic SCH58261 administration, by mini-osmotic pump delivery for 10 days, improved the neurol. deficit up to 10 days after SCI.  Adenosine A2A receptors are physiol. expressed in the spinal cord by astrocytes, microglia and oligodendrocytes.  Soon after SCI (24 h), these receptors showed enhanced expression in neurons.  Both the A2A agonist and antagonist, administered i.p., reduced expression of the A2A receptor, ruling out the possibility that the neuroprotective effects of the A2A agonist are due to A2A receptor desensitization.  When the A2A antagonist and agonist were centrally injected into injured SC, only SCH58261 appeared neuroprotective, while CGS21680 was ineffective.  Conclusions: Our results indicate that the A2A antagonist protects against SCI by acting on centrally located A2A receptors.  It is likely that blockade of A2A receptors reduces excitotoxicity.  In contrast, neuroprotection afforded by the A2A agonist may be primarily due to peripheral effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpH4aBI5clJBbVg90H21EOLACvtfcHk0liTlWIJcNQ26A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXlsVamsL8%253D&md5=cee045c88a97571e1c0f4b836da9dc90</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1186%2F1742-2094-8-31&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1742-2094-8-31%26sid%3Dliteratum%253Aachs%26aulast%3DPaterniti%26aufirst%3DI.%26aulast%3DMelani%26aufirst%3DA.%26aulast%3DCipriani%26aufirst%3DS.%26aulast%3DCorti%26aufirst%3DF.%26aulast%3DMello%26aufirst%3DT.%26aulast%3DMazzon%26aufirst%3DE.%26aulast%3DEsposito%26aufirst%3DE.%26aulast%3DBramanti%26aufirst%3DP.%26aulast%3DCuzzocrea%26aufirst%3DS.%26aulast%3DPedata%26aufirst%3DF.%26atitle%3DSelective%2520adenosine%2520A2A%2520receptor%2520agonists%2520and%2520antagonists%2520protect%2520against%2520spinal%2520cord%2520injury%2520through%2520peripheral%2520and%2520central%2520effects%26jtitle%3DJ.%2520Neuroinflammation%26date%3D2011%26volume%3D8%26spage%3D31%26epage%3D44" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Mohamed, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agha, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nassar, N. N.</span><span> </span><span class="NLM_article-title">SCH58261 the selective adenosine A<sub>2A</sub> receptor blocker modulates ischemia reperfusion injury following bilateral carotid occlusion: role of inflammatory mediators</span> <span class="citation_source-journal">Neurochem. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">538</span><span class="NLM_x">â</span> <span class="NLM_lpage">547</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2Fs11064-011-0640-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=22071908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVektrrO" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2012&pages=538-547&issue=3&author=R.+A.+Mohamedauthor=A.+M.+Aghaauthor=N.+N.+Nassar&title=SCH58261+the+selective+adenosine+A2A+receptor+blocker+modulates+ischemia+reperfusion+injury+following+bilateral+carotid+occlusion%3A+role+of+inflammatory+mediators"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">SCH58261 the Selective Adenosine A2A Receptor Blocker Modulates Ischemia Reperfusion Injury Following Bilateral Carotid Occlusion: Role of Inflammatory Mediators</span></div><div class="casAuthors">Mohamed, R. A.; Agha, A. M.; Nassar, N. N.</div><div class="citationInfo"><span class="NLM_cas:title">Neurochemical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">538-547</span>CODEN:
                <span class="NLM_cas:coden">NEREDZ</span>;
        ISSN:<span class="NLM_cas:issn">0364-3190</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">In the present study, the effects of SCH58261, a selective adenosine A2A receptor antagonist that crosses the blood brain barrier (BBB) and 8-(4-sulfophenyl) theophylline (8-SPT), a non-selective adenosine receptor antagonist that acts peripherally, were investigated on cerebral ischemia reperfusion injury (IR).  Male Wistar rats (200-250 g) were divided into four groups: (1) sham-operated (SO), IR pretreated with either (2) vehicle (DMSO); (3) SCH58261 (0.01 mg/kg); (4) 8-SPT (2.5 mg/kg).  Animals were anesthetized and submitted to occlusion of both carotid arteries for 45 min.  All treatments were administered i.p. post carotid occlusion prior to exposure to a 24 h reperfusion period.  Ischemic rats showed increased infarct size compared to their control counterparts that corroborated with histopathol. changes as well as increased lactate dehydrogenase (LDH) activity in the hippocampus.  Moreover, ischemic animals showed habituation deficit, increased anxiety and locomotor activity.  IR increased hippocampal glutamate (Glu), GABA, glycine (Gly) and aspartate (ASP).  SCH58261 significantly reversed these effects while 8-SPT elicited minimal change.  IR raised myeloperoxidase (MPO), tumor necrosis factor-alpha (TNF-Î±), nitric oxide (NO), prostaglandin E2 (PGE2) accompanied by a decrease in interleukin-10 (IL-10), effects that were again reversed by SCH58261, but 8-SPT elicited less changes.  Results from the present study point towards the importance of central blockade of adenosine A2A receptor in ameliorating hippocampal damage following IR injury by halting inflammatory cascades as well as modulating excitotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP6EgOLW89JbVg90H21EOLACvtfcHk0liTlWIJcNQ26A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVektrrO&md5=9dec8f6dacd131ea7a24d347f8e91d48</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1007%2Fs11064-011-0640-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11064-011-0640-x%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DR.%2BA.%26aulast%3DAgha%26aufirst%3DA.%2BM.%26aulast%3DNassar%26aufirst%3DN.%2BN.%26atitle%3DSCH58261%2520the%2520selective%2520adenosine%2520A2A%2520receptor%2520blocker%2520modulates%2520ischemia%2520reperfusion%2520injury%2520following%2520bilateral%2520carotid%2520occlusion%253A%2520role%2520of%2520inflammatory%2520mediators%26jtitle%3DNeurochem.%2520Res.%26date%3D2012%26volume%3D37%26issue%3D3%26spage%3D538%26epage%3D547" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tikhonova, I. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Structure and function of G protein-coupled receptors studied using sequence analysis, molecular modeling and receptor engineering: adenosine receptors</span> <span class="citation_source-journal">Front. Drug Des. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">63</span><span class="NLM_x">â</span> <span class="NLM_lpage">79</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlWlur3N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2007&pages=63-79&author=S.+Costanziauthor=A.+A.+Ivanovauthor=I.+G.+Tikhonovaauthor=K.+A.+Jacobson&title=Structure+and+function+of+G+protein-coupled+receptors+studied+using+sequence+analysis%2C+molecular+modeling+and+receptor+engineering%3A+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Structure and function of G protein-coupled receptors studied using sequence analysis, molecular modeling and receptor engineering: adenosine receptors</span></div><div class="casAuthors">Costanzi, Stefano; Ivanov, Andrei A.; Tikhonova, Irina G.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Drug Design and Discovery</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-79</span>CODEN:
                <span class="NLM_cas:coden">FDDDBZ</span>;
        ISSN:<span class="NLM_cas:issn">1574-0889</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Rhodopsin is the only member of the G protein-coupled receptors (GPCRs) superfamily for which crystallog. data are available.  Thus, the study of the structure-function relationships of most GPCRs relies on bioinformatics, rhodopsin-based homol. modeling, and docking expts. conducted in an iterative manner utilizing site-directed mutagenesis and chem. modification of the ligands.  Adenosine receptors (ARs) are presented as a case study to illustrate this indirect composite approach relying on an intimate combination of computational and exptl. techniques.  In the first section we discuss the phylogenesis of the ARs from an evolutionary perspective.  Furthermore, we review sequence comparison studies from the perspective of similarities with other GPCRs, chemogenomics, and coupling to G proteins.  In the second section, we review various rhodopsin-based homol. models of the ARs and docking studies of agonists and antagonists.  As reported for other GPCRs, several different modes have been hypothesized for ligands binding to ARs.  Here, we critically review the proposed binding modes of agonists and antagonists in light of the available matagenesis data and the structure-activity relationships of ligands.  Lastly, we review an exptl.-supported strategy for validating theor. binding hypotheses based on the complementary reengineering of receptors and ligands (neoceptors and neoligands).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAswktiw8RYbVg90H21EOLACvtfcHk0liTlWIJcNQ26A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlWlur3N&md5=c631351430d3703fbfa31efb487d8388</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DIvanov%26aufirst%3DA.%2BA.%26aulast%3DTikhonova%26aufirst%3DI.%2BG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DStructure%2520and%2520function%2520of%2520G%2520protein-coupled%2520receptors%2520studied%2520using%2520sequence%2520analysis%252C%2520molecular%2520modeling%2520and%2520receptor%2520engineering%253A%2520adenosine%2520receptors%26jtitle%3DFront.%2520Drug%2520Des.%2520Discovery%26date%3D2007%26volume%3D3%26spage%3D63%26epage%3D79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marucci, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span> </span><span class="NLM_article-title">A<sub>2A</sub> adenosine receptors and its modulators: overview on a druggable GPCR and on SAR analysis and binding requirements of agonists and antagonists</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1525</span><span class="NLM_x">â</span> <span class="NLM_lpage">1552</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.2174%2F138161208784480081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=18537675" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1cXns1ymsrk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=1525-1552&author=G.+Cristalliauthor=C.+Lambertucciauthor=G.+Marucciauthor=R.+Volpiniauthor=D.+Dal+Ben&title=A2A+adenosine+receptors+and+its+modulators%3A+overview+on+a+druggable+GPCR+and+on+SAR+analysis+and+binding+requirements+of+agonists+and+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">A2A adenosine receptor and its modulators: overview on a druggable GPCR and on structure-activity relationship analysis and binding requirements of agonists and antagonists</span></div><div class="casAuthors">Cristalli, G.; Lambertucci, C.; Marucci, G.; Volpini, R.; Dal Ben, D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1525-1552</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Since the discovery of the biol. effects of adenosine, the development of potent and selective agonists and antagonists of adenosine receptors has been the subject of medicinal chem. research for several decades, even if their clin. evaluation has been discontinued.  Main problems include side effects due to the ubiquity of the receptors and the possibility of side effects, or to low brain penetration (in particular for the targeting of CNS diseases), short half-life of compds., lack of effects.  Furthermore, species differences in the affinity of ligands make difficult preclin. testing in animal models.  Nevertheless, adenosine receptors continue to represent promising drug targets.  A2A receptor has proved to be a promising pharmacol. target for small synthetic ligands, and while A2A agonists are undergoing clin. trials for myocardial perfusion imaging and as anti-inflammatory agents, A2A antagonists represent an attractive field of research to discover new drugs for the treatment of neurodegenerative disorders, such as Parkinson's disease.  Furthermore, the information coming from bioinformatics and mol. modeling studies for the A2A receptor has made easier the understanding of ligand-target interaction and the rational design of agonists and antagonists for this subtype.  The aim of this review is to show an overview of the most significant steps and progresses in developing A2A adenosine receptor agonists and antagonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLD7b3gsaCZrVg90H21EOLACvtfcHk0lix_ep8z13PbA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXns1ymsrk%253D&md5=3b8c004d9a1fbff02c0a0ee1b476fcea</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.2174%2F138161208784480081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161208784480081%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DMarucci%26aufirst%3DG.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DDal%2BBen%26aufirst%3DD.%26atitle%3DA2A%2520adenosine%2520receptors%2520and%2520its%2520modulators%253A%2520overview%2520on%2520a%2520druggable%2520GPCR%2520and%2520on%2520SAR%2520analysis%2520and%2520binding%2520requirements%2520of%2520agonists%2520and%2520antagonists%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2008%26volume%3D14%26spage%3D1525%26epage%3D1552" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Jaakola, V.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffith, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherezov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chien, E. Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span> </span><span class="NLM_article-title">The 2.6 angstrom crystal structure of a human A<sub>2A</sub> adenosine receptor bound to an antagonist</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">1211</span><span class="NLM_x">â</span> <span class="NLM_lpage">1217</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1126%2Fscience.1164772" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=18832607" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtlyqtbfN" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2008&pages=1211-1217&author=V.-P.+Jaakolaauthor=M.+Griffithauthor=M.+A.+Hansonauthor=V.+Cherezovauthor=E.+Y.+T.+Chienauthor=J.+R.+Laneauthor=A.+P.+Ijzermanauthor=R.+C.+Stevens&title=The+2.6+angstrom+crystal+structure+of+a+human+A2A+adenosine+receptor+bound+to+an+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">The 2.6 Angstrom Crystal Structure of a Human A2A Adenosine Receptor Bound to an Antagonist</span></div><div class="casAuthors">Jaakola, Veli-Pekka; Griffith, Mark T.; Hanson, Michael A.; Cherezov, Vadim; Chien, Ellen Y. T.; Lane, J. Robert; IJzerman, Adriaan P.; Stevens, Raymond C.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">5905</span>),
    <span class="NLM_cas:pages">1211-1217</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The adenosine class of heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) mediates the important role of extracellular adenosine in many physiol. processes and is antagonized by caffeine.  The authors have detd. the crystal structure of the human A2A adenosine receptor, in complex with a high-affinity subtype-selective antagonist, ZM241385, to 2.6 angstrom resoln.  Four disulfide bridges in the extracellular domain, combined with a subtle repacking of the transmembrane helixes relative to the adrenergic and rhodopsin receptor structures, define a pocket distinct from that of other structurally detd. GPCRs.  The arrangement allows for the binding of the antagonist in an extended conformation, perpendicular to the membrane plane.  The binding site highlights an integral role for the extracellular loops, together with the helical core, in ligand recognition by this class of GPCRs and suggests a role for ZM241385 in restricting the movement of a tryptophan residue important in the activation mechanism of the class A receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7QL4wN4TdhrVg90H21EOLACvtfcHk0lix_ep8z13PbA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtlyqtbfN&md5=5bdb862b41f345c244f3c162e058206b</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1126%2Fscience.1164772&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1164772%26sid%3Dliteratum%253Aachs%26aulast%3DJaakola%26aufirst%3DV.-P.%26aulast%3DGriffith%26aufirst%3DM.%26aulast%3DHanson%26aufirst%3DM.%2BA.%26aulast%3DCherezov%26aufirst%3DV.%26aulast%3DChien%26aufirst%3DE.%2BY.%2BT.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26atitle%3DThe%25202.6%2520angstrom%2520crystal%2520structure%2520of%2520a%2520human%2520A2A%2520adenosine%2520receptor%2520bound%2520to%2520an%2520antagonist%26jtitle%3DScience%26date%3D2008%26volume%3D322%26spage%3D1211%26epage%3D1217" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Lebon, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warne, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leslie, A. G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tate, C. G.</span><span> </span><span class="NLM_article-title">Agonist-bound adenosine A<sub>2A</sub> receptor structures reveal common features of GPCR activation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">474</span><span class="NLM_x">, </span> <span class="NLM_fpage">521</span><span class="NLM_x">â</span> <span class="NLM_lpage">525</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1038%2Fnature10136" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=21593763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsFyqsrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=474&publication_year=2011&pages=521-525&author=G.+Lebonauthor=T.+Warneauthor=P.+C.+Edwardsauthor=K.+Bennettauthor=C.+J.+Langmeadauthor=A.+G.+W.+Leslieauthor=C.+G.+Tate&title=Agonist-bound+adenosine+A2A+receptor+structures+reveal+common+features+of+GPCR+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation</span></div><div class="casAuthors">Lebon, Guillaume; Warne, Tony; Edwards, Patricia C.; Bennett, Kirstie; Langmead, Christopher J.; Leslie, Andrew G. W.; Tate, Christopher G.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">474</span>
        (<span class="NLM_cas:issue">7352</span>),
    <span class="NLM_cas:pages">521-525</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Adenosine receptors and Î²-adrenoceptors are G-protein-coupled receptors (GPCRs) that activate intracellular G proteins on binding the agonists adenosine or noradrenaline, resp.  GPCRs have similar structures consisting of seven transmembrane helixes that contain well-conserved sequence motifs, indicating that they are probably activated by a common mechanism.  Recent structures of Î²-adrenoceptors highlight residues in transmembrane region 5 that initially bind specifically to agonists rather than to antagonists, indicating that these residues have an important role in agonist-induced activation of receptors.  Here we present two crystal structures of the thermostabilized human adenosine A2A receptor (A2AR-GL31) bound to its endogenous agonist adenosine and the synthetic agonist NECA.  The structures represent an intermediate conformation between the inactive and active states, because they share all the features of GPCRs that are thought to be in a fully activated state, except that the cytoplasmic end of transmembrane helix 6 partially occludes the G-protein-binding site.  The adenine substituent of the agonists binds in a similar fashion to the chem. related region of the inverse agonist ZM241385 (ref. 8).  Both agonists contain a ribose group, not found in ZM241385, which extends deep into the ligand-binding pocket where it makes polar interactions with conserved residues in H7 (Ser 2777.42 and His 2787.43; superscripts refer to Ballesteros-Weinstein numbering) and non-polar interactions with residues in H3.  In contrast, the inverse agonist ZM241385 does not interact with any of these residues and comparison with the agonist-bound structures indicates that ZM241385 sterically prevents the conformational change in H5 and therefore it acts as an inverse agonist.  Comparison of the agonist-bound structures of A2AR with the agonist-bound structures of Î²-adrenoceptors indicates that the contraction of the ligand-binding pocket caused by the inward motion of helixes 3, 5 and 7 may be a common feature in the activation of all GPCRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1rCKkCsE9CrVg90H21EOLACvtfcHk0lix_ep8z13PbA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsFyqsrg%253D&md5=1b8161216b878db48ad33d7e8e007dc7</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1038%2Fnature10136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10136%26sid%3Dliteratum%253Aachs%26aulast%3DLebon%26aufirst%3DG.%26aulast%3DWarne%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DP.%2BC.%26aulast%3DBennett%26aufirst%3DK.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DLeslie%26aufirst%3DA.%2BG.%2BW.%26aulast%3DTate%26aufirst%3DC.%2BG.%26atitle%3DAgonist-bound%2520adenosine%2520A2A%2520receptor%2520structures%2520reveal%2520common%2520features%2520of%2520GPCR%2520activation%26jtitle%3DNature%26date%3D2011%26volume%3D474%26spage%3D521%26epage%3D525" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Zhukov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Errey, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span> </span><span class="NLM_article-title">Biophysical mapping of the adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">4312</span><span class="NLM_x">â</span> <span class="NLM_lpage">4323</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm2003798" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4312-4323&issue=13&author=A.+Zhukovauthor=S.+P.+Andrewsauthor=J.+C.+Erreyauthor=N.+Robertsonauthor=B.+Tehanauthor=J.+S.+Masonauthor=F.+H.+Marshallauthor=M.+Weirauthor=M.+Congreve&title=Biophysical+mapping+of+the+adenosine+A2A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57a&amp;dbid=16384&amp;doi=10.1021%2Fjm2003798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2003798%26sid%3Dliteratum%253Aachs%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DRobertson%26aufirst%3DN.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DCongreve%26aufirst%3DM.%26atitle%3DBiophysical%2520mapping%2520of%2520the%2520adenosine%2520A2A%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26issue%3D13%26spage%3D4312%26epage%3D4323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit57b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Yasuda, M.; Harada, H.; Miyazawa, S.; Kobayashi, S.; Harada, K.; Hida, T.; Shibata, H.; Yasuda, N.; Asano, O.; Kotake, Y.</span><span> </span><span class="NLM_article-title">Pharmaceutical Composition Promoting Defecation</span>. U.S. Pat. Appl. Publ. US20060270674 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=M.+Yasuda&author=H.+Harada&author=S.+Miyazawa&author=S.+Kobayashi&author=K.+Harada&author=T.+Hida&author=H.+Shibata&author=N.+Yasuda&author=O.+Asano&author=Y.+Kotake&title=Pharmaceutical+Composition+Promoting+Defecation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYasuda%26aufirst%3DM.%26atitle%3DPharmaceutical%2520Composition%2520Promoting%2520Defecation%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Katritch, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaakola, V.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lane, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeager, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kufareva, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span> </span><span class="NLM_article-title">Structure-based discovery of novel chemotypes for adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1799</span><span class="NLM_x">â</span> <span class="NLM_lpage">1809</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901647p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3cXptlKqsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=1799-1809&author=V.+Katritchauthor=V.-P.+Jaakolaauthor=J.+R.+Laneauthor=J.+Linauthor=A.+P.+Ijzermanauthor=I.+K.+Yeagerauthor=I.+Kufarevaauthor=R.+C.+Stevensauthor=R.+Abagyan&title=Structure-based+discovery+of+novel+chemotypes+for+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of Novel Chemotypes for Adenosine A2A Receptor Antagonists</span></div><div class="casAuthors">Katritch, Vsevolod; Jaakola, Veli-Pekka; Lane, J. Robert; Lin, Judy; IJzerman, Adriaan P.; Yeager, Mark; Kufareva, Irina; Stevens, Raymond C.; Abagyan, Ruben</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1799-1809</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The recent progress in crystallog. of G-protein coupled receptors opens an unprecedented venue for structure-based GPCR drug discovery.  To test efficiency of the structure-based approach, we performed mol. docking and virtual ligand screening (VLS) of more than 4 million com. available "drug-like" and "lead-like" compds. against the A2AAR 2.6 Ã resoln. crystal structure.  Out of 56 high ranking compds. tested in A2AAR binding assays, 23 showed affinities under 10 Î¼M, 11 of those had sub-Î¼M affinities and two compds. had affinities under 60 nM.  The identified hits represent at least 9 different chem. scaffolds and are characterized by very high ligand efficiency (0.3-0.5 kcal/mol per heavy atom).  Significant A2AAR antagonist activities were confirmed for 10 out of 13 ligands tested in functional assays.  High success rate, novelty, and diversity of the chem. scaffolds and strong ligand efficiency of the A2AAR antagonists identified in this study suggest practical applicability of receptor-based VLS in GPCR drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpX-YAwoEVzEbVg90H21EOLACvtfcHk0ljsK1ecIp757A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXptlKqsw%253D%253D&md5=5a54df43f6edd20d83e7e5942e2f9811</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1021%2Fjm901647p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901647p%26sid%3Dliteratum%253Aachs%26aulast%3DKatritch%26aufirst%3DV.%26aulast%3DJaakola%26aufirst%3DV.-P.%26aulast%3DLane%26aufirst%3DJ.%2BR.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DYeager%26aufirst%3DI.%2BK.%26aulast%3DKufareva%26aufirst%3DI.%26aulast%3DStevens%26aufirst%3DR.%2BC.%26aulast%3DAbagyan%26aufirst%3DR.%26atitle%3DStructure-based%2520discovery%2520of%2520novel%2520chemotypes%2520for%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D1799%26epage%3D1809" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Klotz, K.-N.</span><span> </span><span class="NLM_article-title">Adenosine receptors and their ligands</span> <span class="citation_source-journal">Naunyn-Schmiedebergâs Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">362</span><span class="NLM_x">, </span> <span class="NLM_fpage">382</span><span class="NLM_x">â</span> <span class="NLM_lpage">391</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2Fs002100000315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=11111832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotFCru7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=362&publication_year=2000&pages=382-391&author=K.-N.+Klotz&title=Adenosine+receptors+and+their+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors and their ligands</span></div><div class="casAuthors">Klotz, Karl-Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">362</span>
        (<span class="NLM_cas:issue">4-5</span>),
    <span class="NLM_cas:pages">382-391</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">A review with 65 refs.  The regulatory actions of adenosine are mediated via four subtypes of G protein-coupled receptors distinguished as A1, A2A, A2B and A3 receptors.  Their presence on basically every cell makes them an interesting target for the pharmacol. intervention in many pathophysiol. situations.  A large no. of ligands have been synthesized over the last two decades and provide agonists and antagonists that are more or less selective for the known receptor subtypes.  In addn., many radioligands are available in tritiated or radioiodinated form.  The comparative pharmacol. characterization of all four human adenosine receptor subtypes revealed that some of the compds. thought to be selective from data in other species have unexpected potencies at human receptors.  As a result, compds. that exhibit high affinity to only one subtype are an exception.  Although the selection of ligands is immense, it is less than satisfying for most subtypes of adenosine receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsGzhFkL72vbVg90H21EOLACvtfcHk0ljsK1ecIp757A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotFCru7Y%253D&md5=56b1c3ef50390d3c9bfc874da65baf58</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1007%2Fs002100000315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs002100000315%26sid%3Dliteratum%253Aachs%26aulast%3DKlotz%26aufirst%3DK.-N.%26atitle%3DAdenosine%2520receptors%2520and%2520their%2520ligands%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2000%26volume%3D362%26spage%3D382%26epage%3D391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taffi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of adenosine A<sub>2A</sub> receptor agonists</span> <span class="citation_source-journal">Curr. Top. Med. Chem. (Sharjah, United Arab Emirates)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">387</span><span class="NLM_x">â</span> <span class="NLM_lpage">401</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.2174%2F1568026033392282" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=12570757" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGjuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=387-401&author=G.+Cristalliauthor=C.+Lambertucciauthor=S.+Taffiauthor=S.+Vittoriauthor=R.+Volpini&title=Medicinal+chemistry+of+adenosine+A2A+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of adenosine A2A receptor agonists</span></div><div class="casAuthors">Cristalli, Gloria; Lambertucci, Catia; Taffi, Sara; Vittori, Sauro; Volpini, Rosaria</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">387-401</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The search for potent and selective A2A adenosine receptor agonists has been particularly fruitful in the early nineties.  A series of 2-amino, 2-alkoxy, 2-alkythio-, 2-alkynyl-, and 2-alkenyl-derivs. of adenosine (Ado, 1) and N-ethylcarboxamidoadenosine (NECA, 30) have been synthesized and tested mainly on different model of rat A1 and A2A receptor subtypes.  From these studies some ligands, such as CGS 21680 (33), HENECA (42), and (S)-PHPNECA (46b), showed to possess high A2A affinity combined with good A2A vs A1 selectivity.  More detailed characterization of these ligands at the four cloned human adenosine receptor subtypes revealed that none of the prototypical adenosine receptor agonists exhibits at the same time high affinity and selectivity for the human A2AAR subtype.  Both NECA and CGS 21680, which are available as radioligands for this subtype, have lower affinity at human than at rat receptor.  The 2-alkynylNECA derivs. HENECA an PHPNECA showed high affinity also at human A3 receptors.  In particular, (S)-PHPNECA displayed Kis in the low nanomolar range at A1, A2A, and A3 subtypes and an EC50 of 220 nM at human A2B receptor.  It is now well known that the coronary vasodilation induced by Ado in different species is mediated by activation of A2AAR and a compd. capable of producing coronary vasodilation through activation of A2AAR, but that is devoid of A1-and A3-agonist activity would have advantage over Ado for use in myocardial perfusion imaging studies.  Other potential therapeutic applications of selective A2AAR agonists are as anti-aggregatory, anti-inflammatory, anti-psychotic, and anti-Huntington's disease agents.  This review is aimed at presenting a complete overview of the medicinal chem. development of A2A adenosine receptor agonists and at stressing the strong need for more selective ligands at A2A human subtype.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGotZ9WytCwyQLVg90H21EOLACvtfcHk0ljsK1ecIp757A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGjuw%253D%253D&md5=4d2aef4b8cb3f1f30efe8d4f839e01d1</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.2174%2F1568026033392282&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392282%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DTaffi%26aufirst%3DS.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DVolpini%26aufirst%3DR.%26atitle%3DMedicinal%2520chemistry%2520of%2520adenosine%2520A2A%2520receptor%2520agonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%2520%2528Sharjah%252C%2520United%2520Arab%2520Emirates%2529%26date%3D2003%26volume%3D3%26spage%3D387%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span> </span><span class="NLM_article-title">Recent developments in adenosine A<sub>2A</sub> receptor ligands</span> <span class="citation_source-journal">Handb. Exp. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">193</span><span class="NLM_x">, </span> <span class="NLM_fpage">59</span><span class="NLM_x">â</span> <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2F978-3-540-89615-9_3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=19639279" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr7E" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=193&publication_year=2009&pages=59-98&author=G.+Cristalliauthor=C.+E.+Mullerauthor=R.+Volpini&title=Recent+developments+in+adenosine+A2A+receptor+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in adenosine A2A receptor ligands</span></div><div class="casAuthors">Cristalli, Gloria; Muller, Christa E.; Volpini, Rosaria</div><div class="citationInfo"><span class="NLM_cas:title">Handbook of Experimental Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">193</span>
        (<span class="NLM_cas:issue">Adenosine Receptors in Health and Disease</span>),
    <span class="NLM_cas:pages">59-98</span>CODEN:
                <span class="NLM_cas:coden">HEPHD2</span>;
        ISSN:<span class="NLM_cas:issn">0171-2004</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  The development of potent and selective agonists and antagonists of adenosine receptors (ARs) has been a target of medicinal chem. research for several decades, and recently the US Food and Drug Administration has approved Lexiscan, an adenosine deriv. substituted at the 2 position, for use as a pharmacol. stress agent in radionuclide myocardial perfusion imaging.  Currently, some other adenosine A2A receptor (A2AAR) agonists and antagonists are undergoing preclin. testing and clin. trials.  While agonists are potent antiinflammatory agents also showing hypotensive effects, antagonists are being developed for the treatment of Parkinson's disease.  However, since there are still major problems in this field, including side effects, low brain penetration (for the targeting of CNS diseases), short half-life, or lack of in vivo effects, the design and development of new AR ligands is a hot research topic.  This review presents an update on the medicinal chem. of A2AAR agonists and antagonists, and stresses the strong need for more selective ligands at the human A2AAR subtype, in particular in the case of agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZlneM0HaH4rVg90H21EOLACvtfcHk0lhJBYXS1sYrjQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1Sktr7E&md5=95c3e8fde30c9094d81cea882987ae64</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1007%2F978-3-540-89615-9_3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-540-89615-9_3%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DMuller%26aufirst%3DC.%2BE.%26aulast%3DVolpini%26aufirst%3DR.%26atitle%3DRecent%2520developments%2520in%2520adenosine%2520A2A%2520receptor%2520ligands%26jtitle%3DHandb.%2520Exp.%2520Pharmacol.%26date%3D2009%26volume%3D193%26spage%3D59%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Mueller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Recent developments in adenosine receptor ligands and their potential as novel drugs</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Biomembr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1808</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1290</span><span class="NLM_x">â</span> <span class="NLM_lpage">1308</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.bbamem.2010.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=21185259" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXjvFSrsr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1808&publication_year=2011&pages=1290-1308&issue=5&author=C.+E.+Muellerauthor=K.+A.+Jacobson&title=Recent+developments+in+adenosine+receptor+ligands+and+their+potential+as+novel+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Recent developments in adenosine receptor ligands and their potential as novel drugs</span></div><div class="casAuthors">Mueller, Christa E.; Jacobson, Kenneth A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Biomembranes</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1808</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1290-1308</span>CODEN:
                <span class="NLM_cas:coden">BBBMBS</span>;
        ISSN:<span class="NLM_cas:issn">0005-2736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Medicinal chem. approaches have been applied to all four of the adenosine receptor (AR) subtypes (A1, A2A, A2B, and A3) to create selective agonists and antagonists for each.  The most recent class of selective AR ligands to be reported is the class of A2BAR agonists.  The availability of these selective ligands has facilitated research on therapeutic applications of modulating the ARs and in some cases has provided clin. candidates.  Prodrug approaches have been developed which improve the bioavailability of the drugs, reduce side-effects, and/or may lead to site-selective effects.  The A2A agonist regadenoson (Lexiscan), a diagnostic drug for myocardial perfusion imaging, is the first selective AR agonist to be approved.  Other selective agonists and antagonists are or were undergoing clin. trials for a broad range of indications, including capadenoson and tecadenoson (A1 agonists) for atrial fibrillation, or paroxysmal supraventricular tachycardia, resp., apadenoson and binodenoson (A2A agonists) for myocardial perfusion imaging, preladenant (A2A antagonist) for the treatment of Parkinson's disease, and CF101 and CF102 (A3 agonists) for inflammatory diseases and cancer, resp.  This article is part of a Special Issue entitled: "Adenosine Receptors".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY8Cuch7XkT7Vg90H21EOLACvtfcHk0lhJBYXS1sYrjQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXjvFSrsr8%253D&md5=f143d2424c178c0a75e956ffb6b8320a</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamem.2010.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamem.2010.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DMueller%26aufirst%3DC.%2BE.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DRecent%2520developments%2520in%2520adenosine%2520receptor%2520ligands%2520and%2520their%2520potential%2520as%2520novel%2520drugs%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Biomembr.%26date%3D2011%26volume%3D1808%26issue%3D5%26spage%3D1290%26epage%3D1308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Siddiqi, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Esker, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olah, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ji, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melman, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tiwari, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secrist Iii, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schneller, S. W.</span><span> </span><span class="NLM_article-title">Search for new purine-and ribose-modified adenosine analogs as selective agonists and antagonists at adenosine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1174</span><span class="NLM_x">â</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00007a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=1174-1188&author=S.+M.+Siddiqiauthor=K.+A.+Jacobsonauthor=J.+L.+Eskerauthor=M.+E.+Olahauthor=X.+Jiauthor=N.+Melmanauthor=K.+N.+Tiwariauthor=J.+A.+Secrist+Iiiauthor=S.+W.+Schneller&title=Search+for+new+purine-and+ribose-modified+adenosine+analogs+as+selective+agonists+and+antagonists+at+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm00007a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00007a014%26sid%3Dliteratum%253Aachs%26aulast%3DSiddiqi%26aufirst%3DS.%2BM.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DEsker%26aufirst%3DJ.%2BL.%26aulast%3DOlah%26aufirst%3DM.%2BE.%26aulast%3DJi%26aufirst%3DX.%26aulast%3DMelman%26aufirst%3DN.%26aulast%3DTiwari%26aufirst%3DK.%2BN.%26aulast%3DSecrist%2BIii%26aufirst%3DJ.%2BA.%26aulast%3DSchneller%26aufirst%3DS.%2BW.%26atitle%3DSearch%2520for%2520new%2520purine-and%2520ribose-modified%2520adenosine%2520analogs%2520as%2520selective%2520agonists%2520and%2520antagonists%2520at%2520adenosine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D1174%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Yan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burbiel, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maass, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, C. E.</span><span> </span><span class="NLM_article-title">Adenosine receptor agonists: from basic medicinal chemistry to clinical development</span> <span class="citation_source-journal">Expert Opin. Emerging Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">â</span> <span class="NLM_lpage">576</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1517%2F14728214.8.2.537" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=14662005" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFOqug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=537-576&author=L.+Yanauthor=J.+C.+Burbielauthor=A.+Maassauthor=C.+E.+Mueller&title=Adenosine+receptor+agonists%3A+from+basic+medicinal+chemistry+to+clinical+development"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptor agonists: from basic medicinal chemistry to clinical development</span></div><div class="casAuthors">Yan, Luo; Burbiel, Joachim C.; Maass, Astrid; Mueller, Christa E.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Emerging Drugs</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">537-576</span>CODEN:
                <span class="NLM_cas:coden">EOEDA3</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Adenosine is a physiol. nucleoside which acts as an autocoid and activates G protein-coupled membrane receptors, designated A1, A2A, A2B and A3.  Adenosine plays an important role in many (patho)physiol. conditions in the CNS as well as in peripheral organs and tissues.  Adenosine receptors are present on virtually every cell.  However, receptor subtype distribution and densities vary greatly.  Adenosine itself is used as a therapeutic agent for the treatment of supraventricular paroxysmal tachycardia and arrhythmias and as a vasodilatatory agent in cardiac imaging.  During the past 20 yr, a no. of selective agonists for A1, A2A and A3 adenosine receptors have been developed, all of them structurally derived from adenosine.  Several such compds. are currently undergoing clin. trials for the treatment of cardiovascular diseases (A1 and A2A), pain (A1), wound healing (A2A), diabetic foot ulcers (A2A), colorectal cancer (A3) and rheumatoid arthritis (A3).  Clin. evaluation of some A1, and A2A adenosine receptor agonists has been discontinued.  Major problems include side effects due to the wide distribution of adenosine receptors; low brain penetration, which is important for the targeting of CNS diseases; short half-lives of compds.; or a lack of effects, in some cases perhaps due to receptor desensitization or to low receptor d. in the targeted tissue.  Partial agonists, inhibitors of adenosine metab. (adenosine kinase and deaminase inhibitors) or allosteric activators of adenosine receptors may be advantageous for certain indications, as they may exhibit fewer side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCnhX_DnCYs7Vg90H21EOLACvtfcHk0lhJBYXS1sYrjQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFOqug%253D%253D&md5=d695e919750ae509a9e7a7b87c108382</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1517%2F14728214.8.2.537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728214.8.2.537%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DL.%26aulast%3DBurbiel%26aufirst%3DJ.%2BC.%26aulast%3DMaass%26aufirst%3DA.%26aulast%3DMueller%26aufirst%3DC.%2BE.%26atitle%3DAdenosine%2520receptor%2520agonists%253A%2520from%2520basic%2520medicinal%2520chemistry%2520to%2520clinical%2520development%26jtitle%3DExpert%2520Opin.%2520Emerging%2520Drugs%26date%3D2003%26volume%3D8%26spage%3D537%26epage%3D576" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">van Tilburg, E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gremmen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Frijtag Drabbe KÃ¼nzel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Groote, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">2,8-Disubstituted adenosine derivatives as partial agonists for the adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">2183</span><span class="NLM_x">â</span> <span class="NLM_lpage">2192</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2003&pages=2183-2192&author=E.+W.+van+Tilburgauthor=M.+Gremmenauthor=J.+von+Frijtag+Drabbe+K%C3%BCnzelauthor=M.+de+Grooteauthor=A.+P.+Ijzerman&title=2%2C8-Disubstituted+adenosine+derivatives+as+partial+agonists+for+the+adenosine+A2A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2BTilburg%26aufirst%3DE.%2BW.%26aulast%3DGremmen%26aufirst%3DM.%26aulast%3Dvon%2BFrijtag%2BDrabbe%2BK%25C3%25BCnzel%26aufirst%3DJ.%26aulast%3Dde%2BGroote%26aufirst%3DM.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3D2%252C8-Disubstituted%2520adenosine%2520derivatives%2520as%2520partial%2520agonists%2520for%2520the%2520adenosine%2520A2A%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2003%26volume%3D11%26spage%3D2183%26epage%3D2192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Prasad, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bariana, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fung, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savic, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tietje, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stein, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brondyk, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Egan, R. S.</span><span> </span><span class="NLM_article-title">Modification of the 5â²position of purine nucleosides. 2. Synthesis and some cardiovascular properties of adenosine-5â²-(N-substituted) carboxamides</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">313</span><span class="NLM_x">â</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00177a021" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=1980&pages=313-319&author=R.+N.+Prasadauthor=D.+S.+Barianaauthor=A.+Fungauthor=M.+Savicauthor=K.+Tietjeauthor=H.+H.+Steinauthor=H.+Brondykauthor=R.+S.+Egan&title=Modification+of+the+5%E2%80%B2position+of+purine+nucleosides.+2.+Synthesis+and+some+cardiovascular+properties+of+adenosine-5%E2%80%B2-%28N-substituted%29+carboxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1021%2Fjm00177a021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00177a021%26sid%3Dliteratum%253Aachs%26aulast%3DPrasad%26aufirst%3DR.%2BN.%26aulast%3DBariana%26aufirst%3DD.%2BS.%26aulast%3DFung%26aufirst%3DA.%26aulast%3DSavic%26aufirst%3DM.%26aulast%3DTietje%26aufirst%3DK.%26aulast%3DStein%26aufirst%3DH.%2BH.%26aulast%3DBrondyk%26aufirst%3DH.%26aulast%3DEgan%26aufirst%3DR.%2BS.%26atitle%3DModification%2520of%2520the%25205%25E2%2580%25B2position%2520of%2520purine%2520nucleosides.%25202.%2520Synthesis%2520and%2520some%2520cardiovascular%2520properties%2520of%2520adenosine-5%25E2%2580%25B2-%2528N-substituted%2529%2520carboxamides%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1980%26volume%3D23%26spage%3D313%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccomanni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span> </span><span class="NLM_article-title">Adenosine receptor modelling. A<sub>1</sub>/A<sub>2A</sub> selectivity</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">321</span><span class="NLM_x">â</span> <span class="NLM_lpage">329</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=321-329&author=T.+Tuccinardiauthor=G.+Ortoreauthor=C.+Maneraauthor=G.+Saccomanniauthor=A.+Martinelli&title=Adenosine+receptor+modelling.+A1%2FA2A+selectivity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DOrtore%26aufirst%3DG.%26aulast%3DManera%26aufirst%3DC.%26aulast%3DSaccomanni%26aufirst%3DG.%26aulast%3DMartinelli%26aufirst%3DA.%26atitle%3DAdenosine%2520receptor%2520modelling.%2520A1%252FA2A%2520selectivity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D321%26epage%3D329" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">de Zwart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kourounakis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooijman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spek, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Frijtag Drabbe KÃ¼nzel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">5â²-N-substituted carboxamidoadenosines as agonists for adenosine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1384</span><span class="NLM_x">â</span> <span class="NLM_lpage">1392</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9804984" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1999&pages=1384-1392&author=M.+de+Zwartauthor=A.+Kourounakisauthor=H.+Kooijmanauthor=A.+L.+Spekauthor=R.+Linkauthor=J.+K.+von+Frijtag+Drabbe+K%C3%BCnzelauthor=A.+P.+Ijzerman&title=5%E2%80%B2-N-substituted+carboxamidoadenosines+as+agonists+for+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm9804984&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9804984%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BZwart%26aufirst%3DM.%26aulast%3DKourounakis%26aufirst%3DA.%26aulast%3DKooijman%26aufirst%3DH.%26aulast%3DSpek%26aufirst%3DA.%2BL.%26aulast%3DLink%26aufirst%3DR.%26aulast%3Dvon%2BFrijtag%2BDrabbe%2BK%25C3%25BCnzel%26aufirst%3DJ.%2BK.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3D5%25E2%2580%25B2-N-substituted%2520carboxamidoadenosines%2520as%2520agonists%2520for%2520adenosine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1999%26volume%3D42%26spage%3D1384%26epage%3D1392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eleuteri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohse, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K. N.</span><span> </span><span class="NLM_article-title">2-Alkynyl derivatives of adenosine and adenosine-5â²-<i>N</i>-ethyluronamide as selective agonists at A<sub>2</sub> adenosine receptors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">2363</span><span class="NLM_x">â</span> <span class="NLM_lpage">2368</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00091a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=2363-2368&author=G.+Cristalliauthor=A.+Eleuteriauthor=S.+Vittoriauthor=R.+Volpiniauthor=M.+J.+Lohseauthor=K.+N.+Klotz&title=2-Alkynyl+derivatives+of+adenosine+and+adenosine-5%E2%80%B2-N-ethyluronamide+as+selective+agonists+at+A2+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm00091a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00091a003%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DEleuteri%26aufirst%3DA.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DLohse%26aufirst%3DM.%2BJ.%26aulast%3DKlotz%26aufirst%3DK.%2BN.%26atitle%3D2-Alkynyl%2520derivatives%2520of%2520adenosine%2520and%2520adenosine-5%25E2%2580%25B2-N-ethyluronamide%2520as%2520selective%2520agonists%2520at%2520A2%2520adenosine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D2363%26epage%3D2368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Mantell, S.-J.; Stephenson, P.-T.</span><span> </span><span class="NLM_article-title">Purine Derivatives </span>. PCT Int. Appl. Publ. WO2002022630 A1,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=S.-J.+Mantell&author=P.-T.+Stephenson&title=Purine+Derivatives+"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMantell%26aufirst%3DS.-J.%26atitle%3DPurine%2520Derivatives%2520%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">de Zwart, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Link, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Frijtag Drabbe KÃ¼nzel, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Townsend-Nicholson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">A functional screening of adenosine analogs at the adenosine A<sub>2B</sub> receptor: a search for potent agonists</span> <span class="citation_source-journal">Nucleosides Nucleotides</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">969</span><span class="NLM_x">â</span> <span class="NLM_lpage">985</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1080%2F07328319808004215" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9708319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1cXjt12ju7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=1998&pages=969-985&author=M.+de+Zwartauthor=R.+Linkauthor=J.+K.+von+Frijtag+Drabbe+K%C3%BCnzelauthor=G.+Cristalliauthor=K.+A.+Jacobsonauthor=A.+Townsend-Nicholsonauthor=A.+P.+Ijzerman&title=A+functional+screening+of+adenosine+analogs+at+the+adenosine+A2B+receptor%3A+a+search+for+potent+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">A functional screening of adenosine analogs at the adenosine A2B receptor: a search for potent agonists</span></div><div class="casAuthors">De Zwart, Maarten; Link, Regina; Von Frijtag Drabbe Kunzel, Jacobien K.; Cristalli, Gloria; Jacobson, Kenneth A.; Townsend-Nicholson, Andrea; Ijzerman, Ad P.</div><div class="citationInfo"><span class="NLM_cas:title">Nucleosides & Nucleotides</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">969-985</span>CODEN:
                <span class="NLM_cas:coden">NUNUD5</span>;
        ISSN:<span class="NLM_cas:issn">0732-8311</span>.
    
            (<span class="NLM_cas:orgname">Marcel Dekker, Inc.</span>)
        </div><div class="casAbstract">Various adenosine analogs were tested at the adenosine A2B receptor.  Agonist potencies were detd. by measuring the cAMP prodn. in Chinese Hamster Ovary cells expressing human A2B receptors.  5'-N-Substituted carboxamidoadenosines were most potent.  5'-N-Ethylcarboxamidoadenosine (NECA) was most active with an EC50 value of 3.1 Î¼M.  Other ribose modified derivs. displayed low to negligible activity.  Potency was reduced by substitution on the exocyclic amino function (N6) of the purine ring system.  The most active N6-substituted deriv. N6-methyl-NECA was 5 fold less potent than NECA.  C8- and most C2-substituted analogs were virtually inactive.  1-Deaza-analogs had a reduced potency, 3- and 7- deazaanalogues were not active.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3wpgJtobi6LVg90H21EOLACvtfcHk0liRZim2m16Aug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjt12ju7s%253D&md5=0cb26d515a13257b6309e3d5e6a146e9</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1080%2F07328319808004215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F07328319808004215%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BZwart%26aufirst%3DM.%26aulast%3DLink%26aufirst%3DR.%26aulast%3Dvon%2BFrijtag%2BDrabbe%2BK%25C3%25BCnzel%26aufirst%3DJ.%2BK.%26aulast%3DCristalli%26aufirst%3DG.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DTownsend-Nicholson%26aufirst%3DA.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DA%2520functional%2520screening%2520of%2520adenosine%2520analogs%2520at%2520the%2520adenosine%2520A2B%2520receptor%253A%2520a%2520search%2520for%2520potent%2520agonists%26jtitle%3DNucleosides%2520Nucleotides%26date%3D1998%26volume%3D17%26spage%3D969%26epage%3D985" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Daly, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padgett, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Secunda, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R. A.</span><span> </span><span class="NLM_article-title">Structureâactivity relationships for 2-substituted adenosines at A<sub>1</sub> and A<sub>2</sub> adenosine receptors</span> <span class="citation_source-journal">Pharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">91</span><span class="NLM_x">â</span> <span class="NLM_lpage">100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1993&pages=91-100&author=J.+W.+Dalyauthor=W.+L.+Padgettauthor=S.+I.+Secundaauthor=R.+D.+Thompsonauthor=R.+A.+Olsson&title=Structure%E2%80%93activity+relationships+for+2-substituted+adenosines+at+A1+and+A2+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26aulast%3DPadgett%26aufirst%3DW.%2BL.%26aulast%3DSecunda%26aufirst%3DS.%2BI.%26aulast%3DThompson%26aufirst%3DR.%2BD.%26aulast%3DOlsson%26aufirst%3DR.%2BA.%26atitle%3DStructure%25E2%2580%2593activity%2520relationships%2520for%25202-substituted%2520adenosines%2520at%2520A1%2520and%2520A2%2520adenosine%2520receptors%26jtitle%3DPharmacology%26date%3D1993%26volume%3D46%26spage%3D91%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">Matova, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nacheva, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boicheva, S.</span><span> </span><span class="NLM_article-title">QSAR analysis of 2-alkyloxy and 2-aralkyloxy adenosine A<sub>1</sub> and A<sub>2</sub> agonists</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">505</span><span class="NLM_x">â</span> <span class="NLM_lpage">513</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1997&pages=505-513&author=M.+Matovaauthor=R.+Nachevaauthor=S.+Boicheva&title=QSAR+analysis+of+2-alkyloxy+and+2-aralkyloxy+adenosine+A1+and+A2+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatova%26aufirst%3DM.%26aulast%3DNacheva%26aufirst%3DR.%26aulast%3DBoicheva%26aufirst%3DS.%26atitle%3DQSAR%2520analysis%2520of%25202-alkyloxy%2520and%25202-aralkyloxy%2520adenosine%2520A1%2520and%2520A2%2520agonists%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D1997%26volume%3D32%26spage%3D505%26epage%3D513" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Hasan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hussain, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mustafa, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Srivastava, P. C.</span><span> </span><span class="NLM_article-title">2-Substituted thioadenine nucleoside and nucleotide analogs: synthesis and receptor subtype binding affinities</span> <span class="citation_source-journal">Bioconjugate Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">364</span><span class="NLM_x">â</span> <span class="NLM_lpage">369</span></span><div class="citationLinks">[<a href="/doi/10.1021/bc00028a014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK2cXkslejtL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1994&pages=364-369&author=A.+Hasanauthor=T.+Hussainauthor=S.+J.+Mustafaauthor=P.+C.+Srivastava&title=2-Substituted+thioadenine+nucleoside+and+nucleotide+analogs%3A+synthesis+and+receptor+subtype+binding+affinities"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted Thioadenine Nucleoside and Nucleotide Analogs: Synthesis and Receptor Subtype Binding Affinities</span></div><div class="casAuthors">Hasan, Ahmad; Hussain, Tahir; Mustafa, S. Jamal; Srivastava, Prem C.</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">364-9</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    </div><div class="casAbstract">The design, synthesis, and receptor subtype binding affinities of several 2-substituted thioadenosine nucleoside and nucleotide analogs are described.  The analogs were evaluated for their affinities toward A1 and A2 adenosine receptors in rat brain cortex and striatum, resp. using [3H]DPCPX and [3H]CGS 21680 as ligands.  Four of the nucleotide analogs inhibited binding of [3H]DPCPX by 10-20% and of [3H]CGS 21680 by 40-50% at a concn. of 100 Î¼M suggesting weak affinity toward adenosine receptors.  Six of the nucleoside analogs inhibited the A2 receptor binding of [3H]CGS 21680 with Ki values of 1.2-3.67Î¼M, while A1 receptor binding of [3H]DPCPX was inhibited with Ki values 10-17 Î¼M.  The A1/A2 ratios suggest 4-8-fold A2 receptor selectivity.  Obsd. binding affinities indicate that introduction of the S atom at the C-2 position of adenine does not contribute toward the affinity or selectivity of these compds.  However, the presence of a hydrophobic group at the C-2 position appears to increase the A2 receptor selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCmoulkjC0_7Vg90H21EOLACvtfcHk0liStH_ke2fotQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkslejtL0%253D&md5=12963518bb296a1deeb72dfd3c58f1ba</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1021%2Fbc00028a014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbc00028a014%26sid%3Dliteratum%253Aachs%26aulast%3DHasan%26aufirst%3DA.%26aulast%3DHussain%26aufirst%3DT.%26aulast%3DMustafa%26aufirst%3DS.%2BJ.%26aulast%3DSrivastava%26aufirst%3DP.%2BC.%26atitle%3D2-Substituted%2520thioadenine%2520nucleoside%2520and%2520nucleotide%2520analogs%253A%2520synthesis%2520and%2520receptor%2520subtype%2520binding%2520affinities%26jtitle%3DBioconjugate%2520Chem.%26date%3D1994%26volume%3D5%26spage%3D364%26epage%3D369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title">2-Thioether A<sub>2A</sub> Receptor Agonists</span>. PCT Int. Appl. Publ. WO2001062768A1,<span class="NLM_x"> </span><span class="NLM_year">2001</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&author=G.+Cristalli&title=2-Thioether+A2A+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3D2-Thioether%2520A2A%2520Receptor%2520Agonists%26date%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Francis, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Webb, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghai, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moskal, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeJesus, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokoyama, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovinski, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Contardo, N.</span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Highly selective adenosine A<sub>2</sub> receptor agonists in a series of N-alkylated 2-aminoadenosines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">2570</span><span class="NLM_x">â</span> <span class="NLM_lpage">2579</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00112a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1991&pages=2570-2579&author=J.+E.+Francisauthor=R.+L.+Webbauthor=G.+R.+Ghaiauthor=A.+J.+Hutchisonauthor=M.+A.+Moskalauthor=R.+DeJesusauthor=R.+Yokoyamaauthor=S.+L.+Rovinskiauthor=N.+Contardo&title=Highly+selective+adenosine+A2+receptor+agonists+in+a+series+of+N-alkylated+2-aminoadenosines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1021%2Fjm00112a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00112a035%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DJ.%2BE.%26aulast%3DWebb%26aufirst%3DR.%2BL.%26aulast%3DGhai%26aufirst%3DG.%2BR.%26aulast%3DHutchison%26aufirst%3DA.%2BJ.%26aulast%3DMoskal%26aufirst%3DM.%2BA.%26aulast%3DDeJesus%26aufirst%3DR.%26aulast%3DYokoyama%26aufirst%3DR.%26aulast%3DRovinski%26aufirst%3DS.%2BL.%26aulast%3DContardo%26aufirst%3DN.%26atitle%3DHighly%2520selective%2520adenosine%2520A2%2520receptor%2520agonists%2520in%2520a%2520series%2520of%2520N-alkylated%25202-aminoadenosines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1991%26volume%3D34%26spage%3D2570%26epage%3D2579" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Ohno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tchilibon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duong, H. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Modulation of adenosine receptor affinity and intrinsic efficacy in adenine nucleosides substituted at the 2-position</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2995</span><span class="NLM_x">â</span> <span class="NLM_lpage">3007</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2995-3007&author=M.+Ohnoauthor=Z.-G.+Gaoauthor=R.+P.+Vanauthor=S.+Tchilibonauthor=S.-K.+Kimauthor=B.+A.+Harrisauthor=A.+S.+Grossauthor=H.+T.+Duongauthor=C.+S.+Vanauthor=K.+A.+Jacobson&title=Modulation+of+adenosine+receptor+affinity+and+intrinsic+efficacy+in+adenine+nucleosides+substituted+at+the+2-position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOhno%26aufirst%3DM.%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DVan%26aufirst%3DR.%2BP.%26aulast%3DTchilibon%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DS.-K.%26aulast%3DHarris%26aufirst%3DB.%2BA.%26aulast%3DGross%26aufirst%3DA.%2BS.%26aulast%3DDuong%26aufirst%3DH.%2BT.%26aulast%3DVan%26aufirst%3DC.%2BS.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DModulation%2520of%2520adenosine%2520receptor%2520affinity%2520and%2520intrinsic%2520efficacy%2520in%2520adenine%2520nucleosides%2520substituted%2520at%2520the%25202-position%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D2995%26epage%3D3007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costanzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taffi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vittori, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title"><i>N</i>6-Alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A<sub>3</sub> receptor and a starting point for searching A<sub>2B</sub> ligands</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3271</span><span class="NLM_x">â</span> <span class="NLM_lpage">3279</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0109762" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=3271-3279&author=R.+Volpiniauthor=S.+Costanziauthor=C.+Lambertucciauthor=S.+Taffiauthor=S.+Vittoriauthor=K.-N.+Klotzauthor=G.+Cristalli&title=N6-Alkyl-2-alkynyl+derivatives+of+adenosine+as+potent+and+selective+agonists+at+the+human+adenosine+A3+receptor+and+a+starting+point+for+searching+A2B+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1021%2Fjm0109762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0109762%26sid%3Dliteratum%253Aachs%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DCostanzi%26aufirst%3DS.%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DTaffi%26aufirst%3DS.%26aulast%3DVittori%26aufirst%3DS.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3DN6-Alkyl-2-alkynyl%2520derivatives%2520of%2520adenosine%2520as%2520potent%2520and%2520selective%2520agonists%2520at%2520the%2520human%2520adenosine%2520A3%2520receptor%2520and%2520a%2520starting%2520point%2520for%2520searching%2520A2B%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D3271%26epage%3D3279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Niiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvia, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueeda, M.</span><span> </span><span class="NLM_article-title">2-(<i>N</i>â²-alkylidenehydrazino)adenosines: potent and selective coronary vasodilators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">4557</span><span class="NLM_x">â</span> <span class="NLM_lpage">4561</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00102a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=4557-4561&author=K.+Niiyaauthor=R.+A.+Olssonauthor=R.+D.+Thompsonauthor=S.+K.+Silviaauthor=M.+Ueeda&title=2-%28N%E2%80%B2-alkylidenehydrazino%29adenosines%3A+potent+and+selective+coronary+vasodilators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fjm00102a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00102a007%26sid%3Dliteratum%253Aachs%26aulast%3DNiiya%26aufirst%3DK.%26aulast%3DOlsson%26aufirst%3DR.%2BA.%26aulast%3DThompson%26aufirst%3DR.%2BD.%26aulast%3DSilvia%26aufirst%3DS.%2BK.%26aulast%3DUeeda%26aufirst%3DM.%26atitle%3D2-%2528N%25E2%2580%25B2-alkylidenehydrazino%2529adenosines%253A%2520potent%2520and%2520selective%2520coronary%2520vasodilators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D4557%26epage%3D4561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Niiya, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvia, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R. A.</span><span> </span><span class="NLM_article-title">2-(<i>N</i>â²-aralkylidenehydrazino)adenosines: potent and selective coronary vasodilators</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">4562</span><span class="NLM_x">â</span> <span class="NLM_lpage">4566</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00102a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=4562-4566&author=K.+Niiyaauthor=R.+D.+Thompsonauthor=S.+K.+Silviaauthor=R.+A.+Olsson&title=2-%28N%E2%80%B2-aralkylidenehydrazino%29adenosines%3A+potent+and+selective+coronary+vasodilators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1021%2Fjm00102a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00102a008%26sid%3Dliteratum%253Aachs%26aulast%3DNiiya%26aufirst%3DK.%26aulast%3DThompson%26aufirst%3DR.%2BD.%26aulast%3DSilvia%26aufirst%3DS.%2BK.%26aulast%3DOlsson%26aufirst%3DR.%2BA.%26atitle%3D2-%2528N%25E2%2580%25B2-aralkylidenehydrazino%2529adenosines%253A%2520potent%2520and%2520selective%2520coronary%2520vasodilators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D4562%26epage%3D4566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Viziano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conti, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seminati, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pocar, D.</span><span> </span><span class="NLM_article-title">2-[<i>N</i>â²-(3-Arylallylidene)hydrazino]adenosines showing A<sub>2A</sub> adenosine agonist properties and vasodilation activity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">3581</span><span class="NLM_x">â</span> <span class="NLM_lpage">3585</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00018a017" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1995&pages=3581-3585&author=M.+Vizianoauthor=E.+Onginiauthor=A.+Contiauthor=C.+Zocchiauthor=M.+Seminatiauthor=D.+Pocar&title=2-%5BN%E2%80%B2-%283-Arylallylidene%29hydrazino%5Dadenosines+showing+A2A+adenosine+agonist+properties+and+vasodilation+activity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1021%2Fjm00018a017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00018a017%26sid%3Dliteratum%253Aachs%26aulast%3DViziano%26aufirst%3DM.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DConti%26aufirst%3DA.%26aulast%3DZocchi%26aufirst%3DC.%26aulast%3DSeminati%26aufirst%3DM.%26aulast%3DPocar%26aufirst%3DD.%26atitle%3D2-%255BN%25E2%2580%25B2-%25283-Arylallylidene%2529hydrazino%255Dadenosines%2520showing%2520A2A%2520adenosine%2520agonist%2520properties%2520and%2520vasodilation%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1995%26volume%3D38%26spage%3D3581%26epage%3D3585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Daly, J. W.</span><span> </span><span class="NLM_article-title">Adenosine receptors: targets for future drugs</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1982</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">â</span> <span class="NLM_lpage">207</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00345a001" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=197-207&author=J.+W.+Daly&title=Adenosine+receptors%3A+targets+for+future+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Fjm00345a001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00345a001%26sid%3Dliteratum%253Aachs%26aulast%3DDaly%26aufirst%3DJ.%2BW.%26atitle%3DAdenosine%2520receptors%253A%2520targets%2520for%2520future%2520drugs%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26spage%3D197%26epage%3D207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J.</span><span> </span><span class="NLM_article-title">A<sub>1</sub> adenosine receptor agonists and their potential therapeutic applications</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">1901</span><span class="NLM_x">â</span> <span class="NLM_lpage">1910</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2008&pages=1901-1910&author=E.+Elzeinauthor=J.+Zablocki&title=A1+adenosine+receptor+agonists+and+their+potential+therapeutic+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DZablocki%26aufirst%3DJ.%26atitle%3DA1%2520adenosine%2520receptor%2520agonists%2520and%2520their%2520potential%2520therapeutic%2520applications%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2008%26volume%3D17%26spage%3D1901%26epage%3D1910" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Morrison, C. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, P. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquart, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palle, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenk, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varkhedkar, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fong, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lustig, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J. A.</span><span> </span><span class="NLM_article-title">Structureâaffinity relationships of 5â²-aromatic ethers and 5â²-aromatic sulfides as partial A<sub>1</sub> adenosine agonists, potential supraventricular anti-arrhythmic agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">3793</span><span class="NLM_x">â</span> <span class="NLM_lpage">3797</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3793-3797&author=C.+F.+Morrisonauthor=E.+Elzeinauthor=B.+Jiangauthor=P.+N.+Ibrahimauthor=T.+Marquartauthor=V.+Palleauthor=K.+D.+Shenkauthor=V.+Varkhedkarauthor=T.+Maaauthor=L.+Wuauthor=Y.+Wuauthor=D.+Zengauthor=I.+Fongauthor=D.+Lustigauthor=K.+Leungauthor=J.+A.+Zablocki&title=Structure%E2%80%93affinity+relationships+of+5%E2%80%B2-aromatic+ethers+and+5%E2%80%B2-aromatic+sulfides+as+partial+A1+adenosine+agonists%2C+potential+supraventricular+anti-arrhythmic+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMorrison%26aufirst%3DC.%2BF.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DJiang%26aufirst%3DB.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DMarquart%26aufirst%3DT.%26aulast%3DPalle%26aufirst%3DV.%26aulast%3DShenk%26aufirst%3DK.%2BD.%26aulast%3DVarkhedkar%26aufirst%3DV.%26aulast%3DMaa%26aufirst%3DT.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DWu%26aufirst%3DY.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DFong%26aufirst%3DI.%26aulast%3DLustig%26aufirst%3DD.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26atitle%3DStructure%25E2%2580%2593affinity%2520relationships%2520of%25205%25E2%2580%25B2-aromatic%2520ethers%2520and%25205%25E2%2580%25B2-aromatic%2520sulfides%2520as%2520partial%2520A1%2520adenosine%2520agonists%252C%2520potential%2520supraventricular%2520anti-arrhythmic%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D3793%26epage%3D3797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Brand, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klutz, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulte, G.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor dynamics studied with the novel fluorescent agonist Alexa488-APEC</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">590</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">â</span> <span class="NLM_lpage">42</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.ejphar.2008.05.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=18603240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpt1Kntbo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=590&publication_year=2008&pages=36-42&author=F.+Brandauthor=A.+M.+Klutzauthor=K.+A.+Jacobsonauthor=B.+B.+Fredholmauthor=G.+Schulte&title=Adenosine+A2A+receptor+dynamics+studied+with+the+novel+fluorescent+agonist+Alexa488-APEC"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A receptor dynamics studied with the novel fluorescent agonist Alexa488-APEC</span></div><div class="casAuthors">Brand, Frank; Klutz, Athena M.; Jacobson, Kenneth A.; Fredholm, Bertil B.; Schulte, Gunnar</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">590</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">36-42</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">G protein-coupled receptors, such as the adenosine A2A receptor, are dynamic proteins, which undergo agonist-dependent redistribution from the cell surface to intracellular membranous compartments, such as endosomes.  In order to study the kinetics of adenosine A2A receptor redistribution in living cells, we synthesized a novel fluorescent agonist, Alexa488-APEC.  Alexa488-APEC binds to adenosine A2A (Ki = 149 nM) as well as A3 receptors (Ki = 240 nM) but not to adenosine A1 receptors.  Further, we characterized the dose-dependent increase in Alexa488-APEC-induced cAMP prodn. as well as cAMP response element binding (CREB) protein phosphorylation, verifying the ligand's functionality at adenosine A2A but not A2B receptors.  In live-cell imaging studies, Alexa488-APEC-induced adenosine A2A receptor internalization, which was blocked by the competitive reversible antagonist ZM 241385 and hyperosmolaric sucrose.  Further, internalized adenosine A2A receptors colocalized with clathrin and Rab5, indicating that agonist stimulation promotes adenosine A2A receptor uptake through a clathrin-dependent mechanism to Rab5-pos. endosomes.  The basic characterization of Alexa488-APEC described here showed that it provides a useful tool for tracing adenosine A2A receptors in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqLrhh1rC3xF7Vg90H21EOLACvtfcHk0lhfT3hkTyVvCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpt1Kntbo%253D&md5=70669d999975108a80e1448081265331</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2008.05.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2008.05.036%26sid%3Dliteratum%253Aachs%26aulast%3DBrand%26aufirst%3DF.%26aulast%3DKlutz%26aufirst%3DA.%2BM.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DSchulte%26aufirst%3DG.%26atitle%3DAdenosine%2520A2A%2520receptor%2520dynamics%2520studied%2520with%2520the%2520novel%2520fluorescent%2520agonist%2520Alexa488-APEC%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2008%26volume%3D590%26spage%3D36%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Hendel, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wackers, F. J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ficaro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Depuey, E. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klein, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerqueira, M.</span><span> </span><span class="NLM_article-title">Reporting of radionuclide myocardial perfusion imaging studies</span> <span class="citation_source-journal">J. Nucl. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">â</span> <span class="NLM_lpage">708</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.nuclcard.2003.08.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=14668786" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADC%252BD3sroslWjsA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=705-708&author=R.+C.+Hendelauthor=F.+J.+T.+Wackersauthor=D.+S.+Bermanauthor=E.+Ficaroauthor=E.+G.+Depueyauthor=L.+Kleinauthor=M.+Cerqueira&title=Reporting+of+radionuclide+myocardial+perfusion+imaging+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">American society of nuclear cardiology consensus statement: reporting of radionuclide myocardial perfusion imaging studies</span></div><div class="casAuthors">Hendel Robert C; Wackers Frans J Th; Berman Daniel S; Ficaro Edward; Depuey E Gordon; Klein Larry; Cerqueira Manuel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">705-8</span>
        ISSN:<span class="NLM_cas:issn">1071-3581</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTAWgqdOQ2p8lvAgqb2vdc5fW6udTcc2ebgK6mu0SWBm7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3sroslWjsA%253D%253D&md5=ccb4e1d2100216bd6cb0be215992eaad</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.nuclcard.2003.08.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nuclcard.2003.08.004%26sid%3Dliteratum%253Aachs%26aulast%3DHendel%26aufirst%3DR.%2BC.%26aulast%3DWackers%26aufirst%3DF.%2BJ.%2BT.%26aulast%3DBerman%26aufirst%3DD.%2BS.%26aulast%3DFicaro%26aufirst%3DE.%26aulast%3DDepuey%26aufirst%3DE.%2BG.%26aulast%3DKlein%26aufirst%3DL.%26aulast%3DCerqueira%26aufirst%3DM.%26atitle%3DReporting%2520of%2520radionuclide%2520myocardial%2520perfusion%2520imaging%2520studies%26jtitle%3DJ.%2520Nucl.%2520Cardiol.%26date%3D2003%26volume%3D10%26spage%3D705%26epage%3D708" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Hendel, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jamil, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glover, D. K.</span><span> </span><span class="NLM_article-title">Pharmacologic stress testing: new methods and new agents</span> <span class="citation_source-journal">J. Nucl. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">197</span><span class="NLM_x">â</span> <span class="NLM_lpage">204</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1067%2Fmnc.2003.5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=12673185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADC%252BD3s7lsleksQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2003&pages=197-204&author=R.+C.+Hendelauthor=T.+Jamilauthor=D.+K.+Glover&title=Pharmacologic+stress+testing%3A+new+methods+and+new+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacologic stress testing: new methods and new agents</span></div><div class="casAuthors">Hendel Robert C; Jamil Tariq; Glover David K</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">197-204</span>
        ISSN:<span class="NLM_cas:issn">1071-3581</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTQeUH2h_3phmgRQsDqrjW_fW6udTcc2eb0DS-cQWpyOLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s7lsleksQ%253D%253D&md5=429807f2eababdcb2d779b8b1f99e64a</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1067%2Fmnc.2003.5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1067%252Fmnc.2003.5%26sid%3Dliteratum%253Aachs%26aulast%3DHendel%26aufirst%3DR.%2BC.%26aulast%3DJamil%26aufirst%3DT.%26aulast%3DGlover%26aufirst%3DD.%2BK.%26atitle%3DPharmacologic%2520stress%2520testing%253A%2520new%2520methods%2520and%2520new%2520agents%26jtitle%3DJ.%2520Nucl.%2520Cardiol.%26date%3D2003%26volume%3D10%26spage%3D197%26epage%3D204" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Cerqueira, M.</span><span> </span><span class="NLM_article-title">Advances in pharmacologic agents in imaging: new A<sub>2A</sub> receptor agonists</span> <span class="citation_source-journal">Curr. Cardiol. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">119</span><span class="NLM_x">â</span> <span class="NLM_lpage">122</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2Fs11886-006-0022-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=16524538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADC%252BD287jslSlug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2006&pages=119-122&author=M.+Cerqueira&title=Advances+in+pharmacologic+agents+in+imaging%3A+new+A2A+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in pharmacologic agents in imaging: new A2A receptor agonists</span></div><div class="casAuthors">Cerqueira Manuel D</div><div class="citationInfo"><span class="NLM_cas:title">Current cardiology reports</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">119-22</span>
        ISSN:<span class="NLM_cas:issn">1523-3782</span>.
    </div><div class="casAbstract">Pharmacologic stress myocardial perfusion imaging is being performed with increasing frequency over exercise stress.  Dipyridamole and adenosine have a high side-effect profile, provide higher than needed coronary artery flow rates, and use a relatively complicated method of administration.  Based on preclinical animal work, three selective adenosine A2A receptor agonists, regadenoson (CVT3146), binodenoson (MRE0470 or WRC0470), and apadenoson (BMS068645 or ATL146e), may overcome these limitations and are now in Phase III studies as pharmacologic stress agents.  For single-photon emission CT imaging, binodenoson and regadenoson were concordant with adenosine images for detection and quantitation of ischemia.  Despite the high A2A selectivity of binodenoson and regadenoson in preclinical studies, subjective side effects attributable to other adenosine receptor subtypes were still observed in human studies and are similar to or slightly lower than adenosine.  There have been no reports of atrioventricular block or bronchospasm with either regadenoson or binodenoson in published trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQzqtNn0TVk3VHFYivNCdPRfW6udTcc2eb0DS-cQWpyOLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD287jslSlug%253D%253D&md5=cfc18ab073625cd546a9f32f32fb9a37</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1007%2Fs11886-006-0022-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11886-006-0022-1%26sid%3Dliteratum%253Aachs%26aulast%3DCerqueira%26aufirst%3DM.%26atitle%3DAdvances%2520in%2520pharmacologic%2520agents%2520in%2520imaging%253A%2520new%2520A2A%2520receptor%2520agonists%26jtitle%3DCurr.%2520Cardiol.%2520Rep.%26date%3D2006%26volume%3D8%26spage%3D119%26epage%3D122" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Cerqueira, M.</span><span> </span><span class="NLM_article-title">The future of pharmacologic stress: selective A<sub>2A</sub> adenosine receptor agonists</span> <span class="citation_source-journal">Am. J. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x">, </span> <span class="NLM_fpage">33D</span><span class="NLM_x">â</span> <span class="NLM_lpage">40D</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2004&pages=33D-40D&author=M.+Cerqueira&title=The+future+of+pharmacologic+stress%3A+selective+A2A+adenosine+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCerqueira%26aufirst%3DM.%26atitle%3DThe%2520future%2520of%2520pharmacologic%2520stress%253A%2520selective%2520A2A%2520adenosine%2520receptor%2520agonists%26jtitle%3DAm.%2520J.%2520Cardiol.%26date%3D2004%26volume%3D94%26spage%3D33D%26epage%3D40D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Moorman, A.; OâNeil, M.</span><span> </span><span class="NLM_article-title">Crystal forms of 2-(2-[(Cyclohexyl)methylene]hydrazino)adenosine</span>. Eur. Pat. EP2257162 A2,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=A.+Moorman&author=M.+O%E2%80%99Neil&title=Crystal+forms+of+2-%282-%5B%28Cyclohexyl%29methylene%5Dhydrazino%29adenosine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoorman%26aufirst%3DA.%26atitle%3DCrystal%2520forms%2520of%25202-%25282-%255B%2528Cyclohexyl%2529methylene%255Dhydrazino%2529adenosine%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Barrett, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, W. B.</span><span> </span><span class="NLM_article-title">Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers</span> <span class="citation_source-journal">J. Nucl. Cardiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">166</span><span class="NLM_x">â</span> <span class="NLM_lpage">171</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.nuclcard.2004.12.294" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=15812370" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADC%252BD2M7nvFKmtQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=166-171&author=R.+J.+Barrettauthor=M.+J.+Lamsonauthor=J.+Johnsonauthor=W.+B.+Smith&title=Pharmacokinetics+and+safety+of+binodenoson+after+intravenous+dose+escalation+in+healthy+volunteers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers</span></div><div class="casAuthors">Barrett Richard J; Lamson Michael J; Johnson James; Smith William B</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">166-71</span>
        ISSN:<span class="NLM_cas:issn">1071-3581</span>.
    </div><div class="casAbstract">BACKGROUND:  Binodenoson, a highly selective agonist of the adenosine A 2A receptor, is being developed as a short-acting coronary vasodilator as an adjunct to radiotracers for use in myocardial stress imaging.  This study was designed to assess the single-dose pharmacokinetics, safety, and tolerability of intravenous binodenoson.  METHODS AND RESULTS:  This was a single-center, open-label, nonrandomized, dose-escalation study in 24 healthy volunteers.  Each subject received 3 successive intravenous doses of binodenoson (0.1, 0.2, 0.4, 0.6, 1, 2, 3, 4, 5, and 6 microg/kg), each infused over a period of 10 minutes and separated by washout periods of at least 120 minutes.  Generally, binodenoson was well tolerated.  There were no serious adverse events.  However, there was a dose-related increase in adverse events (e.g., headache, nausea, vasodilation, chest pain), consistent with the pharmacology of the drug.  Binodenoson exhibited linear pharmacokinetics as indicated by a dose-proportional increase in peak concentration (C max ) and area under the concentration-time curve (AUC).  Systemic clearance was independent of dose but was correlated with body weight.  The mean terminal half-life of binodenoson across all doses was 10 +/- 4 minutes.  CONCLUSIONS:  Overall, binodenoson was well tolerated and exhibited linear pharmacokinetics when administered intravenously over a 60-fold dose range from 0.1 to 6 microg/kg.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQfBXzTWL8C0vcsfMJQC1ZdfW6udTcc2eb0DS-cQWpyOLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2M7nvFKmtQ%253D%253D&md5=60ec7a94b653100b804791e52145b7e2</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.nuclcard.2004.12.294&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nuclcard.2004.12.294%26sid%3Dliteratum%253Aachs%26aulast%3DBarrett%26aufirst%3DR.%2BJ.%26aulast%3DLamson%26aufirst%3DM.%2BJ.%26aulast%3DJohnson%26aufirst%3DJ.%26aulast%3DSmith%26aufirst%3DW.%2BB.%26atitle%3DPharmacokinetics%2520and%2520safety%2520of%2520binodenoson%2520after%2520intravenous%2520dose%2520escalation%2520in%2520healthy%2520volunteers%26jtitle%3DJ.%2520Nucl.%2520Cardiol.%26date%3D2005%26volume%3D12%26spage%3D166%26epage%3D171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Murphree, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacDonald, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span> </span><span class="NLM_article-title">Human A<sub>2A</sub> adenosine receptors: high-affinity agonist binding to receptor-G protein complexes containing GÎ²4</span> <span class="citation_source-journal">Mol. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">455</span><span class="NLM_x">â</span> <span class="NLM_lpage">462</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=455-462&author=L.+J.+Murphreeauthor=M.+A.+Marshallauthor=J.+M.+Riegerauthor=T.+L.+MacDonaldauthor=J.+Linden&title=Human+A2A+adenosine+receptors%3A+high-affinity+agonist+binding+to+receptor-G+protein+complexes+containing+G%CE%B24"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMurphree%26aufirst%3DL.%2BJ.%26aulast%3DMarshall%26aufirst%3DM.%2BA.%26aulast%3DRieger%26aufirst%3DJ.%2BM.%26aulast%3DMacDonald%26aufirst%3DT.%2BL.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DHuman%2520A2A%2520adenosine%2520receptors%253A%2520high-affinity%2520agonist%2520binding%2520to%2520receptor-G%2520protein%2520complexes%2520containing%2520G%25CE%25B24%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D61%26spage%3D455%26epage%3D462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Garnock-Jones, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Curran, M. P.</span><span> </span><span class="NLM_article-title">Regadenoson</span> <span class="citation_source-journal">Am. J. Cardiovasc. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">65</span><span class="NLM_x">â</span> <span class="NLM_lpage">71</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=65-71&issue=1&author=K.+P.+Garnock-Jonesauthor=M.+P.+Curran&title=Regadenoson"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarnock-Jones%26aufirst%3DK.%2BP.%26aulast%3DCurran%26aufirst%3DM.%2BP.%26atitle%3DRegadenoson%26jtitle%3DAm.%2520J.%2520Cardiovasc.%2520Drugs%26date%3D2010%26volume%3D10%26issue%3D1%26spage%3D65%26epage%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Palle, V. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elzein, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gothe, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J. A.</span><span> </span><span class="NLM_article-title">Structureâaffinity relationships of the affinity of 2-pyrazolyl adenosine analogs for the adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2935</span><span class="NLM_x">â</span> <span class="NLM_lpage">2939</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2935-2939&author=V.+P.+Palleauthor=E.+O.+Elzeinauthor=S.+A.+Gotheauthor=Z.+Liauthor=Z.+Gaoauthor=S.+Meyerauthor=B.+Blackburnauthor=J.+A.+Zablocki&title=Structure%E2%80%93affinity+relationships+of+the+affinity+of+2-pyrazolyl+adenosine+analogs+for+the+adenosine+A2A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPalle%26aufirst%3DV.%2BP.%26aulast%3DElzein%26aufirst%3DE.%2BO.%26aulast%3DGothe%26aufirst%3DS.%2BA.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DBlackburn%26aufirst%3DB.%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26atitle%3DStructure%25E2%2580%2593affinity%2520relationships%2520of%2520the%2520affinity%2520of%25202-pyrazolyl%2520adenosine%2520analogs%2520for%2520the%2520adenosine%2520A2A%2520receptor%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D2935%26epage%3D2939" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Gordi, T.; Olmsted, A. W.; Lieu, H. D.; Belardinelli, L.</span><span> </span><span class="NLM_article-title">Use of A<sub>2A</sub> Adenosine Receptor Agonists</span>. PCT Int. Appl. Publ. US20060084625A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=T.+Gordi&author=A.+W.+Olmsted&author=H.+D.+Lieu&author=L.+Belardinelli&title=Use+of+A2A+Adenosine+Receptor+Agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGordi%26aufirst%3DT.%26atitle%3DUse%2520of%2520A2A%2520Adenosine%2520Receptor%2520Agonists%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Lappas, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> agonists in development for the treatment of inflammation</span> <span class="citation_source-journal">Expert Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">797</span><span class="NLM_x">â</span> <span class="NLM_lpage">806</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2005&pages=797-806&issue=7&author=C.+M.+Lappasauthor=G.+W.+Sullivanauthor=J.+Linden&title=Adenosine+A2A+agonists+in+development+for+the+treatment+of+inflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLappas%26aufirst%3DC.%2BM.%26aulast%3DSullivan%26aufirst%3DG.%2BW.%26aulast%3DLinden%26aufirst%3DJ.%26atitle%3DAdenosine%2520A2A%2520agonists%2520in%2520development%2520for%2520the%2520treatment%2520of%2520inflammation%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2005%26volume%3D14%26issue%3D7%26spage%3D797%26epage%3D806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Hasko, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pacher, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deitch, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vizi, E. S.</span><span> </span><span class="NLM_article-title">Shaping of monocyte and macrophage function by adenosine receptors</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">113</span><span class="NLM_x">, </span> <span class="NLM_fpage">264</span><span class="NLM_x">â</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.pharmthera.2006.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=17056121" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVCgt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2007&pages=264-275&author=G.+Haskoauthor=P.+Pacherauthor=E.+A.+Deitchauthor=E.+S.+Vizi&title=Shaping+of+monocyte+and+macrophage+function+by+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Shaping of monocyte and macrophage function by adenosine receptors</span></div><div class="casAuthors">Hasko, Gyoergy; Pacher, Pal; Deitch, Edwin A.; Vizi, E. Sylvester</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">264-275</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Adenosine is an endogenous purine nucleoside that, following its release into the extracellular space, binds to specific adenosine receptors expressed on the cell surface.  Adenosine appears in the extracellular space under metabolically stressful conditions, which are assocd. with ischemia, inflammation, and cell damage.  There are 4 types of adenosine receptors (A1, A2A, A2B and A3) and all adenosine receptors are members of the G protein-coupled family of receptors.  Adenosine receptors are expressed on monocytes and macrophages and through these receptors adenosine modulates monocyte and macrophage function.  Since monocytes and macrophages are activated by the same danger signals that cause accumulation of extracellular adenosine, adenosine receptors expressed on macrophages represent a sensor system that provide monocytes and macrophages with information about the stressful environment.  Adenosine receptors, thus, allow monocytes and macrophages to fine-tune their responses to stressful stimuli.  Here, the authors review the consequences of adenosine receptor activation on monocyte/macrophage function.  The authors will detail the effect of stimulating the various adenosine receptor subtypes on macrophage differentiation/proliferation, phagocytosis, and tissue factor (TF) expression.  The authors will also summarize their knowledge of how adenosine impacts the prodn. of extracellular mediators secreted by monocytes and macrophages in response to Toll-like receptor (TLR) ligands and other inflammatory stimuli.  Specifically, the authors will delineate how adenosine affects the prodn. of superoxide, nitric oxide (NO), tumor necrosis factor-Î±, interleukin (IL)-12, IL-10, and vascular endothelial growth factor (VEGF).  A deeper insight into the regulation of monocyte and macrophage function by adenosine receptors should assist in developing new therapies for inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0pqyGpq9YMbVg90H21EOLACvtfcHk0liQaKtKKLtbmQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVCgt7o%253D&md5=d793caeb6be4cc48ca6b7d465827919f</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2006.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2006.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DHasko%26aufirst%3DG.%26aulast%3DPacher%26aufirst%3DP.%26aulast%3DDeitch%26aufirst%3DE.%2BA.%26aulast%3DVizi%26aufirst%3DE.%2BS.%26atitle%3DShaping%2520of%2520monocyte%2520and%2520macrophage%2520function%2520by%2520adenosine%2520receptors%26jtitle%3DPharmacol.%2520Ther.%26date%3D2007%26volume%3D113%26spage%3D264%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Cohen, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baer, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leo, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scheld, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diduch, D. R.</span><span> </span><span class="NLM_article-title">Reducing joint destruction due to septic arthrosis using an adenosine A<sub>2A</sub> receptor agonist</span> <span class="citation_source-journal">J. Orthop. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">427</span><span class="NLM_x">â</span> <span class="NLM_lpage">435</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.orthres.2003.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=15013106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpsVGgtw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2004&pages=427-435&author=S.+B.+Cohenauthor=S.+S.+Gillauthor=G.+S.+Baerauthor=B.+M.+Leoauthor=W.+M.+Scheldauthor=D.+R.+Diduch&title=Reducing+joint+destruction+due+to+septic+arthrosis+using+an+adenosine+A2A+receptor+agonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing joint destruction due to septic arthrosis using an adenosine2A receptor agonist</span></div><div class="casAuthors">Cohen, Steven B.; Gill, Sanjitpal S.; Baer, Geoffrey S.; Leo, Brian M.; Scheld, W. Michael; Diduch, David R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Orthopaedic Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">427-435</span>CODEN:
                <span class="NLM_cas:coden">JOREDR</span>;
        ISSN:<span class="NLM_cas:issn">0736-0266</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">We assessed the efficacy of a new adenosine A2A agonist ATL146e, a potent inhibitor of white blood cell chemotaxis, to reduce cartilage damage in the treatment of septic arthrosis.  A live septic arthrosis model was created using Staphylococcus aureus in rabbit knees.  Animals were divided into five treatment groups: (1) untreated infected control, (2) antibiotics control, and antibiotics plus ATL146e for (3) 24, (4) 48, or (5) 72 h and assessed at 1, 4, and 7 days.  Knees in all ATL146e treated animals exhibited no detectable effusion, and histol. examn. revealed near normal cartilage and diminished synovial inflammatory response.  Synovial WBC counts decreased with the addn. of ATL146e when compared to infected and antibiotic controls.  Histol. grading of osteochondral specimens demonstrated improved scores for animals treated with ATL146e compared to infected (p<0.00004) and antibiotics controls (p<0.05).  Anal. of glycosaminoglycan content revealed significantly decreased loss of articular cartilage following infection in the ATL146e groups when compared to infected (p<0.03) and antibiotics controls (p<0.05).  Addn. of an adenosine A2A agonist to antibiotic therapy decreases joint inflammation and articular cartilage destruction without compromising bacterial clearance in rabbit knees following intraarticular bacterial infection.  The use of adenosine agonists selective to the A2A receptor to augment conventional treatment of joint sepsis may be chondroprotective and ultimately help prevent arthrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqnOZVcK_D8bVg90H21EOLACvtfcHk0liQaKtKKLtbmQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpsVGgtw%253D%253D&md5=ff66293fba4f68136acdfe1a77408109</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1016%2Fj.orthres.2003.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.orthres.2003.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DS.%2BB.%26aulast%3DGill%26aufirst%3DS.%2BS.%26aulast%3DBaer%26aufirst%3DG.%2BS.%26aulast%3DLeo%26aufirst%3DB.%2BM.%26aulast%3DScheld%26aufirst%3DW.%2BM.%26aulast%3DDiduch%26aufirst%3DD.%2BR.%26atitle%3DReducing%2520joint%2520destruction%2520due%2520to%2520septic%2520arthrosis%2520using%2520an%2520adenosine%2520A2A%2520receptor%2520agonist%26jtitle%3DJ.%2520Orthop.%2520Res.%26date%3D2004%26volume%3D22%26spage%3D427%26epage%3D435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Beattie, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brearley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charlton, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cox, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fairhurst, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fozard, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kirkham, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meja, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nanson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neef, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oakman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spooner, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodward, H.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of two series of 4â²-aza-carbocyclic nucleosides as adenosine A<sub>2A</sub> receptor agonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1219</span><span class="NLM_x">â</span> <span class="NLM_lpage">1224</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1219-1224&issue=3&author=D.+Beattieauthor=A.+Brearleyauthor=Z.+Brownauthor=S.+J.+Charltonauthor=B.+Coxauthor=R.+A.+Fairhurstauthor=J.+R.+Fozardauthor=P.+Gedeckauthor=P.+Kirkhamauthor=K.+Mejaauthor=L.+Nansonauthor=J.+Neefauthor=H.+Oakmanauthor=G.+Spoonerauthor=R.+J.+Taylorauthor=R.+J.+Turnerauthor=R.+Westauthor=H.+Woodward&title=Synthesis+and+evaluation+of+two+series+of+4%E2%80%B2-aza-carbocyclic+nucleosides+as+adenosine+A2A+receptor+agonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBeattie%26aufirst%3DD.%26aulast%3DBrearley%26aufirst%3DA.%26aulast%3DBrown%26aufirst%3DZ.%26aulast%3DCharlton%26aufirst%3DS.%2BJ.%26aulast%3DCox%26aufirst%3DB.%26aulast%3DFairhurst%26aufirst%3DR.%2BA.%26aulast%3DFozard%26aufirst%3DJ.%2BR.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DKirkham%26aufirst%3DP.%26aulast%3DMeja%26aufirst%3DK.%26aulast%3DNanson%26aufirst%3DL.%26aulast%3DNeef%26aufirst%3DJ.%26aulast%3DOakman%26aufirst%3DH.%26aulast%3DSpooner%26aufirst%3DG.%26aulast%3DTaylor%26aufirst%3DR.%2BJ.%26aulast%3DTurner%26aufirst%3DR.%2BJ.%26aulast%3DWest%26aufirst%3DR.%26aulast%3DWoodward%26aufirst%3DH.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520two%2520series%2520of%25204%25E2%2580%25B2-aza-carbocyclic%2520nucleosides%2520as%2520adenosine%2520A2A%2520receptor%2520agonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26issue%3D3%26spage%3D1219%26epage%3D1224" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Bosch, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campos, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Niubo, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosell, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrero, A.</span><span> </span><span class="NLM_article-title">Synthesis and biological activity of new potential agonists for the human adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">4041</span><span class="NLM_x">â</span> <span class="NLM_lpage">4053</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm031143%2B" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4041-4053&author=M.+P.+Boschauthor=F.+Camposauthor=I.+Niuboauthor=G.+Rosellauthor=J.+L.+Diazauthor=J.+Breaauthor=M.+I.+Lozaauthor=A.+Guerrero&title=Synthesis+and+biological+activity+of+new+potential+agonists+for+the+human+adenosine+A2A+receptor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1021%2Fjm031143%2B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm031143%252B%26sid%3Dliteratum%253Aachs%26aulast%3DBosch%26aufirst%3DM.%2BP.%26aulast%3DCampos%26aufirst%3DF.%26aulast%3DNiubo%26aufirst%3DI.%26aulast%3DRosell%26aufirst%3DG.%26aulast%3DDiaz%26aufirst%3DJ.%2BL.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DGuerrero%26aufirst%3DA.%26atitle%3DSynthesis%2520and%2520biological%2520activity%2520of%2520new%2520potential%2520agonists%2520for%2520the%2520human%2520adenosine%2520A2A%2520receptor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D4041%26epage%3D4053" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Folkesson, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuzenko, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lipson, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthay, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmons, M. A.</span><span> </span><span class="NLM_article-title">The adenosine A<sub>2A</sub> receptor agonist GW328267C improves lung function after acute lung injury in rats</span> <span class="citation_source-journal">Am. J. Physiol.: Lung Cell. Mol. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">L259</span><span class="NLM_x">â</span> <span class="NLM_lpage">271</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2012&pages=L259-271&issue=3&author=H.+G.+Folkessonauthor=S.+R.+Kuzenkoauthor=D.+A.+Lipsonauthor=M.+A.+Matthayauthor=M.+A.+Simmons&title=The+adenosine+A2A+receptor+agonist+GW328267C+improves+lung+function+after+acute+lung+injury+in+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFolkesson%26aufirst%3DH.%2BG.%26aulast%3DKuzenko%26aufirst%3DS.%2BR.%26aulast%3DLipson%26aufirst%3DD.%2BA.%26aulast%3DMatthay%26aufirst%3DM.%2BA.%26aulast%3DSimmons%26aufirst%3DM.%2BA.%26atitle%3DThe%2520adenosine%2520A2A%2520receptor%2520agonist%2520GW328267C%2520improves%2520lung%2520function%2520after%2520acute%2520lung%2520injury%2520in%2520rats%26jtitle%3DAm.%2520J.%2520Physiol.%253A%2520Lung%2520Cell.%2520Mol.%2520Physiol.%26date%3D2012%26volume%3D303%26issue%3D3%26spage%3DL259%26epage%3D271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Mantell, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monaghan, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maw, G. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevethick, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeadon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selby, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Batchelor, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rozze, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chavaroche, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemaitre, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, K. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitlock, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuart, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wright, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macintyre, F.</span><span> </span><span class="NLM_article-title">SAR of a series of inhaled A<sub>2A</sub> agonists and comparison of inhaled pharmacokinetics in a preclinical model with clinical pharmacokinetic data</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4471</span><span class="NLM_x">â</span> <span class="NLM_lpage">4475</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4471-4475&author=S.+J.+Mantellauthor=P.+T.+Stephensonauthor=S.+M.+Monaghanauthor=G.+N.+Mawauthor=M.+A.+Trevethickauthor=M.+Yeadonauthor=D.+K.+Walkerauthor=M.+D.+Selbyauthor=D.+V.+Batchelorauthor=S.+Rozzeauthor=H.+Chavarocheauthor=A.+Lemaitreauthor=K.+N.+Wrightauthor=L.+Whitlockauthor=E.+F.+Stuartauthor=P.+A.+Wrightauthor=F.+Macintyre&title=SAR+of+a+series+of+inhaled+A2A+agonists+and+comparison+of+inhaled+pharmacokinetics+in+a+preclinical+model+with+clinical+pharmacokinetic+data"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMantell%26aufirst%3DS.%2BJ.%26aulast%3DStephenson%26aufirst%3DP.%2BT.%26aulast%3DMonaghan%26aufirst%3DS.%2BM.%26aulast%3DMaw%26aufirst%3DG.%2BN.%26aulast%3DTrevethick%26aufirst%3DM.%2BA.%26aulast%3DYeadon%26aufirst%3DM.%26aulast%3DWalker%26aufirst%3DD.%2BK.%26aulast%3DSelby%26aufirst%3DM.%2BD.%26aulast%3DBatchelor%26aufirst%3DD.%2BV.%26aulast%3DRozze%26aufirst%3DS.%26aulast%3DChavaroche%26aufirst%3DH.%26aulast%3DLemaitre%26aufirst%3DA.%26aulast%3DWright%26aufirst%3DK.%2BN.%26aulast%3DWhitlock%26aufirst%3DL.%26aulast%3DStuart%26aufirst%3DE.%2BF.%26aulast%3DWright%26aufirst%3DP.%2BA.%26aulast%3DMacintyre%26aufirst%3DF.%26atitle%3DSAR%2520of%2520a%2520series%2520of%2520inhaled%2520A2A%2520agonists%2520and%2520comparison%2520of%2520inhaled%2520pharmacokinetics%2520in%2520a%2520preclinical%2520model%2520with%2520clinical%2520pharmacokinetic%2520data%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4471%26epage%3D4475" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Rieger, J. M.; Kimpel, D. L.; Linden, J. M.; Sullivan, G. W.</span><span> </span><span class="NLM_article-title">Method To Reduce an Inflammatory Response from Arthritis</span>. U.S. Pat. Appl. Publ. US20060100169 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=J.+M.+Rieger&author=D.+L.+Kimpel&author=J.+M.+Linden&author=G.+W.+Sullivan&title=Method+To+Reduce+an+Inflammatory+Response+from+Arthritis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRieger%26aufirst%3DJ.%2BM.%26atitle%3DMethod%2520To%2520Reduce%2520an%2520Inflammatory%2520Response%2520from%2520Arthritis%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Impagnatiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bastia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span> </span><span class="NLM_article-title">Adenosine receptors in neurological disorders</span> <span class="citation_source-journal">Emerging Ther. Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">635</span><span class="NLM_x">â</span> <span class="NLM_lpage">664</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1517%2F14728222.4.5.635" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1ynt74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2000&pages=635-664&author=F.+Impagnatielloauthor=E.+Bastiaauthor=E.+Onginiauthor=A.+Monopoli&title=Adenosine+receptors+in+neurological+disorders"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine receptors in neurological disorders</span></div><div class="casAuthors">Impagnatiello, Francesco; Bastia, Elena; Ongini, Ennio; Monopoli, Angela</div><div class="citationInfo"><span class="NLM_cas:title">Emerging Therapeutic Targets</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">635-664</span>CODEN:
                <span class="NLM_cas:coden">ETTAF7</span>;
        ISSN:<span class="NLM_cas:issn">1460-0412</span>.
    
            (<span class="NLM_cas:orgname">Ashley Publications Ltd.</span>)
        </div><div class="casAbstract">A review, with 165 refs.  Adenosine is present in the extracellular space of organs and tissues in the mammalian organism where it modulates a variety of physiol. processes through specific cell membrane receptors which have been identified as members of the G-protein coupled receptors (GPCRs).  Currently, four receptors have been cloned and characterized, namely A1, A2A, A2B, A3 adenosine receptors.  The different distribution of receptor populations in organs and tissues together with their importance in normal and altered conditions make each individual adenosine receptor an attractive target for the discovery of new pharmacol. agents.  Major efforts have involved the A1 and A2A receptors with the central nervous (and cardiovascular) systems being the medical areas of highest interest.  Thus, a variety of selective receptor agonists and antagonists have been discovered and some are currently under development for the treatment of neurol. disorders.  Treatment of pain, neurodegenerative diseases, such as Parkinson's (PD) and Huntington's disease (HD), cognitive impairment and epilepsy are all potential therapy areas of future drug development.  This review describes the scientific background information currently available together with the rationale underlying the innovative strategies assocd. with the modulation of each individual adenosine receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCK9lAExzYK7Vg90H21EOLACvtfcHk0lggwnaisVASLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1ynt74%253D&md5=9fe39b62c530a99532d16af67316f2c3</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1517%2F14728222.4.5.635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.4.5.635%26sid%3Dliteratum%253Aachs%26aulast%3DImpagnatiello%26aufirst%3DF.%26aulast%3DBastia%26aufirst%3DE.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DMonopoli%26aufirst%3DA.%26atitle%3DAdenosine%2520receptors%2520in%2520neurological%2520disorders%26jtitle%3DEmerging%2520Ther.%2520Targets%26date%3D2000%26volume%3D4%26spage%3D635%26epage%3D664" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group">Loram, L. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloane, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchinson, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sholar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berkelhammer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coats, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poole, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Milligan, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maier, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watkins, L. R.</span><span> </span><span class="NLM_article-title">Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine A<sub>2A</sub> receptor agonists: a novel therapy for neuropathic pain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">14015</span><span class="NLM_x">â</span> <span class="NLM_lpage">14025</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1523%2FJNEUROSCI.3447-09.2009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=19890011" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVSmsbnE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=14015-14025&author=L.+C.+Loramauthor=J.+A.+Harrisonauthor=E.+M.+Sloaneauthor=M.+R.+Hutchinsonauthor=P.+Sholarauthor=F.+R.+Taylorauthor=D.+Berkelhammerauthor=B.+D.+Coatsauthor=S.+Pooleauthor=E.+D.+Milliganauthor=S.+F.+Maierauthor=J.+Riegerauthor=L.+R.+Watkins&title=Enduring+reversal+of+neuropathic+pain+by+a+single+intrathecal+injection+of+adenosine+A2A+receptor+agonists%3A+a+novel+therapy+for+neuropathic+pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain</span></div><div class="casAuthors">Loram, Lisa C.; Harrison, Jacqueline A.; Sloane, Evan M.; Hutchinson, Mark R.; Sholar, Paige; Taylor, Frederick R.; Berkelhammer, Debra; Coats, Benjamen D.; Poole, Stephen; Milligan, Erin D.; Maier, Steven F.; Rieger, Jayson; Watkins, Linda R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">44</span>),
    <span class="NLM_cas:pages">14015-14025</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">Previous studies of peripheral immune cells have documented that activation of adenosine 2A receptors (A2ARs) decrease proinflammatory cytokine release and increase release of the potent anti-inflammatory cytokine, interleukin-10 (IL-10).  Given the growing literature supporting that glial proinflammatory cytokines importantly contribute to neuropathic pain and that IL-10 can suppress such pain, we evaluated the effects of intrathecally administered A2AR agonists on neuropathic pain using the chronic constriction injury (CCI) model.  A single intrathecal injection of the A2AR agonists 4-(3-(6-amino-9-(5-cyclopropylcarbamoyl-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-2-yl)prop-2-ynyl)piperidine-1-carboxylic acid Me ester (ATL313) or 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamido adenosine HCl (CGS21680), 10-14 d after CCI vs. sham surgery, produced a long-duration reversal of mech. allodynia and thermal hyperalgesia for at least 4 wk.  Neither drug altered the nociceptive responses of sham-operated controls.  An A2AR antagonist [ZM241385 (4-(2-[7-amino-2-(2-furyl)(1,2,4)triazolo(2,3-a)(1,3,5)triazin-5-ylamino]ethyl)phenol)] coadministered intrathecally with ATL313 abolished the action of ATL313 in rats with neuropathy-induced allodynia but had no effect on allodynia in the absence of the A2AR agonist.  ATL313 attenuated CCI-induced upregulation of spinal cord activation markers for microglia and astrocytes in the L4-L6 spinal cord segments both 1 and 4 wk after a single intrathecal ATL313 administration.  Neutralizing IL-10 antibodies administered intrathecally transiently abolished the effect of ATL313 on neuropathic pain.  In addn., IL-10 mRNA was significantly elevated in the CSF cells collected from the lumbar region.  Activation of A2ARs after intrathecal administration may be a novel, therapeutic approach for the treatment of neuropathic pain by increasing IL-10 in the immunocompetent cells of the CNS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYa7OimtQi_LVg90H21EOLACvtfcHk0lggwnaisVASLA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVSmsbnE&md5=ccdf1c9331bb1337e25ed372e9013df0</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.3447-09.2009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.3447-09.2009%26sid%3Dliteratum%253Aachs%26aulast%3DLoram%26aufirst%3DL.%2BC.%26aulast%3DHarrison%26aufirst%3DJ.%2BA.%26aulast%3DSloane%26aufirst%3DE.%2BM.%26aulast%3DHutchinson%26aufirst%3DM.%2BR.%26aulast%3DSholar%26aufirst%3DP.%26aulast%3DTaylor%26aufirst%3DF.%2BR.%26aulast%3DBerkelhammer%26aufirst%3DD.%26aulast%3DCoats%26aufirst%3DB.%2BD.%26aulast%3DPoole%26aufirst%3DS.%26aulast%3DMilligan%26aufirst%3DE.%2BD.%26aulast%3DMaier%26aufirst%3DS.%2BF.%26aulast%3DRieger%26aufirst%3DJ.%26aulast%3DWatkins%26aufirst%3DL.%2BR.%26atitle%3DEnduring%2520reversal%2520of%2520neuropathic%2520pain%2520by%2520a%2520single%2520intrathecal%2520injection%2520of%2520adenosine%2520A2A%2520receptor%2520agonists%253A%2520a%2520novel%2520therapy%2520for%2520neuropathic%2520pain%26jtitle%3DJ.%2520Neurosci.%26date%3D2009%26volume%3D29%26spage%3D14015%26epage%3D14025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group">Mantell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trevethick, M.</span><span> </span><span class="NLM_article-title">Design and application of locally delivered agonists of the adenosine A<sub>2A</sub> receptor</span> <span class="citation_source-journal">Expert Rev. Clin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">â</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1586%2Fecp.09.57" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=22111533" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFyiur7N" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2010&pages=55-72&author=S.+Mantellauthor=R.+Jonesauthor=M.+Trevethick&title=Design+and+application+of+locally+delivered+agonists+of+the+adenosine+A2A+receptor"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Design and application of locally delivered agonists of the adenosine A2A receptor</span></div><div class="casAuthors">Mantell, Simon; Jones, Rhys; Trevethick, Mike</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Clinical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-72</span>CODEN:
                <span class="NLM_cas:coden">ERCPAG</span>;
        ISSN:<span class="NLM_cas:issn">1751-2433</span>.
    
            (<span class="NLM_cas:orgname">Expert Reviews Ltd.</span>)
        </div><div class="casAbstract">A review.  The broad spectrum anti-inflammatory actions of adenosine A2A receptor agonists are well described.  The wide distribution of this receptor, however, suggests that the therapeutic potential of these agents is likely to reside in topical treatments to avoid systemic side effects assocd. with oral administration.  Adenosine A2A receptor agonists have been assessed as topical agents: GW328267X (GSK; allergic rhinitis and asthma), UK-432097 (Pfizer; chronic obstructive pulmonary disease [COPD]) and Sonedenoson (MRE0094, King Pharmaceuticals; wound healing).  All trials failed to achieve effects against the desired clin. end points.  This broad-based review will discuss general principles of chem. design of topically applied agents and potential therapeutic topical applications of current adenosine A2A receptor agonists.  Potential factors contributing to the lack of efficacy in the above clin. trials will be discussed together with design principles, which may influence efficacy in disease states.  Our anal. suggests that adenosine A2A receptor agonists have a wide therapeutic potential as topical agents in a wide variety of diseases, such as neutrophil-dependent lung diseases (acute lung injury, exacerbations in asthma and COPD), allergic rhinitis, glaucoma and wound repair.  Factors that will influence topical activity include formulation, tissue retention, compd. potency, receptor kinetics and pharmacokinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpq1S7ZYIysqbVg90H21EOLACvtfcHk0lgZpJEiFMgt6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFyiur7N&md5=570bbb72a3670b0b317c4f4dbe1a9b00</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1586%2Fecp.09.57&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252Fecp.09.57%26sid%3Dliteratum%253Aachs%26aulast%3DMantell%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DR.%26aulast%3DTrevethick%26aufirst%3DM.%26atitle%3DDesign%2520and%2520application%2520of%2520locally%2520delivered%2520agonists%2520of%2520the%2520adenosine%2520A2A%2520receptor%26jtitle%3DExpert%2520Rev.%2520Clin.%2520Pharmacol.%26date%3D2010%26volume%3D3%26spage%3D55%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group">Warren, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calabrese, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pawlowski, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figler, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, P. B. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linden, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guerrant, R. L.</span><span> </span><span class="NLM_article-title">Effects of adenosine A<sub>2A</sub> receptor activation and alanyl-glutamine in <i>Clostridium difficile</i> toxin-induced ileitis in rabbits and cecitis in mice</span> <span class="citation_source-journal">BMC Infect. Dis.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">13</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1186%2F1471-2334-12-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=22214291" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1-13&author=C.+A.+Warrenauthor=G.+M.+Calabreseauthor=Y.+Liauthor=S.+W.+Pawlowskiauthor=R.+A.+Figlerauthor=P.+B.+E.+Riegerauthor=J.+Lindenauthor=R.+L.+Guerrant&title=Effects+of+adenosine+A2A+receptor+activation+and+alanyl-glutamine+in+Clostridium+difficile+toxin-induced+ileitis+in+rabbits+and+cecitis+in+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1186%2F1471-2334-12-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2334-12-13%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DC.%2BA.%26aulast%3DCalabrese%26aufirst%3DG.%2BM.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DPawlowski%26aufirst%3DS.%2BW.%26aulast%3DFigler%26aufirst%3DR.%2BA.%26aulast%3DRieger%26aufirst%3DP.%2BB.%2BE.%26aulast%3DLinden%26aufirst%3DJ.%26aulast%3DGuerrant%26aufirst%3DR.%2BL.%26atitle%3DEffects%2520of%2520adenosine%2520A2A%2520receptor%2520activation%2520and%2520alanyl-glutamine%2520in%2520Clostridium%2520difficile%2520toxin-induced%2520ileitis%2520in%2520rabbits%2520and%2520cecitis%2520in%2520mice%26jtitle%3DBMC%2520Infect.%2520Dis.%26date%3D2012%26volume%3D12%26spage%3D1%26epage%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group">Rickles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giordano, T. P.,  III</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pierce, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farwell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMillin, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Necheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crowe, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avery, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Navrocki, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carew, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giles, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitsiades, C. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borisy, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, M. S.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> and beta-2 adrenergic receptor agonists: novel selective and synergistic multiple myeloma targets discovered through systematic combination screening</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1432</span><span class="NLM_x">â</span> <span class="NLM_lpage">1442</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1158%2F1535-7163.MCT-11-0925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=22474168" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvVKrtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2012&pages=1432-1442&issue=7&author=R.+J.+Ricklesauthor=W.+F.+Tamauthor=T.+P.+Giordanoauthor=L.+T.+Pierceauthor=M.+Farwellauthor=D.+W.+McMillinauthor=A.+Nechevaauthor=D.+Croweauthor=M.+Chenauthor=W.+Averyauthor=V.+Kansraauthor=S.+T.+Navrockiauthor=J.+S.+Carewauthor=F.+J.+Gilesauthor=C.+S.+Mitsiadesauthor=A.+A.+Borisyauthor=K.+C.+Andersonauthor=M.+S.+Lee&title=Adenosine+A2A+and+beta-2+adrenergic+receptor+agonists%3A+novel+selective+and+synergistic+multiple+myeloma+targets+discovered+through+systematic+combination+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A and Beta-2 Adrenergic Receptor Agonists: Novel Selective and Synergistic Multiple Myeloma Targets Discovered through Systematic Combination Screening</span></div><div class="casAuthors">Rickles, Richard J.; Tam, Winnie F.; Giordano, Thomas P., III; Pierce, Laura T.; Farwell, Melissa; McMillin, Douglas W.; Necheva, Antoaneta; Crowe, David; Chen, Mei; Avery, William; Kansra, Vikram; Nawrocki, Steffan T.; Carew, Jennifer S.; Giles, Francis J.; Mitsiades, Constantine S.; Borisy, Alexis A.; Anderson, Kenneth C.; Lee, Margaret S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1432-1442</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The use of combination drug regimens has dramatically improved the clin. outcome for patients with multiple myeloma.  However, to date, combination treatments have been limited to approved drugs and a small no. of emerging agents.  Using a systematic approach to identify synergistic drug combinations, combination high-throughput screening (cHTS) technol., adenosine A2A and Î²-2 adrenergic receptor (Î²2AR) agonists were shown to be highly synergistic, selective, and novel agents that enhance glucocorticoid activity in B-cell malignancies.  Unexpectedly, A2A and Î²2AR agonists also synergize with melphalan, lenalidomide, bortezomib, and doxorubicin.  An anal. of agonists, in combination with dexamethasone or melphalan in 83 cell lines, reveals substantial activity in multiple myeloma and diffuse large B-cell lymphoma cell lines.  Combination effects are also obsd. with dexamethasone as well as bortezomib, using multiple myeloma patient samples and mouse multiple myeloma xenograft assays.  Our results provide compelling evidence in support of development of A2A and Î²2AR agonists for use in multi-drug combination therapy for multiple myeloma.  Furthermore, use of cHTS for the discovery and evaluation of new targets and combination therapies has the potential to improve cancer treatment paradigms and patient outcomes.  Mol Cancer Ther; 11(7); 1432-42. Â©2012 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE-1C5c76NcrVg90H21EOLACvtfcHk0lgZpJEiFMgt6Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvVKrtLk%253D&md5=9334b1b241d21b084f89b617a68cf86d</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0925%26sid%3Dliteratum%253Aachs%26aulast%3DRickles%26aufirst%3DR.%2BJ.%26aulast%3DTam%26aufirst%3DW.%2BF.%26aulast%3DGiordano%26aufirst%3DT.%2BP.%26aulast%3DPierce%26aufirst%3DL.%2BT.%26aulast%3DFarwell%26aufirst%3DM.%26aulast%3DMcMillin%26aufirst%3DD.%2BW.%26aulast%3DNecheva%26aufirst%3DA.%26aulast%3DCrowe%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DM.%26aulast%3DAvery%26aufirst%3DW.%26aulast%3DKansra%26aufirst%3DV.%26aulast%3DNavrocki%26aufirst%3DS.%2BT.%26aulast%3DCarew%26aufirst%3DJ.%2BS.%26aulast%3DGiles%26aufirst%3DF.%2BJ.%26aulast%3DMitsiades%26aufirst%3DC.%2BS.%26aulast%3DBorisy%26aufirst%3DA.%2BA.%26aulast%3DAnderson%26aufirst%3DK.%2BC.%26aulast%3DLee%26aufirst%3DM.%2BS.%26atitle%3DAdenosine%2520A2A%2520and%2520beta-2%2520adrenergic%2520receptor%2520agonists%253A%2520novel%2520selective%2520and%2520synergistic%2520multiple%2520myeloma%2520targets%2520discovered%2520through%2520systematic%2520combination%2520screening%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2012%26volume%3D11%26issue%3D7%26spage%3D1432%26epage%3D1442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group">Linden, J. M.; Rieger, J. M.; Mcdonald, T. L.; Sullivan, G. W.; Murphree, L. J.; Figler, R. A.</span><span> </span><span class="NLM_article-title">2-Propynyl Adenosine Analogs Having A<sub>2A</sub> Agonist Activity and Compositions Thereof</span>. U.S. Pat. Appl. US7737127 B2,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=J.+M.+Linden&author=J.+M.+Rieger&author=T.+L.+Mcdonald&author=G.+W.+Sullivan&author=L.+J.+Murphree&author=R.+A.+Figler&title=2-Propynyl+Adenosine+Analogs+Having+A2A+Agonist+Activity+and+Compositions+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLinden%26aufirst%3DJ.%2BM.%26atitle%3D2-Propynyl%2520Adenosine%2520Analogs%2520Having%2520A2A%2520Agonist%2520Activity%2520and%2520Compositions%2520Thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group">Gao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lasley, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elzein, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palle, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zablocki, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blackburn, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span> </span><span class="NLM_article-title">Novel short-acting A<sub>2A</sub> adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A<sub>2A</sub> agonists</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">â</span> <span class="NLM_lpage">218</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=11408544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksFChtbk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2001&pages=209-218&author=Z.+Gaoauthor=Z.+Liauthor=S.+P.+Bakerauthor=R.+D.+Lasleyauthor=S.+Meyerauthor=E.+Elzeinauthor=V.+Palleauthor=J.+A.+Zablockiauthor=B.+Blackburnauthor=L.+Belardinelli&title=Novel+short-acting+A2A+adenosine+receptor+agonists+for+coronary+vasodilation%3A+inverse+relationship+between+affinity+and+duration+of+action+of+A2A+agonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Novel short-acting A2A adenosine receptor agonists for coronary vasodilation: inverse relationship between affinity and duration of action of A2A agonists</span></div><div class="casAuthors">Gao, Zhenhai; Li, Zhihe; Baker, Stephen P.; Lasley, Robert D.; Meyer, Stephanie; Elzein, Elfatih; Palle, Venkata; Zablocki, Jeff A.; Blackburn, Brent; Belardinelli, Luiz</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">209-218</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Several potent and selective A2A adenosine receptor agonists are currently available.  These compds. have a high affinity for the A2A receptor and a long duration of action.  However, in situations where a short duration of action is desired, currently available A2A receptor agonists are less than ideal.  From a series of recently synthesized A2A receptor agonists, two agonists (CVT-3146 and CVT-3033) with low affinity were selected for further characterization as selective and short-acting coronary vasodilators.  Both compds. were selective for the A2A adenosine receptor (AdoR) vs. the A1, A2B, and A3AdoR in binding and functional studies.  CVT-3146 and CVT-3033 appeared to be weak partial agonists to cause cAMP accumulation in PC12 cells, but were full and potent agonists to cause coronary vasodilation, a response that has a very large A2A receptor reserve.  However, the durations of action of CVT-3146 and CVT-3033 were remarkably shorter than those of the high-affinity agonists CGS21680 or WRC0470, presumably due to the relative lower affinity of CVT-3146 and CVT-3033 for the A2A receptor.  Indeed, an inverse relation was found between the affinity of the various agonists for the A2A receptor and the duration of their actions.  These data indicate that low-affinity agonists can produce a response that is of equiv. magnitude but more rapid in termination than that caused by a high-affinity agonist.  Hence, the low-affinity A2A agonists CVT-3146 and CVT-3033 may prove to be superior to currently available high-affinity agonists as coronary vasodilators during myocardial imaging with radionuclide agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrHUi8guQpTbVg90H21EOLACvtfcHk0lgtO3Ye1_Llpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksFChtbk%253D&md5=737a2ee654cd919208e12b5043ab2349</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DBaker%26aufirst%3DS.%2BP.%26aulast%3DLasley%26aufirst%3DR.%2BD.%26aulast%3DMeyer%26aufirst%3DS.%26aulast%3DElzein%26aufirst%3DE.%26aulast%3DPalle%26aufirst%3DV.%26aulast%3DZablocki%26aufirst%3DJ.%2BA.%26aulast%3DBlackburn%26aufirst%3DB.%26aulast%3DBelardinelli%26aufirst%3DL.%26atitle%3DNovel%2520short-acting%2520A2A%2520adenosine%2520receptor%2520agonists%2520for%2520coronary%2520vasodilation%253A%2520inverse%2520relationship%2520between%2520affinity%2520and%2520duration%2520of%2520action%2520of%2520A2A%2520agonists%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2001%26volume%3D298%26spage%3D209%26epage%3D218" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group">Kirk, I. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, P. J.</span><span> </span><span class="NLM_article-title">Further characterization of [<sup>3</sup>H]-CGS21680 binding sites in the rat striatum and cortex</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">114</span><span class="NLM_x">, </span> <span class="NLM_fpage">537</span><span class="NLM_x">â</span> <span class="NLM_lpage">543</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1111%2Fj.1476-5381.1995.tb13260.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=7881753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK2MXjt12ltb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=1995&pages=537-543&author=I.+P.+Kirkauthor=P.+J.+Richardson&title=Further+characterization+of+%5B3H%5D-CGS21680+binding+sites+in+the+rat+striatum+and+cortex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Further characterization of [3H]-CGS 2168 binding sites in the rat striatum and cortex</span></div><div class="casAuthors">Kirk, Ian P.; Richardson, Peter J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">537-43</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The putative high affinity binding site for the adenosine A2A receptor agonist 2-p-(2-carboxyethyl)phenethylamino-5'-N-ethylcarboxamidoadenosine (CGS 21680) in the rat cerebral cortex was characterized by use of a no. of selective A1 and A2 adenosine receptor ligands, and compared to the characteristics of the more abundant striatal A2A receptor.  The binding of [3H]-CGS 21680 to cortical membranes was performed at pH 5.5, to increase the amt. of specific binding.  Redn. of the pH from 7.4 to 5.5 increased the apparent affinity of the striatal binding side for both agonists and antagonists.  The relative order of potencies of both groups of ligands were the same at both pH values, and were consistent with binding to the A2A receptor.  There was no observable change in the Bmax, the values being 415 and 446 fmol mg-1 protein at pH 5.5 and 7.4 resp.  The cortical binding site yielded a Bmax value of 117 fmol mg-1 protein.  The relative order of potencies of the adenosine receptor ligands obsd. at this binding site were not the same as those obsd. in the striatum, exhibiting a profile with both A1 and A2 characteristics.  Further characterization of this cortical binding site in the presence of A1 selective antagonist 1,3-dipropyl-8-cyclopentylxanthine (DPCPX) revealed a more typical A2A profile.  This indicated that under these conditions used there were two components of [3H]-CGS 21680 binding, approx. 20% of the A1 receptor and 80% to the A2A receptor.  It is concluded that in the cerebral cortex there is a CGS 21680 binding site showing the characteristic properties of the striatal A2A receptor, and no evidence was obtained for the existence of a novel A2A-like binding site.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGolg_eJ8W4ya7Vg90H21EOLACvtfcHk0lgtO3Ye1_Llpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXjt12ltb0%253D&md5=97de90da9dcf054bb52ce92a0f847ace</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1995.tb13260.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1995.tb13260.x%26sid%3Dliteratum%253Aachs%26aulast%3DKirk%26aufirst%3DI.%2BP.%26aulast%3DRichardson%26aufirst%3DP.%2BJ.%26atitle%3DFurther%2520characterization%2520of%2520%255B3H%255D-CGS21680%2520binding%2520sites%2520in%2520the%2520rat%2520striatum%2520and%2520cortex%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1995%26volume%3D114%26spage%3D537%26epage%3D543" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group">Jacobson, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Z.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goblyos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">Allosteric modulation of purine and pyrimidine receptors</span> <span class="citation_source-journal">Adv. Pharmacol. (San Diego, CA, U. S.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">187</span><span class="NLM_x">â</span> <span class="NLM_lpage">220</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2FB978-0-12-385526-8.00007-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=21586360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXpsVKmsL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=187-220&author=K.+A.+Jacobsonauthor=Z.-G.+Gaoauthor=A.+Goblyosauthor=A.+P.+Ijzerman&title=Allosteric+modulation+of+purine+and+pyrimidine+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Allosteric modulation of purine and pyrimidine receptors</span></div><div class="casAuthors">Jacobson, Kenneth A.; Gao, Zhan-Guo; Goblyos, Aniko; Ijzerman, Adriaan P.</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Pharmacology (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">Pharmacology of Purine and Pyrimidine Receptors</span>),
    <span class="NLM_cas:pages">187-220</span>CODEN:
                <span class="NLM_cas:coden">ADPHEL</span>;
        ISSN:<span class="NLM_cas:issn">1054-3589</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  Among the purine and pyrimidine receptors, the discovery of small mol. allosteric modulators has been most highly advanced for the A1 and A3 adenosine receptors (ARs).  These AR modulators have allosteric effects that are structurally sepd. from the orthosteric effects in SAR studies.  The benzoylthiophene derivs. tend to act as allosteric agonists as well as selective pos. allosteric modulators (PAMs) of the A1 AR.  A 2-amino-3-aroylthiophene deriv. T-62 has been under development as a PAM of the A1 AR for the treatment of chronic pain.  Several structurally distinct classes of allosteric modulators of the human A3 AR have been reported: 3-(2-pyridinyl)isoquinolines, 2,4-disubstituted quinolines, 1H-imidazo-[4,5-c]quinolin-4-amines, endocannabinoid 2-arachidonylglycerol, and the food dye Brilliant Black BN.  Site-directed mutagenesis of A1 and A3 ARs has identified residues assocd. with the allosteric effect, distinct from those that affect orthosteric binding.  A few small mol. allosteric modulators have been reported for several of the P2X ligand-gated ion channels and the G protein-coupled P2Y receptor nucleotides.  Metal ion modulation of the P2X receptors has been extensively explored.  The allosteric approach to modulation of purine and pyrimidine receptors looks promising for development of drugs that are event and site specific in action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrf8nqRx1ZoQ7Vg90H21EOLACvtfcHk0lgtO3Ye1_Llpg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXpsVKmsL4%253D&md5=418a4cd16efc876f25597cca2189cc34</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-385526-8.00007-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-385526-8.00007-2%26sid%3Dliteratum%253Aachs%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DGoblyos%26aufirst%3DA.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DAllosteric%2520modulation%2520of%2520purine%2520and%2520pyrimidine%2520receptors%26jtitle%3DAdv.%2520Pharmacol.%2520%2528San%2520Diego%252C%2520CA%252C%2520U.%2520S.%2529%26date%3D2011%26volume%3D61%26spage%3D187%26epage%3D220" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group">Gao, Z.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobson, K. A.</span><span> </span><span class="NLM_article-title">Allosteric modulation of the adenosine family of receptors</span> <span class="citation_source-journal">Mini-Rev. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">545</span><span class="NLM_x">â</span> <span class="NLM_lpage">553</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=545-553&author=Z.-G.+Gaoauthor=S.-K.+Kimauthor=A.+P.+Ijzermanauthor=K.+A.+Jacobson&title=Allosteric+modulation+of+the+adenosine+family+of+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.-G.%26aulast%3DKim%26aufirst%3DS.-K.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26aulast%3DJacobson%26aufirst%3DK.%2BA.%26atitle%3DAllosteric%2520modulation%2520of%2520the%2520adenosine%2520family%2520of%2520receptors%26jtitle%3DMini-Rev.%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D545%26epage%3D553" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group">Gao, Z. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ijzerman, A. P.</span><span> </span><span class="NLM_article-title">Allosteric modulation of A<sub>2A</sub> adenosine receptors by amiloride analogs and sodium ions</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">669</span><span class="NLM_x">â</span> <span class="NLM_lpage">676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=669-676&author=Z.+G.+Gaoauthor=A.+P.+Ijzerman&title=Allosteric+modulation+of+A2A+adenosine+receptors+by+amiloride+analogs+and+sodium+ions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DZ.%2BG.%26aulast%3DIjzerman%26aufirst%3DA.%2BP.%26atitle%3DAllosteric%2520modulation%2520of%2520A2A%2520adenosine%2520receptors%2520by%2520amiloride%2520analogs%2520and%2520sodium%2520ions%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2000%26volume%3D60%26spage%3D669%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group">Giorgi, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biagi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bianucci, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borghini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Livi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pietra, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calderone, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martelli, A.</span><span> </span><span class="NLM_article-title"><i>N</i>6-1,3-Diphenylurea derivatives of 2-phenyl-9-benzyladenines and 8-azaadenines: synthesis and biological evaluation as allosteric modulators of A<sub>2A</sub> adenosine receptors</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">1639</span><span class="NLM_x">â</span> <span class="NLM_lpage">1647</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2008&pages=1639-1647&author=I.+Giorgiauthor=G.+Biagiauthor=A.+M.+Bianucciauthor=A.+Borghiniauthor=O.+Liviauthor=M.+Leonardiauthor=D.+Pietraauthor=V.+Calderoneauthor=A.+Martelli&title=N6-1%2C3-Diphenylurea+derivatives+of+2-phenyl-9-benzyladenines+and+8-azaadenines%3A+synthesis+and+biological+evaluation+as+allosteric+modulators+of+A2A+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGiorgi%26aufirst%3DI.%26aulast%3DBiagi%26aufirst%3DG.%26aulast%3DBianucci%26aufirst%3DA.%2BM.%26aulast%3DBorghini%26aufirst%3DA.%26aulast%3DLivi%26aufirst%3DO.%26aulast%3DLeonardi%26aufirst%3DM.%26aulast%3DPietra%26aufirst%3DD.%26aulast%3DCalderone%26aufirst%3DV.%26aulast%3DMartelli%26aufirst%3DA.%26atitle%3DN6-1%252C3-Diphenylurea%2520derivatives%2520of%25202-phenyl-9-benzyladenines%2520and%25208-azaadenines%253A%2520synthesis%2520and%2520biological%2520evaluation%2520as%2520allosteric%2520modulators%2520of%2520A2A%2520adenosine%2520receptors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2008%26volume%3D43%26spage%3D1639%26epage%3D1647" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group">Parkinson, J.</span><span> </span><span class="NLM_article-title">An essay on the shaking palsy</span> <span class="citation_source-journal">J. Neurosychiatry Clin. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">â</span> <span class="NLM_lpage">236</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1176%2Fappi.neuropsych.14.2.223" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2002&pages=223-236&issue=2&author=J.+Parkinson&title=An+essay+on+the+shaking+palsy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1176%2Fappi.neuropsych.14.2.223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.neuropsych.14.2.223%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DJ.%26atitle%3DAn%2520essay%2520on%2520the%2520shaking%2520palsy%26jtitle%3DJ.%2520Neurosychiatry%2520Clin.%2520Neurosci.%26date%3D2002%26volume%3D14%26issue%3D2%26spage%3D223%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">The original article was published as a short monograph in an assay on the shaking palsy. London, 1817.</p></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">The pathogenesis of cell death in Parkinsonâs disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 10)</span><span class="NLM_x">) </span> <span class="NLM_fpage">S24</span><span class="NLM_x">â</span> <span class="NLM_lpage">S36</span><div class="note"><p class="first last">and references therein.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2006&pages=S24-S36&issue=Suppl.+10%29&author=P.+Jennerauthor=C.+W.+Olanow&title=The+pathogenesis+of+cell+death+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DThe%2520pathogenesis%2520of%2520cell%2520death%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D2006%26volume%3D66%26issue%3DSuppl.%252010%2529%26spage%3DS24%26epage%3DS36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group">Lozano, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutchison, W. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dostrovsky, J. O.</span><span> </span><span class="NLM_article-title">New developments in understanding the etiology of Parkinsonâs disease and in its treatment</span> <span class="citation_source-journal">Curr. Opin. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">783</span><span class="NLM_x">â</span> <span class="NLM_lpage">790</span><div class="note"><p class="first last">and Parkinsonâs disease, National Parkinson Foundation, Miami, FL, U.S., <a href="http://www.parkinson.org/parkinson-s-disease.aspx" class="extLink">www.parkinson.org/parkinson-s-disease.aspx</a></p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=783-790&author=A.+M.+Lozanoauthor=A.+E.+Langauthor=W.+D.+Hutchisonauthor=J.+O.+Dostrovsky&title=New+developments+in+understanding+the+etiology+of+Parkinson%E2%80%99s+disease+and+in+its+treatment"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLozano%26aufirst%3DA.%2BM.%26aulast%3DLang%26aufirst%3DA.%2BE.%26aulast%3DHutchison%26aufirst%3DW.%2BD.%26aulast%3DDostrovsky%26aufirst%3DJ.%2BO.%26atitle%3DNew%2520developments%2520in%2520understanding%2520the%2520etiology%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520in%2520its%2520treatment%26jtitle%3DCurr.%2520Opin.%2520Neurobiol.%26date%3D1998%26volume%3D8%26spage%3D783%26epage%3D790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group">Mercuri, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bernardi, G.</span><span> </span><span class="NLM_article-title">The âmagicâ of L-dopa: Why is it the gold standard Parkinsonâs disease therapy?</span> <span class="citation_source-journal">Trends Pharmacol. Sci</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">341</span><span class="NLM_x">â</span> <span class="NLM_lpage">344</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2005&pages=341-344&issue=7&author=N.+B.+Mercuriauthor=G.+Bernardi&title=The+%E2%80%9Cmagic%E2%80%9D+of+L-dopa%3A+Why+is+it+the+gold+standard+Parkinson%E2%80%99s+disease+therapy%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMercuri%26aufirst%3DN.%2BB.%26aulast%3DBernardi%26aufirst%3DG.%26atitle%3DThe%2520%25E2%2580%259Cmagic%25E2%2580%259D%2520of%2520L-dopa%253A%2520Why%2520is%2520it%2520the%2520gold%2520standard%2520Parkinson%25E2%2580%2599s%2520disease%2520therapy%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci%26date%3D2005%26volume%3D26%26issue%3D7%26spage%3D341%26epage%3D344" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group">Yamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schapira, A. H. V.</span><span> </span><span class="NLM_article-title">Dopamine agonists in Parkinsonâs disease</span> <span class="citation_source-journal">Expert Rev. Neurother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">671</span><span class="NLM_x">â</span> <span class="NLM_lpage">677</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1586%2F14737175.8.4.671" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=18416667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFSht70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2008&pages=671-677&author=M.+Yamamotoauthor=A.+H.+V.+Schapira&title=Dopamine+agonists+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine agonists in Parkinson's disease</span></div><div class="casAuthors">Yamamoto, Mitsutoshi; Schapira, Anthony H. V.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Review of Neurotherapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">671-677</span>CODEN:
                <span class="NLM_cas:coden">ERNXAR</span>;
        ISSN:<span class="NLM_cas:issn">1473-7175</span>.
    
            (<span class="NLM_cas:orgname">Future Drugs Ltd.</span>)
        </div><div class="casAbstract">A review.  Dopamine agonists are established as effective drugs for the symptomatic treatment of Parkinson's disease (PD) throughout its course.  As monotherapy, they produce effective control of motor symptoms and combine this with a low risk for motor complications.  As an adjunct to levodopa, they improve motor control and limit the need for levodopa in those patients in whom this may be considered relevant.  The non-ergot dopamine agonists in particular have a good safety profile, although as with other agonists, sedation, and cognitive and behavioral problems may be limiting in some patients.  Pramipexole has shown benefit in improving depressive symptoms in PD.  Ropinirole and pramipexole have both demonstrated a redn. in the rate of loss of nigrostriatal innervation as detd. by imaging in PD patients, when compared with levodopa.  Thus, dopamine agonists contribute to several dimensions of the management of PD and have become an integral part of the disease treatment algorithm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxVM_IekUXprVg90H21EOLACvtfcHk0lgjB-fMsnX3lw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFSht70%253D&md5=9a145ab9c49de374322fb02fe543d4ad</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1586%2F14737175.8.4.671&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1586%252F14737175.8.4.671%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DM.%26aulast%3DSchapira%26aufirst%3DA.%2BH.%2BV.%26atitle%3DDopamine%2520agonists%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DExpert%2520Rev.%2520Neurother.%26date%3D2008%26volume%3D8%26spage%3D671%26epage%3D677" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group">Hansard, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheetam, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">Dopamine, but not norepinephrine or serotonin reuptake inhibition reverse motor deficts in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">303</span><span class="NLM_x">, </span> <span class="NLM_fpage">952</span><span class="NLM_x">â</span> <span class="NLM_lpage">958</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1124%2Fjpet.102.039743" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=12438514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD38Xptlamt7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=303&publication_year=2002&pages=952-958&author=M.+J.+Hansardauthor=L.+A.+Smithauthor=M.+J.+Jacksonauthor=S.+C.+Cheetamauthor=P.+Jenner&title=Dopamine%2C+but+not+norepinephrine+or+serotonin+reuptake+inhibition+reverse+motor+deficts+in+1-methyl-4-phenyl-1%2C2%2C3%2C6-tetrahydropyridine-treated+primates"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Dopamine, but not norepinephrine or serotonin, reuptake inhibition reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates</span></div><div class="casAuthors">Hansard, Matthew J.; Smith, Lance A.; Jackson, Michael J.; Cheetham, Sharon C.; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">303</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">952-958</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Monoamine reuptake inhibitors that do not discriminate between the transporters for dopamine (DA), norepinephrine (NE), or 5-hydroxytryptamine (5-HT, serotonin) can reverse locomotor deficits and motor disability in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosets.  DA reuptake inhibition is presumed to be primarily responsible, but the role played by inhibition of NE and 5-HT reuptake is unknown.  This work evaluated the efficacy of a range of monoamine reuptake inhibitors either alone or in combination in MPTP-treated common marmosets to det. the actions required for effective antiparkinsonian activity.  Monoamine reuptake inhibitors not discriminating between the DA, NE, and 5-HT transporters [1-[1-(3,4-dichlororphenyl)cyclobutyl]-2-(3-diaminethylaminopropylthio)ethanone monocitrate (BTS 74 398) and nomifensine] reversed locomotor deficits and motor disability in MPTP-treated marmosets but bupropion was without effect.  The selective DA reuptake inhibitor 1-(2-(bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine dihydrochloride (GBR 12909) also reversed these motor deficits.  The relative efficacy of the compds. (BTS 74 398 > GBR 12909 > nomifensine Â» bupropion) paralleled their previously detd. potency in inhibiting DA uptake in vitro and in vivo.  In contrast, the selective NE reuptake inhibitor nisoxetine and the 5-HT reuptake inhibitor sertraline administered alone failed to improve motor function and tended to worsen the deficits.  Coadministration of nisoxetine attenuated the improvement in motor deficits produced by GBR 12909.  Coadministration of sertraline also abolished the reversal of motor deficits produced by GBR 12909.  Coadministration of both sertraline and nisoxetine similarly abolished the improvement of motor deficits produced by GBR 12909.  Mols. possessing potent DA reuptake inhibitory activity may be useful in the treatment of the motor symptoms of Parkinson's disease.  In contrast, there seems to be no role for NE or 5-HT reuptake inhibitors, and they may impair antiparkinsonian activity mediated through dopaminergic mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprkAiG5hgKS7Vg90H21EOLACvtfcHk0lgjB-fMsnX3lw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xptlamt7g%253D&md5=f5b88eadd0c931fe318d49b4701b8760</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1124%2Fjpet.102.039743&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.102.039743%26sid%3Dliteratum%253Aachs%26aulast%3DHansard%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DCheetam%26aufirst%3DS.%2BC.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DDopamine%252C%2520but%2520not%2520norepinephrine%2520or%2520serotonin%2520reuptake%2520inhibition%2520reverse%2520motor%2520deficts%2520in%25201-methyl-4-phenyl-1%252C2%252C3%252C6-tetrahydropyridine-treated%2520primates%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2002%26volume%3D303%26spage%3D952%26epage%3D958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group">Olanow, C. W.</span><span> </span><span class="NLM_article-title">MAO-B inhibitors in Parkinsonâs disease</span> <span class="citation_source-journal">Adv. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">666</span><span class="NLM_x">â</span> <span class="NLM_lpage">671</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=8420207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK3sXktF2lurw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1993&pages=666-671&author=C.+W.+Olanow&title=MAO-B+inhibitors+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">MAO-B inhibitors in Parkinson's disease</span></div><div class="casAuthors">Olanow, C. Warren</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Neurology</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">Parkinson's Disease</span>),
    <span class="NLM_cas:pages">666-71</span>CODEN:
                <span class="NLM_cas:coden">ADNRA3</span>;
        ISSN:<span class="NLM_cas:issn">0091-3952</span>.
    </div><div class="casAbstract">A review with 46 ref.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQFDRpN_SkdrVg90H21EOLACvtfcHk0lgjB-fMsnX3lw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXktF2lurw%253D&md5=e90fcc306d9c58991fe71c94a48e5fba</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26atitle%3DMAO-B%2520inhibitors%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DAdv.%2520Neurol.%26date%3D1993%26volume%3D60%26spage%3D666%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group">Gordin, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brooks, D. J.</span><span> </span><span class="NLM_article-title">Clinical pharmacology and therapeutic use of COMT inhibition in Parkinsonâs disease</span> <span class="citation_source-journal">J. Neurol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">254</span><span class="NLM_x">, </span> <span class="NLM_fpage">IV/37</span><span class="NLM_x">â</span> <span class="NLM_lpage">IV/48</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=254&publication_year=2007&pages=IV%2F37-IV%2F48&author=A.+Gordinauthor=D.+J.+Brooks&title=Clinical+pharmacology+and+therapeutic+use+of+COMT+inhibition+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGordin%26aufirst%3DA.%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26atitle%3DClinical%2520pharmacology%2520and%2520therapeutic%2520use%2520of%2520COMT%2520inhibition%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurol.%26date%3D2007%26volume%3D254%26spage%3DIV%252F37%26epage%3DIV%252F48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Olanow, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stern, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sethi, K.</span><span> </span><span class="NLM_article-title">The scientific and clinical basis for the treatment of Parkinson disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x"> (</span><span class="NLM_issue">21, Suppl. 4</span><span class="NLM_x">) </span> <span class="NLM_fpage">S1</span><span class="NLM_x">â</span> <span class="NLM_lpage">S136</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2009&pages=S1-S136&issue=21%2C+Suppl.+4&author=C.+W.+Olanowauthor=M.+B.+Sternauthor=K.+Sethi&title=The+scientific+and+clinical+basis+for+the+treatment+of+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOlanow%26aufirst%3DC.%2BW.%26aulast%3DStern%26aufirst%3DM.%2BB.%26aulast%3DSethi%26aufirst%3DK.%26atitle%3DThe%2520scientific%2520and%2520clinical%2520basis%2520for%2520the%2520treatment%2520of%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D2009%26volume%3D72%26issue%3D21%252C%2520Suppl.%25204%26spage%3DS1%26epage%3DS136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit124b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Antonini, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clilia, R.</span><span> </span><span class="NLM_article-title">Behavioural adverse effects of dopaminergic treatments in Parkinsonâs disease: incidence, neurobiological basis, management and prevention</span> <span class="citation_source-journal">Drug Safety</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">475</span><span class="NLM_x">â</span> <span class="NLM_lpage">488</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2009&pages=475-488&author=A.+Antoniniauthor=R.+Clilia&title=Behavioural+adverse+effects+of+dopaminergic+treatments+in+Parkinson%E2%80%99s+disease%3A+incidence%2C+neurobiological+basis%2C+management+and+prevention"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit124b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAntonini%26aufirst%3DA.%26aulast%3DClilia%26aufirst%3DR.%26atitle%3DBehavioural%2520adverse%2520effects%2520of%2520dopaminergic%2520treatments%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520incidence%252C%2520neurobiological%2520basis%252C%2520management%2520and%2520prevention%26jtitle%3DDrug%2520Safety%26date%3D2009%26volume%3D32%26spage%3D475%26epage%3D488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group">Bonuccelli, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del Dotto, P.</span><span> </span><span class="NLM_article-title">New pharmacologic horizons in the treatment of Parkinson disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x"> (</span><span class="NLM_issue">7, Suppl. 2</span><span class="NLM_x">) </span> <span class="NLM_fpage">S30</span><span class="NLM_x">â</span> <span class="NLM_lpage">S38</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2006&pages=S30-S38&issue=7%2C+Suppl.+2&author=U.+Bonuccelliauthor=P.+Del+Dotto&title=New+pharmacologic+horizons+in+the+treatment+of+Parkinson+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBonuccelli%26aufirst%3DU.%26aulast%3DDel%2BDotto%26aufirst%3DP.%26atitle%3DNew%2520pharmacologic%2520horizons%2520in%2520the%2520treatment%2520of%2520Parkinson%2520disease%26jtitle%3DNeurology%26date%3D2006%26volume%3D67%26issue%3D7%252C%2520Suppl.%25202%26spage%3DS30%26epage%3DS38" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schwarzschild, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agnati, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuxe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, M.</span><span> </span><span class="NLM_article-title">Targeting adenosine A<sub>2A</sub> receptors in Parkinsonâs disease</span> <span class="citation_source-journal">Trends Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">647</span><span class="NLM_x">â</span> <span class="NLM_lpage">654</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2006&pages=647-654&issue=11&author=M.+A.+Schwarzschildauthor=L.+Agnatiauthor=K.+Fuxeauthor=J.+F.+Chenauthor=M.+Morelli&title=Targeting+adenosine+A2A+receptors+in+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit126a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchwarzschild%26aufirst%3DM.%2BA.%26aulast%3DAgnati%26aufirst%3DL.%26aulast%3DFuxe%26aufirst%3DK.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26aulast%3DMorelli%26aufirst%3DM.%26atitle%3DTargeting%2520adenosine%2520A2A%2520receptors%2520in%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DTrends%2520Neurosci.%26date%3D2006%26volume%3D29%26issue%3D11%26spage%3D647%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit126b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Salamone, J. D.</span><span> </span><span class="NLM_article-title">Facing dyskinesia in Parkinsonâs disease: nondopaminergic approaches</span> <span class="citation_source-journal">Drugs Future</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">35</span><span class="NLM_x">, </span> <span class="NLM_fpage">567</span><span class="NLM_x">â</span> <span class="NLM_lpage">573</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1358%2Fdof.2010.035.07.1516041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlems7nJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2010&pages=567-573&author=J.+D.+Salamone&title=Facing+dyskinesia+in+Parkinson%E2%80%99s+disease%3A+nondopaminergic+approaches"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126bR"><div class="casContent"><span class="casTitleNuber">126b</span><div class="casTitle"><span class="NLM_cas:atitle">Facing dyskinesia in Parkinson's disease: nondopaminergic approaches</span></div><div class="casAuthors">Salamone, J. D.</div><div class="citationInfo"><span class="NLM_cas:title">Drugs of the Future</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">567-573</span>CODEN:
                <span class="NLM_cas:coden">DRFUD4</span>;
        ISSN:<span class="NLM_cas:issn">0377-8282</span>.
    
            (<span class="NLM_cas:orgname">Prous Science</span>)
        </div><div class="casAbstract">A review.  L-DOPA has been the gold std. for the treatment of Parkinson's disease for the last 5 decades.  Nevertheless, problems with long-term use, such as motor fluctuations and dyskinesias, have led investigators to search for alternative therapies and for various approaches designed to minimize or ameliorate dyskinesias.  Dopaminergic strategies are being studied, including continuous drug infusion.  Moreover, non-dopaminergic approaches such as serotonergic agents, adenosine A2A receptor antagonists and amantadine are also being investigated.  Serotonin 5-HT2A receptor antagonists and 5-HT1A receptor agonists have been studied for their antidyskinetic effects.  Adenosine A2A receptor antagonists exert antiparkinsonian effects in animal models and several candidates have progressed to phase II or III clin. testing.  Generally, these agents have been shown to decrease L-DOPA "off" time and increase "on" time, without worsening L-DOPA-induced dyskinesias.  Of all the drugs tested so far, amantadine appears to produce the most consistent antidyskinetic actions.  In conclusion, numerous approaches appear to offer promise for the management of dyskinesias, one of the most troubling aspects of the current treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfZky7YUA737Vg90H21EOLACvtfcHk0li2r64phJ6Kag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlems7nJ&md5=3a61e4d753eb2c3d0c57acde5f2e6e8a</span></div><a href="/servlet/linkout?suffix=cit126b&amp;dbid=16384&amp;doi=10.1358%2Fdof.2010.035.07.1516041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1358%252Fdof.2010.035.07.1516041%26sid%3Dliteratum%253Aachs%26aulast%3DSalamone%26aufirst%3DJ.%2BD.%26atitle%3DFacing%2520dyskinesia%2520in%2520Parkinson%25E2%2580%2599s%2520disease%253A%2520nondopaminergic%2520approaches%26jtitle%3DDrugs%2520Future%26date%3D2010%26volume%3D35%26spage%3D567%26epage%3D573" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group">Fink, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weaver, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivkees, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterfreund, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollack, A. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adler, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reppert, S. M.</span><span> </span><span class="NLM_article-title">Molecular cloning of the rat A<sub>2</sub> adenosine receptor: selective co-expression with D<sub>2</sub> dopamine receptors in rat striatum</span> <span class="citation_source-journal">Mol. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">â</span> <span class="NLM_lpage">195</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2F0169-328X%2892%2990173-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=1279342" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK3sXhvVelt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=1992&pages=186-195&author=J.+S.+Finkauthor=D.+R.+Weaverauthor=S.+A.+Rivkeesauthor=R.+A.+Peterfreundauthor=A.+E.+Pollackauthor=E.+M.+Adlerauthor=S.+M.+Reppert&title=Molecular+cloning+of+the+rat+A2+adenosine+receptor%3A+selective+co-expression+with+D2+dopamine+receptors+in+rat+striatum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum</span></div><div class="casAuthors">Fink, J. Stephen; Weaver, David R.; Rivkees, Scott A.; Peterfreund, Robert A.; Pollack, Alexia E.; Adler, Elizabeth M.; Reppert, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Brain Research</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">186-95</span>CODEN:
                <span class="NLM_cas:coden">MBREE4</span>;
        ISSN:<span class="NLM_cas:issn">0169-328X</span>.
    </div><div class="casAbstract">A cDNA fragment homologous to other G protein-coupled receptors was isolated from rat brain using the PCR method and demonstrated to be abundantly expressed in striatum.  Using this fragment as a probe, a 2.1 kb full-length cDNA was isolated from a rat striatal cDNA library.  This cDNA encodes a protein of 410 amino acids and is highly homologous to previously isolated adenosine receptor cDNA.  Expression of this cDNA in COS cells revealed high affinity (Kd = 38.6 nM) and saturable binding of the A2 adenosine receptor-selective ligand [3H]CGS 21680.  Agonist displacement profile of [3H]CGS 21680 binding was consistent with an adenosine receptor of the A2 subtype (NECA > (R)-PIA > CPA > (S)-PIA).  In situ hybridization demonstrated that rat A2 adenosine receptor mRNA was co-expressed in the same striatal neurons as D2 dopamine receptor mRNA, and never co-expressed with striatal D1 dopamine receptor mRNA.  Several lines of evidence have previously suggested that dopamine-induced changes in motor behavior can be modulated by adenosine analogs acting at the A2 subtype of adenosine receptor in the forebrain.  The co-expression of D2 dopamine and A2 adenosine receptors in a subset of striatal cells provides an anatomical basis for dopaminergic-adenosinergic interactions on motor behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2Daq1pagx8bVg90H21EOLACvtfcHk0li2r64phJ6Kag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhvVelt7o%253D&md5=c625968121ce9599d80d0d7cad3e1b56</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1016%2F0169-328X%2892%2990173-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0169-328X%252892%252990173-9%26sid%3Dliteratum%253Aachs%26aulast%3DFink%26aufirst%3DJ.%2BS.%26aulast%3DWeaver%26aufirst%3DD.%2BR.%26aulast%3DRivkees%26aufirst%3DS.%2BA.%26aulast%3DPeterfreund%26aufirst%3DR.%2BA.%26aulast%3DPollack%26aufirst%3DA.%2BE.%26aulast%3DAdler%26aufirst%3DE.%2BM.%26aulast%3DReppert%26aufirst%3DS.%2BM.%26atitle%3DMolecular%2520cloning%2520of%2520the%2520rat%2520A2%2520adenosine%2520receptor%253A%2520selective%2520co-expression%2520with%2520D2%2520dopamine%2520receptors%2520in%2520rat%2520striatum%26jtitle%3DMol.%2520Brain%2520Res.%26date%3D1992%26volume%3D14%26spage%3D186%26epage%3D195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group">Ungerstedt, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arbuthnott, G. W.</span><span> </span><span class="NLM_article-title">Quantitative recording of rotational behavior in rats after 6-hyroxy-dopamine lesions of the nigrostriatal dopamine system</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1970</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">485</span><span class="NLM_x">â</span> <span class="NLM_lpage">493</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2F0006-8993%2870%2990187-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=5494536" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADyaE3M%252Fotl2msA%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=1970&pages=485-493&author=U.+Ungerstedtauthor=G.+W.+Arbuthnott&title=Quantitative+recording+of+rotational+behavior+in+rats+after+6-hyroxy-dopamine+lesions+of+the+nigrostriatal+dopamine+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system</span></div><div class="casAuthors">Ungerstedt U; Arbuthnott G W</div><div class="citationInfo"><span class="NLM_cas:title">Brain research</span>
        (<span class="NLM_cas:date">1970</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">485-93</span>
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxWjpxbmSViUg6wdEZmT2rfW6udTcc2eZ0VqNUrGxc07ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE3M%252Fotl2msA%253D%253D&md5=e31a2eee4f4fff68329c0ab8a8a62788</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2F0006-8993%2870%2990187-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0006-8993%252870%252990187-3%26sid%3Dliteratum%253Aachs%26aulast%3DUngerstedt%26aufirst%3DU.%26aulast%3DArbuthnott%26aufirst%3DG.%2BW.%26atitle%3DQuantitative%2520recording%2520of%2520rotational%2520behavior%2520in%2520rats%2520after%25206-hyroxy-dopamine%2520lesions%2520of%2520the%2520nigrostriatal%2520dopamine%2520system%26jtitle%3DBrain%2520Res.%26date%3D1970%26volume%3D24%26spage%3D485%26epage%3D493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group">Campos-Romo, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojeda-Flores, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreno-Briseno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fernadez-Ruiz, J.</span><span> </span><span class="NLM_article-title">Quantitative evaluation of MPTP-treated nonhuman pakinsonian primates in the hallway task</span> <span class="citation_source-journal">J. Neurosci. Methods</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">177</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="NLM_x">â</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.jneumeth.2008.10.026" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2009&pages=36-368&author=A.+Campos-Romoauthor=R.+Ojeda-Floresauthor=P.+Moreno-Brisenoauthor=J.+Fernadez-Ruiz&title=Quantitative+evaluation+of+MPTP-treated+nonhuman+pakinsonian+primates+in+the+hallway+task"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1016%2Fj.jneumeth.2008.10.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jneumeth.2008.10.026%26sid%3Dliteratum%253Aachs%26aulast%3DCampos-Romo%26aufirst%3DA.%26aulast%3DOjeda-Flores%26aufirst%3DR.%26aulast%3DMoreno-Briseno%26aufirst%3DP.%26aulast%3DFernadez-Ruiz%26aufirst%3DJ.%26atitle%3DQuantitative%2520evaluation%2520of%2520MPTP-treated%2520nonhuman%2520pakinsonian%2520primates%2520in%2520the%2520hallway%2520task%26jtitle%3DJ.%2520Neurosci.%2520Methods%26date%3D2009%26volume%3D177%26spage%3D36%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group">Bara-Jimenez, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherzai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dimitrova, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Favit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bibbiani, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morris, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouradian, M. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, T. N.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonist treatment of Parkinsonâs disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">293</span><span class="NLM_x">â</span> <span class="NLM_lpage">296</span><div class="note"><p class="first last">and references therein</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=293-296&author=W.+Bara-Jimenezauthor=A.+Sherzaiauthor=T.+Dimitrovaauthor=A.+Favitauthor=F.+Bibbianiauthor=M.+Gillespieauthor=M.+J.+Morrisauthor=M.+M.+Mouradianauthor=T.+N.+Chase&title=Adenosine+A2A+receptor+antagonist+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBara-Jimenez%26aufirst%3DW.%26aulast%3DSherzai%26aufirst%3DA.%26aulast%3DDimitrova%26aufirst%3DT.%26aulast%3DFavit%26aufirst%3DA.%26aulast%3DBibbiani%26aufirst%3DF.%26aulast%3DGillespie%26aufirst%3DM.%26aulast%3DMorris%26aufirst%3DM.%2BJ.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26aulast%3DChase%26aufirst%3DT.%2BN.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonist%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3D293%26epage%3D296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">jackson, P. F.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptor antagonists and Parkinsonâs disease</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">â</span> <span class="NLM_lpage">567</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn2000537" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref131/cit131a&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosVSrsrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=555-567&author=B.+C.+Shookauthor=P.+F.+jackson&title=Adenosine+A2A+receptor+antagonists+and+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131aR"><div class="casContent"><span class="casTitleNuber">131a</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine A2A Receptor Antagonists and Parkinson's Disease</span></div><div class="casAuthors">Shook, Brian C.; Jackson, Paul F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">555-567</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This Review summarizes and updates the work on adenosine A2A receptor antagonists for Parkinson's disease from 2006 to the present.  There have been numerous publications, patent applications, and press releases within this time frame that highlight new medicinal chem. approaches to this attractive and promising target to treat Parkinson's disease.  The Review is broken down by scaffold type and will discuss the efforts to optimize particular scaffolds for activity, pharmacokinetics, and other drug discovery parameters.  The majority of approaches focus on prepg. selective A2A antagonists, but a few approaches to dual A2A/A1 antagonists will also be highlighted.  The in vivo profiles of compds. will be highlighted and discussed to compare activities across different chem. series.  A clin. report and update will be given on compds. that have entered clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9jbqVC-a6P7Vg90H21EOLACvtfcHk0ljtB1Rp6y06Wg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosVSrsrc%253D&md5=81746259f96dd1a270f12c3cb2dbe1d3</span></div><a href="/servlet/linkout?suffix=cit131a&amp;dbid=16384&amp;doi=10.1021%2Fcn2000537&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn2000537%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3Djackson%26aufirst%3DP.%2BF.%26atitle%3DAdenosine%2520A2A%2520receptor%2520antagonists%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2011%26volume%3D2%26spage%3D555%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit131b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Armentero, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinna, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferre, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanciego, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Muller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Franco, R.</span><span> </span><span class="NLM_article-title">Past, present and future of A<sub>2A</sub> adenosine receptor antagonists in the therapy of Parkinsonâs disease</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">132</span><span class="NLM_x">, </span> <span class="NLM_fpage">280</span><span class="NLM_x">â</span> <span class="NLM_lpage">299</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.pharmthera.2011.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=21810444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtl2ntrzP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2011&pages=280-299&author=M.+T.+Armenteroauthor=A.+Pinnaauthor=S.+Ferreauthor=J.+L.+Lanciegoauthor=C.+E.+Mullerauthor=R.+Franco&title=Past%2C+present+and+future+of+A2A+adenosine+receptor+antagonists+in+the+therapy+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131bR"><div class="casContent"><span class="casTitleNuber">131b</span><div class="casTitle"><span class="NLM_cas:atitle">Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease</span></div><div class="casAuthors">Armentero, Marie Therese; Pinna, Annalisa; Ferre, Sergi; Lanciego, Jose Luis; Mueller, Christa E.; Franco, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">280-299</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Several selective antagonists for adenosine A2A receptors (A2AR) are currently under evaluation in clin. trials (phases I to III) to treat Parkinson's disease, and they will probably soon reach the market.  The usefulness of these antagonists has been deduced from studies demonstrating functional interactions between dopamine D2 and adenosine A2A receptors in the basal ganglia.  At present it is believed that A2AR antagonists can be used in combination with the dopamine precursor L-DOPA to minimize the motor symptoms of Parkinson's patients.  However, a considerable body of data indicates that in addn. to ameliorating motor symptoms, adenosine A2AR antagonists may also prevent neurodegeneration.  Despite these promising indications, one further issue must be considered in order to develop fully optimized antiparkinsonian drug therapy, namely the existence of (hetero)dimers/oligomers of G protein-coupled receptors, a topic that is currently the focus of intense debate within the scientific community.  Dopamine D2 receptors (D2Rs) expressed in the striatum are known to form heteromers with A2A adenosine receptors.  Thus, the development of heteromer-specific A2A receptor antagonists represents a promising strategy for the identification of more selective and safer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2pOYdmdfQMLVg90H21EOLACvtfcHk0ljtB1Rp6y06Wg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtl2ntrzP&md5=39fa871338516f7574deb7845029e624</span></div><a href="/servlet/linkout?suffix=cit131b&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2011.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2011.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DArmentero%26aufirst%3DM.%2BT.%26aulast%3DPinna%26aufirst%3DA.%26aulast%3DFerre%26aufirst%3DS.%26aulast%3DLanciego%26aufirst%3DJ.%2BL.%26aulast%3DMuller%26aufirst%3DC.%2BE.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DPast%252C%2520present%2520and%2520future%2520of%2520A2A%2520adenosine%2520receptor%2520antagonists%2520in%2520the%2520therapy%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2011%26volume%3D132%26spage%3D280%26epage%3D299" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit131c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Shah, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span> </span><span class="NLM_article-title">Recent progress in the discovery of adenosine A<sub>2A</sub> receptor antagonists for the treatment of Parkinsonâs disease</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">466</span><span class="NLM_x">â</span> <span class="NLM_lpage">480</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131c&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=20597030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131c&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSju7zK" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2010&pages=466-480&author=U.+Shahauthor=R.+Hodgson&title=Recent+progress+in+the+discovery+of+adenosine+A2A+receptor+antagonists+for+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131cR"><div class="casContent"><span class="casTitleNuber">131c</span><div class="casTitle"><span class="NLM_cas:atitle">Recent progress in the discovery of adenosine A2A receptor antagonists for the treatment of Parkinson's disease</span></div><div class="casAuthors">Shah, Unmesh; Hodgson, Robert</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Drug Discovery & Development</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">466-480</span>CODEN:
                <span class="NLM_cas:coden">CODDFF</span>;
        ISSN:<span class="NLM_cas:issn">2040-3437</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  Antagonism of the A2A receptor has emerged as a promising non-dopaminergic approach for the potential treatment of Parkinson's disease (PD).  Several pharmaceutical and academic institutions have ongoing research programs in this area, and orally efficacious A2A receptor antagonists were advanced into clin. development.  Traditionally, antagonists of the A2A receptor are classified as xanthine and non-xanthine derivs.  This review provides a detailed summary of the recent SAR development that has led to the discovery of promising non-xanthine-based A2A receptor antagonists.  The current clin. status and the potential utility of A2A receptor antagonists in indications other than PD are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouWpTRXO9ll7Vg90H21EOLACvtfcHk0ljfKhF1quYTHA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSju7zK&md5=1e9fb4644949ab0efeb9a208bdb1d3d7</span></div><a href="/servlet/linkout?suffix=cit131c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DU.%26aulast%3DHodgson%26aufirst%3DR.%26atitle%3DRecent%2520progress%2520in%2520the%2520discovery%2520of%2520adenosine%2520A2A%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2010%26volume%3D13%26spage%3D466%26epage%3D480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit131d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Jenner, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mori, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hauser, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J. F.</span><span> </span><span class="NLM_article-title">Adenosine, adenosine A<sub>2A</sub> antagonists, and Parkinsonâs disease</span> <span class="citation_source-journal">Parkinsonism Relat. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">406</span><span class="NLM_x">â</span> <span class="NLM_lpage">413</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131d&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.parkreldis.2008.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131d&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=19446490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131d&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADC%252BD1MvksVWnsg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=406-413&author=P.+Jennerauthor=A.+Moriauthor=R.+Hauserauthor=M.+Morelliauthor=B.+B.+Fredholmauthor=J.+F.+Chen&title=Adenosine%2C+adenosine+A2A+antagonists%2C+and+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131dR"><div class="casContent"><span class="casTitleNuber">131d</span><div class="casTitle"><span class="NLM_cas:atitle">Adenosine, adenosine A 2A antagonists, and Parkinson's disease</span></div><div class="casAuthors">Jenner P; Mori A; Hauser R; Morelli M; Fredholm B B; Chen J F</div><div class="citationInfo"><span class="NLM_cas:title">Parkinsonism & related disorders</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">406-13</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Adenosine derived from the degradation of ATP/AMP functions as a signalling molecule in the nervous system through the occupation of A1, A2, and A3 adenosine receptors.  Adenosine A(2A) receptors have a selective localization to the basal ganglia and specifically to the indirect output pathway, and as a consequence offer a unique opportunity to modulate the output from the striatum that is believed critical to the occurrence of motor components of PD.  Indeed, the ability of A(2A) antagonists to modulate basal ganglia neurotransmission has been shown to be associated with improved motor function in experimental models of PD.  This suggests that A(2A) antagonists would be effective as a symptomatic treatment in humans without provoking marked dyskinesia.  Indeed, the A(2A) antagonist istradefylline reduces OFF time in moderate- to late-stage patients with PD already receiving dopaminergic therapy, with an increase in non-troublesome dyskinesia.  Adenosine and adenosine receptors also exert actions relevant to pathogenesis in PD, raising the possibility of their use as neuroprotective agents.  Both epidemiologic evidence and the current preclinical data strongly support a role for A(2A) antagonists in protecting dopaminergic neurons and influencing the onset and progression of PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQsdd-F41SVOmBAiYWy6n3SfW6udTcc2ebmiBppOsrvW7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MvksVWnsg%253D%253D&md5=3c823d672ed66ea92ef6876eedf544a5</span></div><a href="/servlet/linkout?suffix=cit131d&amp;dbid=16384&amp;doi=10.1016%2Fj.parkreldis.2008.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.parkreldis.2008.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DJenner%26aufirst%3DP.%26aulast%3DMori%26aufirst%3DA.%26aulast%3DHauser%26aufirst%3DR.%26aulast%3DMorelli%26aufirst%3DM.%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DChen%26aufirst%3DJ.%2BF.%26atitle%3DAdenosine%252C%2520adenosine%2520A2A%2520antagonists%252C%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DParkinsonism%2520Relat.%2520Disord.%26date%3D2009%26volume%3D15%26spage%3D406%26epage%3D413" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit131e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Adenosine receptor antagonists: translating medicinal chemistry and pharmacology into clinical utility</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">238</span><span class="NLM_x">â</span> <span class="NLM_lpage">263</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr0682195" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2008&pages=238-263&issue=1&author=P.+G.+Baraldiauthor=M.+A.+Tabriziauthor=S.+Gessiauthor=P.+A.+Borea&title=Adenosine+receptor+antagonists%3A+translating+medicinal+chemistry+and+pharmacology+into+clinical+utility"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131e&amp;dbid=16384&amp;doi=10.1021%2Fcr0682195&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr0682195%26sid%3Dliteratum%253Aachs%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DTabrizi%26aufirst%3DM.%2BA.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DAdenosine%2520receptor%2520antagonists%253A%2520translating%2520medicinal%2520chemistry%2520and%2520pharmacology%2520into%2520clinical%2520utility%26jtitle%3DChem.%2520Rev.%26date%3D2008%26volume%3D108%26issue%3D1%26spage%3D238%26epage%3D263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit131f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Muller, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferre, S.</span><span> </span><span class="NLM_article-title">Blocking striatal adenosine A<sub>2A</sub> receptors: a new strategy basal ganglia disorder</span> <span class="citation_source-journal">Recent Pat. CNS Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">â</span> <span class="NLM_lpage">21</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1-21&author=C.+E.+Mullerauthor=S.+Ferre&title=Blocking+striatal+adenosine+A2A+receptors%3A+a+new+strategy+basal+ganglia+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMuller%26aufirst%3DC.%2BE.%26aulast%3DFerre%26aufirst%3DS.%26atitle%3DBlocking%2520striatal%2520adenosine%2520A2A%2520receptors%253A%2520a%2520new%2520strategy%2520basal%2520ganglia%2520disorder%26jtitle%3DRecent%2520Pat.%2520CNS%2520Drug%2520Discovery%26date%3D2007%26volume%3D2%26spage%3D1%26epage%3D21" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group">Jackson, E. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herzer, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, F.</span><span> </span><span class="NLM_article-title">KF17837 is an A<sub>2</sub> adenosine receptor antagonist in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">1304</span><span class="NLM_x">â</span> <span class="NLM_lpage">1310</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=8263794" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK2cXitlKisr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1993&pages=1304-1310&author=E.+K.+Jacksonauthor=W.+A.+Herzerauthor=F.+Suzuki&title=KF17837+is+an+A2+adenosine+receptor+antagonist+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">KF17837 is an A2 adenosine receptor antagonist in vivo</span></div><div class="casAuthors">Jackson, Edwin K.; Herzer, William A.; Suzuki, Fumio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1304-10</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The goal of this study was to det. whether KF17837 (I) is a useful pharmacol. probe for investigating in the rat the in vivo physiol. roles of A2 adenosine receptors.  In anesthetized rats, bradycardic responses to N6-cyclopentyladenosine and hypotensive responses to 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamido adenosine (CGS21680C) were used to assess A1 receptor and A2 receptor activation, resp.  After obtaining control responses to N6-cyclopentyladenosine and CGS21680C, the rats received infusions of either vehicle or one of two dosage levels of KF17837, a compd. recently demonstrated to be a potent and selective A2 receptor antagonist in vitro.  KF17837 was infused for 4 h and, at various times during the infusions, bradycardic and hypotensive responses to N6-cyclopentyladenosine and CGS21680C, resp., were elicited.  Infusion of either 10 or 30 Î¼g kg-1 min-1 (2.4 or 7.4 mg kg-1 4 h-1) of KF17837 did not significantly affect the bradycardic responses to N6-cyclopentyladenosine.  By contrast, 10 Î¼g kg-1 min-1 of KF17837 attenuated and 30 Î¼g kg-1 min-1 of KF17837 nearly abolished hypotensive responses to CGS21680C.  In a second study, pretreatment with KF17837 (30 Î¼g kg-1 min-1) did not affect the hypotensive response to either PGI2 (3 Î¼g kg-1 min-1) or acetylcholine (100 Î¼g kg-1 min-1); however, it attenuated the hypotensive response to adenosine (300 Î¼g kg-1 min-1).  In a third study, hypotension was induced and maintained with an infusion of adenosine (300 Î¼g kg-1 min-1).  Subsequent initiation of an infusion of KF17837 (30 Î¼g kg-1 min-1) completely reversed the adenosine-induced hypotension.  This study suggests that in vivo KF17837 has relative selectivity for the A2 receptor and may be a useful pharmacol. probe for elucidating the role of endogenous adenosine-A2 receptor interactions in vivo in the rat.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqN9ejyWlCCqrVg90H21EOLACvtfcHk0ljfKhF1quYTHA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXitlKisr0%253D&md5=9477b07493ca01f4141bcfc0d1ecbb54</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DE.%2BK.%26aulast%3DHerzer%26aufirst%3DW.%2BA.%26aulast%3DSuzuki%26aufirst%3DF.%26atitle%3DKF17837%2520is%2520an%2520A2%2520adenosine%2520receptor%2520antagonist%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1993%26volume%3D267%26spage%3D1304%26epage%3D1310" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group">Nonaka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nonaka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koike, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kase, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaguchi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, F.</span><span> </span><span class="NLM_article-title">Photoisomerization of a potent and selective adenosine A<sub>2</sub> antagonist, (<i>E</i>)-1,3-dipropyl-8-(3,4-dimethoxystyryl)-7-methylxanthine</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">3731</span><span class="NLM_x">â</span> <span class="NLM_lpage">3733</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm00075a031" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1993&pages=3731-3733&author=Y.+Nonakaauthor=J.+Shimadaauthor=H.+Nonakaauthor=N.+Koikeauthor=N.+Aokiauthor=H.+Kobayashiauthor=H.+Kaseauthor=K.+Yamaguchiauthor=F.+Suzuki&title=Photoisomerization+of+a+potent+and+selective+adenosine+A2+antagonist%2C+%28E%29-1%2C3-dipropyl-8-%283%2C4-dimethoxystyryl%29-7-methylxanthine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1021%2Fjm00075a031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00075a031%26sid%3Dliteratum%253Aachs%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DShimada%26aufirst%3DJ.%26aulast%3DNonaka%26aufirst%3DH.%26aulast%3DKoike%26aufirst%3DN.%26aulast%3DAoki%26aufirst%3DN.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DKase%26aufirst%3DH.%26aulast%3DYamaguchi%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DF.%26atitle%3DPhotoisomerization%2520of%2520a%2520potent%2520and%2520selective%2520adenosine%2520A2%2520antagonist%252C%2520%2528E%2529-1%252C3-dipropyl-8-%25283%252C4-dimethoxystyryl%2529-7-methylxanthine%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1993%26volume%3D36%26spage%3D3731%26epage%3D3733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="note"><p class="first last">Representitive monocyclic core examples:</p></div><div class="NLM_citation" id="rightTab-cit134a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Alanine, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anselm, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steward, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vifian, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groaning, M. D.</span><span> </span><span class="NLM_article-title">Synthesis and SAR evaluation of 1,2,4-triazoles as A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">â</span> <span class="NLM_lpage">821</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=817-821&author=A.+Alanineauthor=L.+Anselmauthor=L.+Stewardauthor=S.+Thomiauthor=W.+Vifianauthor=M.+D.+Groaning&title=Synthesis+and+SAR+evaluation+of+1%2C2%2C4-triazoles+as+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlanine%26aufirst%3DA.%26aulast%3DAnselm%26aufirst%3DL.%26aulast%3DSteward%26aufirst%3DL.%26aulast%3DThomi%26aufirst%3DS.%26aulast%3DVifian%26aufirst%3DW.%26aulast%3DGroaning%26aufirst%3DM.%2BD.%26atitle%3DSynthesis%2520and%2520SAR%2520evaluation%2520of%25201%252C2%252C4-triazoles%2520as%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D817%26epage%3D821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit134b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Richardson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fink, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sellwood, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span> </span><span class="NLM_article-title">Identification of non-furan containing A<sub>2A</sub> antagonists using databasemining and molecular similarity approaches</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">5993</span><span class="NLM_x">â</span> <span class="NLM_lpage">5997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5993-5997&author=C.+M.+Richardsonauthor=R.+J.+Gillespieauthor=D.+S.+Williamsonauthor=A.+M.+Jordanauthor=A.+Finkauthor=A.+R.+Knightauthor=D.+W.+Sellwoodauthor=A.+Misra&title=Identification+of+non-furan+containing+A2A+antagonists+using+databasemining+and+molecular+similarity+approaches"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRichardson%26aufirst%3DC.%2BM.%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DFink%26aufirst%3DA.%26aulast%3DKnight%26aufirst%3DA.%2BR.%26aulast%3DSellwood%26aufirst%3DD.%2BW.%26aulast%3DMisra%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520non-furan%2520containing%2520A2A%2520antagonists%2520using%2520databasemining%2520and%2520molecular%2520similarity%2520approaches%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5993%26epage%3D5997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit134c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Sams, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mikkelsen, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larsen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torup, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brennum, L. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroder, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bang-Andersen, B.</span><span> </span><span class="NLM_article-title">Hit-to-lead optimization of a series of carboxamides of ethyl 2-amino-4-phenylthiazole-5-carboxylates as novel adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">5241</span><span class="NLM_x">â</span> <span class="NLM_lpage">5244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=5241-5244&author=A.+G.+Samsauthor=G.+K.+Mikkelsenauthor=M.+Larsenauthor=L.+Torupauthor=L.+T.+Brennumauthor=T.+J.+Schroderauthor=B.+Bang-Andersen&title=Hit-to-lead+optimization+of+a+series+of+carboxamides+of+ethyl+2-amino-4-phenylthiazole-5-carboxylates+as+novel+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSams%26aufirst%3DA.%2BG.%26aulast%3DMikkelsen%26aufirst%3DG.%2BK.%26aulast%3DLarsen%26aufirst%3DM.%26aulast%3DTorup%26aufirst%3DL.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DSchroder%26aufirst%3DT.%2BJ.%26aulast%3DBang-Andersen%26aufirst%3DB.%26atitle%3DHit-to-lead%2520optimization%2520of%2520a%2520series%2520of%2520carboxamides%2520of%2520ethyl%25202-amino-4-phenylthiazole-5-carboxylates%2520as%2520novel%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D5241%26epage%3D5244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="note"><p class="first last">Representative bicyclic core examples:</p></div><div class="NLM_citation" id="rightTab-cit135a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Manera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Betti, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cavallini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giannaccini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ortore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saccomanni, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trincavelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuccinardi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferraini, P. L.</span><span> </span><span class="NLM_article-title">1,8-Naphthyridine-4-one derivatives as new ligands of A<sub>2A</sub> adenosine receptors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">4604</span><span class="NLM_x">â</span> <span class="NLM_lpage">4610</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=4604-4610&author=C.+Maneraauthor=L.+Bettiauthor=T.+Cavalliniauthor=G.+Giannacciniauthor=A.+Martinelliauthor=G.+Ortoreauthor=G.+Saccomanniauthor=L.+Trincavelliauthor=T.+Tuccinardiauthor=P.+L.+Ferraini&title=1%2C8-Naphthyridine-4-one+derivatives+as+new+ligands+of+A2A+adenosine+receptors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManera%26aufirst%3DC.%26aulast%3DBetti%26aufirst%3DL.%26aulast%3DCavallini%26aufirst%3DT.%26aulast%3DGiannaccini%26aufirst%3DG.%26aulast%3DMartinelli%26aufirst%3DA.%26aulast%3DOrtore%26aufirst%3DG.%26aulast%3DSaccomanni%26aufirst%3DG.%26aulast%3DTrincavelli%26aufirst%3DL.%26aulast%3DTuccinardi%26aufirst%3DT.%26aulast%3DFerraini%26aufirst%3DP.%2BL.%26atitle%3D1%252C8-Naphthyridine-4-one%2520derivatives%2520as%2520new%2520ligands%2520of%2520A2A%2520adenosine%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D4604%26epage%3D4610" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit135b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Vu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smits, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phadke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reilly, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hetu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span> </span><span class="NLM_article-title">Novel diaminoderivatives of [1,2,4]triazolo[1,5-<i>a</i>][1,3,5]triazine as potent and selective adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2009</span><span class="NLM_x">â</span> <span class="NLM_lpage">2018</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0498396" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=2009-2018&author=C.+B.+Vuauthor=D.+Panauthor=B.+Pengauthor=G.+Kumaravelauthor=G.+Smitsauthor=X.+Jinauthor=D.+Phadkeauthor=T.+Engberauthor=C.+Huangauthor=J.+Reillyauthor=S.+Tamauthor=D.+Grantauthor=G.+Hetuauthor=R.+C.+Petter&title=Novel+diaminoderivatives+of+%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-a%5D%5B1%2C3%2C5%5Dtriazine+as+potent+and+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135b&amp;dbid=16384&amp;doi=10.1021%2Fjm0498396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0498396%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DC.%2BB.%26aulast%3DPan%26aufirst%3DD.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DSmits%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DPhadke%26aufirst%3DD.%26aulast%3DEngber%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DReilly%26aufirst%3DJ.%26aulast%3DTam%26aufirst%3DS.%26aulast%3DGrant%26aufirst%3DD.%26aulast%3DHetu%26aufirst%3DG.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26atitle%3DNovel%2520diaminoderivatives%2520of%2520%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-a%255D%255B1%252C3%252C5%255Dtriazine%2520as%2520potent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D2009%26epage%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit135c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Holschbach, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bier, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stuesgen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wutz, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sihver, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coenen, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsson, R. A.</span><span> </span><span class="NLM_article-title">Synthesis and evaluation of 7-amino-2-(2(3)-furyl)-5-phenylethylamino-oxazolo[5,4-<i>d</i>]pyrimidines as potential A<sub>2A</sub> adenosine receptor antagonists for positron emission tomography (PET)</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">7</span><span class="NLM_x">â</span> <span class="NLM_lpage">15</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2006&pages=7-15&author=M.+H.+Holschbachauthor=D.+Bierauthor=S.+Stuesgenauthor=W.+Wutzauthor=W.+Sihverauthor=H.+H.+Coenenauthor=R.+A.+Olsson&title=Synthesis+and+evaluation+of+7-amino-2-%282%283%29-furyl%29-5-phenylethylamino-oxazolo%5B5%2C4-d%5Dpyrimidines+as+potential+A2A+adenosine+receptor+antagonists+for+positron+emission+tomography+%28PET%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHolschbach%26aufirst%3DM.%2BH.%26aulast%3DBier%26aufirst%3DD.%26aulast%3DStuesgen%26aufirst%3DS.%26aulast%3DWutz%26aufirst%3DW.%26aulast%3DSihver%26aufirst%3DW.%26aulast%3DCoenen%26aufirst%3DH.%2BH.%26aulast%3DOlsson%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25207-amino-2-%25282%25283%2529-furyl%2529-5-phenylethylamino-oxazolo%255B5%252C4-d%255Dpyrimidines%2520as%2520potential%2520A2A%2520adenosine%2520receptor%2520antagonists%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2006%26volume%3D41%26spage%3D7%26epage%3D15" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit135d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Lambertucci, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Antonini, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buccioni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dal Ben, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kachare, D. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Volpini, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klotz, K.-N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cristalli, G.</span><span> </span><span class="NLM_article-title">8-Bromo-9-alkyl adenine derivatives as tools for developing new adenosine A<sub>2A</sub> and A<sub>2B</sub> receptors ligands</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2812</span><span class="NLM_x">â</span> <span class="NLM_lpage">2822</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=2812-2822&author=C.+Lambertucciauthor=I.+Antoniniauthor=M.+Buccioniauthor=D.+Dal+Benauthor=D.+D.+Kachareauthor=R.+Volpiniauthor=K.-N.+Klotzauthor=G.+Cristalli&title=8-Bromo-9-alkyl+adenine+derivatives+as+tools+for+developing+new+adenosine+A2A+and+A2B+receptors+ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLambertucci%26aufirst%3DC.%26aulast%3DAntonini%26aufirst%3DI.%26aulast%3DBuccioni%26aufirst%3DM.%26aulast%3DDal%2BBen%26aufirst%3DD.%26aulast%3DKachare%26aufirst%3DD.%2BD.%26aulast%3DVolpini%26aufirst%3DR.%26aulast%3DKlotz%26aufirst%3DK.-N.%26aulast%3DCristalli%26aufirst%3DG.%26atitle%3D8-Bromo-9-alkyl%2520adenine%2520derivatives%2520as%2520tools%2520for%2520developing%2520new%2520adenosine%2520A2A%2520and%2520A2B%2520receptors%2520ligands%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2009%26volume%3D17%26spage%3D2812%26epage%3D2822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="note"><p class="first last">Representative tricyclic core examples:</p></div><div class="NLM_citation" id="rightTab-cit136a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Moorman, A. R.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> Receptor Antagonists</span>. PCT Int. Appl. WO2008121748,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=A.+R.+Moorman&title=Adenosine+A2A+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMoorman%26aufirst%3DA.%2BR.%26atitle%3DAdenosine%2520A2A%2520Receptor%2520Antagonists%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit136b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pastorin, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span> </span><span class="NLM_article-title">Medicinal chemistry of A<sub>2A</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">403</span><span class="NLM_x">â</span> <span class="NLM_lpage">411</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.2174%2F1568026033392183" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=12570758" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD3sXntVGisg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=403-411&author=B.+Cacciariauthor=G.+Pastorinauthor=G.+Spalluto&title=Medicinal+chemistry+of+A2A+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136bR"><div class="casContent"><span class="casTitleNuber">136b</span><div class="casTitle"><span class="NLM_cas:atitle">Medicinal chemistry of A2A adenosine receptor antagonists</span></div><div class="casAuthors">Cacciari, Barbara; Pastorin, Giorgia; Spalluto, Giampiero</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">403-411</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Due to the clearly demonstrated receptor-receptor interaction between adenosine A2A and dopamine D2 receptors in the basal ganglia, the discovery and development of potent and selective A2A adenosine receptor antagonists became, in the last ten years, an attractive field of research to discovery new drugs for the treatment of neurodegenerative disorders, such as Parkinsons disease.  Different compds. have been deeply investigated as A2A adenosine receptor antagonists, which could be classified in two great families: xanthine derivs. and nitrogen polyheterocyclic systems.  These studies led to the discovery of some highly potent and selective A2A adenosine receptor antagonists such as ZM241385, SCH58261 and some xanthine derivs. (KW6002), which have been used as pharmacol. tools for studying this receptor subtype.  However, those compds. showed some problems that do not permit their use in clin. studies, such as poor water soly. (SCH58261, and xanthine derivs.) or good affinity for A2B adenosine receptor subtype (ZM241385).  In the last few years great efforts have been made to overcome these problems, trying to optimize not only the pharmacol. profile but also the pharmacokinetic character of this class of compds.  The aim of this report is to briefly summarize the recent progress made in this attractive field of research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0Js9jSgCJ7LVg90H21EOLACvtfcHk0liQDke_FoQAHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXntVGisg%253D%253D&md5=28a5cf572c5400ec56ab33b2120e717f</span></div><a href="/servlet/linkout?suffix=cit136b&amp;dbid=16384&amp;doi=10.2174%2F1568026033392183&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026033392183%26sid%3Dliteratum%253Aachs%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DPastorin%26aufirst%3DG.%26aulast%3DSpalluto%26aufirst%3DG.%26atitle%3DMedicinal%2520chemistry%2520of%2520A2A%2520adenosine%2520receptor%2520antagonists%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2003%26volume%3D3%26spage%3D403%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit136c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Martinez, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teran, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brea, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ravina, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loza, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cadavid, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanz, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vidal, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Segarra, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sotelo, E.</span><span> </span><span class="NLM_article-title">Synthesis, adenosine receptor binding and 3D-QSAR of 4-ubstituted 2-(2â²-furyl)-1,2,4-triazolo[1,5-<i>a</i>]quinoxalines</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2103</span><span class="NLM_x">â</span> <span class="NLM_lpage">2113</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=2103-2113&author=A.+Martinezauthor=H.+G.+Teranauthor=J.+Breaauthor=E.+Ravinaauthor=M.+I.+Lozaauthor=M.+I.+Cadavidauthor=F.+Sanzauthor=B.+Vidalauthor=V.+Segarraauthor=E.+Sotelo&title=Synthesis%2C+adenosine+receptor+binding+and+3D-QSAR+of+4-ubstituted+2-%282%E2%80%B2-furyl%29-1%2C2%2C4-triazolo%5B1%2C5-a%5Dquinoxalines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DTeran%26aufirst%3DH.%2BG.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DRavina%26aufirst%3DE.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DSanz%26aufirst%3DF.%26aulast%3DVidal%26aufirst%3DB.%26aulast%3DSegarra%26aufirst%3DV.%26aulast%3DSotelo%26aufirst%3DE.%26atitle%3DSynthesis%252C%2520adenosine%2520receptor%2520binding%2520and%25203D-QSAR%2520of%25204-ubstituted%25202-%25282%25E2%2580%25B2-furyl%2529-1%252C2%252C4-triazolo%255B1%252C5-a%255Dquinoxalines%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2008%26volume%3D16%26spage%3D2103%26epage%3D2113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group">Maemoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tada, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueyama, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamaji, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shirakawa, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuroda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahane, A.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of FR194921, a new potent, selective, and orally active antagonist for central adenosine A<sub>1</sub> receptors</span> <span class="citation_source-journal">J. Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">42</span><span class="NLM_x">â</span> <span class="NLM_lpage">52</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1254%2Fjphs.FP0040359" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=15351792" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvFyjs78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2004&pages=42-52&author=T.+Maemotoauthor=M.+Tadaauthor=T.+Miharaauthor=N.+Ueyamaauthor=H.+Matsuokaauthor=K.+Haradaauthor=T.+Yamajiauthor=K.+Shirakawaauthor=S.+Kurodaauthor=A.+Akahane&title=Pharmacological+characterization+of+FR194921%2C+a+new+potent%2C+selective%2C+and+orally+active+antagonist+for+central+adenosine+A1+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of FR194921, a new potent, selective, and orally active antagonist for central adenosine A1 receptors</span></div><div class="casAuthors">Maemoto, Takuya; Tada, Miho; Mihara, Takuma; Ueyama, Noriko; Matsuoka, Hideaki; Harada, Katsuya; Yamaji, Takayuki; Shirakawa, Kiyoharu; Kuroda, Satoru; Akahane, Atsushi; Iwashita, Akinori; Matsuoka, Nobuya; Mutoh, Seitaro</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological Sciences (Tokyo, Japan)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">42-52</span>CODEN:
                <span class="NLM_cas:coden">JPSTGJ</span>;
        ISSN:<span class="NLM_cas:issn">1347-8613</span>.
    
            (<span class="NLM_cas:orgname">Japanese Pharmacological Society</span>)
        </div><div class="casAbstract">Adenosine A1 receptors in the brain are believed to play an important role in brain functioning.  We have discovered a novel adenosine A1 receptor antagonist, FR194921 (2-(1-methyl-4-piperidinyl)-6-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)-3(2H)-pyridazinone), and characterized the pharmacol. activity in the present study.  FR194921 showed potent and selective affinity for the adenosine A1 receptor without affinity for A2A and A3 receptors and did not show any species differences in binding affinity profile among human, rat, and mouse.  Pharmacokinetic study in rats revealed that FR194921 was orally active and highly brain penetrable.  Oral administration of FR194921 dose-dependently ameliorated the hypolocomotion induced by the A1 receptor agonist N6-cyclopentyladenosine in rats, indicating this compd. exerts A1-antagonistic action in vivo.  In the passive avoidance test, scopolamine (1 mg/kg)-induced memory deficits were significantly ameliorated by FR194921 (0.32, 1 mg/kg).  In two animal models of anxiety, the social interaction test and elevated plus maze, FR194921 showed specific anxiolytic activity without significantly influencing general behavior.  In contrast, FR194921 did not show antidepressant activity even at a dose of 32 mg/kg in the rat forced swimming test.  These results indicate that the novel, potent, and selective adenosine A1 receptor antagonist FR194921 exerts both cognitive-enhancing and anxiolytic activity, suggesting the therapeutic potential of this compd. for dementia and anxiety disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpor8cuLg5xVrVg90H21EOLACvtfcHk0liQDke_FoQAHw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvFyjs78%253D&md5=1828b4e7afe4c25a61aa0fa094f64c38</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1254%2Fjphs.FP0040359&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1254%252Fjphs.FP0040359%26sid%3Dliteratum%253Aachs%26aulast%3DMaemoto%26aufirst%3DT.%26aulast%3DTada%26aufirst%3DM.%26aulast%3DMihara%26aufirst%3DT.%26aulast%3DUeyama%26aufirst%3DN.%26aulast%3DMatsuoka%26aufirst%3DH.%26aulast%3DHarada%26aufirst%3DK.%26aulast%3DYamaji%26aufirst%3DT.%26aulast%3DShirakawa%26aufirst%3DK.%26aulast%3DKuroda%26aufirst%3DS.%26aulast%3DAkahane%26aufirst%3DA.%26atitle%3DPharmacological%2520characterization%2520of%2520FR194921%252C%2520a%2520new%2520potent%252C%2520selective%252C%2520and%2520orally%2520active%2520antagonist%2520for%2520central%2520adenosine%2520A1%2520receptors%26jtitle%3DJ.%2520Pharmacol.%2520Sci.%26date%3D2004%26volume%3D96%26spage%3D42%26epage%3D52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osborne, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boulet, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupert, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heintzelman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullington, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reyes, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">In vivo characterization of a dual adenosine A<sub>2A</sub>/A<sub>1</sub> receptor antagonist in animal models of Parkinsonâs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8104</span><span class="NLM_x">â</span> <span class="NLM_lpage">8115</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100971t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8104-8115&author=B.+C.+Shookauthor=S.+Rassnickauthor=M.+C.+Osborneauthor=S.+Davisauthor=L.+Westoverauthor=J.+Bouletauthor=D.+Hallauthor=K.+C.+Rupertauthor=G.+R.+Heintzelmanauthor=K.+Hansenauthor=D.+Chakravartyauthor=J.+L.+Bullingtonauthor=R.+Russellauthor=S.+Branumauthor=K.+M.+Wellsauthor=S.+Damonauthor=S.+Youellsauthor=X.+Liauthor=D.+A.+Beauchampauthor=D.+Palmerauthor=M.+Reyesauthor=K.+Demarestauthor=Y.-T.+Tangauthor=K.+Rhodesauthor=P.+F.+Jackson&title=In+vivo+characterization+of+a+dual+adenosine+A2A%2FA1+receptor+antagonist+in+animal+models+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1021%2Fjm100971t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100971t%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DOsborne%26aufirst%3DM.%2BC.%26aulast%3DDavis%26aufirst%3DS.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DBoulet%26aufirst%3DJ.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHeintzelman%26aufirst%3DG.%2BR.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DBullington%26aufirst%3DJ.%2BL.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBranum%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DK.%2BM.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DYouells%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBeauchamp%26aufirst%3DD.%2BA.%26aulast%3DPalmer%26aufirst%3DD.%26aulast%3DReyes%26aufirst%3DM.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DY.-T.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DIn%2520vivo%2520characterization%2520of%2520a%2520dual%2520adenosine%2520A2A%252FA1%2520receptor%2520antagonist%2520in%2520animal%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8104%26epage%3D8115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group">Shah, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowics, J. E.</span><span> </span><span class="NLM_article-title">Biaryl and heteroaryl derivatives of SCH58261 as potent and selective adenosine A<sub>2A</sub> receptor antagonist</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4199</span><span class="NLM_x">â</span> <span class="NLM_lpage">4203</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4199-4203&issue=14&author=U.+Shahauthor=C.+D.+Boyleauthor=S.+Chackalamannilauthor=B.+R.+Neustadtauthor=N.+Lindoauthor=W.+J.+Greenleeauthor=C.+Fosterauthor=L.+Arikauthor=Y.+Zhaiauthor=K.+Ngauthor=S.+Wangauthor=A.+Monopoliauthor=J.+E.+Lachowics&title=Biaryl+and+heteroaryl+derivatives+of+SCH58261+as+potent+and+selective+adenosine+A2A+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DU.%26aulast%3DBoyle%26aufirst%3DC.%2BD.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DLindo%26aufirst%3DN.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DArik%26aufirst%3DL.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DNg%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DLachowics%26aufirst%3DJ.%2BE.%26atitle%3DBiaryl%2520and%2520heteroaryl%2520derivatives%2520of%2520SCH58261%2520as%2520potent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonist%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D14%26spage%3D4199%26epage%3D4203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindo, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feng, K.-I.</span><span> </span><span class="NLM_article-title">Potent, selective and orally active adenosine A<sub>2A</sub> receptor antagonist: arylpiperazine derivatives of pyrazolo[4,3-<i>e</i>]-1,2,4-triazolo[1,5-<i>c</i>]pyrimidines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1376</span><span class="NLM_x">â</span> <span class="NLM_lpage">1380</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1376-1380&issue=5&author=B.+R.+Neustadtauthor=J.+Haoauthor=N.+Lindoauthor=W.+J.+Greenleeauthor=A.+W.+Stamfordauthor=D.+Tulshianauthor=E.+Onginiauthor=J.+Hunterauthor=A.+Monopoliauthor=R.+Berorelliauthor=C.+Fosterauthor=L.+Arikauthor=J.+Lachowiczauthor=K.+Ngauthor=K.-I.+Feng&title=Potent%2C+selective+and+orally+active+adenosine+A2A+receptor+antagonist%3A+arylpiperazine+derivatives+of+pyrazolo%5B4%2C3-e%5D-1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DLindo%26aufirst%3DN.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DTulshian%26aufirst%3DD.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DHunter%26aufirst%3DJ.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DBerorelli%26aufirst%3DR.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DArik%26aufirst%3DL.%26aulast%3DLachowicz%26aufirst%3DJ.%26aulast%3DNg%26aufirst%3DK.%26aulast%3DFeng%26aufirst%3DK.-I.%26atitle%3DPotent%252C%2520selective%2520and%2520orally%2520active%2520adenosine%2520A2A%2520receptor%2520antagonist%253A%2520arylpiperazine%2520derivatives%2520of%2520pyrazolo%255B4%252C3-e%255D-1%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D5%26spage%3D1376%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group">Hodgson, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forlani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredduzzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Impagnatiello, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicolussi, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parra, L. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parker, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reggiani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, J. C.</span><span> </span><span class="NLM_article-title">Characterization of the potent and highly selective A<sub>2A</sub> receptor antagonists preladenant and SCH412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7<i>H</i>-pyrazolo[4,3-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidin-5-amine] in rodent models of movement disorders and depression</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">330</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">294</span><span class="NLM_x">â</span> <span class="NLM_lpage">303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1124%2Fjpet.108.149617" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=19332567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosFeluro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=330&publication_year=2009&pages=294-303&issue=1&author=R.+A.+Hodgsonauthor=R.+Bertorelliauthor=G.+B.+Vartyauthor=J.+E.+Lachowiczauthor=A.+Forlaniauthor=S.+Fredduzziauthor=M.+E.+Cohen-Williamsauthor=G.+A.+Higginsauthor=F.+Impagnatielloauthor=E.+Nicolussiauthor=L.+E.+Parraauthor=C.+Fosterauthor=Y.+Zhaiauthor=B.+R.+Neustadtauthor=A.+W.+Stamfordauthor=E.+M.+Parkerauthor=A.+Reggianiauthor=J.+C.+Hunter&title=Characterization+of+the+potent+and+highly+selective+A2A+receptor+antagonists+preladenant+and+SCH412348+%5B7-%5B2-%5B4-2%2C4-difluorophenyl%5D-1-piperazinyl%5Dethyl%5D-2-%282-furanyl%29-7H-pyrazolo%5B4%2C3-e%5D%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-c%5Dpyrimidin-5-amine%5D+in+rodent+models+of+movement+disorders+and+depression"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the potent and highly selective A2A receptor antagonists preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] in rodent models of movement disorders and depression</span></div><div class="casAuthors">Hodgson, Robert A.; Bertorelli, Rosalia; Varty, Geoffrey B.; Lachowicz, Jean E.; Forlani, Angelo; Fredduzzi, Silva; Cohen-Williams, Mary E.; Higgins, Guy A.; Impagnatiello, Francesco; Nicolussi, Elisa; Parra, Leonard E.; Foster, Carolyn; Zhai, Ying; Neustadt, Bernie R.; Stamford, Andrew W.; Parker, Eric M.; Reggiani, Angelo; Hunter, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">330</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">294-303</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The adenosine A2A receptor has been implicated in the underlying biol. of various neurol. and psychiatric disorders, including Parkinson's disease (PD) and depression.  Preladenant and SCH 412348 [7-[2-[4-2,4-difluorophenyl]-1-piperazinyl]ethyl]-2-(2-furanyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine] are potent competitive antagonists of the human A2A receptor (Ki = 1.1 and 0.6 nM, resp.) and have > 1000-fold selectivity over all other adenosine receptors, making these compds. the most selective A2A receptor antagonists reported to date.  Both compds. attenuate hypolocomotion induced by the A2A receptor agonist CGS-21680 [2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine], suggesting that they inhibit A2A receptor activity in vivo.  Their high degree of selectivity and robust in vivo activity make preladenant and SCH 412348 useful tools to investigate the role of the A2A receptor system in animal models of PD and depression.  Oral administration of preladenant and SCH 412348 (0.1-1 mg/kg) to rats potentiated 3,4-dihydroxy-L-phenylalanine (L-Dopa)-induced contralateral rotations after 6-hydroxydopamine lesions in the medial forebrain bundle and potently attenuated the cataleptic effects of haloperidol.  Preladenant (1 mg/kg) inhibited L-Dopa-induced behavioral sensitization after repeated daily administration, which suggests a reduced risk of the development of dyskinesias.  Finally, preladenant and SCH 412348 exhibited antidepressant-like profiles in models of behavioral despair, namely the mouse tail suspension test and the mouse and rat forced swim test.  These studies demonstrate that preladenant and SCH 412348 are potent and selective A2A receptor antagonists and provide further evidence of the potential therapeutic benefits of A2A receptor inhibition in PD (with reduced risk of dyskinesias) and depression (one of the primary nonmotor symptoms of PD).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNkJMOfNlLc7Vg90H21EOLACvtfcHk0lhkf06eM0JRmA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosFeluro%253D&md5=b8ce809c2d57a994d201ecca4daa39a3</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1124%2Fjpet.108.149617&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.108.149617%26sid%3Dliteratum%253Aachs%26aulast%3DHodgson%26aufirst%3DR.%2BA.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DVarty%26aufirst%3DG.%2BB.%26aulast%3DLachowicz%26aufirst%3DJ.%2BE.%26aulast%3DForlani%26aufirst%3DA.%26aulast%3DFredduzzi%26aufirst%3DS.%26aulast%3DCohen-Williams%26aufirst%3DM.%2BE.%26aulast%3DHiggins%26aufirst%3DG.%2BA.%26aulast%3DImpagnatiello%26aufirst%3DF.%26aulast%3DNicolussi%26aufirst%3DE.%26aulast%3DParra%26aufirst%3DL.%2BE.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DZhai%26aufirst%3DY.%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26aulast%3DParker%26aufirst%3DE.%2BM.%26aulast%3DReggiani%26aufirst%3DA.%26aulast%3DHunter%26aufirst%3DJ.%2BC.%26atitle%3DCharacterization%2520of%2520the%2520potent%2520and%2520highly%2520selective%2520A2A%2520receptor%2520antagonists%2520preladenant%2520and%2520SCH412348%2520%255B7-%255B2-%255B4-2%252C4-difluorophenyl%255D-1-piperazinyl%255Dethyl%255D-2-%25282-furanyl%2529-7H-pyrazolo%255B4%252C3-e%255D%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-c%255Dpyrimidin-5-amine%255D%2520in%2520rodent%2520models%2520of%2520movement%2520disorders%2520and%2520depression%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2009%26volume%3D330%26issue%3D1%26spage%3D294%26epage%3D303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span>Thomson Reuters Pharma. <a href="https://www.thomson-pharma.com/portal/page/portal/Popups/NEWS%20ARTICLE%20DETAILS?_dummy=&#xA;y&amp;referenceid=1427557&amp;dbsource=Iddb" class="extLink">https://www.thomson-pharma.com/portal/page/portal/Popups/NEWS%20ARTICLE%20DETAILS?_dummy= y&referenceid=1427557&dbsource=Iddb</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomson+Reuters+Pharma.+https%3A%2F%2Fwww.thomson-pharma.com%2Fportal%2Fpage%2Fportal%2FPopups%2FNEWS%2520ARTICLE%2520DETAILS%3F_dummy%3D+y%26referenceid%3D1427557%26dbsource%3DIddb."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group">Silverman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiselgof, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matasi, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tulshian, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">3H-[1,2,4]-triazolo[5,1-<i>i</i>]purin-5-amine derivatives as adenosine A<sub>2A</sub> antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1659</span><span class="NLM_x">â</span> <span class="NLM_lpage">1662</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=1659-1662&issue=6&author=L.+S.+Silvermanauthor=J.+P.+Caldwellauthor=W.+J.+Greenleeauthor=E.+Kiselgofauthor=J.+J.+Matasiauthor=D.+B.+Tulshianauthor=L.+Arikauthor=C.+Fosterauthor=R.+Bertorelliauthor=A.+Monopoliauthor=E.+Ongini&title=3H-%5B1%2C2%2C4%5D-triazolo%5B5%2C1-i%5Dpurin-5-amine+derivatives+as+adenosine+A2A+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSilverman%26aufirst%3DL.%2BS.%26aulast%3DCaldwell%26aufirst%3DJ.%2BP.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DKiselgof%26aufirst%3DE.%26aulast%3DMatasi%26aufirst%3DJ.%2BJ.%26aulast%3DTulshian%26aufirst%3DD.%2BB.%26aulast%3DArik%26aufirst%3DL.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3D3H-%255B1%252C2%252C4%255D-triazolo%255B5%252C1-i%255Dpurin-5-amine%2520derivatives%2520as%2520adenosine%2520A2A%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26issue%3D6%26spage%3D1659%26epage%3D1662" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group">Shah, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lankin, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyle, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chackalamannil, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">higgins, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J. E.</span><span> </span><span class="NLM_article-title">Design, synthesis, and evaluations of fused heterocyclic analogs of SCH58261 as adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">14</span><span class="NLM_x">) </span> <span class="NLM_fpage">4204</span><span class="NLM_x">â</span> <span class="NLM_lpage">4209</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4204-4209&issue=14&author=U.+Shahauthor=C.+M.+Lankinauthor=C.+D.+Boyleauthor=S.+Chackalamannilauthor=W.+J.+Greenleeauthor=B.+R.+Neustadtauthor=M.+E.+Cohen-Williamsauthor=G.+A.+higginsauthor=K.+Ngauthor=G.+B.+Vartyauthor=H.+Zhangauthor=J.+E.+Lachowicz&title=Design%2C+synthesis%2C+and+evaluations+of+fused+heterocyclic+analogs+of+SCH58261+as+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShah%26aufirst%3DU.%26aulast%3DLankin%26aufirst%3DC.%2BM.%26aulast%3DBoyle%26aufirst%3DC.%2BD.%26aulast%3DChackalamannil%26aufirst%3DS.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DCohen-Williams%26aufirst%3DM.%2BE.%26aulast%3Dhiggins%26aufirst%3DG.%2BA.%26aulast%3DNg%26aufirst%3DK.%26aulast%3DVarty%26aufirst%3DG.%2BB.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLachowicz%26aufirst%3DJ.%2BE.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluations%2520of%2520fused%2520heterocyclic%2520analogs%2520of%2520SCH58261%2520as%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26issue%3D14%26spage%3D4204%26epage%3D4209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenlee, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foster, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arik, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lachowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertorelli, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fredduzzi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, K.</span><span> </span><span class="NLM_article-title">Potent and selective adenosine A<sub>2A</sub> receptor antagonists: 1,2,4-triazolo[1,5-<i>c</i>]pyrimidines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">967</span><span class="NLM_x">â</span> <span class="NLM_lpage">971</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=967-971&author=B.+R.+Neustadtauthor=H.+Liuauthor=J.+Haoauthor=W.+J.+Greenleeauthor=A.+Stamfordauthor=C.+Fosterauthor=L.+Arikauthor=J.+Lachowiczauthor=H.+Zhangauthor=R.+Bertorelliauthor=S.+Fredduzziauthor=G.+Vartyauthor=M.+Cohen-Williamsauthor=K.+Ng&title=Potent+and+selective+adenosine+A2A+receptor+antagonists%3A+1%2C2%2C4-triazolo%5B1%2C5-c%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DGreenlee%26aufirst%3DW.%2BJ.%26aulast%3DStamford%26aufirst%3DA.%26aulast%3DFoster%26aufirst%3DC.%26aulast%3DArik%26aufirst%3DL.%26aulast%3DLachowicz%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DBertorelli%26aufirst%3DR.%26aulast%3DFredduzzi%26aufirst%3DS.%26aulast%3DVarty%26aufirst%3DG.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DNg%26aufirst%3DK.%26atitle%3DPotent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%253A%25201%252C2%252C4-triazolo%255B1%252C5-c%255Dpyrimidines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D967%26epage%3D971" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group">Harris, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neustadt, B. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">lachowicz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen-Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varty, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stamford, A. W.</span><span> </span><span class="NLM_article-title">Potent and selective adenosine A<sub>2A</sub> receptor antagonists: [1,2,4]-triazolo[4,3-<i>c</i>]pyrimidin-3-ones</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">2497</span><span class="NLM_x">â</span> <span class="NLM_lpage">2501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=2497-2501&author=J.+M.+Harrisauthor=B.+R.+Neustadtauthor=H.+Zhangauthor=J.+lachowiczauthor=M.+Cohen-Williamsauthor=G.+Vartyauthor=J.+Haoauthor=A.+W.+Stamford&title=Potent+and+selective+adenosine+A2A+receptor+antagonists%3A+%5B1%2C2%2C4%5D-triazolo%5B4%2C3-c%5Dpyrimidin-3-ones"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarris%26aufirst%3DJ.%2BM.%26aulast%3DNeustadt%26aufirst%3DB.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3Dlachowicz%26aufirst%3DJ.%26aulast%3DCohen-Williams%26aufirst%3DM.%26aulast%3DVarty%26aufirst%3DG.%26aulast%3DHao%26aufirst%3DJ.%26aulast%3DStamford%26aufirst%3DA.%2BW.%26atitle%3DPotent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%253A%2520%255B1%252C2%252C4%255D-triazolo%255B4%252C3-c%255Dpyrimidin-3-ones%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D21%26spage%3D2497%26epage%3D2501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group">Vu, C. B.</span><span> </span><span class="NLM_article-title">Recent advances in the design and optimization of adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">458</span><span class="NLM_x">â</span> <span class="NLM_lpage">468</span><div class="note"><p class="first last">and references therein.</p></div></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2005&pages=458-468&issue=4&author=C.+B.+Vu&title=Recent+advances+in+the+design+and+optimization+of+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DC.%2BB.%26atitle%3DRecent%2520advances%2520in%2520the%2520design%2520and%2520optimization%2520of%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2005%26volume%3D8%26issue%3D4%26spage%3D458%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group">Norcross, R. D.</span><span> </span><span class="NLM_article-title">Benzoxazole Derivatives and Their Use as Adenosine Receptor Ligands</span>. PCT Int. Appl. WO2004063177,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=R.+D.+Norcross&title=Benzoxazole+Derivatives+and+Their+Use+as+Adenosine+Receptor+Ligands"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNorcross%26aufirst%3DR.%2BD.%26atitle%3DBenzoxazole%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Adenosine%2520Receptor%2520Ligands%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group">Norcross, R. D.</span><span> </span><span class="NLM_article-title">Thiazolopyridine</span>. U.S. Pat. Appl. Publ. US20050065151,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=R.+D.+Norcross&title=Thiazolopyridine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNorcross%26aufirst%3DR.%2BD.%26atitle%3DThiazolopyridine%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group">Flohr, A.; Moreau, J.-L.; Poli, S. M.; Riemer, C.; Steward, L.</span><span> </span><span class="NLM_article-title">4-Hydroxy-4-methyl-piperidine-1-carboxylic Acid (4-Methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide</span>. U.S. Pat. Appl. Publ. US20050261289 A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+Flohr&author=J.-L.+Moreau&author=S.+M.+Poli&author=C.+Riemer&author=L.+Steward&title=4-Hydroxy-4-methyl-piperidine-1-carboxylic+Acid+%284-Methoxy-7-morpholin-4-yl-benzothiazol-2-yl%29-amide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DFlohr%26aufirst%3DA.%26atitle%3D4-Hydroxy-4-methyl-piperidine-1-carboxylic%2520Acid%2520%25284-Methoxy-7-morpholin-4-yl-benzothiazol-2-yl%2529-amide%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group">Woiwode, T.; Moran, M.</span><span> </span><span class="NLM_article-title">4-Hydroxy-4-methyl-piperidine-1-carboxylic Acid (4-Methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide for the Treatment of Post-Traumatic Stress Disorder</span>. PCT Int. Appl. WO2009015236 A1,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=T.+Woiwode&author=M.+Moran&title=4-Hydroxy-4-methyl-piperidine-1-carboxylic+Acid+%284-Methoxy-7-morpholin-4-yl-benzothiazol-2-yl%29-amide+for+the+Treatment+of+Post-Traumatic+Stress+Disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWoiwode%26aufirst%3DT.%26atitle%3D4-Hydroxy-4-methyl-piperidine-1-carboxylic%2520Acid%2520%25284-Methoxy-7-morpholin-4-yl-benzothiazol-2-yl%2529-amide%2520for%2520the%2520Treatment%2520of%2520Post-Traumatic%2520Stress%2520Disorder%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span>Biotie Therapies: Biotieâs Tozadenant (SYN115) Meets Primary and Multiple Secondary Endpoints in Phase 2b Study in Parkinsonâs Disease. Press Release, December 11,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Biotie+Therapies%3A+Biotie%E2%80%99s+Tozadenant+%28SYN115%29+Meets+Primary+and+Multiple+Secondary+Endpoints+in+Phase+2b+Study+in+Parkinson%E2%80%99s+Disease.+Press+Release%2C+December+11%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group">Weiss, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benwell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillespie, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerpiniere, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Revell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dourish, C. T.</span><span> </span><span class="NLM_article-title">Discovery of nonxanthine adenosine A<sub>2A</sub> receptor antagonists for the treatment of Parkinsonâs disease</span> <span class="citation_source-journal">Neurology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">S101</span><span class="NLM_x">â</span> <span class="NLM_lpage">S106</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2003&pages=S101-S106&author=S.+M.+Weissauthor=K.+Benwellauthor=I.+A.+Cliffeauthor=R.+J.+Gillespieauthor=A.+R.+Knightauthor=J.+Lerpiniereauthor=A.+Misraauthor=R.+M.+Prattauthor=D.+Revellauthor=R.+Uptonauthor=C.+T.+Dourish&title=Discovery+of+nonxanthine+adenosine+A2A+receptor+antagonists+for+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeiss%26aufirst%3DS.%2BM.%26aulast%3DBenwell%26aufirst%3DK.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26aulast%3DKnight%26aufirst%3DA.%2BR.%26aulast%3DLerpiniere%26aufirst%3DJ.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DPratt%26aufirst%3DR.%2BM.%26aulast%3DRevell%26aufirst%3DD.%26aulast%3DUpton%26aufirst%3DR.%26aulast%3DDourish%26aufirst%3DC.%2BT.%26atitle%3DDiscovery%2520of%2520nonxanthine%2520adenosine%2520A2A%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DNeurology%26date%3D2003%26volume%3D61%26spage%3DS101%26epage%3DS106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group">Yang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soohoo, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soelaiman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabiocki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chu, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diamond, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shryock, J. C.</span><span> </span><span class="NLM_article-title">Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Naunyn-Schmiedebergâs Arch. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">375</span><span class="NLM_x">, </span> <span class="NLM_fpage">133</span><span class="NLM_x">â</span> <span class="NLM_lpage">144</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1007%2Fs00210-007-0135-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=17310264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2sXivVamurk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=375&publication_year=2007&pages=133-144&author=M.+Yangauthor=D.+Soohooauthor=S.+Soelaimanauthor=R.+Kallaauthor=J.+Zabiockiauthor=N.+Chuauthor=K.+Leungauthor=L.+Yaoauthor=I.+Diamondauthor=L.+Belardinelliauthor=J.+C.+Shryock&title=Characterization+of+the+potency%2C+selectivity%2C+and+pharmacokinetic+profile+for+six+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists</span></div><div class="casAuthors">Yang, Ming; Soohoo, Daniel; Soelaiman, Sandriyana; Kalla, Rao; Zablocki, Jeff; Chu, Nancy; Leung, Kwan; Yao, Lina; Diamond, Ivan; Belardinelli, Luiz; Shryock, John C.</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">375</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">133-144</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Antagonists of adenosine A2A receptors (A2A-antagonists) with different chem. structures have been developed by several pharmaceutical companies for the potential treatment of Parkinson's disease.  Pharmacol. characterization of these antagonists was incomplete, and different assay conditions were used in different labs.  Therefore, we characterized the potencies, selectivities, and pharmacokinetic profiles of six prototypical A2A-antagonists.  Displacements of [3H]MSX-2 and of [3H]CGS21680 binding to the human cloned and rat A2A receptors were performed.  The rank order of potency of antagonists to displace [3H]MSX-2 binding to the human A2A was SCH58261 â¥ Biogen-34 â¥ Ver-6623 â¥ MSX-2 > KW-6002 > > DMPX.  For the rat striatal A2A, the order of potency was Biogen-34 â¥ SCH58261 â¥ Ver-6623 â¥ MSX-2 â¥ KW-6002 > > DMPX.  SCH58261 was the most potent antagonist of the human A2A with a K i value of 4 nM, whereas Biogen-34 was the most potent antagonist of the rat A2A with a K i value of 1.2 nM.  Similar results were obtained from cAMP assays.  Selectivities of A2A-antagonists were detd. using radioligands [3H]DPCPX, [3H]ZM241385, and [125I]-AB-MECA for A1, A2B, and A3 receptors, resp.  KW-6002 and Biogen-34 exhibited the highest selectivity for A2A vs A1 (human and rat), resp.  The pharmacokinetic profiles of antagonists were evaluated in vivo in rats.  DMPX and KW-6002 had the greatest oral bioavailability.  In contrast, SCH58261, MSX-2, and Ver-6623 had low or poor oral bioavailability.  In summary, SCH58261, Biogen-34, MSX-2, and Ver-6623 had high affinities for both human and rat A2A receptors, with reasonable selectivity for A2A over A1 and A2B receptors.  They are suitable as A2A-antagonists for in vitro pharmacol. studies.  Among the six A2A-antagonists, KW-6002 is the best for use in in vivo animal studies, particularly for a CNS target, based on its bioavailability, half life, and brain penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAzTTwucKRCrVg90H21EOLACvtfcHk0ljRqdhGMvbpDw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXivVamurk%253D&md5=0d31392603956cc9e016123edd88d5ea</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1007%2Fs00210-007-0135-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00210-007-0135-0%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DM.%26aulast%3DSoohoo%26aufirst%3DD.%26aulast%3DSoelaiman%26aufirst%3DS.%26aulast%3DKalla%26aufirst%3DR.%26aulast%3DZabiocki%26aufirst%3DJ.%26aulast%3DChu%26aufirst%3DN.%26aulast%3DLeung%26aufirst%3DK.%26aulast%3DYao%26aufirst%3DL.%26aulast%3DDiamond%26aufirst%3DI.%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DShryock%26aufirst%3DJ.%2BC.%26atitle%3DCharacterization%2520of%2520the%2520potency%252C%2520selectivity%252C%2520and%2520pharmacokinetic%2520profile%2520for%2520six%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DNaunyn-Schmiedeberg%25E2%2580%2599s%2520Arch.%2520Pharmacol.%26date%3D2007%26volume%3D375%26spage%3D133%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group">Gillespie, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cliffe, I. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawson, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dourish, C. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerpiniere, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pratt, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roffey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. S.</span><span> </span><span class="NLM_article-title">Antagonists of the human adenosine A<sub>2A</sub> receptor. Part 3: Design and synthesis of pyrazolo[3,4-<i>d</i>]pyrimidines, pyrrolo[2,3-<i>d</i>]pyrdimidines and 6-arylpurines</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2924</span><span class="NLM_x">â</span> <span class="NLM_lpage">2929</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=2924-2929&author=R.+J.+Gillespieauthor=I.+A.+Cliffeauthor=C.+E.+Dawsonauthor=C.+T.+Dourishauthor=S.+Gaurauthor=A.+M.+Jordanauthor=A.+R.+Knightauthor=J.+Lerpiniereauthor=A.+Misraauthor=R.+M.+Prattauthor=J.+Roffeyauthor=G.+C.+Strattonauthor=R.+Uptonauthor=S.+M.+Weissauthor=D.+S.+Williamson&title=Antagonists+of+the+human+adenosine+A2A+receptor.+Part+3%3A+Design+and+synthesis+of+pyrazolo%5B3%2C4-d%5Dpyrimidines%2C+pyrrolo%5B2%2C3-d%5Dpyrdimidines+and+6-arylpurines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26aulast%3DCliffe%26aufirst%3DI.%2BA.%26aulast%3DDawson%26aufirst%3DC.%2BE.%26aulast%3DDourish%26aufirst%3DC.%2BT.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DKnight%26aufirst%3DA.%2BR.%26aulast%3DLerpiniere%26aufirst%3DJ.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DPratt%26aufirst%3DR.%2BM.%26aulast%3DRoffey%26aufirst%3DJ.%26aulast%3DStratton%26aufirst%3DG.%2BC.%26aulast%3DUpton%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DS.%2BM.%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26atitle%3DAntagonists%2520of%2520the%2520human%2520adenosine%2520A2A%2520receptor.%2520Part%25203%253A%2520Design%2520and%2520synthesis%2520of%2520pyrazolo%255B3%252C4-d%255Dpyrimidines%252C%2520pyrrolo%255B2%252C3-d%255Dpyrdimidines%2520and%25206-arylpurines%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D2924%26epage%3D2929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group">Gillespie, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Botting, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Comer, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knight, A. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerpiniere, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lightowler, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAteer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merrett, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misra, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padfield, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reece, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selwood, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surry, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruston, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Upton, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiss, S. M.</span><span> </span><span class="NLM_article-title">Antagonist of the human A<sub>2A</sub> adenosine receptor. 4. Design, synthesis, and preclinical evaluations of 7-aryltriazolo[4,5-<i>d</i>]pyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">33</span><span class="NLM_x">â</span> <span class="NLM_lpage">47</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800961g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=33-47&author=R.+J.+Gillespieauthor=S.+J.+Bamfordauthor=R.+Bottingauthor=M.+Comerauthor=S.+Dennyauthor=S.+Gaurauthor=M.+Griffinauthor=A.+M.+Jordanauthor=A.+R.+Knightauthor=J.+Lerpiniereauthor=S.+Leonardiauthor=S.+Lightowlerauthor=S.+McAteerauthor=A.+Merrettauthor=A.+Misraauthor=A.+Padfieldauthor=M.+Reeceauthor=M.+Saadiauthor=D.+L.+Selwoodauthor=G.+C.+Strattonauthor=D.+Surryauthor=R.+Toddauthor=X.+Tongauthor=V.+Rustonauthor=R.+Uptonauthor=S.+M.+Weiss&title=Antagonist+of+the+human+A2A+adenosine+receptor.+4.+Design%2C+synthesis%2C+and+preclinical+evaluations+of+7-aryltriazolo%5B4%2C5-d%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1021%2Fjm800961g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800961g%26sid%3Dliteratum%253Aachs%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26aulast%3DBamford%26aufirst%3DS.%2BJ.%26aulast%3DBotting%26aufirst%3DR.%26aulast%3DComer%26aufirst%3DM.%26aulast%3DDenny%26aufirst%3DS.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DGriffin%26aufirst%3DM.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DKnight%26aufirst%3DA.%2BR.%26aulast%3DLerpiniere%26aufirst%3DJ.%26aulast%3DLeonardi%26aufirst%3DS.%26aulast%3DLightowler%26aufirst%3DS.%26aulast%3DMcAteer%26aufirst%3DS.%26aulast%3DMerrett%26aufirst%3DA.%26aulast%3DMisra%26aufirst%3DA.%26aulast%3DPadfield%26aufirst%3DA.%26aulast%3DReece%26aufirst%3DM.%26aulast%3DSaadi%26aufirst%3DM.%26aulast%3DSelwood%26aufirst%3DD.%2BL.%26aulast%3DStratton%26aufirst%3DG.%2BC.%26aulast%3DSurry%26aufirst%3DD.%26aulast%3DTodd%26aufirst%3DR.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DRuston%26aufirst%3DV.%26aulast%3DUpton%26aufirst%3DR.%26aulast%3DWeiss%26aufirst%3DS.%2BM.%26atitle%3DAntagonist%2520of%2520the%2520human%2520A2A%2520adenosine%2520receptor.%25204.%2520Design%252C%2520synthesis%252C%2520and%2520preclinical%2520evaluations%2520of%25207-aryltriazolo%255B4%252C5-d%255Dpyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D33%26epage%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span>Vernalis: Vernalis Announces A<sub>2A</sub> Receptor Antagonist Programme for Parkinsonâs Disease Continues with Next Generation Compound. Press Release, July 16,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vernalis%3A+Vernalis+Announces+A2A+Receptor+Antagonist+Programme+for+Parkinson%E2%80%99s+Disease+Continues+with+Next+Generation+Compound.+Press+Release%2C+July+16%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span>Vernalis: Positive Results Achieved in Vernalisâ Receptor Occupancy Study of V81444 for Parkinsonâs Disease and Other CNS Indications. Press Release, December 12,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Vernalis%3A+Positive+Results+Achieved+in+Vernalis%E2%80%99+Receptor+Occupancy+Study+of+V81444+for+Parkinson%E2%80%99s+Disease+and+Other+CNS+Indications.+Press+Release%2C+December+12%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group">Gillespie, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lerpiniere, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansell, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, G. C.</span><span> </span><span class="NLM_article-title">Antagonists of the human A<sub>2A</sub> receptor. Part 5: Highly bio-available pyrimidine-4-carboxamides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2664</span><span class="NLM_x">â</span> <span class="NLM_lpage">2667</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2664-2667&author=R.+J.+Gillespieauthor=S.+J.+Bamfordauthor=S.+Gaurauthor=A.+M.+Jordanauthor=J.+Lerpiniereauthor=H.+L.+Mansellauthor=G.+C.+Stratton&title=Antagonists+of+the+human+A2A+receptor.+Part+5%3A+Highly+bio-available+pyrimidine-4-carboxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26aulast%3DBamford%26aufirst%3DS.%2BJ.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DLerpiniere%26aufirst%3DJ.%26aulast%3DMansell%26aufirst%3DH.%2BL.%26aulast%3DStratton%26aufirst%3DG.%2BC.%26atitle%3DAntagonists%2520of%2520the%2520human%2520A2A%2520receptor.%2520Part%25205%253A%2520Highly%2520bio-available%2520pyrimidine-4-carboxamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D2664%26epage%3D2667" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group">Gillespie, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamford, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gaur, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haymes, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jordan, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klenke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonardi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mansell, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmonite, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratton, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williamson, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yule, I. A.</span><span> </span><span class="NLM_article-title">Antagonists of the human A<sub>2A</sub> receptor. Part 6: Further optimization of pyridmidine-4-carboxamides</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">6590</span><span class="NLM_x">â</span> <span class="NLM_lpage">6605</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=6590-6605&author=R.+J.+Gillespieauthor=S.+J.+Bamfordauthor=A.+Clayauthor=S.+Gaurauthor=T.+Haymesauthor=P.+S.+Jacksonauthor=A.+M.+Jordanauthor=B.+Klenkeauthor=S.+Leonardiauthor=J.+Liuauthor=H.+L.+Mansellauthor=S.+Ngauthor=M.+Saadiauthor=H.+Simmoniteauthor=G.+C.+Strattonauthor=R.+S.+Toddauthor=D.+S.+Williamsonauthor=I.+A.+Yule&title=Antagonists+of+the+human+A2A+receptor.+Part+6%3A+Further+optimization+of+pyridmidine-4-carboxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGillespie%26aufirst%3DR.%2BJ.%26aulast%3DBamford%26aufirst%3DS.%2BJ.%26aulast%3DClay%26aufirst%3DA.%26aulast%3DGaur%26aufirst%3DS.%26aulast%3DHaymes%26aufirst%3DT.%26aulast%3DJackson%26aufirst%3DP.%2BS.%26aulast%3DJordan%26aufirst%3DA.%2BM.%26aulast%3DKlenke%26aufirst%3DB.%26aulast%3DLeonardi%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMansell%26aufirst%3DH.%2BL.%26aulast%3DNg%26aufirst%3DS.%26aulast%3DSaadi%26aufirst%3DM.%26aulast%3DSimmonite%26aufirst%3DH.%26aulast%3DStratton%26aufirst%3DG.%2BC.%26aulast%3DTodd%26aufirst%3DR.%2BS.%26aulast%3DWilliamson%26aufirst%3DD.%2BS.%26aulast%3DYule%26aufirst%3DI.%2BA.%26atitle%3DAntagonists%2520of%2520the%2520human%2520A2A%2520receptor.%2520Part%25206%253A%2520Further%2520optimization%2520of%2520pyridmidine-4-carboxamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D17%26spage%3D6590%26epage%3D6605" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Errey, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurrell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhukov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, M.</span><span> </span><span class="NLM_article-title">Identification of novel adenosine A<sub>2A</sub> receptor antagonists by virtual screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1904</span><span class="NLM_x">â</span> <span class="NLM_lpage">1909</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201455y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC38XpsVOqug%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1904-1909&author=C.+J.+Langmeadauthor=S.+P.+Andrewsauthor=M.+Congreveauthor=J.+C.+Erreyauthor=E.+Hurrellauthor=F.+H.+Marshallauthor=J.+S.+Masonauthor=C.+M.+Richardsonauthor=N.+Robertsonauthor=A.+Zhukovauthor=M.+Weir&title=Identification+of+novel+adenosine+A2A+receptor+antagonists+by+virtual+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Novel Adenosine A2A Receptor Antagonists by Virtual Screening</span></div><div class="casAuthors">Langmead, Christopher J.; Andrews, Stephen P.; Congreve, Miles; Errey, James C.; Hurrell, Edward; Marshall, Fiona H.; Mason, Jonathan S.; Richardson, Christine M.; Robertson, Nathan; Zhukov, Andrei; Weir, Malcolm</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1904-1909</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Virtual screening was performed against exptl. enabled homol. models of the adenosine A2A receptor, identifying a diverse range of ligand efficient antagonists (hit rate 9%).  By use of ligand docking and Biophys. Mapping (BPM), hits 1 and 5 were optimized to potent and selective lead mols. (11-13 from 5, pKI = 7.5-8.5, 13- to >100-fold selective vs. adenosine A1; 14-16 from 1, pKI = 7.9-9.0, 19- to 59-fold selective).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroN2ZrmhhzurVg90H21EOLACvtfcHk0lj7MsAuMP9p4Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpsVOqug%253D%253D&md5=89f18c8a19339aeb6d082bbb8bb0c830</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1021%2Fjm201455y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201455y%26sid%3Dliteratum%253Aachs%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DErrey%26aufirst%3DJ.%2BC.%26aulast%3DHurrell%26aufirst%3DE.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DRichardson%26aufirst%3DC.%2BM.%26aulast%3DRobertson%26aufirst%3DN.%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DWeir%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520novel%2520adenosine%2520A2A%2520receptor%2520antagonists%2520by%2520virtual%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1904%26epage%3D1909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group">Congreve, M. S.; Andrews, S. P.; Mason, J. S.; Richardson, C. M.; Brown, G. A.</span><span> </span><span class="NLM_article-title">1,2,4-Triazine-4-amine Derivatives</span>. PCT Int. Appl. WO2011095625 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=M.+S.+Congreve&author=S.+P.+Andrews&author=J.+S.+Mason&author=C.+M.+Richardson&author=G.+A.+Brown&title=1%2C2%2C4-Triazine-4-amine+Derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%2BS.%26atitle%3D1%252C2%252C4-Triazine-4-amine%2520Derivatives%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group">Congreve, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dore, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollenstein, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurrell, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Langmead, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tehan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhukov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weir, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, F. H.</span><span> </span><span class="NLM_article-title">Discovery of 1,2,4-triazine derivatives as adenosine A<sub>2A</sub> antagonists using structure based drug design</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1898</span><span class="NLM_x">â</span> <span class="NLM_lpage">1903</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201376w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVGqsw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1898-1903&author=M.+Congreveauthor=S.+P.+Andrewsauthor=A.+S.+Doreauthor=K.+Hollensteinauthor=E.+Hurrellauthor=C.+J.+Langmeadauthor=J.+S.+Masonauthor=I.+W.+Ngauthor=B.+Tehanauthor=A.+Zhukovauthor=M.+Weirauthor=F.+H.+Marshall&title=Discovery+of+1%2C2%2C4-triazine+derivatives+as+adenosine+A2A+antagonists+using+structure+based+drug+design"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 1,2,4-Triazine Derivatives as Adenosine A2A Antagonists using Structure Based Drug Design</span></div><div class="casAuthors">Congreve, Miles; Andrews, Stephen P.; Dore, Andrew S.; Hollenstein, Kaspar; Hurrell, Edward; Langmead, Christopher J.; Mason, Jonathan S.; Ng, Irene W.; Tehan, Benjamin; Zhukov, Andrei; Weir, Malcolm; Marshall, Fiona H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1898-1903</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Potent, ligand efficient, selective, and orally efficacious 1,2,4-triazine derivs. have been identified using structure based drug design approaches as antagonists of the adenosine A2A receptor.  The X-ray crystal structures of compds. 4e and 4g (I) bound to the GPCR illustrate that the mols. bind deeply inside the orthosteric binding cavity.  In vivo pharmacokinetic and efficacy data for compd. 4k are presented, demonstrating the potential of this series of compds. for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpddydZvtRPv7Vg90H21EOLACvtfcHk0liqWBwoAVpc2Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVGqsw%253D%253D&md5=71d76db8a22bf82f11d3632d2917e155</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1021%2Fjm201376w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201376w%26sid%3Dliteratum%253Aachs%26aulast%3DCongreve%26aufirst%3DM.%26aulast%3DAndrews%26aufirst%3DS.%2BP.%26aulast%3DDore%26aufirst%3DA.%2BS.%26aulast%3DHollenstein%26aufirst%3DK.%26aulast%3DHurrell%26aufirst%3DE.%26aulast%3DLangmead%26aufirst%3DC.%2BJ.%26aulast%3DMason%26aufirst%3DJ.%2BS.%26aulast%3DNg%26aufirst%3DI.%2BW.%26aulast%3DTehan%26aufirst%3DB.%26aulast%3DZhukov%26aufirst%3DA.%26aulast%3DWeir%26aufirst%3DM.%26aulast%3DMarshall%26aufirst%3DF.%2BH.%26atitle%3DDiscovery%2520of%25201%252C2%252C4-triazine%2520derivatives%2520as%2520adenosine%2520A2A%2520antagonists%2520using%2520structure%2520based%2520drug%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1898%26epage%3D1903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span>DT-1133 was listed on the Domain Therapeutics Web site <a href="http://www.domaintherapeutics.com/" class="extLink">http://www.domaintherapeutics.com/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=DT-1133+was+listed+on+the+Domain+Therapeutics+Web+site+http%3A%2F%2Fwww.domaintherapeutics.com%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group">Mayer, S.; Schann, S.</span><span> </span><span class="NLM_article-title">New Adenosine Receptor Ligands and Uses Thereof</span>. PCT Int. Appl. WO2010084425 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=S.+Mayer&author=S.+Schann&title=New+Adenosine+Receptor+Ligands+and+Uses+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMayer%26aufirst%3DS.%26atitle%3DNew%2520Adenosine%2520Receptor%2520Ligands%2520and%2520Uses%2520Thereof%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span>Kyowa Kirin: News Releases. <a href="http://www.kyowa-kirin.com/news_releases/2013/e20130325_04.html" class="extLink">http://www.kyowa-kirin.com/news_releases/2013/e20130325_04.html</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Kyowa+Kirin%3A+News+Releases.+http%3A%2F%2Fwww.kyowa-kirin.com%2Fnews_releases%2F2013%2Fe20130325_04.html."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group">Saku, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurosawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takizawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uesaka, N.</span><span> </span><span class="NLM_article-title">Synthetic studies on selective adenosine A<sub>2A</sub> receptor antagonists: synthesis and structureâactivity relationships of novel benzofuran derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1090</span><span class="NLM_x">â</span> <span class="NLM_lpage">1093</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=1090-1093&author=O.+Sakuauthor=M.+Sakiauthor=M.+Kurosawaauthor=K.+Ikedaauthor=T.+Takizawaauthor=N.+Uesaka&title=Synthetic+studies+on+selective+adenosine+A2A+receptor+antagonists%3A+synthesis+and+structure%E2%80%93activity+relationships+of+novel+benzofuran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaku%26aufirst%3DO.%26aulast%3DSaki%26aufirst%3DM.%26aulast%3DKurosawa%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DTakizawa%26aufirst%3DT.%26aulast%3DUesaka%26aufirst%3DN.%26atitle%3DSynthetic%2520studies%2520on%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%253A%2520synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520novel%2520benzofuran%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D1090%26epage%3D1093" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group">Saku, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurokawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ikeda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uchida, S.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takizawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uesaka, N.</span><span> </span><span class="NLM_article-title">Synthetic studies on selective adenosine A<sub>2A</sub> receptor antagonists. Part II: Synthesis and structureâactivity relationships of novel benzofuran derivatives</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">3768</span><span class="NLM_x">â</span> <span class="NLM_lpage">3771</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=3768-3771&author=O.+Sakuauthor=M.+Sakiauthor=M.+Kurokawaauthor=K.+Ikedaauthor=S.-L.+Uchidaauthor=T.+Takizawaauthor=N.+Uesaka&title=Synthetic+studies+on+selective+adenosine+A2A+receptor+antagonists.+Part+II%3A+Synthesis+and+structure%E2%80%93activity+relationships+of+novel+benzofuran+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSaku%26aufirst%3DO.%26aulast%3DSaki%26aufirst%3DM.%26aulast%3DKurokawa%26aufirst%3DM.%26aulast%3DIkeda%26aufirst%3DK.%26aulast%3DUchida%26aufirst%3DS.-L.%26aulast%3DTakizawa%26aufirst%3DT.%26aulast%3DUesaka%26aufirst%3DN.%26atitle%3DSynthetic%2520studies%2520on%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists.%2520Part%2520II%253A%2520Synthesis%2520and%2520structure%25E2%2580%2593activity%2520relationships%2520of%2520novel%2520benzofuran%2520derivatives%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D3768%26epage%3D3771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group">Vu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shields, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phadke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ayyub, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span> </span><span class="NLM_article-title">Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">4835</span><span class="NLM_x">â</span> <span class="NLM_lpage">4838</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4835-4838&author=C.+B.+Vuauthor=P.+Shieldsauthor=B.+Pengauthor=G.+Kumaravelauthor=X.+Jinauthor=D.+Phadkeauthor=J.+Wangauthor=T.+Engberauthor=E.+Ayyubauthor=R.+C.+Petter&title=Triamino+derivatives+of+triazolotriazine+and+triazolopyrimidine+as+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVu%26aufirst%3DC.%2BB.%26aulast%3DShields%26aufirst%3DP.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DJin%26aufirst%3DX.%26aulast%3DPhadke%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DEngber%26aufirst%3DT.%26aulast%3DAyyub%26aufirst%3DE.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26atitle%3DTriamino%2520derivatives%2520of%2520triazolotriazine%2520and%2520triazolopyrimidine%2520as%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4835%26epage%3D4838" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group">Peng, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sha, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Vlijmen, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bohnert, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vu, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ensinger, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalley, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span> </span><span class="NLM_article-title">Novel bicyclic piperazine derivatives of triazolotriazine and triazolopyrimidines as highly potent and selective adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6218</span><span class="NLM_x">â</span> <span class="NLM_lpage">6229</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0494321" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6218-6229&author=H.+Pengauthor=G.+Kumaravelauthor=G.+Yaoauthor=L.+Shaauthor=J.+Wangauthor=V.+Van+Vlijmenauthor=T.+Bohnertauthor=C.+Huangauthor=C.+B.+Vuauthor=C.+L.+Ensingerauthor=H.+Changauthor=T.+M.+Engberauthor=E.+T.+Whalleyauthor=R.+C.+Petter&title=Novel+bicyclic+piperazine+derivatives+of+triazolotriazine+and+triazolopyrimidines+as+highly+potent+and+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1021%2Fjm0494321&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0494321%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DH.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DYao%26aufirst%3DG.%26aulast%3DSha%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DVan%2BVlijmen%26aufirst%3DV.%26aulast%3DBohnert%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DC.%26aulast%3DVu%26aufirst%3DC.%2BB.%26aulast%3DEnsinger%26aufirst%3DC.%2BL.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DEngber%26aufirst%3DT.%2BM.%26aulast%3DWhalley%26aufirst%3DE.%2BT.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26atitle%3DNovel%2520bicyclic%2520piperazine%2520derivatives%2520of%2520triazolotriazine%2520and%2520triazolopyrimidines%2520as%2520highly%2520potent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6218%26epage%3D6229" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group">Yao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haque, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sha, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumaravel, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Engber, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whalley, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conlon, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiesman, W. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petter, R. C.</span><span> </span><span class="NLM_article-title">Synthesis of alkyne derivatives of a novel triazolopyrazine as A<sub>2A</sub> adenosine receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">511</span><span class="NLM_x">â</span> <span class="NLM_lpage">515</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2005&pages=511-515&author=G.+Yaoauthor=S.+Haqueauthor=L.+Shaauthor=G.+Kumaravelauthor=J.+Wangauthor=T.+M.+Engberauthor=E.+T.+Whalleyauthor=P.+R.+Conlonauthor=H.+Changauthor=W.+F.+Kiesmanauthor=R.+C.+Petter&title=Synthesis+of+alkyne+derivatives+of+a+novel+triazolopyrazine+as+A2A+adenosine+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DG.%26aulast%3DHaque%26aufirst%3DS.%26aulast%3DSha%26aufirst%3DL.%26aulast%3DKumaravel%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DEngber%26aufirst%3DT.%2BM.%26aulast%3DWhalley%26aufirst%3DE.%2BT.%26aulast%3DConlon%26aufirst%3DP.%2BR.%26aulast%3DChang%26aufirst%3DH.%26aulast%3DKiesman%26aufirst%3DW.%2BF.%26aulast%3DPetter%26aufirst%3DR.%2BC.%26atitle%3DSynthesis%2520of%2520alkyne%2520derivatives%2520of%2520a%2520novel%2520triazolopyrazine%2520as%2520A2A%2520adenosine%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2005%26volume%3D15%26spage%3D511%26epage%3D515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group">Minetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tinti, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carminati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castorina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cesare, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Serio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gallo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghirardi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piersanti, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartoccini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarzia, G.</span><span> </span><span class="NLM_article-title">2-<i>n</i>-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9<i>H</i>-purin-6-ylamine and analogs as A<sub>2A</sub> adenosine receptor antagonists. Design, synthesis, and pharmacological characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6887</span><span class="NLM_x">â</span> <span class="NLM_lpage">6896</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm058018d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=6887-6896&author=P.+Minettiauthor=M.+O.+Tintiauthor=P.+Carminatiauthor=M.+Castorinaauthor=M.+A.+Di+Cesareauthor=S.+Di+Serioauthor=G.+Galloauthor=O.+Ghirardiauthor=F.+Giorgiauthor=L.+Giorgiauthor=G.+Piersantiauthor=F.+Bartocciniauthor=G.+Tarzia&title=2-n-Butyl-9-methyl-8-%5B1%2C2%2C3%5Dtriazol-2-yl-9H-purin-6-ylamine+and+analogs+as+A2A+adenosine+receptor+antagonists.+Design%2C+synthesis%2C+and+pharmacological+characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1021%2Fjm058018d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm058018d%26sid%3Dliteratum%253Aachs%26aulast%3DMinetti%26aufirst%3DP.%26aulast%3DTinti%26aufirst%3DM.%2BO.%26aulast%3DCarminati%26aufirst%3DP.%26aulast%3DCastorina%26aufirst%3DM.%26aulast%3DDi%2BCesare%26aufirst%3DM.%2BA.%26aulast%3DDi%2BSerio%26aufirst%3DS.%26aulast%3DGallo%26aufirst%3DG.%26aulast%3DGhirardi%26aufirst%3DO.%26aulast%3DGiorgi%26aufirst%3DF.%26aulast%3DGiorgi%26aufirst%3DL.%26aulast%3DPiersanti%26aufirst%3DG.%26aulast%3DBartoccini%26aufirst%3DF.%26aulast%3DTarzia%26aufirst%3DG.%26atitle%3D2-n-Butyl-9-methyl-8-%255B1%252C2%252C3%255Dtriazol-2-yl-9H-purin-6-ylamine%2520and%2520analogs%2520as%2520A2A%2520adenosine%2520receptor%2520antagonists.%2520Design%252C%2520synthesis%252C%2520and%2520pharmacological%2520characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D6887%26epage%3D6896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Stasi, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borisini, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vincenzi, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di Cesare, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Minetti, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghirardi, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carminati, P.</span><span> </span><span class="NLM_article-title">ST 1535: a preferential A<sub>2A</sub> adenosine receptor antagonist</span> <span class="citation_source-journal">Int. J. Neuropsychopharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">575</span><span class="NLM_x">â</span> <span class="NLM_lpage">584</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173a&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1017%2FS1461145705006188" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173a&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=16867213" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173a&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFKku7rJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=575-584&issue=5&author=M.+A.+Stasiauthor=F.+Borisiniauthor=K.+Varaniauthor=F.+Vincenziauthor=M.+A.+Di+Cesareauthor=P.+Minettiauthor=O.+Ghirardiauthor=P.+Carminati&title=ST+1535%3A+a+preferential+A2A+adenosine+receptor+antagonist"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173aR"><div class="casContent"><span class="casTitleNuber">173a</span><div class="casTitle"><span class="NLM_cas:atitle">ST 1535: a preferential A2A adenosine receptor antagonist</span></div><div class="casAuthors">Stasi, Maria Antonietta; Borsini, Franco; Varani, Katia; Vincenzi, Fabrizio; Di Cesare, Maria Assunta; Minetti, Patrizia; Ghirardi, Orlando; Carminati, Paolo</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">575-584</span>CODEN:
                <span class="NLM_cas:coden">IJNUFB</span>;
        ISSN:<span class="NLM_cas:issn">1461-1457</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Antagonism of the A2A adenosine function has proved beneficial in the treatment of Parkinson's disease, in that it increases L-dopa therapeutical effects without concomitant worsening of its side-effects.  In this paper we describe a preferential A2A adenosine antagonist, ST 1535, with long-lasting pharmacodynamic effects.  It competitively antagonizes the effects of the A2A adenosine agonist NECA on cAMP in cells cloned with the human A2A adenosine receptor (IC50=353Â±30 nM), and the effects of the A1 adenosine agonist CHA on cAMP in cells cloned with the human A1 adenosine receptor (IC50=510Â±38 nM).  ST 1535, at oral doses of 5 and 10 mg/kg, antagonizes catalepsy induced by intracerebroventricular administration of the A2A adenosine agonist CGS 21680 (10 Î¼g/5 Î¼l) in mice.  At oral doses ranging between 5 and 20 mg/kg, ST 1535 induces hypermotility and antagonizes haloperidol-induced catalepsy in mice up to 7 h.  Oral ST 1535, at 1.25 and 2.5 mg/kg, potentiates L-dopa effects in reducing haloperidol-induced catalepsy.  ST 1535 represents a potential new compd., with long-lasting activity, for the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpK-eQmf_KyF7Vg90H21EOLACvtfcHk0lgTZq9wVzHL3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFKku7rJ&md5=937d0a67ece946a9b8c6cea4edb2a8ca</span></div><a href="/servlet/linkout?suffix=cit173a&amp;dbid=16384&amp;doi=10.1017%2FS1461145705006188&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS1461145705006188%26sid%3Dliteratum%253Aachs%26aulast%3DStasi%26aufirst%3DM.%2BA.%26aulast%3DBorisini%26aufirst%3DF.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DVincenzi%26aufirst%3DF.%26aulast%3DDi%2BCesare%26aufirst%3DM.%2BA.%26aulast%3DMinetti%26aufirst%3DP.%26aulast%3DGhirardi%26aufirst%3DO.%26aulast%3DCarminati%26aufirst%3DP.%26atitle%3DST%25201535%253A%2520a%2520preferential%2520A2A%2520adenosine%2520receptor%2520antagonist%26jtitle%3DInt.%2520J.%2520Neuropsychopharmacol.%26date%3D2006%26volume%3D9%26issue%3D5%26spage%3D575%26epage%3D584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit173b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramsay Croft, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, p.</span><span> </span><span class="NLM_article-title">The novel adenosine A<sub>2A</sub> antagonist ST1535 potentiates the effects of a threshold dose of L-dopa in unilaterally 6-OHDA-lesioned rats</span> <span class="citation_source-journal">Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1133</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">110</span><span class="NLM_x">â</span> <span class="NLM_lpage">114</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.brainres.2006.10.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=17196564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpvV2msQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1133&publication_year=2007&pages=110-114&issue=1&author=S.+Roseauthor=N.+Ramsay+Croftauthor=p.+Jenner&title=The+novel+adenosine+A2A+antagonist+ST1535+potentiates+the+effects+of+a+threshold+dose+of+L-dopa+in+unilaterally+6-OHDA-lesioned+rats"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173bR"><div class="casContent"><span class="casTitleNuber">173b</span><div class="casTitle"><span class="NLM_cas:atitle">The novel adenosine A2a antagonist ST1535 potentiates the effects of a threshold dose of L-dopa in unilaterally 6-OHDA-lesioned rats</span></div><div class="casAuthors">Rose, Sarah; Ramsay Croft, Neil; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1133</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">110-114</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Adenosine A2a antagonists can modulate dopamine-mediated motor behaviors, however, their ability to induce rotational behavior in 6-hydroxydopamine (6-OHDA)-lesioned rats and to potentiate the effects of L-dopa differs.  We now report on the effects of the novel A2a antagonist ST1535 on rotational responses in this model.  When administered alone, ST1535 (2.5-40 mg/kg po) enhanced exploratory behavior and produced a dose-related increase in ipsilateral rotation in rats with a unilateral 6-OHDA lesion of the nigro-striatal pathway.  Administration of ST1535 (40 mg/kg po) in combination with a high dose of L-dopa (12 mg/kg i.p.) caused marked contraversive rotation but did not alter the rotational response produced by L-dopa alone.  In contrast, when administered in combination with L-dopa (7 mg/kg i.p.) that alone produced a submaximal circling response, ST1535 enhanced the intensity and duration of rotation.  These results suggest that ST1535 is able to alter dopamine-mediated behavior when given alone and to potentiate the effects of submaximal doses of L-dopa.  ST1535 may be useful in the treatment of Parkinson's disease and effective in reducing the use of L-dopa.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMcs-c9bnjzLVg90H21EOLACvtfcHk0lgTZq9wVzHL3w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpvV2msQ%253D%253D&md5=d6ed93e51c36589221e7a42e33c29c4f</span></div><a href="/servlet/linkout?suffix=cit173b&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2006.10.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2006.10.038%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DS.%26aulast%3DRamsay%2BCroft%26aufirst%3DN.%26aulast%3DJenner%26aufirst%3Dp.%26atitle%3DThe%2520novel%2520adenosine%2520A2A%2520antagonist%2520ST1535%2520potentiates%2520the%2520effects%2520of%2520a%2520threshold%2520dose%2520of%2520L-dopa%2520in%2520unilaterally%25206-OHDA-lesioned%2520rats%26jtitle%3DBrain%2520Res.%26date%3D2007%26volume%3D1133%26issue%3D1%26spage%3D110%26epage%3D114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit173c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Rose, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stockwell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carminati, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenner, P.</span><span> </span><span class="NLM_article-title">The novel adenosine A<sub>2A</sub> receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets</span> <span class="citation_source-journal">Eur. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">546</span><span class="NLM_x">, </span> <span class="NLM_fpage">82</span><span class="NLM_x">â</span> <span class="NLM_lpage">87</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173c&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1016%2Fj.ejphar.2006.07.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173c&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=16925991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173c&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD28XpsVWqu7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=546&publication_year=2006&pages=82-87&author=S.+Roseauthor=M.+J.+Jacksonauthor=L.+A.+Smithauthor=K.+Stockwellauthor=L.+Johnsonauthor=P.+Carminatiauthor=P.+Jenner&title=The+novel+adenosine+A2A+receptor+antagonist+ST1535+potentiates+the+effects+of+a+threshold+dose+of+L-DOPA+in+MPTP+treated+common+marmosets"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173cR"><div class="casContent"><span class="casTitleNuber">173c</span><div class="casTitle"><span class="NLM_cas:atitle">The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosets</span></div><div class="casAuthors">Rose, Sarah; Jackson, Michael J.; Smith, Lance A.; Stockwell, Kim; Johnson, Louisa; Carminati, Paolo; Jenner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">546</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">82-87</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Adenosine A2a receptor antagonists may represent a novel non-dopaminergic approach to the treatment of Parkinson's disease.  However, there is little information available on their ability to reverse motor deficits in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine hydrochloride (MPTP)-treated primates.  We have studied the effects of the novel A2a receptor antagonist 2-butyl-9-methyl-8-(2H-1,2,3-triazol 2-yl)-9 H-purin-6-ylamine (ST1535) alone and in combination with L-3,4-dihydroxyphenylalanine (L-DOPA) in MPTP-treated common marmosets.  ST1535 (10, 20 and 40 mg/kg, p.o.) when administered alone to MPTP-treated common marmosets produced a dose related increase in locomotor motor activity and tended to reverse motor disability.  Treatment with a threshold dose of L-DOPA (2.5 mg/kg, p.o.) produced an increase in locomotor activity and again tended to reverse motor disability.  When L-DOPA (2.5 mg/kg, p.o.) was administered in combination with ST1535 (20 mg/kg, p.o.), there was an enhancement in the intensity and duration of the effect of L-DOPA (2.5 mg/kg, p.o.) in reversing motor deficits as shown by both a further increase in locomotor activity and reversal of motor disability.  The combination of L-DOPA (2.5 mg/kg, p.o.) plus ST1535 (20 mg/kg, p.o.) significantly increased "on time" in these animals.  These data substantiate the evidence that adenosine A2a receptor antagonists are able to reverse motor deficits in a highly predictive model of clin. efficacy in Parkinson's disease.  The data suggests that ST1535 will be an effective anti-parkinsonian agent in combination with L-DOPA and allow a redn. in L-DOPA usage in the treatment of Parkinson's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqIOO5uXa6zbVg90H21EOLACvtfcHk0lj43iQMNHt_wg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XpsVWqu7s%253D&md5=fd99e0204761e4c667df8e561a89b084</span></div><a href="/servlet/linkout?suffix=cit173c&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2006.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2006.07.017%26sid%3Dliteratum%253Aachs%26aulast%3DRose%26aufirst%3DS.%26aulast%3DJackson%26aufirst%3DM.%2BJ.%26aulast%3DSmith%26aufirst%3DL.%2BA.%26aulast%3DStockwell%26aufirst%3DK.%26aulast%3DJohnson%26aufirst%3DL.%26aulast%3DCarminati%26aufirst%3DP.%26aulast%3DJenner%26aufirst%3DP.%26atitle%3DThe%2520novel%2520adenosine%2520A2A%2520receptor%2520antagonist%2520ST1535%2520potentiates%2520the%2520effects%2520of%2520a%2520threshold%2520dose%2520of%2520L-DOPA%2520in%2520MPTP%2520treated%2520common%2520marmosets%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2006%26volume%3D546%26spage%3D82%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group">Cabri, W.; Minetti, P.; Piersanti, G.; Tarsia, G.</span><span> </span><span class="NLM_article-title">Oxidated Derivatives of Triazolypurines Useful as Ligands of the Adenosine A<sub>2A</sub> Receptor and Their Use as Medicaments</span>. PCT Int. Appl. WO2010106145 A1,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=W.+Cabri&author=P.+Minetti&author=G.+Piersanti&author=G.+Tarsia&title=Oxidated+Derivatives+of+Triazolypurines+Useful+as+Ligands+of+the+Adenosine+A2A+Receptor+and+Their+Use+as+Medicaments"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCabri%26aufirst%3DW.%26atitle%3DOxidated%2520Derivatives%2520of%2520Triazolypurines%2520Useful%2520as%2520Ligands%2520of%2520the%2520Adenosine%2520A2A%2520Receptor%2520and%2520Their%2520Use%2520as%2520Medicaments%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group">Akahane, A.; Aoki, S.; Matsushima, Y.; Yonishi, S.</span><span> </span><span class="NLM_article-title">Pyrazine Derivatives and Pharmaceutical Use Thereof</span>. PCT Int. Appl. WO2005040151 A1,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=A.+Akahane&author=S.+Aoki&author=Y.+Matsushima&author=S.+Yonishi&title=Pyrazine+Derivatives+and+Pharmaceutical+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAkahane%26aufirst%3DA.%26atitle%3DPyrazine%2520Derivatives%2520and%2520Pharmaceutical%2520Use%2520Thereof%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group">Mihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noda, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murakami, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyoshi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nishimura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, N.</span><span> </span><span class="NLM_article-title">Brain adenosine A2A receptor occupancy by a novel A<sub>1</sub>/A<sub>2A</sub> receptor antagonist, ASP5854, in rhesus monkeys: relationship to anticataleptic effect</span> <span class="citation_source-journal">J. Nucl. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1183</span><span class="NLM_x">â</span> <span class="NLM_lpage">1188</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2008&pages=1183-1188&author=T.+Miharaauthor=A.+Nodaauthor=H.+Araiauthor=K.+Miharaauthor=A.+Iwashitaauthor=Y.+Murakamiauthor=T.+Matsuyaauthor=S.+Miyoshiauthor=S.+Nishimuraauthor=N.+Matsuoka&title=Brain+adenosine+A2A+receptor+occupancy+by+a+novel+A1%2FA2A+receptor+antagonist%2C+ASP5854%2C+in+rhesus+monkeys%3A+relationship+to+anticataleptic+effect"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMihara%26aufirst%3DT.%26aulast%3DNoda%26aufirst%3DA.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DMihara%26aufirst%3DK.%26aulast%3DIwashita%26aufirst%3DA.%26aulast%3DMurakami%26aufirst%3DY.%26aulast%3DMatsuya%26aufirst%3DT.%26aulast%3DMiyoshi%26aufirst%3DS.%26aulast%3DNishimura%26aufirst%3DS.%26aulast%3DMatsuoka%26aufirst%3DN.%26atitle%3DBrain%2520adenosine%2520A2A%2520receptor%2520occupancy%2520by%2520a%2520novel%2520A1%252FA2A%2520receptor%2520antagonist%252C%2520ASP5854%252C%2520in%2520rhesus%2520monkeys%253A%2520relationship%2520to%2520anticataleptic%2520effect%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2008%26volume%3D49%26spage%3D1183%26epage%3D1188" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group">Mihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuoka, M.</span><span> </span><span class="NLM_article-title">A novel adenosine A<sub>1</sub> and A<sub>2A</sub> receptor antagonist ASP5854 ameliorates motor impairment in MPTP-treated marmosets: comparison with existing anti-Parkinsonâs disease drugs</span> <span class="citation_source-journal">Behav. Brain Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">194</span><span class="NLM_x">, </span> <span class="NLM_fpage">152</span><span class="NLM_x">â</span> <span class="NLM_lpage">161</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=194&publication_year=2008&pages=152-161&author=T.+Miharaauthor=A.+Iwashitaauthor=M.+Matsuoka&title=A+novel+adenosine+A1+and+A2A+receptor+antagonist+ASP5854+ameliorates+motor+impairment+in+MPTP-treated+marmosets%3A+comparison+with+existing+anti-Parkinson%E2%80%99s+disease+drugs"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMihara%26aufirst%3DT.%26aulast%3DIwashita%26aufirst%3DA.%26aulast%3DMatsuoka%26aufirst%3DM.%26atitle%3DA%2520novel%2520adenosine%2520A1%2520and%2520A2A%2520receptor%2520antagonist%2520ASP5854%2520ameliorates%2520motor%2520impairment%2520in%2520MPTP-treated%2520marmosets%253A%2520comparison%2520with%2520existing%2520anti-Parkinson%25E2%2580%2599s%2520disease%2520drugs%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2008%26volume%3D194%26spage%3D152%26epage%3D161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group">Mihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarimizu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mitani, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aoki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Akahane, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iwashita, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuda, N.</span><span> </span><span class="NLM_article-title">Pharmacological characterization of a novel, potent adenosine A<sub>1</sub> and A<sub>2A</sub> receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1<i>H</i>)-one (ASP5854), in models of Parkinsonâs disease and cognition</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">323</span><span class="NLM_x">, </span> <span class="NLM_fpage">708</span><span class="NLM_x">â</span> <span class="NLM_lpage">719</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1124%2Fjpet.107.121962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=17684118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1ynsb%252FF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=323&publication_year=2007&pages=708-719&author=T.+Miharaauthor=K.+Miharaauthor=J.+Yarimizuauthor=Y.+Mitaniauthor=R.+Matsudaauthor=H.+Yamamotoauthor=S.+Aokiauthor=A.+Akahaneauthor=A.+Iwashitaauthor=N.+Matsuda&title=Pharmacological+characterization+of+a+novel%2C+potent+adenosine+A1+and+A2A+receptor+dual+antagonist%2C+5-%5B5-amino-3-%284-fluorophenyl%29pyrazin-2-yl%5D-1-isopropylpyridine-2%281H%29-one+%28ASP5854%29%2C+in+models+of+Parkinson%E2%80%99s+disease+and+cognition"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological characterization of a novel, potent adenosine A1 and A2A receptor dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one (ASP5854), in models of Parkinson's disease and cognition</span></div><div class="casAuthors">Mihara, Takuma; Mihara, Kayoko; Yarimizu, Junko; Mitani, Yasuyuki; Matsuda, Ritsuko; Yamamoto, Hiroko; Aoki, Satoshi; Akahane, Atsushi; Iwashita, Akinori; Matsuoka, Nobuya</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">323</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">708-719</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Central adenosine A2A receptor is a promising target for drugs to treat Parkinson's disease (PD), and the central blockade of adenosine A1 receptor improves cognitive function.  In the present study, we investigated the effect of a novel adenosine A1 and A2A dual antagonist, 5-[5-amino-3-(4-fluorophenyl)pyrazin-2-yl]-1-isopropylpyridine-2(1H)-one(ASP5854),in animal models of PD and cognition.  The binding affinities of ASP5854 for human A1 and A2A receptors were 9.03 and 1.76 nM, resp., with higher specificity and no species differences.  ASP5854 also showed antagonistic action on A1 and A2A agonist-induced increases of intracellular Ca2+ concn.  ASP5854 ameliorated A2A agonist 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine (CGS21680)- and haloperidol-induced catalepsy in mice, with the min. EDs of 0.32 and 0.1 mg/kg, resp., and it also improved haloperidol-induced catalepsy in rats at doses higher than 0.1 mg/kg.  In unilateral 6-hydroxydopamine-lesioned rats, ASP5854 significantly potentiated 7-dihydroxyphenylalanine (L-DOPA)-induced rotational behavior at doses higher than 0.032 mg/kg.  ASP5854 also significantly restored the striatal dopamine content reduced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment in mice at doses higher than 0.1 mg/kg.  Furthermore, in the rat passive avoidance test, ASP5854 significantly reversed the scopolamine-induced memory deficits, whereas the specific adenosine A2A antagonist 8-((E)-2-(3,4-dimethoxyphenyl)ethenyl)-1,3-diethyl-7-methyl-3,7-dihydro-1H-purine-2,6-dione (KW-6002; istradefylline) did not.  Scopolamine- or 5H-dibenzo[a,d]cyclohepten-5,10-imine (dizocilpine maleate) (MK-801)-induced impairment of spontaneous alternation in the mouse Y-maze test was ameliorated by ASP5854, whereas KW-6002 did not exert improvement at therapeutically relevant dosages.  These results demonstrate that the novel, selective, and orally active dual adenosine A1 and A2A receptors antagonist ASP5854 improves motor impairments, is neuroprotective via A2A antagonism, and also enhances cognitive function through A1 antagonism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKhOITDQ8dxrVg90H21EOLACvtfcHk0lj43iQMNHt_wg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1ynsb%252FF&md5=2d9770179a47a228d825a49feab70ef2</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1124%2Fjpet.107.121962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.107.121962%26sid%3Dliteratum%253Aachs%26aulast%3DMihara%26aufirst%3DT.%26aulast%3DMihara%26aufirst%3DK.%26aulast%3DYarimizu%26aufirst%3DJ.%26aulast%3DMitani%26aufirst%3DY.%26aulast%3DMatsuda%26aufirst%3DR.%26aulast%3DYamamoto%26aufirst%3DH.%26aulast%3DAoki%26aufirst%3DS.%26aulast%3DAkahane%26aufirst%3DA.%26aulast%3DIwashita%26aufirst%3DA.%26aulast%3DMatsuda%26aufirst%3DN.%26atitle%3DPharmacological%2520characterization%2520of%2520a%2520novel%252C%2520potent%2520adenosine%2520A1%2520and%2520A2A%2520receptor%2520dual%2520antagonist%252C%25205-%255B5-amino-3-%25284-fluorophenyl%2529pyrazin-2-yl%255D-1-isopropylpyridine-2%25281H%2529-one%2520%2528ASP5854%2529%252C%2520in%2520models%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520and%2520cognition%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D323%26spage%3D708%26epage%3D719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupert, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heintzelman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullington, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Osbourne, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Demarest, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Methylene amine substituted arylindenopyrimidines as potent adenosine A<sub>2A</sub>/A<sub>1</sub> antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2864</span><span class="NLM_x">â</span> <span class="NLM_lpage">2867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2864-2867&author=B.+C.+Shookauthor=S.+Rassnickauthor=D.+Hallauthor=K.+C.+Rupertauthor=G.+R.+Heintzelmanauthor=K.+Hansenauthor=D.+Chakravartyauthor=J.+L.+Bullingtonauthor=R.+H.+Scannevinauthor=B.+Magliaroauthor=L.+Westoverauthor=K.+Carrollauthor=L.+Lampronauthor=R.+Russellauthor=S.+Branumauthor=K.+Wellsauthor=S.+Damonauthor=S.+Youellsauthor=X.+Liauthor=M.+Osbourneauthor=K.+Demarestauthor=Y.+Tangauthor=K.+Rhodesauthor=P.+F.+Jackson&title=Methylene+amine+substituted+arylindenopyrimidines+as+potent+adenosine+A2A%2FA1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHeintzelman%26aufirst%3DG.%2BR.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DBullington%26aufirst%3DJ.%2BL.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DMagliaro%26aufirst%3DB.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DLampron%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBranum%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DK.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DYouells%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DOsbourne%26aufirst%3DM.%26aulast%3DDemarest%26aufirst%3DK.%26aulast%3DTang%26aufirst%3DY.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DMethylene%2520amine%2520substituted%2520arylindenopyrimidines%2520as%2520potent%2520adenosine%2520A2A%252FA1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2864%26epage%3D2867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbay, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alford, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupert, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heintzeman, G. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hansen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bullington, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Optimization of arylindenopyridimidines as potent adenosine A<sub>2A</sub>/A<sub>1</sub> antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">2868</span><span class="NLM_x">â</span> <span class="NLM_lpage">2871</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=2868-2871&author=B.+C.+Shookauthor=S.+Rassnickauthor=D.+Chakravartyauthor=N.+Wallaceauthor=M.+Aultauthor=J.+Crookeauthor=J.+K.+Barbayauthor=A.+Wangauthor=K.+Leonardauthor=M.+T.+Powellauthor=V.+Alfordauthor=D.+Hallauthor=K.+C.+Rupertauthor=G.+R.+Heintzemanauthor=K.+Hansenauthor=J.+L.+Bullingtonauthor=R.+H.+Scannevinauthor=K.+Carrollauthor=L.+Lampronauthor=L.+Westoverauthor=R.+Russellauthor=S.+Branumauthor=K.+Wellsauthor=S.+Damonauthor=S.+Youellsauthor=D.+Beauchampauthor=X.+Liauthor=K.+Rhodesauthor=P.+F.+Jackson&title=Optimization+of+arylindenopyridimidines+as+potent+adenosine+A2A%2FA1+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DWallace%26aufirst%3DN.%26aulast%3DAult%26aufirst%3DM.%26aulast%3DCrooke%26aufirst%3DJ.%26aulast%3DBarbay%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DPowell%26aufirst%3DM.%2BT.%26aulast%3DAlford%26aufirst%3DV.%26aulast%3DHall%26aufirst%3DD.%26aulast%3DRupert%26aufirst%3DK.%2BC.%26aulast%3DHeintzeman%26aufirst%3DG.%2BR.%26aulast%3DHansen%26aufirst%3DK.%26aulast%3DBullington%26aufirst%3DJ.%2BL.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DLampron%26aufirst%3DL.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBranum%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DK.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DYouells%26aufirst%3DS.%26aulast%3DBeauchamp%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DOptimization%2520of%2520arylindenopyridimidines%2520as%2520potent%2520adenosine%2520A2A%252FA1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D2868%26epage%3D2871" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chakravarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbay, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alford, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, H.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Branum, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damon, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Youells, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Design and characterization of optimized adenosine A<sub>2A</sub>/A<sub>1</sub> receptor antagonists for the treatment of Parkinsonâs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">1402</span><span class="NLM_x">â</span> <span class="NLM_lpage">1417</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201640m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1402-1417&author=B.+C.+Shookauthor=S.+Rassnickauthor=N.+Wallaceauthor=J.+Crookeauthor=M.+Aultauthor=D.+Chakravartyauthor=J.+K.+Barbayauthor=A.+Wangauthor=M.+T.+Powellauthor=K.+Leonardauthor=V.+Alfordauthor=R.+H.+Scannevinauthor=K.+Carrollauthor=L.+Lampronauthor=L.+Westoverauthor=H.-K.+Limauthor=R.+Russellauthor=S.+Branumauthor=K.+M.+Wellsauthor=S.+Damonauthor=S.+Youellsauthor=X.+Liauthor=D.+A.+Beauchampauthor=K.+Rhodesauthor=P.+F.+Jackson&title=Design+and+characterization+of+optimized+adenosine+A2A%2FA1+receptor+antagonists+for+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1021%2Fjm201640m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201640m%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DWallace%26aufirst%3DN.%26aulast%3DCrooke%26aufirst%3DJ.%26aulast%3DAult%26aufirst%3DM.%26aulast%3DChakravarty%26aufirst%3DD.%26aulast%3DBarbay%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DPowell%26aufirst%3DM.%2BT.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DAlford%26aufirst%3DV.%26aulast%3DScannevin%26aufirst%3DR.%2BH.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DLampron%26aufirst%3DL.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DLim%26aufirst%3DH.-K.%26aulast%3DRussell%26aufirst%3DR.%26aulast%3DBranum%26aufirst%3DS.%26aulast%3DWells%26aufirst%3DK.%2BM.%26aulast%3DDamon%26aufirst%3DS.%26aulast%3DYouells%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBeauchamp%26aufirst%3DD.%2BA.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DDesign%2520and%2520characterization%2520of%2520optimized%2520adenosine%2520A2A%252FA1%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1402%26epage%3D1417" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group">Shook, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charavarty, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barbay, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leonard, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alford, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beauchamp, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rassnick, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scannevin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wallace, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooke, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ault, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lampron, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westover, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhodes, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jackson, P. F.</span><span> </span><span class="NLM_article-title">Aminomethyl substituted thieno[2,3-<i>d</i>]pyrimidines as adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Med. Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">950</span><span class="NLM_x">â</span> <span class="NLM_lpage">965</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1039%2Fc1md00082a" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2011&pages=950-965&author=B.+C.+Shookauthor=D.+Charavartyauthor=J.+K.+Barbayauthor=A.+Wangauthor=K.+Leonardauthor=V.+Alfordauthor=M.+Powellauthor=D.+A.+Beauchampauthor=S.+Rassnickauthor=R.+Scannevinauthor=K.+Carrollauthor=N.+Wallaceauthor=J.+Crookeauthor=M.+Aultauthor=L.+Lampronauthor=L.+Westoverauthor=K.+Rhodesauthor=P.+F.+Jackson&title=Aminomethyl+substituted+thieno%5B2%2C3-d%5Dpyrimidines+as+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1039%2Fc1md00082a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1md00082a%26sid%3Dliteratum%253Aachs%26aulast%3DShook%26aufirst%3DB.%2BC.%26aulast%3DCharavarty%26aufirst%3DD.%26aulast%3DBarbay%26aufirst%3DJ.%2BK.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DLeonard%26aufirst%3DK.%26aulast%3DAlford%26aufirst%3DV.%26aulast%3DPowell%26aufirst%3DM.%26aulast%3DBeauchamp%26aufirst%3DD.%2BA.%26aulast%3DRassnick%26aufirst%3DS.%26aulast%3DScannevin%26aufirst%3DR.%26aulast%3DCarroll%26aufirst%3DK.%26aulast%3DWallace%26aufirst%3DN.%26aulast%3DCrooke%26aufirst%3DJ.%26aulast%3DAult%26aufirst%3DM.%26aulast%3DLampron%26aufirst%3DL.%26aulast%3DWestover%26aufirst%3DL.%26aulast%3DRhodes%26aufirst%3DK.%26aulast%3DJackson%26aufirst%3DP.%2BF.%26atitle%3DAminomethyl%2520substituted%2520thieno%255B2%252C3-d%255Dpyrimidines%2520as%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DMed.%2520Chem.%2520Commun.%26date%3D2011%26volume%3D2%26spage%3D950%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâBrien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">Identification of novel, water-soluble, 2-amino-<i>N</i>-pyrimidine-4-yl acetamides as A<sub>2A</sub> receptor antagonists with in vivo efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">400</span><span class="NLM_x">â</span> <span class="NLM_lpage">406</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm070623o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=400-406&author=D.+H.+Sleeauthor=X.+Zhangauthor=M.+Moorjaniauthor=E.+Linauthor=M.+C.+Lanierauthor=Y.+Chenauthor=J.+K.+Rueterauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=S.+Malanyauthor=T.+Joswigauthor=M.+Santosauthor=R.+S.+Grossauthor=J.+P.+Williamsauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Wenauthor=Z.+O%E2%80%99Brienauthor=J.+Saunders&title=Identification+of+novel%2C+water-soluble%2C+2-amino-N-pyrimidine-4-yl+acetamides+as+A2A+receptor+antagonists+with+in+vivo+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1021%2Fjm070623o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070623o%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3DIdentification%2520of%2520novel%252C%2520water-soluble%252C%25202-amino-N-pyrimidine-4-yl%2520acetamides%2520as%2520A2A%2520receptor%2520antagonists%2520with%2520in%2520vivo%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D400%26epage%3D406" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group">Slee, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen., Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span> </span><span class="NLM_article-title">2-Amino-<i>N</i>-pyrimidin-4-ylacetamides as A<sub>2A</sub> receptor antagonists: 1. Structureâactivity relationships and optimization of heterocyclic substituents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">1719</span><span class="NLM_x">â</span> <span class="NLM_lpage">1729</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701185v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=1719-1729&author=D.+H.+Sleeauthor=Y.+Chen.author=X.+Zhangauthor=M.+Moorjaniauthor=E.+Linauthor=M.+C.+Lanierauthor=E.+Linauthor=J.+K.+Rueterauthor=J.+P.+Williamsauthor=S.+M.+Pechnerauthor=S.+Markisonauthor=S.+Malanyauthor=M.+Santosauthor=R.+S.+Grossauthor=K.+Jalaliauthor=Y.+Saiauthor=Z.+Zuoauthor=C.+Yangauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Saunders&title=2-Amino-N-pyrimidin-4-ylacetamides+as+A2A+receptor+antagonists%3A+1.+Structure%E2%80%93activity+relationships+and+optimization+of+heterocyclic+substituents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1021%2Fjm701185v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701185v%26sid%3Dliteratum%253Aachs%26aulast%3DSlee%26aufirst%3DD.%2BH.%26aulast%3DChen.%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DPechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DSai%26aufirst%3DY.%26aulast%3DZuo%26aufirst%3DZ.%26aulast%3DYang%26aufirst%3DC.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSaunders%26aufirst%3DJ.%26atitle%3D2-Amino-N-pyrimidin-4-ylacetamides%2520as%2520A2A%2520receptor%2520antagonists%253A%25201.%2520Structure%25E2%2580%2593activity%2520relationships%2520and%2520optimization%2520of%2520heterocyclic%2520substituents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D1719%26epage%3D1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rueter, J. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lecher, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro-Palomino, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prat, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, D. H.</span><span> </span><span class="NLM_article-title">Synthesis of <i>N</i>-pyrimidinyl-2-phenoxyacetamides as adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">1778</span><span class="NLM_x">â</span> <span class="NLM_lpage">1783</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=1778-1783&author=X.+Zhangauthor=J.+K.+Rueterauthor=Y.+Chenauthor=M.+Moorjaniauthor=M.+C.+Lanierauthor=E.+Linauthor=R.+S.+Grossauthor=J.+E.+Tellewauthor=J.+P.+Williamsauthor=S.+M.+Lecherauthor=S.+Markisonauthor=T.+Joswigauthor=S.+Malanyauthor=M.+Santosauthor=J.+C.+Castro-Palominoauthor=M.+I.+Crespoauthor=M.+Pratauthor=S.+Gualauthor=J.-L.+Diazauthor=J.+Saundersauthor=D.+H.+Slee&title=Synthesis+of+N-pyrimidinyl-2-phenoxyacetamides+as+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DRueter%26aufirst%3DJ.%2BK.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DLecher%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DCastro-Palomino%26aufirst%3DJ.%2BC.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DPrat%26aufirst%3DM.%26aulast%3DGual%26aufirst%3DS.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DSlee%26aufirst%3DD.%2BH.%26atitle%3DSynthesis%2520of%2520N-pyrimidinyl-2-phenoxyacetamides%2520as%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D1778%26epage%3D1783" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâBrien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stotz, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, D. H.</span><span> </span><span class="NLM_article-title">Lead optimization of 4-acetylamino-2-(3,5-dimetylpyrazol-1yl)-6-pyridylpyrimidines as A<sub>2A</sub> adenosine receptor antagonists for the treatment of Parkinsonâs disease</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">7099</span><span class="NLM_x">â</span> <span class="NLM_lpage">7110</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800851u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=7099-7110&author=X.+Zhangauthor=J.+E.+Tellewauthor=Z.+Luoauthor=M.+Moorjaniauthor=E.+Linauthor=M.+C.+Lanierauthor=Y.+Chenauthor=J.+P.+Williamsauthor=J.+Saundersauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=T.+Joswigauthor=R.+Petroskiauthor=J.+Pierceyauthor=W.+Kargoauthor=S.+Malanyauthor=M.+Santosauthor=R.+S.+Grossauthor=J.+Wenauthor=K.+Jalaliauthor=Z.+O%E2%80%99Brienauthor=C.+E.+Stotzauthor=M.+I.+Crespoauthor=J.-L.+Diazauthor=D.+H.+Slee&title=Lead+optimization+of+4-acetylamino-2-%283%2C5-dimetylpyrazol-1yl%29-6-pyridylpyrimidines+as+A2A+adenosine+receptor+antagonists+for+the+treatment+of+Parkinson%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1021%2Fjm800851u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800851u%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DWilliams%26aufirst%3DJ.%2BP.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DPiercey%26aufirst%3DJ.%26aulast%3DKargo%26aufirst%3DW.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DStotz%26aufirst%3DC.%2BE.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSlee%26aufirst%3DD.%2BH.%26atitle%3DLead%2520optimization%2520of%25204-acetylamino-2-%25283%252C5-dimetylpyrazol-1yl%2529-6-pyridylpyrimidines%2520as%2520A2A%2520adenosine%2520receptor%2520antagonists%2520for%2520the%2520treatment%2520of%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D7099%26epage%3D7110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group">Lanier, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moorjani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tellew, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willams, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gross, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lechner, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markison, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joswig, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kargo, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piercey, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malany, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petroski, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crespo, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz, J.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâBrien, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jalali, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slee, D. H.</span><span> </span><span class="NLM_article-title"><i>N</i>-[6-Amino-2-(heteroaryl)pyrimidine-4-yl]aceamides as A<sub>2A</sub> receptor antagonists with improved druglike properties and in vivo efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">709</span><span class="NLM_x">â</span> <span class="NLM_lpage">717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800908d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=709-717&author=M.+C.+Lanierauthor=M.+Moorjaniauthor=Z.+Luoauthor=Y.+Chenauthor=E.+Linauthor=J.+E.+Tellewauthor=X.+Zhangauthor=J.+P.+Willamsauthor=R.+S.+Grossauthor=S.+M.+Lechnerauthor=S.+Markisonauthor=T.+Joswigauthor=W.+Kargoauthor=J.+Pierceyauthor=M.+Santosauthor=S.+Malanyauthor=M.+Zhaoauthor=R.+Petroskiauthor=M.+I.+Crespoauthor=J.-L.+Diazauthor=J.+Saundersauthor=J.+Wenauthor=Z.+O%E2%80%99Brienauthor=K.+Jalaliauthor=A.+Madanauthor=D.+H.+Slee&title=N-%5B6-Amino-2-%28heteroaryl%29pyrimidine-4-yl%5Daceamides+as+A2A+receptor+antagonists+with+improved+druglike+properties+and+in+vivo+efficacy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.1021%2Fjm800908d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800908d%26sid%3Dliteratum%253Aachs%26aulast%3DLanier%26aufirst%3DM.%2BC.%26aulast%3DMoorjani%26aufirst%3DM.%26aulast%3DLuo%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DLin%26aufirst%3DE.%26aulast%3DTellew%26aufirst%3DJ.%2BE.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWillams%26aufirst%3DJ.%2BP.%26aulast%3DGross%26aufirst%3DR.%2BS.%26aulast%3DLechner%26aufirst%3DS.%2BM.%26aulast%3DMarkison%26aufirst%3DS.%26aulast%3DJoswig%26aufirst%3DT.%26aulast%3DKargo%26aufirst%3DW.%26aulast%3DPiercey%26aufirst%3DJ.%26aulast%3DSantos%26aufirst%3DM.%26aulast%3DMalany%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DM.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DCrespo%26aufirst%3DM.%2BI.%26aulast%3DDiaz%26aufirst%3DJ.-L.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DWen%26aufirst%3DJ.%26aulast%3DO%25E2%2580%2599Brien%26aufirst%3DZ.%26aulast%3DJalali%26aufirst%3DK.%26aulast%3DMadan%26aufirst%3DA.%26aulast%3DSlee%26aufirst%3DD.%2BH.%26atitle%3DN-%255B6-Amino-2-%2528heteroaryl%2529pyrimidine-4-yl%255Daceamides%2520as%2520A2A%2520receptor%2520antagonists%2520with%2520improved%2520druglike%2520properties%2520and%2520in%2520vivo%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D709%26epage%3D717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span>In June, 2012, on the pipeline Web site, PBF509 was listed as being in phase I development as an adenosine A<sub>2A</sub> antagonist for the potential treatment of Parkinsonâs disease. <a href="http://www.palobiofarma.com" class="extLink">http://www.palobiofarma.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=In+June%2C+2012%2C+on+the+pipeline+Web+site%2C+PBF509+was+listed+as+being+in+phase+I+development+as+an+adenosine+A2A+antagonist+for+the+potential+treatment+of+Parkinson%E2%80%99s+disease.+http%3A%2F%2Fwww.palobiofarma.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group">Camacho Gomez, J. A.; Castro-Palomino Laria, J. C.</span><span> </span><span class="NLM_article-title">4-Aminopyrimidine Derivatives and Their Use as Adenosine A2a Receptor Antagonists</span>. PCT Int. Appl. WO2011121418 A1,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=J.+A.+Camacho+Gomez&author=J.+C.+Castro-Palomino+Laria&title=4-Aminopyrimidine+Derivatives+and+Their+Use+as+Adenosine+A2a+Receptor+Antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCamacho%2BGomez%26aufirst%3DJ.%2BA.%26atitle%3D4-Aminopyrimidine%2520Derivatives%2520and%2520Their%2520Use%2520as%2520Adenosine%2520A2a%2520Receptor%2520Antagonists%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group">Shiohara, H.; Nakamura, T.; Kobayashi, S.</span><span> </span><span class="NLM_article-title">Novel Benzofuran Derivative, Pharmaceutical Composition Comprising the Same, and Use of the Derivative or Composition</span>. PCT Int. Appl. WO2006115134 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=H.+Shiohara&author=T.+Nakamura&author=S.+Kobayashi&title=Novel+Benzofuran+Derivative%2C+Pharmaceutical+Composition+Comprising+the+Same%2C+and+Use+of+the+Derivative+or+Composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShiohara%26aufirst%3DH.%26atitle%3DNovel%2520Benzofuran%2520Derivative%252C%2520Pharmaceutical%2520Composition%2520Comprising%2520the%2520Same%252C%2520and%2520Use%2520of%2520the%2520Derivative%2520or%2520Composition%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group">Shiohara, H.; Nakamura, T.; Mukaiyama, H.; Kobayashi, S.; Jo, K.</span><span> </span><span class="NLM_article-title">Novel Furopyridine Derivative, Pharmaceutical Composition Comprising the Derivative, and Use of the Derivative or Composition</span>. PCT Int. Appl. WO2006137350 A1,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=H.+Shiohara&author=T.+Nakamura&author=H.+Mukaiyama&author=S.+Kobayashi&author=K.+Jo&title=Novel+Furopyridine+Derivative%2C+Pharmaceutical+Composition+Comprising+the+Derivative%2C+and+Use+of+the+Derivative+or+Composition"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DShiohara%26aufirst%3DH.%26atitle%3DNovel%2520Furopyridine%2520Derivative%252C%2520Pharmaceutical%2520Composition%2520Comprising%2520the%2520Derivative%252C%2520and%2520Use%2520of%2520the%2520Derivative%2520or%2520Composition%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group">Mishra, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barodia, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prakash, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, J. B. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luthra, P. M.</span><span> </span><span class="NLM_article-title">Novel 8-(furan-2-yl)-3-substituted thiazolo[5,4-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidine-2(3<i>H</i>)-thio derivatives as potential adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">2491</span><span class="NLM_x">â</span> <span class="NLM_lpage">2500</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2491-2500&author=C.+B.+Mishraauthor=S.+K.+Barodiaauthor=A.+Prakashauthor=J.+B.+S.+Kumarauthor=P.+M.+Luthra&title=Novel+8-%28furan-2-yl%29-3-substituted+thiazolo%5B5%2C4-e%5D%5B1%2C2%2C4%5Dtriazolo%5B1%2C5-c%5Dpyrimidine-2%283H%29-thio+derivatives+as+potential+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMishra%26aufirst%3DC.%2BB.%26aulast%3DBarodia%26aufirst%3DS.%2BK.%26aulast%3DPrakash%26aufirst%3DA.%26aulast%3DKumar%26aufirst%3DJ.%2BB.%2BS.%26aulast%3DLuthra%26aufirst%3DP.%2BM.%26atitle%3DNovel%25208-%2528furan-2-yl%2529-3-substituted%2520thiazolo%255B5%252C4-e%255D%255B1%252C2%252C4%255Dtriazolo%255B1%252C5-c%255Dpyrimidine-2%25283H%2529-thio%2520derivatives%2520as%2520potential%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2491%26epage%3D2500" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group">McGinness, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dong, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brescia, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokosz, L. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mannava, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimble, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hicks, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wines, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quadros, E.</span><span> </span><span class="NLM_article-title">Discovery of 2-aminoimidazopyridine adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">6845</span><span class="NLM_x">â</span> <span class="NLM_lpage">6849</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6845-6849&author=B.+F.+McGinnessauthor=A.+G.+Coleauthor=G.+Dongauthor=M.-R.+Bresciaauthor=Y.+Shaoauthor=I.+Hendersonauthor=L.+L+Rokoszauthor=T.+M.+Staufferauthor=N.+Mannavaauthor=E.+F.+Kimbleauthor=C.+Hicksauthor=N.+Whiteauthor=P.+G.+Winesauthor=E.+Quadros&title=Discovery+of+2-aminoimidazopyridine+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMcGinness%26aufirst%3DB.%2BF.%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DBrescia%26aufirst%3DM.-R.%26aulast%3DShao%26aufirst%3DY.%26aulast%3DHenderson%26aufirst%3DI.%26aulast%3DRokosz%26aufirst%3DL.%2BL%26aulast%3DStauffer%26aufirst%3DT.%2BM.%26aulast%3DMannava%26aufirst%3DN.%26aulast%3DKimble%26aufirst%3DE.%2BF.%26aulast%3DHicks%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DN.%26aulast%3DWines%26aufirst%3DP.%2BG.%26aulast%3DQuadros%26aufirst%3DE.%26atitle%3DDiscovery%2520of%25202-aminoimidazopyridine%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6845%26epage%3D6849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group">Shao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cole, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brescia, M.-R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, L.-Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stauffer, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rokosz, L. L</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGuniiess, B. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henderson, L.</span><span> </span><span class="NLM_article-title">Synthesis and SAR studies of trisubsituted purinones as potent and selective adenosine A<sub>2A</sub> receptor antagonists</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1399</span><span class="NLM_x">â</span> <span class="NLM_lpage">1402</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1399-1402&author=Y.+Shaoauthor=A.+G.+Coleauthor=M.-R.+Bresciaauthor=L.-Y.+Qinauthor=J.+Duoauthor=T.+M.+Staufferauthor=L.+L+Rokoszauthor=B.+F.+McGuniiessauthor=L.+Henderson&title=Synthesis+and+SAR+studies+of+trisubsituted+purinones+as+potent+and+selective+adenosine+A2A+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DY.%26aulast%3DCole%26aufirst%3DA.%2BG.%26aulast%3DBrescia%26aufirst%3DM.-R.%26aulast%3DQin%26aufirst%3DL.-Y.%26aulast%3DDuo%26aufirst%3DJ.%26aulast%3DStauffer%26aufirst%3DT.%2BM.%26aulast%3DRokosz%26aufirst%3DL.%2BL%26aulast%3DMcGuniiess%26aufirst%3DB.%2BF.%26aulast%3DHenderson%26aufirst%3DL.%26atitle%3DSynthesis%2520and%2520SAR%2520studies%2520of%2520trisubsituted%2520purinones%2520as%2520potent%2520and%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1399%26epage%3D1402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span>Thomson Reuters Pharma. <a href="https://www.thomson-pharma.com/portal/page/portal/Reports/DRUG%20TABBED%20REPORT?_dummy&#xA;=y&amp;" class="extLink">https://www.thomson-pharma.com/portal/page/portal/Reports/DRUG%20TABBED%20REPORT?_dummy =y&</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomson+Reuters+Pharma.+https%3A%2F%2Fwww.thomson-pharma.com%2Fportal%2Fpage%2Fportal%2FReports%2FDRUG%2520TABBED%2520REPORT%3F_dummy+%3Dy%26."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196a"><span><span class="NLM_label">(a) </span>Thomson Reuters Pharma. <a href="https://www.thomson-pharma.com/portal/page/portal/Reports/DRUG%20TABBED%20REPORT?_&#xA;dummy=y&amp;" class="extLink">https://www.thomson-pharma.com/portal/page/portal/Reports/DRUG%20TABBED%20REPORT?_ dummy=y&</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Thomson+Reuters+Pharma.+https%3A%2F%2Fwww.thomson-pharma.com%2Fportal%2Fpage%2Fportal%2FReports%2FDRUG%2520TABBED%2520REPORT%3F_+dummy%3Dy%26."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit196b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ivachtchenko, A. V.; Mitkin, O. D.; Kadieva, M. G.; Okun, I. M.</span><span> </span><span class="NLM_article-title">Substituted Phenoxyacetic Acids and Esters and Amides Thereof, Comprising a 2,6-Dioxo-2,3,6,7-tetrahydro-1<i>H</i>-purine-8-yl fragment and constituting A<sub>2A</sub> Adenosine Receptor Antagonists, and the Use Thereof</span>. PCT Int. Appl. WO2013058681 A2,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=A.+V.+Ivachtchenko&author=O.+D.+Mitkin&author=M.+G.+Kadieva&author=I.+M.+Okun&title=Substituted+Phenoxyacetic+Acids+and+Esters+and+Amides+Thereof%2C+Comprising+a+2%2C6-Dioxo-2%2C3%2C6%2C7-tetrahydro-1H-purine-8-yl+fragment+and+constituting+A2A+Adenosine+Receptor+Antagonists%2C+and+the+Use+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit196b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DIvachtchenko%26aufirst%3DA.%2BV.%26atitle%3DSubstituted%2520Phenoxyacetic%2520Acids%2520and%2520Esters%2520and%2520Amides%2520Thereof%252C%2520Comprising%2520a%25202%252C6-Dioxo-2%252C3%252C6%252C7-tetrahydro-1H-purine-8-yl%2520fragment%2520and%2520constituting%2520A2A%2520Adenosine%2520Receptor%2520Antagonists%252C%2520and%2520the%2520Use%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Mishina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naganawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, K.</span><span> </span><span class="NLM_article-title">Evaluation of distribution of adenosine A<sub>2A</sub> receptors in normal human brain measured with [<sup>11</sup>C]-TMSX PET</span> <span class="citation_source-journal">Synapse</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">778</span><span class="NLM_x">â</span> <span class="NLM_lpage">784</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2007&pages=778-784&author=M.+Mishinaauthor=K.+Ishiwataauthor=Y.+Kimuraauthor=M.+Naganawaauthor=K.+Odaauthor=S.+Kobayashiauthor=Y.+Katayamaauthor=K.+Ishii&title=Evaluation+of+distribution+of+adenosine+A2A+receptors+in+normal+human+brain+measured+with+%5B11C%5D-TMSX+PET"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMishina%26aufirst%3DM.%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DNaganawa%26aufirst%3DM.%26aulast%3DOda%26aufirst%3DK.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DKatayama%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DK.%26atitle%3DEvaluation%2520of%2520distribution%2520of%2520adenosine%2520A2A%2520receptors%2520in%2520normal%2520human%2520brain%2520measured%2520with%2520%255B11C%255D-TMSX%2520PET%26jtitle%3DSynapse%26date%3D2007%26volume%3D61%26spage%3D778%26epage%3D784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit197b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Mishina, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiwata, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kimura, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Naganawa, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kitamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashimoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishibashi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kobayashi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katayama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishii, K.</span><span> </span><span class="NLM_article-title">Adenosine A<sub>2A</sub> receptors measured with [<sup>11</sup>C]-TMSX PET in the striata of Parkinsonâs disease patients</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">e17338</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=e17338&issue=2&author=M.+Mishinaauthor=K.+Ishiwataauthor=Y.+Kimuraauthor=M.+Naganawaauthor=S.+Kitamuraauthor=M.+Suzukiauthor=M.+Hashimotoauthor=K.+Ishibashiauthor=K.+Odaauthor=M.+Sakataauthor=M.+Hamamotoauthor=S.+Kobayashiauthor=Y.+Katayamaauthor=K.+Ishii&title=Adenosine+A2A+receptors+measured+with+%5B11C%5D-TMSX+PET+in+the+striata+of+Parkinson%E2%80%99s+disease+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit197b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMishina%26aufirst%3DM.%26aulast%3DIshiwata%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DNaganawa%26aufirst%3DM.%26aulast%3DKitamura%26aufirst%3DS.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DHashimoto%26aufirst%3DM.%26aulast%3DIshibashi%26aufirst%3DK.%26aulast%3DOda%26aufirst%3DK.%26aulast%3DSakata%26aufirst%3DM.%26aulast%3DHamamoto%26aufirst%3DM.%26aulast%3DKobayashi%26aufirst%3DS.%26aulast%3DKatayama%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DK.%26atitle%3DAdenosine%2520A2A%2520receptors%2520measured%2520with%2520%255B11C%255D-TMSX%2520PET%2520in%2520the%2520striata%2520of%2520Parkinson%25E2%2580%2599s%2520disease%2520patients%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26issue%3D2%26spage%3De17338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group">Zocchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span> </span><span class="NLM_article-title">Binding of the radioligand [<sup>3</sup>H]-SCH58261, a new non-xanthine A<sub>2A</sub> adenosine receptor antagonist, to rat striatal membranes</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">117</span><span class="NLM_x">, </span> <span class="NLM_fpage">1381</span><span class="NLM_x">â</span> <span class="NLM_lpage">1386</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1111%2Fj.1476-5381.1996.tb15296.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=8730729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK28XisFensbY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=117&publication_year=1996&pages=1381-1386&author=C.+Zocchiauthor=E.+Onginiauthor=S.+Ferraraauthor=P.+G.+Baraldiauthor=S.+Dionisotti&title=Binding+of+the+radioligand+%5B3H%5D-SCH58261%2C+a+new+non-xanthine+A2A+adenosine+receptor+antagonist%2C+to+rat+striatal+membranes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of the radioligand [3H]-SCH 58261, a new non-xanthine A2A adenosine receptor antagonist, to rat striatal membranes</span></div><div class="casAuthors">Zocchi, Cristina; Ongini, Ennio; Ferrara, Silvia; Baraldi, Pier Giovanni; Dionisotti, Silvio</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">117</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1381-6</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The present study describes the binding to rat striatal A2A adenosine receptors of the new potent and selective antagonist radioligand, [3H]-5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine, [3H]-SCH 58261.  [3H]-SCH 58261 specific binding to rat striatal membranes (>90%) was saturable, reversible and dependent upon protein concn.  Satn. expts. revealed that [3H]-SCH 58261 labeled a single class of recognition sites with high affinity (Kd = 0.70 nM) and limited capacity (apparent Bmax = 971 fmol mg-1 of protein).  The presence of 100 Î¼M GTP in the incubation mixt. did not modify [3H]-SCH 58261 binding parameters.  Competition expts. showed that [3H]-SCH 58261 binding is consistent with the labeling of A2A striatal receptors.  Adenosine receptor agonists competed with the binding of 0.2 nM [3H]-SCH 58261 with the following order of potency: 2-hexynyl-5'-ethylcarboxamidoadenosine (2HE-NECA)>5'-N-ethylcarboxamidoadenosine (NECA)>2-[4-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine (CGS 21680)>2-phenylaminoadenosine (CV 1808)>R-N6-phenylisopropyladenosine (R-PIA)>N6-cyclohexyladenosine (CCPA)>S-N6-phenylisopropyladenosine (S-PIA).  Adenosine antagonists inhibited [3H]-SCH 58261 binding in the following order: 5-amino-9-chloro-2-(furyl)-[1,2,4]-triazolo[1,5-c]quinazoline (CGS 15943)>5-amino-8-(4-fluorobenzyl)-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine (8FB-PTP)=SCH 58261>xanthine amine congener (XAC)=(E,18%-Z,82%)7-methyl-8-(3,4-dimethoxystyryl)-1,3-dipropylxanthine (KF 17837S)>8-cyclopentyl-1,3-dipropylxanthine (DPCPX)â¥8-phenyltheophylline (8-PT).  The Ki values for adenosine antagonists were similar to those labeled with the A2A agonist [3H]-CGS 21680.  Affinities of agonists were generally lower.  The A1-selective agonist, R-PIA, was found to be about 9 fold more potent than its stereoisomer, S-PIA, thus showing the stereoselectivity of [3H]-SCH 58261 binding.  Except for 8-PT, the adenosine agonists and antagonists examd. inhibited [3H]-SCH 58261 binding with Hill coeffs. not significantly different from unity.  The present results indicate that [3H]-SCH 58261 is the first non-xanthine adenosine antagonist radioligand which directly labels A2A striatal receptors.  High receptor affinity, good selectivity and very low non-specific binding make [3H]-SCH 58261 an excellent probe for studying the A2A adenosine receptor subtype in mammalian brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrv6NZsS5vYirVg90H21EOLACvtfcHk0lgnm_6z-j25FQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XisFensbY%253D&md5=4908046838559424aea1aa319bd33167</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.1996.tb15296.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.1996.tb15296.x%26sid%3Dliteratum%253Aachs%26aulast%3DZocchi%26aufirst%3DC.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DFerrara%26aufirst%3DS.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DDionisotti%26aufirst%3DS.%26atitle%3DBinding%2520of%2520the%2520radioligand%2520%255B3H%255D-SCH58261%252C%2520a%2520new%2520non-xanthine%2520A2A%2520adenosine%2520receptor%2520antagonist%252C%2520to%2520rat%2520striatal%2520membranes%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1996%26volume%3D117%26spage%3D1381%26epage%3D1386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group">Belardinelli, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shryok, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruble, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dennis, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, S. P.</span><span> </span><span class="NLM_article-title">Binding of the novel nonxanthine A<sub>2A</sub> adenosine receptor antagonist [<sup>3</sup>H]-SCH58261 to coronary artery membranes</span> <span class="citation_source-journal">Circ. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">1153</span><span class="NLM_x">â</span> <span class="NLM_lpage">1160</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1996&pages=1153-1160&author=L.+Belardinelliauthor=J.+C.+Shryokauthor=J.+Rubleauthor=A.+Monopoliauthor=S.+Dionisottiauthor=E.+Onginiauthor=D.+M.+Dennisauthor=S.+P.+Baker&title=Binding+of+the+novel+nonxanthine+A2A+adenosine+receptor+antagonist+%5B3H%5D-SCH58261+to+coronary+artery+membranes"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBelardinelli%26aufirst%3DL.%26aulast%3DShryok%26aufirst%3DJ.%2BC.%26aulast%3DRuble%26aufirst%3DJ.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DDennis%26aufirst%3DD.%2BM.%26aulast%3DBaker%26aufirst%3DS.%2BP.%26atitle%3DBinding%2520of%2520the%2520novel%2520nonxanthine%2520A2A%2520adenosine%2520receptor%2520antagonist%2520%255B3H%255D-SCH58261%2520to%2520coronary%2520artery%2520membranes%26jtitle%3DCirc.%2520Res.%26date%3D1996%26volume%3D79%26spage%3D1153%26epage%3D1160" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrara, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molta, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zocchi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">Labeling of A<sub>2A</sub> adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [<sup>3</sup>H]-SCH58261</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1209</span><span class="NLM_x">â</span> <span class="NLM_lpage">1214</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200a&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=8819504" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200a&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A280%3ADyaK28vhs1Ojuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=1996&pages=1209-1214&issue=3&author=S.+Dionisottiauthor=S.+Ferraraauthor=C.+Moltaauthor=C.+Zocchiauthor=E.+Ongini&title=Labeling+of+A2A+adenosine+receptors+in+human+platelets+by+use+of+the+new+nonxanthine+antagonist+radioligand+%5B3H%5D-SCH58261"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200aR"><div class="casContent"><span class="casTitleNuber">200a</span><div class="casTitle"><span class="NLM_cas:atitle">Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261</span></div><div class="casAuthors">Dionisotti S; Ferrara S; Molta C; Zocchi C; Ongini E</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacology and experimental therapeutics</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1209-14</span>
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    </div><div class="casAbstract">The present study describes the binding to human platelet A2A adenosine receptors of the new potent and selective antagonist radioligand [3H]5-amino-7-(2-phenylethyl)-2-(2-furyl)-pyrazolo[4,3-e]-1,2,4-triazolo [1,5-c] pyrimidine ([3H]SCH 58261).  Saturation experiments revealed that [3H]SCH 58261 labels a single class of recognition sites with high affinity (Kd = 0.85 nM), limited capacity (apparent Bmax = 85 fmol/mg of protein) and good specific binding (about 60%). [3H]SCH 58261 binding was not modulated by either the divalent cation Mg(+2) or guanine nucleotides.  In competition experiments, a series of both adenosine agonists and antagonists inhibited [3H]SCH 58261 binding to A2A platelet receptors with rank order of potency and affinity similar to those observed in rat striatal membranes with the same radioligand.  This confirms that the platelet A2A receptor is similar to that labeled in the brain striatum.  Binding data were also found to be in good agreement with the results from functional studies such as A2A agonist-induced stimulation of adenylate cyclase or platelet aggregation inhibition.  The present findings indicate that [3H]SCH 58261 is the first radioligand available for the characterization of the A2A receptor subtype in platelets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSaFsw8-qb6flw2ofyr07jXfW6udTcc2eZHHedqq60PW7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28vhs1Ojuw%253D%253D&md5=36316e4a277567d4697c2a86fc93e2d8</span></div><a href="/servlet/linkout?suffix=cit200a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DFerrara%26aufirst%3DS.%26aulast%3DMolta%26aufirst%3DC.%26aulast%3DZocchi%26aufirst%3DC.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3DLabeling%2520of%2520A2A%2520adenosine%2520receptors%2520in%2520human%2520platelets%2520by%2520use%2520of%2520the%2520new%2520nonxanthine%2520antagonist%2520radioligand%2520%255B3H%255D-SCH58261%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D1996%26volume%3D278%26issue%3D3%26spage%3D1209%26epage%3D1214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit200b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]-SCH58261 labeling of functional A<sub>2A</sub> adenosine receptors in human neutrophil membranes</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">123</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1723</span><span class="NLM_x">â</span> <span class="NLM_lpage">1731</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200b&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1038%2Fsj.bjp.0701758" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200b&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9605581" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200b&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1cXislarsbg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=123&publication_year=1998&pages=1723-1731&issue=8&author=K.+Varaniauthor=S.+Gessiauthor=S.+Dionisottiauthor=E.+Onginiauthor=P.+A.+Borea&title=%5B3H%5D-SCH58261+labeling+of+functional+A2A+adenosine+receptors+in+human+neutrophil+membranes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200bR"><div class="casContent"><span class="casTitleNuber">200b</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]-SCH 58261 labeling of functional A2A adenosine receptors in human neutrophil membranes</span></div><div class="casAuthors">Varani, Katia; Gessi, Stefania; Dionisotti, Silvio; Ongini, Ennio; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">123</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1723-1731</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton Press</span>)
        </div><div class="casAbstract">The present study describes the direct labeling of A2A adenosine receptors in human neutrophil membranes with the potent and selective antagonist radioligand, [3H]-SCH 58261.  In addn., both receptor affinity and potency of a no. of adenosine receptor agonists and antagonists were detd. in binding, adenylyl cyclase and superoxide anion prodn. assays.  Satn. expts. revealed a single class of binding sites with Kd and Bmax values of 1.34 nM and 75 fmol mg-1 protein, resp.  Adenosine receptor ligands competed for the binding of 1 nM [3H]-SCH 58261 to human neutrophil membranes, with a rank order of potency consistent with that typically found for interactions with the A2A adenosine receptors.  In the adenylyl cyclase and in the superoxide anion prodn. assays the same compds. exhibited a rank order of potency identical to that obsd. in binding expts.  Thermodn. data indicated that [3H]-SCH 58261 binding to human neutrophils is entropy and enthalpy-driven.  This finding is in agreement with the thermodn. behavior of antagonists binding to rat striatal A2A adenosine receptors.  It was concluded that in human neutrophil membranes, [3H]-SCH 58261 directly labels binding sites with pharmacol. properties similar to those of A2A adenosine receptors of other tissues.  The receptors labeled by [3H]-SCH 58261 mediated the effects of adenosine and adenosine receptor agonists to stimulate cAMP accumulation and inhibition of superoxide anion prodn. in human neutrophils.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqWvXET6hg7irVg90H21EOLACvtfcHk0lgnm_6z-j25FQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXislarsbg%253D&md5=442232e102df7b0dec587c2cbc49600c</span></div><a href="/servlet/linkout?suffix=cit200b&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0701758&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0701758%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3D%255B3H%255D-SCH58261%2520labeling%2520of%2520functional%2520A2A%2520adenosine%2520receptors%2520in%2520human%2520neutrophil%2520membranes%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1998%26volume%3D123%26issue%3D8%26spage%3D1723%26epage%3D1731" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gessi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dalpiaz, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borea, P. A.</span><span> </span><span class="NLM_article-title">Characterization of A<sub>2A</sub> adenosine receptors in human lymphocyte membranes by . [<sup>3</sup>H]-SCH58261 binding</span> <span class="citation_source-journal">Br. J. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">386</span><span class="NLM_x">â</span> <span class="NLM_lpage">392</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1038%2Fsj.bjp.0701378" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9313951" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref201/cit201&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK2sXmtlyqsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1997&pages=386-392&issue=2&author=K.+Varaniauthor=S.+Gessiauthor=A.+Dalpiazauthor=E.+Onginiauthor=P.+A.+Borea&title=Characterization+of+A2A+adenosine+receptors+in+human+lymphocyte+membranes+by+.+%5B3H%5D-SCH58261+binding"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit201R"><div class="casContent"><span class="casTitleNuber">201</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of A2A adenosine receptors in human lymphocyte membranes by [3H]-SCH 58261 binding</span></div><div class="casAuthors">Varani, Katia; Gessi, Stefania; Dalpiaz, Alessandro; Ongini, Ennio; Borea, Pier Andrea</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">386-392</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Stockton</span>)
        </div><div class="casAbstract">The present study describes for the first time the characterization of the adenosine A2A receptor in human lymphocyte membranes with the new potent and selective antagonist radioligand, [3H]-5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine, ([3H]-SCH 58261).  In addn., both receptor affinity and potency of ref. adenosine receptor agonists and antagonists were detd. in binding and adenylyl cyclase studies.  Satn. expts. revealed a single class of binding sites with Kd and Bmax values of 0.85 nM and 35 fmol mg-1 protein, resp.  A series of adenosine receptor ligands were found to compete for the binding of 0.8 nM [3H]-SCH 58261 to human lymphocyte membranes with a rank order of potency consistent with that typically found for interactions with the A2A-adenosine receptor.  In the adenylyl cyclase assay the same compds. exhibited a rank order of potency similar to that obsd. in binding expts.  Thermodn. data indicate that [3H]-SCH 57251 binding to human lymphocytes is entropy and enthalpy-driven, a finding in agreement with the thermodn. behavior of antagonists for rat striatal A2A-adenosine receptors.  It is concluded that in human lymphocyte membranes [3H]-SCH 58261 directly labels binding sites showing the characteristic properties of the adenosine A2A-receptor.  The presence of A2A-receptors in peripheral tissue such as human lymphocytes strongly suggests an important role for adenosine in modulating immune and inflammatory responses.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn-wwjaPvaerVg90H21EOLACvtfcHk0lhe8XALC71Vag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmtlyqsL0%253D&md5=9187e79f45b951159585f617291f5463</span></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0701378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0701378%26sid%3Dliteratum%253Aachs%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DGessi%26aufirst%3DS.%26aulast%3DDalpiaz%26aufirst%3DA.%26aulast%3DOngini%26aufirst%3DE.%26aulast%3DBorea%26aufirst%3DP.%2BA.%26atitle%3DCharacterization%2520of%2520A2A%2520adenosine%2520receptors%2520in%2520human%2520lymphocyte%2520membranes%2520by%2520.%2520%255B3H%255D-SCH58261%2520binding%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D1997%26volume%3D122%26issue%3D2%26spage%3D386%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group">Fredholm, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindstrom, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dionisotti, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ongini, E.</span><span> </span><span class="NLM_article-title">[<sup>3</sup>H]-SCH58261, a selective adenosine A<sub>2A</sub> receptor antagonist, is a useful ligand in autoradiographic studies</span> <span class="citation_source-journal">Neurochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">1210</span><span class="NLM_x">â</span> <span class="NLM_lpage">1216</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Fjm4011669&amp;key=10.1046%2Fj.1471-4159.1998.70031210.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Fjm4011669&amp;key=9489743" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Fjm4011669&amp;key=1%3ACAS%3A528%3ADyaK1cXht1yru74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=1998&pages=1210-1216&issue=3&author=B.+B.+Fredholmauthor=K.+Lindstromauthor=S.+Dionisottiauthor=E.+Ongini&title=%5B3H%5D-SCH58261%2C+a+selective+adenosine+A2A+receptor+antagonist%2C+is+a+useful+ligand+in+autoradiographic+studies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">[3H]SCH 58261, a selective adenosine A2A receptor antagonist, is a useful ligand in autoradiographic studies</span></div><div class="casAuthors">Fredholm, Bertil B.; Lindstrom, Karin; Dionisotti, Silvio; Ongini, Ennio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1210-1216</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Lippincott-Raven Publishers</span>)
        </div><div class="casAbstract">We have characterized the new potent and selective nonxanthine adenosine A2A receptor antagonist SCH 58261 as a new radioligand for receptor autoradiog.  In autoradiog. studies using agonist radioligands for A2A receptors ([3H] CGS 21680) or A1 receptors (N6-[3H]cyclohexyladenosine), it was found that SCH 58261 is close to 800-fold selective for rat brain A2A vs. A1 receptors (Ki values of 1.2 nM vs. 0.8 Î¼M).  Moreover, receptor autoradiog. showed that [3H]SCH 58261, in concns. below 2 nM, binds only to the dopamine-rich regions of the rat brain, with a KD value of 1.4 (0.8-1.8) nM.  The maximal no. of binding sites was 310 fmol/mg of protein in the striatum.  Below concns. of 3 nM, the nonspecific binding was <15%.  Three adenosine analogs displaced all specific binding of [3H]SCH 58261 with the following estd. Ki values (nM): 2-hex-1-ynyl-5'-N-ethylcarboxamidoadenosine, 3.9 (1.8-8.4); CGS 21680, 130 (42-405); N6-cyclohexyladenosine, 9,985 (3,169-31,462).  The binding of low concns. of SCH 58261 was not influenced by either GTP (100 Î¼M) or Mg2+ (10 mM).  The present results show that in its tritium-labeled form, SCH 58261 appears to be a good radioligand for autoradiog. studies, because it does not suffer from some of the problems encountered with the currently used agonist radioligand [3H]CGS 21680.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq_GQSALPBwLVg90H21EOLACvtfcHk0lhe8XALC71Vag"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXht1yru74%253D&md5=f3364bca00ef72a19d29b86596a31046</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.1998.70031210.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.1998.70031210.x%26sid%3Dliteratum%253Aachs%26aulast%3DFredholm%26aufirst%3DB.%2BB.%26aulast%3DLindstrom%26aufirst%3DK.%26aulast%3DDionisotti%26aufirst%3DS.%26aulast%3DOngini%26aufirst%3DE.%26atitle%3D%255B3H%255D-SCH58261%252C%2520a%2520selective%2520adenosine%2520A2A%2520receptor%2520antagonist%252C%2520is%2520a%2520useful%2520ligand%2520in%2520autoradiographic%2520studies%26jtitle%3DNeurochemistry%26date%3D1998%26volume%3D70%26issue%3D3%26spage%3D1210%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group">Todde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moresco, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simonelli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baraldi, P. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacciari, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spalluto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Varani, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monopoli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matarrese, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carpinelli, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magni, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kienle, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazio, F.</span><span> </span><span class="NLM_article-title">Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A<sub>2A</sub> receptor system using positron emmision tomography</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x"> (</span><span class="NLM_issue">23</span><span class="NLM_x">) </span> <span class="NLM_fpage">4359</span><span class="NLM_x">â</span> <span class="NLM_lpage">4362</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0009843" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=4359-4362&issue=23&author=S.+Toddeauthor=R.+M.+Morescoauthor=P.+Simonelliauthor=P.+G.+Baraldiauthor=B.+Cacciariauthor=G.+Spallutoauthor=K.+Varaniauthor=A.+Monopoliauthor=M.+Matarreseauthor=A.+Carpinelliauthor=F.+Magniauthor=M.+G.+Kienleauthor=F.+Fazio&title=Design%2C+radiosynthesis%2C+and+biodistribution+of+a+new+potent+and+selective+ligand+for+in+vivo+imaging+of+the+adenosine+A2A+receptor+system+using+positron+emmision+tomography"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.1021%2Fjm0009843&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0009843%26sid%3Dliteratum%253Aachs%26aulast%3DTodde%26aufirst%3DS.%26aulast%3DMoresco%26aufirst%3DR.%2BM.%26aulast%3DSimonelli%26aufirst%3DP.%26aulast%3DBaraldi%26aufirst%3DP.%2BG.%26aulast%3DCacciari%26aufirst%3DB.%26aulast%3DSpalluto%26aufirst%3DG.%26aulast%3DVarani%26aufirst%3DK.%26aulast%3DMonopoli%26aufirst%3DA.%26aulast%3DMatarrese%26aufirst%3DM.%26aulast%3DCarpinelli%26aufirst%3DA.%26aulast%3DMagni%26aufirst%3DF.%26aulast%3DKienle%26aufirst%3DM.%2BG.%26aulast%3DFazio%26aufirst%3DF.%26atitle%3DDesign%252C%2520radiosynthesis%252C%2520and%2520biodistribution%2520of%2520a%2520new%2520potent%2520and%2520selective%2520ligand%2520for%2520in%2520vivo%2520imaging%2520of%2520the%2520adenosine%2520A2A%2520receptor%2520system%2520using%2520positron%2520emmision%2520tomography%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26issue%3D23%26spage%3D4359%26epage%3D4362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group">Brooks, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papapetropoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vandenhende, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coppell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâNeill, G.</span><span> </span><span class="NLM_article-title">An open-label, positron emission tomography study to assess adenosine A<sub>2A</sub> brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers</span> <span class="citation_source-journal">Clin. Neuropharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">55</span><span class="NLM_x">â</span> <span class="NLM_lpage">60</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2010&pages=55-60&issue=2&author=D.+J.+Brooksauthor=S.+Papapetropoulosauthor=F.+Vandenhendeauthor=D.+Tomicauthor=A.+Coppellauthor=G.+O%E2%80%99Neill&title=An+open-label%2C+positron+emission+tomography+study+to+assess+adenosine+A2A+brain+receptor+occupancy+of+vipadenant+%28BIIB014%29+at+steady-state+levels+in+healthy+male+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DD.%2BJ.%26aulast%3DPapapetropoulos%26aufirst%3DS.%26aulast%3DVandenhende%26aufirst%3DF.%26aulast%3DTomic%26aufirst%3DD.%26aulast%3DCoppell%26aufirst%3DA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DG.%26atitle%3DAn%2520open-label%252C%2520positron%2520emission%2520tomography%2520study%2520to%2520assess%2520adenosine%2520A2A%2520brain%2520receptor%2520occupancy%2520of%2520vipadenant%2520%2528BIIB014%2529%2520at%2520steady-state%2520levels%2520in%2520healthy%2520male%2520volunteers%26jtitle%3DClin.%2520Neuropharmacol.%26date%3D2010%26volume%3D33%26issue%3D2%26spage%3D55%26epage%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4011669&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Barticle%3Aarticle%3A10.1021%2Fjm4011669%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-9" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4011669" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67996ea869003d2a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
